
<html lang="en"     class="pb-page"  data-request-id="89f8f313-e687-434a-82f6-48860bfd5806"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2017.60.issue-22;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.7b00965"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions" /></meta><meta name="dc.Creator" content="Enza  Lacivita" /></meta><meta name="dc.Creator" content="Roberto  Perrone" /></meta><meta name="dc.Creator" content="Lucia  Margari" /></meta><meta name="dc.Creator" content="Marcello  Leopoldo" /></meta><meta name="dc.Description" content="Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication and interaction and restricted, repetitive patterns of behavior, interes..." /></meta><meta name="Description" content="Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication and interaction and restricted, repetitive patterns of behavior, interes..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 30, 2017" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00965" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00965" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00965" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00965" /></link>
        
    
    

<title>Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00965" /></meta><meta property="og:title" content="Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0019.jpeg" /></meta><meta property="og:description" content="Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication and interaction and restricted, repetitive patterns of behavior, interests, and activities. Various factors are involved in the etiopathogenesis of ASD, including genetic factors, environmental toxins and stressors, impaired immune responses, mitochondrial dysfunction, and neuroinflammation. The heterogeneity in the phenotype among ASD patients and the complex etiology of the condition have long impeded the advancement of the development of pharmacological therapies. In the recent years, the integration of findings from mouse models to human genetics resulted in considerable progress toward the understanding of ASD pathophysiology. Currently, strategies to treat core symptoms of ASD are directed to correct synaptic dysfunctions, abnormalities in central oxytocin, vasopressin, and serotonin neurotransmission, and neuroinflammation. Here, we present a survey of the studies that have suggested molecular targets for drug development for ASD and the state-of-the-art of medicinal chemistry efforts in related areas." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00965"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00965">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00965&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00965&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00965&amp;href=/doi/10.1021/acs.jmedchem.7b00965" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 9114-9141</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00487" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.7b00797" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Enza++Lacivita">Enza Lacivita</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-2443-1174" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberto++Perrone">Roberto Perrone</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lucia++Margari">Lucia Margari</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marcello++Leopoldo">Marcello Leopoldo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-8401-2815" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Dipartimento di Farmacia—Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, via Orabona 4, 70125, Bari, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Dipartimento di Scienze Mediche di Base, Neuroscienze e Organi di Senso, Unità di Neuropsichiatria Infantile, Università degli Studi di Bari Aldo Moro, Piazza Giulio Cesare 11, 70124 Bari, Italy</span></div><div class="corresp-info"><strong>*</strong>Phone: +39 080 5442798. Fax: +39 080 5442231. E-mail: <a href="/cdn-cgi/l/email-protection#75181407161019191a5b19101a051a19111a35001b1c17145b1c01"><span class="__cf_email__" data-cfemail="214c405342444d4d4e0f4d444e514e4d454e61544f4843400f4855">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00965&amp;href=/doi/10.1021%2Facs.jmedchem.7b00965" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 9114–9141</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 17, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 June 2017</li><li><span class="item_label"><b>Published</b> online</span>30 October 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 November 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00965" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00965</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9114%26pageCount%3D28%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DEnza%2BLacivita%252C%2BRoberto%2BPerrone%252C%2BLucia%2BMargari%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D22%26contentID%3Dacs.jmedchem.7b00965%26title%3DTargets%2Bfor%2BDrug%2BTherapy%2Bfor%2BAutism%2BSpectrum%2BDisorder%253A%2BChallenges%2Band%2BFuture%2BDirections%26numPages%3D28%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9141%26publicationDate%3DNovember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00965"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3756</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">29</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00965" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Enza&quot;,&quot;last_name&quot;:&quot;Lacivita&quot;},{&quot;first_name&quot;:&quot;Roberto&quot;,&quot;last_name&quot;:&quot;Perrone&quot;},{&quot;first_name&quot;:&quot;Lucia&quot;,&quot;last_name&quot;:&quot;Margari&quot;},{&quot;first_name&quot;:&quot;Marcello&quot;,&quot;last_name&quot;:&quot;Leopoldo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;9114-9141&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00965&quot;},&quot;abstract&quot;:&quot;Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication and interaction and restricted, repetitive patterns of behavior, interests, and activities. Various factors are involved in the etiopathogenesis of ASD, including genetic factors, environmental toxins and stressors, impaired immune responses, mitochondrial dysfunction, and neuroinflammation. The heterogeneity in the phenotype among ASD patients and the complex etiology of the condition have long impeded the advancement of the development of pharmacological therapies. In the recent years, the integration of findings from mouse models to human genetics resulted in considerable progress toward the understanding of ASD pathophysiology. Currently, strategies to treat core symptoms of ASD are directed to correct synaptic dysfunctions, abnormalities in central oxytocin, vasopressin, and serotonin neurotransmission, and neuroinflammation. Here, we present a survey of the studies that have sugge&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00965&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00965" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00965&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00965" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00965&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00965" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00965&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00965&amp;href=/doi/10.1021/acs.jmedchem.7b00965" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00965" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00965" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00965%26sid%3Dliteratum%253Aachs%26pmid%3D29039668%26genre%3Darticle%26aulast%3DLacivita%26date%3D2017%26atitle%3DTargets%2Bfor%2BDrug%2BTherapy%2Bfor%2BAutism%2BSpectrum%2BDisorder%253A%2BChallenges%2Band%2BFuture%2BDirections%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D22%26spage%3D9114%26epage%3D9141%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/jmcmar.2017.60.issue-22/20171122/jmcmar.2017.60.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by persistent deficits in social communication and interaction and restricted, repetitive patterns of behavior, interests, and activities. Various factors are involved in the etiopathogenesis of ASD, including genetic factors, environmental toxins and stressors, impaired immune responses, mitochondrial dysfunction, and neuroinflammation. The heterogeneity in the phenotype among ASD patients and the complex etiology of the condition have long impeded the advancement of the development of pharmacological therapies. In the recent years, the integration of findings from mouse models to human genetics resulted in considerable progress toward the understanding of ASD pathophysiology. Currently, strategies to treat core symptoms of ASD are directed to correct synaptic dysfunctions, abnormalities in central oxytocin, vasopressin, and serotonin neurotransmission, and neuroinflammation. Here, we present a survey of the studies that have suggested molecular targets for drug development for ASD and the state-of-the-art of medicinal chemistry efforts in related areas.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35661" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35661" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder that is typically recognized in early childhood and has a lifelong course. According to the latest diagnostic criteria, it is characterized by two core symptoms: (1) persistent deficits in social communication and social interaction, (2) restricted, repetitive patterns of behavior, interests, and activities.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The diagnosis is based on clinical observation and further established by standardized testing of the patient with the Autism Diagnostic Observation Schedule-2,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and/or by parental interview with the Autism Diagnostic Interview-Revised.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Thus far, no behavioral, neuroimaging, electrophysiological, or genetic tests can specifically diagnose ASD. Comorbid conditions such as intellectual disability, seizures, and sleep problems are frequent, whereas anxiety, depression, and obsessive–compulsive disorder (OCD) are less frequent.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a></div><div class="NLM_p">ASD distinguishes from most other behavioral disorders for the impressive clinical and pathogenetic heterogeneity, which has led to the designation with the term ASD of a set of neurodevelopmental disorders with early onset in life, sharing autism as a common feature, but caused by separate processes.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Originally, ASD was believed to be relatively rare, but the prevalence rates have dramatically increased in the past decade, from approximately 4/10000 to 1/68 children.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Various reasons have been put forward to account for this dramatic increase, including broadening of the spectrum to include even milder forms, improved clinical detection, and higher public awareness.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> As a result, ASD has recently emerged as a major public health issue worldwide.</div><div class="NLM_p">Altered neurodevelopment during the first and second trimesters of prenatal life is believed to be an underlying neuropathological cause of ASD.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Post-mortem studies have unveiled neuroanatomic and cytoarchitectonic aberrations in various brain regions, including cerebellum, hippocampus, inferior olivary complex, amygdala, entorhinal cortex, fusiform gyrus, and anterior and posterior cingulate cortex, with increased growth of the frontal lobes, thinner cortical minicolumns, and increased dendritic spine density.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> These aberrations appear to be related to alterations occurring during early pregnancy, such as reduced programmed cell death and/or increased cell proliferation, altered cell migration, abnormal cell differentiation with reduced neuronal body size, abnormal neurite sprouting, and pruning that cause atypical wiring into the brain. In addition, because neurodevelopmental processes are still active into late prenatal and postnatal life, aberrations involve reduced synapse formation and delayed myelination.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The observed abnormal neuronal wiring was previously thought to be characterized by long-range hypoconnectivity and local hyperconnectivity.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Recent studies have instead shown that abnormal neuronal wiring is characterized by a highly individualized combination of hyper- and hypoconnectivity specific to each ASD patient.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_p last">The neurocognitive phenotype of ASD is the result of a complex and highly heterogeneous set of genetic and environmental causes. However, in some patients, the disorder is the result of purely genetic causes due to known chromosomal aberrations or mutations,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> while in other patients, the disorder is more likely related to environmental causes, such as prenatal exposure to chemical pollutants, toxins, viruses, or even drugs.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> To date, hundreds of risk genes have been identified and not a major causative gene, with either rare variants that are highly penetrant or common variants with small effects.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> It is therefore not surprising that this genetic heterogeneity is not associated with a characteristic neuropathology for ASD. Finally, neuroinflammation in ASD is receiving attention because of the altered expression of neuroinflammatory markers observed in the amniotic fluid, serum, cerebrospinal fluid, and the brain tissue of ASD patients.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 Current Psychotropic Drugs Are Not Effective to Treat Core Symptoms of ASD</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20586" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20586" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The use of pharmacotherapy as a component of treatment for ASD patients is common. However, psychotropic medications alleviate co-occurring psychiatric and behavioral problems, such as aggression, self-injury, impulsivity, hyperactivity, anxiety, and mood symptoms, but they do not have effect on the core symptoms of ASD.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The observed improvements in social interaction is a secondary effect of an overall reduction in maladaptive behaviors and not a primary effect of these medications.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">Benefits have been reported with (i) atypical antipsychotics for aggression, self-injurious behavior, or temper tantrums, (ii) selective serotonin reuptake inhibitors (SSRI) for anxiety and repetitive behaviors, and (iii) psychostimulants or opioid antagonists for hyperactivity.</div><div class="NLM_p">To date, the only approved drugs to treat symptoms in ASD patients are compounds <b>1</b> (risperidone, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) and <b>2</b> (aripiprazole, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), both used to treat aggression, self-injury, and severe tantrums. Compound <b>1</b> is generally well tolerated, with no evidence of extrapyramidal side effects or seizures, whereas mild sedation, increased appetite, fatigue, dizziness, and drowsiness are frequent side effects. In addition, other side effects of this drug are metabolic alterations, including increased anthropometric and metabolic parameters, such as body mass index, waist circumference, and prolactin serum levels.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> Compound <b>2</b> has similar effects but shows milder side effects which involve weight gain, fatigue and somnolence, gastrointestinal symptoms, and motor restlessness. Before the approval of compounds <b>1</b> and <b>2</b>, the second-generation antipsychotic agent clozapine was used for aggression and tantrums but has a limited usage because of the hematological safety concerns. Ziprasidone has also shown some beneficial effects targeting irritability in ASD patients without any significant weight gain or other adverse effect.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Antipsychotis and antidepressant drugs that are currently used in pharmacological treatment of ASD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The SSRI <b>3</b> (fluoxetine, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) has shown various potential benefits, including reductions in rituals, stereotyped and repetitive behaviors in ASD patients. However, compound <b>3</b> produced effects like disinhibition, hypomania, agitation, and hyperactivity. Also, compounds <b>4</b> (escitalopram), <b>5</b> (fluvoxamine), <b>6</b> (paroxetine), and <b>7</b> (sertraline) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) displayed the same potential benefits and adverse effects as <b>3</b>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> A recent review has highlighted the limited evidence of the effectiveness of SSRIs in adults.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Tricyclic antidepressants such as <b>8</b> (imipramine), <b>9</b> (nortryptiline), <b>10</b> (clomipramine), or <b>11</b> (tianeptine) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) have been used in the treatment of ASD symptoms and comorbidities in ASD patients. However, limited and conflicting evidence emerged about either therapeutic effects or side effects of these medications.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">It has been proposed that anticonvulsants may be efficacious in the treatment of irritability and repetitive patterns of behavior in children with ASD (see ref <a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">26</a> and references therein cited). However, compounds <b>12</b> (lamotrigine) and <b>13</b> (levetiracetam) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) did not show efficacy in improving ASD behaviors. On the other hand, compound <b>14</b> (valproate) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) was found efficacious in the treatment of irritability and repetitive patterns of behavior in children with ASD.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Psychotropic drugs that have been studied for ASD treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because deficits in brain cholinergic function have been described in some ASD individuals,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> the use of acetylcholinesterase inhibitors <b>15</b> (rivastigmine), <b>16</b> (donepezil), and <b>17</b> (galantamine) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) has been tested in ASD children. Collectively, these studies reported some improvements in overall ASD behaviors and also in sleep patterns. Side effects include irritability, verbal or behavioral regression, headaches, rash, tremor, sedation, vomiting, and gastrointestinal problems.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">Compound <b>18</b> (methylphenidate, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) has been shown to be effective in improving attention deficit hyperactivity disorder (ADHD) symptoms in children with ASD. However, response rates are lower than those seen in typically developing children with ADHD. Moreover, discontinuation rates due to adverse events are high.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p last">The opiate antagonist <b>19</b> (naltrexone, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) has been evaluated in ASD patients on the basis of the hypothesis that endogenous opioids such as β-endorphin and enkephalins modulate social behavior.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Treatment with <b>19</b> improves self-injurious behavior, hyperactivity, social withdrawal, agitation, and irritability in ASD children.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">3 Strategies to Treat Core Symptoms of ASD</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41104" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41104" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">ASD has been classified into syndromic and nonsyndromic on the basis of clinical criteria. The term syndromic refers to conditions in which ASD occurs in conjunction with additional phenotypes and/or dysmorphic features. The etiology of syndromic ASD is known in most cases and can involve chromosomal abnormalities or mutations in a single gene. The study of syndromic ASD has yielded information on ASD at the molecular level on the pathways critical for cognitive and social development. Genetically modified mice based on human genetic findings have been crucial to deciphering previously unknown pathogenic mechanisms (for a recent review on ASD animal models see ref <a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">32</a>). These findings have led to the identification of potential targets for therapeutic intervention. Because new research reveals common features between syndromic and nonsyndromic forms of ASD, shared therapeutic approaches seem possible for this class of conditions.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> We here recapitulate core phenotypes of syndromic forms of ASD that can be helpful for the reader.</div><div class="NLM_p">Fragile X syndrome (FXS) is the most common genetic disorder associated with autism, affecting approximately 1/4000 males and 1/7000 females. FXS is caused by silencing of the <i>FMR1</i> gene, which encodes for the fragile X mental retardation protein (FMRP), an mRNA binding protein that functions as a regulator of protein synthesis and translation. FXS is characterized by intellectual disabilities, ranging from mild to severe, social anxiety and autistic disorders, such as stereotypical movements, increased susceptibility to seizures, attention deficit hyperactivity disorder symptoms, and sensory hypersensitivity.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The FXS animal model, the FMR1 knockout mice, recapitulates several behavioral and physical phenotypes of FXS observed in human patients.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> These mice show increased density in dendritic spines, alteration in spine morphology,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and elevated metabotropic glutamate receptor-dependent long-term depression (mGluR-LTD). This latter observation has led to the mGluR theory of FXS.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In addition, FMR1 knockout mice show enhanced transmission activity of group I metabotropic glutamate receptor type 5 (mGlu<sub>5</sub>)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and GABAergic deficits in several brain areas (cortex, hippocampus, amygdala, striatum, and subiculum).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p">Rett Syndrome (RTT) is a rare neurodevelopmental disorder that affects 1/15000 women. RTT is due to loss-of-function mutations in the X-linked <i>MECP2</i>, a gene encoding a multifunctional protein that binds to methylated DNA and acts as a key transcriptional regulator. RTT is also associated with regression of language, cognitive functions, social and motor skills, stereotypies, seizures, and breathing difficulties. At the cellular level, the brains of RTT patients are characterized by reduced neuronal size, increased cell density in several regions, reduced dendritic arborization, low spine density, and altered spine morphology.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> In addition, transgenic mice studies have reported that MeCP2 deficiency is critical for normal activity of GABA-releasing neurons and that dysfunctions of GABAergic neurons contributes to the altered behavioral phenotypes observed in RTT.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">Tuberous sclerosis complex (TSC) is a genetic disorder related to ASD characterized by the formation of hamartomas (tumor-like nodules) in multiple organ systems, including central nervous system (CNS), and affects 1/6000 individuals. TSC is associated with learning abnormalities, intellectual disabilities, developmental delay, autistic features, and epilepsy.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> TSC is caused by mutations in either <i>TSC1</i> or <i>TSC2</i> genes encoding for hamartin and tuberin, respectively, two proteins that regulate the activity of the mammalian target of rapamycin (mTOR) pathway. In TSC, mTOR is hyperactive, and this translates into abnormal protein synthesis and synaptic plasticity, reduced neuronal connectivity and CNS myelination, and imbalance of synaptic excitatory/inhibitory ratio. Moreover, loss of functional <i>TSC1</i>/<i>TSC2</i> genes affects dendritic spine formation and structure and dendritic arborization.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">3.1 Targeting Synaptic Dysfunction</h3><div class="NLM_p">Several lines of evidence indicate that disrupted synaptic function appears to be a basis of ASD pathophysiology. Several genes associated with ASD encode proteins that directly or indirectly affect synaptic function. Impaired synaptic plasticity might lead to neuronal networks with reduced capacity to change their structure and function. Therefore, improving neurological deficits by enhancing synaptic plasticity in a way that is independent from the disorder-specific etiology can represent a valuable therapeutic strategy.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i5" class="anchor-spacer"></div><h4 class="article-section__title" id="_i5">3.1.1 Excitatory/Inhibitory (E/I) Balance</h4><div class="NLM_p">A widely accepted hypothesis on the etiology of ASD proposes that there is E/I imbalance in brain neural circuits.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> E/I imbalance may be due to an increase of glutamatergic or to a decrease of GABAergic signaling and it may give rise to altered synaptic plasticity and learning and memory, seizures, neural network oscillatory abnormalities, visual system abnormalities, general dyspraxia, behavioral changes, and social dysfunction.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Yizhar et al. have demonstrated in mice that increased E/I ratio in the prefrontal cortex is related to behavioral and social impairments relevant to ASD.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> On the other hand, decreased E/I ratio was observed in a mouse model of RTT.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><div class="NLM_p">Different pharmacological approaches have been proposed to restore E/I imbalance.</div><div id="sec3_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i6" class="anchor-spacer"></div><h5 class="article-section__title" id="_i6"> Modulation of mGlu<sub>5</sub> Receptor</h5><div class="NLM_p">The “mGluR theory” of FXS implicated that blockade of mGlu<sub>5</sub> receptor could be useful to treat the neurological and psychiatric symptoms of FXS,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and preclinical studies have supported this theory (for a comprehensive review see ref <a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">47</a> and references therein cited).</div><div class="NLM_p">The design of competitive ligands for mGlu receptors has been challenging due to the difficulty to identify selective molecules. Competitive ligands for mGlu receptors are usually polar amino acid-like molecules with reduced ability to cross the blood–brain barrier (BBB). Instead, allosteric modulators of mGlu<sub>5</sub> receptor (positive allosteric modulators, PAMs, or negative allosteric modulators, NAMs) are more drug-like small molecules structurally unrelated to glutamate and allow fine-tuning of the signal transduction toward predefined level.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p">The potent, selective, and brain penetrant mGlu<sub>5</sub> NAMs <b>20</b> (MPEP) and <b>21</b> (MTEP) (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) have been two milestones in this research field.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> In fact, treatment of FMR1 knockout mice with <b>20</b> suppressed the audiogenic seizure phenotype, rescued prepulse inhibition, and reduced repetitive autistic-like behavior. In addition, administration of compound <b>20</b> rescued the immature morphological phenotype of pyramidal neurons in the somatosensory cortex of neonatal FMR1 knockout mice.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Structure of mGlu<sub>5</sub> NAMs that have been studied in ASD models. (B) Structure of mGlu<sub>5</sub> PAMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In BTBR mice, a well-validated model of idiopathic autism,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> compound <b>20</b> significantly reduced repetitive self-grooming without inducing sedation on open field activity but did not improve sociability.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> In the BTBR and C58 mouse strains, the mGlu<sub>5</sub> receptor NAM <b>22</b> (GRN-529, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) suppressed repetitive behaviors and social behavior deficits.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">In addition, compound <b>20</b> normalizes learning measures in BTBR mice (hippocampus-dependent object location memory). In contrast, semichronic treatment with the AMPA receptor PAM ampakine, which facilitates memory in other models of cognitive impairment, had no effect on object location memory in BTBR mice.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Moreover, compound <b>20</b> significantly reduced elevated stereotyped, repetitive, and anxiety-like behaviors in the valproic acid mouse model of ASD.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><div class="NLM_p">Besides compounds <b>20</b> and <b>21</b>, a number of mGlu<sub>5</sub> NAMs have been reported in the literature, showing structures different from the diarylethynyl scaffold (for extensive reviews see refs <a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">53</a> and <a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">54</a>). Here, the mGlu<sub>5</sub> NAMs studied in ASD context are illustrated. Compound <b>23</b> (fenobam, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) was able to rescue abnormalities in neuronal morphology in FMR1 knockout mice.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Using the structure of <b>23</b> as a template, Hoffmann-La Roche developed a series of benzoxazolones, exemplified by compound <b>24</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), as mGlu<sub>5</sub> NAMs with good pharmacokinetic (PK) properties and activity in anxiety models after oral administration.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><div class="NLM_p">Compound <b>25</b> (AFQ056 or mavoglurant, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) was identified by Novartis via an HTS campaign focused on the identification of mGlu<sub>5</sub> NAMs structurally different from <b>20</b>. Compound <b>25</b> was characterized as a potent and selective mGlu<sub>5</sub> NAM in vitro and demonstrated improved in vivo bioavailability in rats and reduced in vitro clearance in human microsomes as compared to <b>20</b>.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Compound <b>25</b> was able to rescue dendritic spine phenotype in FMR1 knockout mice.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> However, randomized, double-blind, placebo-controlled studies with this compound in FXS adults did not allow confirmation of the results observed in animal models.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p">Starting from the screening hit <b>26</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), having weak mGlu<sub>5</sub> activity but potent GABA<sub>A</sub> agonistic activity, Roche identified the compound <b>27</b> (RO4917523 or basimglurant, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), which showed potent in vivo activity in preclinical models of anxiety, favorable PK properties in rats and monkeys, and an excellent preclinical safety profile.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Also, compound <b>27</b> entered clinical trials for the treatment of FXS, but the results did not confirm the results observed in animal models.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p">The results of mGlu<sub>5</sub> receptor inhibitors in preclinical studies and proof-of-concept clinical trials generated high excitement. However, the trials failed to demonstrate sufficient significance. As highlighted in a detailed review on the clinical trials with investigational drugs for the treatment of FXS,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> the differences in outcome between the animal models and humans have evidenced the unique challenges of carrying out trials in these cognitively and behaviorally challenged individuals as well as a paucity of clinically relevant outcome measures for use in these trials.</div><div class="NLM_p last">Results with compound <b>28</b> (CDPPB, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), an mGlu<sub>5</sub> PAM, in animal models of ASD (see below) have revived the interest in the development of PAMs. For many years, the development of mGlu<sub>5</sub> PAMs has not been pursued because they can induce potent activation of mGlu<sub>5</sub> signaling, which can in turn induce epileptiform activity, seizures, and neurotoxicity.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> However, compound <b>29</b> (NCFP, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) was found to positively modulate mGlu<sub>5</sub> without the induction of LTD and LTP in the hippocampus, suggesting that the compound stabilizes a unique active receptor conformation.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Moreover, the adverse effect liability of mGlu<sub>5</sub> PAMs is thought to be related to the NMDA receptor. Therefore, the identification of PAMs displaying signal bias away from potentiation of NMDA activation offers an alternative for modulating mGlu<sub>5</sub> receptor signaling without inducing neurotoxicity.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Researchers at Vanderbilt University reported the compound <b>30</b> (VU0409551, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) as a potent and orally bioavailable mGlu<sub>5</sub> PAM that displays robust antipsychotic and cognition-enhancing efficacy in the absence of direct potentiation of NMDA receptor.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div></div><div id="sec3_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i7" class="anchor-spacer"></div><h5 class="article-section__title" id="_i7"> Modulation of Group II Metabotropic Glutamate Receptors</h5><div class="NLM_p">Group II metabotropic glutamate receptors (mGlu<sub>2</sub> and mGlu<sub>3</sub>) have also been proposed as potential targets for therapeutic intervention in ASD. Chen et al. have reported that activation of mGlu<sub>2/3</sub> may underlie the effects of <i>N</i>-acetylcysteine on amygdala-associated autism-like phenotypes in a valproate-induced rat model of autism.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><div class="NLM_p">Several classes of compounds have been described as modulators of mGlu<sub>2</sub> and mGlu<sub>3</sub> receptors which have proved to be effective in various preclinical models of CNS disorders, such as schizophrenia and OCD, but none have been studied in preclinical models of ASD (for an extensive review see ref <a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">48</a> and references herein cited).</div><div class="NLM_p">Orthosteric agonists and antagonists have been developed starting from glutamate as lead structure. Eli Lilly described the bicyclo[3.1.0]hexane <b>31</b> (LY354740 or eglumetad) and its closely related ether analogue <b>32</b> (LY379268) as prototypical mGlu<sub>2/3</sub> orthosteric agonist tools (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Two highly functionalized glutamate analogues, compounds <b>33</b> (LY341495) and <b>34</b> (MGS0039) (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>), have been used to evaluate the potential of mGlu<sub>2/3</sub> blockade to treat OCD, anxiety, and cognitive deficits.<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66, 67)</a> In addition, several mGlu<sub>2/3</sub> PAMs have been developed as an alternative to orthosteric agonists. Prototypical mGlu<sub>2</sub> PAMs are two structurally unrelated compounds, i.e., the tertiary sulfonamide <b>35</b> (LY487379)<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> and the 2-cyclopentyl indanone <b>36</b> (BINA)<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Researchers at Taisho Pharmaceuticals reported the characterization of the selective mGlu<sub>2</sub> PAM <b>37</b> (TASP0433864, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>), which was useful in restoring E/I imbalance underlying schizophrenia.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Addex Pharmaceutical has developed the compound <b>38</b> (ADX71149 or JNJ-40411813, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>), which demonstrated positive effects as adjunctive treatment to antipsychotics in patients with negative symptoms of schizophrenia.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Astra Zeneca has reported the isoindolinone <b>39</b> (AZD8529, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>), which displayed antipsychotic properties in different preclinical models of schizophrenia.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of orthosteric agonists and antagonists of mGlu<sub>2/3</sub> receptors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of mGlu<sub>2/3</sub> PAMs and NAMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As for mGlu<sub>2/3</sub> NAMs, Roche reported a series of benzodiazepine derivatives exemplified by <b>40</b> (RO4491533, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>), which proved to be effective in rodent models of depression and cognition.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div></div><div id="sec3_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i8" class="anchor-spacer"></div><h5 class="article-section__title" id="_i8"> Modulation of Ionotropic Glutamate NMDA Receptors</h5><div class="NLM_p">mGlu<sub>5</sub> receptor and the ionotropic glutamate receptor NMDA show a positive reciprocal regulation, where activation of one of them potentiates the response elicited by the other one. Conversely, blocking one of them indirectly inhibits the other.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Thus, by extension of the findings described above for mGlu<sub>5</sub> antagonists, the NMDA receptor antagonist <b>41</b> (memantine, <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>) (approved by the U.S. Food and Drug Administration (FDA) for use in Alzheimer’s disease) has been evaluated as pharmacotherapy in ASD. It was shown that either NMDA antagonism through compound <b>41</b> or mGlu<sub>5</sub> antagonism through <b>20</b> was able to rescue social deficits as well as NMDA hyperactivity in IRSp53 knockout mice, a gene linked to ASD in humans.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Conversely, in Shank2 knockout mice, another gene linked to ASD, which show decreased NMDA receptor function, the treatment with either the NMDA agonist <b>42</b> (<span class="smallcaps smallerCapital">d</span>-cycloserine, <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>) or an mGlu<sub>5</sub> PAM is able to restore NMDA activity and social behavior.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Accordingly, clinical trials have shown that compound <b>42</b> improves social and repetitive behaviors in ASD patients.<a onclick="showRef(event, 'ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref77 ref78">(77, 78)</a> Furthermore, clinical trials in individuals with ASD reported improvements with NMDA receptor antagonist <b>41</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) NMDA antagonists that have studied in ASD animal models. (B) New NMDA antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Recently, Volkman et al. have described the identification of the antagonists <b>43</b> (MPX-004) and <b>44</b> (MPX-007) (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>) as pharmacological tools to study the function of the NMDA receptors containing a GluN2A subunit. Both compounds were able to antagonize GluN2A-containing NMDA receptors expressed in HEK cells. Electrophysiology studies demonstrated that maximal concentrations of both compounds inhibited the whole-cell current (∼30%) in primary culture of rat pyramidal neurons and NMDA receptor-mediated EPSP (∼60%) in rat hippocampal slices, suggesting that both <b>43</b> and <b>44</b> could be useful to study GluN2A involvement in neuropsychiatric and neurodevelopmental disorders.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div></div><div id="sec3_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i9" class="anchor-spacer"></div><h5 class="article-section__title" id="_i9"> Modulation of GABAergic Activity</h5><div class="NLM_p">GABA is generally considered as the main inhibitory neurotransmitter that regulates the release of other neurotransmitters and neurons excitation. In 2001, Hussman proposed that several functional deficits in ASD might be linked to the suppression of the GABAergic inhibitory tone in several brain regions and that the loss of inhibitory control from GABAergic neurons might result in hyperexcitation of target neurons or selective vulnerability to glutamate.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Physiological effects of GABA are mediated through the interaction with three different receptor subtypes: GABA<sub>A</sub>, GABA<sub>B</sub>, and GABA<sub>C</sub>. GABA<sub>A</sub> and GABA<sub>C</sub> are ligand-gated ion channels that suppress neuronal excitability. GABA<sub>B</sub> is an unusual G-protein-coupled receptor which is a heterodimer of GABA<sub>B1</sub> and GABA<sub>B2</sub> subunits. These receptors can inhibit the release of many neurotransmitters, such as dopamine, serotonin, and acetylcholine, via a G-protein-dependent inhibition of neuronal voltage-gated Ca<sup>2+</sup> channels.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div><div class="NLM_p">Experimental evidence from in vitro and in vivo studies in animal models or in humans seem to support the hypothesis that an imbalance of either GABA<sub>A</sub> and GABA<sub>B</sub> receptor signaling may result in increased postsynaptic neuronal excitability and altered glutamate release.<a onclick="showRef(event, 'ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref82 ref83">(82, 83)</a> Thus, increasing GABAergic transmission might improve behavior by compensating a potentially excessive glutamatergic neurotransmission. Both ionotropic and metabotropic GABA receptor subtypes represent potential targets for development of therapeutic agents. Interestingly, pharmacological enhancement of GABA neurotransmission is able to improve the core social interaction deficits in BTBR mice.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> On the basis of these data, Astra Zeneca and NIH have initiated clinical trials of the α<sub>2,3</sub>-selective PAM of GABA<sub>A</sub> receptor <b>45</b> (AZD7325, <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>)<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> for treatment of social disability in young adults with ASD (NCT01966679). On the basis of these observations, various clinically approved drugs that modulate GABA transmission, such as <b>46</b> (acamprosate), <b>47</b> (bumetanide), <b>48</b> (flumazenil), <b>49</b> (riluzole), and <b>50</b> (arbaclofen) (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>), have been subjected to clinical trials (for a recent review see ref <a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">86</a>). The clinical trials yielded mixed and inconclusive results. With this respect, the failure of compound <b>50</b> in clinical trials has been the major disappointment in ASD research.<a onclick="showRef(event, 'ref87 ref88'); return false;" href="javascript:void(0);" class="ref ref87 ref88">(87, 88)</a> The largest clinical trial on compound <b>50</b> failed to provide significant difference in the primary outcome measure (ABC-Social Withdrawal score) but provided significant improvement in secondary outcome measures (social impairment among others).<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Possible explanations for the lack of efficacy of compound <b>50</b> (and other medications) could arise from the extreme heterogeneity of ASD. In fact, as the symptoms may differ significantly in quality and severity among patients, it could be difficult to measure significant changes with a single outcome.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Drugs modulating GABA transmission that have been subjected to clinical trials for ASD treatment. (B) Structure of a GABA<sub>B</sub> PAM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To date, compound <b>51</b> (baclofen, <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>) is the only drug approved by the FDA which targets the GABA<sub>B</sub> receptor. However, compound <b>51</b> showed severe side effects, which include hypothermia, seizures, sedation, cognitive deficits, and drug tolerance. Compound <b>51</b> also exhibits poor brain penetrance and therefore requires high doses for engagement of the GABA<sub>B</sub> receptor in the CNS, resulting in elevated plasma concentrations and activation of peripheral GABA<sub>B</sub> receptors on smooth and skeletal muscle. Numerous GABA<sub>B</sub> agonists have been developed from compound <b>51</b> with the aim to improve potency and CNS penetration. Moreover, the scaffold of compound <b>51</b> has been manipulated to develop GABA<sub>B</sub> antagonists, which, however, show poor selectivity. Also for GABA<sub>B</sub> receptors, PAMs and NAMs have been developed as an alternative to orthosteric agonists and antagonists and tested in different behavioral paradigms. For an extensive review on orthosteric agonists and PAMs of GABA<sub>B</sub> receptor, see ref <a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">89</a>. Recently, the potent, selective, and brain penetrant GABA<sub>B</sub> PAM <b>52</b> (ADX71441, <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>) has been reported, showing efficacy in animal models of anxiety and pain. No data on ASD-relevant behavioral tests were reported.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a></div></div><div id="sec3_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i10" class="anchor-spacer"></div><h5 class="article-section__title" id="_i10"> Glycogen Synthase Kinase 3 (GSK-3) Inhibition</h5><div class="NLM_p">GSK-3 is an evolutionarly conserved serine/threonine kinase highly abundant in the brain and acts as the main suppressor of the Wingless (Wnt)/β-catenin signaling pathway. The Wnt/β-catenin pathway plays a crucial role in the proliferation, differentiation, apoptosis, and outgrowth of CNS cells during embryonic development. Several genes belonging to the Wnt/β-catenin cascade have been genetically associated with ASD.<a onclick="showRef(event, 'ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref91 ref92">(91, 92)</a> Moreover, the mood-stabilizing drug lithium inhibits GSK-3, mimicking the activation of the Wnt/β-catenin signaling pathway.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> In addition, Wnt/β-catenin signaling plays a prominent role in the regulation of excitatory synaptic transmission in pre- and postsynaptic compartments, thus contributing to E/I balance. At presynaptic level, Wnt/β-catenin signaling modulates cell adhesion, clustering, and recycling of synaptic vesicles.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Abnormalities in the presynaptic Wnt/β-catenin signaling translate in defects in spine morphogenesis and excitatory synaptic transmission.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> At postsynaptic terminals, the Wnt/β-catenin pathway is involved in Ca<sup>2+</sup> homeostasis through activation of different proteins such as L-type voltage sensitive Ca<sup>2+</sup> channels, NMDA receptors, and CAMKII kinases.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> This translates in a major role of Wnt/β-catenin pathway in the establishment of LTP and, therefore, the modulation of this signaling pathway through GSK-3β isoform could rescue defects in LTP and contribute to the fine-tuning of synaptic plasticity.</div><div class="NLM_p">GSK-3β is constitutively active, and different upstream signaling cascades converge on GSK-3β to inhibit its activity. Studies with transgenic mice indicate that postnatal ablation of GSK-3β in the forebrain induces anxiolytic and prosocial effects,<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> whereas GSK-3β overexpression accounts for learning deficits.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a></div><div class="NLM_p">Although lithium has been widely used to manage mood disorders symptoms in psychiatric disorders, only a few studies have documented the effects of lithium administration in ASD patients. For instance, lithium administration to 30 children and adolescents diagnosed with ASD through DSM-IV-TR criteria improved symptoms such as euphoria, mania, or paranoia on 43% of patients.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a></div><div class="NLM_p">Chronic administration of lithium to neonatal isolated rats exhibiting ASD-like behaviors abolished symptoms and improved defects in neurogenesis and E/I balance.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> In addition, chronic lithium treatment reversed the increase in cerebral protein synthesis and ameliorated the behavioral abnormalities commonly observed in FMR1 knockout mice.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> In line with these studies, pharmacological inhibition of GSK-3β, using the inhibitor <b>53</b> (SB216763, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>), reverses the hippocampus-dependent learning deficits and rescues adult hippocampal neurogenesis in FMR1 knockout mice, suggesting that modulation of Wnt/β<b>-</b>catenin is crucial in reactivating synaptic plasticity, and these effects may account for the observed behavioral and learning improvements.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> In addition, administration of lithium or GSK-3 inhibitor <b>54</b> (AR-A014418, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>) reduced audiogenic seizure susceptibility, a well-defined phenotype of FMR1 knockout mice.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Finally, it has been proposed that the mGlu<sub>5</sub> NAM <b>20</b> selectively increases inhibitory GSK-3β phosphorylation in FMR1 knockout mice, mimicking the effect elicited by chronic lithium treatment.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of GSK-3β inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Numerous chemical scaffolds have been reported as small-molecule GSK-3β inhibitors mostly acting by competing with the ATP binding site of the kinase, while there are also known inhibitors which do not target the ATP binding site.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> The first generation of ATP competitive inhibitors, such as compound <b>55</b> (staurosporine), lack suitable selectivity over other kinases. 3-(7-Azaindolyl)-4-arylmaleimides, exemplified by <b>53</b> and <b>56</b> (ING-135, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>), benzo[<i>e</i>]isoindole-1,3-diones (compound <b>57</b>, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>), and phenylmethylenehydantoins (compound <b>58</b>, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>) belong to the second generation of GSK-3β inhibitors endowed with good selectivity. 5-Imino-1,2,4-thiadiazole derivatives, exemplified by <b>59</b> (tideglusib, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>) are reversible non-ATP competitive and substrate competitive inhibitors of GSK-3β.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Compound <b>59</b> is currently in phase II clinical trials for the treatment of adolescents with ASD (NCT02586935).</div></div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11">3.1.2 Dendritic Spine Morphology</h4><div class="NLM_p">In recent years, it has become evident that many psychiatric and neurologic disorders, including ASD, are linked to alterations in synapse structure and function and in dendritic spine morphology.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> In addition, many of the genes associated with ASD encode proteins involved in synaptic transmission.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Dendritic spines are small membrane protrusions that contain the postsynaptic machinery, including glutamate receptors and the postsynaptic density (PSD) components, and contribute to the transmission of electrical signals. It is becoming increasingly apparent that synapse function and spine morphology are intimately linked. In fact, smaller spines have smaller synapses and this translates into reduced synaptic transmission. Abnormalities in spine density and morphology have been evidenced in ASD patients. A study on post-mortem ASD human brains has revealed an increase in spine density on apical dendrites of pyramidal neurons in frontal, temporal, and parietal lobes.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> The observed increased spine density was inversely correlated with cognitive function. These findings are in line with the emerging hypothesis that the brains of ASD patients are characterized by hyperconnectivity in local circuits and hypoconnectivity between brain regions.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Spine dysgenesis is a common feature of syndromic forms of ASD. As an example, in FXS patients, spine morphology has been described as “immature” with long and tortuous spines, whereas in RTT individuals lower spine density and decreased proportion of mushroom-type spines in the cortex and hippocampus have been described.<a onclick="showRef(event, 'ref36 ref40'); return false;" href="javascript:void(0);" class="ref ref36 ref40">(36, 40)</a> In TSC mouse models it was observed a deficit in spinogenesis in early of postnatal life followed by impaired spine pruning, which led to higher spine densities in one-month-old mice.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> It is therefore conceivable that converging deregulated signaling pathways downstream of the dysfunctional genes and upstream of dendritic spine formation and maturation exist.</div><div id="sec3_1_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i12" class="anchor-spacer"></div><h5 class="article-section__title" id="_i12"> PI3K/mTOR Pathway</h5><div class="NLM_p">PI3K/mTOR pathway regulates protein translation in dendrites near excitatory synapses and is being studied as a convergence point in syndromic forms of ASD. In FXS, FMRP is a regulator of protein translation in dendritic spines and modulates components directly downstream of the PI3K/mTOR pathway. In TSC, loss-of-function mutations in TSC1 and TSC2 proteins result in higher activity of mTOR. In MeCP2-deficient mice, a mouse model of RTT, the levels of mGlu receptors and BDNF, which are upstream in PI3K/mTOR pathways, are lower and this causes a decrease in levels of the serine/threonine kinase Akt and mTOR. In addition, mTOR activity increases dendritic protein translation, whereas in TSC, heightened mTOR activity impedes the synthesis of proteins required for stabilization of mGluR-dependent LTD.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Therefore, it has been proposed that the level of mTOR activity should be within an appropriate range in order to support synaptic plasticity. In support of this hypothesis TSC and RTT, which are characterized by impaired mTOR-dependent protein translation, show impaired LTD, while FXS, which is characterized by sustained dendritic protein translation, displays elevated LTD.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> In addition, mTOR inhibitors such as compounds <b>60</b> (rapamycin) and <b>61</b> (everolimus) (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>) have been used to treat behavioral and molecular abnormalities in TSC deficient mice.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> The positive results in preclinical studies mentioned above opened the way for randomized placebo-controlled trials of mTOR inhibitors for neurocognitive deficits in children with TSC (NCT01730209, NCT01289912, NCT01954693). A case report has described a 27 years-old female patient with TSC, autism, and renal angiomyolipomas, in whom treatment with compound <b>61</b> was associated with improvements in irritability, stereotypic behavior, and inappropriate speech.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of mTOR inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Abnormal mTOR activation has also been found in other neurodevelopmental disorders characterized by defective synaptogenesis or connectivity,<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> but the observed link could be epistatic or be caused by downstream effects of the defective gene rather than related to mTOR signaling per se.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> In BTBR mice, compound <b>60</b> improved several measures of sociability (but not stereotypic behaviors), suggesting that mTOR overactivation represents a therapeutic target that mediates or contributes to impaired sociability in this mouse model of ASD.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> One recent study has also implicated mTOR in ASD in humans: post-mortem analysis of brain tissue from ASD patients revealed increased density of dendritic spines on layer V pyramidal cells as well as aberrant mTOR activation and reduced autophagy.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> However, whether mTOR is a key pathway in all types of ASD or only in syndromic forms remains to be established. Moreover, translating the findings from preclinical models to humans will be challenging because the optimal temporal frame of the treatment is not known.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Finally, it has been reported that withdrawal of mTOR inhibitors leads to recrudescence of clinical symptoms.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> In addition, because mTOR inhibitors might display potentially serious adverse effects, such as immunosuppression, mucositis, hyperlipidaemia, and dysmenorrhea, long-term treatment could be problematic.</div><div class="NLM_p last">To date, different chemical classes of PI3K/mTOR inhibitors have been reported in the literature, and numerous compounds have been advanced to clinical trials to treat brain cancer and even approved by the FDA. However, none of them has been studied in preclinical or clinical models of ASD, except <b>60</b> and <b>61</b>. BBB penetration is one of the main issues in the development of mTOR inhibitors because of unfavorable physicochemical properties or strong interaction with BBB efflux systems, as for compounds <b>61</b> and <b>62</b> (temsirolimus) (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>), which is a prodrug of compound <b>60</b>. Compound <b>63</b> (buparlisib) and <b>64</b> (pamolid 529) (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>) are two examples of mTOR inhibitors with favorable PK properties that are able to accumulate into the brain and to inhibit mTOR activity. Another approch to modulate PI3K/mTOR activity is the inhibition of the upstream Akt kinase. Also in this case, although different inhibitors have been reported, the main issue in the optimization is the brain penetrance.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></div></div><div id="sec3_1_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i13" class="anchor-spacer"></div><h5 class="article-section__title" id="_i13"> Insulin-Like Growth Factor-1</h5><div class="NLM_p">Insulin-like growth factor 1 (IGF-1) is a peptide hormone belonging to a superfamily of hormones termed insulin-like peptides. IGF-1 is synthesized and secreted by the liver in response to the growth hormone and acts on a broad range of cell types. IGF-1 is also produced in the CNS where it has a crucial role in growth, development, and maturation of both neuronal and glial cells and neuronal plasticity.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> In the CNS, IGF-1 exerts its action by binding to IGF-1 receptor (IGF1R), a heterotetrameric glycoprotein expressed in both neural stem cells and all neural cells throughout the lifespan. When IGF-1 binds to IGF1R, the tyrosine kinase domains on the β subunits activate PI3K/Akt kinase and Ras-Raf-MAP pathways to induce downstream effects. Relevant downstream effectors of PI3K/Akt pathway are mTOR, GSK-3β, and β-catenin. Downstream effectors of Ras-Raf-MAP pathway are Erk1/2 and p38 MAPK, which are important in cellular maturation and survival (see ref <a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">121</a> and references therein cited). During CNS development, IGF-1 is crucial for the differentiation and proliferation of neuronal cells as well as for their structural and functional integration into pre-existing neural circuitry, regulating changes in morphology, synaptic efficacy, and cellular organization. These effects are mediated by a myriad of mechanisms that include modulation of glutamatergic receptor units, alteration in Ca<sup>2+</sup> channels conductance, modulation of E/I balance in neural circuitry, effects on synaptic proteins, and interactions with other neurotrophic factors.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> As for the effect on spine morphology, Igf1–/– mice display shorter dendrites, reducing dendritic spine density.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Once released in the serum, IGF-1 is cleaved into the active amino terminal glycine–proline–glutamate (GPE) tripeptide <b>65</b> ((1–3) IGF-1, <a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>) and the truncated IGF-1 form called <i>des</i>-<i>N</i>-(1–3) IGF-1. Compound <b>65</b> is capable of crossing the BBB and retains strong neurotrophic and behavior-modifying activities.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Compound <b>65</b> displays neuroprotective effects as well as effects on excitatory synaptic markers, recapitulating many of the effects of IGF-1 on synaptic maturation and plasticity.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> The effects of compound <b>65</b> may be different in neuronal and non-neuronal cell populations. Corvin et al. demonstrated that compound <b>65</b>, differently from IGF-1, is able to activate PI3K in glial cells and this reflects on synaptic markers because glial cells play a role in the formation and maintenance of synapses.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> In addition, the same study proposed that compound <b>65</b> may indirectly activate the IGF-1 receptor by increasing the release of endogenous IGF-1.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of compounds <b>65</b> and <b>66</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The therapeutic potential of IGF-1 and compound <b>65</b> in neurodevelopmental disorders such as RTT, FXS, as well as idiopathic ASD has been explored. Administration of compound <b>65</b> in MeCP2 mutant mice (a mouse model of RTT) led to an increase in brain size and excitatory synaptic markers, indicating that compound <b>65</b> promotes synapse maturation and influences synaptic plasticity. An increase of dendritic spine formation was also observed, and electrophysiology studies showed increased excitatory synaptic transmission in the sensorimotor cortex.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> Moreover, administration of both IGF-1 and compound <b>65</b> in Mecp2 mice was able to improve social behavior.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a></div><div class="NLM_p">Deacon et al. have demonstrated that prolonged administration of compound <b>66</b> (NNZ-2566, <a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>), an analogue of <b>65</b>, in FMR1 knockout mice was able to rescue of MAPK/ERK and PI3K/mTOR signaling abnormalities and to correct dendritic spine morphology. In addition, compound <b>66</b> in FMR1 knockout mice reduced anxiety levels and hyperactivity, improved short-term and long-term memory and learning, and normalized social recognition and behaviors.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> The lack of adverse events and positive therapeutic profile in preclinical studies with FMR1 knockout mice provided evidence of the potential therapeutic effects of IGF-1 in FXS. A phase 2 industry-led clinical trial has been completed using compound <b>66</b>, with clinical improvement in many of the core symptoms in FXS patients (NCT01894958).</div><div class="NLM_p last">The studies illustrated above make IGF-1 a potentially attractive target for the treatment of ASD. In a study using neural cells derived from idiopathic ASD individuals, it was shown a partial rescue of deficits in neuronal networks (neuronal spike number and activity) on application of IGF-1.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> At present, clinical trials are ongoing with the aim to use IGF-1 to treat the core symptoms of ASD (NCT01970345).</div></div><div id="sec3_1_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i14" class="anchor-spacer"></div><h5 class="article-section__title" id="_i14"> SHANK Proteins</h5><div class="NLM_p">Cumulative gene analysis in ASD subjects have identified several mutations in <i>SHANK3</i> gene, suggesting that abnormalities in this gene could be related to the neuropathology of ASD.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Moreover, mutations in <i>SHANK3</i> is a causable gene of Phelan–McDermid syndrome (PMDS) that is characterized by severe speech and expressive language deficits, global developmental delay, and autistic behavior.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></div><div class="NLM_p">SH3 domain and ankyrin repeat containing protein (SHANK) proteins are major scaffolding proteins and have a major role in neuronal development. The SHANK family comprises three members: SHANK1, SHANK2, and SHANK3 proteins. SHANK3 is mainly localized in the PSD and is involved in cytoskeleton-associated signaling complex.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a><i>SHANK3</i> gene encodes a multidomain protein containing ankyrin repeats, SH3 domain, PDZ domain, a proline-rich region, and the sterile alpha motif (SAM) domain.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Through these domains, SHANK3 can bind and interact with a wide variety of proteins, including modulators of small GTPases, such as RhoA and Cdc42, actin binding proteins, and actin modulators.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Dysregulation of SHANK proteins alters actin dynamics, and this translates in alterations in dendritic spine morphology and synaptic activity. Moreover, dysregulation of SHANK proteins leads to alteration in NMDA and AMPA receptors trafficking and, consequently, to alteration in the balance between E/I signals.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></div><div class="NLM_p">It has been hypothesized that restoration of synaptic dysfuntion caused by abnormality of <i>SHANK3</i> gene may serve as a useful therapeutic strategy for ASD. IGF-1 has been proposed as a candidate molecule to restore synaptic dysfunctions related to <i>SHANK3</i> abnormalities. Daily intraperitoneal injections of IGF-1 for 2 weeks in <i>SHANK3</i>-deficient mice reversed deficits in hippocampal LTP, AMPA signaling, and motor performance.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Moreover, treatment of neurons differentiated from induced pluripotent stem cells (iPSC) from PMDS patients promotes the formation of mature excitatory synapses by increasing AMPA and NMDA receptors and corrects defects in excitatory synaptic transmission.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> In a double blind, placebo controlled phase 2 trial, IGF-1 treatment significantly improved social impairment and restrictive behaviors.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></div><div class="NLM_p last">It has been proposed that enhancement of glutamate receptor activity may be of therapeutic relevance for the treatment of ASD related to alterations in SHANK proteins. In fact, SHANK3 is essential in mediating mGlu<sub>5</sub> receptor signaling by recruiting the scaffolding protein Homer1b/c to the PSD in the striatum and cortex.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> A mGlu<sub>5</sub> PAM should enhance NMDA receptor function via mGlu<sub>5</sub> activation, and this would translate in improvement of synaptic plasticity. To this end, the mGlu<sub>5</sub> PAM <b>28</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) was able to rescue behavioral deficits in <i>SHANK3</i> knockout mice.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></div></div><div id="sec3_1_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i15" class="anchor-spacer"></div><h5 class="article-section__title" id="_i15"> ROCK Kinases</h5><div class="NLM_p">The Rho family of GTPases is a family of small signaling G proteins belonging to the Ras superfamily. RhoA, Cdc42, and Rac1 belong to the Rho family of GTPases and are currently studied because they are regulators of actin dynamics and greatly influence dendritic spine biology and synaptic plasticity.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Active, GTPbound RhoA is a potent inhibitor of spine outgrowth through its main downstream effectors, Rho-associated coiled-coil containing protein kinases (ROCK) 1 and ROCK2, which are ubiquitous serine/threonine kinases.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Inhibition of both ROCK1 and ROCK2 with compound <b>67</b> (hydroxyfasudil, <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>) improved learning and working memory in aged rats.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> At the cellular level, ROCK1 and ROCK2 inhibition by compound <b>68</b> (Y-27632, <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>) increases the number and the proportion of thin spines, which are considered as precursors of mature spines. These results suggested that ROCK inhibition may enhance the capacity for synapse formation and structural plasticity in hippocampal neurons<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> and may be used to treat those CNS disorders characterized by altered dendritic spine morphology, such as ASD. It has also been proposed that dual inhibitors of ROCK1 and NADPH oxidase might be used to treat neurological diseases, including ASD.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> To date, a large number of nonselective ROCK1/2 inhibitors have been reported (for a review see ref <a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">143</a>) and numerous compounds have entered in clinical trials for ophthalmic applications. Only a small number of nonselective ROCK1/2 inhibitors has entered clinical development for other applications, including CNS disorders, because of their narrow therapeutic window. In fact, ROCK1 inhibition has been related to cardiovascular adverse effects. Thus, selective ROCK2 inhibitors have been proposed as potential drugs to treat CNS disorders.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> To date, selective ROCK2 inhibitors have not been described in the literature.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structure of the ROCK inhibitors that can modulate dendritic spines morphology.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">3.2 Targeting Central Neurotransmission Systems</h3><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17">3.2.1 Serotonin System</h4><div class="NLM_p">The serotonin (5-hydroxytryptamine, 5-HT) system is involved in many neurobiological processes, including brain development. Disturbances in 5-HT neurotransmission have been indicated as an underlying cause of several neuropsychiatric disorders including ASD. Platelet hyperserotonemia was one of the first biochemical changes observed in ASD individuals, with 50–70% increase of the level of 5-HT in platelet compared to the normal value demonstrated in ∼30% of patients.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Variants in genes involved in the 5-HT system (the serotonin transporter gene <i>SLC6A4</i>) or in its degradation (the monoamine oxidase A gene) have been proposed to be related to ASD in humans.<a onclick="showRef(event, 'ref145 ref146'); return false;" href="javascript:void(0);" class="ref ref145 ref146">(145, 146)</a> In support of this, mice with mutations in the above genes show abnormal serotonergic transmission and social deficits.<a onclick="showRef(event, 'ref147 ref148'); return false;" href="javascript:void(0);" class="ref ref147 ref148">(147, 148)</a> In addition, developmental manipulations targeting 5-HT signaling in mice have indicated that excess 5-HT clearance during early stages of neurodevelopment could influence neuronal migration, axonal projections, and synapse development (see ref <a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">149</a> and references therein cited). Thus, it is reasonable that defects in 5-HT system would affect circuits relevant for ASD-related behaviors.</div><div class="NLM_p">As already illustrated above, SSRIs are used to treat depression, anxiety, and obsessive-compulsive behaviors in ASD individuals. However, the treatment with an SSRI has not shown to improve the core features of ASD nor other noncore aspects such as self-injurious behavior.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> In contrast, a study in adults showed that compound <b>3</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) gave significantly greater improvement in repetitive behaviors than placebo.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> It is likely that the variability of SSRIs responses is a result of dysfunction of the 5-HT system at distinct levels (receptor, transport, processing, etc.).<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> Thus, the possibility of developing drugs acting on 5-HT system at more specific levels is being explored.</div><div class="NLM_p">A clinical trial has determined the efficacy of the 5-HT<sub>1A</sub> receptor partial agonist <b>69</b> (buspirone, <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>) on core symptoms and associated features in young children with ASD. Analyses of the main outcome of the study indicated that treatment with compound <b>69</b> did not result in decreased overall symptoms of ASD. On the other hand, secondary outcome measures demonstrated significant improvement in repetitive and restricted behaviors. The authors suggested that this treatment might be considered as an adjunct therapy to treat restrictive and repetitive behavior in association with early behavioral intervention.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Serotonergic drugs and ligands that have been studied in ASD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">BTBR mice show reduced SERT density in various brain regions and increased 5-HT<sub>1A</sub> receptor activity in the hippocampus.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> In these mice, compounds <b>3</b> and <b>69</b> enhanced social interactions. Compound <b>1</b>, which is a dopamine D<sub>2</sub>/5-HT<sub>2</sub> receptor antagonist, reduced marble burying, but had no effect on sociability in BTBR mice.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Also, in wild-type mice, drugs targeting 5-HT receptors, particularly 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptors, have shown promise for increasing social interaction or decreasing cognitive rigidity, which are behavioral phenotypes relevant to ASD.<a onclick="showRef(event, 'ref155 ref156'); return false;" href="javascript:void(0);" class="ref ref155 ref156">(155, 156)</a></div><div class="NLM_p">Preclinical and clinical studies have suggested that altered 5-HT<sub>2A</sub> receptor signaling contributes to ASD symptoms.<a onclick="showRef(event, 'ref147 ref149'); return false;" href="javascript:void(0);" class="ref ref147 ref149">(147, 149)</a> To this end, systemic administration of the selective 5-HT<sub>2A</sub> receptor antagonist <b>70</b> (M100907, <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>) in BTBR mice facilitates set-shifting and alleviates both a reversal learning deficit and elevated grooming behavior, suggesting that increased 5-HT<sub>2A</sub> receptor activity in certain brain regions may contribute to repetitive behaviors of these mice.<a onclick="showRef(event, 'ref157 ref158'); return false;" href="javascript:void(0);" class="ref ref157 ref158">(157, 158)</a> Moreover, because compound <b>1</b> can cause unwanted side effects due to dopamine D<sub>2</sub> antagonism, treatment with a selective 5-HT<sub>2A</sub> receptor antagonist has been proposed to improve cognitive flexibility in individuals with ASD.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> In addition, microinfusion of <b>70</b> into the dorsomedial striatum alleviated a reversal learning impairment and attenuated grooming behavior, whereas the microinfusion into the orbitofrontal cortex increased perseveration during reversal learning and potentiated grooming. Consequently, it was suggested that elevated 5-HT<sub>2A</sub> receptor activity in the dorsomedial striatum may contribute to behavioral inflexibility and stereotyped behaviors of BTBR mice. It was therefore suggested that systemic treatment with <b>70</b> principally acts on dorsomedial striatum to attenuate repetitive behaviors at least in BTBR mice.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a></div><div class="NLM_p">The involvement of 5-HT<sub>7</sub> receptors during brain development has emerged recently. It was demonstrated in mouse hippocampal neurons that activation of 5-HT<sub>7</sub> receptors stimulated the small GTP-ases RhoA and Cdc42 and enhanced neurite elongation, dendritic spine density, and the number of synaptic contacts. In addition, activation of 5-HT<sub>7</sub> receptors increased the expression of AMPA receptors and this led to increased synaptic efficacy.<a onclick="showRef(event, 'ref160 ref161'); return false;" href="javascript:void(0);" class="ref ref160 ref161">(160, 161)</a> Consistent with these data, stimulation of 5-HT<sub>7</sub> receptors by the agonist <b>71</b> (LP-211, <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>) enhanced neurite outgrowth in embryonic neuronal primary cultures from hippocampus, cortex, and striatum by activating signaling transduction pathways that converge on the reorganization of cytoskeletal proteins.<a onclick="showRef(event, 'ref162 ref163 ref164'); return false;" href="javascript:void(0);" class="ref ref162 ref163 ref164">(162-164)</a> These studies have proposed 5-HT<sub>7</sub> receptor as one of the key mediator of the well-known 5-HT effects in the correct establishment of neurites projections during critical periods of embryonic neuronal wiring. Very recently, it was also shown that the expression level of 5-HT<sub>7</sub> receptor in hippocampus progressively decreases during the postnatal development, whereas it is stable in cortex and striatum during the whole postnatal development.<a onclick="showRef(event, 'ref165 ref166'); return false;" href="javascript:void(0);" class="ref ref165 ref166">(165, 166)</a> Thus, it is very likely that the 5-HT<sub>7</sub> receptor participates in reorganization of neuronal networks and modulation of neural plasticity also during the later developmental stages and in adulthood. These data seem to be linked to the beneficial effects of 5-HT<sub>7</sub> receptor stimulation seen in mouse models of RTT and FXS. In a mouse model of RTT, 5-HT<sub>7</sub> receptor activation by compound <b>71</b> substantially rescues the neurobehavioral phenotype.<a onclick="showRef(event, 'ref167 ref168 ref169'); return false;" href="javascript:void(0);" class="ref ref167 ref168 ref169">(167-169)</a> This effect may be linked to the capacity of 5-HT<sub>7</sub> receptor agonist to activate mTOR pathway. As for FXS, 5-HT<sub>7</sub> receptor activation reversed mGluR-mediated endocytosis of AMPA receptors and mGluR-LTD in both FMR1 knockout and wild-type mice.<a onclick="showRef(event, 'ref170 ref171'); return false;" href="javascript:void(0);" class="ref ref170 ref171">(170, 171)</a> In addition, systemic administration of the mixed 5-HT<sub>1A</sub> and 5-HT<sub>7</sub> receptor agonist <b>72</b> ((+)-5-FPT, <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>) reduced or abolished stereotypy in three different mouse models of stereotypy but not altered locomotor behavior on its own. Moreover, agonist <b>72</b> also enhanced social interaction.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a></div><div class="NLM_p">It has been suggested that blockade of 5-HT<sub>6</sub> receptors may be effective for individuals who suffer from working memory deficits such as in ASD because the selective 5-HT<sub>6</sub> receptor antagonist <b>73</b> (PRX-07034, <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>) was able to enhance working memory and cognitive flexibility in rats.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> Interestingly, 5-HT<sub>6</sub> receptors are expressed early during brain development, and more direct evidence of their morphogenic role are being accumulated.<a onclick="showRef(event, 'ref174 ref175'); return false;" href="javascript:void(0);" class="ref ref174 ref175">(174, 175)</a></div><div class="NLM_p last">5-HT receptor subtypes have long been objects of intense research with the aim to discover potent and selective agonists and antagonists. Over the last 30 years, hundreds of papers have been published on this topic. Several extensive reviews on the structure–activity relationships of 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>6</sub>, and 5-HT<sub>7</sub> receptor agonists and antagonists may be recommended to those who have more interest in these topics.<a onclick="showRef(event, 'ref176 ref177 ref178 ref179 ref180'); return false;" href="javascript:void(0);" class="ref ref176 ref177 ref178 ref179 ref180">(176-180)</a> While clinical candidates that could target selectively 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, and 5-HT<sub>6</sub> receptors are available, this is not the case for 5-HT<sub>7</sub> receptor. On the other hand, the studies illustrated above suggest that targeting more than one 5-HT receptor subtype could represent an approach to treat different behavioral features of ASD as, at least in part, shown by the study of Canal et al.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> As targeting multiple 5-HT receptors has been pursued for other therapeutic purposes, the identification of serotonergic agents having an activity profile adequate to treat core symptoms of ASD can be envisaged.</div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">3.2.2 Cholinergic System</h4><div class="NLM_p">Several post-mortem studies have evidenced abnormalities in the expression of cholinergic binding sites in brain areas of ASD individuals. In particular, the reduced expression of the gene encoding the α4β2 nicotinic receptor in the cerebral cortex is a major feature of the neurochemical pathology of ASD, while post-transcriptional abnormalities of α4β2 and α7 nicotinic receptor subtypes are apparent in the cerebellum.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Moreover, cholinergic neurons project throughout the brain and contribute to the modulation of attention, learning, memory, cognitive flexibility, and sociability. Cholinergic projections are also critical for the maintenance of the E/I balance.<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a> The evidence for cholinergic deficiencies has prompted the investigation of compound <b>16</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) in animal models of ASD. Chronic administration of compound <b>16</b> in BTBR mice and in valproate-treated mice offspring improved cognitive flexibility in different behavioral paradigms, social behavior, and social recognition memory but did not induce any effect on repetitive behaviors. Initial outcomes of clinical trials with <b>15</b> and <b>17</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) support further exploration of cholinergic intervention for the treatment of core and associated symptoms of ASD.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a></div><div class="NLM_p">It has been proposed that α7 nicotinic acetylcholine receptor (α7 nAChR) may be a valuable target in ASD. In fact, microdeletions in the proximal region of chromosome 15q between breakpoint (BP) 3 or BP4 and BP5 (15q13.3) encompassing <i>CHRNA7</i>, the gene encoding the α7 nAChR, are associated with several neuropsychiatric disorders, including intellectual disability, schizophrenia, and ASD, suggesting that α7 nAChR plays a crucial role in the developing brain and in the normal processes of attention, cognition, memory, and behavior throughout life.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> The α7 nAChR is the most highly expressed nicotinic receptor subtype in the human brain, with particularly high levels in the cerebral cortex and the hippocampus. Within the hippocampus, α7 nAChRs facilitate the release of glutamate and GABA transmitters at the presynaptic level, whereas mediate fast synaptic transmission postsynaptically.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a></div><div class="NLM_p">Several drug discovery programs have targeted α7 nAChRs for neuropsychiatric disorders leading to the identification of brain penetrant full or partial agonists (for an extensive review see ref <a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">185</a>). Several α7 nAChR agonists, such as <b>74</b> (DMXB-A), <b>75</b> (SSR180711), and <b>76</b> (EVP-6124) (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>), have shown to enhance cognitive functions and to elicit antipsychotic-like effects in preclinical models. However, no data have been reported yet in ASD animal models.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. (A) Structures of α7 nACh agonists. (B) Structures of α7 nACh PAMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">It has also been proposed that the development of α7 nAChR PAMs may provide several advantages for therapeutics development. In fact, a key concern for α7 nAChR competitive agonists is the possibility that chronic administration may result in limited or diminished efficacy because of in vivo receptor desensitization and adverse effects due to the activation of other nicotinic receptor subtypes. Instead, PAMs require the endogenous ligand to elicit the activation of the nicotinic receptor and thus would maintain the natural temporal phasic stimulation pattern of the receptor. Several α7 nAChR PAMs have been developed, such as <b>77</b> (PNU120596)<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> and <b>78</b> (A-867744)<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>), and proved to be effective in preclinical models of cognitive and behavioral deficits associated with schizophrenia.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> These results leave room for a potential application of α7 nAChR PAMs in ASD.</div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">3.2.3 Oxytocin System</h4><div class="NLM_p">In recent years, oxytocin (OT) is receiving increased attention as a potential treatment for social deficits in ASD. OT is a hypothalamic neuropeptide linked to numerous social behaviors in mammals such as emotional bonding, maternal care, affiliation, and social attachment.<a onclick="showRef(event, 'ref189 ref190'); return false;" href="javascript:void(0);" class="ref ref189 ref190">(189, 190)</a> Altered OT concentrations have been reported in individuals with ASD, indicating that disturbances in OT levels lead to social and communicative dysfunction and suggesting that exogenous OT administration may be effective in reversing these symptoms.<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> It has been observed that ASD children have lower average levels of blood OT and higher OT precursors levels in comparison with typically developing age-matched children.<a onclick="showRef(event, 'ref191 ref192'); return false;" href="javascript:void(0);" class="ref ref191 ref192">(191, 192)</a> In addition, several genetic studies have suggested that ASD is linked to alteration of the genetic background of the OT receptor.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> Finally, genetic variation in CD38, a transmembrane protein with ADP ribosyl cyclase activity involved in OT release, has been recently associated with differential response in social eye cues in children.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a></div><div class="NLM_p">Various randomized controlled trials of OT interventions in ASD patients have been carried out.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> The outcomes of these studies demonstrate that, overall, OT is well tolerated and induces generally mild side effects either after intranasal or intravenous administration. The trials yielded potentially promising findings in neuropsychological measures of emotion recognition and eye gaze, whereas no significant improvements for repetitive behaviors were observed. The studies evidenced also a certain degree of variability among patients, although the effectiveness of OT was classified, in most of the cases, of medium size as compared to placebo. Only one study evidenced that the improvement in emotion recognition was maintained after 6 weeks of treatment with intranasal OT.</div><div class="NLM_p">However, various concerns have been raised about the validity of these clinical trials, with respect to the unreliability of small clinical trials (median of the recruited patients was 15), questionable statistical analysis, and methodologic weaknesses.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> In addition, only a very little fraction of the huge amounts of OT administered intranasally or intravenously reaches the cerebrospinal fluid and the brain. Instead, peripheral OT concentrations increase to supraphysiologic levels with likely side effects on peripheral organs.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> Therefore, further studies are needed to establish OT as a treatment for individuals with ASD.</div><div class="NLM_p">To circumvent the limitations of OT administration, efforts have been made to identify compounds with improved PK properties. Wisńiewski et al. have reported a series of potent and selective peptidic OT receptor agonists, exemplified by compound <b>79</b> (FE 202767, <a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>), which shows excellent selectivity versus the related V<sub>1a</sub>, V<sub>1b</sub>, and V<sub>2</sub> vasopressin receptors and improved PK properties as compared to OT.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> No data on behavioral efficacy have been reported.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a></div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Peptidic and nonpeptidic oxytonergic ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Nonpeptide small-molecule OT agonists or partial agonists could offer advantages over peptides because they can be designed to modulate potency, selectivity over the structurally similar vasopressin receptors, CNS penetration, and oral bioavailability.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> Among nonpeptide agonists, compound <b>80</b> (WAY-267464, <a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>) showed high affinity at both human and mouse OT receptors (<i>K</i><sub>i</sub> = 58.4 nM and 51.6 nM, respectively) and was characterized as an agonist in CHO-K1 cells stably expressing human or mouse OT receptor (EC<sub>50</sub> = 61.3 and 29.0 nM, respectively). Moreover, compound <b>80</b> is 100-fold selective over V<sub>1a</sub>, V<sub>2</sub>, and V<sub>1b</sub> vasopressin receptors.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> The compound produces OT receptor-mediated anxiolytic effects in rodent behavioral paradigms similar to those elicited by OT. In the social preference test, compound <b>80</b> significantly improved social cognition.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> Ferring Pharmaceuticals developed a series of potent nonpeptide agonists exemplified by compound <b>81</b> (TC-OT 39, <a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>), which maximally stimulated OT receptor to the same extent as OT and was 25-fold selective over vasopressin V<sub>2</sub> receptors.<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> In a subsequent study, it was shown that compound <b>81</b> was only 2-fold selective over V<sub>1a</sub> receptor.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> Behavioral efficacy of compound <b>81</b> has not been reported. Hoffmann-La-Roche reported in a patent application a series of OT agonists with 5-sulfonamidopyrazole scaffold, exemplified by compound <b>82</b> (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>). The compounds were specifically designed to treat CNS disorders related to OT dysfunction, but no data on either PK properties or behavioral efficacy of the compounds were disclosed.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a></div><div class="NLM_p">An alternative approach to modulate OT system is targeting receptors and pathways that affect OT levels. For instance, the neuropeptide galanin modulates OT release by acting on hypothalamo-neurohypophysal system.<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> The OT system can be also enhanced by inducing CD38 enzyme transcription. All-<i>trans</i>-retinoic acid (ATRA) is a potent inducer of CD38 and thus presumably of OT release. In a study on lymphoblastoid cell lines of ASD patients and their parents, ATRA increased CD38 mRNA expression, suggesting that molecules capable to induce CD38 transcription may be potential therapeutic candidates.<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a></div><div class="NLM_p">Stimulation of melanocortin receptors located on oxytocinergic neurons of the supraoptic neurons is able to induce central, but not peripheral release of OT in rats. This effect can be blocked by the administration of a melanocortin 4 receptor (MC4R) antagonist.<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> The administration of compound <b>83</b> (Ro27-3225, <a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>), a selective MC4R agonist, in Cntnap knockout mice restores social behavior.<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a> Therefore, MC4R agonists could presumably increase central OT release, bypassing the limitations of peripheral peptide administration. The tone of OT system is also modulated by 5-HT. Serotoninergic neurons and receptors are localized on the oxytocinergic supraoptic nucleus and paraventricular nuclei of the hypothalamus, where they control the release of neurohypophyseal hormones.<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a> Several papers have highlighted the complex interaction between the OT and 5-HT systems. As an example, 5-HT<sub>1A</sub> receptor agonists, such as <b>69</b> or 8-hydroxy-2-(di-<i>n</i>-propylamino)tetralin (8-OH-DPAT), substantially increase plasma OT levels and promote OT-dependent prosocial behaviors.<a onclick="showRef(event, 'ref208 ref209'); return false;" href="javascript:void(0);" class="ref ref208 ref209">(208, 209)</a> On the other hand, stimulation of 5-HT<sub>1B</sub> receptor induces deficits in sociability in mice, preference for social novelty, and nonselective attention that can be reversed by administration of OT.<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. (A) Modulators of oxytonergic transmission. (B) Structure of the brain penetrant V1a antagonist <b>86</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These evidence indicate that there are potentially numerous druggable receptors on oxytocinergic neurons that could be targeted to increase OT release. This will require a systematic characterization to identify the target(s) leading to the greatest efficacy and the lowest off-target effects.</div><div class="NLM_p last">Finally, because extracellular OT is degraded by aminopeptidases, OT levels could be enhanced by limiting its enzymatic degradation. High levels of placental leucine aminopeptidase (P-LAP), which degrades OT, have been found in selected olfactory regions, hippocampus, and hypothalamus, co-localized with OT and vasopressin neurons, suggesting that P-LAP contributes to regulate OT levels in the brain.<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a> Recently, competitive peptide P-LAP inhibitors <b>84</b> (amastatin) and <b>85</b> (angiotensin IV) (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>) have been identified. As these molecules facilitate memory in different behavioral paradigms,<a onclick="showRef(event, 'ref212'); return false;" href="javascript:void(0);" class="ref ref212">(212)</a> P-LAP inhibition may represent a viable strategy to enhance OT brain levels. However, aminopeptidases are not specific for OT and, therefore, potential side effects arising from the reduced degradation of other neuropeptides must be taken into account.</div></div><div id="sec3_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Vasopressin System</h4><div class="NLM_p last">Besides OT, vasopressin has also been implicated in the regulation of social behavior in animals and humans.<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a> Vasopressin interacts with three G-protein coupled receptors which are classified into V1 (V1a), V2, and V3 (V1b) receptor subtypes. In the rodent brain, vasopressin release increases during stress which causes passive coping behavior. This effect is reduced by the administration of peptidic V1 vasopressin receptor antagonists which, injected in the amygdala, reduce passive coping behavior.<a onclick="showRef(event, 'ref214'); return false;" href="javascript:void(0);" class="ref ref214">(214)</a> A functional neuroimaging study in humans showed that vasopressin administration can modulate medial prefrontal cortex–amygdala circuitry during emotion processing.<a onclick="showRef(event, 'ref215'); return false;" href="javascript:void(0);" class="ref ref215">(215)</a> In humans, V1a receptors are expressed in brain limbic areas and in cortical areas.<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a> This pointed to a role of vasopressin in increasing the brain response to socially threatening stimuli in humans. It was postulated that V1a antagonists may have prosocial effects due to the modulation of the social brain, and therefore they may have potential for the treatment of psychiatric disorders related to social emotional dysfunction, including ASD.<a onclick="showRef(event, 'ref217'); return false;" href="javascript:void(0);" class="ref ref217">(217)</a> Researchers at Roche, through an extensive medicinal chemistry campaign, identified the brain penetrant V1a antagonist <b>86</b> (RG7713 or RO5028442, <a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>), devoid of V2 and OT receptors blocking properties.<a onclick="showRef(event, 'ref218'); return false;" href="javascript:void(0);" class="ref ref218">(218)</a> A multicenter, randomized, double-blind study in adult male high-functioning ASD patients assessed the effects of <b>86</b> on behavioral and clinical measures of social cognition and communication. The results provided initial evidence that treatment with compound <b>86</b> provides subtle improvements in social communication surrogates in adults with high-functioning ASD, supporting further clinical exploration of V1a receptor antagonism as a therapeutic approach to treat core symptoms in ASD.<a onclick="showRef(event, 'ref218'); return false;" href="javascript:void(0);" class="ref ref218">(218)</a></div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">3.3 Targeting Neuroinflammation</h3><div class="NLM_p">The presence of inflammation in ASD is a concept that is receiving momentum. Neuroinflammation is emerging as a common element in numerous neurological and neuropsychiatric disorders such as schizophrenia, bipolar disorder, and major depression.<a onclick="showRef(event, 'ref219'); return false;" href="javascript:void(0);" class="ref ref219">(219)</a> This posed the question if neuroinflammation is a contributing mechanism in the development of ASD and if neuroinflammation is a causal or reactive process.</div><div class="NLM_p">The hypothesis of a role of early (prenatal) inflammation in the etiology of ASD was initially based on the high correlation of ASD with the occurrence of viral epidemics evidenced by several epidemiological studies. Since then, maternal viral and bacterial infections and autoimmune diseases have been shown to be associated with the development of ASD. During brain development, cytokines and chemokines, which contribute to modulate neuronal and glial cell migration, differentiation, and synaptic maturation, are expressed at very low levels.<a onclick="showRef(event, 'ref220'); return false;" href="javascript:void(0);" class="ref ref220">(220)</a> Maternal immune activation increases the levels in the maternal blood of specific brain chemokines and/or cytokines that could reach the fetal brain and affect brain development. As an example, increased concentration of IL-1β, IL-6, and TNF-α in the chord blood have been related to perinatal complications.<a onclick="showRef(event, 'ref221 ref222'); return false;" href="javascript:void(0);" class="ref ref221 ref222">(221, 222)</a> Additionally, it is not known how permeable is the developing BBB to antibodies and how maternal antibodies can reach fetal brain.<a onclick="showRef(event, 'ref223'); return false;" href="javascript:void(0);" class="ref ref223">(223)</a></div><div class="NLM_p">Clinical and post-mortem studies show that in ASD inflammatory processes are not limited to the perinatal period. In fact, chronic inflammatory conditions and the abnormal response to infection have been described in ASD children and adults.<a onclick="showRef(event, 'ref224'); return false;" href="javascript:void(0);" class="ref ref224">(224)</a></div><div class="NLM_p">Abnormal inflammatory processes may be an etiological factor in ASD that affects behavior and other symptoms throughout the life of ASD patients, as demonstrated by astrogliosis and microglial activation, along with increased expression of pro-inflammatory mediators, such as IL-6, TNF-α, TGF-β1, IFN-γ, IL-8, and other genes associated with the immune response in the brain and in the cerebrospinal fluid.<a onclick="showRef(event, 'ref225'); return false;" href="javascript:void(0);" class="ref ref225">(225)</a></div><div class="NLM_p">Astrocyte pathophysiology can be critical in the progression of neurodevelopmental disorders. Astroglia organize the architecture of the brain, nurture synapses and perceive synaptic activity, participate in neurotransmission, neuron–astrocyte metabolic coupling, and cytokine secretion. As a result, astrocytes affect all processes associated with brain development, maturation, and aging.<a onclick="showRef(event, 'ref226 ref227 ref228'); return false;" href="javascript:void(0);" class="ref ref226 ref227 ref228">(226-228)</a> Microglial cells are, on the other hand, the resident immune cells within the CNS that detect damage to the nervous system, secrete cytokines, and control neuroinflammation.<a onclick="showRef(event, 'ref229'); return false;" href="javascript:void(0);" class="ref ref229">(229)</a> Thus, abnormal microglial activation or alteration of the physiological role of microglia in synapse removal may be crucial in neurodevelopmental disorders, including ASD.</div><div class="NLM_p">Different neuroinflammatory targets have been proposed for developing novel therapeutic strategies to target neuroinflammation in ASD.</div><div class="NLM_p">In addition to the role in synaptic plasticity discussed above, mGlu<sub>5</sub> receptor is involved in the modulation of neurotrophic effects as well as proliferation and inflammatory responses of glial cells. mGlu<sub>5</sub> receptors are located on microglia where they are involved in neuronal–glial communication and contribute to the maintainance of neuronal homeostasis by controlling glutamate release and uptake by astrocytes.<a onclick="showRef(event, 'ref230'); return false;" href="javascript:void(0);" class="ref ref230">(230)</a> It has been demonstrated that in primary microglia cultures the selective mGlu<sub>5</sub> receptor agonist (<i>RS</i>)-2-chloro-5- hydroxyphenylglycine (CHPG) can attenuate microglial activation as well as associated neurotoxicity following exposure to lipopolysaccharide (LPS).<a onclick="showRef(event, 'ref230 ref231'); return false;" href="javascript:void(0);" class="ref ref230 ref231">(230, 231)</a> Accordingly, studies in mouse models demonstrate that mGlu<sub>5</sub> receptor activation have neuroprotective effects by inhibiting microglial activation and proliferation.<a onclick="showRef(event, 'ref230 ref232'); return false;" href="javascript:void(0);" class="ref ref230 ref232">(230, 232)</a> Thus, there is evidence that mGlu<sub>5</sub> agonists may dampen down possible neuroinflammatory processes in ASD. However, considering the complex role of mGlu receptors in neuronal excitability and the cross-talk between metabotropic and ionotropic glutamate receptors, further studies are required to elucidate if chronic administration of selective mGlu<sub>5</sub> agonists may induce adverse effects, such as epileptic activity or seizures, and if mGlu<sub>5</sub> PAMs may also exert neuroprotective effects by inhibiting microglial activation.</div><div class="NLM_p">It has been proposed that inflammasome activation through Toll-like receptor (TLR) 3- or TLR4-mediated pathways may underlie well-known animal models of ASD, such as LPS- or poly(I:C)- or group B streptococcus-induced maternal immune activation.<a onclick="showRef(event, 'ref233 ref234 ref235'); return false;" href="javascript:void(0);" class="ref ref233 ref234 ref235">(233-235)</a> TLR3 and TLR4 are expressed in astrocytes and microglia, and it seems that the response of astrocytes to TLR3 and TLR4 agonists is dependent on the presence of functional microglia.<a onclick="showRef(event, 'ref236'); return false;" href="javascript:void(0);" class="ref ref236">(236)</a> At the molecular level, TLR4 activation by the agonist LPS is related to the increased production of inflammatory cytokines/chemokines and ROS by activation of NFκB pathway.<a onclick="showRef(event, 'ref234'); return false;" href="javascript:void(0);" class="ref ref234">(234)</a></div><div class="NLM_p">Modulation of TLR4 signaling pathway has been recently proposed as a new therapeutic approach to reduce the inflammatory burden in ASD children.<a onclick="showRef(event, 'ref237'); return false;" href="javascript:void(0);" class="ref ref237">(237)</a> TLR4 signaling was explored in peripheral T cells of ASD patients. TLR4 expression was upregulated in ASD children as compared to normal controls. The activation of TLR4 signaling was associated with increased expression of NOX-2 and ROS generation, which was reduced by inhibition of NFκB pathway.<a onclick="showRef(event, 'ref237'); return false;" href="javascript:void(0);" class="ref ref237">(237)</a> These findings are in agreement with previous studies reporting that stimulation of peripheral blood mononuclear cells of ASD children with LPS enhanced proinflammatory cytokine production and that NFκB expression was shown to be elevated in ASD patients in both peripheral blood and CNS.<a onclick="showRef(event, 'ref238'); return false;" href="javascript:void(0);" class="ref ref238">(238)</a></div><div class="NLM_p">In recent years, the elucidation of the crystal structure of the complex formed by TLR4 and accessory proteins has strongly supported progresses in the design of small-molecule TLR4 antagonists. Several chemical classes of TLR4 antagonists have been described and studied in different models of peripheral or central inflammation.<a onclick="showRef(event, 'ref239'); return false;" href="javascript:void(0);" class="ref ref239">(239)</a> Among these, the β-aminoalcohol derivatives <b>87</b> and <b>88</b> (<a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>) have proved to be effective suppressor of TLR4 activation with good solubility and PK properties.<a onclick="showRef(event, 'ref239'); return false;" href="javascript:void(0);" class="ref ref239">(239)</a> Compound <b>89</b> (TAK-242, <a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>) suppresses TLR4 activation by blocking the formation of TLR4–accessory proteins complex and thus the activation of the downstream pathways related to the production of pro-inflammatory cytokines.<a onclick="showRef(event, 'ref239'); return false;" href="javascript:void(0);" class="ref ref239">(239)</a> Compound <b>89</b> was able to decrease neuroinflammation in rat frontal cortex after stress.<a onclick="showRef(event, 'ref240'); return false;" href="javascript:void(0);" class="ref ref240">(240)</a> No data in animal models of ASD have been reported to date. It has been also reported that tricyclic antidepressants, such as <b>90</b> (amitriptyline), <b>91</b> (mianserin), and <b>92</b> (desimipramine) (<a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>), have showed varying degrees of inhibition on TLR4 activation in different cell lines, including murine microglial BV-2 cells.<a onclick="showRef(event, 'ref241'); return false;" href="javascript:void(0);" class="ref ref241">(241)</a></div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. (A) Structures of TLR4 agonists. (B) Tricyclic antidepressants that can inhibit TLR4 activation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Besides the role in the modulation of synaptic plasticity and OT release, 5-HT may also have a role in the modulation of neuroinflammation. Serotonin functions not only as a neurotrophic factor controlling brain development, but it also modulates immune response.<a onclick="showRef(event, 'ref242'); return false;" href="javascript:void(0);" class="ref ref242">(242)</a> In fact, 5-HT modulates a wide variety of immune functions, such as inflammation, phagocytosis, T cell migration, and cytokine production.<a onclick="showRef(event, 'ref243'); return false;" href="javascript:void(0);" class="ref ref243">(243)</a> To date, the intercommunication between serotonergic events and abnormalities of immune responses in autistic phenotypes has not been elucidated. High levels of 5-HT can directly influence innate and adaptive response of the immune system and influence overproduction of cytokines and chemokines, which, in turn, can enter the brain influencing neuronal maturation in the developmental stages. Increased reuptake results in reduced 5-HT levels, which are important for proper function of the immune system.<a onclick="showRef(event, 'ref244'); return false;" href="javascript:void(0);" class="ref ref244">(244)</a> On the other hand, the increased expression of pro-inflammatory cytokines regulates SERT function through p38 MAPK signaling pathway and induces behavioral changes.<a onclick="showRef(event, 'ref245'); return false;" href="javascript:void(0);" class="ref ref245">(245)</a> It is therefore evident that a better understanding of the relation between serotonergic transmission and immune system can open new therapeutic perspectives to address behavioral deficits in ASD.</div><div class="NLM_p">Starting from the observation that children with ASD show increased levels of neurotensin (NT) in the serum,<a onclick="showRef(event, 'ref246'); return false;" href="javascript:void(0);" class="ref ref246">(246)</a> Patel and co-workers have reported that NT is able to activate primary microglia cultures obtained from human brains as well as the immortalized human microglial cell line SV40.<a onclick="showRef(event, 'ref247'); return false;" href="javascript:void(0);" class="ref ref247">(247)</a> They showed that NT increases gene expression and release of the pro-inflammatory cytokine IL-1β and chemokines CXCL8, CCL2, and CCL5 by activating sortilin and not neurotensin receptors 1 or 2. Sortilin is a type I membrane receptor belonging to the vacuolar protein sorting 10 protein (VPS10P) family of sorting receptors<a onclick="showRef(event, 'ref248'); return false;" href="javascript:void(0);" class="ref ref248">(248)</a> and is mainly expressed in CNS during embryonic development and inflammatory processes.<a onclick="showRef(event, 'ref249 ref250'); return false;" href="javascript:void(0);" class="ref ref249 ref250">(249, 250)</a> On such basis, it has been suggested that inhibiting sortilin may provide novel therapeutic approaches for ASD. However, challenging sortilin signaling could induce several adverse effects due to the important role of sortilin in numerous physiological functions in the body.<a onclick="showRef(event, 'ref251'); return false;" href="javascript:void(0);" class="ref ref251">(251)</a> Researchers at Lundbeck have recently disclosed the orally bioavailable small-molecule sortilin inhibitor <b>93</b> (AF38469, <a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>).<a onclick="showRef(event, 'ref252'); return false;" href="javascript:void(0);" class="ref ref252">(252)</a> However, the compound exhibits poor CNS exposure because of the presence in the molecule of a carboxylic group, and hence it is not useful to study sortilin biology in CNS in vivo. In a subsequent study, using fragment-based and structure-based drug design approaches, <i>N</i>-substituted 1,2,3-triazol-4-one/ol was identified as a template for the development of sortilin inhibitors because it acts as a carboxylic acid isostere and allows crucial interactions with sortilin. Compounds <b>94</b> and <b>95</b> were identified as cell permeable sortilin inhibitors, albeit with modest potency (<a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>).<a onclick="showRef(event, 'ref253'); return false;" href="javascript:void(0);" class="ref ref253">(253)</a></div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Structures of sortilin inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Matrix metalloproteinases (MMPs) is a group of proteases involved in neuroinflammation and neurodevelopment processes and, as such, they have been indicated as possible players in the etiopathology of ASD. For example, MMPs can either promote or suppress inflammation through proteolysis of cytokines and chemokines.<a onclick="showRef(event, 'ref254'); return false;" href="javascript:void(0);" class="ref ref254">(254)</a> However, despite the biologic plausibility of the involvement of MMPs in ASD,<a onclick="showRef(event, 'ref255'); return false;" href="javascript:void(0);" class="ref ref255">(255)</a> further investigations in this area are needed. Interestingly, it has been reported that FMR1 knockout mice show abnormal elevated expression of MMP-9 in the brain which can be downregulated by treatment with compound <b>96</b> (minocycline, <a class="ref internalNav" href="#fig18" aria-label="Figure 18">Figure 18</a>), a tetracycline antibiotic with MMP-9 inhibitor activity. Downregulation of MMP-9 rescues either immature dendritic spine morphology and abnormal behavior.<a onclick="showRef(event, 'ref256'); return false;" href="javascript:void(0);" class="ref ref256">(256)</a> In addition, high plasma activity of MMP-9 was observed in FXS patients. Thus, subsequent trials showed that activity levels of MMP-9 could be lowered by administration of compound <b>96</b> and that, in some cases, changes in MMP-9 activity were positively associated with improvements of clinical measures.<a onclick="showRef(event, 'ref257'); return false;" href="javascript:void(0);" class="ref ref257">(257)</a> These findings might be relevant also for ASD because elevations of MMP-9 in amniotic fluid samples in ASD cases have been reported.<a onclick="showRef(event, 'ref255'); return false;" href="javascript:void(0);" class="ref ref255">(255)</a> Thus, MMP-9 inhibitors might be pursued for treatment of ASD. Several efforts have been done in order to develop selective inhibitors of MMPs, leading to the identification of different chemical classes of inhibitors. As for MMP-9 inhibitors, however, compound <b>96</b> is the only small molecule able to cross the BBB available to date.</div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structure of compound <b>96</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">4 Conclusions and Future Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45588" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45588" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Over the past few years, more and more data have become available on the etiology of ASD. As the neurobiology underlying ASD is being discovered, targeted drug therapy is becoming possible, at least in theory. The very high clinical and etiological variability between individuals with ASD indicates that no single treatment will benefit every ASD patient. Identifying the genetic causes of ASD has proven to be elusive, as ASD is believed to be polygenic. However, the “many genes, common pathways” hypothesis suggests that the many genes associated with ASD will converge, through different molecular mechanisms, onto common processes in the brain responsible for the core symptoms of ASD.<a onclick="showRef(event, 'ref258'); return false;" href="javascript:void(0);" class="ref ref258">(258)</a> The elucidation of these common pathways will likely lead to the development of therapies to treat core symptoms of ASD. However, to estimate whether a target may be useful for large patient groups it is important to understand how different etiologies converge on specific molecular mechanisms and how they map onto difference in circuit-level brain, cognitive development, and behavioral symptom profiles.</div><div class="NLM_p">Animal models of syndromic and nonsyndromic forms of ASD have greatly advanced the understanding of the biochemical pathways involved in ASD and have provided the opportunity to study developmental changes or expression of genetic variants in different brain areas and to manipulate brain regions and circuits to test their precise functions. However, animal models fail to recapitulate many aspects of ASD due to species differences and to the possible contribution of epigenetics in the pathophysiology of ASD.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In addition, some neocortical regions affected in humans are not obtainable from mouse brain, and brain development of mice does not perfectly reflect the development of the human brain.<a onclick="showRef(event, 'ref259'); return false;" href="javascript:void(0);" class="ref ref259">(259)</a> Therefore, clinical studies in human populations are crucial for understanding the genetic and nongenetic contributions to ASD and for validating potential drug targets. With this respect, iPSCs technology is providing a remarkable alternative tool to bridge the translational gap between animal models and human clinical trials for the study of human brain diseases through the scalable, manipulable production of human neural cells derived directly from ASD patients. Recent progress in iPSC technology as well as in the techniques for in vitro neural differentiation have allowed to functionally characterize neurons and to analyze cortical development during neural differentiation contributing to the understanding of the pathogenic mechanisms of ASD and to identify molecular biomarkers for patient stratification and personalized medicine.<a onclick="showRef(event, 'ref259'); return false;" href="javascript:void(0);" class="ref ref259">(259)</a></div><div class="NLM_p">As illustrated in the present perspective, synaptic dysfunction is receiving much attention. Imbalance between excitatory and inhibitory transmission is a common mechanism in ASD that is responsible for learning and memory, cognitive, sensory, motor deficits, and seizures. E/I imbalance can be corrected by acting on mGlu, NMDA, or GABA receptors or by inhibiting GSK-3β signaling. Medicinal chemistry efforts have eventually led to the identification of molecules targeting mGlu, NMDA, and GABA receptors that have entered clinical trials. As for GSK-3β inhibitors, promising candidates have been identified. Developing highly selective allosteric modulators or targeting the intracellular pathways downstream of glutamatergic receptors may open new therapeutic perspectives because they can enhance neuroplasticity without inducing neurotoxicity.</div><div class="NLM_p">Another strategy to correct synapse disfunction is targeting abnormalities in dendritic spine morphology and density. mTOR is probably the most studied and promising target, and the inhibitors <b>60</b> and <b>61</b> have entered clinical trials for treatment of ASD core symptoms. The outcomes of clinical trials will answer the question if targeting mTOR will translate into clinical improvements. ROCK1 and ROCK2 kinases have also been proposed as valuable target in this context but inhibitors targeting the brain have not been identified yet. However, it has been pointed out that challenging ubiquitous targets such as mTOR or ROCK kinases may be associated with potentially serious adverse side effects that can negatively impact on long-term tolerability and compliance.</div><div class="NLM_p">Targeting IGF1 system is another strategy to correct dendritic spine abnormalities. Early clinical evidence obtained with compound <b>66</b> (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>) are encouraging. However, how compound <b>66</b> exerts its effects is still not completely elucidated. Once this will be clarified, it will be possible to design new analogues of compounds <b>65</b> and <b>66</b> that will likely open new perspectives in drug development.</div><div class="NLM_p">Besides glutamatergic and GABAergic transmission, the therapeutic potential of other neuronal transmission systems, such as OT, vasopressin, acetylcholine, and serotonin, have been explored in ASD field. OT has become a focus of investigation because of its role in social behavior and the ongoing clinical trials will contribute to assess the therapeutic potential of addressing oxytonergic system. However, the efficacy of long-term OT administration as well as potential detrimental effects related to overstimulation of this system are still to be fully elucidated. An alternative approach could be targeting receptors and pathways that modulate OT levels. In this respect, it has been proposed that targeting galanin or melanocortin receptors could deserve investigation. While small-molecule melanocortin agonists have been identified so far,<a onclick="showRef(event, 'ref260'); return false;" href="javascript:void(0);" class="ref ref260">(260)</a> the same does not apply for galanin receptors.</div><div class="NLM_p">Central serotonin neurotransmission may also be targeted for treatment of ASD. It has been shown that 5-HT<sub>1A</sub> receptor agonists or 5-HT<sub>2A</sub> receptor antagonists act on neural circuits relevant to ASD, whereas 5-HT<sub>7</sub> agonists or 5-HT<sub>6</sub> antagonists play a role in synaptic plasticity by acting on RhoGTPase, thus correcting abnormalities in dendritic spine morphology. While clinical candidates that could target selectively 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, and 5-HT<sub>6</sub> receptors are available, this is not the case for 5-HT<sub>7</sub> receptor. In addition, it is likely that targeting multiple serotonin receptor subtypes can lead to the identification of new serotonergic agents having an activity profile adequate to treat core symptoms of ASD. Recent studies have proposed that acetylcholine neurotransmission may contribute to synaptic plasticity through the activation of α7 nicotinic receptor, which, in turn activates RhoGTPases leading to cytoskeletal changes during neurite growth.<a onclick="showRef(event, 'ref261'); return false;" href="javascript:void(0);" class="ref ref261">(261)</a> These data might add a new target to correct abnormal synaptic plasticity.</div><div class="NLM_p">Besides synaptic dysfuntion and defects in certain neurotransmitter systems, neuroinflammation is also thought to underlie ASD pathology. Current research is indicating Toll-like receptors, such as TLR3 and TLR4, MMP-9, and sortilin as possible players in neuroinflammation and it is likely that other players will be identified in the near future. Of note, targets initially investigated to correct synaptic dysfunction (i.e.: mGlu<sub>5</sub> receptor, IGF-1 signaling, and some 5-HT receptor subtypes) are also important players in neuroinflammation. With this respect, the study of the interaction between neurons, microglia, and astrocytes is at the very beginning. It is now becoming evident the impact of neuroinflammation on synapses functioning, and this could unveil new scenarios even more complex than present.</div><div class="NLM_p">As already pointed out, the wide heterogeneity of clinical and behavioral symptoms in ASD suggests that no single treatment will be efficacious to treat every ASD patient. The assessment of the validity of the target will greatly depend on the selection of patient groups for clinical trials that are likely to respond to the treatment under consideration. This requires the identification and validation of stratification biomarkers that divide patients into subgroups with shared biological characteristics.<a onclick="showRef(event, 'ref262'); return false;" href="javascript:void(0);" class="ref ref262">(262)</a> To date, no generally accepted biomarkers for ASD diagnosis exist. In addition, biomarkers will supplement the outcomes of clinical trials.</div><div class="NLM_p">Another crucial point to assessing the validity of an ASD drug target is the identification of the critical periods when different factors impact on neuronal development. Brain development is initially determined by distinct temporal and spatial stages of gene expression and intrinsic neuronal activity, then it is refined by interactions with the environment. Therefore, some treatment effects may be different in developing or adult brains. The vast majority of animal studies have been carried out only on adult animals, and this impacts on the translatability of the outcomes to humans.</div><div class="NLM_p last">Finally, a treatment that is likely to be only effective in early development would raise important implications for the design of clinical trials, which usually test efficacy and side effects in adults. The common phrase “children are not little adults” needs to be true even in the drug development stage. All these different factors will converge to address the challenges posed by ASD through a personalized medicine approach.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00965" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75052" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75052" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marcello Leopoldo</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, via Orabona 4, 70125, Bari, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8401-2815" title="Orcid link">http://orcid.org/0000-0001-8401-2815</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f09d918293959c9c9fde9c959f809f9c949fb0859e999291de9984"><span class="__cf_email__" data-cfemail="7e131f0c1d1b12121150121b110e11121a113e0b10171c1f50170a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Enza Lacivita</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, via Orabona 4, 70125, Bari, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2443-1174" title="Orcid link">http://orcid.org/0000-0003-2443-1174</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberto Perrone</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Farmacia—Scienze del Farmaco, Università degli Studi di Bari Aldo Moro, via Orabona 4, 70125, Bari, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lucia Margari</span> - <span class="hlFld-Affiliation affiliation">Dipartimento
di Scienze Mediche di Base, Neuroscienze e Organi di Senso, Unità
di Neuropsichiatria Infantile, Università
degli Studi di Bari Aldo Moro, Piazza Giulio Cesare 11, 70124 Bari, Italy</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83807" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83807" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Enza Lacivita</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=BIO-d573e2573-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Enza Lacivita</b> is Associate Professor at the Department of Pharmacy—Drug Science at the University of Bari Aldo Moro since 2017. She obtained her Ph.D. in Medicinal Chemistry in 2001, working on the development of 5-HT<sub>1A</sub> receptor ligands. From 2001 to 2005, she worked as Associate Researcher on the identification of arylpiperazine derivatives selective for serotonergic or dopaminergic receptors. In 2005, she was appointed as Assistant Professor at the same University. She has published more than 60 papers in peer-reviewed journals focused on the development of selective ligands for GPCRs involved in neuropsychiatric disorders. She has contributed to the identification of the selective 5-HT<sub>7</sub> receptor agonist, LP-211.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Roberto Perrone</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=BIO-d573e2584-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Roberto Perrone</b> is Full Professor of Medicinal Chemistry in the Department of Pharmacy—Drug Science at the University of Bari Aldo Moro since 1991. Since 1987, he has been teaching Pharmaceutical Chemistry for graduate courses of Pharmacy and Chemistry and Pharmaceutical Technologies at the University of Bari. Since 2007, he has been elected Director of the Department of Pharmacy—Drug Science at the University of Bari three times. His research topics include: the development of P-gp ligands able to overcome multidrug resistance, the development of selective sigma1 and sigma2 ligands, and the identification of arylpiperazine derivatives selective for serotonergic or dopaminergic receptors. He is author of more than 150 papers and 10 patent applications.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Lucia Margari</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=BIO-d573e2589-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Lucia Margari</b> obtained a degree in Medicine and Surgery at the University of Bari in 1978. Later, she completed her training to become a Specialist in Neurology (1983) and in Child and Adolescent Neuropsychiatry (1997) at the University of Bari Aldo Moro. Since 2006, she is Full Professor of Child and Adolescent Neuropsychiatry at the University of Bari Aldo Moro. She is Director of the School of Specialization in Child and Adolescent Neuropsychiatry at the same University since 2004 and Director of the Unit of Child Neuropsychiatry at the Policlinico Hospital of Bari since 2009. She is author of more than 170 scientific publications on national and international journals, monographs, book chapters, and conference proceedings.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Marcello Leopoldo</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=BIO-d573e2594-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Marcello Leopoldo</b> obtained the degree in Chemistry and Pharmaceutical Technologies (honors) at the University of Bari in 1991. At the same University, he was appointed Research Associate in Medicinal Chemistry (1992) and Associate Professor in Medicinal Chemistry in 2001 (Department of Pharmacy—Drug Sciences). He has received the Habilitation as Full Professor in Medicinal Chemistry in 2015. He has published more than 100 papers on peer-reviewed journals, focused on the development of selective ligands for dopamine and serotonin receptors. In particular, the potent and selective 5-HT<sub>7</sub> receptor agonist LP-211 was identified in his lab nearly 10 years ago. LP-211 is being used to explore the potential therapeutic effects of 5-HT<sub>7</sub> receptor activation in neurodevelopmental disorders. He is inventor of eight patent applications.</p></figure></div><div class="ack" id="ACK-d573e2605-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the Rector of the University of Bari Aldo Moro, Professor Antonio Felice Uricchio, who established the Working Group on Autism (Gruppo di Lavoro per l’Autismo).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i28" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i28"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i29" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i29"> Abbreviations Used</h2><tr><td class="NLM_term">AMPA</td><td class="NLM_def"><p class="first last">α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid</p></td></tr><tr><td class="NLM_term">ASD</td><td class="NLM_def"><p class="first last">autism spectrum disorder</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">CDPPB</td><td class="NLM_def"><p class="first last">3-cyano-<i>N</i>-(1,3-diphenyl-1<i>H</i>-pyrazol-5-yl)benzamide</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">FXS</td><td class="NLM_def"><p class="first last">fragile X syndrome</p></td></tr><tr><td class="NLM_term">GABA</td><td class="NLM_def"><p class="first last">gamma aminobutyric acid</p></td></tr><tr><td class="NLM_term">LTD</td><td class="NLM_def"><p class="first last">long-term depression</p></td></tr><tr><td class="NLM_term">LTP</td><td class="NLM_def"><p class="first last">long-term potentiation</p></td></tr><tr><td class="NLM_term">MPEP</td><td class="NLM_def"><p class="first last">2-methyl-6-(phenylethynyl)pyridine</p></td></tr><tr><td class="NLM_term">MTEP</td><td class="NLM_def"><p class="first last">3-((2-methyl-4-thiazolyl)ethynyl)pyridine</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">NAM</td><td class="NLM_def"><p class="first last">negative allosteric modulator</p></td></tr><tr><td class="NLM_term">NCFP</td><td class="NLM_def"><p class="first last"><i>N</i>-(4-chloro-2-((4-fluoro-1,3-dioxoisoindolin-2-yl)methyl)phenyl)picolinamide</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">OCD</td><td class="NLM_def"><p class="first last">obsessive–compulsive disorder</p></td></tr><tr><td class="NLM_term">OT</td><td class="NLM_def"><p class="first last">oxytocin</p></td></tr><tr><td class="NLM_term">PAM</td><td class="NLM_def"><p class="first last">positive allosteric modulator</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">PSD</td><td class="NLM_def"><p class="first last">postsynaptic density</p></td></tr><tr><td class="NLM_term">RTT</td><td class="NLM_def"><p class="first last">Rett syndrome</p></td></tr><tr><td class="NLM_term">SSRI</td><td class="NLM_def"><p class="first last">selective serotonin reuptake inhibitors</p></td></tr><tr><td class="NLM_term">TSC</td><td class="NLM_def"><p class="first last">tuberous sclerosis complex</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48057" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48057" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 262 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span> <span class="citation_source-book">Diagnostic and Statistical Manual of Mental Disorders</span>, <span class="NLM_edition">5th</span> ed.; <span class="NLM_publisher-name">American Psychiatric Association</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Diagnostic+and+Statistical+Manual+of+Mental+Disorders%2C+5th+ed.%3B+American+Psychiatric+Association%3A+Washington%2C+DC%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DDiagnostic%2520and%2520Statistical%2520Manual%2520of%2520Mental%2520Disorders%26pub%3DAmerican%2520Psychiatric%2520Association%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Gotham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickles, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C.</span><span> </span><span class="NLM_article-title">The autism diagnostic observation schedule: revised algorithms for improved diagnostic validity</span> <span class="citation_source-journal">J. Autism Dev. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">627</span><span class="refDoi"> DOI: 10.1007/s10803-006-0280-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs10803-006-0280-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=17180459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD2s3ns1Clug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=613-627&author=K.+Gothamauthor=S.+Risiauthor=A.+Picklesauthor=C.+Lord&title=The+autism+diagnostic+observation+schedule%3A+revised+algorithms+for+improved+diagnostic+validity&doi=10.1007%2Fs10803-006-0280-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The Autism Diagnostic Observation Schedule: revised algorithms for improved diagnostic validity</span></div><div class="casAuthors">Gotham Katherine; Risi Susan; Pickles Andrew; Lord Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autism and developmental disorders</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">613-27</span>
        ISSN:<span class="NLM_cas:issn">0162-3257</span>.
    </div><div class="casAbstract">Autism Diagnostic Observation Schedule (ADOS) Modules 1-3 item and domain total distributions were reviewed for 1,630 assessments of children aged 14 months to 16 years with an autism spectrum disorder (ASD) or with heterogeneous non-spectrum disorders.  Children were divided by language level and age to yield more homogeneous cells.  Items were chosen that best differentiated between diagnoses and were arranged into domains on the basis of multi-factor item-response analysis.  Reflecting recent research, the revised algorithm now consists of two new domains, Social Affect and Restricted, Repetitive Behaviors (RRB), combined to one score to which thresholds are applied, resulting in generally improved predictive value.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSA4BbJKIYMTxdUSIfHIn4FfW6udTcc2eZkKgCHoITN2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3ns1Clug%253D%253D&md5=97db507b15d46bd380221cd1a855a87e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs10803-006-0280-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10803-006-0280-1%26sid%3Dliteratum%253Aachs%26aulast%3DGotham%26aufirst%3DK.%26aulast%3DRisi%26aufirst%3DS.%26aulast%3DPickles%26aufirst%3DA.%26aulast%3DLord%26aufirst%3DC.%26atitle%3DThe%2520autism%2520diagnostic%2520observation%2520schedule%253A%2520revised%2520algorithms%2520for%2520improved%2520diagnostic%2520validity%26jtitle%3DJ.%2520Autism%2520Dev.%2520Disord.%26date%3D2007%26volume%3D37%26spage%3D613%26epage%3D627%26doi%3D10.1007%2Fs10803-006-0280-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Rutter, M.; Le Couter, A.; Lord, C.</span> <span class="citation_source-book">ADI-R, Autism Diagnostic Interview: Revised</span>. <span class="NLM_publisher-name">Western Psychological Services</span>, <span class="NLM_publisher-loc">Los Angeles, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=M.+Rutter&author=A.+Le+Couter&author=C.+Lord&title=ADI-R%2C+Autism+Diagnostic+Interview%3A+Revised"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRutter%26aufirst%3DM.%26btitle%3DADI-R%252C%2520Autism%2520Diagnostic%2520Interview%253A%2520Revised%26pub%3DWestern%2520Psychological%2520Services%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Maski, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeste, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, S. J.</span><span> </span><span class="NLM_article-title">Common neurological co-morbidities in autism spectrum disorders</span> <span class="citation_source-journal">Curr. Opin. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span><span class="refDoi"> DOI: 10.1097/MOP.0b013e32834c9282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1097%2FMOP.0b013e32834c9282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21970828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlGqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2011&pages=609-615&author=K.+P.+Maskiauthor=S.+S.+Jesteauthor=S.+J.+Spence&title=Common+neurological+co-morbidities+in+autism+spectrum+disorders&doi=10.1097%2FMOP.0b013e32834c9282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Common neurological co-morbidities in autism spectrum disorders</span></div><div class="casAuthors">Maski, Kiran P.; Jeste, Shafali S.; Spence, Sarah J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pediatrics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">609-615</span>CODEN:
                <span class="NLM_cas:coden">COPEE9</span>;
        ISSN:<span class="NLM_cas:issn">1040-8703</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review Autism spectrum disorders (ASDs) are heterogeneous neurodevelopmental disorders assocd. with various co-morbidities.  Neurol. co-morbidities include motor impairments, epilepsy, and sleep dysfunction.  These impairments have been receiving more attention recently, perhaps because of their significant impact on the behavior and cognitive function of children with ASDs.  Here, we review the epidemiol., etiol., and clin. approach to these neurol. co-morbidities and highlight future research directions.  Recent findings Motor impairments include stereotypies, motor delays, and deficits, such as dyspraxia, incoordination, and gait problems.  Sleep dysfunction typically presents as difficulty with sleep onset and prolonged awakenings during the night.  Recent data suggest that abnormalities in melatonin may affect sleep and may be a potential treatment target.  There is no classic epilepsy syndrome assocd. with ASDs.  Intellectual disability, syndromic autism, and female sex are specific risk factors.  Recent research has focused on identifying the overlapping pathways between these neurol. co-morbidities and the core deficits in ASDs, which may have direct and powerful implications for treatment and prognosis.  Summary Motor impairment, epilepsy, and sleep dysfunction are common neurol. co-morbidities in ASDs.  Clinicians should be aware that recognition and treatment of these issues may improve the function and outcome of children with ASDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpShlkIg__v17Vg90H21EOLACvtfcHk0lhnUxFE5fsltw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlGqtrk%253D&md5=462fa6735c100bc77861eaa42b784880</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1097%2FMOP.0b013e32834c9282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMOP.0b013e32834c9282%26sid%3Dliteratum%253Aachs%26aulast%3DMaski%26aufirst%3DK.%2BP.%26aulast%3DJeste%26aufirst%3DS.%2BS.%26aulast%3DSpence%26aufirst%3DS.%2BJ.%26atitle%3DCommon%2520neurological%2520co-morbidities%2520in%2520autism%2520spectrum%2520disorders%26jtitle%3DCurr.%2520Opin.%2520Pediatr.%26date%3D2011%26volume%3D23%26spage%3D609%26epage%3D615%26doi%3D10.1097%2FMOP.0b013e32834c9282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Leyfer, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folstein, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacalman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tager-Flusberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lainhart, J. E.</span><span> </span><span class="NLM_article-title">Comorbid psychiatric disorders in children with autism: interview development and rates of disorders</span> <span class="citation_source-journal">J. Autism Dev. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">849</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span><span class="refDoi"> DOI: 10.1007/s10803-006-0123-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs10803-006-0123-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=16845581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD28rmsVOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=849-861&author=O.+T.+Leyferauthor=S.+E.+Folsteinauthor=S.+Bacalmanauthor=N.+O.+Davisauthor=E.+Dinhauthor=J.+Morganauthor=H.+Tager-Flusbergauthor=J.+E.+Lainhart&title=Comorbid+psychiatric+disorders+in+children+with+autism%3A+interview+development+and+rates+of+disorders&doi=10.1007%2Fs10803-006-0123-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Comorbid psychiatric disorders in children with autism: interview development and rates of disorders</span></div><div class="casAuthors">Leyfer Ovsanna T; Folstein Susan E; Bacalman Susan; Davis Naomi O; Dinh Elena; Morgan Jubel; Tager-Flusberg Helen; Lainhart Janet E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autism and developmental disorders</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">849-61</span>
        ISSN:<span class="NLM_cas:issn">0162-3257</span>.
    </div><div class="casAbstract">The Kiddie Schedule for Affective Disorders and Schizophrenia was modified for use in children and adolescents with autism by developing additional screening questions and coding options that reflect the presentation of psychiatric disorders in autism spectrum disorders.  The modified instrument, the Autism Comorbidity Interview-Present and Lifetime Version (ACI-PL), was piloted and frequently diagnosed disorders, depression, ADHD, and OCD, were tested for reliability and validity.  The ACI-PL provides reliable DSM diagnoses that are valid based on clinical psychiatric diagnosis and treatment history.  The sample demonstrated a high prevalence of specific phobia, obsessive compulsive disorder, and ADHD.  The rates of psychiatric disorder in autism are high and are associated with functional impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpMuQiMCKOH8KL0FlyGHDofW6udTcc2eab2Fd8gwtELrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rmsVOruw%253D%253D&md5=c702c2edbf7fd36d9fef757a97e25872</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs10803-006-0123-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10803-006-0123-0%26sid%3Dliteratum%253Aachs%26aulast%3DLeyfer%26aufirst%3DO.%2BT.%26aulast%3DFolstein%26aufirst%3DS.%2BE.%26aulast%3DBacalman%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DN.%2BO.%26aulast%3DDinh%26aufirst%3DE.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DTager-Flusberg%26aufirst%3DH.%26aulast%3DLainhart%26aufirst%3DJ.%2BE.%26atitle%3DComorbid%2520psychiatric%2520disorders%2520in%2520children%2520with%2520autism%253A%2520interview%2520development%2520and%2520rates%2520of%2520disorders%26jtitle%3DJ.%2520Autism%2520Dev.%2520Disord.%26date%3D2006%26volume%3D36%26spage%3D849%26epage%3D861%26doi%3D10.1007%2Fs10803-006-0123-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Persico, A. M.</span><span> </span><span class="NLM_article-title">Autisms</span>. In  <span class="citation_source-book">Neural Circuit Development and Function in the Healthy and Diseased Brain: Comprehensive Developmental Neuroscience</span>; Vol.  <span class="NLM_volume">3</span>; <span class="NLM_contrib-group">Rakic, P.; Rubenstein, J.</span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">694</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FB978-0-12-397267-5.00045-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=651-694&author=A.+M.+Persicoauthor=P.+Rakic&author=J.+Rubenstein&title=Neural+Circuit+Development+and+Function+in+the+Healthy+and+Diseased+Brain%3A+Comprehensive+Developmental+Neuroscience"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-397267-5.00045-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-397267-5.00045-5%26sid%3Dliteratum%253Aachs%26aulast%3DPersico%26aufirst%3DA.%2BM.%26atitle%3DAutisms%26btitle%3DNeural%2520Circuit%2520Development%2520and%2520Function%2520in%2520the%2520Healthy%2520and%2520Diseased%2520Brain%253A%2520Comprehensive%2520Developmental%2520Neuroscience%26volume%3D3%26aulast%3DRakic%26aufirst%3DP.%26pub%3DElsevier%26date%3D2013%26spage%3D651%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Baio, J.</span><span> </span><span class="NLM_article-title">Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2010</span> <span class="citation_source-journal">MMWR Surveill. Summ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=1-21&author=J.+Baio&title=Prevalence+of+autism+spectrum+disorder+among+children+aged+8+years%E2%80%94autism+and+developmental+disabilities+monitoring+network%2C+11+sites%2C+United+States%2C+2010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaio%26aufirst%3DJ.%26atitle%3DPrevalence%2520of%2520autism%2520spectrum%2520disorder%2520among%2520children%2520aged%25208%2520years%25E2%2580%2594autism%2520and%2520developmental%2520disabilities%2520monitoring%2520network%252C%252011%2520sites%252C%2520United%2520States%252C%25202010%26jtitle%3DMMWR%2520Surveill.%2520Summ.%26date%3D2014%26volume%3D63%26spage%3D1%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Levy, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, R. T.</span><span> </span><span class="NLM_article-title">Autism</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">1627</span><span class="NLM_x">–</span> <span class="NLM_lpage">1638</span><span class="refDoi"> DOI: 10.1016/S0140-6736(09)61376-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0140-6736%2809%2961376-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2009&pages=1627-1638&author=S.+E.+Levyauthor=D.+S.+Mandellauthor=R.+T.+Schultz&title=Autism&doi=10.1016%2FS0140-6736%2809%2961376-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2809%2961376-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252809%252961376-3%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DS.%2BE.%26aulast%3DMandell%26aufirst%3DD.%2BS.%26aulast%3DSchultz%26aufirst%3DR.%2BT.%26atitle%3DAutism%26jtitle%3DLancet%26date%3D2009%26volume%3D374%26spage%3D1627%26epage%3D1638%26doi%3D10.1016%2FS0140-6736%2809%2961376-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">DiCicco-Bloom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwaigenbaum, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courchesne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dager, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. J.</span><span> </span><span class="NLM_article-title">The developmental neurobiology of autism spectrum disorder</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">6897</span><span class="NLM_x">–</span> <span class="NLM_lpage">6906</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1712-06.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1523%2FJNEUROSCI.1712-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=16807320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVGqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=6897-6906&author=E.+DiCicco-Bloomauthor=C.+Lordauthor=L.+Zwaigenbaumauthor=E.+Courchesneauthor=S.+R.+Dagerauthor=C.+Schmitzauthor=R.+T.+Schultzauthor=J.+Crawleyauthor=L.+J.+Young&title=The+developmental+neurobiology+of+autism+spectrum+disorder&doi=10.1523%2FJNEUROSCI.1712-06.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The developmental neurobiology of autism spectrum disorder</span></div><div class="casAuthors">DiCicco-Bloom, Emanuel; Lord, Catherine; Zwaigenbaum, Lonnie; Courchesne, Eric; Dager, Stephen R.; Schmitz, Christoph; Schultz, Robert T.; Crawley, Jacqueline; Young, Larry J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">6897-6906</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  Autism spectrum disorder (ASD) is a devastating childhood disorder that affects about 1 in 166 children.  ASD comprises several different disorders as defined by deficits in social behaviors and interactions that prevent the development of normal interpersonal relationships of affected patients with their parents, siblings, and other children.  Studies of the ASD brain using structural and functional imaging and neuropathol. techniques have revealed macroscopic and microscopic abnormalities of development.  Children with ASD show an increased postnatal brain growth trajectory, with the greatest differences occurring in rostral cerebral cortex, amygdala, and cerebellar hemispheres and reflecting greater changes in white than gray matter.  However, the underlying etiol. of ASD remains unclear.  Given the developmental origins of ASD and the identification of early behavioral and brain growth abnormalities, sensitive tools may soon become available to diagnose the disease during the first year of life.  Furthermore, genetic discoveries might also focus attention on a no. of developmental regulators and processes, neurotransmitter and synaptic components and possibly novel genetic mechanisms that contribute to ASD susceptibility in the context of specific environmental factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMUMN4iHT1IbVg90H21EOLACvtfcHk0lhMwLjrVGRLDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVGqtr0%253D&md5=9c0870580b94dc56518a676323e6d8da</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1712-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1712-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DDiCicco-Bloom%26aufirst%3DE.%26aulast%3DLord%26aufirst%3DC.%26aulast%3DZwaigenbaum%26aufirst%3DL.%26aulast%3DCourchesne%26aufirst%3DE.%26aulast%3DDager%26aufirst%3DS.%2BR.%26aulast%3DSchmitz%26aufirst%3DC.%26aulast%3DSchultz%26aufirst%3DR.%2BT.%26aulast%3DCrawley%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DL.%2BJ.%26atitle%3DThe%2520developmental%2520neurobiology%2520of%2520autism%2520spectrum%2520disorder%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D6897%26epage%3D6906%26doi%3D10.1523%2FJNEUROSCI.1712-06.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Bauman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemper, T. L.</span><span> </span><span class="NLM_article-title">Neuroanatomic observations of the brain in autism: a review and future directions</span> <span class="citation_source-journal">Int. J. Dev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span><span class="refDoi"> DOI: 10.1016/j.ijdevneu.2004.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.ijdevneu.2004.09.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=183-187&author=M.+L.+Baumanauthor=T.+L.+Kemper&title=Neuroanatomic+observations+of+the+brain+in+autism%3A+a+review+and+future+directions&doi=10.1016%2Fj.ijdevneu.2004.09.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ijdevneu.2004.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijdevneu.2004.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DBauman%26aufirst%3DM.%2BL.%26aulast%3DKemper%26aufirst%3DT.%2BL.%26atitle%3DNeuroanatomic%2520observations%2520of%2520the%2520brain%2520in%2520autism%253A%2520a%2520review%2520and%2520future%2520directions%26jtitle%3DInt.%2520J.%2520Dev.%2520Neurosci.%26date%3D2005%26volume%3D23%26spage%3D183%26epage%3D187%26doi%3D10.1016%2Fj.ijdevneu.2004.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Rice, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barone, S.,  Jr.</span><span> </span><span class="NLM_article-title">Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models</span> <span class="citation_source-journal">Environ. Health Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span><span class="refDoi"> DOI: 10.2307/3454543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.2307%2F3454543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10852851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252FhtVKktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2000&pages=511-533&author=D.+Riceauthor=S.+Barone&title=Critical+periods+of+vulnerability+for+the+developing+nervous+system%3A+evidence+from+humans+and+animal+models&doi=10.2307%2F3454543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models</span></div><div class="casAuthors">Rice D; Barone S Jr</div><div class="citationInfo"><span class="NLM_cas:title">Environmental health perspectives</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">108 Suppl 3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">511-33</span>
        ISSN:<span class="NLM_cas:issn">0091-6765</span>.
    </div><div class="casAbstract">Vulnerable periods during the development of the nervous system are sensitive to environmental insults because they are dependent on the temporal and regional emergence of critical developmental processes (i.e., proliferation, migration, differentiation, synaptogenesis, myelination, and apoptosis).  Evidence from numerous sources demonstrates that neural development extends from the embryonic period through adolescence.  In general, the sequence of events is comparable among species, although the time scales are considerably different.  Developmental exposure of animals or humans to numerous agents (e.g., X-ray irradiation, methylazoxymethanol, ethanol, lead, methyl mercury, or chlorpyrifos) demonstrates that interference with one or more of these developmental processes can lead to developmental neurotoxicity.  Different behavioral domains (e.g., sensory, motor, and various cognitive functions) are subserved by different brain areas.  Although there are important differences between the rodent and human brain, analogous structures can be identified.  Moreover, the ontogeny of specific behaviors can be used to draw inferences regarding the maturation of specific brain structures or neural circuits in rodents and primates, including humans.  Furthermore, various clinical disorders in humans (e.g., schizophrenia, dyslexia, epilepsy, and autism) may also be the result of interference with normal ontogeny of developmental processes in the nervous system.  Of critical concern is the possibility that developmental exposure to neurotoxicants may result in an acceleration of age-related decline in function.  This concern is compounded by the fact that developmental neurotoxicity that results in small effects can have a profound societal impact when amortized across the entire population and across the life span of humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7SmmI3YHPTx0LsK7uFuY7fW6udTcc2eZf4Ggs5ELVu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252FhtVKktQ%253D%253D&md5=88c1a16d6a945fbd0cc9485e49210bc9</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2307%2F3454543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2307%252F3454543%26sid%3Dliteratum%253Aachs%26aulast%3DRice%26aufirst%3DD.%26aulast%3DBarone%26aufirst%3DS.%26atitle%3DCritical%2520periods%2520of%2520vulnerability%2520for%2520the%2520developing%2520nervous%2520system%253A%2520evidence%2520from%2520humans%2520and%2520animal%2520models%26jtitle%3DEnviron.%2520Health%2520Perspect.%26date%3D2000%26volume%3D108%26spage%3D511%26epage%3D533%26doi%3D10.2307%2F3454543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Geschwind, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levitt, P.</span><span> </span><span class="NLM_article-title">Autism spectrum disorders: developmental disconnection syndromes</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span><span class="refDoi"> DOI: 10.1016/j.conb.2007.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.conb.2007.01.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=103-111&author=D.+H.+Geschwindauthor=P.+Levitt&title=Autism+spectrum+disorders%3A+developmental+disconnection+syndromes&doi=10.1016%2Fj.conb.2007.01.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.conb.2007.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.conb.2007.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26aulast%3DLevitt%26aufirst%3DP.%26atitle%3DAutism%2520spectrum%2520disorders%253A%2520developmental%2520disconnection%2520syndromes%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D2007%26volume%3D17%26spage%3D103%26epage%3D111%26doi%3D10.1016%2Fj.conb.2007.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Hahamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malach, R.</span><span> </span><span class="NLM_article-title">The idiosyncratic brain: distortion of spontaneous connectivity patterns in autism spectrum disorder</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span><span class="refDoi"> DOI: 10.1038/nn.3919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnn.3919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25599222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=302-309&author=A.+Hahamyauthor=M.+Behrmannauthor=R.+Malach&title=The+idiosyncratic+brain%3A+distortion+of+spontaneous+connectivity+patterns+in+autism+spectrum+disorder&doi=10.1038%2Fnn.3919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The idiosyncratic brain: distortion of spontaneous connectivity patterns in autism spectrum disorder</span></div><div class="casAuthors">Hahamy, Avital; Behrmann, Marlene; Malach, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">302-309</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autism spectrum disorder (ASD) has been assocd. with a redn. in resting state functional connectivity, though this assertion has recently been challenged by reports of increased connectivity in ASD.  To address these contradictory findings, we examd. both inter- and intrahemispheric functional connectivity in several resting state data sets acquired from adults with high-functioning ASD and matched control participants.  Our results reveal areas of both increased and decreased connectivity in multiple ASD groups as compared to control groups.  We propose that this heterogeneity stems from a previously unrecognized ASD characteristic: idiosyncratic distortions of the functional connectivity pattern relative to the typical, canonical template.  The magnitude of an individual's pattern distortion in homotopic interhemispheric connectivity correlated significantly with behavioral symptoms of ASD.  We propose that individualized alterations in functional connectivity organization are a core characteristic of high-functioning ASD, and that this may account for previous discrepant findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtc-acXprjL7Vg90H21EOLACvtfcHk0li6WY6y81u1iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKjsL8%253D&md5=bfbcd937350f17a93291e509125326eb</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnn.3919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3919%26sid%3Dliteratum%253Aachs%26aulast%3DHahamy%26aufirst%3DA.%26aulast%3DBehrmann%26aufirst%3DM.%26aulast%3DMalach%26aufirst%3DR.%26atitle%3DThe%2520idiosyncratic%2520brain%253A%2520distortion%2520of%2520spontaneous%2520connectivity%2520patterns%2520in%2520autism%2520spectrum%2520disorder%26jtitle%3DNat.%2520Neurosci.%26date%3D2015%26volume%3D18%26spage%3D302%26epage%3D309%26doi%3D10.1038%2Fnn.3919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Geschwind, D. H.</span><span> </span><span class="NLM_article-title">Genetics of autism spectrum disorders</span> <span class="citation_source-journal">Trends Cognit. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span><span class="refDoi"> DOI: 10.1016/j.tics.2011.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.tics.2011.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21855394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC3MjptlOhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=409-416&author=D.+H.+Geschwind&title=Genetics+of+autism+spectrum+disorders&doi=10.1016%2Fj.tics.2011.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Genetics of autism spectrum disorders</span></div><div class="casAuthors">Geschwind Daniel H</div><div class="citationInfo"><span class="NLM_cas:title">Trends in cognitive sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">409-16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Characterized by a combination of abnormalities in language, social cognition and mental flexibility, autism is not a single disorder but a neurodevelopmental syndrome commonly referred to as autism spectrum disorder (ASD).  Several dozen ASD susceptibility genes have been identified in the past decade, collectively accounting for 10-20% of ASD cases.  These findings, although demonstrating that ASD is etiologically heterogeneous, provide important clues about its pathophysiology.  Diverse genetic and genomic approaches provide evidence converging on disruption of key biological pathways, many of which are also implicated in other allied neurodevelopmental disorders.  Knowing the genes involved in ASD provides us with a crucial tool to probe both the specificity of ASD and the shared neurobiological and cognitive features across what are considered clinically distinct disorders, with the goal of linking gene to brain circuits to cognitive function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8jry8eEXXtTjk2McQZ6XmfW6udTcc2eaX539rTOPJ2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjptlOhtA%253D%253D&md5=8eebec6732562f1379bcdbdce8c22415</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tics.2011.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tics.2011.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26atitle%3DGenetics%2520of%2520autism%2520spectrum%2520disorders%26jtitle%3DTrends%2520Cognit.%2520Sci.%26date%3D2011%26volume%3D15%26spage%3D409%26epage%3D416%26doi%3D10.1016%2Fj.tics.2011.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Persico, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merelli, S.</span><span> </span><span class="NLM_article-title">Environmental factors and autism spectrum disorder</span> <span class="citation_source-journal">Curr. Dev. Disord. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span><span class="refDoi"> DOI: 10.1007/s40474-013-0002-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs40474-013-0002-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=8-19&author=A.+M.+Persicoauthor=S.+Merelli&title=Environmental+factors+and+autism+spectrum+disorder&doi=10.1007%2Fs40474-013-0002-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs40474-013-0002-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40474-013-0002-2%26sid%3Dliteratum%253Aachs%26aulast%3DPersico%26aufirst%3DA.%2BM.%26aulast%3DMerelli%26aufirst%3DS.%26atitle%3DEnvironmental%2520factors%2520and%2520autism%2520spectrum%2520disorder%26jtitle%3DCurr.%2520Dev.%2520Disord.%2520Rep.%26date%3D2014%26volume%3D1%26spage%3D8%26epage%3D19%26doi%3D10.1007%2Fs40474-013-0002-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Young, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suckling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron-Cohen, S.</span><span> </span><span class="NLM_article-title">From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition</span> <span class="citation_source-journal">Mol. Autism</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="refDoi"> DOI: 10.1186/s13229-016-0068-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2Fs13229-016-0068-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26793298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslKgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=9&author=A.+M.+Youngauthor=B.+Chakrabartiauthor=D.+Robertsauthor=M.+C.+Laiauthor=J.+Sucklingauthor=S.+Baron-Cohen&title=From+molecules+to+neural+morphology%3A+understanding+neuroinflammation+in+autism+spectrum+condition&doi=10.1186%2Fs13229-016-0068-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition</span></div><div class="casAuthors">Young, Adam M. H.; Chakrabarti, Bhismadev; Roberts, David; Lai, Meng-Chuan; Suckling, John; Baron-Cohen, Simon</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Autism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9/1-9/8</span>CODEN:
                <span class="NLM_cas:coden">MAOUBR</span>;
        ISSN:<span class="NLM_cas:issn">2040-2392</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Growing evidence points toward a crit. role for early (prenatal) atypical neurodevelopmental processes in the etiol. of autism spectrum condition (ASC).  One such process that could impact early neural development is inflammation.  We review the evidence for atypical expression of mol. markers in the amniotic fluid, serum, cerebrospinal fluid (CSF), and the brain parenchyma that suggest a role for inflammation in the emergence of ASC.  This is complemented with a no. of neuroimaging and neuropathol. studies describing microglial activation.  Implications for treatment are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojpUDM7nzEJrVg90H21EOLACvtfcHk0li6WY6y81u1iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslKgsLY%253D&md5=19d6c2f2a023cdf8d40f6edbe5434a60</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1186%2Fs13229-016-0068-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13229-016-0068-x%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DA.%2BM.%26aulast%3DChakrabarti%26aufirst%3DB.%26aulast%3DRoberts%26aufirst%3DD.%26aulast%3DLai%26aufirst%3DM.%2BC.%26aulast%3DSuckling%26aufirst%3DJ.%26aulast%3DBaron-Cohen%26aufirst%3DS.%26atitle%3DFrom%2520molecules%2520to%2520neural%2520morphology%253A%2520understanding%2520neuroinflammation%2520in%2520autism%2520spectrum%2520condition%26jtitle%3DMol.%2520Autism%26date%3D2016%26volume%3D7%26spage%3D9%26doi%3D10.1186%2Fs13229-016-0068-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ji, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findling, R. L.</span><span> </span><span class="NLM_article-title">An update on pharmacotherapy for autism spectrum disorder in children and adolescents</span> <span class="citation_source-journal">Curr. Opin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span><span class="refDoi"> DOI: 10.1097/YCO.0000000000000132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1097%2FYCO.0000000000000132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25602248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2Mvns1yiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=91-101&author=N.+Jiauthor=R.+L.+Findling&title=An+update+on+pharmacotherapy+for+autism+spectrum+disorder+in+children+and+adolescents&doi=10.1097%2FYCO.0000000000000132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">An update on pharmacotherapy for autism spectrum disorder in children and adolescents</span></div><div class="casAuthors">Ji Na  Young; Findling Robert L</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in psychiatry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-101</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  Although there is no known efficacious pharmacotherapy for core symptoms of autism spectrum disorder (ASD), psychotropic medications are commonly prescribed for behavioral/emotional symptoms associated with ASD.  We reviewed current evidence-based pharmacotherapy options and updates from recent noteworthy studies.  RECENT FINDINGS:  Atypical antipsychotics, particularly risperidone and aripiprazole, are effective in reducing irritability, stereotypy and hyperactivity.  Metabolic adverse events, including weight gain and dyslipidemia, are common.  Methylphenidate is effective in reducing attention-deficit hyperactivity disorder (ADHD) symptoms.  Atomoxetine and alpha-2 agonists appear effective in reducing ADHD symptoms.  Selective serotonin reuptake inhibitors are not effective in improving repetitive behaviors in children with ASD, and frequently cause activating adverse events.  Efficacy of antiepileptic drugs is inconclusive.  Overall, efficacy and tolerability of pharmacotherapy in children with ASD are less favorable than data seen in typically developing children with similar symptoms.  Newer agents, including glutamatergic agents and oxytocin, appear promising albeit with mixed results.  SUMMARY:  Current evidence-based pharmacotherapy options in children with ASD are very limited, and many have substantial adverse events.  Clinicians should use pharmacotherapy as a part of comprehensive treatment, and judiciously weigh risks and benefits.  New pharmacotherapy options for core symptoms as well as co-occurring symptoms of ASD are in urgent need.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7z98uqLHqqtXdcedVHT5tfW6udTcc2eaATwAmyq_XVrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mvns1yiug%253D%253D&md5=84b1b3c456e743b6f7ac916a87189fab</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1097%2FYCO.0000000000000132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FYCO.0000000000000132%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DN.%26aulast%3DFindling%26aufirst%3DR.%2BL.%26atitle%3DAn%2520update%2520on%2520pharmacotherapy%2520for%2520autism%2520spectrum%2520disorder%2520in%2520children%2520and%2520adolescents%26jtitle%3DCurr.%2520Opin.%2520Psychiatry%26date%3D2015%26volume%3D28%26spage%3D91%26epage%3D101%26doi%3D10.1097%2FYCO.0000000000000132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Matera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmieri, V. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagaria, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margari, F.</span><span> </span><span class="NLM_article-title">Risperidone and cardiometabolic risk in children and adolescents: clinical and instrumental issues</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span><span class="refDoi"> DOI: 10.1097/JCP.0000000000000688</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1097%2FJCP.0000000000000688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=28338545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvF2qurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=302-309&author=E.+Materaauthor=L.+Margariauthor=V.+O.+Palmieriauthor=G.+Zagariaauthor=R.+Palumbiauthor=F.+Margari&title=Risperidone+and+cardiometabolic+risk+in+children+and+adolescents%3A+clinical+and+instrumental+issues&doi=10.1097%2FJCP.0000000000000688"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Risperidone and Cardiometabolic Risk in Children and Adolescents: Clinical and Instrumental Issues</span></div><div class="casAuthors">Matera, Emilia; Margari, Lucia; Palmieri, Vincenzo Ostilio; Zagaria, Giuseppina; Palumbi, Roberto; Margari, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">302-309</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose/background: Although second-generation antipsychotics are used to treat and manage symptoms for several psychiatric disorders, data about their adverse effects in developmental age are limited.  The aim of this prospective observational study was to verify the cardiovascular and metabolic risk in a sample of antipsychotic-naive children/adolescent patients starting risperidone therapy.  Methods: Twenty-two patients, younger than 18 years, were recruited.  The assessment included anthropometric data, cardiovascular parameters, blood tests, and ultrasonog. abdominal study.  Results: After an av. follow-up period of 7.6 mo, statistically significant increases in mean values of waist circumference, body mass index (BMI), BMI percentile, BMI z score, total cholesterol, and prolactin were found.  Other cardiometabolic parameters showed an upward trend in time.  Subjects in pubertal/postpubertal stage and female patients were more susceptible to developing cardiometabolic changes.  Moreover, significant correlations between changes in anthropometric and several metabolic parameters were found.  A tendency to change in constitution of the liver parenchyma and distribution of the abdominal fat mass with ultrasonog. abdominal study was also evident.  Conclusions: In our sample, several metabolic parameters showed a sensitivity to risperidone treatment.  Because most of these parameters are age dependent, metabolic syndrome criteria used for adults were inappropriate in children and adolescents.  Periodic clin. and instrumental evaluations and guidelines for monitoring of any metabolic, lab., and instrumental complications are necessary in the perspective of even long-time second-generation antipsychotics treatment in children and adolescents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt1k9nAYP1GrVg90H21EOLACvtfcHk0lhWsNVtK27zFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvF2qurw%253D&md5=9cb2b034b9aaff17922c9f4622657dd6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1097%2FJCP.0000000000000688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJCP.0000000000000688%26sid%3Dliteratum%253Aachs%26aulast%3DMatera%26aufirst%3DE.%26aulast%3DMargari%26aufirst%3DL.%26aulast%3DPalmieri%26aufirst%3DV.%2BO.%26aulast%3DZagaria%26aufirst%3DG.%26aulast%3DPalumbi%26aufirst%3DR.%26aulast%3DMargari%26aufirst%3DF.%26atitle%3DRisperidone%2520and%2520cardiometabolic%2520risk%2520in%2520children%2520and%2520adolescents%253A%2520clinical%2520and%2520instrumental%2520issues%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2017%26volume%3D37%26spage%3D302%26epage%3D309%26doi%3D10.1097%2FJCP.0000000000000688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Margari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petruzzelli, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamanna, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmieri, V. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margari, F.</span><span> </span><span class="NLM_article-title">Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span><span class="refDoi"> DOI: 10.1097/YIC.0000000000000063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1097%2FYIC.0000000000000063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25514607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2MznvFKqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2015&pages=103-108&author=L.+Margariauthor=E.+Materaauthor=M.+G.+Petruzzelliauthor=M.+Simoneauthor=A.+L.+Lamannaauthor=A.+Pastoreauthor=V.+O.+Palmieriauthor=F.+Margari&title=Prolactin+variations+during+risperidone+therapy+in+a+sample+of+drug-naive+children+and+adolescents&doi=10.1097%2FYIC.0000000000000063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents</span></div><div class="casAuthors">Margari Lucia; Matera Emilia; Petruzzelli Maria G; Simone Marta; Lamanna Anna L; Pastore Adriana; Palmieri Vincenzo O; Margari Francesco</div><div class="citationInfo"><span class="NLM_cas:title">International clinical psychopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">103-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The aim of this prospective observational study was to investigate the variations of serum prolactin hormone (PRL) in a sample of 34 drug-naive patients (mean age 13 years) who started risperidone therapy assuming that several factors may favor the increase in serum PRL.  Serum PRL and hyperprolactinemia clinical signs were examined at baseline (T0) and after almost 3 months of treatment (T1).  We considered sex, pubertal status, risperidone dosage, psychiatric diagnosis, and any personal/family history of autoimmune diseases.  The mean serum PRL value increased between T0 and T1 (P=0.004).  The mean serum PRL was higher in females in the pubertal/postpubertal stage and for risperidone dosage up 1 mg/day.  Hyperprolactinemia was found in 20% of patients at T0 and in 38% of patients at T1 (P=0.03).  The mean serum PRL increase was greater in early-onset schizophrenia spectrum psychosis patients compared with no-early-onset schizophrenia spectrum psychosis patients (P=0.04).  The increase in PRL was higher in patients with a personal and a family history of autoimmune diseases.  This study suggests that the increase in serum PRL in patients treated with risperidone may be linked not only to the drug and its dosage but also to several risk factors such as sex, pubertal stage, psychiatric disease, and autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRWhnKWAUjbzLxanA7vODO6fW6udTcc2eaATwAmyq_XVrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MznvFKqtA%253D%253D&md5=11ff8f08314d95c90ce390623c25bb7f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1097%2FYIC.0000000000000063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FYIC.0000000000000063%26sid%3Dliteratum%253Aachs%26aulast%3DMargari%26aufirst%3DL.%26aulast%3DMatera%26aufirst%3DE.%26aulast%3DPetruzzelli%26aufirst%3DM.%2BG.%26aulast%3DSimone%26aufirst%3DM.%26aulast%3DLamanna%26aufirst%3DA.%2BL.%26aulast%3DPastore%26aufirst%3DA.%26aulast%3DPalmieri%26aufirst%3DV.%2BO.%26aulast%3DMargari%26aufirst%3DF.%26atitle%3DProlactin%2520variations%2520during%2520risperidone%2520therapy%2520in%2520a%2520sample%2520of%2520drug-naive%2520children%2520and%2520adolescents%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D2015%26volume%3D30%26spage%3D103%26epage%3D108%26doi%3D10.1097%2FYIC.0000000000000063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Margari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petruzzelli, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmieri, V. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margari, F.</span><span> </span><span class="NLM_article-title">Tolerability and safety profile of risperidone in a sample of children and adolescents</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1097/YIC.0b013e328362497b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1097%2FYIC.0b013e328362497b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=23689836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC3snlt1Cktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=177-183&author=L.+Margariauthor=E.+Materaauthor=F.+Craigauthor=M.+G.+Petruzzelliauthor=V.+O.+Palmieriauthor=A.+Pastoreauthor=F.+Margari&title=Tolerability+and+safety+profile+of+risperidone+in+a+sample+of+children+and+adolescents&doi=10.1097%2FYIC.0b013e328362497b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Tolerability and safety profile of risperidone in a sample of children and adolescents</span></div><div class="casAuthors">Margari Lucia; Matera Emilia; Craig Francesco; Petruzzelli Maria G; Palmieri Vincenzo O; Pastore Adriana; Margari Francesco</div><div class="citationInfo"><span class="NLM_cas:title">International clinical psychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">177-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The aim of this prospective observational study was to verify the tolerability and safety profile of risperidone in a sample of antipsychotic-naive children/adolescent patients having a different psychiatric diagnosis.  Twenty-two (mean age of 12±3.2) antipsychotic-naive patients who started therapy with risperidone were recruited.  The assessment involved anthropometric data (weight, height, BMI, BMI z-score and BMI percentile), cardiovascular parameters (blood pressure and QTc interval) and blood tests (levels of glucose, triglycerides, total cholesterol, glutamic oxaloacetic and pyruvic transaminases, γ-glutamyl transferase, prolactin, free triiodothyronine, free thyroxine, thyroid-stimulating hormone, thyroglobulin, antithyroid peroxidase and antithyroglobulin).  After an average follow-up of 6 months of risperidone therapy, a statistically significant increase in weight and body composition was observed.  Furthermore, an increase in serum levels of prolactin was observed in 50% of patients.  No other significant changes in metabolic and cardiovascular parameters were found.  Although an increase in these parameters was detected, it remained in the normal range.  This study suggests the use of specific protocols for monitoring children/adolescents treated with second-generation antipsychotics to manage the metabolic long-term complications and progression to more severe disease states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRsLI4Tm6tClpNiNltV31zlfW6udTcc2eYn50XExZpW0bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snlt1Cktg%253D%253D&md5=9975ded4a704989f8bf80c43b2ba78f1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1097%2FYIC.0b013e328362497b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FYIC.0b013e328362497b%26sid%3Dliteratum%253Aachs%26aulast%3DMargari%26aufirst%3DL.%26aulast%3DMatera%26aufirst%3DE.%26aulast%3DCraig%26aufirst%3DF.%26aulast%3DPetruzzelli%26aufirst%3DM.%2BG.%26aulast%3DPalmieri%26aufirst%3DV.%2BO.%26aulast%3DPastore%26aufirst%3DA.%26aulast%3DMargari%26aufirst%3DF.%26atitle%3DTolerability%2520and%2520safety%2520profile%2520of%2520risperidone%2520in%2520a%2520sample%2520of%2520children%2520and%2520adolescents%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D2013%26volume%3D28%26spage%3D177%26epage%3D183%26doi%3D10.1097%2FYIC.0b013e328362497b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">McDougle, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stigler, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posey, D. J.</span><span> </span><span class="NLM_article-title">Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=18533764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1WqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2008&pages=15-20&issue=Suppl+4&author=C.+J.+McDougleauthor=K.+A.+Stiglerauthor=C.+A.+Ericksonauthor=D.+J.+Posey&title=Atypical+antipsychotics+in+children+and+adolescents+with+autistic+and+other+pervasive+developmental+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders</span></div><div class="casAuthors">McDougle, Christopher J.; Stigler, Kimberly A.; Erickson, Craig A.; Posey, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry (Memphis, TN, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">Suppl. 4</span>),
    <span class="NLM_cas:pages">15-20</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review.  Atypical antipsychotics are emerging as the first-line pharmacol. treatment for irritability (i.e., aggression, self-injurious behavior, and severe tantrums) in children and adolescents with autistic and other pervasive developmental disorders.  Results from placebo-controlled and open-label studies of clozapine, risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole in this subject population are reviewed.  Addnl. placebo-controlled trials and studies of longer-term safety and tolerability are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsFmS7i1CdW7Vg90H21EOLACvtfcHk0lh0nN89S_p0wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1WqsL4%253D&md5=edb581577b458cbeb8c2b2f33cd671ec</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcDougle%26aufirst%3DC.%2BJ.%26aulast%3DStigler%26aufirst%3DK.%2BA.%26aulast%3DErickson%26aufirst%3DC.%2BA.%26aulast%3DPosey%26aufirst%3DD.%2BJ.%26atitle%3DAtypical%2520antipsychotics%2520in%2520children%2520and%2520adolescents%2520with%2520autistic%2520and%2520other%2520pervasive%2520developmental%2520disorders%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2008%26volume%3D69%26issue%3DSuppl%25204%26spage%3D15%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">McCracken, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGough, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aman, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollway, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDougle, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swiezy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scahill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tierney, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghuman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitiello, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, D.</span><span> </span><span class="NLM_article-title">Research units on pediatric psychopharmacology autism network. Risperidone in children with autism and serious behavioral problems</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span><span class="refDoi"> DOI: 10.1056/NEJMoa013171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1056%2FNEJMoa013171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=12151468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD38XlslWqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=314-321&author=J.+T.+McCrackenauthor=J.+McGoughauthor=B.+Shahauthor=P.+Croninauthor=D.+Hongauthor=M.+G.+Amanauthor=L.+E.+Arnoldauthor=R.+Lindsayauthor=P.+Nashauthor=J.+Hollwayauthor=C.+J.+McDougleauthor=D.+Poseyauthor=N.+Swiezyauthor=A.+Kohnauthor=L.+Scahillauthor=A.+Martinauthor=K.+Koenigauthor=F.+Volkmarauthor=D.+Carrollauthor=A.+Lancorauthor=E.+Tierneyauthor=J.+Ghumanauthor=N.+M.+Gonzalezauthor=M.+Gradosauthor=B.+Vitielloauthor=L.+Ritzauthor=M.+Daviesauthor=J.+Robinsonauthor=D.+McMahon&title=Research+units+on+pediatric+psychopharmacology+autism+network.+Risperidone+in+children+with+autism+and+serious+behavioral+problems&doi=10.1056%2FNEJMoa013171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Risperidone in children with autism and serious behavioral problems</span></div><div class="casAuthors">McCracken, James T.; McGough, James; Shah, Bhavik; Cronin, Pegeen; Hong, Daniel; Aman, Michael G.; Arnold, L. Eugene; Lindsay, Ronald; Nash, Patricia; Hollway, Jill; McDougle, Christopher J.; Posey, David; Swiezy, Naomi; Kohn, Arlene; Schaill, Lawrence; Martin, Andres; Koenig, Kathleen; Volkmar, Fred; Carroll, Deirdre; Lancor, Allison; Tierney, Elaine; Ghuman, Jaswinder; Gonzalez, Nilda M.; Grados, Marco; Vitiello, Benedetto; Ritz, Louise; Davies, Mark; Robinson, James; McMahon, Don</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">314-321</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Atypical antipsychotic agents, which block postsynaptic dopamine and serotonin receptors, have advantages over traditional antipsychotic medications in the treatment of adults with schizophrenia and may be beneficial in children with autistic disorder who have serious behavioral disturbances.  However, data on the safety and efficacy of atypical antipsychotic agents in children are limited.  We conducted a multisite, randomized, double-blind trial of risperidone as compared with placebo for the treatment of autistic disorder accompanied by severe tantrums, aggression, or self-injurious behavior in children 5 to 17 yr old.  The primary outcome measures were the score on the Irritability sub-scale of the Aberrant Behavior Checklist and the rating on the Clin. Global Impressions-Improvement (CGI-I) scale at eight weeks.  A total of 101 children (82 boys and 19 girls; mean [SD] age, 8.82.7 yr) were randomly assigned to receive risperidone (49 children) or placebo (52).  Treatment with risperidone for eight weeks (dose range, 0.5 to 3.5 mg per day) resulted in a 56.9 % redn. in the Irritability score, as compared with a 14.1 % decrease in the placebo group (P<0.001).  The rate of a pos. response, defined as at least a 25 % decrease in the Irritability score and a rating of much improved or very much improved on the CGI-I scale, was 69 % in the risperidone group (34 of 49 children had a pos. response) and 12 % in the placebo group (6 of 52, P<0.001).  Risperidone therapy was assocd. with an av. wt. gain of 2.72.9 kg, as compared with 0.82.2 kg with placebo (P<0.001).  Increased appetite, fatigue, drowsiness, dizziness, and drooling were more common in the risperidone group than in the placebo group (P< 0.05 for each comparison).  In two thirds of the children with a pos. response to risperidone at eight weeks (23 of 34), the benefit was maintained at six months.  Risperidone was effective and well tolerated for the treatment of tantrums, aggression, or self-injurious behavior in children with autistic disorder.  The short period of this trial limits inferences about adverse effects such as tardive dyskinesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqldDtdrxrpnrVg90H21EOLACvtfcHk0lj18F3g3IqGkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlslWqt7Y%253D&md5=01efa8c7a2285ceae5a0cd646c165626</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa013171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa013171%26sid%3Dliteratum%253Aachs%26aulast%3DMcCracken%26aufirst%3DJ.%2BT.%26aulast%3DMcGough%26aufirst%3DJ.%26aulast%3DShah%26aufirst%3DB.%26aulast%3DCronin%26aufirst%3DP.%26aulast%3DHong%26aufirst%3DD.%26aulast%3DAman%26aufirst%3DM.%2BG.%26aulast%3DArnold%26aufirst%3DL.%2BE.%26aulast%3DLindsay%26aufirst%3DR.%26aulast%3DNash%26aufirst%3DP.%26aulast%3DHollway%26aufirst%3DJ.%26aulast%3DMcDougle%26aufirst%3DC.%2BJ.%26aulast%3DPosey%26aufirst%3DD.%26aulast%3DSwiezy%26aufirst%3DN.%26aulast%3DKohn%26aufirst%3DA.%26aulast%3DScahill%26aufirst%3DL.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DKoenig%26aufirst%3DK.%26aulast%3DVolkmar%26aufirst%3DF.%26aulast%3DCarroll%26aufirst%3DD.%26aulast%3DLancor%26aufirst%3DA.%26aulast%3DTierney%26aufirst%3DE.%26aulast%3DGhuman%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DN.%2BM.%26aulast%3DGrados%26aufirst%3DM.%26aulast%3DVitiello%26aufirst%3DB.%26aulast%3DRitz%26aufirst%3DL.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DMcMahon%26aufirst%3DD.%26atitle%3DResearch%2520units%2520on%2520pediatric%2520psychopharmacology%2520autism%2520network.%2520Risperidone%2520in%2520children%2520with%2520autism%2520and%2520serious%2520behavioral%2520problems%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26spage%3D314%26epage%3D321%26doi%3D10.1056%2FNEJMoa013171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Moore, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichner, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. R.</span><span> </span><span class="NLM_article-title">Treating functional impairment of autism with selective serotonin-reuptake inhibitors</span> <span class="citation_source-journal">Ann. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1519</span><span class="refDoi"> DOI: 10.1345/aph.1D543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1345%2Faph.1D543" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2004&pages=1515-1519&author=M.+L.+Mooreauthor=S.+F.+Eichnerauthor=J.+R.+Jones&title=Treating+functional+impairment+of+autism+with+selective+serotonin-reuptake+inhibitors&doi=10.1345%2Faph.1D543"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1345%2Faph.1D543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1345%252Faph.1D543%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DM.%2BL.%26aulast%3DEichner%26aufirst%3DS.%2BF.%26aulast%3DJones%26aufirst%3DJ.%2BR.%26atitle%3DTreating%2520functional%2520impairment%2520of%2520autism%2520with%2520selective%2520serotonin-reuptake%2520inhibitors%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2004%26volume%3D38%26spage%3D1515%26epage%3D1519%26doi%3D10.1345%2Faph.1D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brignell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silove, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazell, P.</span><span> </span><span class="NLM_article-title">Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD004677</span><span class="refDoi"> DOI: 10.1002/14651858.CD004677.pub3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2F14651858.CD004677.pub3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=CD004677&author=K.+Williamsauthor=A.+Brignellauthor=M.+Randallauthor=N.+Siloveauthor=P.+Hazell&title=Selective+serotonin+reuptake+inhibitors+%28SSRIs%29+for+autism+spectrum+disorders+%28ASD%29&doi=10.1002%2F14651858.CD004677.pub3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD004677.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD004677.pub3%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DBrignell%26aufirst%3DA.%26aulast%3DRandall%26aufirst%3DM.%26aulast%3DSilove%26aufirst%3DN.%26aulast%3DHazell%26aufirst%3DP.%26atitle%3DSelective%2520serotonin%2520reuptake%2520inhibitors%2520%2528SSRIs%2529%2520for%2520autism%2520spectrum%2520disorders%2520%2528ASD%2529%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2013%26volume%3D8%26spage%3DCD004677%26doi%3D10.1002%2F14651858.CD004677.pub3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Hurwitz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackmore, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolfenden, S.</span><span> </span><span class="NLM_article-title">Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD008372</span><span class="refDoi"> DOI: 10.1002/14651858.CD008372.pub2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2F14651858.CD008372.pub2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=CD008372&author=R.+Hurwitzauthor=R.+Blackmoreauthor=P.+Hazellauthor=K.+Williamsauthor=S.+Woolfenden&title=Tricyclic+antidepressants+for+autism+spectrum+disorders+%28ASD%29+in+children+and+adolescents&doi=10.1002%2F14651858.CD008372.pub2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD008372.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD008372.pub2%26sid%3Dliteratum%253Aachs%26aulast%3DHurwitz%26aufirst%3DR.%26aulast%3DBlackmore%26aufirst%3DR.%26aulast%3DHazell%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DWoolfenden%26aufirst%3DS.%26atitle%3DTricyclic%2520antidepressants%2520for%2520autism%2520spectrum%2520disorders%2520%2528ASD%2529%2520in%2520children%2520and%2520adolescents%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2012%26volume%3D3%26spage%3DCD008372%26doi%3D10.1002%2F14651858.CD008372.pub2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Hirota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veenstra-Vanderweele, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishi, T.</span><span> </span><span class="NLM_article-title">Antiepileptic medications in autism spectrum disorder: a systematic review and meta-analysis</span> <span class="citation_source-journal">J. Autism Dev. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">948</span><span class="NLM_x">–</span> <span class="NLM_lpage">957</span><span class="refDoi"> DOI: 10.1007/s10803-013-1952-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs10803-013-1952-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24077782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FitFemsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=948-957&author=T.+Hirotaauthor=J.+Veenstra-Vanderweeleauthor=E.+Hollanderauthor=T.+Kishi&title=Antiepileptic+medications+in+autism+spectrum+disorder%3A+a+systematic+review+and+meta-analysis&doi=10.1007%2Fs10803-013-1952-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Antiepileptic medications in autism spectrum disorder: a systematic review and meta-analysis</span></div><div class="casAuthors">Hirota Tomoya; Veenstra-Vanderweele Jeremy; Hollander Eric; Kishi Taro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autism and developmental disorders</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">948-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Electroencephalogram-recorded epileptiform activity is common in children with autism spectrum disorder (ASD), even without clinical seizures.  A systematic literature search identified 7 randomized, placebo-controlled trials of antiepileptic drugs (AEDs) in ASD (total n = 171), including three of valproate, and one each of lamotrigine, levetiracetam, and topiramate.  Meta-analysis revealed no significant difference between medication and placebo in four studies targeting irritability/agitation and three studies investigating global improvement, although limitations include lack of power and different medications with diverse actions.  Across all seven studies, there was no significant difference in discontinuation rate between two groups.  AEDs do not appear to have a large effect size to treat behavioral symptoms in ASD, but further research is needed, particularly in the subgroup of patients with epileptiform abnormalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRWoKJoTs3QNuxsqfvU0ziafW6udTcc2eZZP8McH24aYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FitFemsw%253D%253D&md5=c3ff2944874d87b611e8d221d272c4b2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs10803-013-1952-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10803-013-1952-2%26sid%3Dliteratum%253Aachs%26aulast%3DHirota%26aufirst%3DT.%26aulast%3DVeenstra-Vanderweele%26aufirst%3DJ.%26aulast%3DHollander%26aufirst%3DE.%26aulast%3DKishi%26aufirst%3DT.%26atitle%3DAntiepileptic%2520medications%2520in%2520autism%2520spectrum%2520disorder%253A%2520a%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DJ.%2520Autism%2520Dev.%2520Disord.%26date%3D2014%26volume%3D44%26spage%3D948%26epage%3D957%26doi%3D10.1007%2Fs10803-013-1952-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Perry, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Ruiz, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Court, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volsen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folly, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iversen, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenk, G. L.</span><span> </span><span class="NLM_article-title">Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1058</span><span class="NLM_x">–</span> <span class="NLM_lpage">1066</span><span class="refDoi"> DOI: 10.1176/appi.ajp.158.7.1058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1176%2Fappi.ajp.158.7.1058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=11431227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD3MznsVegtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2001&pages=1058-1066&author=E.+K.+Perryauthor=M.+L.+Leeauthor=C.+M.+Martin-Ruizauthor=J.+A.+Courtauthor=S.+G.+Volsenauthor=J.+Merritauthor=E.+Follyauthor=P.+E.+Iversenauthor=M.+L.+Baumanauthor=R.+H.+Perryauthor=G.+L.+Wenk&title=Cholinergic+activity+in+autism%3A+abnormalities+in+the+cerebral+cortex+and+basal+forebrain&doi=10.1176%2Fappi.ajp.158.7.1058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain</span></div><div class="casAuthors">Perry E K; Lee M L; Martin-Ruiz C M; Court J A; Volsen S G; Merrit J; Folly E; Iversen P E; Bauman M L; Perry R H; Wenk G L</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1058-66</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Measures of cholinergic transmitter activity were investigated in patients with autism because of reported neuropathological abnormalities in cholinergic nuclei in the basal forebrain.  METHOD:  Levels of cholinergic enzyme and receptor activity were measured in the frontal and parietal cerebral cortex of deceased autistic adults, similarly aged normal adults without mental retardation, and nonautistic mentally retarded adults.  The immunoreactivity levels of brain-derived neurotrophic factor and nerve growth factor were measured in the basal forebrain.  RESULTS:  There were no differences between the autistic and comparison groups in choline acetyltransferase or acetylcholinesterase activity in the cerebral cortex and basal forebrain or in muscarinic M(2) receptor or alpha-bungarotoxin binding within the cortex.  Cortical M(1) receptor binding was up to 30% lower than normal in the autistic subjects, and the difference reached significance in the parietal cortex.  In both the parietal and frontal cortices, differences in nicotinic receptors assessed by [(3)H]epibatidine binding were significant and extensive (65%-73% lower in the autistic group than in the normal subjects); there were no differences in nicotine binding in the basal forebrain.  Immunochemical analysis indicated lower levels of both the alpha(4) and beta(2) nicotinic receptor subunits in the parietal cortex.  The M(1) receptor abnormality was not evident in the nonautistic group with mental retardation, although the lower [(3)H]epibatidine binding was apparent.  In the basal forebrain, the level of brain-derived neurotrophic factor in the autistic group was three times as high as the level of the normal group.  CONCLUSIONS:  These neurochemical abnormalities implicate the cholinergic system in developmental disorders such as autism and suggest the potential for intervention based on cholinergic receptor modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcx_1FDHwS4RpyrDyM_m9cfW6udTcc2eamdWnlX3F0fLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MznsVegtA%253D%253D&md5=d0533418769a83b9d842b4baedaee4cd</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.158.7.1058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.158.7.1058%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DE.%2BK.%26aulast%3DLee%26aufirst%3DM.%2BL.%26aulast%3DMartin-Ruiz%26aufirst%3DC.%2BM.%26aulast%3DCourt%26aufirst%3DJ.%2BA.%26aulast%3DVolsen%26aufirst%3DS.%2BG.%26aulast%3DMerrit%26aufirst%3DJ.%26aulast%3DFolly%26aufirst%3DE.%26aulast%3DIversen%26aufirst%3DP.%2BE.%26aulast%3DBauman%26aufirst%3DM.%2BL.%26aulast%3DPerry%26aufirst%3DR.%2BH.%26aulast%3DWenk%26aufirst%3DG.%2BL.%26atitle%3DCholinergic%2520activity%2520in%2520autism%253A%2520abnormalities%2520in%2520the%2520cerebral%2520cortex%2520and%2520basal%2520forebrain%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2001%26volume%3D158%26spage%3D1058%26epage%3D1066%26doi%3D10.1176%2Fappi.ajp.158.7.1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Rossignol, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, R. E.</span><span> </span><span class="NLM_article-title">The use of medications approved for Alzheimer’s disease in autism spectrum disorder: a systematic review</span> <span class="citation_source-journal">Front. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="refDoi"> DOI: 10.3389/fped.2014.00087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3389%2Ffped.2014.00087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25202686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252Fps1ahtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=87&author=D.+A.+Rossignolauthor=R.+E.+Frye&title=The+use+of+medications+approved+for+Alzheimer%E2%80%99s+disease+in+autism+spectrum+disorder%3A+a+systematic+review&doi=10.3389%2Ffped.2014.00087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review</span></div><div class="casAuthors">Rossignol Daniel A; Frye Richard E</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pediatrics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autism spectrum disorder (ASD) is a neurodevelopmental disorder that affects 1 in 68 children in the United States.  Even though it is a common disorder, only two medications (risperidone and aripiprazole) are approved by the U.S.  Food and Drug Administration (FDA) to treat symptoms associated with ASD.  However, these medications are approved to treat irritability, which is not a core symptom of ASD.  A number of novel medications, which have not been approved by the FDA to treat ASD have been used off-label in some studies to treat ASD symptoms, including medications approved for Alzheimer's disease.  Interestingly, some of these studies are high-quality, double-blind, placebo-controlled (DBPC) studies.  This article systematically reviews studies published through April, 2014, which examined the use of Alzheimer's medications in ASD, including donepezil (seven studies, two were DBPC, five out of seven reported improvements), galantamine (four studies, two were DBPC, all reported improvements), rivastigmine (one study reporting improvements), tacrine (one study reporting improvements), and memantine (nine studies, one was DBPC, eight reported improvements).  An evidence-based scale was used to rank each medication.  Collectively, these studies reported improvements in expressive language and communication, receptive language, social interaction, irritability, hyperactivity, attention, eye contact, emotional lability, repetitive or self-stimulatory behaviors, motor planning, disruptive behaviors, obsessive-compulsive symptoms, lethargy, overall ASD behaviors, and increased REM sleep.  Reported side effects are reviewed and include irritability, gastrointestinal problems, verbal or behavioral regression, headaches, irritability, rash, tremor, sedation, vomiting, and speech problems.  Both galantamine and memantine had sufficient evidence ranking for improving both core and associated symptoms of ASD.  Given the lack of medications approved to treat ASD, further studies on novel medications, including Alzheimer's disease medications, are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVuIz0BrbXQXqj_yg7twvpfW6udTcc2eamdWnlX3F0fLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252Fps1ahtA%253D%253D&md5=f1ed3002839bfe400cb142be50d85e38</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.3389%2Ffped.2014.00087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffped.2014.00087%26sid%3Dliteratum%253Aachs%26aulast%3DRossignol%26aufirst%3DD.%2BA.%26aulast%3DFrye%26aufirst%3DR.%2BE.%26atitle%3DThe%2520use%2520of%2520medications%2520approved%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520autism%2520spectrum%2520disorder%253A%2520a%2520systematic%2520review%26jtitle%3DFront.%2520Pediatr.%26date%3D2014%26volume%3D2%26spage%3D87%26doi%3D10.3389%2Ffped.2014.00087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Pearson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casat, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loveland, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukstein, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerger, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Factor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanwoerden, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleveland, L. A.</span><span> </span><span class="NLM_article-title">Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms</span> <span class="citation_source-journal">J. Child Adolesc. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span><span class="refDoi"> DOI: 10.1089/cap.2012.0096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1089%2Fcap.2012.0096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=23782128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVOkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=337-351&author=D.+Pearsonauthor=C.+Santosauthor=M.+Amanauthor=L.+E.+Arnoldauthor=C.+D.+Casatauthor=R.+Mansourauthor=D.+M.+Laneauthor=K.+A.+Lovelandauthor=O.+G.+Buksteinauthor=S.+W.+Jergerauthor=P.+Factorauthor=S.+Vanwoerdenauthor=E.+Perezauthor=L.+A.+Cleveland&title=Effects+of+extended+release+methylphenidate+treatment+on+ratings+of+attention-deficit%2Fhyperactivity+disorder+%28ADHD%29+and+associated+behavior+in+children+with+autism+spectrum+disorders+and+ADHD+symptoms&doi=10.1089%2Fcap.2012.0096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Extended Release Methylphenidate Treatment on Ratings of Attention-Deficit/Hyperactivity Disorder (ADHD) and Associated Behavior in Children with Autism Spectrum Disorders and ADHD Symptoms</span></div><div class="casAuthors">Pearson, Deborah A.; Santos, Cynthia W.; Aman, Michael G.; Arnold, L. Eugene; Casat, Charles D.; Mansour, Rosleen; Lane, David M.; Loveland, Katherine A.; Bukstein, Oscar G.; Jerger, Susan W.; Factor, Perry; Vanwoerden, Salome; Perez, Evelyn; Cleveland, Lynne A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Child and Adolescent Psychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">337-351</span>CODEN:
                <span class="NLM_cas:coden">JADPET</span>;
        ISSN:<span class="NLM_cas:issn">1044-5463</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Objective: The purpose of this study was to examine the behavioral effects of four doses of psychostimulant medication, combining extended-release methylphenidate (MPH) in the morning with immediate-release MPH in the afternoon.  Method: The sample comprised 24 children (19 boys; 5 girls) who met American Psychiatric Assocn., Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV-TR) criteria for an autism spectrum disorder (ASD) on the Autism Diagnostic Interview-Revised (ADI-R) and the Autism Diagnostic Observation Schedule (ADOS), and had significant symptoms of attention-deficit/hyperactivity disorder (ADHD).  This sample consisted of elementary school-age, community-based children (mean chronol. age=8.8 years, SD=1.7; mean intelligence quotient [IQ]=85; SD=16.8).  Effects of four dose levels of MPH on parent and teacher behavioral ratings were investigated using a within-subject, crossover, placebo-controlled design.  Results: MPH treatment was assocd. with significant declines in hyperactive and impulsive behavior at both home and school.  Parents noted significant declines in inattentive and oppositional behavior, and improvements in social skills.  No exacerbation of stereotypies was noted, and side effects were similar to those seen in typically developing children with ADHD.  Dose response was primarily linear in the dose range studied.  Conclusions: The results of this study suggest that MPH formulations are efficacious and well-tolerated for children with ASD and significant ADHD symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxublQ8_Ne37Vg90H21EOLACvtfcHk0ljuOXjLAr7eUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVOkur0%253D&md5=2c1679c9a3f03acafdd2feef51f28673</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1089%2Fcap.2012.0096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcap.2012.0096%26sid%3Dliteratum%253Aachs%26aulast%3DPearson%26aufirst%3DD.%26aulast%3DSantos%26aufirst%3DC.%26aulast%3DAman%26aufirst%3DM.%26aulast%3DArnold%26aufirst%3DL.%2BE.%26aulast%3DCasat%26aufirst%3DC.%2BD.%26aulast%3DMansour%26aufirst%3DR.%26aulast%3DLane%26aufirst%3DD.%2BM.%26aulast%3DLoveland%26aufirst%3DK.%2BA.%26aulast%3DBukstein%26aufirst%3DO.%2BG.%26aulast%3DJerger%26aufirst%3DS.%2BW.%26aulast%3DFactor%26aufirst%3DP.%26aulast%3DVanwoerden%26aufirst%3DS.%26aulast%3DPerez%26aufirst%3DE.%26aulast%3DCleveland%26aufirst%3DL.%2BA.%26atitle%3DEffects%2520of%2520extended%2520release%2520methylphenidate%2520treatment%2520on%2520ratings%2520of%2520attention-deficit%252Fhyperactivity%2520disorder%2520%2528ADHD%2529%2520and%2520associated%2520behavior%2520in%2520children%2520with%2520autism%2520spectrum%2520disorders%2520and%2520ADHD%2520symptoms%26jtitle%3DJ.%2520Child%2520Adolesc.%2520Psychopharmacol.%26date%3D2013%26volume%3D23%26spage%3D337%26epage%3D351%26doi%3D10.1089%2Fcap.2012.0096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Panksepp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensing, P.</span><span> </span><span class="NLM_article-title">Brief report: a synopsis of an open-trial of naltrexone treatment of autism with four children</span> <span class="citation_source-journal">J. Autism Dev. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1007/BF02284764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2FBF02284764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1864831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADyaK3MzisVaqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1991&pages=243-249&author=J.+Pankseppauthor=P.+Lensing&title=Brief+report%3A+a+synopsis+of+an+open-trial+of+naltrexone+treatment+of+autism+with+four+children&doi=10.1007%2FBF02284764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Brief report: a synopsis of an open-trial of naltrexone treatment of autism with four children</span></div><div class="casAuthors">Panksepp J; Lensing P</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autism and developmental disorders</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-9</span>
        ISSN:<span class="NLM_cas:issn">0162-3257</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRsN3ZR_oy622hHGZei4OW9fW6udTcc2ebSclursNZI8bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3MzisVaqtg%253D%253D&md5=34bb0fd0a345abb9d88d0f24f969bf02</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2FBF02284764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02284764%26sid%3Dliteratum%253Aachs%26aulast%3DPanksepp%26aufirst%3DJ.%26aulast%3DLensing%26aufirst%3DP.%26atitle%3DBrief%2520report%253A%2520a%2520synopsis%2520of%2520an%2520open-trial%2520of%2520naltrexone%2520treatment%2520of%2520autism%2520with%2520four%2520children%26jtitle%3DJ.%2520Autism%2520Dev.%2520Disord.%26date%3D1991%26volume%3D21%26spage%3D243%26epage%3D249%26doi%3D10.1007%2FBF02284764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Eichaar, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maisch, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augusto, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehring, H. J.</span><span> </span><span class="NLM_article-title">Efficacy and safety of naltrexone use in pediatric patients with autistic disorder</span> <span class="citation_source-journal">Ann. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span><span class="refDoi"> DOI: 10.1345/aph.1G499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1345%2Faph.1G499" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2006&pages=1086-1095&author=G.+M.+Eichaarauthor=N.+M.+Maischauthor=L.+M.+Augustoauthor=H.+J.+Wehring&title=Efficacy+and+safety+of+naltrexone+use+in+pediatric+patients+with+autistic+disorder&doi=10.1345%2Faph.1G499"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1345%2Faph.1G499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1345%252Faph.1G499%26sid%3Dliteratum%253Aachs%26aulast%3DEichaar%26aufirst%3DG.%2BM.%26aulast%3DMaisch%26aufirst%3DN.%2BM.%26aulast%3DAugusto%26aufirst%3DL.%2BM.%26aulast%3DWehring%26aufirst%3DH.%2BJ.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520naltrexone%2520use%2520in%2520pediatric%2520patients%2520with%2520autistic%2520disorder%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2006%26volume%3D40%26spage%3D1086%26epage%3D1095%26doi%3D10.1345%2Faph.1G499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Varghese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshav, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacot-Descombes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wicinski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickstein, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harony-Nicolas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Rubeis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drapeau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buxbaum, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, P. R.</span><span> </span><span class="NLM_article-title">Autism spectrum disorder: neuropathology and animal models</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span><span class="refDoi"> DOI: 10.1007/s00401-017-1736-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs00401-017-1736-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2017&pages=537-566&author=M.+Vargheseauthor=N.+Keshavauthor=S.+Jacot-Descombesauthor=T.+Wardaauthor=B.+Wicinskiauthor=D.+L.+Dicksteinauthor=H.+Harony-Nicolasauthor=S.+De+Rubeisauthor=E.+Drapeauauthor=J.+D.+Buxbaumauthor=P.+R.+Hof&title=Autism+spectrum+disorder%3A+neuropathology+and+animal+models&doi=10.1007%2Fs00401-017-1736-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs00401-017-1736-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-017-1736-4%26sid%3Dliteratum%253Aachs%26aulast%3DVarghese%26aufirst%3DM.%26aulast%3DKeshav%26aufirst%3DN.%26aulast%3DJacot-Descombes%26aufirst%3DS.%26aulast%3DWarda%26aufirst%3DT.%26aulast%3DWicinski%26aufirst%3DB.%26aulast%3DDickstein%26aufirst%3DD.%2BL.%26aulast%3DHarony-Nicolas%26aufirst%3DH.%26aulast%3DDe%2BRubeis%26aufirst%3DS.%26aulast%3DDrapeau%26aufirst%3DE.%26aulast%3DBuxbaum%26aufirst%3DJ.%2BD.%26aulast%3DHof%26aufirst%3DP.%2BR.%26atitle%3DAutism%2520spectrum%2520disorder%253A%2520neuropathology%2520and%2520animal%2520models%26jtitle%3DActa%2520Neuropathol.%26date%3D2017%26volume%3D134%26spage%3D537%26epage%3D566%26doi%3D10.1007%2Fs00401-017-1736-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Sztainberg, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, H. Y.</span><span> </span><span class="NLM_article-title">Lessons learned from studying syndromic autism spectrum disorders</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1408</span><span class="NLM_x">–</span> <span class="NLM_lpage">1417</span><span class="refDoi"> DOI: 10.1038/nn.4420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnn.4420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27786181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslGgsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2016&pages=1408-1417&author=Y.+Sztainbergauthor=H.+Y.+Zoghbi&title=Lessons+learned+from+studying+syndromic+autism+spectrum+disorders&doi=10.1038%2Fnn.4420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons learned from studying syndromic autism spectrum disorders</span></div><div class="casAuthors">Sztainberg, Yehezkel; Zoghbi, Huda Y.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1408-1417</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Syndromic autism spectrum disorders represent a group of childhood neurol. conditions, typically assocd. with chromosomal abnormalities or mutations in a single gene.  The discovery of their genetic causes has increased our understanding of the mol. pathways crit. for normal cognitive and social development.  Human studies have revealed that the brain is particularly sensitive to changes in dosage of various proteins from transcriptional and translational regulators to synaptic proteins.  Investigations of these disorders in animals have shed light on previously unknown pathogenic mechanisms leading to the identification of potential targets for therapeutic intervention.  The demonstration of reversibility of several phenotypes in adult mice is encouraging, and brings hope that with novel therapies, skills and functionality might improve in affected children and young adults.  As new research reveals points of convergence between syndromic and nonsyndromic autism spectrum disorders, we believe there will be opportunities for shared therapeutics for this class of conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreBCusjuxzr7Vg90H21EOLACvtfcHk0li-KZByN3Re0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslGgsLfL&md5=e5a8a2784ac4e9943fe909fefc66bd72</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnn.4420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.4420%26sid%3Dliteratum%253Aachs%26aulast%3DSztainberg%26aufirst%3DY.%26aulast%3DZoghbi%26aufirst%3DH.%2BY.%26atitle%3DLessons%2520learned%2520from%2520studying%2520syndromic%2520autism%2520spectrum%2520disorders%26jtitle%3DNat.%2520Neurosci.%26date%3D2016%26volume%3D19%26spage%3D1408%26epage%3D1417%26doi%3D10.1038%2Fnn.4420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Jacquemont, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagerman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagerman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leehey, M. A.</span><span> </span><span class="NLM_article-title">Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1016/S1474-4422(06)70676-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS1474-4422%2806%2970676-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=17166801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpslWmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=45-55&author=S.+Jacquemontauthor=R.+J.+Hagermanauthor=P.+J.+Hagermanauthor=M.+A.+Leehey&title=Fragile-X+syndrome+and+fragile+X-associated+tremor%2Fataxia+syndrome%3A+two+faces+of+FMR1&doi=10.1016%2FS1474-4422%2806%2970676-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1</span></div><div class="casAuthors">Jacquemont, Sebastien; Hagerman, Randi; Hagerman, Paul; Leehey, Maureen A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-55</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent advances in our understanding of the clin. and mol. features of the fragile-X mental-retardation 1 gene, FMR1, highlight the importance of single-gene disorders.  15 Years after its discovery, FMR1 continues to reveal new and unexpected clin. presentations and mol. mechanisms.  Loss of function of FMR1 is a model for neurodevelopmental and behavioral disorders, including mental retardation, autism, anxiety, and mood instability.  In addn., overexpression and CNS toxicity of FMR1 mRNA causes a late-onset neurodegenerative disorder, the fragile-X-assocd. tremor/ataxia syndrome (FXTAS).  A similar mechanism is probably involved in premature ovarian failure, which affects up to 20% of female carriers of an altered FMR1 gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJhuRo1JnBLbVg90H21EOLACvtfcHk0li-KZByN3Re0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpslWmuw%253D%253D&md5=3063996e801ef74f42d95e7d91ae3906</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2806%2970676-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252806%252970676-7%26sid%3Dliteratum%253Aachs%26aulast%3DJacquemont%26aufirst%3DS.%26aulast%3DHagerman%26aufirst%3DR.%2BJ.%26aulast%3DHagerman%26aufirst%3DP.%2BJ.%26aulast%3DLeehey%26aufirst%3DM.%2BA.%26atitle%3DFragile-X%2520syndrome%2520and%2520fragile%2520X-associated%2520tremor%252Fataxia%2520syndrome%253A%2520two%2520faces%2520of%2520FMR1%26jtitle%3DLancet%2520Neurol.%26date%3D2007%26volume%3D6%26spage%3D45%26epage%3D55%26doi%3D10.1016%2FS1474-4422%2806%2970676-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Huber, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bear, M. F.</span><span> </span><span class="NLM_article-title">Altered synaptic plasticity in a mouse model of fragile X mental retardation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">7746</span><span class="NLM_x">–</span> <span class="NLM_lpage">7750</span><span class="refDoi"> DOI: 10.1073/pnas.122205699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.122205699" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=7746-7750&author=K.+M.+Huberauthor=S.+M.+Gallagherauthor=S.+T.+Warrenauthor=M.+F.+Bear&title=Altered+synaptic+plasticity+in+a+mouse+model+of+fragile+X+mental+retardation&doi=10.1073%2Fpnas.122205699"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1073%2Fpnas.122205699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.122205699%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DK.%2BM.%26aulast%3DGallagher%26aufirst%3DS.%2BM.%26aulast%3DWarren%26aufirst%3DS.%2BT.%26aulast%3DBear%26aufirst%3DM.%2BF.%26atitle%3DAltered%2520synaptic%2520plasticity%2520in%2520a%2520mouse%2520model%2520of%2520fragile%2520X%2520mental%2520retardation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D7746%26epage%3D7750%26doi%3D10.1073%2Fpnas.122205699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Irwin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenough, W. T.</span><span> </span><span class="NLM_article-title">Dendritic spine structural anomalies in fragile-X mental retardation syndrome</span> <span class="citation_source-journal">Cereb. Cortex</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1038</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span><span class="refDoi"> DOI: 10.1093/cercor/10.10.1038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1093%2Fcercor%2F10.10.1038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=11007554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252FgvV2lsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1038-1044&author=S.+A.+Irwinauthor=R.+Galvezauthor=W.+T.+Greenough&title=Dendritic+spine+structural+anomalies+in+fragile-X+mental+retardation+syndrome&doi=10.1093%2Fcercor%2F10.10.1038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Dendritic spine structural anomalies in fragile-X mental retardation syndrome</span></div><div class="casAuthors">Irwin S A; Galvez R; Greenough W T</div><div class="citationInfo"><span class="NLM_cas:title">Cerebral cortex (New York, N.Y. : 1991)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1038-44</span>
        ISSN:<span class="NLM_cas:issn">1047-3211</span>.
    </div><div class="casAbstract">Fragile-X syndrome is the most common single-gene inherited form of mental retardation.  Morphological studies suggest a possible failure of the synapse maturation process.  Cerebral cortical spine morphology in fragile-X syndrome and in a knockout mouse model of it appears immature, with long, thin spines much more common than the stubby and mushroom-shaped spines more characteristic of normal development.  In human fragile-X syndrome there is also a higher density of spines along dendrites, suggesting a possible failure of synapse elimination.  While variously misshapen spines are characteristic of a number of mental retardation syndromes, the overabundance of spines seen in fragile-X syndrome is unusual.  Taken with evidence of neurotransmitter activation of the synthesis of the fragile-X protein (FMRP) at synapses in vitro and evidence for behaviorally induced FMRP expression in vivo, and with evidence compatible with a role for FMRP in regulating the synthesis of other proteins, it is possible that FMRP serves as an 'immediate early protein' at the synapse that orchestrates aspects of synaptic development and plasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS0jfkd5cHPJ7mQt-ICR3qNfW6udTcc2ea6yvhg3CHy27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252FgvV2lsw%253D%253D&md5=2a1323b8a564ac437846daeb964c73ef</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1093%2Fcercor%2F10.10.1038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcercor%252F10.10.1038%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DS.%2BA.%26aulast%3DGalvez%26aufirst%3DR.%26aulast%3DGreenough%26aufirst%3DW.%2BT.%26atitle%3DDendritic%2520spine%2520structural%2520anomalies%2520in%2520fragile-X%2520mental%2520retardation%2520syndrome%26jtitle%3DCereb.%2520Cortex%26date%3D2000%26volume%3D10%26spage%3D1038%26epage%3D1044%26doi%3D10.1093%2Fcercor%2F10.10.1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Bear, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, S. T.</span><span> </span><span class="NLM_article-title">The mGluR theory of fragile X mental retardation</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span><span class="refDoi"> DOI: 10.1016/j.tins.2004.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.tins.2004.04.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=370-377&author=M.+F.+Bearauthor=K.+M.+Huberauthor=S.+T.+Warren&title=The+mGluR+theory+of+fragile+X+mental+retardation&doi=10.1016%2Fj.tins.2004.04.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2004.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2004.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DBear%26aufirst%3DM.%2BF.%26aulast%3DHuber%26aufirst%3DK.%2BM.%26aulast%3DWarren%26aufirst%3DS.%2BT.%26atitle%3DThe%2520mGluR%2520theory%2520of%2520fragile%2520X%2520mental%2520retardation%26jtitle%3DTrends%2520Neurosci.%26date%3D2004%26volume%3D27%26spage%3D370%26epage%3D377%26doi%3D10.1016%2Fj.tins.2004.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Paluszkiewicz, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntsman, M. M.</span><span> </span><span class="NLM_article-title">Fragile X syndrome: the GABAergic system and circuit dysfunction</span> <span class="citation_source-journal">Dev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1159/000329420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1159%2F000329420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21934270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1GktbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2011&pages=349-364&author=S.+M.+Paluszkiewiczauthor=B.+S.+Martinauthor=M.+M.+Huntsman&title=Fragile+X+syndrome%3A+the+GABAergic+system+and+circuit+dysfunction&doi=10.1159%2F000329420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Fragile X syndrome: the GABAergic system and circuit dysfunction</span></div><div class="casAuthors">Paluszkiewicz, Scott M.; Martin, Brandon S.; Huntsman, Molly M.</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Neuroscience (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">349-364</span>CODEN:
                <span class="NLM_cas:coden">DENED7</span>;
        ISSN:<span class="NLM_cas:issn">0378-5866</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Fragile X syndrome (FXS) is a neurodevelopmental disorder characterized by intellectual disability, sensory hypersensitivity, and high incidences of autism spectrum disorders and epilepsy.  These phenotypes are suggestive of defects in neural circuit development and imbalances in excitatory glutamatergic and inhibitory GABAergic neurotransmission.  While alterations in excitatory synapse function and plasticity are well-established in Fmr1 knockout (KO) mouse models of FXS, a no. of recent electrophysiol. and mol. studies now identify prominent defects in inhibitory GABAergic transmission in behaviorally relevant forebrain regions such as the amygdala, cortex, and hippocampus.  In this review, the authors summarize evidence for GABAergic system dysfunction in FXS patients and Fmr1 KO mouse models alike.  The authors then discuss some of the known developmental roles of GABAergic signaling, as well as the development and refinement of GABAergic synapses as a framework for understanding potential causes of mature circuit dysfunction.  Finally, the authors highlight the GABAergic system as a relevant target for the treatment of FXS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3C3Y8B-1_T7Vg90H21EOLACvtfcHk0ljGBgl_prIC-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1GktbrO&md5=7077c1b74771767305a35bb5203e0e99</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1159%2F000329420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000329420%26sid%3Dliteratum%253Aachs%26aulast%3DPaluszkiewicz%26aufirst%3DS.%2BM.%26aulast%3DMartin%26aufirst%3DB.%2BS.%26aulast%3DHuntsman%26aufirst%3DM.%2BM.%26atitle%3DFragile%2520X%2520syndrome%253A%2520the%2520GABAergic%2520system%2520and%2520circuit%2520dysfunction%26jtitle%3DDev.%2520Neurosci.%26date%3D2011%26volume%3D33%26spage%3D349%26epage%3D364%26doi%3D10.1159%2F000329420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Chahrour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, H. Y.</span><span> </span><span class="NLM_article-title">The story of Rett syndrome: from clinic to neurobiology</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span><span class="refDoi"> DOI: 10.1016/j.neuron.2007.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuron.2007.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=17988628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=422-437&author=M.+Chahrourauthor=H.+Y.+Zoghbi&title=The+story+of+Rett+syndrome%3A+from+clinic+to+neurobiology&doi=10.1016%2Fj.neuron.2007.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The story of Rett syndrome: from clinic to neurobiology</span></div><div class="casAuthors">Chahrour, Maria; Zoghbi, Huda Y.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">422-437</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Mutations in the gene encoding methyl-CpG binding protein 2 (MeCP2), a transcriptional repressor involved in chromatin remodeling and the modulation of RNA splicing.  MECP2 aberrations result in a constellation of neuropsychiatric abnormalities, whereby both loss of function and gain in MECP2 dosage lead to similar neurol. phenotypes.  Recent studies demonstrate disease reversibility in RTT mouse models, suggesting that the neurol. defects in MECP2 disorders are not permanent.  To investigate the potential for restoring neuronal function in RTT patients, it is essential to identify MeCP2 targets or modifiers of the phenotype that can be therapeutically modulated.  Moreover, deciphering the mol. underpinnings of RTT is likely to contribute to the understanding of the pathogenesis of a broader class of neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopG5K6_7b0rrVg90H21EOLACvtfcHk0ljGBgl_prIC-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrvP&md5=95dd875581895cb15bd31e65d6eb4002</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2007.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2007.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DChahrour%26aufirst%3DM.%26aulast%3DZoghbi%26aufirst%3DH.%2BY.%26atitle%3DThe%2520story%2520of%2520Rett%2520syndrome%253A%2520from%2520clinic%2520to%2520neurobiology%26jtitle%3DNeuron%26date%3D2007%26volume%3D56%26spage%3D422%26epage%3D437%26doi%3D10.1016%2Fj.neuron.2007.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Chao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samaco, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chahrour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neul, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heintz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubenstein, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noebels, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenmund, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, H. Y.</span><span> </span><span class="NLM_article-title">Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1038/nature09582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnature09582" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=263-269&author=H.+T.+Chaoauthor=H.+Chenauthor=R.+C.+Samacoauthor=M.+Xueauthor=M.+Chahrourauthor=J.+Yooauthor=J.+L.+Neulauthor=S.+Gongauthor=H.+C.+Luauthor=N.+Heintzauthor=M.+Ekkerauthor=J.+L.+Rubensteinauthor=J.+L.+Noebelsauthor=C.+Rosenmundauthor=H.+Y.+Zoghbi&title=Dysfunction+in+GABA+signalling+mediates+autism-like+stereotypies+and+Rett+syndrome+phenotypes&doi=10.1038%2Fnature09582"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnature09582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09582%26sid%3Dliteratum%253Aachs%26aulast%3DChao%26aufirst%3DH.%2BT.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSamaco%26aufirst%3DR.%2BC.%26aulast%3DXue%26aufirst%3DM.%26aulast%3DChahrour%26aufirst%3DM.%26aulast%3DYoo%26aufirst%3DJ.%26aulast%3DNeul%26aufirst%3DJ.%2BL.%26aulast%3DGong%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DH.%2BC.%26aulast%3DHeintz%26aufirst%3DN.%26aulast%3DEkker%26aufirst%3DM.%26aulast%3DRubenstein%26aufirst%3DJ.%2BL.%26aulast%3DNoebels%26aufirst%3DJ.%2BL.%26aulast%3DRosenmund%26aufirst%3DC.%26aulast%3DZoghbi%26aufirst%3DH.%2BY.%26atitle%3DDysfunction%2520in%2520GABA%2520signalling%2520mediates%2520autism-like%2520stereotypies%2520and%2520Rett%2520syndrome%2520phenotypes%26jtitle%3DNature%26date%3D2010%26volume%3D468%26spage%3D263%26epage%3D269%26doi%3D10.1038%2Fnature09582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Jeste, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploubidis, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, A.</span><span> </span><span class="NLM_article-title">Characterization of autism in young children with tuberous sclerosis complex</span> <span class="citation_source-journal">J. Child Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span><span class="refDoi"> DOI: 10.1177/0883073807309788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1177%2F0883073807309788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=18160549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD1c3osVemtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=520-525&author=S.+S.+Jesteauthor=M.+Sahinauthor=P.+Boltonauthor=J.+B.+Ploubidisauthor=A.+Humphrey&title=Characterization+of+autism+in+young+children+with+tuberous+sclerosis+complex&doi=10.1177%2F0883073807309788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of autism in young children with tuberous sclerosis complex</span></div><div class="casAuthors">Jeste Shafali S; Sahin Mustafa; Bolton Patrick; Ploubidis George B; Humphrey Ayla</div><div class="citationInfo"><span class="NLM_cas:title">Journal of child neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">520-5</span>
        ISSN:<span class="NLM_cas:issn">0883-0738</span>.
    </div><div class="casAbstract">Both cognitive impairment and autism are common in the tuberous sclerosis complex, but the relationship between the 2 diagnoses has not been formally explored.  The authors evaluated 20 clinic-referred children with tuberous sclerosis complex at ages 18, 24, 36, and 60 months and classified them as autism, autism spectrum disorder, or normal on the basis of the Autism Diagnostic Observation Schedule.  Using the Mullen Scale of Early Learning, cognitive function in each subgroup was assessed.  The authors then analyzed the subscores of the Autism Diagnostic Observation Schedule in children with autism.  Children with autism showed significantly more global cognitive impairment than those without autism.  In addition, all children had some baseline cognitive impairment and the majority had deficits in play scores.  The authors conclude that clinic-referred children with tuberous sclerosis complex and autism are at considerable risk for cognitive impairment.  These characteristics may help to guide more tailored services for these high-risk children.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSb4glqw3lXMbYtC3U5jeOifW6udTcc2eZy_2MbE0wdKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3osVemtg%253D%253D&md5=bbc3eb9869325f2a671ea9d8b02a667b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1177%2F0883073807309788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0883073807309788%26sid%3Dliteratum%253Aachs%26aulast%3DJeste%26aufirst%3DS.%2BS.%26aulast%3DSahin%26aufirst%3DM.%26aulast%3DBolton%26aufirst%3DP.%26aulast%3DPloubidis%26aufirst%3DJ.%2BB.%26aulast%3DHumphrey%26aufirst%3DA.%26atitle%3DCharacterization%2520of%2520autism%2520in%2520young%2520children%2520with%2520tuberous%2520sclerosis%2520complex%26jtitle%3DJ.%2520Child%2520Neurol.%26date%3D2008%26volume%3D23%26spage%3D520%26epage%3D525%26doi%3D10.1177%2F0883073807309788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Han, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahin, M.</span><span> </span><span class="NLM_article-title">TSC1/TSC2 signaling in the CNS</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">585</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">980</span><span class="refDoi"> DOI: 10.1016/j.febslet.2011.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.febslet.2011.02.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2011&pages=973-980&author=J.+M.+Hanauthor=M.+Sahin&title=TSC1%2FTSC2+signaling+in+the+CNS&doi=10.1016%2Fj.febslet.2011.02.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2011.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2011.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DJ.%2BM.%26aulast%3DSahin%26aufirst%3DM.%26atitle%3DTSC1%252FTSC2%2520signaling%2520in%2520the%2520CNS%26jtitle%3DFEBS%2520Lett.%26date%3D2011%26volume%3D585%26spage%3D973%26epage%3D980%26doi%3D10.1016%2Fj.febslet.2011.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Rubenstein, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merzenich, M. M.</span><span> </span><span class="NLM_article-title">Model of autism: increased ratio of excitation/inhibition in key neural systems</span> <span class="citation_source-journal">Genes, Brain Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span><span class="refDoi"> DOI: 10.1034/j.1601-183X.2003.00037.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1034%2Fj.1601-183X.2003.00037.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=14606691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD3srivVKnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=255-267&author=J.+L.+Rubensteinauthor=M.+M.+Merzenich&title=Model+of+autism%3A+increased+ratio+of+excitation%2Finhibition+in+key+neural+systems&doi=10.1034%2Fj.1601-183X.2003.00037.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Model of autism: increased ratio of excitation/inhibition in key neural systems</span></div><div class="casAuthors">Rubenstein J L R; Merzenich M M</div><div class="citationInfo"><span class="NLM_cas:title">Genes, brain, and behavior</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">255-67</span>
        ISSN:<span class="NLM_cas:issn">1601-1848</span>.
    </div><div class="casAbstract">Autism is a severe neurobehavioral syndrome, arising largely as an inherited disorder, which can arise from several diseases.  Despite recent advances in identifying some genes that can cause autism, its underlying neurological mechanisms are uncertain.  Autism is best conceptualized by considering the neural systems that may be defective in autistic individuals.  Recent advances in understanding neural systems that process sensory information, various types of memories and social and emotional behaviors are reviewed and compared with known abnormalities in autism.  Then, specific genetic abnormalities that are linked with autism are examined.  Synthesis of this information leads to a model that postulates that some forms of autism are caused by an increased ratio of excitation/inhibition in sensory, mnemonic, social and emotional systems.  The model further postulates that the increased ratio of excitation/inhibition can be caused by combinatorial effects of genetic and environmental variables that impinge upon a given neural system.  Furthermore, the model suggests potential therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQjdvqZKnV9JqNc3HjJRoFAfW6udTcc2eZy_2MbE0wdKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srivVKnug%253D%253D&md5=b446351fe4c91902c5da1bcbdcb9048e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1034%2Fj.1601-183X.2003.00037.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1601-183X.2003.00037.x%26sid%3Dliteratum%253Aachs%26aulast%3DRubenstein%26aufirst%3DJ.%2BL.%26aulast%3DMerzenich%26aufirst%3DM.%2BM.%26atitle%3DModel%2520of%2520autism%253A%2520increased%2520ratio%2520of%2520excitation%252Finhibition%2520in%2520key%2520neural%2520systems%26jtitle%3DGenes%252C%2520Brain%2520Behav.%26date%3D2003%26volume%3D2%26spage%3D255%26epage%3D267%26doi%3D10.1034%2Fj.1601-183X.2003.00037.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Uzunova, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallanti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, E.</span><span> </span><span class="NLM_article-title">Excitatory/inhibitory imbalance in autism spectrum disorders: implications for interventions and therapeutics</span> <span class="citation_source-journal">World J. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.3109/15622975.2015.1085597</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3109%2F15622975.2015.1085597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26469219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC28zhvFehsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=174-186&author=G.+Uzunovaauthor=S.+Pallantiauthor=E.+Hollander&title=Excitatory%2Finhibitory+imbalance+in+autism+spectrum+disorders%3A+implications+for+interventions+and+therapeutics&doi=10.3109%2F15622975.2015.1085597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics</span></div><div class="casAuthors">Uzunova Genoveva; Pallanti Stefano; Hollander Eric; Pallanti Stefano; Pallanti Stefano; Pallanti Stefano</div><div class="citationInfo"><span class="NLM_cas:title">The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">174-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  Imbalance between excitation and inhibition and increased excitatory-inhibitory (E-I) ratio is a common mechanism in autism spectrum disorders (ASD) that is responsible for the learning and memory, cognitive, sensory, motor deficits, and seizures occurring in these disorders.  ASD are very heterogeneous and better understanding of E-I imbalance in brain will lead to better diagnosis and treatments.  METHODS:  We perform a critical literature review of the causes and presentations of E-I imbalance in ASD.  RESULTS:  E-I imbalance in ASD is due primarily to abnormal glutamatergic and GABAergic neurotransmission in key brain regions such as neocortex, hippocampus, amygdala, and cerebellum.  Other causes are due to dysfunction of neuropeptides (oxytocin), synaptic proteins (neuroligins), and immune system molecules (cytokines).  At the neuropathological level E-I imbalance in ASD is presented as a "minicolumnopathy".  E-I imbalance alters the manner by which the brain processes information and regulates behaviour.  New developments for investigating E-I imbalance such as optogenetics and transcranial magnetic stimulation (TMS) are presented.  Non-invasive brain stimulation methods such as TMS for treatment of the core symptoms of ASD are discussed.  CONCLUSIONS:  Understanding E-I imbalance has important implications for developing better pharmacological and behavioural treatments for ASD, including TMS, new drugs, biomarkers and patient stratification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8n37XrrY07_69nzq6467DfW6udTcc2eZy_2MbE0wdKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zhvFehsA%253D%253D&md5=0b0fb016f04f52ac9caeb8a39de6d467</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3109%2F15622975.2015.1085597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F15622975.2015.1085597%26sid%3Dliteratum%253Aachs%26aulast%3DUzunova%26aufirst%3DG.%26aulast%3DPallanti%26aufirst%3DS.%26aulast%3DHollander%26aufirst%3DE.%26atitle%3DExcitatory%252Finhibitory%2520imbalance%2520in%2520autism%2520spectrum%2520disorders%253A%2520implications%2520for%2520interventions%2520and%2520therapeutics%26jtitle%3DWorld%2520J.%2520Biol.%2520Psychiatry%26date%3D2016%26volume%3D17%26spage%3D174%26epage%3D186%26doi%3D10.3109%2F15622975.2015.1085597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Yizhar, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenno, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prigge, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goshen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paz, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehfest, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fudim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakrishnan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huguenard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegemann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deisseroth, K.</span><span> </span><span class="NLM_article-title">Neocortical excitation/inhibition balance in information processing and social dysfunction</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">477</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span><span class="refDoi"> DOI: 10.1038/nature10360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnature10360" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=477&publication_year=2011&pages=171-178&author=O.+Yizharauthor=L.+E.+Fennoauthor=M.+Priggeauthor=F.+Schneiderauthor=T.+J.+Davidsonauthor=D.+J.+O%E2%80%99Sheaauthor=V.+S.+Sohalauthor=I.+Goshenauthor=J.+Finkelsteinauthor=J.+T.+Pazauthor=K.+Stehfestauthor=R.+Fudimauthor=C.+Ramakrishnanauthor=J.+R.+Huguenardauthor=P.+Hegemannauthor=K.+Deisseroth&title=Neocortical+excitation%2Finhibition+balance+in+information+processing+and+social+dysfunction&doi=10.1038%2Fnature10360"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnature10360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10360%26sid%3Dliteratum%253Aachs%26aulast%3DYizhar%26aufirst%3DO.%26aulast%3DFenno%26aufirst%3DL.%2BE.%26aulast%3DPrigge%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DF.%26aulast%3DDavidson%26aufirst%3DT.%2BJ.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DD.%2BJ.%26aulast%3DSohal%26aufirst%3DV.%2BS.%26aulast%3DGoshen%26aufirst%3DI.%26aulast%3DFinkelstein%26aufirst%3DJ.%26aulast%3DPaz%26aufirst%3DJ.%2BT.%26aulast%3DStehfest%26aufirst%3DK.%26aulast%3DFudim%26aufirst%3DR.%26aulast%3DRamakrishnan%26aufirst%3DC.%26aulast%3DHuguenard%26aufirst%3DJ.%2BR.%26aulast%3DHegemann%26aufirst%3DP.%26aulast%3DDeisseroth%26aufirst%3DK.%26atitle%3DNeocortical%2520excitation%252Finhibition%2520balance%2520in%2520information%2520processing%2520and%2520social%2520dysfunction%26jtitle%3DNature%26date%3D2011%26volume%3D477%26spage%3D171%26epage%3D178%26doi%3D10.1038%2Fnature10360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Dani, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turrigiano, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaenisch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, S. B.</span><span> </span><span class="NLM_article-title">Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">12560</span><span class="NLM_x">–</span> <span class="NLM_lpage">12565</span><span class="refDoi"> DOI: 10.1073/pnas.0506071102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.0506071102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=12560-12565&author=V.+S.+Daniauthor=Q.+Changauthor=A.+Maffeiauthor=G.+G.+Turrigianoauthor=R.+Jaenischauthor=S.+B.+Nelson&title=Reduced+cortical+activity+due+to+a+shift+in+the+balance+between+excitation+and+inhibition+in+a+mouse+model+of+Rett+syndrome&doi=10.1073%2Fpnas.0506071102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0506071102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0506071102%26sid%3Dliteratum%253Aachs%26aulast%3DDani%26aufirst%3DV.%2BS.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DMaffei%26aufirst%3DA.%26aulast%3DTurrigiano%26aufirst%3DG.%2BG.%26aulast%3DJaenisch%26aufirst%3DR.%26aulast%3DNelson%26aufirst%3DS.%2BB.%26atitle%3DReduced%2520cortical%2520activity%2520due%2520to%2520a%2520shift%2520in%2520the%2520balance%2520between%2520excitation%2520and%2520inhibition%2520in%2520a%2520mouse%2520model%2520of%2520Rett%2520syndrome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D12560%26epage%3D12565%26doi%3D10.1073%2Fpnas.0506071102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Pop, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levenga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buijsen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieuwenhuizen, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasparini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oostra, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willemsen, R.</span><span> </span><span class="NLM_article-title">Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">1227</span><span class="NLM_x">–</span> <span class="NLM_lpage">1235</span><span class="refDoi"> DOI: 10.1007/s00213-012-2947-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs00213-012-2947-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=23254376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKgtbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=2014&pages=1227-1235&author=A.+S.+Popauthor=J.+Levengaauthor=C.+E.+de+Eschauthor=R.+A.+Buijsenauthor=I.+M.+Nieuwenhuizenauthor=T.+Liauthor=A.+Isaacsauthor=F.+Gaspariniauthor=B.+A.+Oostraauthor=R.+Willemsen&title=Rescue+of+dendritic+spine+phenotype+in+Fmr1+KO+mice+with+the+mGluR5+antagonist+AFQ056%2FMavoglurant&doi=10.1007%2Fs00213-012-2947-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant</span></div><div class="casAuthors">Pop, Andreea S.; Levenga, Josien; de Esch, Celine E. F.; Buijsen, Ronald A. M.; Nieuwenhuizen, Ingeborg M.; Li, Tracy; Isaacs, Aaron; Gasparini, Fabrizio; Oostra, Ben A.; Willemsen, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1227-1235</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Fragile X syndrome (FXS) is the leading monogenic cause of intellectual disability and autism.  The disease is a result of lack of expression of the fragile X mental retardation protein.  Brain tissues of patients with FXS and mice with FMRP deficiency have shown an abnormal dendritic spine phenotype.  We investigated the dendritic spine length and d. of hippocampal CA1 pyramidal neurons in 2-, 10-, and 25-wk-old Fmr1 knockout (KO).  Next, we studied the effects of long-term treatment with an mGluR5 antagonist, AFQ056/Mavoglurant, on the spine phenotype in adult Fmr1 KO mice.  We obsd. alterations in the spine phenotype during development, with a decreased spine length in 2-wk-old Fmr1 KO mice compared with age-match wild-type littermates, but with increased spine length in Fmr1 KO mice compared with 10- and 25-wk-old wild-type controls.  No difference was found in spine d. at any age.  We report a rescue of the abnormal spine length in adult Fmr1 KO mice after a long-term treatment with AFQ056/Mavoglurant.  This finding suggests that long-term treatment at later stage is sufficient to reverse the structural spine abnormalities and represents a starting point for future studies aimed at improving treatments for FXS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt2oI77gxPsrVg90H21EOLACvtfcHk0li8yXi4R7OD2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKgtbrN&md5=f27f7213f095d039cab261855c8c54c4</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs00213-012-2947-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-012-2947-y%26sid%3Dliteratum%253Aachs%26aulast%3DPop%26aufirst%3DA.%2BS.%26aulast%3DLevenga%26aufirst%3DJ.%26aulast%3Dde%2BEsch%26aufirst%3DC.%2BE.%26aulast%3DBuijsen%26aufirst%3DR.%2BA.%26aulast%3DNieuwenhuizen%26aufirst%3DI.%2BM.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DIsaacs%26aufirst%3DA.%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DOostra%26aufirst%3DB.%2BA.%26aulast%3DWillemsen%26aufirst%3DR.%26atitle%3DRescue%2520of%2520dendritic%2520spine%2520phenotype%2520in%2520Fmr1%2520KO%2520mice%2520with%2520the%2520mGluR5%2520antagonist%2520AFQ056%252FMavoglurant%26jtitle%3DPsychopharmacology%26date%3D2014%26volume%3D231%26spage%3D1227%26epage%3D1235%26doi%3D10.1007%2Fs00213-012-2947-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmitte, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Practical strategies and concepts in GPCR allosteric modulator discovery: recent advances with metabotropic glutamate receptors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">6707</span><span class="NLM_x">–</span> <span class="NLM_lpage">6741</span><span class="refDoi"> DOI: 10.1021/acs.chemrev.5b00656</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00656" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFahsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=6707-6741&author=C.+W.+Lindsleyauthor=K.+A.+Emmitteauthor=C.+R.+Hopkinsauthor=T.+M.+Bridgesauthor=K.+J.+Gregoryauthor=C.+M.+Niswenderauthor=P.+J.+Conn&title=Practical+strategies+and+concepts+in+GPCR+allosteric+modulator+discovery%3A+recent+advances+with+metabotropic+glutamate+receptors&doi=10.1021%2Facs.chemrev.5b00656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors</span></div><div class="casAuthors">Lindsley, Craig W.; Emmitte, Kyle A.; Hopkins, Corey R.; Bridges, Thomas M.; Gregory, Karen J.; Niswender, Colleen M.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6707-6741</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Allosteric modulation of GPCRs has initiated a new era of basic and translational discovery, filled with therapeutic promise yet fraught with caveats.  Allosteric ligands stabilize unique conformations of the GPCR that afford fundamentally new receptors, capable of novel pharmacol., unprecedented subtype selectivity, and unique signal bias.  This review provides a comprehensive overview of the basics of GPCR allosteric pharmacol., medicinal chem., drug metab., and validated approaches to address each of the major challenges and caveats.  Then, the review narrows focus to highlight recent advances in the discovery of allosteric ligands for metabotropic glutamate receptor subtypes 1-5 and 7 (mGlu1-5,7) highlighting key concepts ("mol. switches", signal bias, heterodimers) and practical solns. to enable the development of tool compds. and clin. candidates.  The review closes with a section on late-breaking new advances with allosteric ligands for other GPCRs and emerging data for endogenous allosteric modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq18XJrjVel-7Vg90H21EOLACvtfcHk0ljaGdqlInFilA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFahsr8%253D&md5=c12704b6602b6c50add92e7fd9350382</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00656%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DPractical%2520strategies%2520and%2520concepts%2520in%2520GPCR%2520allosteric%2520modulator%2520discovery%253A%2520recent%2520advances%2520with%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D6707%26epage%3D6741%26doi%3D10.1021%2Facs.chemrev.5b00656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Silverman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolu, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barkan, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawley, J. N.</span><span> </span><span class="NLM_article-title">Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">976</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span><span class="refDoi"> DOI: 10.1038/npp.2009.201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnpp.2009.201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20032969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslOju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=976-989&author=J.+L.+Silvermanauthor=S.+S.+Toluauthor=C.+L.+Barkanauthor=J.+N.+Crawley&title=Repetitive+self-grooming+behavior+in+the+BTBR+mouse+model+of+autism+is+blocked+by+the+mGluR5+antagonist+MPEP&doi=10.1038%2Fnpp.2009.201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Repetitive Self-Grooming Behavior in the BTBR Mouse Model of Autism is Blocked by the mGluR5 Antagonist MPEP</span></div><div class="casAuthors">Silverman, Jill L.; Tolu, Seda S.; Barkan, Charlotte L.; Crawley, Jacqueline N.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">976-989</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autism is a neurodevelopmental disorder characterized by abnormal reciprocal social interactions, communication deficits, and repetitive behaviors with restricted interests.  BTBR T+tf/J (BTBR) is an inbred mouse strain that shows robust behavioral phenotypes with analogies to all three of the diagnostic symptoms of autism, including well-replicated deficits in reciprocal social interactions and social approach, unusual patterns of ultrasonic vocalization, and high levels of repetitive self-grooming.  These phenotypes offer straightforward behavioral assays for translational investigations of pharmacol. compds.  Two suggested treatments for autism were evaluated in the BTBR mouse model.  Methyl-6-phenylethynyl-pyridine (MPEP), an antagonist of the mGluR5 metabotropic glutamate receptor, blocks aberrant phenotypes in the Fmr1 mouse model of Fragile X, a comorbid neurodevelopmental disorder with autistic features.  Risperidone has been approved by the United States Food and Drug Administration for the treatment of irritability, tantrums, and self-injurious behavior in autistic individuals.  We evaluated the actions of MPEP and risperidone on two BTBR phenotypes, low sociability and high repetitive self-grooming.  Open field activity served as an independent control for non-social exploratory activity and motor functions.  C57BL/6J (B6), an inbred strain with high sociability and low self-grooming, served as the strain control.  MPEP significantly reduced repetitive self-grooming in BTBR, at doses that had no sedating effects on open field activity.  Risperidone reduced repetitive self-grooming in BTBR, but only at doses that induced sedation in both strains.  No overall improvements in sociability were detected in BTBR after treatment with either MPEP or risperidone.  Our findings suggest that antagonists of mGluR5 receptors may have selective therapeutic efficacy in treating repetitive behaviors in autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXnIAZEZ9t_LVg90H21EOLACvtfcHk0ljaGdqlInFilA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslOju7Y%253D&md5=173070defb6ae57acd383e335fcb1013</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2009.201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2009.201%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DJ.%2BL.%26aulast%3DTolu%26aufirst%3DS.%2BS.%26aulast%3DBarkan%26aufirst%3DC.%2BL.%26aulast%3DCrawley%26aufirst%3DJ.%2BN.%26atitle%3DRepetitive%2520self-grooming%2520behavior%2520in%2520the%2520BTBR%2520mouse%2520model%2520of%2520autism%2520is%2520blocked%2520by%2520the%2520mGluR5%2520antagonist%2520MPEP%26jtitle%3DNeuropsychopharmacology%26date%3D2010%26volume%3D35%26spage%3D976%26epage%3D989%26doi%3D10.1038%2Fnpp.2009.201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Silverman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karras, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolu, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawley, J. N.</span><span> </span><span class="NLM_article-title">Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">131ra51</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3003501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1126%2Fscitranslmed.3003501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22539775" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=131ra51&author=J.+L.+Silvermanauthor=D.+G.+Smithauthor=S.+J.+Rizzoauthor=M.+N.+Karrasauthor=S.+M.+Turnerauthor=S.+S.+Toluauthor=D.+K.+Bryceauthor=D.+L.+Smithauthor=K.+Fonsecaauthor=R.+H.+Ringauthor=J.+N.+Crawley&title=Negative+allosteric+modulation+of+the+mGluR5+receptor+reduces+repetitive+behaviors+and+rescues+social+deficits+in+mouse+models+of+autism&doi=10.1126%2Fscitranslmed.3003501"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003501%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DJ.%2BL.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DRizzo%26aufirst%3DS.%2BJ.%26aulast%3DKarras%26aufirst%3DM.%2BN.%26aulast%3DTurner%26aufirst%3DS.%2BM.%26aulast%3DTolu%26aufirst%3DS.%2BS.%26aulast%3DBryce%26aufirst%3DD.%2BK.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DFonseca%26aufirst%3DK.%26aulast%3DRing%26aufirst%3DR.%2BH.%26aulast%3DCrawley%26aufirst%3DJ.%2BN.%26atitle%3DNegative%2520allosteric%2520modulation%2520of%2520the%2520mGluR5%2520receptor%2520reduces%2520repetitive%2520behaviors%2520and%2520rescues%2520social%2520deficits%2520in%2520mouse%2520models%2520of%2520autism%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D131ra51%26doi%3D10.1126%2Fscitranslmed.3003501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Seese, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maske, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gall, C. M.</span><span> </span><span class="NLM_article-title">Long-term memory deficits are associated with elevated synaptic ERK1/2 activation and reversed by mGluR5 antagonism in an animal model of autism</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1664</span><span class="NLM_x">–</span> <span class="NLM_lpage">1673</span><span class="refDoi"> DOI: 10.1038/npp.2014.13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnpp.2014.13" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=1664-1673&author=R.+R.+Seeseauthor=A.+R.+Maskeauthor=G.+Lynchauthor=C.+M.+Gall&title=Long-term+memory+deficits+are+associated+with+elevated+synaptic+ERK1%2F2+activation+and+reversed+by+mGluR5+antagonism+in+an+animal+model+of+autism&doi=10.1038%2Fnpp.2014.13"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2014.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2014.13%26sid%3Dliteratum%253Aachs%26aulast%3DSeese%26aufirst%3DR.%2BR.%26aulast%3DMaske%26aufirst%3DA.%2BR.%26aulast%3DLynch%26aufirst%3DG.%26aulast%3DGall%26aufirst%3DC.%2BM.%26atitle%3DLong-term%2520memory%2520deficits%2520are%2520associated%2520with%2520elevated%2520synaptic%2520ERK1%252F2%2520activation%2520and%2520reversed%2520by%2520mGluR5%2520antagonism%2520in%2520an%2520animal%2520model%2520of%2520autism%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D1664%26epage%3D1673%26doi%3D10.1038%2Fnpp.2014.13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Mehta, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandal, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, S. J.</span><span> </span><span class="NLM_article-title">mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e26077</span><span class="refDoi"> DOI: 10.1371/journal.pone.0026077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1371%2Fjournal.pone.0026077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e26077&author=M.+V.+Mehtaauthor=M.+J.+Gandalauthor=S.+J.+Siegel&title=mGluR5-antagonist+mediated+reversal+of+elevated+stereotyped%2C+repetitive+behaviors+in+the+VPA+model+of+autism&doi=10.1371%2Fjournal.pone.0026077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0026077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0026077%26sid%3Dliteratum%253Aachs%26aulast%3DMehta%26aufirst%3DM.%2BV.%26aulast%3DGandal%26aufirst%3DM.%2BJ.%26aulast%3DSiegel%26aufirst%3DS.%2BJ.%26atitle%3DmGluR5-antagonist%2520mediated%2520reversal%2520of%2520elevated%2520stereotyped%252C%2520repetitive%2520behaviors%2520in%2520the%2520VPA%2520model%2520of%2520autism%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De26077%26doi%3D10.1371%2Fjournal.pone.0026077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Rocher, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boléa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lütjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epping-Jordan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessis, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutel, V.</span><span> </span><span class="NLM_article-title">mGluR5 negative allosteric modulators overview: a medicinal chemistry approach towards a series of novel therapeutic agents</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">680</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span><span class="refDoi"> DOI: 10.2174/1568026611109060680</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.2174%2F1568026611109060680" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21261592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=680-695&author=J.+P.+Rocherauthor=B.+Bonnetauthor=C.+Bol%C3%A9aauthor=R.+L%C3%BCtjensauthor=E.+Le+Poulauthor=S.+Poliauthor=M.+Epping-Jordanauthor=A.+S.+Bessisauthor=B.+Ludwigauthor=V.+Mutel&title=mGluR5+negative+allosteric+modulators+overview%3A+a+medicinal+chemistry+approach+towards+a+series+of+novel+therapeutic+agents&doi=10.2174%2F1568026611109060680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">mGluR5 negative allosteric modulators overview: a medicinal chemistry approach towards a series of novel therapeutic agents</span></div><div class="casAuthors">Rocher, Jean-Philippe; Bonnet, Beatrice; Bolea, Christelle; Lutjens, Robert; Le Poul, Emmanuel; Poli, Sonia; Epping-Jordan, Mark; Bessis, Anne-Sophie; Ludwig, Bernard; Mutel, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">680-695</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Allosteric modulators of metabotropic glutamate receptors (mGluRs) subtypes 1-8 have been shown to offer a valid way to develop small mol. non aminoacid-like therapeutics that can be administered orally and that readily cross the blood-brain barrier.  Allosteric modulators of glutamatergic receptors and in particular mGluR5 have emerged as a novel and highly desirable class of compds. for the treatment of central nervous system (CNS) disorders and peripheral disorders.  This article provides medicinal chem. highlights around the chem. classes of potent and highly selective mGluR5 neg. allosteric modulators (NAMs) and their therapeutic potential.  In addn., it describes the medicinal chem. approach from the discovery to the clin. candidate selection of a new series of heteroaryl-butynylpyridines targeting mGluR5.  The multiparametric optimization of the initial starting point which ended in the selection of potential clin. candidates combining the best pharmacophoric features is presented.  The pharmacol. properties are reported and support the interest of these agents for new therapeutic approaches.  Furthermore, a summary of the diverse mGluR5 Positron Emission Tomog. (PET) radioligands is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeXrv5HnHG77Vg90H21EOLACvtfcHk0lgd_Z9t3IvW0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSmsrw%253D&md5=aab29725fa93c1895f32f7dbe93a16f1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.2174%2F1568026611109060680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611109060680%26sid%3Dliteratum%253Aachs%26aulast%3DRocher%26aufirst%3DJ.%2BP.%26aulast%3DBonnet%26aufirst%3DB.%26aulast%3DBol%25C3%25A9a%26aufirst%3DC.%26aulast%3DL%25C3%25BCtjens%26aufirst%3DR.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DEpping-Jordan%26aufirst%3DM.%26aulast%3DBessis%26aufirst%3DA.%2BS.%26aulast%3DLudwig%26aufirst%3DB.%26aulast%3DMutel%26aufirst%3DV.%26atitle%3DmGluR5%2520negative%2520allosteric%2520modulators%2520overview%253A%2520a%2520medicinal%2520chemistry%2520approach%2520towards%2520a%2520series%2520of%2520novel%2520therapeutic%2520agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D680%26epage%3D695%26doi%3D10.2174%2F1568026611109060680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Emmitte, K. A.</span><span> </span><span class="NLM_article-title">Recent advances in the design and development of novel negative allosteric modulators of mGlu5</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span><span class="refDoi"> DOI: 10.1021/cn2000266</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn2000266" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVWjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=411-432&author=K.+A.+Emmitte&title=Recent+advances+in+the+design+and+development+of+novel+negative+allosteric+modulators+of+mGlu5&doi=10.1021%2Fcn2000266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the design and development of novel negative allosteric modulators of mGlu5</span></div><div class="casAuthors">Emmitte, Kyle A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">411-432</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Neg. allosteric modulators (NAMs) of metabotropic glutamate receptor subtype 5 (mGlu5) have remained attractive to researchers as potential therapies for a no. of central nervous system related diseases, including anxiety, pain, gastroesophageal reflux disease (GERD), addiction, Parkinson's disease (PD), and fragile X syndrome (FXS).  In addn. to the many publications with supportive preclin. data with key tool mols., recent pos. reports from the clinic have bolstered the confidence in this approach.  During the 2 yr time span from 2009 through 2010, a no. of new mGlu5 NAM chemotypes have been disclosed and discussed in the primary and patent literature.  A summary of several efforts representing many diverse chemotypes are presented here, along with a discussion of representative structure-activity relationships (SAR) and synthetic approaches to the templates where possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs7RmgtM8r7LVg90H21EOLACvtfcHk0lgd_Z9t3IvW0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVWjsbs%253D&md5=ac71bcd9a9deb35fbfbfa4b26edcd3cf</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fcn2000266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn2000266%26sid%3Dliteratum%253Aachs%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26atitle%3DRecent%2520advances%2520in%2520the%2520design%2520and%2520development%2520of%2520novel%2520negative%2520allosteric%2520modulators%2520of%2520mGlu5%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D411%26epage%3D432%26doi%3D10.1021%2Fcn2000266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">de Vrij, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levenga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Linde, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koekkoek, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Zeeuw, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oostra, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willemsen, R.</span><span> </span><span class="NLM_article-title">Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1016/j.nbd.2008.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.nbd.2008.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=18571098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsF2ltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=127-132&author=F.+M.+de+Vrijauthor=J.+Levengaauthor=H.+C.+van+der+Lindeauthor=S.+K.+Koekkoekauthor=C.+I.+De+Zeeuwauthor=D.+L.+Nelsonauthor=B.+A.+Oostraauthor=R.+Willemsen&title=Rescue+of+behavioral+phenotype+and+neuronal+protrusion+morphology+in+Fmr1+KO+mice&doi=10.1016%2Fj.nbd.2008.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice</span></div><div class="casAuthors">de Vrij, Femke M. S.; Levenga, Josien; van der Linde, Herma C.; Koekkoek, Sebastiaan K.; De Zeeuw, Chris I.; Nelson, David L.; Oostra, Ben A.; Willemsen, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Lack of fragile X mental retardation protein (FMRP) causes Fragile X Syndrome, the most common form of inherited mental retardation.  FMRP is an RNA-binding protein and is a component of messenger ribonucleoprotein complexes, assocd. with brain polyribosomes, including dendritic polysomes.  FMRP is therefore thought to be involved in translational control of specific mRNAs at synaptic sites.  In mice lacking FMRP, protein synthesis-dependent synaptic plasticity is altered and structural malformations of dendritic protrusions occur.  One hypothesized cause of the disease mechanism is based on exaggerated group I mGluR receptor activation.  In this study, we examd. the effect of the mGluR5 antagonist MPEP on Fragile X related behavior in Fmr1 KO mice.  Our results demonstrate a clear defect in prepulse inhibition of startle in Fmr1 KO mice, that could be rescued by MPEP.  Moreover, we show for the first time a structural rescue of Fragile X related protrusion morphol. with two independent mGluR5 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8B9SAxzKhy7Vg90H21EOLACvtfcHk0lgubQBSCNvznQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsF2ltrc%253D&md5=a643f104d26db67e7a6020bddc31fbe4</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2008.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2008.04.002%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVrij%26aufirst%3DF.%2BM.%26aulast%3DLevenga%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BLinde%26aufirst%3DH.%2BC.%26aulast%3DKoekkoek%26aufirst%3DS.%2BK.%26aulast%3DDe%2BZeeuw%26aufirst%3DC.%2BI.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DOostra%26aufirst%3DB.%2BA.%26aulast%3DWillemsen%26aufirst%3DR.%26atitle%3DRescue%2520of%2520behavioral%2520phenotype%2520and%2520neuronal%2520protrusion%2520morphology%2520in%2520Fmr1%2520KO%2520mice%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2008%26volume%3D31%26spage%3D127%26epage%3D132%26doi%3D10.1016%2Fj.nbd.2008.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Ceccarelli, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeschke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettelmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huwyler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolczewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinssen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span> </span><span class="NLM_article-title">Rational design, synthesis, and structure-activity relationship of benzoxazolones: new potent mGlu5 receptor antagonists based on the fenobam structure</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1302</span><span class="NLM_x">–</span> <span class="NLM_lpage">1306</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bmcl.2006.12.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1302-1306&author=S.+M.+Ceccarelliauthor=G.+Jaeschkeauthor=B.+Buettelmannauthor=J.+Huwylerauthor=S.+Kolczewskiauthor=J.+U.+Petersauthor=E.+Prinssenauthor=R.+Porterauthor=W.+Spoorenauthor=E.+Vieira&title=Rational+design%2C+synthesis%2C+and+structure-activity+relationship+of+benzoxazolones%3A+new+potent+mGlu5+receptor+antagonists+based+on+the+fenobam+structure&doi=10.1016%2Fj.bmcl.2006.12.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DCeccarelli%26aufirst%3DS.%2BM.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DBuettelmann%26aufirst%3DB.%26aulast%3DHuwyler%26aufirst%3DJ.%26aulast%3DKolczewski%26aufirst%3DS.%26aulast%3DPeters%26aufirst%3DJ.%2BU.%26aulast%3DPrinssen%26aufirst%3DE.%26aulast%3DPorter%26aufirst%3DR.%26aulast%3DSpooren%26aufirst%3DW.%26aulast%3DVieira%26aufirst%3DE.%26atitle%3DRational%2520design%252C%2520synthesis%252C%2520and%2520structure-activity%2520relationship%2520of%2520benzoxazolones%253A%2520new%2520potent%2520mGlu5%2520receptor%2520antagonists%2520based%2520on%2520the%2520fenobam%2520structure%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1302%26epage%3D1306%26doi%3D10.1016%2Fj.bmcl.2006.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Vranesic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ofner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flor, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilbe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouhelal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desrayaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasparini, F.</span><span> </span><span class="NLM_article-title">AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: identification, SAR and pharmacological characterization</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5790</span><span class="NLM_x">–</span> <span class="NLM_lpage">5803</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bmc.2014.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25316499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGns7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5790-5803&author=I.+Vranesicauthor=S.+Ofnerauthor=P.+J.+Florauthor=G.+Bilbeauthor=R.+Bouhelalauthor=A.+Enzauthor=S.+Desrayaudauthor=K.+McAllisterauthor=R.+Kuhnauthor=F.+Gasparini&title=AFQ056%2Fmavoglurant%2C+a+novel+clinically+effective+mGluR5+antagonist%3A+identification%2C+SAR+and+pharmacological+characterization&doi=10.1016%2Fj.bmc.2014.09.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: Identification, SAR and pharmacological characterization</span></div><div class="casAuthors">Vranesic, Ivo; Ofner, Silvio; Flor, Peter Josef; Bilbe, Graeme; Bouhelal, Rochdi; Enz, Albert; Desrayaud, Sandrine; McAllister, Kevin; Kuhn, Rainer; Gasparini, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5790-5803</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here we describe the identification, structure-activity relation and the initial pharmacol. characterization of AFQ056/mavoglurant, a structurally novel, non-competitive mGlu5 receptor antagonist.  AFQ056/mavoglurant was identified by chem. derivatization of a lead compd. discovered in a HTS campaign.  In vitro, AFQ056/mavoglurant had an IC50 of 30 nM in a functional assay with human mGluR5 and was selective over the other mGluR subtypes, iGluRs and a panel of 238 CNS relevant receptors, transporter or enzymes.  In vivo, AFQ056/mavoglurant showed an improved pharmacokinetic profile in rat and efficacy in the stress-induced hyperthermia test in mice as compared to the prototypic mGluR5 antagonist MPEP.  The efficacy of AFQ056/mavoglurant in humans has been assessed in L-dopa induced dyskinesia in Parkinson's disease and Fragile X syndrome in proof of principle clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomfnTAWNW_RbVg90H21EOLACvtfcHk0lgubQBSCNvznQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGns7bJ&md5=a34ab6585a186730f2fbf09d8c97180c</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DVranesic%26aufirst%3DI.%26aulast%3DOfner%26aufirst%3DS.%26aulast%3DFlor%26aufirst%3DP.%2BJ.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DBouhelal%26aufirst%3DR.%26aulast%3DEnz%26aufirst%3DA.%26aulast%3DDesrayaud%26aufirst%3DS.%26aulast%3DMcAllister%26aufirst%3DK.%26aulast%3DKuhn%26aufirst%3DR.%26aulast%3DGasparini%26aufirst%3DF.%26atitle%3DAFQ056%252Fmavoglurant%252C%2520a%2520novel%2520clinically%2520effective%2520mGluR5%2520antagonist%253A%2520identification%252C%2520SAR%2520and%2520pharmacological%2520characterization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D5790%26epage%3D5803%26doi%3D10.1016%2Fj.bmc.2014.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Scharf, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeschke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettstein, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindemann, L.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptor 5 as drug target for Fragile X syndrome</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span><span class="refDoi"> DOI: 10.1016/j.coph.2014.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.coph.2014.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25488569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVWrsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=124-134&author=S.+H.+Scharfauthor=G.+Jaeschkeauthor=J.+G.+Wettsteinauthor=L.+Lindemann&title=Metabotropic+glutamate+receptor+5+as+drug+target+for+Fragile+X+syndrome&doi=10.1016%2Fj.coph.2014.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic glutamate receptor 5 as drug target for Fragile X syndrome</span></div><div class="casAuthors">Scharf, Sebastian H.; Jaeschke, Georg; Wettstein, Joseph G.; Lindemann, Lothar</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">124-134</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Fragile X syndrome (FXS) is the most common monogenic form of inherited mental retardation caused by a trinucleotid repeat expansion and transcriptional shutdown of the FMR1 gene.  FXS patients present a complex and often severe neuropsychiatric phenotype yet have mild somatic symptoms, normal life expectancies, and no indications of neurodegeneration.  The therapeutic potential of mGlu5 inhibitors was proposed in the 'mGluR theory of FXS' based on early insights into the mol. pathophysiol. of FXS.  Studies in Fragile X mental retardation 1 (Fmr1) knock-out mice, a widely used disease model, demonstrated that mGlu5 inhibitors can correct a broad range of disease-related phenotypes.  Recent clin. trials, however, with two different mGlu5 inhibitors (basimglurant and mavoglurant) showed no therapeutic benefit in FXS patients for reasons as yet unclear.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbD6x0TJKC0rVg90H21EOLACvtfcHk0lhZDfVwfw203A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVWrsb7E&md5=242f124e6c5e0100b197e29d8f70865a</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2014.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2014.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DScharf%26aufirst%3DS.%2BH.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26aulast%3DLindemann%26aufirst%3DL.%26atitle%3DMetabotropic%2520glutamate%2520receptor%25205%2520as%2520drug%2520target%2520for%2520Fragile%2520X%2520syndrome%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2015%26volume%3D20%26spage%3D124%26epage%3D134%26doi%3D10.1016%2Fj.coph.2014.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Jaeschke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolczewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitter-Stoll, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boissin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büttelmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccarelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huwyler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuratli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niederhauser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pähler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinssen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tännler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettstein, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindemann, L.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1<i>H</i>-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1358</span><span class="NLM_x">–</span> <span class="NLM_lpage">1371</span><span class="refDoi"> DOI: 10.1021/jm501642c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501642c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1358-1371&author=G.+Jaeschkeauthor=S.+Kolczewskiauthor=W.+Spoorenauthor=E.+Vieiraauthor=N.+Bitter-Stollauthor=P.+Boissinauthor=E.+Borroniauthor=B.+B%C3%BCttelmannauthor=S.+Ceccarelliauthor=N.+Clemannauthor=B.+Davidauthor=C.+Funkauthor=W.+Gubaauthor=A.+Harrisonauthor=T.+Hartungauthor=M.+Honerauthor=J.+Huwylerauthor=M.+Kuratliauthor=U.+Niederhauserauthor=A.+P%C3%A4hlerauthor=J.+U.+Petersauthor=A.+Petersenauthor=E.+Prinssenauthor=A.+Ricciauthor=D.+Rueherauthor=M.+Rueherauthor=M.+Schneiderauthor=P.+Spurrauthor=T.+Stollauthor=D.+T%C3%A4nnlerauthor=J.+Wichmannauthor=R.+H.+Porterauthor=J.+G.+Wettsteinauthor=L.+Lindemann&title=Metabotropic+glutamate+receptor+5+negative+allosteric+modulators%3A+discovery+of+2-chloro-4-%5B1-%284-fluorophenyl%29-2%2C5-dimethyl-1H-imidazol-4-ylethynyl%5Dpyridine+%28basimglurant%2C+RO4917523%29%2C+a+promising+novel+medicine+for+psychiatric+diseases&doi=10.1021%2Fjm501642c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm501642c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501642c%26sid%3Dliteratum%253Aachs%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DKolczewski%26aufirst%3DS.%26aulast%3DSpooren%26aufirst%3DW.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DBitter-Stoll%26aufirst%3DN.%26aulast%3DBoissin%26aufirst%3DP.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DB%25C3%25BCttelmann%26aufirst%3DB.%26aulast%3DCeccarelli%26aufirst%3DS.%26aulast%3DClemann%26aufirst%3DN.%26aulast%3DDavid%26aufirst%3DB.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DHarrison%26aufirst%3DA.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DHoner%26aufirst%3DM.%26aulast%3DHuwyler%26aufirst%3DJ.%26aulast%3DKuratli%26aufirst%3DM.%26aulast%3DNiederhauser%26aufirst%3DU.%26aulast%3DP%25C3%25A4hler%26aufirst%3DA.%26aulast%3DPeters%26aufirst%3DJ.%2BU.%26aulast%3DPetersen%26aufirst%3DA.%26aulast%3DPrinssen%26aufirst%3DE.%26aulast%3DRicci%26aufirst%3DA.%26aulast%3DRueher%26aufirst%3DD.%26aulast%3DRueher%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DSpurr%26aufirst%3DP.%26aulast%3DStoll%26aufirst%3DT.%26aulast%3DT%25C3%25A4nnler%26aufirst%3DD.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DPorter%26aufirst%3DR.%2BH.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26aulast%3DLindemann%26aufirst%3DL.%26atitle%3DMetabotropic%2520glutamate%2520receptor%25205%2520negative%2520allosteric%2520modulators%253A%2520discovery%2520of%25202-chloro-4-%255B1-%25284-fluorophenyl%2529-2%252C5-dimethyl-1H-imidazol-4-ylethynyl%255Dpyridine%2520%2528basimglurant%252C%2520RO4917523%2529%252C%2520a%2520promising%2520novel%2520medicine%2520for%2520psychiatric%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1358%26epage%3D1371%26doi%3D10.1021%2Fjm501642c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Munshi, K.; Pawlowski, K.; Gonzalez-Heydrich, J.; Picker, J. D.</span><span> </span><span class="NLM_article-title">Review of salient investigational drugs for the treatment of fragile X syndrome</span>.  <span class="citation_source-journal">J. Child Adolesc. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1089/cap.2016.0200</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1089%2Fcap.2016.0200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=28475355" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=K.+Munshi&author=K.+Pawlowski&author=J.+Gonzalez-Heydrich&author=J.+D.+Picker&title=Review+of+salient+investigational+drugs+for+the+treatment+of+fragile+X+syndrome&doi=10.1089%2Fcap.2016.0200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1089%2Fcap.2016.0200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcap.2016.0200%26sid%3Dliteratum%253Aachs%26aulast%3DMunshi%26aufirst%3DK.%26atitle%3DReview%2520of%2520salient%2520investigational%2520drugs%2520for%2520the%2520treatment%2520of%2520fragile%2520X%2520syndrome%26jtitle%3DJ.%2520Child%2520Adolesc.%2520Psychopharmacol.%26date%3D2017%26doi%3D10.1089%2Fcap.2016.0200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manka, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">A novel metabotropic glutamate receptor 5 positive allosteric modulator acts at a unique site and confers stimulus bias to mGlu5 signaling</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">847</span><span class="refDoi"> DOI: 10.1124/mol.112.082891</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1124%2Fmol.112.082891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=23348500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsVyrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2013&pages=835-847&author=M.+J.+Noetzelauthor=K.+J.+Gregoryauthor=P.+N.+Vinsonauthor=J.+T.+Mankaauthor=S.+R.+Staufferauthor=C.+W.+Lindsleyauthor=C.+M.+Niswenderauthor=Z.+Xiangauthor=P.+J.+Conn&title=A+novel+metabotropic+glutamate+receptor+5+positive+allosteric+modulator+acts+at+a+unique+site+and+confers+stimulus+bias+to+mGlu5+signaling&doi=10.1124%2Fmol.112.082891"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">A novel metabotropic glutamate receptor 5 positive allosteric modulator acts at a unique site and confers stimulus bias to mGlu5 signaling</span></div><div class="casAuthors">Noetzel, M. J.; Gregory, K. J.; Vinson, P. N.; Manka, J. T.; Stauffer, S. R.; Lindsley, C. W.; Niswender, C. M.; Xiang, Z.; Conn, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">835-847</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Metabotropic glutamate receptor 5 (mGlu5) is a target for the treatment of central nervous system (CNS) disorders, such as schizophrenia and Alzheimer's disease.  Furthermore, mGlu5 has been shown to play an important role in hippocampal synaptic plasticity, specifically in long-term depression (LTD) and long-term potentiation (LTP), which is thought to be involved in cognition.  Multiple mGlu5-pos. allosteric modulators (PAMs) have been developed from a variety of different scaffolds.  Previous work has extensively characterized a common allosteric site on mGlu5, termed the MPEP (2-Methyl-6-(phenylethynyl)pyridine) binding site.  However, one mGlu5 PAM, CPPHA (N-(4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl)-2-hydroxybenzamide), interacts with a sep. allosteric site on mGlu5.  Using cell-based assays and brain slice prepns., we characterized the interaction of a potent and efficacious mGlu5 PAM from the CPPHA series termed NCFP (N-(4-chloro-2-((4-fluoro-1,3-dioxoisoindolin-2-yl)methyl)phenyl)picolinamide).  NCFP binds to the CPPHA site on mGlu5 and potentiates mGlu5-mediated responses in both recombinant and native systems.  However, NCFP provides greater mGlu5 subtype selectivity than does CPPHA, making it more suitable for studies of effects on mGlu5 in CNS prepns.  Of interest, NCFP does not potentiate responses involved in hippocampal synaptic plasticity (LTD/LTP), setting it apart from other previously characterized MPEP site PAMs.  This suggests that although mGlu5 PAMs may have similar responses in some systems, they can induce differential effects on mGlu5-mediated physiol. responses in the CNS.  Such stimulus bias by mGlu5 PAMs may complicate drug discovery efforts but would also allow for specifically tailored therapies, if pharmacol. biases can be attributed to different therapeutic outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrBH7IPviPNbVg90H21EOLACvtfcHk0lj2x6QMH3O38w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsVyrt7s%253D&md5=175d8e7aef535a8df57a73420200c8b0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.082891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.082891%26sid%3Dliteratum%253Aachs%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DManka%26aufirst%3DJ.%2BT.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DA%2520novel%2520metabotropic%2520glutamate%2520receptor%25205%2520positive%2520allosteric%2520modulator%2520acts%2520at%2520a%2520unique%2520site%2520and%2520confers%2520stimulus%2520bias%2520to%2520mGlu5%2520signaling%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D83%26spage%3D835%26epage%3D847%26doi%3D10.1124%2Fmol.112.082891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Rook, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouliot, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogliotti, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manka, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudek, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Unique signaling profiles of positive allosteric modulators of mGlu5 determine differences in in vivo activity</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2012.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.biopsych.2012.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=23140665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GktLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=501-509&author=J.+M.+Rookauthor=M.+J.+Noetzelauthor=W.+A.+Pouliotauthor=T.+M.+Bridgesauthor=P.+N.+Vinsonauthor=H.+P.+Choauthor=Y.+Zhouauthor=R.+D.+Gogliottiauthor=J.+T.+Mankaauthor=K.+J.+Gregoryauthor=S.+R.+Staufferauthor=F.+E.+Dudekauthor=Z.+Xiangauthor=C.+M.+Niswenderauthor=J.+S.+Danielsauthor=C.+K.+Jonesauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Unique+signaling+profiles+of+positive+allosteric+modulators+of+mGlu5+determine+differences+in+in+vivo+activity&doi=10.1016%2Fj.biopsych.2012.09.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Unique Signaling Profiles of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Determine Differences in In Vivo Activity</span></div><div class="casAuthors">Rook, Jerri M.; Noetzel, Meredith J.; Pouliot, Wendy A.; Bridges, Thomas M.; Vinson, Paige N.; Cho, Hyekyung P.; Zhou, Ya; Gogliotti, Rocco D.; Manka, Jason T.; Gregory, Karen J.; Stauffer, Shaun R.; Dudek, F. Edward; Xiang, Zixiu; Niswender, Colleen M.; Daniels, J. Scott; Jones, Carrie K.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">501-509</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Metabotropic glutamate receptor subtype 5 (mGlu5) activators have emerged as a novel approach to the treatment of schizophrenia.  Pos. allosteric modulators (PAMs) of mGlu5 have generated tremendous excitement and fueled major drug discovery efforts.  Although mGlu5 PAMs have robust efficacy in preclin. models of schizophrenia, preliminary reports suggest that these compds. may induce seizure activity.  Prototypical mGlu5 PAMs do not activate mGlu5 directly but selectively potentiate activation of mGlu5 by glutamate.  This mechanism may be crit. to maintaining normal activity-dependence of mGlu5 activation and achieving optimal in vivo effects.Using specially engineered mGlu5 cell lines incorporating point mutations within the allosteric and orthosteric binding sites, as well as brain slice electrophysiol. and in vivo electroencephalog. and behavioral pharmacol., we found that some mGlu5 PAMs have intrinsic allosteric agonist activity in the absence of glutamate.  Both in vitro mutagenesis and in vivo pharmacol. studies demonstrate that VU0422465 is an agonist PAM that induces epileptiform activity and behavioral convulsions in rodents.  In contrast, VU0361747, an mGlu5 PAMs optimized to eliminate allosteric agonist activity, has robust in vivo efficacy and does not induce adverse effects at doses that yield high brain concns.Loss of the abs. dependence of mGlu5 PAMs on glutamate release for their activity can lead to severe adverse effects.  The finding that closely related mGlu5 PAMs can differ in their intrinsic agonist activity provides crit. new insights that is essential for advancing these mols. through clin. development for treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEnfOyxRj5nrVg90H21EOLACvtfcHk0lj2x6QMH3O38w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GktLrM&md5=f8aba766e4ddf4fb28b3e3166ce8cd8c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2012.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2012.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DPouliot%26aufirst%3DW.%2BA.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGogliotti%26aufirst%3DR.%2BD.%26aulast%3DManka%26aufirst%3DJ.%2BT.%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DDudek%26aufirst%3DF.%2BE.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DUnique%2520signaling%2520profiles%2520of%2520positive%2520allosteric%2520modulators%2520of%2520mGlu5%2520determine%2520differences%2520in%2520in%2520vivo%2520activity%26jtitle%3DBiol.%2520Psychiatry%26date%3D2013%26volume%3D73%26spage%3D501%26epage%3D509%26doi%3D10.1016%2Fj.biopsych.2012.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Conde-Ceide, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Viturro, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Barrantes, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rook, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Megens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steckler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolomé-Nebreda, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Discovery of VU0409551/JNJ-46778212: an mGlu5 positive allosteric modulator clinical candidate targeting schizophrenia</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">716</span><span class="NLM_x">–</span> <span class="NLM_lpage">720</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00181</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00181" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovVSgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=716-720&author=S.+Conde-Ceideauthor=C.+M.+Martinez-Viturroauthor=J.+Alcazarauthor=P.+M.+Garcia-Barrantesauthor=H.+Lavreysenauthor=C.+Mackieauthor=P.+N.+Vinsonauthor=J.+M.+Rookauthor=T.+M.+Bridgesauthor=S.+J.+Danielsauthor=A.+Megensauthor=X.+Langloisauthor=W.+H.+Drinkenburgauthor=A.+Ahnaouauthor=C.+K.+Niswenderauthor=C.+K.+Jonesauthor=G.+J.+Macdonaldauthor=T.+Stecklerauthor=P.+J.+Connauthor=S.+R.+Staufferauthor=J.+M.+Bartolom%C3%A9-Nebredaauthor=C.+W.+Lindsley&title=Discovery+of+VU0409551%2FJNJ-46778212%3A+an+mGlu5+positive+allosteric+modulator+clinical+candidate+targeting+schizophrenia&doi=10.1021%2Facsmedchemlett.5b00181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of VU0409551/JNJ-46778212: An mGlu5 Positive Allosteric Modulator Clinical Candidate Targeting Schizophrenia</span></div><div class="casAuthors">Conde-Ceide, Susana; Martinez-Viturro, Carlos M.; Alcazar, Jesus; Garcia-Barrantes, Pedro M.; Lavreysen, Hilde; Mackie, Claire; Vinson, Paige N.; Rook, Jerri M.; Bridges, Thomas M.; Daniels, J. Scott; Megens, Anton; Langlois, Xavier; Drinkenburg, Wilhelmus H.; Ahnaou, Abdellah; Niswender, Colleen M.; Jones, Carrie K.; Macdonald, Gregor J.; Steckler, Thomas; Conn, P. Jeffrey; Stauffer, Shaun R.; Bartolome-Nebreda, Jose Manuel; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">716-720</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, the authors report the structure-activity relationship of a novel series of potent, selective, and orally bioavailable metabotropic glutamate receptor subtype 5 (mGlu5) pos. allosteric modulators.  On the basis of its robust in vitro potency and in vivo efficacy in multiple preclin. models of multiple domains of schizophrenia, coupled with a good DMPK profile and an acceptable therapeutic window, I (VU0409551/JNJ-46778212) was selected as a candidate for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz4F4S2MCNz7Vg90H21EOLACvtfcHk0lhtARsX7eKVwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovVSgu78%253D&md5=d92cd4c79b31d664deb53cafee809798</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00181%26sid%3Dliteratum%253Aachs%26aulast%3DConde-Ceide%26aufirst%3DS.%26aulast%3DMartinez-Viturro%26aufirst%3DC.%2BM.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DGarcia-Barrantes%26aufirst%3DP.%2BM.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DDaniels%26aufirst%3DS.%2BJ.%26aulast%3DMegens%26aufirst%3DA.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DDrinkenburg%26aufirst%3DW.%2BH.%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DNiswender%26aufirst%3DC.%2BK.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DSteckler%26aufirst%3DT.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DBartolom%25C3%25A9-Nebreda%26aufirst%3DJ.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520VU0409551%252FJNJ-46778212%253A%2520an%2520mGlu5%2520positive%2520allosteric%2520modulator%2520clinical%2520candidate%2520targeting%2520schizophrenia%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D716%26epage%3D720%26doi%3D10.1021%2Facsmedchemlett.5b00181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Chen, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gean, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. S.</span><span> </span><span class="NLM_article-title">Activation of mGluR2/3 underlies the effects of N-acetylcystein on amygdala-associated autism-like phenotypes in a valproate-induced rat model of autism</span> <span class="citation_source-journal">Front. Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="refDoi"> DOI: 10.3389/fnbeh.2014.00219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3389%2Ffnbeh.2014.00219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24987341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1GjsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=219&author=Y.+W.+Chenauthor=H.+C.+Linauthor=M.+C.+Ngauthor=Y.+H.+Hsiaoauthor=C.+C.+Wangauthor=P.+W.+Geanauthor=P.+S.+Chen&title=Activation+of+mGluR2%2F3+underlies+the+effects+of+N-acetylcystein+on+amygdala-associated+autism-like+phenotypes+in+a+valproate-induced+rat+model+of+autism&doi=10.3389%2Ffnbeh.2014.00219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of mGluR2/3 underlies the effects of N-acetylcystein on amygdala-associated autism-like phenotypes in a valproate-induced rat model of autism</span></div><div class="casAuthors">Chen, Yu-Wen; Lin, Hui-Ching; Ng, Ming-Chong; Hsiao, Ya-Hsin; Wang, Chao-Chuan; Gean, Po-Wu; Chen, Po See</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">219/1-219/9, 9</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Autism-like phenotypes in male valproate (VPA)-exposed offspring have been linked to high glutamatergic neurotransmission in the thalamic-amygdala pathway.  Glial cystine/glutamate exchange (system Xc-), which exchanges extracellular cystine for intracellular glutamate, plays a significant role in the maintenance of extracellular glutamate.  N-acetylcysteine (NAC) is a cystine prodrug that restores extracellular glutamate by stimulating system Xc-.  In this study, we examd. the effects of NAC on autism-like phenotypes and neurotransmission in the thalamic-amygdala synapses, as well as the involvement of metabotropic glutamate receptors 2/3 (mGluR2/3).  Valproate-treated rats received a single i.p. injection of 500 mg/kg NaVPA on E12.5.  On postnatal day 21 (P21), NAC or saline was administered once daily for 10 days.  From day 8 to 10, NAC was given 1/2 h prior to behavioral testing.  Chronic administration of NAC restored the duration and frequency of social interaction and ameliorated anxiety-like behaviors in VPA-exposed offspring.  In amygdala slices, NAC treatment normalized the increased frequency of mEPSCs and decreased the paired pulse facilitation (PPF) induced by VPA exposure.  The effects of NAC on social interaction and anxiety-like behavior in the VPA-exposed offspring were blocked after intra-amygdala infusion of mGluR2/3 antagonist LY341495.  The expressions of mGluR2/3 protein and mGluR2 mRNA were significantly lower in the VPA-exposed offspring.  In contrast, the mGluR3 mRNA level did not differ between the saline- and VPA-exposed offspring.  These results provide the first evidence that the disruption of social interaction and enhanced presynaptic excitatory transmission in VPA-exposed offspring could be rescued by NAC, which depends on the activation of mGluR2/3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLdBNsuTo9KLVg90H21EOLACvtfcHk0lhtARsX7eKVwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1GjsrvK&md5=7d5a98724a4b1e1cd726fcde5db3e5ab</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2014.00219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2014.00219%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BW.%26aulast%3DLin%26aufirst%3DH.%2BC.%26aulast%3DNg%26aufirst%3DM.%2BC.%26aulast%3DHsiao%26aufirst%3DY.%2BH.%26aulast%3DWang%26aufirst%3DC.%2BC.%26aulast%3DGean%26aufirst%3DP.%2BW.%26aulast%3DChen%26aufirst%3DP.%2BS.%26atitle%3DActivation%2520of%2520mGluR2%252F3%2520underlies%2520the%2520effects%2520of%2520N-acetylcystein%2520on%2520amygdala-associated%2520autism-like%2520phenotypes%2520in%2520a%2520valproate-induced%2520rat%2520model%2520of%2520autism%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D219%26doi%3D10.3389%2Ffnbeh.2014.00219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valli, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kress, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wepsiec, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harkness, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grutsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andis, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffey, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tizzano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1040</span><span class="refDoi"> DOI: 10.1021/jm980616n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980616n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADyaK1MXhtlOlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1027-1040&author=J.+A.+Monnauthor=M.+J.+Valliauthor=S.+M.+Masseyauthor=M.+M.+Hansenauthor=T.+J.+Kressauthor=J.+P.+Wepsiecauthor=A.+R.+Harknessauthor=J.+L.+Grutschauthor=R.+A.+Wrightauthor=B.+G.+Johnsonauthor=S.+L.+Andisauthor=A.+Kingstonauthor=R.+Tomlinsonauthor=R.+Lewisauthor=K.+R.+Griffeyauthor=J.+P.+Tizzanoauthor=D.+D.+Schoepp&title=Synthesis%2C+pharmacological+characterization%2C+and+molecular+modeling+of+heterobicyclic+amino+acids+related+to+%28%2B%29-2-aminobicyclo%5B3.1.0%5Dhexane-2%2C6-dicarboxylic+acid+%28LY354740%29%3A+identification+of+two+new+potent%2C+selective%2C+and+systemically+active+agonists+for+group+II+metabotropic+glutamate+receptors&doi=10.1021%2Fjm980616n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Pharmacological Characterization, and Molecular Modeling of Heterobicyclic Amino Acids Related to (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740): Identification of Two New Potent, Selective, and Systemically Active Agonists for Group II Metabotropic Glutamate Receptors</span></div><div class="casAuthors">Monn, James A.; Valli, Matthew J.; Massey, Steven M.; Hansen, Marvin M.; Kress, Thomas J.; Wepsiec, James P.; Harkness, Allen R.; Grutsch, John L., Jr.; Wright, Rebecca A.; Johnson, Bryan G.; Andis, Sherri L.; Kingston, Ann; Tomlinson, Rosemarie; Lewis, Richard; Griffey, Kelly R.; Tizzano, Joseph P.; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1027-1040</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of an ongoing research program aimed at the identification of highly potent, selective, and systemically active agonists for group II metabotropic glutamate (mGlu) receptors, novel heterobicyclic amino acids (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268, I) and (-)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795, II) have been prepd.  I and II are structurally related to the previously described nanomolar potency group II mGlu receptor agonist, (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate monohydrate (LY354740 monohydrate, III), with the C(4)-methylene unit of III being replaced with either an oxygen atom or a sulfur atom.  I and II potently and stereospecifically displaced specific binding of the mGlu2/3 receptor antagonist ([3H]LY341495) in rat cerebral cortical homogenates, displaying IC50 values of 15 ± 4 and 8.4 ± 0.8 nM, resp., while having no effect up to 100,000 nM on radioligand binding to the glutamate recognition site on NMDA, AMPA, or kainate receptors.  I and II also potently displaced [3H]LY341495 binding from membranes expressing recombinant human group II mGlu receptor subtypes: I Ki = 14.1 ± 1.4 nM at mGlu2 and 5.8 ± 0.64 nM at mGlu3; II Ki = 40.6 ± 3.7 nM at mGlu2 and 4.7 ± 1.2 nM at mGlu3.  Evaluation of the functional effects of I and II on second-messenger responses in nonneuronal cells expressing human mGlu receptor subtypes demonstrated each to be a highly potent agonist for group II mGlu receptors: I EC50 = 2.69 ± 0.26 nM at mGlu2 and 4.58 ± 0.04 nM at mGlu3; II EC50 = 3.91 ± 0.81 nM at mGlu2 and 7.63 ± 2.08 nM at mGlu3.  In contrast, neither compd. (up to 10,000 nM) displayed either agonist or antagonist activity in cells expressing recombinant human mGlu1a, mGlu5a, mGlu4a, or mGlu7a receptors.  The agonist effects of I and II at group II mGlu receptors were not totally specific, however, as mGlu6 agonist activity was obsd. at high nanomolar concns. for I (EC50 = 401 ± 46 nM) and at micromolar concns. (EC50 = 2 430 ± 600 nM) for II; furthermore, each activated mGlu8 receptors at micromolar concns. (EC50 = 1 690 ± 130 and 7 340 ± 2 720 nM, resp.).  I.p. administration of either I or II in the mouse resulted in a dose-related blockade of limbic seizure activity produced by the nonselective group I/group II mGluR agonist (1S,3R)-ACPD (I ED50 = 19 mg/kg, II ED50 = 14 mg/kg), indicating that these mols. effectively cross the blood-brain barrier following systemic administration and suppress group I mGluR-mediated limbic excitation.  Thus, I and II are novel pharmacol. tools useful for exploring the functions of mGlu receptors in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJB67CSyXWlrVg90H21EOLACvtfcHk0lhtARsX7eKVwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtlOlurk%253D&md5=6770c78b85dd10620b87ce6c9b4b5fe5</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm980616n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980616n%26sid%3Dliteratum%253Aachs%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DValli%26aufirst%3DM.%2BJ.%26aulast%3DMassey%26aufirst%3DS.%2BM.%26aulast%3DHansen%26aufirst%3DM.%2BM.%26aulast%3DKress%26aufirst%3DT.%2BJ.%26aulast%3DWepsiec%26aufirst%3DJ.%2BP.%26aulast%3DHarkness%26aufirst%3DA.%2BR.%26aulast%3DGrutsch%26aufirst%3DJ.%2BL.%26aulast%3DWright%26aufirst%3DR.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DAndis%26aufirst%3DS.%2BL.%26aulast%3DKingston%26aufirst%3DA.%26aulast%3DTomlinson%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DGriffey%26aufirst%3DK.%2BR.%26aulast%3DTizzano%26aufirst%3DJ.%2BP.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DSynthesis%252C%2520pharmacological%2520characterization%252C%2520and%2520molecular%2520modeling%2520of%2520heterobicyclic%2520amino%2520acids%2520related%2520to%2520%2528%252B%2529-2-aminobicyclo%255B3.1.0%255Dhexane-2%252C6-dicarboxylic%2520acid%2520%2528LY354740%2529%253A%2520identification%2520of%2520two%2520new%2520potent%252C%2520selective%252C%2520and%2520systemically%2520active%2520agonists%2520for%2520group%2520II%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1027%26epage%3D1040%26doi%3D10.1021%2Fjm980616n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Ornstein, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleisch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tizzano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hérin, M.</span><span> </span><span class="NLM_article-title">2-Substituted (2SR)-2-amino-2-((1SR,2SR)-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span><span class="refDoi"> DOI: 10.1021/jm970498o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970498o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=358-378&author=P.+L.+Ornsteinauthor=T.+J.+Bleischauthor=M.+B.+Arnoldauthor=J.+H.+Kennedyauthor=R.+A.+Wrightauthor=B.+G.+Johnsonauthor=J.+P.+Tizzanoauthor=D.+R.+Heltonauthor=M.+J.+Kallmanauthor=D.+D.+Schoeppauthor=M.+H%C3%A9rin&title=2-Substituted+%282SR%29-2-amino-2-%28%281SR%2C2SR%29-carboxycycloprop-1-yl%29glycines+as+potent+and+selective+antagonists+of+group+II+metabotropic+glutamate+receptors.+2.+Effects+of+aromatic+substitution%2C+pharmacological+characterization%2C+and+bioavailability&doi=10.1021%2Fjm970498o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm970498o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970498o%26sid%3Dliteratum%253Aachs%26aulast%3DOrnstein%26aufirst%3DP.%2BL.%26aulast%3DBleisch%26aufirst%3DT.%2BJ.%26aulast%3DArnold%26aufirst%3DM.%2BB.%26aulast%3DKennedy%26aufirst%3DJ.%2BH.%26aulast%3DWright%26aufirst%3DR.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DTizzano%26aufirst%3DJ.%2BP.%26aulast%3DHelton%26aufirst%3DD.%2BR.%26aulast%3DKallman%26aufirst%3DM.%2BJ.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26aulast%3DH%25C3%25A9rin%26aufirst%3DM.%26atitle%3D2-Substituted%2520%25282SR%2529-2-amino-2-%2528%25281SR%252C2SR%2529-carboxycycloprop-1-yl%2529glycines%2520as%2520potent%2520and%2520selective%2520antagonists%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptors.%25202.%2520Effects%2520of%2520aromatic%2520substitution%252C%2520pharmacological%2520characterization%252C%2520and%2520bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D358%26epage%3D378%26doi%3D10.1021%2Fjm970498o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Chaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuhara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakagami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakazato, A.</span><span> </span><span class="NLM_article-title">MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2003.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuropharm.2003.10.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2004&pages=457-467&author=S.+Chakiauthor=R.+Yoshikawaauthor=S.+Hirotaauthor=T.+Shimazakiauthor=M.+Maedaauthor=N.+Kawashimaauthor=T.+Yoshimizuauthor=A.+Yasuharaauthor=K.+Sakagamiauthor=S.+Okuyamaauthor=S.+Nakanishiauthor=A.+Nakazato&title=MGS0039%3A+a+potent+and+selective+group+II+metabotropic+glutamate+receptor+antagonist+with+antidepressant-like+activity&doi=10.1016%2Fj.neuropharm.2003.10.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2003.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2003.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DChaki%26aufirst%3DS.%26aulast%3DYoshikawa%26aufirst%3DR.%26aulast%3DHirota%26aufirst%3DS.%26aulast%3DShimazaki%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DKawashima%26aufirst%3DN.%26aulast%3DYoshimizu%26aufirst%3DT.%26aulast%3DYasuhara%26aufirst%3DA.%26aulast%3DSakagami%26aufirst%3DK.%26aulast%3DOkuyama%26aufirst%3DS.%26aulast%3DNakanishi%26aufirst%3DS.%26aulast%3DNakazato%26aufirst%3DA.%26atitle%3DMGS0039%253A%2520a%2520potent%2520and%2520selective%2520group%2520II%2520metabotropic%2520glutamate%2520receptor%2520antagonist%2520with%2520antidepressant-like%2520activity%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D46%26spage%3D457%26epage%3D467%26doi%3D10.1016%2Fj.neuropharm.2003.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Johnson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagdmann, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britton, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Large, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callagaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tizzano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-yl-methylamine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3189</span><span class="NLM_x">–</span> <span class="NLM_lpage">3192</span><span class="refDoi"> DOI: 10.1021/jm034015u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm034015u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3189-3192&author=M.+P.+Johnsonauthor=M.+Baezauthor=G.+E.+Jagdmannauthor=T.+C.+Brittonauthor=T.+H.+Largeauthor=D.+O.+Callagaroauthor=J.+P.+Tizzanoauthor=J.+A.+Monnauthor=D.+D.+Schoepp&title=Discovery+of+allosteric+potentiators+for+the+metabotropic+glutamate+2+receptor%3A+synthesis+and+subtype+selectivity+of+N-%284-%282-methoxyphenoxy%29phenyl%29-N-%282%2C2%2C2-trifluoroethylsulfonyl%29pyrid-3-yl-methylamine&doi=10.1021%2Fjm034015u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm034015u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034015u%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DM.%2BP.%26aulast%3DBaez%26aufirst%3DM.%26aulast%3DJagdmann%26aufirst%3DG.%2BE.%26aulast%3DBritton%26aufirst%3DT.%2BC.%26aulast%3DLarge%26aufirst%3DT.%2BH.%26aulast%3DCallagaro%26aufirst%3DD.%2BO.%26aulast%3DTizzano%26aufirst%3DJ.%2BP.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DDiscovery%2520of%2520allosteric%2520potentiators%2520for%2520the%2520metabotropic%2520glutamate%25202%2520receptor%253A%2520synthesis%2520and%2520subtype%2520selectivity%2520of%2520N-%25284-%25282-methoxyphenoxy%2529phenyl%2529-N-%25282%252C2%252C2-trifluoroethylsulfonyl%2529pyrid-3-yl-methylamine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3189%26epage%3D3192%26doi%3D10.1021%2Fjm034015u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Galici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hempstapat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echemendia, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Paulis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2 has antipsychotic-and anxiolytic-like effects in mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1124/jpet.106.102046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1124%2Fjpet.106.102046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=16608916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFymsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=173-185&author=R.+Galiciauthor=C.+K.+Jonesauthor=K.+Hempstapatauthor=Y.+Nongauthor=N.+G.+Echemendiaauthor=L.+G.+Williamsauthor=T.+de+Paulisauthor=P.+J.+Conn&title=Biphenyl-indanone+A%2C+a+positive+allosteric+modulator+of+the+metabotropic+glutamate+receptor+subtype+2+has+antipsychotic-and+anxiolytic-like+effects+in+mice&doi=10.1124%2Fjpet.106.102046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice</span></div><div class="casAuthors">Galici, Ruggero; Jonas, Carrie K.; Hemstapat, Kamondanai; Nong, Yi; Echemendia, Nicholas G.; Williams, Lilly C.; de Paulis, Tomas; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">173-185</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Previous studies indicate that agonists of the group II metabotropic glutamate receptors (mGluRs), mGluR2 and mGluR3, may provide a novel approach for the treatment of anxiety disorders and schizophrenia.  However, the relative contributions of the mGluR2 and mGluR3 subtypes to the effects of the group II mGluR agonists remain unclear.  In the present study, we describe an alternate synthesis and further pharmacol. characterization of a recently reported pos. allosteric modulator of mGluR2 termed biphenyl-indanone A (BINA).  In recombinant systems, BINA produced a robust and selective potentiation of the response of mGluR2 to glutamate with no effect on the glutamate response of other mGluR subtypes.  In hippocampal brain slices, BINA (1 μM) significantly potentiated the mGluR2/3 agonist-induced inhibition of excitatory synaptic transmission at the medial perforant path-dentate gyrus synapse.  BINA was also efficacious in several models predictive of antipsychotic- and anxiolytic-like activity in mice.  The behavioral effects of BINA were blocked by the mGluR2/3 antagonist LY341495, suggesting that the in vivo effects of BINA are mediated by increased activation of mGluR2.  Collectively, these results indicate that BINA is a selective mGluR2 pos. allosteric modulator and provide further support for the growing evidence that selective allosteric potentiators of mGluR2 mimic many of the in vivo actions of mGluR2/3 agonists that may predict therapeutic utility of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-1EIY1aXPUrVg90H21EOLACvtfcHk0lixQOd2sTtfDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFymsbc%253D&md5=e51f1d1df8831b32c5b91a62c0919875</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.102046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.102046%26sid%3Dliteratum%253Aachs%26aulast%3DGalici%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DHempstapat%26aufirst%3DK.%26aulast%3DNong%26aufirst%3DY.%26aulast%3DEchemendia%26aufirst%3DN.%2BG.%26aulast%3DWilliams%26aufirst%3DL.%2BG.%26aulast%3Dde%2BPaulis%26aufirst%3DT.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DBiphenyl-indanone%2520A%252C%2520a%2520positive%2520allosteric%2520modulator%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%2520subtype%25202%2520has%2520antipsychotic-and%2520anxiolytic-like%2520effects%2520in%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D173%26epage%3D185%26doi%3D10.1124%2Fjpet.106.102046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Hiyoshi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marumo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hikichi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomishima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuhara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karasawa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaki, S.</span><span> </span><span class="NLM_article-title">Neurophysiologic and antipsychotic profiles of TASP0433864, a novel positive allosteric modulator of metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">642</span><span class="NLM_x">–</span> <span class="NLM_lpage">653</span><span class="refDoi"> DOI: 10.1124/jpet.114.218651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1124%2Fjpet.114.218651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25277141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWhtLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2014&pages=642-653&author=T.+Hiyoshiauthor=T.+Marumoauthor=H.+Hikichiauthor=Y.+Tomishimaauthor=H.+Urabeauthor=T.+Tamitaauthor=I.+Iidaauthor=A.+Yasuharaauthor=J.+Karasawaauthor=S.+Chaki&title=Neurophysiologic+and+antipsychotic+profiles+of+TASP0433864%2C+a+novel+positive+allosteric+modulator+of+metabotropic+glutamate+2+receptor&doi=10.1124%2Fjpet.114.218651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Neurophysiologic and antipsychotic profiles of TASP0433864, a novel positive allosteric modulator of metabotropic glutamate 2 receptor</span></div><div class="casAuthors">Hiyoshi, Tetsuaki; Marumo, Toshiyuki; Hikichi, Hirohiko; Tomishima, Yasumitsu; Urabe, Hiroki; Tamita, Tomoko; Iida, Izumi; Yasuhara, Akito; Karasawa, Jun-ichi; Chaki, Shigeyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">642-653, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Excess glutamatergic neurotransmission has been implicated in the pathophysiol. of schizophrenia, and the activation of metabotropic glutamate 2 (mGlu2) receptor may exert antipsychotic effects by normalizing glutamate transmission.  In the present study, we investigated the neurophysiol. and antipsychotic profiles of TASP0433864 [(2S)-2-[(4-tert-butylphenoxy)methyl]-5-methyl-2,3-dihydroimidazo[2,1-b][1,3]oxazole-6-carboxamide], a newly synthesized pos. allosteric modulator (PAM) of mGlu2 receptor.  TASP0433864 exhibited PAM activity at human and rat mGlu2 receptors with EC50 values of 199 and 206 nM, resp., without exerting agonist activity at rat mGlu2 receptor.  TASP0433864 produced a leftward and upward shift in the concn.-response curve of glutamate-increased guanosine 5'-O-(3-[35S]thio)triphosphate binding to mGlu2 receptor.  In contrast, TASP0433864 had negligible activities for other mGlu receptors, including mGlu3 receptor, and did not have any affinity for other receptors or transporters.  In hippocampal slices, TASP0433864 potentiated an inhibitory effect of DCG-IV [(2S,2'R,3'R)-2-(2',3'-dicarboxylcyclopropyl)glycine], a mGlu2/3 receptor agonist, on the field excitatory postsynaptic potentials in the dentate gyrus, indicating that TASP0433864 potentiates the mGlu2 receptor-mediated presynaptic inhibition of glutamate release.  Moreover, TASP0433864 inhibited both MK-801 [(5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate]- and ketamine-increased cortical γ band oscillation in the rat cortical EEG, which have been considered to reflect the excess activation of cortical pyramidal neurons.  The inhibitory effect of TASP0433864 on cortical activation was also obsd. in the mouse 2-deoxy-glucose uptake study.  In a behavioral study, TASP0433864 significantly inhibited both ketamine- and methamphetamine-increased locomotor activities in mice and rats, resp.  Collectively, these findings indicate that TASP0433864 is a selective mGlu2 receptor PAM with antipsychotic activity, and the attenuation of excess glutamatergic neurotransmission may be involved in the action of TASP0433864.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ZCE3A5-e6rVg90H21EOLACvtfcHk0lixQOd2sTtfDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWhtLbN&md5=975913a2781961123c4171ca71c0638c</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.218651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.218651%26sid%3Dliteratum%253Aachs%26aulast%3DHiyoshi%26aufirst%3DT.%26aulast%3DMarumo%26aufirst%3DT.%26aulast%3DHikichi%26aufirst%3DH.%26aulast%3DTomishima%26aufirst%3DY.%26aulast%3DUrabe%26aufirst%3DH.%26aulast%3DTamita%26aufirst%3DT.%26aulast%3DIida%26aufirst%3DI.%26aulast%3DYasuhara%26aufirst%3DA.%26aulast%3DKarasawa%26aufirst%3DJ.%26aulast%3DChaki%26aufirst%3DS.%26atitle%3DNeurophysiologic%2520and%2520antipsychotic%2520profiles%2520of%2520TASP0433864%252C%2520a%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D351%26spage%3D642%26epage%3D653%26doi%3D10.1124%2Fjpet.114.218651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pype, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Discovery of 1-butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1<i>H</i>)-pyridone (JNJ-40411813): a novel positive allosteric modulator of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6495</span><span class="NLM_x">–</span> <span class="NLM_lpage">6512</span><span class="refDoi"> DOI: 10.1021/jm500496m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500496m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyitLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6495-6512&author=J.+M.+Cidauthor=G.+Tresadernauthor=G.+Duveyauthor=R.+Lutjensauthor=T.+Finnauthor=J.+P.+Rocherauthor=S.+Poliauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=E.+Matesanzauthor=M.+L.+Linaresauthor=J.+I.+Andr%C3%A9sauthor=J.+Alcazarauthor=J.+M.+Alonsoauthor=G.+J.+Macdonaldauthor=D.+Oehlrichauthor=H.+Lavreysenauthor=A.+Ahnaouauthor=W.+Drinkenburgauthor=C.+Mackieauthor=S.+Pypeauthor=D.+Gallacherauthor=A.+A.+Trabanco&title=Discovery+of+1-butyl-3-chloro-4-%284-phenyl-1-piperidinyl%29-%281H%29-pyridone+%28JNJ-40411813%29%3A+a+novel+positive+allosteric+modulator+of+the+metabotropic+glutamate+2+receptor&doi=10.1021%2Fjm500496m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1-Butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1H)-pyridone (JNJ-40411813): A Novel Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor</span></div><div class="casAuthors">Cid, Jose Maria; Tresadern, Gary; Duvey, Guillaume; Lutjens, Robert; Finn, Terry; Rocher, Jean-Philippe; Poli, Sonia; Vega, Juan Antonio; de Lucas, Ana Isabel; Matesanz, Encarnacion; Linares, Maria Lourdes; Andres, Jose Ignacio; Alcazar, Jesus; Alonso, Jose Manuel; Macdonald, Gregor J.; Oehlrich, Daniel; Lavreysen, Hilde; Ahnaou, Abdelah; Drinkenburg, Wilhelmus; Mackie, Claire; Pype, Stefan; Gallacher, David; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6495-6512</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors previously reported the discovery of 4-aryl-substituted pyridones with mGlu2 PAM activity starting from the HTS hit I.  In this article, the authors describe a different exploration I from that led to the discovery of a novel subseries of phenylpiperidine-substituted pyridones.  The optimization strategy involved the introduction of different spacers between the pyridone core and the Ph ring of I.  The fine tuning of metab. and hERG followed by differentiation of advanced leads that were identified on the basis of PK profiles and in vivo potency converged on lead compd. II (JNJ-40411813).  Full in vitro and in vivo profiles indicate that II displayed an optimal interplay between potency, selectivity, favorable ADMET/PK and cardiovascular safety profile, and central EEG activity.  Compd. II has been investigated in the clinic for schizophrenia and anxious depression disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWE5azCuzrDbVg90H21EOLACvtfcHk0lixQOd2sTtfDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyitLfO&md5=d485ac63ceea50eaf8864f08bf903350</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm500496m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500496m%26sid%3Dliteratum%253Aachs%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DFinn%26aufirst%3DT.%26aulast%3DRocher%26aufirst%3DJ.%2BP.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DDrinkenburg%26aufirst%3DW.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DPype%26aufirst%3DS.%26aulast%3DGallacher%26aufirst%3DD.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DDiscovery%2520of%25201-butyl-3-chloro-4-%25284-phenyl-1-piperidinyl%2529-%25281H%2529-pyridone%2520%2528JNJ-40411813%2529%253A%2520a%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6495%26epage%3D6512%26doi%3D10.1021%2Fjm500496m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Cook, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">March, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satterthwaite, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span> </span><span class="NLM_article-title">Lessons learned from the fate of AstraZeneca’s drug pipeline: a five dimensional framework</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1038/nrd4309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnrd4309" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=419-431&author=D.+Cookauthor=D.+Brownauthor=R.+Alexanderauthor=R.+Marchauthor=P.+Morganauthor=G.+Satterthwaiteauthor=M.+N.+Pangalos&title=Lessons+learned+from+the+fate+of+AstraZeneca%E2%80%99s+drug+pipeline%3A+a+five+dimensional+framework&doi=10.1038%2Fnrd4309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fnrd4309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4309%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMarch%26aufirst%3DR.%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DSatterthwaite%26aufirst%3DG.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26atitle%3DLessons%2520learned%2520from%2520the%2520fate%2520of%2520AstraZeneca%25E2%2580%2599s%2520drug%2520pipeline%253A%2520a%2520five%2520dimensional%2520framework%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D419%26epage%3D431%26doi%3D10.1038%2Fnrd4309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Campo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalinichev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yacoubi, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Royer-Urios, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legrand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parron, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessif, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaugeois, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celanire, S.</span><span> </span><span class="NLM_article-title">Characterization of an mGluR2/3 negative allosteric modulator in rodent models of depression</span> <span class="citation_source-journal">J. Neurogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span><span class="refDoi"> DOI: 10.3109/01677063.2011.627485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3109%2F01677063.2011.627485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22091727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=152-166&author=B.+Campoauthor=M.+Kalinichevauthor=N.+Lambengauthor=M.+E.+Yacoubiauthor=I.+Royer-Uriosauthor=M.+Schneiderauthor=C.+Legrandauthor=D.+Parronauthor=F.+Girardauthor=A.+Bessifauthor=S.+Poliauthor=J.+M.+Vaugeoisauthor=E.+Le+Poulauthor=S.+Celanire&title=Characterization+of+an+mGluR2%2F3+negative+allosteric+modulator+in+rodent+models+of+depression&doi=10.3109%2F01677063.2011.627485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of an mGluR2/3 Negative Allosteric Modulator in Rodent Models of Depression</span></div><div class="casAuthors">Campo, Brice; Kalinichev, Mikhail; Lambeng, Nathalie; El Yacoubi, M.; Royer-Urios, Isabelle; Schneider, Manfred; Legrand, Coline; Parron, Delphine; Girard, Francoise; Bessif, Abdelhak; Poli, Sonia; Vaugeois, Jean-Marie; Le Poul, Emmanuel; Celanire, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">152-166</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">There is growing evidence suggesting that antagonists of group II metabotropic glutamate receptors (mGluR2/3) exhibit antidepressant-like properties in several preclin. models of depression.  However, all those studies have been performed using competitive group II non-selective orthosteric antagonists.  In this study we extensively characterized a group II selective neg. allosteric modulator (4-[3-(2,6-Dimethylpyridin-4-yl)phenyl]-7-methyl-8-trifluoromethyl-1,3-dihydrobenzo[b][1,4]diazepin-2-one, namely RO4491533, Woltering et al., 2010) in several in vitro biochem. assays and in vivo models of depression.  In vitro, RO4491533 completely blocked the glutamate-induced Ca2 ++ mobilization and the glutamate-induced accumulation in [35S]GTPγS binding in cells expressing recombinant human or rat mGluR2 and in native tissues.  Results from Schild plot expts. and reversibility test at the target on both cellular and membrane-based assays confirmed the neg. allosteric modulator properties of the compd.  RO4491533 was equipotent on mGluR2 and mGluR3 receptors but not active on any other mGluRs.  RO4491533 has acceptable PK properties in mice and rats, is bioavailable following oral gavage (F == 30%) and brain-penetrant (CSF conc/total plasma conc ratio == 0.8%).  RO4491533 appeared to engage the central mGluR2 and mGluR3 receptors since the compd. reversed the hypolocomotor effect of an mGluR2/3 orthosteric agonist LY379268 in a target-specific manner, as did the group II orthosteric mGluR2/3 antagonist LY341495.  RO4491533 and LY341495 dose-dependently reduced immobility time of C57Bl6/J mice in the forced swim test.  Also, RO4491533 and LY341495 were active in the tail suspension test in a line of Helpless (H) mice, a putative genetic model of depression.  These data suggest that mGluR2/3 receptors are viable targets for development of novel pharmacotherapies for depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovnqA5cdGksrVg90H21EOLACvtfcHk0liAIA1Vd2tZfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7fI&md5=86c0560136504ae513418a2b1fe0c9e1</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.3109%2F01677063.2011.627485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2011.627485%26sid%3Dliteratum%253Aachs%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DKalinichev%26aufirst%3DM.%26aulast%3DLambeng%26aufirst%3DN.%26aulast%3DYacoubi%26aufirst%3DM.%2BE.%26aulast%3DRoyer-Urios%26aufirst%3DI.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DLegrand%26aufirst%3DC.%26aulast%3DParron%26aufirst%3DD.%26aulast%3DGirard%26aufirst%3DF.%26aulast%3DBessif%26aufirst%3DA.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DVaugeois%26aufirst%3DJ.%2BM.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DCelanire%26aufirst%3DS.%26atitle%3DCharacterization%2520of%2520an%2520mGluR2%252F3%2520negative%2520allosteric%2520modulator%2520in%2520rodent%2520models%2520of%2520depression%26jtitle%3DJ.%2520Neurogenet.%26date%3D2011%26volume%3D25%26spage%3D152%26epage%3D166%26doi%3D10.3109%2F01677063.2011.627485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Homayoun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefani, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamagan, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moghaddam, B.</span><span> </span><span class="NLM_article-title">Functional interaction between NMDA and mGlu5 receptors: effects on working memory, instrumental learning, motor behaviors, and dopamine release</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1259</span><span class="NLM_x">–</span> <span class="NLM_lpage">1269</span><span class="refDoi"> DOI: 10.1038/sj.npp.1300417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fsj.npp.1300417" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=1259-1269&author=H.+Homayounauthor=M.+R.+Stefaniauthor=B.+W.+Adamsauthor=G.+D.+Tamaganauthor=B.+Moghaddam&title=Functional+interaction+between+NMDA+and+mGlu5+receptors%3A+effects+on+working+memory%2C+instrumental+learning%2C+motor+behaviors%2C+and+dopamine+release&doi=10.1038%2Fsj.npp.1300417"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1300417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1300417%26sid%3Dliteratum%253Aachs%26aulast%3DHomayoun%26aufirst%3DH.%26aulast%3DStefani%26aufirst%3DM.%2BR.%26aulast%3DAdams%26aufirst%3DB.%2BW.%26aulast%3DTamagan%26aufirst%3DG.%2BD.%26aulast%3DMoghaddam%26aufirst%3DB.%26atitle%3DFunctional%2520interaction%2520between%2520NMDA%2520and%2520mGlu5%2520receptors%253A%2520effects%2520on%2520working%2520memory%252C%2520instrumental%2520learning%252C%2520motor%2520behaviors%252C%2520and%2520dopamine%2520release%26jtitle%3DNeuropsychopharmacology%26date%3D2004%26volume%3D29%26spage%3D1259%26epage%3D1269%26doi%3D10.1038%2Fsj.npp.1300417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Chung, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhim, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E.</span><span> </span><span class="NLM_article-title">Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span><span class="refDoi"> DOI: 10.1038/nn.3927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnn.3927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25622145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVehtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=435-443&author=W.+Chungauthor=S.+Y.+Choiauthor=E.+Leeauthor=H.+Parkauthor=J.+Kangauthor=H.+Parkauthor=Y.+Choiauthor=D.+Leeauthor=S.+G.+Parkauthor=R.+Kimauthor=Y.+S.+Choauthor=J.+Choiauthor=M.+H.+Kimauthor=J.+W.+Leeauthor=S.+Leeauthor=I.+Rhimauthor=M.+W.+Jungauthor=D.+Kimauthor=Y.+C.+Baeauthor=E.+Kim&title=Social+deficits+in+IRSp53+mutant+mice+improved+by+NMDAR+and+mGluR5+suppression&doi=10.1038%2Fnn.3927"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression</span></div><div class="casAuthors">Chung, Woosuk; Choi, Su Yeon; Lee, Eunee; Park, Haram; Kang, Jaeseung; Park, Hanwool; Choi, Yeonsoo; Lee, Dongsoo; Park, Sae-Geun; Kim, Ryunhee; Cho, Yi Sul; Choi, Jeonghoon; Kim, Myoung-Hwan; Lee, Jong Won; Lee, Seungjoon; Rhim, Issac; Jung, Min Whan; Kim, Daesoo; Bae, Yong Chul; Kim, Eunjoon</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">435-443</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Social deficits are obsd. in diverse psychiatric disorders, including autism spectrum disorders and schizophrenia.  We found that mice lacking the excitatory synaptic signaling scaffold IRSp53 (also known as BAIAP2) showed impaired social interaction and communication.  Treatment of IRSp53-/- mice, which display enhanced NMDA receptor (NMDAR) function in the hippocampus, with memantine, an NMDAR antagonist, or MPEP, a metabotropic glutamate receptor 5 antagonist that indirectly inhibits NMDAR function, normalized social interaction.  This social rescue was accompanied by normalization of NMDAR function and plasticity in the hippocampus and neuronal firing in the medial prefrontal cortex.  These results, together with the reduced NMDAR function implicated in social impairments, suggest that deviation of NMDAR function in either direction leads to social deficits and that correcting the deviation has beneficial effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDO8pL-0S9orVg90H21EOLACvtfcHk0lj3T4myBaKB-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVehtL4%253D&md5=c63781b5bcec5d3ecb14f79a53508d63</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fnn.3927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3927%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DW.%26aulast%3DChoi%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DS.%2BG.%26aulast%3DKim%26aufirst%3DR.%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DM.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DRhim%26aufirst%3DI.%26aulast%3DJung%26aufirst%3DM.%2BW.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DBae%26aufirst%3DY.%2BC.%26aulast%3DKim%26aufirst%3DE.%26atitle%3DSocial%2520deficits%2520in%2520IRSp53%2520mutant%2520mice%2520improved%2520by%2520NMDAR%2520and%2520mGluR5%2520suppression%26jtitle%3DNat.%2520Neurosci.%26date%3D2015%26volume%3D18%26spage%3D435%26epage%3D443%26doi%3D10.1038%2Fnn.3927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Won, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mah, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaang, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E.</span><span> </span><span class="NLM_article-title">Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">486</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1038/nature11208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnature11208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22699620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1emtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=486&publication_year=2012&pages=261-265&author=H.+Wonauthor=H.+R.+Leeauthor=H.+Y.+Geeauthor=W.+Mahauthor=J.+I.+Kimauthor=J.+Leeauthor=S.+Haauthor=C.+Chungauthor=E.+S.+Jungauthor=Y.+S.+Choauthor=S.+G.+Parkauthor=J.+S.+Leeauthor=K.+Leeauthor=D.+Kimauthor=Y.+C.+Baeauthor=B.+K.+Kaangauthor=M.+G.+Leeauthor=E.+Kim&title=Autistic-like+social+behaviour+in+Shank2-mutant+mice+improved+by+restoring+NMDA+receptor+function&doi=10.1038%2Fnature11208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Autistic-like social behavior in Shank2-mutant mice improved by restoring NMDA receptor function</span></div><div class="casAuthors">Won, Hyejung; Lee, Hye-Ryeon; Gee, Heon Yung; Mah, Won; Kim, Jae-Ick; Lee, Jiseok; Ha, Seungmin; Chung, Changuk; Jung, Eun Suk; Cho, Yi Sul; Park, Sae-Geun; Lee, Jung-Soo; Lee, Kyungmin; Kim, Daesoo; Bae, Yong Chul; Kaang, Bong-Kiun; Lee, Min Goo; Kim, Eunjoon</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">486</span>
        (<span class="NLM_cas:issue">7402</span>),
    <span class="NLM_cas:pages">261-265</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autism spectrum disorder (ASD) is a group of conditions characterized by impaired social interaction and communication, and restricted and repetitive behaviors.  ASD is a highly heritable disorder involving various genetic determinants.  Shank2 (also known as ProSAP1) is a multi-domain scaffolding protein and signaling adaptor enriched at excitatory neuronal synapses, and mutations in the human SHANK2 gene have recently been assocd. with ASD and intellectual disablility.  Although ASD-assocd. genes are being increasingly identified and studied using various approaches, including mouse genetics, further efforts are required to delineate important causal mechanisms with the potential for therapeutic application.  Here we show that Shank2-mutant (Shank2-/-) mice carrying a mutation identical to the ASD-assocd. microdeletion in the human SHANK2 gene exhibit ASD-like behaviors including reduced social interaction, reduced social communication by ultrasonic vocalizations, and repetitive jumping.  These mice show a marked decrease in NMDA (N-methyl-d-aspartate) glutamate receptor (NMDAR) function.  Direct stimulation of NMDARs with d-cycloserine, a partial agonist of NMDARs, normalizes NMDAR function and improves social interaction in Shank2-/- mice.  Furthermore, treatment of Shank2-/- mice with a pos. allosteric modulator of metabotropic glutamate receptor 5 (mGluR5), which enhances NMDAR function via mGluR5 activation, also normalizes NMDAR function and markedly enhances social interaction.  These results suggest that reduced NMDAR function may contribute to the development of ASD-like phenotypes in Shank2-/- mice, and mGluR modulation of NMDARs offers a potential strategy to treat ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLS1qTT4nQELVg90H21EOLACvtfcHk0lj3T4myBaKB-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1emtrw%253D&md5=0d5478d17f8b572074040b9fe70b64a3</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2Fnature11208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11208%26sid%3Dliteratum%253Aachs%26aulast%3DWon%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DH.%2BR.%26aulast%3DGee%26aufirst%3DH.%2BY.%26aulast%3DMah%26aufirst%3DW.%26aulast%3DKim%26aufirst%3DJ.%2BI.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DHa%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DE.%2BS.%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DPark%26aufirst%3DS.%2BG.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DBae%26aufirst%3DY.%2BC.%26aulast%3DKaang%26aufirst%3DB.%2BK.%26aulast%3DLee%26aufirst%3DM.%2BG.%26aulast%3DKim%26aufirst%3DE.%26atitle%3DAutistic-like%2520social%2520behaviour%2520in%2520Shank2-mutant%2520mice%2520improved%2520by%2520restoring%2520NMDA%2520receptor%2520function%26jtitle%3DNature%26date%3D2012%26volume%3D486%26spage%3D261%26epage%3D265%26doi%3D10.1038%2Fnature11208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Urbano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okwara, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herndon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutsch, S. I.</span><span> </span><span class="NLM_article-title">A trial of D-cycloserine to treat stereotypies in older adolescents and young adults with autism spectrum disorder</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1097/WNF.0000000000000033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1097%2FWNF.0000000000000033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2014&pages=69-72&author=M.+Urbanoauthor=L.+Okwaraauthor=P.+Manserauthor=K.+Hartmannauthor=A.+Herndonauthor=S.+I.+Deutsch&title=A+trial+of+D-cycloserine+to+treat+stereotypies+in+older+adolescents+and+young+adults+with+autism+spectrum+disorder&doi=10.1097%2FWNF.0000000000000033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1097%2FWNF.0000000000000033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWNF.0000000000000033%26sid%3Dliteratum%253Aachs%26aulast%3DUrbano%26aufirst%3DM.%26aulast%3DOkwara%26aufirst%3DL.%26aulast%3DManser%26aufirst%3DP.%26aulast%3DHartmann%26aufirst%3DK.%26aulast%3DHerndon%26aufirst%3DA.%26aulast%3DDeutsch%26aufirst%3DS.%2BI.%26atitle%3DA%2520trial%2520of%2520D-cycloserine%2520to%2520treat%2520stereotypies%2520in%2520older%2520adolescents%2520and%2520young%2520adults%2520with%2520autism%2520spectrum%2520disorder%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2014%26volume%3D37%26spage%3D69%26epage%3D72%26doi%3D10.1097%2FWNF.0000000000000033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Urbano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okwara, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutsch, S. I.</span><span> </span><span class="NLM_article-title">A trial of d-cycloserine to treat the social deficit in older adolescents and young adults with autism spectrum disorders</span> <span class="citation_source-journal">J. Neuropsychiatry Clin. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span><span class="refDoi"> DOI: 10.1176/appi.neuropsych.13070155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1176%2Fappi.neuropsych.13070155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25923852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2Mjpt12lsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=133-138&author=M.+Urbanoauthor=L.+Okwaraauthor=P.+Manserauthor=K.+Hartmannauthor=S.+I.+Deutsch&title=A+trial+of+d-cycloserine+to+treat+the+social+deficit+in+older+adolescents+and+young+adults+with+autism+spectrum+disorders&doi=10.1176%2Fappi.neuropsych.13070155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">A trial of d-cycloserine to treat the social deficit in older adolescents and young adults with autism spectrum disorders</span></div><div class="casAuthors">Urbano Maria; Okwara Leonore; Manser Paul; Hartmann Kathrin; Deutsch Stephen I</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of neuropsychiatry and clinical neurosciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autism spectrum disorders are difficult for older adolescents and young adults as impaired social communication affects the transition to adult life. d-Cycloserine, a partial glycine agonist at the N-methyl-d-aspartic acid receptor, was tested in a double-blind randomized trial in 20 older adolescents and young adults with autism spectrum disorders using two dosing strategies (50 mg daily versus 50 mg weekly) for 8 weeks with a 2-week follow-up after discontinuation. d-Cycloserine caused statistically and clinically significant improvement with no differentiation between dosing strategies on the Social Responsiveness Scale and the Aberrant Behavior Checklist before and after d-cycloserine administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR1U-PhdIV87JZoeNcnHOQ9fW6udTcc2eaDOsDFpIBkFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mjpt12lsg%253D%253D&md5=3f01021d59b473902beef0e4b12a3735</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1176%2Fappi.neuropsych.13070155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.neuropsych.13070155%26sid%3Dliteratum%253Aachs%26aulast%3DUrbano%26aufirst%3DM.%26aulast%3DOkwara%26aufirst%3DL.%26aulast%3DManser%26aufirst%3DP.%26aulast%3DHartmann%26aufirst%3DK.%26aulast%3DDeutsch%26aufirst%3DS.%2BI.%26atitle%3DA%2520trial%2520of%2520d-cycloserine%2520to%2520treat%2520the%2520social%2520deficit%2520in%2520older%2520adolescents%2520and%2520young%2520adults%2520with%2520autism%2520spectrum%2520disorders%26jtitle%3DJ.%2520Neuropsychiatry%2520Clin.%2520Neurosci.%26date%3D2015%26volume%3D27%26spage%3D133%26epage%3D138%26doi%3D10.1176%2Fappi.neuropsych.13070155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Volkmann, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanger, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirivolu, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paschetto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virginio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleyzes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buisson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steidl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mierau, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagiolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span> </span><span class="NLM_article-title">MPX-004 and MPX-007: new pharmacological tools to study the physiology of NMDA receptors containing the GluN2A subunit</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0148129</span><span class="refDoi"> DOI: 10.1371/journal.pone.0148129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1371%2Fjournal.pone.0148129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26829109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlWrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0148129&author=R.+A.+Volkmannauthor=C.+M.+Fangerauthor=D.+R.+Andersonauthor=V.+R.+Sirivoluauthor=K.+Paschettoauthor=E.+Gordonauthor=C.+Virginioauthor=M.+Gleyzesauthor=B.+Buissonauthor=E.+Steidlauthor=S.+B.+Mierauauthor=M.+Fagioliniauthor=F.+S.+Menniti&title=MPX-004+and+MPX-007%3A+new+pharmacological+tools+to+study+the+physiology+of+NMDA+receptors+containing+the+GluN2A+subunit&doi=10.1371%2Fjournal.pone.0148129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">MPX-004 and MPX-007: new pharmacological tools to study the physiology of nmda receptors containing the GluN2A subunit</span></div><div class="casAuthors">Volkmann, Robert A.; Fanger, Christopher M.; Anderson, David R.; Sirivolu, Venkata Ramana; Paschetto, Kathy; Gordon, Earl; Virginio, Caterina; Gleyzes, Melanie; Buisson, Bruno; Steidl, Esther; Mierau, Susanna B.; Fagiolini, Michela; Menniti, Frank S.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0148129/1-e0148129/20</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">GluN2A is the most abundant of the GluN2 NMDA receptor subunits in the mammalian CNS.  Physiol. and genetic evidence implicate GluN2A-contg. receptors in susceptibility to autism, schizophrenia, childhood epilepsy and neurodevelopmental disorders such as Rett Syndrome.  However, GluN2A-selective pharmacol. probes to explore the therapeutic potential of targeting these receptors have been lacking.  Here we disclose a novel series of pyrazine-contg. GluN2A antagonists exemplified byMPX-004 (5-(((3-chloro-4-fluorophenyl) sulfonamido)methyl)-N-((2-methylthiazol-5-yl)methyl)pyrazine-2-carboxamide) and MPX- 007 (5-(((3-fluoro-4-fluorophenyl)sulfonamido)methyl)-N-((2-methylthiazol-5-yl)methyl) methylpyrazine-2-carboxamide).  MPX-004 and MPX-007 inhibit GluN2A-contg. NMDA receptors expressed in HEK cells with IC50s of 79 nM and 27 nM, resp.  In contrast, at concns. that completely inhibited GluN2A activity these compds. have no inhibitory effect on GluN2B or GluN2D receptor-mediated responses in similar HEK cell-based assays.  Potency and selectivity were confirmed in electrophysiol. assays in Xenopus oocytes expressing GluN2A-D receptor subtypes.  Maximal concns. of MPX-004 and MPX-007 inhibited ∼30%of the whole-cell current in rat pyramidal neurons in primary culture and MPX- 004 inhibited ∼60% of the total NMDA receptor-mediated EPSP in rat hippocampal slices.  GluN2A-selectivity at native receptors was confirmed by the finding that MPX-004 had no inhibitory effect on NMDA receptor mediated synaptic currents in cortical slices from GRIN2A knock out mice.  Thus, MPX-004 and MPX-007 offer highly selective pharmacol. tools to probe GluN2A physiol. and involvement in neuropsychiatric and developmental disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFtzNEu3OcX7Vg90H21EOLACvtfcHk0ljDKpWkODc2cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlWrsrk%253D&md5=975f42be516fd25eb8e9a66605c93a67</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0148129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0148129%26sid%3Dliteratum%253Aachs%26aulast%3DVolkmann%26aufirst%3DR.%2BA.%26aulast%3DFanger%26aufirst%3DC.%2BM.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DSirivolu%26aufirst%3DV.%2BR.%26aulast%3DPaschetto%26aufirst%3DK.%26aulast%3DGordon%26aufirst%3DE.%26aulast%3DVirginio%26aufirst%3DC.%26aulast%3DGleyzes%26aufirst%3DM.%26aulast%3DBuisson%26aufirst%3DB.%26aulast%3DSteidl%26aufirst%3DE.%26aulast%3DMierau%26aufirst%3DS.%2BB.%26aulast%3DFagiolini%26aufirst%3DM.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26atitle%3DMPX-004%2520and%2520MPX-007%253A%2520new%2520pharmacological%2520tools%2520to%2520study%2520the%2520physiology%2520of%2520NMDA%2520receptors%2520containing%2520the%2520GluN2A%2520subunit%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0148129%26doi%3D10.1371%2Fjournal.pone.0148129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Hussman, J. P.</span><span> </span><span class="NLM_article-title">Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism</span> <span class="citation_source-journal">J. Autism Dev. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1023/A:1010715619091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1023%2FA%3A1010715619091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=11450824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD38%252FitVCgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2001&pages=247-248&author=J.+P.+Hussman&title=Suppressed+GABAergic+inhibition+as+a+common+factor+in+suspected+etiologies+of+autism&doi=10.1023%2FA%3A1010715619091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism</span></div><div class="casAuthors">Hussman J P</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autism and developmental disorders</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-8</span>
        ISSN:<span class="NLM_cas:issn">0162-3257</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSlJwwv75--L9XdcedVHT5tfW6udTcc2eaO_PjVa6oyrLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252FitVCgtg%253D%253D&md5=7cb9b3b41aad2cedf841003ca452aa93</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1023%2FA%3A1010715619091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1010715619091%26sid%3Dliteratum%253Aachs%26aulast%3DHussman%26aufirst%3DJ.%2BP.%26atitle%3DSuppressed%2520GABAergic%2520inhibition%2520as%2520a%2520common%2520factor%2520in%2520suspected%2520etiologies%2520of%2520autism%26jtitle%3DJ.%2520Autism%2520Dev.%2520Disord.%26date%3D2001%26volume%3D31%26spage%3D247%26epage%3D248%26doi%3D10.1023%2FA%3A1010715619091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Olsen, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sieghart, W.</span><span> </span><span class="NLM_article-title">International union of pharmacology. LXX. Subtypes of gamma-aminobutyric acid receptors: classification on the basis of subunit composition, pharmacology, and function. Update</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span><span class="refDoi"> DOI: 10.1124/pr.108.00505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1124%2Fpr.108.00505" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=243-260&author=R.+W.+Olsenauthor=W.+Sieghart&title=International+union+of+pharmacology.+LXX.+Subtypes+of+gamma-aminobutyric+acid+receptors%3A+classification+on+the+basis+of+subunit+composition%2C+pharmacology%2C+and+function.+Update&doi=10.1124%2Fpr.108.00505"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1124%2Fpr.108.00505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.108.00505%26sid%3Dliteratum%253Aachs%26aulast%3DOlsen%26aufirst%3DR.%2BW.%26aulast%3DSieghart%26aufirst%3DW.%26atitle%3DInternational%2520union%2520of%2520pharmacology.%2520LXX.%2520Subtypes%2520of%2520gamma-aminobutyric%2520acid%2520receptors%253A%2520classification%2520on%2520the%2520basis%2520of%2520subunit%2520composition%252C%2520pharmacology%252C%2520and%2520function.%2520Update%26jtitle%3DPharmacol.%2520Rev.%26date%3D2008%26volume%3D60%26spage%3D243%26epage%3D260%26doi%3D10.1124%2Fpr.108.00505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Coghlan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inkster, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nutt, D. J.</span><span> </span><span class="NLM_article-title">GABA system dysfunction in autism and related disorders: from synapse to symptoms</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2044</span><span class="NLM_x">–</span> <span class="NLM_lpage">2055</span><span class="refDoi"> DOI: 10.1016/j.neubiorev.2012.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neubiorev.2012.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22841562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVCisr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2012&pages=2044-2055&author=S.+Coghlanauthor=J.+Horderauthor=B.+Inksterauthor=M.+A.+Mendezauthor=D.+G.+Murphyauthor=D.+J.+Nutt&title=GABA+system+dysfunction+in+autism+and+related+disorders%3A+from+synapse+to+symptoms&doi=10.1016%2Fj.neubiorev.2012.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">GABA system dysfunction in autism and related disorders: From synapse to symptoms</span></div><div class="casAuthors">Coghlan, Suzanne; Horder, Jamie; Inkster, Becky; Mendez, M. Andreina; Murphy, Declan G.; Nutt, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience & Biobehavioral Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2044-2055</span>CODEN:
                <span class="NLM_cas:coden">NBREDE</span>;
        ISSN:<span class="NLM_cas:issn">0149-7634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Autism spectrum disorders (ASDs) are neurodevelopmental syndromes characterized by repetitive behaviors and restricted interests, impairments in social behavior and relations, and in language and communication.  These symptoms are also obsd. in a no. of developmental disorders of known origin, including Fragile X Syndrome, Rett Syndrome, and Fetal Anticonvulsant Syndrome.  While these conditions have diverse etiologies, and poorly understood pathologies, emerging evidence suggests that they may all be linked to dysfunction in particular aspects of GABAergic inhibitory signalling in the brain.  We review evidence from genetics, mol. neurobiol. and systems neuroscience relating to the role of GABA in these conditions.  We conclude by discussing how these deficits may relate to the specific symptoms obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz5Bzy3mDXfrVg90H21EOLACvtfcHk0ljExgpi9sF3fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVCisr7P&md5=573508a9d1da4d1802b00265386755ee</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2012.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2012.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DCoghlan%26aufirst%3DS.%26aulast%3DHorder%26aufirst%3DJ.%26aulast%3DInkster%26aufirst%3DB.%26aulast%3DMendez%26aufirst%3DM.%2BA.%26aulast%3DMurphy%26aufirst%3DD.%2BG.%26aulast%3DNutt%26aufirst%3DD.%2BJ.%26atitle%3DGABA%2520system%2520dysfunction%2520in%2520autism%2520and%2520related%2520disorders%253A%2520from%2520synapse%2520to%2520symptoms%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2012%26volume%3D36%26spage%3D2044%26epage%3D2055%26doi%3D10.1016%2Fj.neubiorev.2012.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Cellot, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherubini, E.</span><span> </span><span class="NLM_article-title">GABAergic signaling as therapeutic target for autism spectrum disorders</span> <span class="citation_source-journal">Front. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="refDoi"> DOI: 10.3389/fped.2014.00070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3389%2Ffped.2014.00070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25072038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2cbntVaisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=70&author=G.+Cellotauthor=E.+Cherubini&title=GABAergic+signaling+as+therapeutic+target+for+autism+spectrum+disorders&doi=10.3389%2Ffped.2014.00070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">GABAergic signaling as therapeutic target for autism spectrum disorders</span></div><div class="casAuthors">Cellot Giada; Cherubini Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pediatrics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">70</span>
        ISSN:<span class="NLM_cas:issn">2296-2360</span>.
    </div><div class="casAbstract">γ-Aminobutyric acid (GABA), the main inhibitory neurotransmitter in the adult brain, early in postnatal life exerts a depolarizing and excitatory action.  This depends on accumulation of chloride inside the cell via the cation-chloride importer NKCC1, being the expression of the chloride exporter KCC2 very low at birth.  The developmentally regulated expression of KCC2 results in extrusion of chloride with age and a shift of GABA from the depolarizing to the hyperpolarizing direction.  The depolarizing action of GABA leads to intracellular calcium rise through voltage-dependent calcium channels and/or N-methyl-d-aspartate receptors.  GABA-mediated calcium signals regulate a variety of developmental processes from cell proliferation migration, differentiation, synapse maturation, and neuronal wiring.  Therefore, it is not surprising that some forms of neuro-developmental disorders such as autism spectrum disorders (ASDs) are associated with alterations of GABAergic signaling and impairment of the excitatory/inhibitory balance in selective neuronal circuits.  In this review, we will discuss how changes of GABAA-mediated neurotransmission affect several forms of ASDs including the Fragile X, the Angelman, and Rett syndromes.  Then, we will describe various animal models of ASDs with GABAergic dysfunctions, highlighting their behavioral deficits and the possibility to rescue them by targeting selective components of the GABAergic synapse.  In particular, we will discuss how in some cases, reverting the polarity of GABA responses from the depolarizing to the hyperpolarizing direction with the diuretic bumetanide, a selective blocker of NKCC1, may have beneficial effects on ASDs, thus opening new therapeutic perspectives for the treatment of these devastating disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0z4QEAiZ7iDslzEEsg76ufW6udTcc2eZTzUp_ovnmLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbntVaisA%253D%253D&md5=1797a2fb6cc036689777ca1bed7ac7c4</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.3389%2Ffped.2014.00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffped.2014.00070%26sid%3Dliteratum%253Aachs%26aulast%3DCellot%26aufirst%3DG.%26aulast%3DCherubini%26aufirst%3DE.%26atitle%3DGABAergic%2520signaling%2520as%2520therapeutic%2520target%2520for%2520autism%2520spectrum%2520disorders%26jtitle%3DFront.%2520Pediatr.%26date%3D2014%26volume%3D2%26spage%3D70%26doi%3D10.3389%2Ffped.2014.00070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheuer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catterall, W. A.</span><span> </span><span class="NLM_article-title">Enhancement of inhibitory neurotransmission by GABAA receptors having α2,3-subunits ameliorates behavioral deficits in a mouse model of autism</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1282</span><span class="NLM_x">–</span> <span class="NLM_lpage">1289</span><span class="refDoi"> DOI: 10.1016/j.neuron.2014.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuron.2014.01.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2014&pages=1282-1289&author=S.+Hanauthor=C.+Taiauthor=C.+J.+Jonesauthor=T.+Scheuerauthor=W.+A.+Catterall&title=Enhancement+of+inhibitory+neurotransmission+by+GABAA+receptors+having+%CE%B12%2C3-subunits+ameliorates+behavioral+deficits+in+a+mouse+model+of+autism&doi=10.1016%2Fj.neuron.2014.01.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2014.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2014.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DTai%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DC.%2BJ.%26aulast%3DScheuer%26aufirst%3DT.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26atitle%3DEnhancement%2520of%2520inhibitory%2520neurotransmission%2520by%2520GABAA%2520receptors%2520having%2520%25CE%25B12%252C3-subunits%2520ameliorates%2520behavioral%2520deficits%2520in%2520a%2520mouse%2520model%2520of%2520autism%26jtitle%3DNeuron%26date%3D2014%26volume%3D81%26spage%3D1282%26epage%3D1289%26doi%3D10.1016%2Fj.neuron.2014.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Alhambra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damewood, J. R.,  Jr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembofsky, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurley, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzog, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horchler, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnmacht, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmiesing, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribadeneira, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knappenberger, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciag, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christian, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arriza, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapdelaine, M. J.</span><span> </span><span class="NLM_article-title">Development and SAR of functionally selective allosteric modulators of GABAA receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2927</span><span class="NLM_x">–</span> <span class="NLM_lpage">2938</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.03.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bmc.2011.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21498079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltFOrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2927-2938&author=C.+Alhambraauthor=C.+Beckerauthor=T.+Blakeauthor=A.+H.+Changauthor=J.+R.+Damewoodauthor=T.+Danielsauthor=B.+T.+Dembofskyauthor=D.+A.+Gurleyauthor=J.+E.+Hallauthor=K.+J.+Herzogauthor=C.+L.+Horchlerauthor=C.+J.+Ohnmachtauthor=R.+J.+Schmiesingauthor=A.+Dudleyauthor=M.+D.+Ribadeneiraauthor=K.+S.+Knappenbergerauthor=C.+Maciagauthor=M.+M.+Steinauthor=M.+Chopraauthor=X.+F.+Liuauthor=E.+P.+Christianauthor=J.+L.+Arrizaauthor=M.+J.+Chapdelaine&title=Development+and+SAR+of+functionally+selective+allosteric+modulators+of+GABAA+receptors&doi=10.1016%2Fj.bmc.2011.03.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Development and SAR of functionally selective allosteric modulators of GABAA receptors</span></div><div class="casAuthors">Alhambra, Cristobal; Becker, Chris; Blake, Timothy; Chang, Amy; Damewood, James R., Jr.; Daniels, Thalia; Dembofsky, Bruce T.; Gurley, David A.; Hall, James E.; Herzog, Keith J.; Horchler, Carey L.; Ohnmacht, Cyrus J.; Schmiesing, Richard Jon; Dudley, Adam; Ribadeneira, Maria D.; Knappenberger, Katherine S.; Maciag, Carla; Stein, Mark M.; Chopra, Maninder; Liu, Xiaodong F.; Christian, Edward P.; Arriza, Jeffrey L.; Chapdelaine, Marc J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2927-2938</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pos. modulators at the benzodiazepine site of α2- and α3-contg. GABAA receptors are believed to be anxiolytic.  Through oocyte voltage clamp studies, two series of compds. have been discovered that are pos. modulators at α2-/α3-contg. GABAA receptors and that show no functional activity at α1-contg. GABAA receptors.  Studies to improve this functional selectivity and ultimately deliver clin. candidates are reported.  The functional SAR of cinnolines and quinolines that are pos. allosteric modulators of the α2- and α3-contg. GABAA receptors, while simultaneously neutral antagonists at α1-contg. GABAA receptors, is described.  Such functionally selective modulators of GABAA receptors are expected to be useful in the treatment of anxiety and other psychiatric illnesses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVYzfPtmlNCrVg90H21EOLACvtfcHk0lhZjPrcCfzhHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltFOrsbg%253D&md5=24eaa34a5d28e2c7e2cfce14f02267fc</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DAlhambra%26aufirst%3DC.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DBlake%26aufirst%3DT.%26aulast%3DChang%26aufirst%3DA.%2BH.%26aulast%3DDamewood%26aufirst%3DJ.%2BR.%26aulast%3DDaniels%26aufirst%3DT.%26aulast%3DDembofsky%26aufirst%3DB.%2BT.%26aulast%3DGurley%26aufirst%3DD.%2BA.%26aulast%3DHall%26aufirst%3DJ.%2BE.%26aulast%3DHerzog%26aufirst%3DK.%2BJ.%26aulast%3DHorchler%26aufirst%3DC.%2BL.%26aulast%3DOhnmacht%26aufirst%3DC.%2BJ.%26aulast%3DSchmiesing%26aufirst%3DR.%2BJ.%26aulast%3DDudley%26aufirst%3DA.%26aulast%3DRibadeneira%26aufirst%3DM.%2BD.%26aulast%3DKnappenberger%26aufirst%3DK.%2BS.%26aulast%3DMaciag%26aufirst%3DC.%26aulast%3DStein%26aufirst%3DM.%2BM.%26aulast%3DChopra%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%2BF.%26aulast%3DChristian%26aufirst%3DE.%2BP.%26aulast%3DArriza%26aufirst%3DJ.%2BL.%26aulast%3DChapdelaine%26aufirst%3DM.%2BJ.%26atitle%3DDevelopment%2520and%2520SAR%2520of%2520functionally%2520selective%2520allosteric%2520modulators%2520of%2520GABAA%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2927%26epage%3D2938%26doi%3D10.1016%2Fj.bmc.2011.03.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Brondino, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusar-Poli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panisi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barale, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Politi, P.</span><span> </span><span class="NLM_article-title">Pharmacological modulation of GABA function in autism spectrum disorders: a systematic review of human studies</span> <span class="citation_source-journal">J. Autism Dev. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span><span class="refDoi"> DOI: 10.1007/s10803-015-2619-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs10803-015-2619-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26443675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC283psVSntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2016&pages=825-839&author=N.+Brondinoauthor=L.+Fusar-Poliauthor=C.+Panisiauthor=S.+Damianiauthor=F.+Baraleauthor=P.+Politi&title=Pharmacological+modulation+of+GABA+function+in+autism+spectrum+disorders%3A+a+systematic+review+of+human+studies&doi=10.1007%2Fs10803-015-2619-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Modulation of GABA Function in Autism Spectrum Disorders: A Systematic Review of Human Studies</span></div><div class="casAuthors">Brondino Natascia; Fusar-Poli Laura; Panisi Cristina; Damiani Stefano; Barale Francesco; Politi Pierluigi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autism and developmental disorders</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">825-39</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autism spectrum disorders are an emerging health problem worldwide, but little is known about their pathogenesis.  It has been hypothesized that autism may result from an imbalance between excitatory glutamatergic and inhibitory GABAergic pathways.  Commonly used medications such as valproate, acamprosate, and arbaclofen may act on the GABAergic system and be a potential treatment for people with ASD.  The present systematic review aimed at evaluating the state-of-the-art of clinical trials of GABA modulators in autism.  To date there is insufficient evidence to suggest the use of these drugs in autistic subjects, even if data are promising.  Of note, short-term use of all the reviewed medications appears to be safe.  Future well designed trials are needed to elucidate these preliminary findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTbyy_tCw2eHHtlzo9xastyfW6udTcc2eZj5e1V2WJLPbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283psVSntA%253D%253D&md5=1fa93f6a5519e87e4825e57a9274bb0f</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2Fs10803-015-2619-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10803-015-2619-y%26sid%3Dliteratum%253Aachs%26aulast%3DBrondino%26aufirst%3DN.%26aulast%3DFusar-Poli%26aufirst%3DL.%26aulast%3DPanisi%26aufirst%3DC.%26aulast%3DDamiani%26aufirst%3DS.%26aulast%3DBarale%26aufirst%3DF.%26aulast%3DPoliti%26aufirst%3DP.%26atitle%3DPharmacological%2520modulation%2520of%2520GABA%2520function%2520in%2520autism%2520spectrum%2520disorders%253A%2520a%2520systematic%2520review%2520of%2520human%2520studies%26jtitle%3DJ.%2520Autism%2520Dev.%2520Disord.%26date%3D2016%26volume%3D46%26spage%3D825%26epage%3D839%26doi%3D10.1007%2Fs10803-015-2619-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Berry-Kravis, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hessl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathmell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarevics, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherubini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton-Bowen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Heydrich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bear, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagerman, R. J.</span><span> </span><span class="NLM_article-title">Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">152ra127</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3004214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1126%2Fscitranslmed.3004214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22993294" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=152ra127&author=E.+M.+Berry-Kravisauthor=D.+Hesslauthor=B.+Rathmellauthor=P.+Zarevicsauthor=M.+Cherubiniauthor=K.+Walton-Bowenauthor=Y.+Muauthor=D.+V.+Nguyenauthor=J.+Gonzalez-Heydrichauthor=P.+P.+Wangauthor=R.+L.+Carpenterauthor=M.+F.+Bearauthor=R.+J.+Hagerman&title=Effects+of+STX209+%28arbaclofen%29+on+neurobehavioral+function+in+children+and+adults+with+fragile+X+syndrome%3A+a+randomized%2C+controlled%2C+phase+2+trial&doi=10.1126%2Fscitranslmed.3004214"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3004214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3004214%26sid%3Dliteratum%253Aachs%26aulast%3DBerry-Kravis%26aufirst%3DE.%2BM.%26aulast%3DHessl%26aufirst%3DD.%26aulast%3DRathmell%26aufirst%3DB.%26aulast%3DZarevics%26aufirst%3DP.%26aulast%3DCherubini%26aufirst%3DM.%26aulast%3DWalton-Bowen%26aufirst%3DK.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DNguyen%26aufirst%3DD.%2BV.%26aulast%3DGonzalez-Heydrich%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%2BP.%26aulast%3DCarpenter%26aufirst%3DR.%2BL.%26aulast%3DBear%26aufirst%3DM.%2BF.%26aulast%3DHagerman%26aufirst%3DR.%2BJ.%26atitle%3DEffects%2520of%2520STX209%2520%2528arbaclofen%2529%2520on%2520neurobehavioral%2520function%2520in%2520children%2520and%2520adults%2520with%2520fragile%2520X%2520syndrome%253A%2520a%2520randomized%252C%2520controlled%252C%2520phase%25202%2520trial%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D152ra127%26doi%3D10.1126%2Fscitranslmed.3004214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Veenstra-VanderWeele, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarevics, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherubini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton-Bowen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bear, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, R. L.</span><span> </span><span class="NLM_article-title">Arbaclofen in children and adolescents with autism spectrum disorder: a randomized, controlled, Phase 2 trial</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1390</span><span class="NLM_x">–</span> <span class="NLM_lpage">1398</span><span class="refDoi"> DOI: 10.1038/npp.2016.237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnpp.2016.237" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=1390-1398&author=J.+Veenstra-VanderWeeleauthor=E.+H.+Cookauthor=B.+H.+Kingauthor=P.+Zarevicsauthor=M.+Cherubiniauthor=K.+Walton-Bowenauthor=M.+F.+Bearauthor=P.+P.+Wangauthor=R.+L.+Carpenter&title=Arbaclofen+in+children+and+adolescents+with+autism+spectrum+disorder%3A+a+randomized%2C+controlled%2C+Phase+2+trial&doi=10.1038%2Fnpp.2016.237"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2016.237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2016.237%26sid%3Dliteratum%253Aachs%26aulast%3DVeenstra-VanderWeele%26aufirst%3DJ.%26aulast%3DCook%26aufirst%3DE.%2BH.%26aulast%3DKing%26aufirst%3DB.%2BH.%26aulast%3DZarevics%26aufirst%3DP.%26aulast%3DCherubini%26aufirst%3DM.%26aulast%3DWalton-Bowen%26aufirst%3DK.%26aulast%3DBear%26aufirst%3DM.%2BF.%26aulast%3DWang%26aufirst%3DP.%2BP.%26aulast%3DCarpenter%26aufirst%3DR.%2BL.%26atitle%3DArbaclofen%2520in%2520children%2520and%2520adolescents%2520with%2520autism%2520spectrum%2520disorder%253A%2520a%2520randomized%252C%2520controlled%252C%2520Phase%25202%2520trial%26jtitle%3DNeuropsychopharmacology%26date%3D2017%26volume%3D42%26spage%3D1390%26epage%3D1398%26doi%3D10.1038%2Fnpp.2016.237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Brown, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hockerman, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerksen, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colby, D. A.</span><span> </span><span class="NLM_article-title">Activation of the γ-aminobutyric acid type B (GABAB) receptor by agonists and positive allosteric modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6336</span><span class="NLM_x">–</span> <span class="NLM_lpage">6347</span><span class="refDoi"> DOI: 10.1021/jm5018913</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5018913" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtlant7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6336-6347&author=K.+M.+Brownauthor=K.+K.+Royauthor=G.+H.+Hockermanauthor=R.+J.+Doerksenauthor=D.+A.+Colby&title=Activation+of+the+%CE%B3-aminobutyric+acid+type+B+%28GABAB%29+receptor+by+agonists+and+positive+allosteric+modulators&doi=10.1021%2Fjm5018913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the γ-Aminobutyric Acid Type B (GABAB) Receptor by Agonists and Positive Allosteric Modulators</span></div><div class="casAuthors">Brown, Katie M.; Roy, Kuldeep K.; Hockerman, Gregory H.; Doerksen, Robert J.; Colby, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6336-6347</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Since the discovery of the GABAB agonist and muscle relaxant baclofen, there have been substantial advancements in the development of compds. that activate the GABAB receptor as agonists or pos. allosteric modulators.  For the agonists, most of the existing structure-activity data apply to understanding the role of substituents on the backbone of GABA as well as replacing the carboxylic acid and amine groups.  In the cases of the pos. allosteric modulators, the allosteric binding site(s) and structure-activity relationships are less well-defined; however, multiple classes of mols. have been discovered.  The recent report of the X-ray structure of the GABAB receptor with bound agonists and antagonists provides new insights for the development of compds. that bind the orthosteric site of this receptor.  From a therapeutic perspective, these data have enabled efforts in drug discovery in areas of addiction-related behavior, the treatment of anxiety, and the control of muscle contractility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcDXupO8aPDbVg90H21EOLACvtfcHk0li87sVT5QHUjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtlant7Y%253D&md5=90940cf9ded118c6ba931005a97b4f86</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Fjm5018913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5018913%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DK.%2BM.%26aulast%3DRoy%26aufirst%3DK.%2BK.%26aulast%3DHockerman%26aufirst%3DG.%2BH.%26aulast%3DDoerksen%26aufirst%3DR.%2BJ.%26aulast%3DColby%26aufirst%3DD.%2BA.%26atitle%3DActivation%2520of%2520the%2520%25CE%25B3-aminobutyric%2520acid%2520type%2520B%2520%2528GABAB%2529%2520receptor%2520by%2520agonists%2520and%2520positive%2520allosteric%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6336%26epage%3D6347%26doi%3D10.1021%2Fjm5018913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Kalinichev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddouk, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouillier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riguet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Royer-Urios, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lütjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span> </span><span class="NLM_article-title">The drug candidate, ADX71441, is a novel, potent and selective positive allosteric modulator of the GABAB receptor with a potential for treatment of anxiety, pain and spasticity</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2016.11.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuropharm.2016.11.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=34-47&author=M.+Kalinichevauthor=F.+Girardauthor=H.+Haddoukauthor=M.+Rouillierauthor=E.+Riguetauthor=I.+Royer-Uriosauthor=V.+Mutelauthor=R.+L%C3%BCtjensauthor=S.+Poli&title=The+drug+candidate%2C+ADX71441%2C+is+a+novel%2C+potent+and+selective+positive+allosteric+modulator+of+the+GABAB+receptor+with+a+potential+for+treatment+of+anxiety%2C+pain+and+spasticity&doi=10.1016%2Fj.neuropharm.2016.11.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2016.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2016.11.016%26sid%3Dliteratum%253Aachs%26aulast%3DKalinichev%26aufirst%3DM.%26aulast%3DGirard%26aufirst%3DF.%26aulast%3DHaddouk%26aufirst%3DH.%26aulast%3DRouillier%26aufirst%3DM.%26aulast%3DRiguet%26aufirst%3DE.%26aulast%3DRoyer-Urios%26aufirst%3DI.%26aulast%3DMutel%26aufirst%3DV.%26aulast%3DL%25C3%25BCtjens%26aufirst%3DR.%26aulast%3DPoli%26aufirst%3DS.%26atitle%3DThe%2520drug%2520candidate%252C%2520ADX71441%252C%2520is%2520a%2520novel%252C%2520potent%2520and%2520selective%2520positive%2520allosteric%2520modulator%2520of%2520the%2520GABAB%2520receptor%2520with%2520a%2520potential%2520for%2520treatment%2520of%2520anxiety%252C%2520pain%2520and%2520spasticity%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D114%26spage%3D34%26epage%3D47%26doi%3D10.1016%2Fj.neuropharm.2016.11.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Caracci, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ávila, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Ferrari, G. V.</span><span> </span><span class="NLM_article-title">Synaptic Wnt/GSK3β signaling hub in autism</span> <span class="citation_source-journal">Neural Plast.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">2016</span><span class="NLM_x">, </span> <span class="NLM_fpage">9603751</span><span class="refDoi"> DOI: 10.1155/2016/9603751</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1155%2F2016%2F9603751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26881141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC28jhtVylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=9603751&author=M.+O.+Caracciauthor=M.+E.+%C3%81vilaauthor=G.+V.+De+Ferrari&title=Synaptic+Wnt%2FGSK3%CE%B2+signaling+hub+in+autism&doi=10.1155%2F2016%2F9603751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Synaptic Wnt/GSK3β Signaling Hub in Autism</span></div><div class="casAuthors">Caracci Mario O; Avila Miguel E; De Ferrari Giancarlo V</div><div class="citationInfo"><span class="NLM_cas:title">Neural plasticity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2016</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9603751</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hundreds of genes have been associated with autism spectrum disorders (ASDs) and the interaction of weak and de novo variants derive from distinct autistic phenotypes thus making up the "spectrum." The convergence of these variants in networks of genes associated with synaptic function warrants the study of cell signaling pathways involved in the regulation of the synapse.  The Wnt/β-catenin signaling pathway plays a central role in the development and regulation of the central nervous system and several genes belonging to the cascade have been genetically associated with ASDs.  In the present paper, we review basic information regarding the role of Wnt/β-catenin signaling in excitatory/inhibitory balance (E/I balance) through the regulation of pre- and postsynaptic compartments.  Furthermore, we integrate information supporting the role of the glycogen synthase kinase 3β (GSK3β) in the onset/development of ASDs through direct modulation of Wnt/β-catenin signaling.  Finally, given GSK3β activity as key modulator of synaptic plasticity, we explore the potential of this kinase as a therapeutic target for ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRFS7HBs9MUsjl5L8hwNX0fW6udTcc2eZAMlXRw6lB6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jhtVylsg%253D%253D&md5=8dde53877c01a9674e7ad26ab99a8653</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1155%2F2016%2F9603751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F9603751%26sid%3Dliteratum%253Aachs%26aulast%3DCaracci%26aufirst%3DM.%2BO.%26aulast%3D%25C3%2581vila%26aufirst%3DM.%2BE.%26aulast%3DDe%2BFerrari%26aufirst%3DG.%2BV.%26atitle%3DSynaptic%2520Wnt%252FGSK3%25CE%25B2%2520signaling%2520hub%2520in%2520autism%26jtitle%3DNeural%2520Plast.%26date%3D2016%26volume%3D2016%26spage%3D9603751%26doi%3D10.1155%2F2016%2F9603751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Mulligan, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheyette, B. N.</span><span> </span><span class="NLM_article-title">Neurodevelopmental perspectives on Wnt signaling in psychiatry</span> <span class="citation_source-journal">Mol. Neuropsychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span><span class="refDoi"> DOI: 10.1159/000453266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1159%2F000453266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=28277568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC1czks1WitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=219-246&author=K.+A.+Mulliganauthor=B.+N.+Cheyette&title=Neurodevelopmental+perspectives+on+Wnt+signaling+in+psychiatry&doi=10.1159%2F000453266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodevelopmental Perspectives on Wnt Signaling in Psychiatry</span></div><div class="casAuthors">Mulligan Kimberly A; Cheyette Benjamin N R</div><div class="citationInfo"><span class="NLM_cas:title">Molecular neuropsychiatry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">219-246</span>
        ISSN:<span class="NLM_cas:issn">2296-9209</span>.
    </div><div class="casAbstract">Mounting evidence indicates that Wnt signaling is relevant to pathophysiology of diverse mental illnesses including schizophrenia, bipolar disorder, and autism spectrum disorder.  In the 35 years since Wnt ligands were first described, animal studies have richly explored how downstream Wnt signaling pathways affect an array of neurodevelopmental processes and how their disruption can lead to both neurological and behavioral phenotypes.  Recently, human induced pluripotent stem cell (hiPSC) models have begun to contribute to this literature while pushing it in increasingly translational directions.  Simultaneously, large-scale human genomic studies are providing evidence that sequence variation in Wnt signal pathway genes contributes to pathogenesis in several psychiatric disorders.  This article reviews neurodevelopmental and postneurodevelopmental functions of Wnt signaling, highlighting mechanisms, whereby its disruption might contribute to psychiatric illness, and then reviews the most reliable recent genetic evidence supporting that mutations in Wnt pathway genes contribute to psychiatric illness.  We are proponents of the notion that studies in animal and hiPSC models informed by the human genetic data combined with the deep knowledge base and tool kits generated over the last several decades of basic neurodevelopmental research will yield near-term tangible advances in neuropsychiatry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRbMbL0-sgHr9Hxxy173TfNfW6udTcc2ebn8FGfPQVXX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czks1WitQ%253D%253D&md5=cfbfef2ae9c8e4cea3abff7dbf2031f6</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1159%2F000453266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000453266%26sid%3Dliteratum%253Aachs%26aulast%3DMulligan%26aufirst%3DK.%2BA.%26aulast%3DCheyette%26aufirst%3DB.%2BN.%26atitle%3DNeurodevelopmental%2520perspectives%2520on%2520Wnt%2520signaling%2520in%2520psychiatry%26jtitle%3DMol.%2520Neuropsychiatry%26date%3D2017%26volume%3D2%26spage%3D219%26epage%3D246%26doi%3D10.1159%2F000453266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Klein, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melton, D. A.</span><span> </span><span class="NLM_article-title">A molecular mechanism for the effect of lithium on development</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">8455</span><span class="NLM_x">–</span> <span class="NLM_lpage">8459</span><span class="refDoi"> DOI: 10.1073/pnas.93.16.8455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.93.16.8455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=8710892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADyaK28XkvFyksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=8455-8459&author=P.+S.+Kleinauthor=D.+A.+Melton&title=A+molecular+mechanism+for+the+effect+of+lithium+on+development&doi=10.1073%2Fpnas.93.16.8455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">A molecular mechanism for the effect of lithium on development</span></div><div class="casAuthors">Klein, Peter S.; Melton, Douglas A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8455-8459</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Lithium, one of the most effective drugs for the treatment of bipolar (manic-depressive) disorder, also has dramatic effects on morphogenesis in the early development of numerous organisms.  How lithium exerts these diverse effects is unclear, but the favored hypothesis is that lithium acts through inhibition of inositol monophosphatase (IMPase).  We show here that complete inhibition of IMPase has no effect on the morphogenesis of Xenopus embryos and present a different hypothesis to explain the broad action of lithium.  Our results suggest that lithium acts through inhibition of glycogen synthase kinase-3β (GSK-3β), which regulates cell fate detn. in diverse organisms including dictyostelium, Drosophila, and Xenopus.  Lithium potently inhibits GSK-3β activity (Ki = 2 mM), but is not a general inhibitor of other protein kinases.  In support of this hypothesis, lithium treatment phenocopies loss of GSK-3β function of Xenopus and Dictyostelium.  These observations help explain the effect of lithium on cell-fate detn. and could provide insights into the pathogenesis and treatment of bipolar disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwmgF9XN0PabVg90H21EOLACvtfcHk0ljalgZ_pQOppQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFyksLY%253D&md5=611ae73b9ec411df9ff84da5fdaffcfc</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.16.8455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.16.8455%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DP.%2BS.%26aulast%3DMelton%26aufirst%3DD.%2BA.%26atitle%3DA%2520molecular%2520mechanism%2520for%2520the%2520effect%2520of%2520lithium%2520on%2520development%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D8455%26epage%3D8459%26doi%3D10.1073%2Fpnas.93.16.8455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Cerpa, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godoy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfaro, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farías, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalfe, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuentealba, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonansco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span> </span><span class="NLM_article-title">Wnt-7a modulates the synaptic vesicle cycle and synaptic transmission in hippocampal neurons</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">5918</span><span class="NLM_x">–</span> <span class="NLM_lpage">5927</span><span class="refDoi"> DOI: 10.1074/jbc.M705943200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1074%2Fjbc.M705943200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=5918-5927&author=W.+Cerpaauthor=J.+A.+Godoyauthor=I.+Alfaroauthor=G.+G.+Far%C3%ADasauthor=M.+J.+Metcalfeauthor=R.+Fuentealbaauthor=C.+Bonanscoauthor=N.+C.+Inestrosa&title=Wnt-7a+modulates+the+synaptic+vesicle+cycle+and+synaptic+transmission+in+hippocampal+neurons&doi=10.1074%2Fjbc.M705943200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M705943200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M705943200%26sid%3Dliteratum%253Aachs%26aulast%3DCerpa%26aufirst%3DW.%26aulast%3DGodoy%26aufirst%3DJ.%2BA.%26aulast%3DAlfaro%26aufirst%3DI.%26aulast%3DFar%25C3%25ADas%26aufirst%3DG.%2BG.%26aulast%3DMetcalfe%26aufirst%3DM.%2BJ.%26aulast%3DFuentealba%26aufirst%3DR.%26aulast%3DBonansco%26aufirst%3DC.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DWnt-7a%2520modulates%2520the%2520synaptic%2520vesicle%2520cycle%2520and%2520synaptic%2520transmission%2520in%2520hippocampal%2520neurons%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D5918%26epage%3D5927%26doi%3D10.1074%2Fjbc.M705943200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Ahmad-Annuar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeonidis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herreros, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredj, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosso, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brickley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salinas, P. C.</span><span> </span><span class="NLM_article-title">Signaling across the synapse: a role for Wnt and Dishevelled in presynaptic assembly and neurotransmitter release</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">174</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span><span class="refDoi"> DOI: 10.1083/jcb.200511054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1083%2Fjcb.200511054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2006&pages=127-139&author=A.+Ahmad-Annuarauthor=L.+Cianiauthor=I.+Simeonidisauthor=J.+Herrerosauthor=N.+B.+Fredjauthor=S.+B.+Rossoauthor=A.+Hallauthor=S.+Brickleyauthor=P.+C.+Salinas&title=Signaling+across+the+synapse%3A+a+role+for+Wnt+and+Dishevelled+in+presynaptic+assembly+and+neurotransmitter+release&doi=10.1083%2Fjcb.200511054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200511054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200511054%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad-Annuar%26aufirst%3DA.%26aulast%3DCiani%26aufirst%3DL.%26aulast%3DSimeonidis%26aufirst%3DI.%26aulast%3DHerreros%26aufirst%3DJ.%26aulast%3DFredj%26aufirst%3DN.%2BB.%26aulast%3DRosso%26aufirst%3DS.%2BB.%26aulast%3DHall%26aufirst%3DA.%26aulast%3DBrickley%26aufirst%3DS.%26aulast%3DSalinas%26aufirst%3DP.%2BC.%26atitle%3DSignaling%2520across%2520the%2520synapse%253A%2520a%2520role%2520for%2520Wnt%2520and%2520Dishevelled%2520in%2520presynaptic%2520assembly%2520and%2520neurotransmitter%2520release%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2006%26volume%3D174%26spage%3D127%26epage%3D139%26doi%3D10.1083%2Fjcb.200511054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Ciani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickins, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahores, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anane, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibb, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salinas, P. C.</span><span> </span><span class="NLM_article-title">Wnt7a signaling promotes dendritic spine growth and synaptic strength through Ca<sup>2</sup><sup>+</sup>/Calmodulin-dependent protein kinase II</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">10732</span><span class="NLM_x">–</span> <span class="NLM_lpage">10737</span><span class="refDoi"> DOI: 10.1073/pnas.1018132108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.1018132108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=10732-10737&author=L.+Cianiauthor=K.+A.+Boyleauthor=E.+Dickinsauthor=M.+Sahoresauthor=D.+Ananeauthor=D.+M.+Lopesauthor=A.+J.+Gibbauthor=P.+C.+Salinas&title=Wnt7a+signaling+promotes+dendritic+spine+growth+and+synaptic+strength+through+Ca2%2B%2FCalmodulin-dependent+protein+kinase+II&doi=10.1073%2Fpnas.1018132108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1018132108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1018132108%26sid%3Dliteratum%253Aachs%26aulast%3DCiani%26aufirst%3DL.%26aulast%3DBoyle%26aufirst%3DK.%2BA.%26aulast%3DDickins%26aufirst%3DE.%26aulast%3DSahores%26aufirst%3DM.%26aulast%3DAnane%26aufirst%3DD.%26aulast%3DLopes%26aufirst%3DD.%2BM.%26aulast%3DGibb%26aufirst%3DA.%2BJ.%26aulast%3DSalinas%26aufirst%3DP.%2BC.%26atitle%3DWnt7a%2520signaling%2520promotes%2520dendritic%2520spine%2520growth%2520and%2520synaptic%2520strength%2520through%2520Ca2%252B%252FCalmodulin-dependent%2520protein%2520kinase%2520II%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D10732%26epage%3D10737%26doi%3D10.1073%2Fpnas.1018132108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Latapy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioux, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guitton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, J. M.</span><span> </span><span class="NLM_article-title">Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviour</span> <span class="citation_source-journal">Philos. Trans. R. Soc., B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">2460</span><span class="NLM_x">–</span> <span class="NLM_lpage">2474</span><span class="refDoi"> DOI: 10.1098/rstb.2012.0094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1098%2Frstb.2012.0094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22826345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCqt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=2460-2474&author=C.+Latapyauthor=V.+Riouxauthor=M.+J.+Guittonauthor=J.+M.+Beaulieu&title=Selective+deletion+of+forebrain+glycogen+synthase+kinase+3%CE%B2+reveals+a+central+role+in+serotonin-sensitive+anxiety+and+social+behaviour&doi=10.1098%2Frstb.2012.0094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviour</span></div><div class="casAuthors">Latapy, Camille; Rioux, Veronique; Guitton, Matthieu J.; Beaulieu, Jean-Martin</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical Transactions of the Royal Society, B: Biological Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">1601</span>),
    <span class="NLM_cas:pages">2460-2474</span>CODEN:
                <span class="NLM_cas:coden">PTRBAE</span>;
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">Serotonin (5-HT) neurotransmission is thought to underlie mental illnesses, such as bipolar disorder, depression, autism and schizophrenia.  Independent studies have indicated that 5-HT or drugs acting on 5-HT neurotransmission regulate the serine/threonine kinase glycogen synthase kinase 3β (GSK3β).  Furthermore, GSK3β inhibition rescues behavioral abnormalities in 5-HT-deficient mice with a loss-of-function mutation equiv. to the human variant (R441H) of tryptophan hydroxylase 2.  In an effort to define neuroanatomical correlates of GSK3β activity in the regulation of behavior, we generated CamKIIcre-floxGSK3β mice in which the gsk3b gene is post-natally inactivated in forebrain pyramidal neurons.  Behavioral characterization showed that suppression of GSK3β in these brain areas has anxiolytic and pro-social effects.  However, while a global redn. of GSK2β expression reduced responsiveness to amphetamine and increased resilience to social defeat, these behavioral effects were not found in CamKIIcre-floxGSK3β mice.  These findings demonstrate a dissocn. of behavioral effects related to GSK3 inhibition, with forebrain GSK3β being involved in the regulation of anxiety and sociability while social preference, resilience and responsiveness to psychostimulants would involve a function of this kinase in subcortical areas such as the hippocampus and striatum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmnqQN3YIHSbVg90H21EOLACvtfcHk0lhbvag65qOhvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCqt77F&md5=de74e57a27df0f415d84531ba980acb4</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1098%2Frstb.2012.0094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2012.0094%26sid%3Dliteratum%253Aachs%26aulast%3DLatapy%26aufirst%3DC.%26aulast%3DRioux%26aufirst%3DV.%26aulast%3DGuitton%26aufirst%3DM.%2BJ.%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26atitle%3DSelective%2520deletion%2520of%2520forebrain%2520glycogen%2520synthase%2520kinase%25203%25CE%25B2%2520reveals%2520a%2520central%2520role%2520in%2520serotonin-sensitive%2520anxiety%2520and%2520social%2520behaviour%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2012%26volume%3D367%26spage%3D2460%26epage%3D2474%26doi%3D10.1098%2Frstb.2012.0094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Hernàndez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guaza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J. J.</span><span> </span><span class="NLM_article-title">Spatial learning deficit in transgenic mice that conditionally overexpress GSK-3β in the brain but do not form tau filaments</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1529</span><span class="NLM_x">–</span> <span class="NLM_lpage">1533</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.01269.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1046%2Fj.1471-4159.2002.01269.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=12472906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsFym" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2002&pages=1529-1533&author=F.+Hern%C3%A0ndezauthor=J.+Borrellauthor=C.+Guazaauthor=J.+Avilaauthor=J.+J.+Lucas&title=Spatial+learning+deficit+in+transgenic+mice+that+conditionally+overexpress+GSK-3%CE%B2+in+the+brain+but+do+not+form+tau+filaments&doi=10.1046%2Fj.1471-4159.2002.01269.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Spatial learning deficit in transgenic mice that conditionally over-express GSK-3β in the brain but do not form tau filaments</span></div><div class="casAuthors">Hernandez, Felix; Borrell, Jose; Guaza, Carmen; Avila, Jesus; Lucas, Jose J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1529-1533</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Deregulation of glycogen synthase kinase-3 (GSK-3) activity in neurons has been postulated as a key feature in Alzheimer's disease (AD) pathogenesis.  This was further supported by our recent characterization of transgenic mice that conditionally over-express GSK-3β in hippocampal and cortical neurons.  These mice, designated Tet/GSK-3β, showed many of the biochem. and cellular aspects of AD neuropathol. such as tau hyperphosphorylation and somatodendritic localization, decreased nuclear β-catenin, neuronal death and reactive gliosis.  Tet/GSK-3β mice, however, did not show tau filament formation up to the latest tested age of 3 mo at least.  Here we report spatial learning deficits of Tet/GSK-3β mice in the Morris water maze.  In parallel, we also measured the increase in GSK-3 activity while further exploring the possibility of tau filament formation in aged mice.  We found a significant increase in GSK-3 activity in the hippocampus of Tet/GSK-3β mice whereas no tau fibrils could be found even in very old mice.  These data reinforce the hypothesis of GSK-3 deregulation in AD pathogenesis, and suggest that Tet/GSK-3β mice can be used as an AD model and, most remarkably, can be used to test the therapeutic potential of the selective GSK-3 inhibitors that are currently under development.  Addnl., these expts. suggest that destabilization of microtubules and alteration of intracellular metabolic pathways contribute to AD pathogenesis independent of toxicity triggered by the aberrant tau deposits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnmGYVzTRDerVg90H21EOLACvtfcHk0lhbvag65qOhvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsFym&md5=2e8597a2cc0e0a97437ddf9351590cb1</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.01269.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.01269.x%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A0ndez%26aufirst%3DF.%26aulast%3DBorrell%26aufirst%3DJ.%26aulast%3DGuaza%26aufirst%3DC.%26aulast%3DAvila%26aufirst%3DJ.%26aulast%3DLucas%26aufirst%3DJ.%2BJ.%26atitle%3DSpatial%2520learning%2520deficit%2520in%2520transgenic%2520mice%2520that%2520conditionally%2520overexpress%2520GSK-3%25CE%25B2%2520in%2520the%2520brain%2520but%2520do%2520not%2520form%2520tau%2520filaments%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D83%26spage%3D1529%26epage%3D1533%26doi%3D10.1046%2Fj.1471-4159.2002.01269.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Siegel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vishnevetsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stedman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. A.</span><span> </span><span class="NLM_article-title">Preliminary investigation of lithium for mood disorder symptoms in children and adolescents with autism spectrum disorder</span> <span class="citation_source-journal">J. Child Adolesc. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span><span class="refDoi"> DOI: 10.1089/cap.2014.0019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1089%2Fcap.2014.0019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25093602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFamsrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=399-402&author=M.+Siegelauthor=C.+A.+Beresfordauthor=M.+Bunkerauthor=M.+Verdiauthor=D.+Vishnevetskyauthor=C.+Karlssonauthor=O.+Teerauthor=A.+Stedmanauthor=K.+A.+Smith&title=Preliminary+investigation+of+lithium+for+mood+disorder+symptoms+in+children+and+adolescents+with+autism+spectrum+disorder&doi=10.1089%2Fcap.2014.0019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Preliminary Investigation of Lithium for Mood Disorder Symptoms in Children and Adolescents with Autism Spectrum Disorder</span></div><div class="casAuthors">Siegel, Matthew; Beresford, Carol A.; Bunker, Madisun; Verdi, Mary; Vishnevetsky, Donna; Karlsson, Cassie; Teer, Olivia; Stedman, Amy; Smith, Kahsi A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Child and Adolescent Psychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">399-402</span>CODEN:
                <span class="NLM_cas:coden">JADPET</span>;
        ISSN:<span class="NLM_cas:issn">1044-5463</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Objective: Children with autism spectrum disorder (ASD) have higher rates of comorbid psychiatric disorders, including mood disorders, than the general child population.  Although children with ASD may experience irritability (aggression, self-injury, and tantrums), a portion also experience symptoms that are typical of a mood disorder, such as euphoria/elevated mood, mania, hypersexuality, paranoia, or decreased need for sleep.  Despite lithium's established efficacy in controlling mood disorder symptoms in the neurotypical population, lithium has been rarely studied in children with ASD.Methods: We performed a retrospective chart review of 30 children and adolescents diagnosed with ASD by the Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision (DSM-IV-TR) criteria who were prescribed lithium in order to assess target symptoms, safety, and tolerability.  Clin. Global Impressions - Improvement (CGI-I) ratings were performed by two board-certified child psychiatrists with expertise in ASD.  CGI-I scores were dichotomized into "improved" (CGI-I score of 1 or 2) or "not improved" (CGI-I score ≥3).Results: Forty-three percent of patients who received lithium were rated as "improved" on the CGI-I.  Seventy-one percent of patients who had two or more pretreatment mood disorder symptoms were rated as "improved.  " The presence of mania (p=0.033) or euphoria/elevated mood (p=0.041) were the pretreatment symptoms significantly assocd. with an "improved" rating.  The mean lithium blood level was 0.70 mEq/L (SD=0.26), and the av. length of lithium treatment was 29.7 days (SD=23.9).  Forty-seven percent of patients were reported to have at least one side effect, most commonly vomiting (13%), tremor (10%), fatigue (10%), irritability (7%), and enuresis (7%).Conclusions: This preliminary assessment of lithium in children and adolescents with ASD suggests that lithium may be a medication of interest for those who exhibit two or more mood disorder symptoms, particularly mania or euphoria/elevated mood.  A relatively high side effect rate merits caution, and these results are limited by the retrospective, uncontrolled study design.  Future study of lithium in a prospective trial with treatment-sensitive outcome measures may be indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl35nuQjFGnbVg90H21EOLACvtfcHk0lhvPJziiWiyEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFamsrvF&md5=6a361133f71c31a559fd48b72a47ecf4</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1089%2Fcap.2014.0019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcap.2014.0019%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DM.%26aulast%3DBeresford%26aufirst%3DC.%2BA.%26aulast%3DBunker%26aufirst%3DM.%26aulast%3DVerdi%26aufirst%3DM.%26aulast%3DVishnevetsky%26aufirst%3DD.%26aulast%3DKarlsson%26aufirst%3DC.%26aulast%3DTeer%26aufirst%3DO.%26aulast%3DStedman%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DK.%2BA.%26atitle%3DPreliminary%2520investigation%2520of%2520lithium%2520for%2520mood%2520disorder%2520symptoms%2520in%2520children%2520and%2520adolescents%2520with%2520autism%2520spectrum%2520disorder%26jtitle%3DJ.%2520Child%2520Adolesc.%2520Psychopharmacol.%26date%3D2014%26volume%3D24%26spage%3D399%26epage%3D402%26doi%3D10.1089%2Fcap.2014.0019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Z.</span><span> </span><span class="NLM_article-title">Lithium ameliorates autistic-like behaviors induced by neonatal isolation in rats</span> <span class="citation_source-journal">Front. Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">234</span><span class="refDoi"> DOI: 10.3389/fnbeh.2014.00234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3389%2Ffnbeh.2014.00234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25018711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1GltL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=234&author=X.+Wuauthor=Y.+Baiauthor=T.+Tanauthor=H.+Liauthor=S.+Xiaauthor=X.+Changauthor=Z.+Zhouauthor=W.+Zhouauthor=T.+Liauthor=Y.+T.+Wangauthor=Z.+Dong&title=Lithium+ameliorates+autistic-like+behaviors+induced+by+neonatal+isolation+in+rats&doi=10.3389%2Ffnbeh.2014.00234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Lithium ameliorates autistic-like behaviors induced by neonatal isolation in rats</span></div><div class="casAuthors">Wu, Xiaoyan; Bai, Yanrui; Tan, Tao; Li, Hongjie; Xia, Shuting; Chang, Xinxia; Zhou, Zikai; Zhou, Weihui; Li, Tingyu; Wang, Yu Tian; Dong, Zhifang</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">234/1-234/12, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Neonatal isolation is a widely accepted model to study the long-term behavioral changes produced by the early life events.  However, it remains unknown whether neonatal isolation can induce autistic-like behaviors, and if so, whether pharmacol. treatment can overcome it.  Here, we reported that newborn rats subjected to individual isolations from their mother and nest for 1 h per day from postnatal days 1-9 displayed apparent autistic-like symptoms including social deficits, excessive repetitive self-grooming behavior and increased anxiety- and depressive-like behaviors tested in young adult (postnatal days 42-56) compared to normal reared controls.  Furthermore, these behavioral changes were accompanied by impaired adult hippocampal neurogenesis and reduced the ratio of excitatory/inhibitory synaptic transmissions, as reflected by an increase in spontaneous inhibitory postsynaptic current (sIPSC) and normal spontaneous excitatory postsynaptic current (sEPSC) in the hippocampal CA1 pyramidal neuron.  More importantly, chronic administration of lithium, a clin. used mood stabilizer, completely overcame neonatal isolation-induced autistic-like behaviors and restored adult hippocampal neurogenesis as well as the balance between excitatory and inhibitory activities to physiol. levels.  These findings indicate that neonatal isolation may produce autistic-like behaviors and lithium may be a potential therapeutic agent against autism spectrum disorders (ASD) during development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyI2ISniSEILVg90H21EOLACvtfcHk0lhvPJziiWiyEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1GltL%252FL&md5=9abfba2d6b6b744d1df94458179dcd92</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2014.00234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2014.00234%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DXia%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%2BT.%26aulast%3DDong%26aufirst%3DZ.%26atitle%3DLithium%2520ameliorates%2520autistic-like%2520behaviors%2520induced%2520by%2520neonatal%2520isolation%2520in%2520rats%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D234%26doi%3D10.3389%2Ffnbeh.2014.00234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Liu, Z.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. B.</span><span> </span><span class="NLM_article-title">Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1145</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span><span class="refDoi"> DOI: 10.1016/j.nbd.2011.12.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.nbd.2011.12.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22227453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XitlGkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=1145-1152&author=Z.-H.+Liuauthor=T.+Huangauthor=C.+B.+Smith&title=Lithium+reverses+increased+rates+of+cerebral+protein+synthesis+in+a+mouse+model+of+fragile+X+syndrome&doi=10.1016%2Fj.nbd.2011.12.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome</span></div><div class="casAuthors">Liu, Zhong-Hua; Huang, Tianjian; Smith, Carolyn Beebe</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1145-1152</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Individuals with fragile X syndrome (FXS), an inherited form of cognitive disability, have a wide range of symptoms including hyperactivity, autistic behavior, seizures and learning deficits.  FXS is caused by silencing of FMR1 and the consequent absence of fragile X mental retardation protein (FMRP).  FMRP is an RNA-binding protein that assocs. with polyribosomes and neg. regulates translation.  In a previous study of a mouse model of FXS (Fmr1 knockout (KO)) we demonstrated that in vivo rates of cerebral protein synthesis (rCPS) were elevated in selective brain regions suggesting that the absence of FMRP in FXS may result in dysregulation of cerebral protein synthesis.  Lithium, a drug used clin. to treat bipolar disorder, has been used to improve mood dysregulation in individuals with FXS.  We reported previously that in the Fmr1 KO mouse chronic dietary lithium treatment reversed or ameliorated both behavioral and morphol. abnormalities.  Herein we report that chronic dietary lithium treatment reversed the increased rCPS in Fmr1 KO mice with little effect on wild type mice.  We also report our results of analyses of key signaling mols. involved in regulation of mRNA translation.  Our analyses indicate that neither effects on the PI3K/Akt nor the MAPK/ERK 1/2 pathway fully account for the effects of lithium treatment on rCPS.  Collectively our findings and those from other labs. on the efficacy of lithium treatment in animal models support further studies in patients with FXS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_xl88jUTRWrVg90H21EOLACvtfcHk0lgpVYRJujgHuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitlGkt78%253D&md5=49e0e187bc62f9ad0ca17c2514e74a60</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2011.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2011.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.-H.%26aulast%3DHuang%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DC.%2BB.%26atitle%3DLithium%2520reverses%2520increased%2520rates%2520of%2520cerebral%2520protein%2520synthesis%2520in%2520a%2520mouse%2520model%2520of%2520fragile%2520X%2520syndrome%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2012%26volume%3D45%26spage%3D1145%26epage%3D1152%26doi%3D10.1016%2Fj.nbd.2011.12.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaller, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span> </span><span class="NLM_article-title">Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1093/hmg/ddr501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1093%2Fhmg%2Fddr501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22048960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2jurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=681-691&author=W.+Guoauthor=A.+C.+Murthyauthor=L.+Zhangauthor=E.+B.+Johnsonauthor=E.+G.+Schallerauthor=A.+M.+Allanauthor=X.+Zhao&title=Inhibition+of+GSK3%CE%B2+improves+hippocampus-dependent+learning+and+rescues+neurogenesis+in+a+mouse+model+of+fragile+X+syndrome&doi=10.1093%2Fhmg%2Fddr501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome</span></div><div class="casAuthors">Guo, Weixiang; Murthy, Adeline C.; Zhang, Li; Johnson, Eric B.; Schaller, Eric G.; Allan, Andrea M.; Zhao, Xinyu</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">681-691</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Fragile X syndrome (FXS), a common inherited form of intellectual disability with learning deficits, results from a loss of fragile X mental retardation protein (FMRP).  Despite extensive research, treatment options for FXS remain limited.  Since FMRP is known to play an important role in adult hippocampal neurogenesis and hippocampus-dependent learning and FMRP regulates the adult neural stem cell fate through the translational regulation of glycogen synthase kinase 3β (GSK3β), we investigated the effects of a GSK3β inhibitor, SB216763, on Fmr1 knockout mice (Fmr1 KO).  We found that the inhibition of GSK3β could reverse the hippocampus-dependent learning deficits and rescue adult hippocampal neurogenesis at multiple stages in Fmr1 KO mice.  Our results point to GSK3β inhibition as a potential treatment for the learning deficits seen in FXS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZClb5MIi3wLVg90H21EOLACvtfcHk0lgpVYRJujgHuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2jurc%253D&md5=18d17e5cc75c11223d0f79f84e0648ab</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddr501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddr501%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DMurthy%26aufirst%3DA.%2BC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DE.%2BB.%26aulast%3DSchaller%26aufirst%3DE.%2BG.%26aulast%3DAllan%26aufirst%3DA.%2BM.%26aulast%3DZhao%26aufirst%3DX.%26atitle%3DInhibition%2520of%2520GSK3%25CE%25B2%2520improves%2520hippocampus-dependent%2520learning%2520and%2520rescues%2520neurogenesis%2520in%2520a%2520mouse%2520model%2520of%2520fragile%2520X%2520syndrome%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2012%26volume%3D21%26spage%3D681%26epage%3D691%26doi%3D10.1093%2Fhmg%2Fddr501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ormö, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesäter, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerning, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markgren, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgegård, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nylöf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giménez-Cassina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernández, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Díaz-Nido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span> </span><span class="NLM_article-title">Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">45937</span><span class="NLM_x">–</span> <span class="NLM_lpage">45945</span><span class="refDoi"> DOI: 10.1074/jbc.M306268200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1074%2Fjbc.M306268200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=12928438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosl2itL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=45937-45945&author=R.+Bhatauthor=Y.+Xueauthor=S.+Bergauthor=S.+Hellbergauthor=M.+Orm%C3%B6author=Y.+Nilssonauthor=A.+C.+Rades%C3%A4terauthor=E.+Jerningauthor=P.+O.+Markgrenauthor=T.+Borgeg%C3%A5rdauthor=M.+Nyl%C3%B6fauthor=A.+Gim%C3%A9nez-Cassinaauthor=F.+Hern%C3%A1ndezauthor=J.+J.+Lucasauthor=J.+D%C3%ADaz-Nidoauthor=J.+Avila&title=Structural+insights+and+biological+effects+of+glycogen+synthase+kinase+3-specific+inhibitor+AR-A014418&doi=10.1074%2Fjbc.M306268200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418</span></div><div class="casAuthors">Bhat, Ratan; Xue, Yafeng; Berg, Stefan; Hellberg, Sven; Ormoe, Mats; Nilsson, Yvonne; Radesaeter, Ann-Cathrin; Jerning, Eva; Markgren, Per-Olof; Borgegard, Thomas; Nyloef, Martin; Gimenez-Cassina, Alfredo; Hernandez, Felix; Lucas, Jose J.; Diaz-Nido, Javier; Avila, Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">45937-45945</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Glycogen synthase kinase 3 (GSK3) is a serine/threonine kinase that has been implicated in pathol. conditions such as diabetes and Alzheimer's disease.  We report the characterization of a GSK3 inhibitor, AR-A014418, which inhibits GSK3 (IC50 = 104±27 nM), in an ATP-competitive manner (Ki = 38 nM).  AR-A014418 does not significantly inhibit cdk2 or cdk5 (IC50 > 100 μM) or 26 other kinases demonstrating high specificity for GSK3.  We report the co-crystn. of AR-A014418 with the GSK3β protein and provide a description of the interactions within the ATP pocket, as well as an understanding of the structural basis for the selectivity of AR-A014418.  AR-A014418 inhibits tau phosphorylation at a GSK3-specific site (Ser-396) in cells stably expressing human four-repeat tau protein.  AR-A014418 protects N2A neuroblastoma cells against cell death mediated by inhibition of the phosphatidylinositol 3-kinase/protein kinase B survival pathway.  Furthermore, AR-A014418 inhibits neurodegeneration mediated by β-amyloid peptide in hippocampal slices.  AR-A014418 may thus have important applications as a tool to elucidate the role of GSK3 in cellular signaling and possibly in Alzheimer's disease.  AR-A014418 is the first compd. of a family of specific inhibitors of GSK3 that does not significantly inhibit closely related kinases such as cdk2 or cdk5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVw7LgEHct0LVg90H21EOLACvtfcHk0lgpVYRJujgHuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosl2itL0%253D&md5=c52e13ab3dfdcef165620714c3181860</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M306268200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M306268200%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DHellberg%26aufirst%3DS.%26aulast%3DOrm%25C3%25B6%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DY.%26aulast%3DRades%25C3%25A4ter%26aufirst%3DA.%2BC.%26aulast%3DJerning%26aufirst%3DE.%26aulast%3DMarkgren%26aufirst%3DP.%2BO.%26aulast%3DBorgeg%25C3%25A5rd%26aufirst%3DT.%26aulast%3DNyl%25C3%25B6f%26aufirst%3DM.%26aulast%3DGim%25C3%25A9nez-Cassina%26aufirst%3DA.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DF.%26aulast%3DLucas%26aufirst%3DJ.%2BJ.%26aulast%3DD%25C3%25ADaz-Nido%26aufirst%3DJ.%26aulast%3DAvila%26aufirst%3DJ.%26atitle%3DStructural%2520insights%2520and%2520biological%2520effects%2520of%2520glycogen%2520synthase%2520kinase%25203-specific%2520inhibitor%2520AR-A014418%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D45937%26epage%3D45945%26doi%3D10.1074%2Fjbc.M306268200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Yuskaitis, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mines, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweatt, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jope, R. S.</span><span> </span><span class="NLM_article-title">Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">632</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span><span class="refDoi"> DOI: 10.1016/j.bcp.2009.09.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bcp.2009.09.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=632-646&author=C.+J.+Yuskaitisauthor=M.+A.+Minesauthor=M.+K.+Kingauthor=J.+D.+Sweattauthor=C.+A.+Millerauthor=R.+S.+Jope&title=Lithium+ameliorates+altered+glycogen+synthase+kinase-3+and+behavior+in+a+mouse+model+of+fragile+X+syndrome&doi=10.1016%2Fj.bcp.2009.09.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.09.023%26sid%3Dliteratum%253Aachs%26aulast%3DYuskaitis%26aufirst%3DC.%2BJ.%26aulast%3DMines%26aufirst%3DM.%2BA.%26aulast%3DKing%26aufirst%3DM.%2BK.%26aulast%3DSweatt%26aufirst%3DJ.%2BD.%26aulast%3DMiller%26aufirst%3DC.%2BA.%26aulast%3DJope%26aufirst%3DR.%2BS.%26atitle%3DLithium%2520ameliorates%2520altered%2520glycogen%2520synthase%2520kinase-3%2520and%2520behavior%2520in%2520a%2520mouse%2520model%2520of%2520fragile%2520X%2520syndrome%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D632%26epage%3D646%26doi%3D10.1016%2Fj.bcp.2009.09.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Maqbool, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoda, N.</span><span> </span><span class="NLM_article-title">Pivotal role of glycogen synthase kinase-3: a therapeutic target for Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.ejmech.2015.10.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26562543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVWms7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2016&pages=63-81&author=M.+Maqboolauthor=M.+Mobashirauthor=N.+Hoda&title=Pivotal+role+of+glycogen+synthase+kinase-3%3A+a+therapeutic+target+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2015.10.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease</span></div><div class="casAuthors">Maqbool, Mudasir; Mobashir, Mohammad; Hoda, Nasimul</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-81</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Neurodegenerative diseases are among the most challenging diseases with poorly known mechanism of cause and paucity of complete cure.  Out of all the neurodegenerative diseases, Alzheimer's disease is the most devastating and loosening of thinking and judging ability disease that occurs in the old age people.  Many hypotheses came forth in order to explain its causes.  In this review, we have enlightened Glycogen Synthase Kinase-3 which has been considered as a concrete cause for Alzheimer's disease.  Plaques and Tangles (abnormal structures) are the basic suspects in damaging and killing of nerve cells wherein Glycogen Synthase Kinase-3 has a key role in the formation of these fatal accumulations.  Various Glycogen Synthase Kinase-3 inhibitors have been reported to reduce the amt. of amyloid-beta as well as the tau hyperphosphorylation in both neuronal and nonneuronal cells.  Addnl., Glycogen Synthase Kinase-3 inhibitors have been reported to enhance the adult hippocampal neurogenesis in vivo as well as in vitro.  Keeping the chemotype of the reported Glycogen Synthase Kinase-3 inhibitors in consideration, they may be grouped into natural inhibitors, inorg. metal ions, organo-synthetic, and peptide like inhibitors.  On the basis of their mode of binding to the constituent enzyme, they may also be grouped as ATP, nonATP, and allosteric binding sites competitive inhibitors.  ATP competitive inhibitors were known earlier inhibitors but they lack efficient selectivity.  This led to find the new ways for the enzyme inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFXYexXxHIbrVg90H21EOLACvtfcHk0lg0R0vOAjL-rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVWms7rE&md5=df793f92aef5f445948fed494d9bb96e</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DMaqbool%26aufirst%3DM.%26aulast%3DMobashir%26aufirst%3DM.%26aulast%3DHoda%26aufirst%3DN.%26atitle%3DPivotal%2520role%2520of%2520glycogen%2520synthase%2520kinase-3%253A%2520a%2520therapeutic%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D107%26spage%3D63%26epage%3D81%26doi%3D10.1016%2Fj.ejmech.2015.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">van Spronsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoogenraad, C. C.</span><span> </span><span class="NLM_article-title">Synapse pathology in psychiatric and neurologic disease</span> <span class="citation_source-journal">Curr. Neurol. Neurosci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span><span class="refDoi"> DOI: 10.1007/s11910-010-0104-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs11910-010-0104-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20425036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1CjsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=207-214&author=M.+van+Spronsenauthor=C.+C.+Hoogenraad&title=Synapse+pathology+in+psychiatric+and+neurologic+disease&doi=10.1007%2Fs11910-010-0104-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Synapse pathology in psychiatric and neurologic disease</span></div><div class="casAuthors">van Spronsen, Myrrhe; Hoogenraad, Casper C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neurology and Neuroscience Reports</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-214</span>CODEN:
                <span class="NLM_cas:coden">CNNRBS</span>;
        ISSN:<span class="NLM_cas:issn">1534-6293</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Inhibitory and excitatory synapses play a fundamental role in information processing in the brain.  Excitatory synapses usually are situated on dendritic spines, small membrane protrusions that harbor glutamate receptors and postsynaptic d. components and help transmit elec. signals.  In recent years, it has become evident that spine morphol. is intimately linked to synapse function-smaller spines have smaller synapses and support reduced synaptic transmission.  The relationship between synaptic signaling, spine shape, and brain function is never more apparent than when the brain becomes dysfunctional.  Many psychiatric and neurol. disorders, ranging from mental retardation and autism to Alzheimer's disease and addiction, are accompanied by alterations in spine morphol. and synapse no.  In this review, we highlight the structure and mol. organization of synapses and discuss functional effects of synapse pathol. in brain disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEWURs9kuUL7Vg90H21EOLACvtfcHk0lg0R0vOAjL-rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1CjsLrO&md5=98c15fc3ed9510610ce16cc962d65d0c</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1007%2Fs11910-010-0104-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11910-010-0104-8%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BSpronsen%26aufirst%3DM.%26aulast%3DHoogenraad%26aufirst%3DC.%2BC.%26atitle%3DSynapse%2520pathology%2520in%2520psychiatric%2520and%2520neurologic%2520disease%26jtitle%3DCurr.%2520Neurol.%2520Neurosci.%2520Rep.%26date%3D2010%26volume%3D10%26spage%3D207%26epage%3D214%26doi%3D10.1007%2Fs11910-010-0104-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Berg, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwind, D. H.</span><span> </span><span class="NLM_article-title">Autism genetics: searching for specificity and convergence</span> <span class="citation_source-journal">Genome Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="refDoi"> DOI: 10.1186/gb-2012-13-7-247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2Fgb-2012-13-7-247" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=247&author=J.+M.+Bergauthor=D.+H.+Geschwind&title=Autism+genetics%3A+searching+for+specificity+and+convergence&doi=10.1186%2Fgb-2012-13-7-247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1186%2Fgb-2012-13-7-247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2012-13-7-247%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DJ.%2BM.%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26atitle%3DAutism%2520genetics%253A%2520searching%2520for%2520specificity%2520and%2520convergence%26jtitle%3DGenome%2520Biol.%26date%3D2012%26volume%3D13%26spage%3D247%26doi%3D10.1186%2Fgb-2012-13-7-247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Hutsler, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1309</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span><span class="refDoi"> DOI: 10.1016/j.brainres.2009.09.120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.brainres.2009.09.120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=19896929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFams7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1309&publication_year=2010&pages=83-94&author=J.+J.+Hutslerauthor=H.+Zhang&title=Increased+dendritic+spine+densities+on+cortical+projection+neurons+in+autism+spectrum+disorders&doi=10.1016%2Fj.brainres.2009.09.120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders</span></div><div class="casAuthors">Hutsler, Jeffrey J.; Zhang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1309</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">83-94</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Multiple types of indirect evidence have been used to support theories of altered cortical connectivity in autism spectrum disorders (ASD).  In other developmental disorders reduced spine expression is commonly found, while conditions such as fragile X syndrome show increased spine densities.  Despite its relevance to theories of altered cortical connectivity, synaptic spine expression has not been systematically explored in ASD.  Here we examine dendritic spines on Golgi-impregnated cortical pyramidal cells in the cortex of ASD subjects and age-matched control cases.  Pyramidal cells were studied within both the superficial and deep cortical layers of frontal, temporal, and parietal lobe regions.  Relative to controls, spine densities were greater in ASD subjects.  In analyses restricted to the apical dendrites of pyramidal cells, greater spine densities were found predominantly within layer II of each cortical location and within layer V of the temporal lobe.  High spine densities were assocd. with decreased brain wts. and were most commonly found in ASD subjects with lower levels of cognitive functioning.  Greater spine densities in ASD subjects provide structural support for recent suggestions of connectional changes within the cerebral cortex that may result in altered cortical computations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJGNeGj8C3KLVg90H21EOLACvtfcHk0lg0R0vOAjL-rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFams7jE&md5=5d41212ee729b19b904c0d20cd8e1638</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2009.09.120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2009.09.120%26sid%3Dliteratum%253Aachs%26aulast%3DHutsler%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DIncreased%2520dendritic%2520spine%2520densities%2520on%2520cortical%2520projection%2520neurons%2520in%2520autism%2520spectrum%2520disorders%26jtitle%3DBrain%2520Res.%26date%3D2010%26volume%3D1309%26spage%3D83%26epage%3D94%26doi%3D10.1016%2Fj.brainres.2009.09.120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Geschwind, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levitt, P.</span><span> </span><span class="NLM_article-title">Autism spectrum disorders: developmental disconnection syndromes</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span><span class="refDoi"> DOI: 10.1016/j.conb.2007.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.conb.2007.01.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=103-111&author=D.+H.+Geschwindauthor=P.+Levitt&title=Autism+spectrum+disorders%3A+developmental+disconnection+syndromes&doi=10.1016%2Fj.conb.2007.01.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.conb.2007.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.conb.2007.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26aulast%3DLevitt%26aufirst%3DP.%26atitle%3DAutism%2520spectrum%2520disorders%253A%2520developmental%2520disconnection%2520syndromes%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D2007%26volume%3D17%26spage%3D103%26epage%3D111%26doi%3D10.1016%2Fj.conb.2007.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Auerbach, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osterweil, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bear, M. F.</span><span> </span><span class="NLM_article-title">Mutations causing syndromic autism define an axis of synaptic pathophysiology</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">480</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1038/nature10658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnature10658" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=480&publication_year=2011&pages=63-68&author=B.+D.+Auerbachauthor=E.+K.+Osterweilauthor=M.+F.+Bear&title=Mutations+causing+syndromic+autism+define+an+axis+of+synaptic+pathophysiology&doi=10.1038%2Fnature10658"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1038%2Fnature10658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10658%26sid%3Dliteratum%253Aachs%26aulast%3DAuerbach%26aufirst%3DB.%2BD.%26aulast%3DOsterweil%26aufirst%3DE.%2BK.%26aulast%3DBear%26aufirst%3DM.%2BF.%26atitle%3DMutations%2520causing%2520syndromic%2520autism%2520define%2520an%2520axis%2520of%2520synaptic%2520pathophysiology%26jtitle%3DNature%26date%3D2011%26volume%3D480%26spage%3D63%26epage%3D68%26doi%3D10.1038%2Fnature10658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Phillips, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozzo-Miller, L.</span><span> </span><span class="NLM_article-title">Dendritic spine dysgenesis in autism related disorders</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">601</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1016/j.neulet.2015.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neulet.2015.01.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=601&publication_year=2015&pages=30-40&author=M.+Phillipsauthor=L.+Pozzo-Miller&title=Dendritic+spine+dysgenesis+in+autism+related+disorders&doi=10.1016%2Fj.neulet.2015.01.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2015.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2015.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DM.%26aulast%3DPozzo-Miller%26aufirst%3DL.%26atitle%3DDendritic%2520spine%2520dysgenesis%2520in%2520autism%2520related%2520disorders%26jtitle%3DNeurosci.%2520Lett.%26date%3D2015%26volume%3D601%26spage%3D30%26epage%3D40%26doi%3D10.1016%2Fj.neulet.2015.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Tsai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahin, M.</span><span> </span><span class="NLM_article-title">Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex</span> <span class="citation_source-journal">Curr. Opin. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1097/WCO.0b013e32834451c4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1097%2FWCO.0b013e32834451c4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21301339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVGitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=106-113&author=P.+Tsaiauthor=M.+Sahin&title=Mechanisms+of+neurocognitive+dysfunction+and+therapeutic+considerations+in+tuberous+sclerosis+complex&doi=10.1097%2FWCO.0b013e32834451c4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex</span></div><div class="casAuthors">Tsai, Peter; Sahin, Mustafa</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-113</span>CODEN:
                <span class="NLM_cas:coden">CONEEX</span>;
        ISSN:<span class="NLM_cas:issn">1350-7540</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Mendelian disorders that affect cognition provide a unique opportunity to study the mechanisms of neurodevelopmental disorders through the examn. of genetic defects in animals and development of hypotheses that can be tested in human beings.  Tuberous sclerosis complex (TSC) is a genetic disease that presents with epilepsy, autism, and intellectual disability.  Here we review recent advances in our understanding of TSC pathogenesis and signaling pathways that may be modulated to treat the neurol. symptoms.  Accumulating evidence suggests that TSC patients have nontuber abnormalities that contribute to the development of the neurol. phenotype- in particular, disorganization of axon tracts and deficient myelination.  TSC mouse models have failed to replicate the human neuropathol. entirely, but have shed light on the cellular abnormalities and the neurobehavioral phenotypes.  Most importantly, cell culture and animal models have identified the mTORC1 pathway as a therapeutic target in this disease.  Preclin. data strongly suggest that TSC is a disease of abnormal neuronal connectivity.  The high incidence of neurodevelopmental deficits, early detection of the disease in very young ages, and availability of mTORC1 inhibitors make TSC a model for other Mendelian disorders of neurocognition and an avenue for the mechanism-based treatment trials of neurodevelopmental disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbiN2ECb_DWLVg90H21EOLACvtfcHk0lhvr2qiTmIiXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVGitLg%253D&md5=d0f9a3ce4d33af1424221dcf2d804dc9</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1097%2FWCO.0b013e32834451c4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWCO.0b013e32834451c4%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DP.%26aulast%3DSahin%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520neurocognitive%2520dysfunction%2520and%2520therapeutic%2520considerations%2520in%2520tuberous%2520sclerosis%2520complex%26jtitle%3DCurr.%2520Opin.%2520Neurol.%26date%3D2011%26volume%3D24%26spage%3D106%26epage%3D113%26doi%3D10.1097%2FWCO.0b013e32834451c4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Ishii, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wataya-Kaneda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canuet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, M.</span><span> </span><span class="NLM_article-title">Everolimus improves behavioral deficits in a patient with autism associated with tuberous sclerosis: a case report</span> <span class="citation_source-journal">Neuropsychiatric Electrophysiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="refDoi"> DOI: 10.1186/s40810-015-0004-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2Fs40810-015-0004-x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=6&author=R.+Ishiiauthor=M.+Wataya-Kanedaauthor=L.+Canuetauthor=N.+Nonomuraauthor=Y.+Nakaiauthor=M.+Takeda&title=Everolimus+improves+behavioral+deficits+in+a+patient+with+autism+associated+with+tuberous+sclerosis%3A+a+case+report&doi=10.1186%2Fs40810-015-0004-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1186%2Fs40810-015-0004-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40810-015-0004-x%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DR.%26aulast%3DWataya-Kaneda%26aufirst%3DM.%26aulast%3DCanuet%26aufirst%3DL.%26aulast%3DNonomura%26aufirst%3DN.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DM.%26atitle%3DEverolimus%2520improves%2520behavioral%2520deficits%2520in%2520a%2520patient%2520with%2520autism%2520associated%2520with%2520tuberous%2520sclerosis%253A%2520a%2520case%2520report%26jtitle%3DNeuropsychiatric%2520Electrophysiology%26date%3D2015%26volume%3D1%26spage%3D6%26doi%3D10.1186%2Fs40810-015-0004-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Huber, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa-Mattioli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zukin, R. S.</span><span> </span><span class="NLM_article-title">Dysregulation of mammalian target of rapamycin signaling in mouse models of autism</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">13836</span><span class="NLM_x">–</span> <span class="NLM_lpage">13842</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.2656-15.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1523%2FJNEUROSCI.2656-15.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26468183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVymsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=13836-13842&author=K.+M.+Huberauthor=E.+Klannauthor=M.+Costa-Mattioliauthor=R.+S.+Zukin&title=Dysregulation+of+mammalian+target+of+rapamycin+signaling+in+mouse+models+of+autism&doi=10.1523%2FJNEUROSCI.2656-15.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Dysregulation of mammalian target of rapamycin signaling in mouse models of autism</span></div><div class="casAuthors">Huber, Kimberly M.; Klann, Eric; Costa-Mattioli, Mauro; Zukin, R. Suzanne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">13836-13842</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The mammalian target of rapamycin (mTOR) is a central regulator of a diverse array of cellular processes, including cell growth, proliferation, autophagy, translation, and actin polymn.  Components of the mTOR cascade are present at synapses and influence synaptic plasticity and spine morphogenesis.  A prevailing view is that the study of mTOR and its role in autism spectrum disorders (ASDs) will elucidate the mol. mechanisms by which mTOR regulates neuronal function under physiol. and pathol. conditions.  Although many ASDs arise as a result of mutations in genes with multiple mol. functions, they appear to converge on common biol. pathways that give rise to autism-relevant behaviors.  Dysregulation of mTOR signaling has been identified as a phenotypic feature common to fragile X syndrome, tuberous sclerosis complex 1 and 2, neurofibromatosis 1, phosphatase and tensin homolog, and potentially Rett syndrome.  Below are a summary of topics covered in a symposium that presents dysregulation of mTOR as a unifying theme in a subset of ASDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcajpQX5LkC7Vg90H21EOLACvtfcHk0lixVdbuOpK-lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVymsLw%253D&md5=09a8e749ff56d8f439f766356087676b</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2656-15.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2656-15.2015%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DK.%2BM.%26aulast%3DKlann%26aufirst%3DE.%26aulast%3DCosta-Mattioli%26aufirst%3DM.%26aulast%3DZukin%26aufirst%3DR.%2BS.%26atitle%3DDysregulation%2520of%2520mammalian%2520target%2520of%2520rapamycin%2520signaling%2520in%2520mouse%2520models%2520of%2520autism%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D13836%26epage%3D13842%26doi%3D10.1523%2FJNEUROSCI.2656-15.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Crino, P. B.</span><span> </span><span class="NLM_article-title">Evolving neurobiology of tuberous sclerosis complex</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span><span class="refDoi"> DOI: 10.1007/s00401-013-1085-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs00401-013-1085-x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2013&pages=317-332&author=P.+B.+Crino&title=Evolving+neurobiology+of+tuberous+sclerosis+complex&doi=10.1007%2Fs00401-013-1085-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1007%2Fs00401-013-1085-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-013-1085-x%26sid%3Dliteratum%253Aachs%26aulast%3DCrino%26aufirst%3DP.%2BB.%26atitle%3DEvolving%2520neurobiology%2520of%2520tuberous%2520sclerosis%2520complex%26jtitle%3DActa%2520Neuropathol.%26date%3D2013%26volume%3D125%26spage%3D317%26epage%3D332%26doi%3D10.1007%2Fs00401-013-1085-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Burket, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutsch, S. I.</span><span> </span><span class="NLM_article-title">Rapamycin improves sociability in the BTBR T+Itpr3tf/J mouse model of autism spectrum disorders</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span><span class="refDoi"> DOI: 10.1016/j.brainresbull.2013.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.brainresbull.2013.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24295733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisl2gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2014&pages=70-75&author=J.+A.+Burketauthor=A.+D.+Bensonauthor=A.+H.+Tangauthor=S.+I.+Deutsch&title=Rapamycin+improves+sociability+in+the+BTBR+T%2BItpr3tf%2FJ+mouse+model+of+autism+spectrum+disorders&doi=10.1016%2Fj.brainresbull.2013.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Rapamycin improves sociability in the BTBR T+Itpr3tf/J mouse model of autism spectrum disorders</span></div><div class="casAuthors">Burket, Jessica A.; Benson, Andrew D.; Tang, Amy H.; Deutsch, Stephen I.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">70-75</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Overactivation of the mammalian target of rapamycin (mTOR) has been implicated in the pathogenesis of syndromic forms of autism spectrum disorders (ASDs), such as tuberous sclerosis complex, neurofibromatosis 1, and fragile X syndrome.  Administration of mTORC1 (mTOR complex 1) inhibitors (e.g. rapamycin) in syndromic mouse models of ASDs improved behavior, cognition, and neuropathol.  However, since only a minority of ASDs are due to the effects of single genes (∼10%), there is a need to explore inhibition of mTOR activity in mouse models that may be more relevant to the majority of nonsyndromic presentations, such as the genetically inbred BTBR T+Itpr3tf/J (BTBR) mouse model of ASDs.  BTBR mice have social impairment and exhibit increased stereotypic behavior.  In prior work, D-cycloserine, a partial glycineB site agonist that targets the N-methyl-D-aspartate (NMDA) receptor, was shown to improve sociability in both Balb/c and BTBR mouse models of ASDs.  Importantly, NMDA receptor activation regulates mTOR signaling activity.  The current study investigated the ability of rapamycin (10 mg/kg, i.p. × four days), an mTORC1 inhibitor, to improve sociability and stereotypic behavior in BTBR mice.  Using a std. paradigm to assess mouse social behavior, rapamycin improved several measures of sociability in the BTBR mouse, suggesting that mTOR overactivation represents a therapeutic target that mediates or contributes to impaired sociability in the BTBR mouse model of ASDs.  Interestingly, there was no effect of rapamycin on stereotypic behaviors in this mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHmDEzsomCL7Vg90H21EOLACvtfcHk0lixVdbuOpK-lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisl2gsQ%253D%253D&md5=47bb7d9c6dddd184aa56554ad5f8a190</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresbull.2013.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresbull.2013.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DBurket%26aufirst%3DJ.%2BA.%26aulast%3DBenson%26aufirst%3DA.%2BD.%26aulast%3DTang%26aufirst%3DA.%2BH.%26aulast%3DDeutsch%26aufirst%3DS.%2BI.%26atitle%3DRapamycin%2520improves%2520sociability%2520in%2520the%2520BTBR%2520T%252BItpr3tf%252FJ%2520mouse%2520model%2520of%2520autism%2520spectrum%2520disorders%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2014%26volume%3D100%26spage%3D70%26epage%3D75%26doi%3D10.1016%2Fj.brainresbull.2013.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Tang, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingras, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonenberg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuman, E. M.</span><span> </span><span class="NLM_article-title">A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span><span class="refDoi"> DOI: 10.1073/pnas.012605299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.012605299" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=467-472&author=S.+J.+Tangauthor=G.+Reisauthor=H.+Kangauthor=A.+C.+Gingrasauthor=N.+Sonenbergauthor=E.+M.+Schuman&title=A+rapamycin-sensitive+signaling+pathway+contributes+to+long-term+synaptic+plasticity+in+the+hippocampus&doi=10.1073%2Fpnas.012605299"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1073%2Fpnas.012605299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.012605299%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DS.%2BJ.%26aulast%3DReis%26aufirst%3DG.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DGingras%26aufirst%3DA.%2BC.%26aulast%3DSonenberg%26aufirst%3DN.%26aulast%3DSchuman%26aufirst%3DE.%2BM.%26atitle%3DA%2520rapamycin-sensitive%2520signaling%2520pathway%2520contributes%2520to%2520long-term%2520synaptic%2520plasticity%2520in%2520the%2520hippocampus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D467%26epage%3D472%26doi%3D10.1073%2Fpnas.012605299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Krueger, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Care, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agricola, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangeshkar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byars, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahmoud, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franz, D. N.</span><span> </span><span class="NLM_article-title">Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1801</span><span class="NLM_x">–</span> <span class="NLM_lpage">1811</span><span class="refDoi"> DOI: 10.1056/NEJMoa1001671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1056%2FNEJMoa1001671" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21047224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2gsbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1801-1811&author=D.+A.+Kruegerauthor=M.+M.+Careauthor=K.+Hollandauthor=K.+Agricolaauthor=C.+Tudorauthor=P.+Mangeshkarauthor=K.+A.+Wilsonauthor=A.+Byarsauthor=T.+Sahmoudauthor=D.+N.+Franz&title=Everolimus+for+subependymal+giant-cell+astrocytomas+in+tuberous+sclerosis&doi=10.1056%2FNEJMoa1001671"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis</span></div><div class="casAuthors">Krueger, Darcy A.; Care, Marguerite M.; Holland, Katherine; Agricola, Karen; Tudor, Cynthia; Mangeshkar, Prajakta; Wilson, Kimberly A.; Byars, Anna; Sahmoud, Tarek; Franz, David Neal</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1801-1811</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Neurosurgical resection is the std. treatment for subependymal giant-cell astrocytomas in patients with the tuberous sclerosis complex.  An alternative may be the use of everolimus, which inhibits the mammalian target of rapamycin, a protein regulated by gene products involved in the tuberous sclerosis complex.  METHODS: Patients 3 years of age or older with serial growth of subependymal giant-cell astrocytomas were eligible for this open-label study.  The primary efficacy end point was the change in vol. of subependymal giant-cell astrocytomas between baseline and 6 mo.  We gave everolimus orally, at a dose of 3.0 mg per square meter of body-surface area, to achieve a trough concn. of 5 to 15 ng per mL.  RESULTS: We enrolled 28 patients.  Everolimus therapy was assocd. with a clin. meaningful redn. in vol. of the primary subependymal giant-cell astrocytoma, as assessed on independent central review (P < 0.001 for baseline vs. 6 mo), with a redn. of at least 30% in 21 patients (75%) and at least 50% in 9 patients (32%).  Marked redns. were seen within 3 mo and were sustained.  There were no new lesions, worsening hydrocephalus, evidence of increased intracranial pressure, or necessity for surgical resection or other therapy for subependymal giant-cell astrocytoma.  Of the 16 patients for whom 24-h video electroencephalog. data were available, seizure frequency for the 6-mo study period (vs. the previous 6-mo period) decreased in 9, did not change in 6, and increased in 1 (median change, -1 seizure; P = 0.02).  The mean (± SD) score on the validated Quality-of-Life in Childhood Epilepsy questionnaire (on which scores can range from 0 to 100, with higher scores indicating a better quality of life) was improved at 3 mo (63.4 ± 12.4) and 6 mo (62.1 ± 14.2) over the baseline score (57.8 ± 14.0).  Single cases of grade 3 treatment-related sinusitis, pneumonia, viral bronchitis, tooth infection, stomatitis, and leukopenia were reported.  CONCLUSIONS: Everolimus therapy was assocd. with marked redn. in the vol. of subependymal giant-cell astrocytomas and seizure frequency and may be a potential alternative to neurosurgical resection in some cases, though long-term studies are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzwPOsvrgvibVg90H21EOLACvtfcHk0ljx3QORPGfscg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2gsbbP&md5=b2a5b8128167c750fc4f9a8c8d188bcb</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1001671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1001671%26sid%3Dliteratum%253Aachs%26aulast%3DKrueger%26aufirst%3DD.%2BA.%26aulast%3DCare%26aufirst%3DM.%2BM.%26aulast%3DHolland%26aufirst%3DK.%26aulast%3DAgricola%26aufirst%3DK.%26aulast%3DTudor%26aufirst%3DC.%26aulast%3DMangeshkar%26aufirst%3DP.%26aulast%3DWilson%26aufirst%3DK.%2BA.%26aulast%3DByars%26aufirst%3DA.%26aulast%3DSahmoud%26aufirst%3DT.%26aulast%3DFranz%26aufirst%3DD.%2BN.%26atitle%3DEverolimus%2520for%2520subependymal%2520giant-cell%2520astrocytomas%2520in%2520tuberous%2520sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D1801%26epage%3D1811%26doi%3D10.1056%2FNEJMoa1001671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Heffron, T. P.</span><span> </span><span class="NLM_article-title">Small molecule kinase inhibitors for the treatment of brain cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">10030</span><span class="NLM_x">–</span> <span class="NLM_lpage">10066</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00618</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00618" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOjt77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10030-10066&author=T.+P.+Heffron&title=Small+molecule+kinase+inhibitors+for+the+treatment+of+brain+cancer&doi=10.1021%2Facs.jmedchem.6b00618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer</span></div><div class="casAuthors">Heffron, Timothy P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10030-10066</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In addn. to each of the factors that govern the identification of a successful oncol. drug candidate, drug discovery aimed at treating neurol. cancer must also consider the presence of the blood-brain barrier (BBB).  The high level of expression of efflux transporters (e.g., P-glycoprotein (P-gp) and breast cancer resistance protein (Bcrp)) at the BBB limits many small mols. from freely reaching the brain, where neurooncol. malignancies reside.  Furthermore, many of the targets identified for the potential treatment of central nervous system (CNS) malignancies suggest that kinase inhibitors, capable of penetrating the BBB to reach their target, would be desirable.  This Perspective discusses the unmet need for neurooncol. treatments, the appeal of kinase targets in this space, and a summary of what is known about free brain penetration of clin. inhibitors of kinases that are of interest for the treatment of brain cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqij86WIpk16LVg90H21EOLACvtfcHk0ljx3QORPGfscg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOjt77E&md5=7e184f17a60658174cb44a9fbadc8dfd</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00618%26sid%3Dliteratum%253Aachs%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26atitle%3DSmall%2520molecule%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520brain%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10030%26epage%3D10066%26doi%3D10.1021%2Facs.jmedchem.6b00618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Fernandez, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres-Alemán, I.</span><span> </span><span class="NLM_article-title">The many faces of insulin-like peptide signalling in the brain</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span><span class="refDoi"> DOI: 10.1038/nrn3209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnrn3209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22430016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=225-239&author=A.+M.+Fernandezauthor=I.+Torres-Alem%C3%A1n&title=The+many+faces+of+insulin-like+peptide+signalling+in+the+brain&doi=10.1038%2Fnrn3209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The many faces of insulin-like peptide signalling in the brain</span></div><div class="casAuthors">Fernandez, Ana M.; Torres-Aleman, Ignacio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">225-239</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Central and peripheral insulin-like peptides (ILPs), which include insulin, insulin-like growth factor 1 (IGF1) and IGF2, exert many effects in the brain.  Through their actions on brain growth and differentiation, ILPs contribute to building circuitries that subserve metabolic and behavioral adaptation to internal and external cues of energy availability.  In the adult brain each ILP has distinct effects, but together their actions ultimately regulate energy homeostasis - they affect nutrient sensing and regulate neuronal plasticity to modulate adaptive behaviors involved in food seeking, including high-level cognitive operations such as spatial memory.  In essence, the multifaceted activity of ILPs in the brain may be viewed as a system organization involved in the control of energy allocation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6fJj_fCXjlbVg90H21EOLACvtfcHk0ljx3QORPGfscg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSgtr0%253D&md5=e366462795185094b8da0e7c6f8713ec</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1038%2Fnrn3209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3209%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DA.%2BM.%26aulast%3DTorres-Alem%25C3%25A1n%26aufirst%3DI.%26atitle%3DThe%2520many%2520faces%2520of%2520insulin-like%2520peptide%2520signalling%2520in%2520the%2520brain%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2012%26volume%3D13%26spage%3D225%26epage%3D239%26doi%3D10.1038%2Fnrn3209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Dyer, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vahdatpour, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanfeliu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropea, D.</span><span> </span><span class="NLM_article-title">The role of insulin-like growth factor 1 (IGF-1) in brain development, maturation and neuroplasticity</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2016.03.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuroscience.2016.03.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27038749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVWms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2016&pages=89-99&author=A.+H.+Dyerauthor=C.+Vahdatpourauthor=A.+Sanfeliuauthor=D.+Tropea&title=The+role+of+insulin-like+growth+factor+1+%28IGF-1%29+in+brain+development%2C+maturation+and+neuroplasticity&doi=10.1016%2Fj.neuroscience.2016.03.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Insulin-Like Growth Factor 1 (IGF-1) in brain development, maturation and neuroplasticity</span></div><div class="casAuthors">Dyer, Adam H.; Vahdatpour, Cyrus; Sanfeliu, Albert; Tropea, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-99</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Insulin-Like Growth Factor 1 (IGF-1) is a phylogenetically ancient neurotrophic hormone with crucial roles to play in CNS development and maturation.  Recently, IGF-1 has been shown to have potent effects on cellular neuroplasticity.  Neuroplasticty refers to the adaptive changes made by the CNS in the face of changing functional demands and is crucial in processes such as learning and memory.  IGF-1, signaling through its glycoprotein receptor (IGF-1R), and canonical signaling pathways such as the PI3K-Akt and Ras-Raf-MAP pathways, has potent effects on cellular neuroplasticity in the CNS.  In the present review, the role of IGF-1 in brain development is reviewed, followed by a detailed discussion of the role played by IGF in cellular neuroplasticity in the CNS.  Findings from models of perturbed and reparative plasticity detailing the role played by IGF-1 are discussed, followed by the electrophysiol., structural and functional evidence supporting this role.  Finally, the post-lesion and post-injury roles played by IGF-1 are briefly evaluated.  We discuss the putative neurobiol. underlying these changes, reviewing recent evidence and highlighting areas for further research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlsJxC9wkq7Vg90H21EOLACvtfcHk0lhwT1FcZue3qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVWms7o%253D&md5=7782581e29f0d47fff9c7a8b899ad212</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2016.03.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2016.03.056%26sid%3Dliteratum%253Aachs%26aulast%3DDyer%26aufirst%3DA.%2BH.%26aulast%3DVahdatpour%26aufirst%3DC.%26aulast%3DSanfeliu%26aufirst%3DA.%26aulast%3DTropea%26aufirst%3DD.%26atitle%3DThe%2520role%2520of%2520insulin-like%2520growth%2520factor%25201%2520%2528IGF-1%2529%2520in%2520brain%2520development%252C%2520maturation%2520and%2520neuroplasticity%26jtitle%3DNeuroscience%26date%3D2016%26volume%3D325%26spage%3D89%26epage%3D99%26doi%3D10.1016%2Fj.neuroscience.2016.03.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Cheng, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mervis, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salem, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witters, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondy, C. A.</span><span> </span><span class="NLM_article-title">Insulin-like growth factor 1 is essential for normal dendritic growth</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1002/jnr.10634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2Fjnr.10634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=12815703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltlSqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2003&pages=1-9&author=C.+M.+Chengauthor=R.+F.+Mervisauthor=S.+L.+Niuauthor=N.+Salemauthor=L.+A.+Wittersauthor=V.+Tsengauthor=R.+Reinhardtauthor=C.+A.+Bondy&title=Insulin-like+growth+factor+1+is+essential+for+normal+dendritic+growth&doi=10.1002%2Fjnr.10634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin-like growth factor 1 is essential for normal dendritic growth</span></div><div class="casAuthors">Cheng, Clara M.; Mervis, Ronald F.; Niu, Shui-Lin; Salem, Norman, Jr.; Witters, Lee A.; Tseng, Victor; Reinhardt, Rickey; Bondy, Carolyn A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">This study evaluated somatic and dendritic growth of neurons in the frontoparietal cortex of lgf1-/- brains.  Pyramidal neuron d. was increased by ∼25% and soma size reduced by ∼10%.  Golgi staining revealed that cortical layer II-III neurons exhibited a significant redn. in dendritic length and complexity in lgf1 null mice.  Dendritic spine d. and presumably synaptic contacts were reduced by 16%.  Similar findings were obtained for cortical layer V and piriform cortex pyramids.  Supporting a redn. in synapses, synaptotagmin levels were reduced by 30% in the lgf1 null brain.  Investigation of factors critically involved in dendritic growth and synaptogenesis showed an ∼50% redn. in cortical CDC42 protein expression and an ∼10% redn. in brain cholesterol levels in lgf1 null mice.  Evidence is presented that lgf1 deletion causes disruptions in lipid and microtubule metab., leading to impaired neuronal somatic and dendritic growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Smtu04QuHLVg90H21EOLACvtfcHk0lhwT1FcZue3qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltlSqtrk%253D&md5=e58b5c2a6e9ad20038c54fa6733c1bd2</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1002%2Fjnr.10634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.10634%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DC.%2BM.%26aulast%3DMervis%26aufirst%3DR.%2BF.%26aulast%3DNiu%26aufirst%3DS.%2BL.%26aulast%3DSalem%26aufirst%3DN.%26aulast%3DWitters%26aufirst%3DL.%2BA.%26aulast%3DTseng%26aufirst%3DV.%26aulast%3DReinhardt%26aufirst%3DR.%26aulast%3DBondy%26aufirst%3DC.%2BA.%26atitle%3DInsulin-like%2520growth%2520factor%25201%2520is%2520essential%2520for%2520normal%2520dendritic%2520growth%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2003%26volume%3D73%26spage%3D1%26epage%3D9%26doi%3D10.1002%2Fjnr.10634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Baker, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batchelor, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafiee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, J.</span><span> </span><span class="NLM_article-title">Central penetration and stability of N-terminal tripeptide of insulin-like growth factor-I, glycine-proline-glutamate in adult rat</span> <span class="citation_source-journal">Neuropeptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1016/j.npep.2004.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.npep.2004.11.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2005&pages=81-87&author=A.+M.+Bakerauthor=D.+C.+Batchelorauthor=G.+B.+Thomasauthor=J.+Y.+Wenauthor=M.+Rafieeauthor=H.+Linauthor=J.+Guan&title=Central+penetration+and+stability+of+N-terminal+tripeptide+of+insulin-like+growth+factor-I%2C+glycine-proline-glutamate+in+adult+rat&doi=10.1016%2Fj.npep.2004.11.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.npep.2004.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.npep.2004.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DA.%2BM.%26aulast%3DBatchelor%26aufirst%3DD.%2BC.%26aulast%3DThomas%26aufirst%3DG.%2BB.%26aulast%3DWen%26aufirst%3DJ.%2BY.%26aulast%3DRafiee%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DGuan%26aufirst%3DJ.%26atitle%3DCentral%2520penetration%2520and%2520stability%2520of%2520N-terminal%2520tripeptide%2520of%2520insulin-like%2520growth%2520factor-I%252C%2520glycine-proline-glutamate%2520in%2520adult%2520rat%26jtitle%3DNeuropeptides%26date%3D2005%26volume%3D39%26spage%3D81%26epage%3D87%26doi%3D10.1016%2Fj.npep.2004.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Corvin, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Little, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donohoe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropea, D.</span><span> </span><span class="NLM_article-title">Insulin-like growth factor 1 (IGF1) and its active peptide (1–3)IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">520</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/j.neulet.2012.05.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neulet.2012.05.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=520&publication_year=2012&pages=51-56&author=A.+P.+Corvinauthor=I.+Molinosauthor=G.+Littleauthor=G.+Donohoeauthor=M.+Gillauthor=D.+W.+Morrisauthor=D.+Tropea&title=Insulin-like+growth+factor+1+%28IGF1%29+and+its+active+peptide+%281%E2%80%933%29IGF1+enhance+the+expression+of+synaptic+markers+in+neuronal+circuits+through+different+cellular+mechanisms&doi=10.1016%2Fj.neulet.2012.05.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2012.05.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2012.05.029%26sid%3Dliteratum%253Aachs%26aulast%3DCorvin%26aufirst%3DA.%2BP.%26aulast%3DMolinos%26aufirst%3DI.%26aulast%3DLittle%26aufirst%3DG.%26aulast%3DDonohoe%26aufirst%3DG.%26aulast%3DGill%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DD.%2BW.%26aulast%3DTropea%26aufirst%3DD.%26atitle%3DInsulin-like%2520growth%2520factor%25201%2520%2528IGF1%2529%2520and%2520its%2520active%2520peptide%2520%25281%25E2%2580%25933%2529IGF1%2520enhance%2520the%2520expression%2520of%2520synaptic%2520markers%2520in%2520neuronal%2520circuits%2520through%2520different%2520cellular%2520mechanisms%26jtitle%3DNeurosci.%2520Lett.%26date%3D2012%26volume%3D520%26spage%3D51%26epage%3D56%26doi%3D10.1016%2Fj.neulet.2012.05.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Tropea, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacometti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flannery, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaenisch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, M.</span><span> </span><span class="NLM_article-title">Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">2029</span><span class="NLM_x">–</span> <span class="NLM_lpage">2034</span><span class="refDoi"> DOI: 10.1073/pnas.0812394106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.0812394106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=2029-2034&author=D.+Tropeaauthor=E.+Giacomettiauthor=N.+R.+Wilsonauthor=C.+Beardauthor=C.+McCurryauthor=D.+D.+Fuauthor=R.+Flanneryauthor=R.+Jaenischauthor=M.+Sur&title=Partial+reversal+of+Rett+syndrome-like+symptoms+in+MeCP2+mutant+mice&doi=10.1073%2Fpnas.0812394106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0812394106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0812394106%26sid%3Dliteratum%253Aachs%26aulast%3DTropea%26aufirst%3DD.%26aulast%3DGiacometti%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DN.%2BR.%26aulast%3DBeard%26aufirst%3DC.%26aulast%3DMcCurry%26aufirst%3DC.%26aulast%3DFu%26aufirst%3DD.%2BD.%26aulast%3DFlannery%26aufirst%3DR.%26aulast%3DJaenisch%26aufirst%3DR.%26aulast%3DSur%26aufirst%3DM.%26atitle%3DPartial%2520reversal%2520of%2520Rett%2520syndrome-like%2520symptoms%2520in%2520MeCP2%2520mutant%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D2029%26epage%3D2034%26doi%3D10.1073%2Fpnas.0812394106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Castro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwok, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petravicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellios, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropea, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, M.</span><span> </span><span class="NLM_article-title">Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">9941</span><span class="NLM_x">–</span> <span class="NLM_lpage">9946</span><span class="refDoi"> DOI: 10.1073/pnas.1311685111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.1311685111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=9941-9946&author=J.+Castroauthor=R.+I.+Garciaauthor=S.+Kwokauthor=A.+Banerjeeauthor=J.+Petraviczauthor=J.+Woodsonauthor=N.+Melliosauthor=D.+Tropeaauthor=M.+Sur&title=Functional+recovery+with+recombinant+human+IGF1+treatment+in+a+mouse+model+of+Rett+Syndrome&doi=10.1073%2Fpnas.1311685111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1311685111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1311685111%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DJ.%26aulast%3DGarcia%26aufirst%3DR.%2BI.%26aulast%3DKwok%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DPetravicz%26aufirst%3DJ.%26aulast%3DWoodson%26aufirst%3DJ.%26aulast%3DMellios%26aufirst%3DN.%26aulast%3DTropea%26aufirst%3DD.%26aulast%3DSur%26aufirst%3DM.%26atitle%3DFunctional%2520recovery%2520with%2520recombinant%2520human%2520IGF1%2520treatment%2520in%2520a%2520mouse%2520model%2520of%2520Rett%2520Syndrome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D9941%26epage%3D9946%26doi%3D10.1073%2Fpnas.1311685111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Deacon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snape, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altimiras, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biekofsky, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogram, P.</span><span> </span><span class="NLM_article-title">NNZ-2566, a novel analog of (1–3) IGF-1, as a potential therapeutic agent for fragile X syndrome</span> <span class="citation_source-journal">NeuroMol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1007/s12017-015-8341-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs12017-015-8341-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25613838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=71-82&author=R.+M.+Deaconauthor=L.+Glassauthor=M.+Snapeauthor=M.+J.+Hurleyauthor=F.+J.+Altimirasauthor=R.+R.+Biekofskyauthor=P.+Cogram&title=NNZ-2566%2C+a+novel+analog+of+%281%E2%80%933%29+IGF-1%2C+as+a+potential+therapeutic+agent+for+fragile+X+syndrome&doi=10.1007%2Fs12017-015-8341-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">NNZ-2566, a Novel Analog of (1-3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome</span></div><div class="casAuthors">Deacon, Robert M. J.; Glass, Larry; Snape, Mike; Hurley, Michael J.; Altimiras, Francisco J.; Biekofsky, Rodolfo R.; Cogram, Patricia</div><div class="citationInfo"><span class="NLM_cas:title">NeuroMolecular Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-82</span>CODEN:
                <span class="NLM_cas:coden">NMEEAN</span>;
        ISSN:<span class="NLM_cas:issn">1535-1084</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Fragile X syndrome (FXS) is the most common form of inherited intellectual disability.  Previous studies have implicated mGlu5 in the pathogenesis of the disease, and many agents that target the underlying pathophysiol. of FXS have focused on mGluR5 modulation.  In the present work, a novel pharmacol. approach for FXS is investigated.  NNZ-2566, a synthetic analog of a naturally occurring neurotrophic peptide derived from insulin-like growth factor-1 (IGF-1), was administered to fmr1 knockout mice correcting learning and memory deficits, abnormal hyperactivity and social interaction, normalizing aberrant dendritic spine d., overactive ERK and Akt signaling, and macroorchidism.  Altogether, our results indicate a unique disease-modifying potential for NNZ-2566 in FXS.  Most importantly, the present data implicate the IGF-1 mol. pathway in the pathogenesis of FXS.  A clin. trial is under way to ascertain whether these findings translate into clin. effects in FXS patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW2rxzSbk-77Vg90H21EOLACvtfcHk0lgF9vvyQRsRTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsbs%253D&md5=fca3c173927ac34c66039ab0df9ac111</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1007%2Fs12017-015-8341-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12017-015-8341-2%26sid%3Dliteratum%253Aachs%26aulast%3DDeacon%26aufirst%3DR.%2BM.%26aulast%3DGlass%26aufirst%3DL.%26aulast%3DSnape%26aufirst%3DM.%26aulast%3DHurley%26aufirst%3DM.%2BJ.%26aulast%3DAltimiras%26aufirst%3DF.%2BJ.%26aulast%3DBiekofsky%26aufirst%3DR.%2BR.%26aulast%3DCogram%26aufirst%3DP.%26atitle%3DNNZ-2566%252C%2520a%2520novel%2520analog%2520of%2520%25281%25E2%2580%25933%2529%2520IGF-1%252C%2520as%2520a%2520potential%2520therapeutic%2520agent%2520for%2520fragile%2520X%2520syndrome%26jtitle%3DNeuroMol.%2520Med.%26date%3D2015%26volume%3D17%26spage%3D71%26epage%3D82%26doi%3D10.1007%2Fs12017-015-8341-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Marchetto, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belinson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freitas, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vadodaria, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beltrao-Braga, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trujillo, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes, A. P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanabhan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunez, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennand, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichenfield, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pramparo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyler, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courchesne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwind, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynshaw-Boris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muotri, A. R.</span><span> </span><span class="NLM_article-title">Altered proliferation and networks in neural cells derived from idiopathic autistic individuals</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">820</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span><span class="refDoi"> DOI: 10.1038/mp.2016.95</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fmp.2016.95" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27378147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFegtb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=820-835&author=M.+C.+Marchettoauthor=H.+Belinsonauthor=Y.+Tianauthor=B.+C.+Freitasauthor=C.+Fuauthor=K.+C.+Vadodariaauthor=P.+C.+Beltrao-Bragaauthor=C.+A.+Trujilloauthor=A.+P.+D.+Mendesauthor=K.+Padmanabhanauthor=Y.+Nunezauthor=J.+Ouauthor=H.+Ghoshauthor=R.+Wrightauthor=K.+J.+Brennandauthor=K.+Pierceauthor=L.+Eichenfieldauthor=T.+Pramparoauthor=L.+T.+Eylerauthor=C.+C.+Barnesauthor=E.+Courchesneauthor=D.+H.+Geschwindauthor=F.+H.+Gageauthor=A.+Wynshaw-Borisauthor=A.+R.+Muotri&title=Altered+proliferation+and+networks+in+neural+cells+derived+from+idiopathic+autistic+individuals&doi=10.1038%2Fmp.2016.95"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Altered proliferation and networks in neural cells derived from idiopathic autistic individuals</span></div><div class="casAuthors">Marchetto, M. C.; Belinson, H.; Tian, Y.; Freitas, B. C.; Fu, C.; Vadodaria, K. C.; Beltrao-Braga, P. C.; Trujillo, C. A.; Mendes, A. P. D.; Padmanabhan, K.; Nunez, Y.; Ou, J.; Ghosh, H.; Wright, R.; Brennand, K. J.; Pierce, K.; Eichenfield, L.; Pramparo, T.; Eyler, L. T.; Barnes, C. C.; Courchesne, E.; Geschwind, D. H.; Gage, F. H.; Wynshaw-Boris, A.; Muotri, A. R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">820-835</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autism spectrum disorders (ASD) are common, complex and heterogeneous neurodevelopmental disorders.  Cellular and mol. mechanisms responsible for ASD pathogenesis have been proposed based on genetic studies, brain pathol. and imaging, but a major impediment to testing ASD hypotheses is the lack of human cell models.  Here, we reprogrammed fibroblasts to generate induced pluripotent stem cells, neural progenitor cells (NPCs) and neurons from ASD individuals with early brain overgrowth and non-ASD controls with normal brain size.  ASD-derived NPCs display increased cell proliferation because of dysregulation of a β-catenin/BRN2 transcriptional cascade.  ASD-derived neurons display abnormal neurogenesis and reduced synaptogenesis leading to functional defects in neuronal networks.  Interestingly, defects in neuronal networks could be rescued by insulin growth factor 1 (IGF-1), a drug that is currently in clin. trials for ASD.  This work demonstrates that selection of ASD subjects based on endophenotypes unraveled biol. relevant pathway disruption and revealed a potential cellular mechanism for the therapeutic effect of IGF-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYLRk4ASJ8RLVg90H21EOLACvtfcHk0lhEbKky-tbiJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFegtb3E&md5=42a09737de67b7018f37b4e52abd9406</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1038%2Fmp.2016.95&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2016.95%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetto%26aufirst%3DM.%2BC.%26aulast%3DBelinson%26aufirst%3DH.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DFreitas%26aufirst%3DB.%2BC.%26aulast%3DFu%26aufirst%3DC.%26aulast%3DVadodaria%26aufirst%3DK.%2BC.%26aulast%3DBeltrao-Braga%26aufirst%3DP.%2BC.%26aulast%3DTrujillo%26aufirst%3DC.%2BA.%26aulast%3DMendes%26aufirst%3DA.%2BP.%2BD.%26aulast%3DPadmanabhan%26aufirst%3DK.%26aulast%3DNunez%26aufirst%3DY.%26aulast%3DOu%26aufirst%3DJ.%26aulast%3DGhosh%26aufirst%3DH.%26aulast%3DWright%26aufirst%3DR.%26aulast%3DBrennand%26aufirst%3DK.%2BJ.%26aulast%3DPierce%26aufirst%3DK.%26aulast%3DEichenfield%26aufirst%3DL.%26aulast%3DPramparo%26aufirst%3DT.%26aulast%3DEyler%26aufirst%3DL.%2BT.%26aulast%3DBarnes%26aufirst%3DC.%2BC.%26aulast%3DCourchesne%26aufirst%3DE.%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26aulast%3DGage%26aufirst%3DF.%2BH.%26aulast%3DWynshaw-Boris%26aufirst%3DA.%26aulast%3DMuotri%26aufirst%3DA.%2BR.%26atitle%3DAltered%2520proliferation%2520and%2520networks%2520in%2520neural%2520cells%2520derived%2520from%2520idiopathic%2520autistic%2520individuals%26jtitle%3DMol.%2520Psychiatry%26date%3D2017%26volume%3D22%26spage%3D820%26epage%3D835%26doi%3D10.1038%2Fmp.2016.95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Durand, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betancur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckers, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaste, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauchereau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nygren, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillberg, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anckarsäter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sponheim, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goubran-Botros, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delorme, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabane, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouren-Simeoni, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Mas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogé, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Héron, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burglen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leboyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgeron, T.</span><span> </span><span class="NLM_article-title">Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span><span class="refDoi"> DOI: 10.1038/ng1933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fng1933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=17173049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD28jlsF2ntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=25-27&author=C.+M.+Durandauthor=C.+Betancurauthor=T.+M.+Boeckersauthor=J.+Bockmannauthor=P.+Chasteauthor=F.+Fauchereauauthor=G.+Nygrenauthor=M.+Rastamauthor=I.+C.+Gillbergauthor=H.+Anckars%C3%A4terauthor=E.+Sponheimauthor=H.+Goubran-Botrosauthor=R.+Delormeauthor=N.+Chabaneauthor=M.+C.+Mouren-Simeoniauthor=P.+de+Masauthor=E.+Biethauthor=B.+Rog%C3%A9author=D.+H%C3%A9ronauthor=L.+Burglenauthor=C.+Gillbergauthor=M.+Leboyerauthor=T.+Bourgeron&title=Mutations+in+the+gene+encoding+the+synaptic+scaffolding+protein+SHANK3+are+associated+with+autism+spectrum+disorders&doi=10.1038%2Fng1933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders</span></div><div class="casAuthors">Durand Christelle M; Betancur Catalina; Boeckers Tobias M; Bockmann Juergen; Chaste Pauline; Fauchereau Fabien; Nygren Gudrun; Rastam Maria; Gillberg I Carina; Anckarsater Henrik; Sponheim Eili; Goubran-Botros Hany; Delorme Richard; Chabane Nadia; Mouren-Simeoni Marie-Christine; de Mas Philippe; Bieth Eric; Roge Bernadette; Heron Delphine; Burglen Lydie; Gillberg Christopher; Leboyer Marion; Bourgeron Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-7</span>
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    </div><div class="casAbstract">SHANK3 (also known as ProSAP2) regulates the structural organization of dendritic spines and is a binding partner of neuroligins; genes encoding neuroligins are mutated in autism and Asperger syndrome.  Here, we report that a mutation of a single copy of SHANK3 on chromosome 22q13 can result in language and/or social communication disorders.  These mutations concern only a small number of individuals, but they shed light on one gene dosage-sensitive synaptic pathway that is involved in autism spectrum disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHWugWFFBYm70AGQpJZWpJfW6udTcc2eaMSgQdDqcz9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jlsF2ntw%253D%253D&md5=47996cb8244d84634d201931f3a9ab43</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1038%2Fng1933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1933%26sid%3Dliteratum%253Aachs%26aulast%3DDurand%26aufirst%3DC.%2BM.%26aulast%3DBetancur%26aufirst%3DC.%26aulast%3DBoeckers%26aufirst%3DT.%2BM.%26aulast%3DBockmann%26aufirst%3DJ.%26aulast%3DChaste%26aufirst%3DP.%26aulast%3DFauchereau%26aufirst%3DF.%26aulast%3DNygren%26aufirst%3DG.%26aulast%3DRastam%26aufirst%3DM.%26aulast%3DGillberg%26aufirst%3DI.%2BC.%26aulast%3DAnckars%25C3%25A4ter%26aufirst%3DH.%26aulast%3DSponheim%26aufirst%3DE.%26aulast%3DGoubran-Botros%26aufirst%3DH.%26aulast%3DDelorme%26aufirst%3DR.%26aulast%3DChabane%26aufirst%3DN.%26aulast%3DMouren-Simeoni%26aufirst%3DM.%2BC.%26aulast%3Dde%2BMas%26aufirst%3DP.%26aulast%3DBieth%26aufirst%3DE.%26aulast%3DRog%25C3%25A9%26aufirst%3DB.%26aulast%3DH%25C3%25A9ron%26aufirst%3DD.%26aulast%3DBurglen%26aufirst%3DL.%26aulast%3DGillberg%26aufirst%3DC.%26aulast%3DLeboyer%26aufirst%3DM.%26aulast%3DBourgeron%26aufirst%3DT.%26atitle%3DMutations%2520in%2520the%2520gene%2520encoding%2520the%2520synaptic%2520scaffolding%2520protein%2520SHANK3%2520are%2520associated%2520with%2520autism%2520spectrum%2520disorders%26jtitle%3DNat.%2520Genet.%26date%3D2007%26volume%3D39%26spage%3D25%26epage%3D27%26doi%3D10.1038%2Fng1933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Phelan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saul, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stapleton, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweet, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claytor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, D. P.</span><span> </span><span class="NLM_article-title">22q13 deletion syndrome</span> <span class="citation_source-journal">Am. J. Med. Genet., Part A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1002/1096-8628(20010615)101:2<91::AID-AJMG1340>3.0.CO;2-C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2F1096-8628%2820010615%29101%3A2%3C91%3A%3AAID-AJMG1340%3E3.0.CO%3B2-C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2001&pages=91-99&author=M.+C.+Phelanauthor=R.+C.+Rogersauthor=R.+A.+Saulauthor=G.+A.+Stapletonauthor=K.+Sweetauthor=H.+McDermidauthor=S.+R.+Shawauthor=J.+Claytorauthor=J.+Willisauthor=D.+P.+Kelly&title=22q13+deletion+syndrome&doi=10.1002%2F1096-8628%2820010615%29101%3A2%3C91%3A%3AAID-AJMG1340%3E3.0.CO%3B2-C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1002%2F1096-8628%2820010615%29101%3A2%3C91%3A%3AAID-AJMG1340%3E3.0.CO%3B2-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1096-8628%252820010615%2529101%253A2%253C91%253A%253AAID-AJMG1340%253E3.0.CO%253B2-C%26sid%3Dliteratum%253Aachs%26aulast%3DPhelan%26aufirst%3DM.%2BC.%26aulast%3DRogers%26aufirst%3DR.%2BC.%26aulast%3DSaul%26aufirst%3DR.%2BA.%26aulast%3DStapleton%26aufirst%3DG.%2BA.%26aulast%3DSweet%26aufirst%3DK.%26aulast%3DMcDermid%26aufirst%3DH.%26aulast%3DShaw%26aufirst%3DS.%2BR.%26aulast%3DClaytor%26aufirst%3DJ.%26aulast%3DWillis%26aufirst%3DJ.%26aulast%3DKelly%26aufirst%3DD.%2BP.%26atitle%3D22q13%2520deletion%2520syndrome%26jtitle%3DAm.%2520J.%2520Med.%2520Genet.%252C%2520Part%2520A%26date%3D2001%26volume%3D101%26spage%3D91%26epage%3D99%26doi%3D10.1002%2F1096-8628%2820010615%29101%3A2%3C91%3A%3AAID-AJMG1340%3E3.0.CO%3B2-C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Sarowar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grabrucker, A. M.</span><span> </span><span class="NLM_article-title">Actin-dependent alterations of dendritic spine morphology in shankopathies</span> <span class="citation_source-journal">Neural Plast.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">2016</span><span class="NLM_x">, </span> <span class="NLM_fpage">8051861</span><span class="refDoi"> DOI: 10.1155/2016/8051861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1155%2F2016%2F8051861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27795858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2snhtFeqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=8051861&author=T.+Sarowarauthor=A.+M.+Grabrucker&title=Actin-dependent+alterations+of+dendritic+spine+morphology+in+shankopathies&doi=10.1155%2F2016%2F8051861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Actin-Dependent Alterations of Dendritic Spine Morphology in Shankopathies</span></div><div class="casAuthors">Sarowar Tasnuva; Grabrucker Andreas M</div><div class="citationInfo"><span class="NLM_cas:title">Neural plasticity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2016</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8051861</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Shank proteins (Shank1, Shank2, and Shank3) act as scaffolding molecules in the postsynaptic density of many excitatory neurons.  Mutations in SHANK genes, in particular SHANK2 and SHANK3, lead to autism spectrum disorders (ASD) in both human and mouse models.  Shank3 proteins are made of several domains-the Shank/ProSAP N-terminal (SPN) domain, ankyrin repeats, SH3 domain, PDZ domain, a proline-rich region, and the sterile alpha motif (SAM) domain.  Via various binding partners of these domains, Shank3 is able to bind and interact with a wide range of proteins including modulators of small GTPases such as RICH2, a RhoGAP protein, and βPIX, a RhoGEF protein for Rac1 and Cdc42, actin binding proteins and actin modulators.  Dysregulation of all isoforms of Shank proteins, but especially Shank3, leads to alterations in spine morphogenesis, shape, and activity of the synapse via altering actin dynamics.  Therefore, here, we highlight the role of Shank proteins as modulators of small GTPases and, ultimately, actin dynamics, as found in multiple in vitro and in vivo models.  The failure to mediate this regulatory role might present a shared mechanism in the pathophysiology of autism-associated mutations, which leads to dysregulation of spine morphogenesis and synaptic signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQQO0Kg4IryURLDWw4HIq2sfW6udTcc2eaMSgQdDqcz9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snhtFeqsw%253D%253D&md5=f45d0c671761a1900b699643f84c9b0e</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1155%2F2016%2F8051861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F8051861%26sid%3Dliteratum%253Aachs%26aulast%3DSarowar%26aufirst%3DT.%26aulast%3DGrabrucker%26aufirst%3DA.%2BM.%26atitle%3DActin-dependent%2520alterations%2520of%2520dendritic%2520spine%2520morphology%2520in%2520shankopathies%26jtitle%3DNeural%2520Plast.%26date%3D2016%26volume%3D2016%26spage%3D8051861%26doi%3D10.1155%2F2016%2F8051861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Naisbitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sala, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valtschanoff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worley, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, M.</span><span> </span><span class="NLM_article-title">Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span><span class="refDoi"> DOI: 10.1016/S0896-6273(00)80809-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0896-6273%2800%2980809-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=569-582&author=S.+Naisbittauthor=E.+Kimauthor=J.+C.+Tuauthor=B.+Xiaoauthor=C.+Salaauthor=J.+Valtschanoffauthor=R.+J.+Weinbergauthor=P.+F.+Worleyauthor=M.+Sheng&title=Shank%2C+a+novel+family+of+postsynaptic+density+proteins+that+binds+to+the+NMDA+receptor%2FPSD-95%2FGKAP+complex+and+cortactin&doi=10.1016%2FS0896-6273%2800%2980809-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980809-0%26sid%3Dliteratum%253Aachs%26aulast%3DNaisbitt%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DTu%26aufirst%3DJ.%2BC.%26aulast%3DXiao%26aufirst%3DB.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DValtschanoff%26aufirst%3DJ.%26aulast%3DWeinberg%26aufirst%3DR.%2BJ.%26aulast%3DWorley%26aufirst%3DP.%2BF.%26aulast%3DSheng%26aufirst%3DM.%26atitle%3DShank%252C%2520a%2520novel%2520family%2520of%2520postsynaptic%2520density%2520proteins%2520that%2520binds%2520to%2520the%2520NMDA%2520receptor%252FPSD-95%252FGKAP%2520complex%2520and%2520cortactin%26jtitle%3DNeuron%26date%3D1999%26volume%3D23%26spage%3D569%26epage%3D582%26doi%3D10.1016%2FS0896-6273%2800%2980809-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Bozdagi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavassoli, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buxbaum, J. D.</span><span> </span><span class="NLM_article-title">Insulin-like growth factor-1 rescues synaptic and motor deficits in mouse model of autism and developmental delay</span> <span class="citation_source-journal">Mol. Autism</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="refDoi"> DOI: 10.1186/2040-2392-4-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2F2040-2392-4-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=23621888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVSgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=9&author=O.+Bozdagiauthor=T.+Tavassoliauthor=J.+D.+Buxbaum&title=Insulin-like+growth+factor-1+rescues+synaptic+and+motor+deficits+in+mouse+model+of+autism+and+developmental+delay&doi=10.1186%2F2040-2392-4-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay</span></div><div class="casAuthors">Bozdagi, Ozlem; Tavassoli, Teresa; Buxbaum, Joseph D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Autism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9</span>CODEN:
                <span class="NLM_cas:coden">MAOUBR</span>;
        ISSN:<span class="NLM_cas:issn">2040-2392</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Haploinsufficiency of SHANK3, due to either hemizygous gene deletion (termed 22q13 deletion syndrome or Phelan-McDermid syndrome) or to gene mutation, accounts for about 0.5% of the cases of autism spectrum disorder (ASD) and/or developmental delay, and there is evidence for a wider role for SHANK3 and glutamate signaling abnormalities in ASD and related conditions.  Therapeutic approaches that reverse deficits in SHANK3-haploinsufficiency may therefore be broadly beneficial in ASD and in developmental delay.  Findings: We obsd. that daily i.p. injections of human insulin-like growth factor 1 (IGF-1) over a 2-wk period reversed deficits in hippocampal α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) signaling, long-term potentiation (LTP), and motor performance that we had previously reported in Shank3-deficient mice.  Pos. effects were obsd. with an IGF-1 peptide deriv. as well.  Conclusions: We obsd. significant beneficial effects of IGF-1 in a mouse model of ASD and of developmental delay.  Studies in mouse and human neuronal models of Rett syndrome also show benefits with IGF-1, raising the possibility that this compd. may have benefits broadly in ASD and related conditions, even with differing mol. etiol.  Given the extensive safety data for IGF-1 in children with short stature due to primary IGF-1 deficiency, IGF-1 is an attractive candidate for controlled clin. trials in SHANK3-deficiency and in ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPhnl5Spk9LrVg90H21EOLACvtfcHk0li0SamLpFdXOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVSgsL0%253D&md5=cf0e63baecd27fb0e3753efce01349b3</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1186%2F2040-2392-4-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2040-2392-4-9%26sid%3Dliteratum%253Aachs%26aulast%3DBozdagi%26aufirst%3DO.%26aulast%3DTavassoli%26aufirst%3DT.%26aulast%3DBuxbaum%26aufirst%3DJ.%2BD.%26atitle%3DInsulin-like%2520growth%2520factor-1%2520rescues%2520synaptic%2520and%2520motor%2520deficits%2520in%2520mouse%2520model%2520of%2520autism%2520and%2520developmental%2520delay%26jtitle%3DMol.%2520Autism%26date%3D2013%26volume%3D4%26spage%3D9%26doi%3D10.1186%2F2040-2392-4-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Shcheglovitov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shcheglovitova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebastiano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krawisz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froehlich, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallmayer, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolmetsch, R. E.</span><span> </span><span class="NLM_article-title">SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">503</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span><span class="refDoi"> DOI: 10.1038/nature12618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnature12618" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=267-271&author=A.+Shcheglovitovauthor=O.+Shcheglovitovaauthor=M.+Yazawaauthor=T.+Portmannauthor=R.+Shuauthor=V.+Sebastianoauthor=A.+Krawiszauthor=W.+Froehlichauthor=J.+A.+Bernsteinauthor=J.+F.+Hallmayerauthor=R.+E.+Dolmetsch&title=SHANK3+and+IGF1+restore+synaptic+deficits+in+neurons+from+22q13+deletion+syndrome+patients&doi=10.1038%2Fnature12618"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1038%2Fnature12618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12618%26sid%3Dliteratum%253Aachs%26aulast%3DShcheglovitov%26aufirst%3DA.%26aulast%3DShcheglovitova%26aufirst%3DO.%26aulast%3DYazawa%26aufirst%3DM.%26aulast%3DPortmann%26aufirst%3DT.%26aulast%3DShu%26aufirst%3DR.%26aulast%3DSebastiano%26aufirst%3DV.%26aulast%3DKrawisz%26aufirst%3DA.%26aulast%3DFroehlich%26aufirst%3DW.%26aulast%3DBernstein%26aufirst%3DJ.%2BA.%26aulast%3DHallmayer%26aufirst%3DJ.%2BF.%26aulast%3DDolmetsch%26aufirst%3DR.%2BE.%26atitle%3DSHANK3%2520and%2520IGF1%2520restore%2520synaptic%2520deficits%2520in%2520neurons%2520from%252022q13%2520deletion%2520syndrome%2520patients%26jtitle%3DNature%26date%3D2013%26volume%3D503%26spage%3D267%26epage%3D271%26doi%3D10.1038%2Fnature12618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Kolevzon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halpern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grodberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapaport, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavassoli, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soorya, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buxbaum, J. D.</span><span> </span><span class="NLM_article-title">A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome</span> <span class="citation_source-journal">Mol. Autism</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="refDoi"> DOI: 10.1186/2040-2392-5-54</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2F2040-2392-5-54" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25685306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFOjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=54&author=A.+Kolevzonauthor=L.+Bushauthor=A.+T.+Wangauthor=D.+Halpernauthor=Y.+Frankauthor=D.+Grodbergauthor=R.+Rapaportauthor=T.+Tavassoliauthor=W.+Chaplinauthor=L.+Sooryaauthor=J.+D.+Buxbaum&title=A+pilot+controlled+trial+of+insulin-like+growth+factor-1+in+children+with+Phelan-McDermid+syndrome&doi=10.1186%2F2040-2392-5-54"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome</span></div><div class="casAuthors">Kolevzon, Alexander; Bush, Lauren; Wang, A. Ting; Halpern, Danielle; Frank, Yitzchak; Grodberg, David; Rapaport, Robert; Tavassoli, Teresa; Chaplin, William; Soorya, Latha; Buxbaum, Joseph D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Autism</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">54/1-54/18, 18 pp.</span>CODEN:
                <span class="NLM_cas:coden">MAOUBR</span>;
        ISSN:<span class="NLM_cas:issn">2040-2392</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Autism spectrum disorder (ASD) is now understood to have multiple genetic risk genes and one example is SHANK3.  SHANK3 deletions and mutations disrupt synaptic function and result in Phelan-McDermid syndrome (PMS), which causes a monogenic form of ASD with a frequency of at least 0.5% of ASD cases.  Recent evidence from preclin. studies with mouse and human neuronal models of SHANK3 deficiency suggest that insulin-like growth factor-1 (IGF-1) can reverse synaptic plasticity and motor learning deficits.  The objective of this study was to pilot IGF-1 treatment in children with PMS to evaluate safety, tolerability, and efficacy for core deficits of ASD, including social impairment and restricted and repetitive behaviors.  Methods: Nine children with PMS aged 5 to 15 were enrolled in a placebo-controlled, double-blind, crossover design study, with 3 mo of treatment with IGF-1 and 3 mo of placebo in random order, sepd. by a 4-wk wash-out period.  Results: Compared to the placebo phase, the IGF-1 phase was assocd. with significant improvement in both social impairment and restrictive behaviors, as measured by the Aberrant Behavior Checklist and the Repetitive Behavior Scale, resp.  IGF-1 was found to be well tolerated and there were no serious adverse events in any participants.  Conclusions: This study establishes the feasibility of IGF-1 treatment in PMS and contributes pilot data from the first controlled treatment trial in the syndrome.  Results also provide proof of concept to advance knowledge about developing targeted treatments for addnl. causes of ASD assocd. with impaired synaptic development and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIoN-2TAr_8rVg90H21EOLACvtfcHk0ljQ-dbN6flJWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFOjtrw%253D&md5=0c98a02ae3121881b7c14b83058a5d92</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1186%2F2040-2392-5-54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2040-2392-5-54%26sid%3Dliteratum%253Aachs%26aulast%3DKolevzon%26aufirst%3DA.%26aulast%3DBush%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DA.%2BT.%26aulast%3DHalpern%26aufirst%3DD.%26aulast%3DFrank%26aufirst%3DY.%26aulast%3DGrodberg%26aufirst%3DD.%26aulast%3DRapaport%26aufirst%3DR.%26aulast%3DTavassoli%26aufirst%3DT.%26aulast%3DChaplin%26aufirst%3DW.%26aulast%3DSoorya%26aufirst%3DL.%26aulast%3DBuxbaum%26aufirst%3DJ.%2BD.%26atitle%3DA%2520pilot%2520controlled%2520trial%2520of%2520insulin-like%2520growth%2520factor-1%2520in%2520children%2520with%2520Phelan-McDermid%2520syndrome%26jtitle%3DMol.%2520Autism%26date%3D2014%26volume%3D5%26spage%3D54%26doi%3D10.1186%2F2040-2392-5-54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Tu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naisbitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petralia, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brakeman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aakalu, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanahan, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worley, P. F.</span><span> </span><span class="NLM_article-title">Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">592</span><span class="refDoi"> DOI: 10.1016/S0896-6273(00)80810-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0896-6273%2800%2980810-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=583-592&author=J.+C.+Tuauthor=B.+Xiaoauthor=S.+Naisbittauthor=J.+P.+Yuanauthor=R.+S.+Petraliaauthor=P.+Brakemanauthor=A.+Doanauthor=V.+K.+Aakaluauthor=A.+A.+Lanahanauthor=M.+Shengauthor=P.+F.+Worley&title=Coupling+of+mGluR%2FHomer+and+PSD-95+complexes+by+the+Shank+family+of+postsynaptic+density+proteins&doi=10.1016%2FS0896-6273%2800%2980810-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980810-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980810-7%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DJ.%2BC.%26aulast%3DXiao%26aufirst%3DB.%26aulast%3DNaisbitt%26aufirst%3DS.%26aulast%3DYuan%26aufirst%3DJ.%2BP.%26aulast%3DPetralia%26aufirst%3DR.%2BS.%26aulast%3DBrakeman%26aufirst%3DP.%26aulast%3DDoan%26aufirst%3DA.%26aulast%3DAakalu%26aufirst%3DV.%2BK.%26aulast%3DLanahan%26aufirst%3DA.%2BA.%26aulast%3DSheng%26aufirst%3DM.%26aulast%3DWorley%26aufirst%3DP.%2BF.%26atitle%3DCoupling%2520of%2520mGluR%252FHomer%2520and%2520PSD-95%2520complexes%2520by%2520the%2520Shank%2520family%2520of%2520postsynaptic%2520density%2520proteins%26jtitle%3DNeuron%26date%3D1999%26volume%3D23%26spage%3D583%26epage%3D592%26doi%3D10.1016%2FS0896-6273%2800%2980810-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Vicidomini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzoni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmeisser, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morello, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orellana, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durante, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalmani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantegazza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giustetto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabresi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckers, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sala, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verpelli, C.</span><span> </span><span class="NLM_article-title">Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">784</span><span class="refDoi"> DOI: 10.1038/mp.2016.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fmp.2016.70" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27113996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvVSgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=784&author=C.+Vicidominiauthor=L.+Ponzoniauthor=D.+Limauthor=M.+J.+Schmeisserauthor=D.+Reimauthor=N.+Morelloauthor=D.+Orellanaauthor=A.+Tozziauthor=V.+Duranteauthor=P.+Scalmaniauthor=M.+Mantegazzaauthor=A.+A.+Genazzaniauthor=M.+Giustettoauthor=M.+Salaauthor=P.+Calabresiauthor=T.+M.+Boeckersauthor=C.+Salaauthor=C.+Verpelli&title=Pharmacological+enhancement+of+mGlu5+receptors+rescues+behavioral+deficits+in+SHANK3+knock-out+mice&doi=10.1038%2Fmp.2016.70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice [Erratum to document cited in CA166:546730]</span></div><div class="casAuthors">Vicidomini, C.; Ponzoni, L.; Lim, D.; Schmeisser, M. J.; Reim, D.; Morello, N.; Orellana, D.; Tozzi, A.; Durante, V.; Scalmani, P.; Mantegazza, M.; Genazzani, A. A.; Giustetto, M.; Sala, M.; Calabresi, P.; Boeckers, T. M.; Sala, C.; Verpelli, C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">784</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Correction to:Mol. Psychiatry advance online publication 29 March 2016; doi:10.1038/mp.2016.30 Following publication of this paper, the authors noticed that the affiliations for M Giustetto, C Vicidomini, C Sala and C Verpelli were incorrect.  The correct affiliations appear below: C Vicidomini1,2, L Ponzoni, D Lim, MJ Schmeisser, D Reim, N Morello, D Orellana, A Tozzi, V Durante, P Scalmani, M Mantegazza, AA Genazzani, M Giustetto3, M Sala, P Calabresi, TM Boeckers, C Sala1,2 and C Verpelli1,2 1CNR Neuroscience Institute, Milan, Italy; 2BIOMETRA University of Milan, Milan, Italy; 3Department of Neuroscience, University of Turin, Turin, Italy;.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomJ69-dxja3rVg90H21EOLACvtfcHk0ljQ5pm1Bve9bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvVSgsrs%253D&md5=931962589e67f96e4cca024bcaa983d0</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1038%2Fmp.2016.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2016.70%26sid%3Dliteratum%253Aachs%26aulast%3DVicidomini%26aufirst%3DC.%26aulast%3DPonzoni%26aufirst%3DL.%26aulast%3DLim%26aufirst%3DD.%26aulast%3DSchmeisser%26aufirst%3DM.%2BJ.%26aulast%3DReim%26aufirst%3DD.%26aulast%3DMorello%26aufirst%3DN.%26aulast%3DOrellana%26aufirst%3DD.%26aulast%3DTozzi%26aufirst%3DA.%26aulast%3DDurante%26aufirst%3DV.%26aulast%3DScalmani%26aufirst%3DP.%26aulast%3DMantegazza%26aufirst%3DM.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26aulast%3DGiustetto%26aufirst%3DM.%26aulast%3DSala%26aufirst%3DM.%26aulast%3DCalabresi%26aufirst%3DP.%26aulast%3DBoeckers%26aufirst%3DT.%2BM.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DVerpelli%26aufirst%3DC.%26atitle%3DPharmacological%2520enhancement%2520of%2520mGlu5%2520receptors%2520rescues%2520behavioral%2520deficits%2520in%2520SHANK3%2520knock-out%2520mice%26jtitle%3DMol.%2520Psychiatry%26date%3D2017%26volume%3D22%26spage%3D784%26doi%3D10.1038%2Fmp.2016.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Huang, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, D. F.</span><span> </span><span class="NLM_article-title">Rho GTPase-activating proteins: Regulators of Rho GTPase activity in neuronal development and CNS diseases</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span><span class="refDoi"> DOI: 10.1016/j.mcn.2017.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.mcn.2017.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=28163190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXisVygs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2017&pages=18-31&author=G.+H.+Huangauthor=Z.+L.+Sunauthor=H.+J.+Liauthor=D.+F.+Feng&title=Rho+GTPase-activating+proteins%3A+Regulators+of+Rho+GTPase+activity+in+neuronal+development+and+CNS+diseases&doi=10.1016%2Fj.mcn.2017.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Rho GTPase-activating proteins: Regulators of Rho GTPase activity in neuronal development and CNS diseases</span></div><div class="casAuthors">Huang, Guo-Hui; Sun, Zhao-Liang; Li, Hong-Jiang; Feng, Dong-Fu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">18-31</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Rho family of small GTPases was considered as mol. switches in regulating multiple cellular events, including cytoskeleton reorganization.  The Rho GTPase-activating proteins (RhoGAPs) are one of the major families of Rho GTPase regulators.  RhoGAPs were initially considered neg. mediators of Rho signaling pathways via their GAP domain.  Recent studies have demonstrated that RhoGAPs also regulate numerous aspects of neuronal development and are related to various neurodegenerative diseases in GAP-dependent and GAP-independent manners.  Moreover, RhoGAPs are regulated through various mechanisms, such as phosphorylation.  To date, approx. 70 RhoGAPs have been identified; however, only a small portion has been thoroughly investigated.  Thus, the characterization of important RhoGAPs in the central nervous system is crucial to understand their spatiotemporal role during different stages of neuronal development.  In this review, we summarize the current knowledge of RhoGAPs in the brain with an emphasis on their mol. function, regulation mechanism and disease implications in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp25T2fg6nbWLVg90H21EOLACvtfcHk0ljQ5pm1Bve9bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXisVygs74%253D&md5=eecd38b6eb8989431ba53257c9249d36</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2017.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2017.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DG.%2BH.%26aulast%3DSun%26aufirst%3DZ.%2BL.%26aulast%3DLi%26aufirst%3DH.%2BJ.%26aulast%3DFeng%26aufirst%3DD.%2BF.%26atitle%3DRho%2520GTPase-activating%2520proteins%253A%2520Regulators%2520of%2520Rho%2520GTPase%2520activity%2520in%2520neuronal%2520development%2520and%2520CNS%2520diseases%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2017%26volume%3D80%26spage%3D18%26epage%3D31%26doi%3D10.1016%2Fj.mcn.2017.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Nakagawa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujisawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishizaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span> </span><span class="NLM_article-title">ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">392</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span><span class="refDoi"> DOI: 10.1016/0014-5793(96)00811-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2F0014-5793%2896%2900811-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=392&publication_year=1996&pages=189-193&author=O.+Nakagawaauthor=K.+Fujisawaauthor=T.+Ishizakiauthor=Y.+Saitoauthor=K.+Nakaoauthor=S.+Narumiya&title=ROCK-I+and+ROCK-II%2C+two+isoforms+of+Rho-associated+coiled-coil+forming+protein+serine%2Fthreonine+kinase+in+mice&doi=10.1016%2F0014-5793%2896%2900811-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2896%2900811-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252896%252900811-3%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DO.%26aulast%3DFujisawa%26aufirst%3DK.%26aulast%3DIshizaki%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DNakao%26aufirst%3DK.%26aulast%3DNarumiya%26aufirst%3DS.%26atitle%3DROCK-I%2520and%2520ROCK-II%252C%2520two%2520isoforms%2520of%2520Rho-associated%2520coiled-coil%2520forming%2520protein%2520serine%252Fthreonine%2520kinase%2520in%2520mice%26jtitle%3DFEBS%2520Lett.%26date%3D1996%26volume%3D392%26spage%3D189%26epage%3D193%26doi%3D10.1016%2F0014-5793%2896%2900811-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Huentelman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talboom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corneveaux, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiman, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bimonte-Nelson, H. A.</span><span> </span><span class="NLM_article-title">Peripheral delivery of a ROCK inhibitor improves learning and working memory</span> <span class="citation_source-journal">Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span><span class="refDoi"> DOI: 10.1037/a0014260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1037%2Fa0014260" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2009&pages=218-223&author=M.+J.+Huentelmanauthor=D.+A.+Stephanauthor=J.+Talboomauthor=J.+J.+Corneveauxauthor=D.+M.+Reimanauthor=J.+D.+Gerberauthor=C.+A.+Barnesauthor=G.+E.+Alexanderauthor=E.+M.+Reimanauthor=H.+A.+Bimonte-Nelson&title=Peripheral+delivery+of+a+ROCK+inhibitor+improves+learning+and+working+memory&doi=10.1037%2Fa0014260"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1037%2Fa0014260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1037%252Fa0014260%26sid%3Dliteratum%253Aachs%26aulast%3DHuentelman%26aufirst%3DM.%2BJ.%26aulast%3DStephan%26aufirst%3DD.%2BA.%26aulast%3DTalboom%26aufirst%3DJ.%26aulast%3DCorneveaux%26aufirst%3DJ.%2BJ.%26aulast%3DReiman%26aufirst%3DD.%2BM.%26aulast%3DGerber%26aufirst%3DJ.%2BD.%26aulast%3DBarnes%26aufirst%3DC.%2BA.%26aulast%3DAlexander%26aufirst%3DG.%2BE.%26aulast%3DReiman%26aufirst%3DE.%2BM.%26aulast%3DBimonte-Nelson%26aufirst%3DH.%2BA.%26atitle%3DPeripheral%2520delivery%2520of%2520a%2520ROCK%2520inhibitor%2520improves%2520learning%2520and%2520working%2520memory%26jtitle%3DBehav.%2520Neurosci.%26date%3D2009%26volume%3D123%26spage%3D218%26epage%3D223%26doi%3D10.1037%2Fa0014260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Swanger, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattheyses, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herskowitz, J. H.</span><span> </span><span class="NLM_article-title">ROCK1 and ROCK2 inhibition alters dendritic spine morphology in hippocampal neurons</span> <span class="citation_source-journal">Cell Logist.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1133266</span><span class="refDoi"> DOI: 10.1080/21592799.2015.1133266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1080%2F21592799.2015.1133266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27054047" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=e1133266&author=S.+A.+Swangerauthor=A.+L.+Mattheysesauthor=E.+G.+Gentryauthor=J.+H.+Herskowitz&title=ROCK1+and+ROCK2+inhibition+alters+dendritic+spine+morphology+in+hippocampal+neurons&doi=10.1080%2F21592799.2015.1133266"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1080%2F21592799.2015.1133266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21592799.2015.1133266%26sid%3Dliteratum%253Aachs%26aulast%3DSwanger%26aufirst%3DS.%2BA.%26aulast%3DMattheyses%26aufirst%3DA.%2BL.%26aulast%3DGentry%26aufirst%3DE.%2BG.%26aulast%3DHerskowitz%26aufirst%3DJ.%2BH.%26atitle%3DROCK1%2520and%2520ROCK2%2520inhibition%2520alters%2520dendritic%2520spine%2520morphology%2520in%2520hippocampal%2520neurons%26jtitle%3DCell%2520Logist.%26date%3D2015%26volume%3D5%26spage%3De1133266%26doi%3D10.1080%2F21592799.2015.1133266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Alokam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singhal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivathsav, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garigipati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puppala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriram, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perumal, Y.</span><span> </span><span class="NLM_article-title">Design of dual inhibitors of ROCK-I and NOX2 as potential leads for the treatment of neuroinflammation associated with various neurological diseases including autism spectrum disorder</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span><span class="refDoi"> DOI: 10.1039/C4MB00570H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1039%2FC4MB00570H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25465055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFegt77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=607-617&author=R.+Alokamauthor=S.+Singhalauthor=G.+S.+Srivathsavauthor=S.+Garigipatiauthor=S.+Puppalaauthor=D.+Sriramauthor=Y.+Perumal&title=Design+of+dual+inhibitors+of+ROCK-I+and+NOX2+as+potential+leads+for+the+treatment+of+neuroinflammation+associated+with+various+neurological+diseases+including+autism+spectrum+disorder&doi=10.1039%2FC4MB00570H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Design of dual inhibitors of ROCK-I and NOX2 as potential leads for the treatment of neuroinflammation associated with various neurological diseases including autism spectrum disorder</span></div><div class="casAuthors">Alokam, Reshma; Singhal, Sarthak; Srivathsav, Geetha Sai; Garigipati, Sowmya; Puppala, Sripriya; Sriram, Dharmarajan; Perumal, Yogeeswari</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">607-617</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Inhibition of both Rho kinase (ROCK-I) and NADPH oxidase (NOX2) to treat neuroinflammation could be very effective in the treatment of progressive neurol. diseases like Alzheimer's disease, autism spectral disorder, and fragile X syndrome.  NOX2 being a multi-enzyme component is activated during host defense in phagocytes such as microglia, to catalyze the prodn. of superoxide from oxygen, while ROCK is an important mediator of fundamental cell processes like adhesion, proliferation and migration.  Phosphorylated ROCK was found to activate NOX2 assembly via Ras related C3 botulinum toxin substrate (Rac) in disease conditions.  Overexpression of ROCK-I and NOX2 in innate immune cells like microglial cells contribute to progressive neuronal damage early in neurol. disease development.  In the present study we employed a computer-aided methodol. combining pharmacophores and mol. docking to identify new chem. entities that could inhibit ROCK-I as well as NOX2 (p47 phox).  Among the huge dataset of a com. database, top 18 mols. with crucial binding interactions were selected for biol. evaluation.  Seven among the lead mols. exhibited inhibitory potential against ROCK-I and NOX2 with IC50s ranging from 1.588 to 856.2 nM and 0.8942 to 10.24 μM, resp., and emerged as potential hits as dual inhibitors with adequate selectivity index (SI = CC50/GIC50) in cell-based assays.  The most active compd. 3 was further found to show redn. of the pro-inflammatory mediators such as TNFα, interleukin-6 (IL-6) and interleukin-1beta (IL-1β) mRNA expression levels in activated (MeHg treated) human neuroblastoma (IMR32) cell lines.  Hence the present work documented the utility of these dual inhibitors as prototypical leads to be useful for the treatment of neurol. disorders including autism spectrum disorder and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG4-6HYAydFLVg90H21EOLACvtfcHk0lhVmm-T_YiK4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFegt77I&md5=922bff3bb922854f01651c7195de0327</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1039%2FC4MB00570H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MB00570H%26sid%3Dliteratum%253Aachs%26aulast%3DAlokam%26aufirst%3DR.%26aulast%3DSinghal%26aufirst%3DS.%26aulast%3DSrivathsav%26aufirst%3DG.%2BS.%26aulast%3DGarigipati%26aufirst%3DS.%26aulast%3DPuppala%26aufirst%3DS.%26aulast%3DSriram%26aufirst%3DD.%26aulast%3DPerumal%26aufirst%3DY.%26atitle%3DDesign%2520of%2520dual%2520inhibitors%2520of%2520ROCK-I%2520and%2520NOX2%2520as%2520potential%2520leads%2520for%2520the%2520treatment%2520of%2520neuroinflammation%2520associated%2520with%2520various%2520neurological%2520diseases%2520including%2520autism%2520spectrum%2520disorder%26jtitle%3DMol.%2520BioSyst.%26date%3D2015%26volume%3D11%26spage%3D607%26epage%3D617%26doi%3D10.1039%2FC4MB00570H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoGrasso, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defert, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span> </span><span class="NLM_article-title">Rho kinase (ROCK) inhibitors and their therapeutic potential</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2269</span><span class="NLM_x">–</span> <span class="NLM_lpage">2300</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00683</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00683" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Oqtb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2269-2300&author=Y.+Fengauthor=P.+V.+LoGrassoauthor=O.+Defertauthor=R.+Li&title=Rho+kinase+%28ROCK%29+inhibitors+and+their+therapeutic+potential&doi=10.1021%2Facs.jmedchem.5b00683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential</span></div><div class="casAuthors">Feng, Yangbo; LoGrasso, Philip V.; Defert, Olivier; Li, Rongshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2269-2300</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Rho kinases (ROCKs) belong to the serine-threonine family, the inhibition of which affects the function of many downstream substrates.  As such, ROCK inhibitors have potential therapeutic applicability in a wide variety of pathol. conditions including asthma, cancer, erectile dysfunction, glaucoma, insulin resistance, kidney failure, neuronal degeneration, and osteoporosis.  To date, two ROCK inhibitors have been approved for clin. use in Japan (fasudil and ripasudil) and one in China (fasudil).  In 1995 fasudil was approved for the treatment of cerebral vasospasm, and more recently, ripasudil was approved for the treatment of glaucoma in 2014.  In this Perspective, we present a comprehensive review of the physiol. and biol. functions for ROCK, the properties and development of over 170 ROCK inhibitors as well as their therapeutic potential, the current status, and future considerations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXh2BorYftcbVg90H21EOLACvtfcHk0lhVmm-T_YiK4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Oqtb%252FJ&md5=99b0e10dca303023b1bf382fcb255771</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00683%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DLoGrasso%26aufirst%3DP.%2BV.%26aulast%3DDefert%26aufirst%3DO.%26aulast%3DLi%26aufirst%3DR.%26atitle%3DRho%2520kinase%2520%2528ROCK%2529%2520inhibitors%2520and%2520their%2520therapeutic%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2269%26epage%3D2300%26doi%3D10.1021%2Facs.jmedchem.5b00683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Hranilovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bujas-Petkovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vragovic, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jernej, B.</span><span> </span><span class="NLM_article-title">Hyperserotonemia in adults with autistic disorder</span> <span class="citation_source-journal">J. Autism Dev. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1934</span><span class="NLM_x">–</span> <span class="NLM_lpage">1940</span><span class="refDoi"> DOI: 10.1007/s10803-006-0324-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs10803-006-0324-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=17165147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD2snhs1yjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=1934-1940&author=D.+Hranilovicauthor=Z.+Bujas-Petkovicauthor=R.+Vragovicauthor=T.+Vukauthor=K.+Hockauthor=B.+Jernej&title=Hyperserotonemia+in+adults+with+autistic+disorder&doi=10.1007%2Fs10803-006-0324-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperserotonemia in adults with autistic disorder</span></div><div class="casAuthors">Hranilovic Dubravka; Bujas-Petkovic Zorana; Vragovic Renata; Vuk Tomislav; Hock Karlo; Jernej Branimir</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autism and developmental disorders</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1934-40</span>
        ISSN:<span class="NLM_cas:issn">0162-3257</span>.
    </div><div class="casAbstract">Hyperserotonemia is the most consistent serotonin-related finding in autism.  The basis of this phenomenon, and its relationship to the central serotonergic dysfunction remains unclear.  Platelet serotonin level (PSL) in 53 autistic adults and 45 healthy controls was measured.  Mean PSL in autistic group (75.7 +/- 37.4 ng/microL) was significantly higher than the control sample (59.2 +/- 16.2 ng/microL) due to a presence of hyperserotonemic subjects which comprised 32% of the patients.  PSL of autistic subjects did not correlate with the severity of symptoms, as measured by total CARS score, or the degree of mental retardation.  However, significant negative relationship was observed between PSL and speech development, indicating the relationship between the peripheral 5HT concentrations and verbal abilities in autistic subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCYqigiN2N3gxyojvcjibhfW6udTcc2eYL_JeKKIOK_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snhs1yjtw%253D%253D&md5=47982ccad0da149672b77532afa6ac0d</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1007%2Fs10803-006-0324-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10803-006-0324-6%26sid%3Dliteratum%253Aachs%26aulast%3DHranilovic%26aufirst%3DD.%26aulast%3DBujas-Petkovic%26aufirst%3DZ.%26aulast%3DVragovic%26aufirst%3DR.%26aulast%3DVuk%26aufirst%3DT.%26aulast%3DHock%26aufirst%3DK.%26aulast%3DJernej%26aufirst%3DB.%26atitle%3DHyperserotonemia%2520in%2520adults%2520with%2520autistic%2520disorder%26jtitle%3DJ.%2520Autism%2520Dev.%2520Disord.%26date%3D2007%26volume%3D37%26spage%3D1934%26epage%3D1940%26doi%3D10.1007%2Fs10803-006-0324-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Coutinho, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgadinho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macedo, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bento, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marques, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ataíde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente, A. M.</span><span> </span><span class="NLM_article-title">Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">264</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span><span class="refDoi"> DOI: 10.1038/sj.mp.4001409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fsj.mp.4001409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=15094787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFCmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=264-271&author=A.+M.+Coutinhoauthor=G.+Oliveiraauthor=T.+Morgadinhoauthor=C.+Feselauthor=T.+R.+Macedoauthor=C.+Bentoauthor=C.+Marquesauthor=A.+Ata%C3%ADdeauthor=T.+Miguelauthor=L.+Borgesauthor=A.+M.+Vicente&title=Variants+of+the+serotonin+transporter+gene+%28SLC6A4%29+significantly+contribute+to+hyperserotonemia+in+autism&doi=10.1038%2Fsj.mp.4001409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism</span></div><div class="casAuthors">Coutinho, A. M.; Oliveira, G.; Morgadinho, T.; Fesel, C.; Macedo, T. R.; Bento, C.; Marques, C.; Ataide, A.; Miguel, T.; Borges, L.; Vicente, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">264-271</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The role of the serotonin system in the etiol. and pathogenesis of autism spectrum disorders (ASD) is not clearly defined.  High levels of platelet serotonin (5-HT) have been consistently found in a proportion of patients, and it is known that specific 5-HT transporter gene (SLC6A4) variants modulate transporter reuptake function, therefore possibly influencing the occurrence of hyperserotonemia in a subset of autistic patients.  We have examd. the assocn. of platelet serotonin levels with two SLC6A4 polymorphisms, 5-HTT gene-linked polymorphic region (HTTLPR) in the promoter and intron 2 variable no. of tandem repeats (VNTR), in a sample of 105 ASD patients, their parents, and 52 control children.  Quant. transmission disequil. test (QTDT) results showed a significant effect on 5-HT levels of each SLC6A4 marker (P=0.017 for HTTLPR; P=0.047 for intron 2 VNTR) and of haplotypes of the two markers (P=0.017), with a major contribution of the L.Stin2.10 haplotype (P=0.0013).  A 5-HT mean value in the range of hyperserotonemia was assocd. with the homozygous L.Stin2.10 haplotype (H (1,N=97)=7.76, P=0.0054), which occurred in 33% of hyperserotonemic patients against 6% of patients with normal 5-HT levels (Fisher's exact test: P=0.013, OR=8).  Allele interaction at the HTTLPR locus was found, with a significant dominance variance effect on 5-HT levels.  We found no transmission disequil. of any of the SLC6A4 variants in ASD.  Our results show that the SLC6A4 gene is a significant factor in the detn. of 5-HT levels, and that specific SLC6A4 variants are assocd. with an increased risk for hyperserotonemia in our sample of autistic patients.  The biol. mechanism, however, is unlikely to involve the SLC6A4 gene solely.  The assocd. SLC6A4 alleles likely interact with other genes or environmental factors to produce the abnormally high 5-HT levels obsd. in this subset of autistic patients, who possibly represent a sep. etiol. group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCI_1tmZTIHrVg90H21EOLACvtfcHk0ljyCQR_ci-yrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFCmsLs%253D&md5=5b856dd5aa3dd5d102e842f802cacb43</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001409%26sid%3Dliteratum%253Aachs%26aulast%3DCoutinho%26aufirst%3DA.%2BM.%26aulast%3DOliveira%26aufirst%3DG.%26aulast%3DMorgadinho%26aufirst%3DT.%26aulast%3DFesel%26aufirst%3DC.%26aulast%3DMacedo%26aufirst%3DT.%2BR.%26aulast%3DBento%26aufirst%3DC.%26aulast%3DMarques%26aufirst%3DC.%26aulast%3DAta%25C3%25ADde%26aufirst%3DA.%26aulast%3DMiguel%26aufirst%3DT.%26aulast%3DBorges%26aufirst%3DL.%26aulast%3DVicente%26aufirst%3DA.%2BM.%26atitle%3DVariants%2520of%2520the%2520serotonin%2520transporter%2520gene%2520%2528SLC6A4%2529%2520significantly%2520contribute%2520to%2520hyperserotonemia%2520in%2520autism%26jtitle%3DMol.%2520Psychiatry%26date%3D2004%26volume%3D9%26spage%3D264%26epage%3D271%26doi%3D10.1038%2Fsj.mp.4001409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Cohen, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, J. J. A.</span><span> </span><span class="NLM_article-title">Association of autism severity with a monoamine oxidase A functional polymorphism</span> <span class="citation_source-journal">Clin. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span><span class="refDoi"> DOI: 10.1034/j.1399-0004.2003.00115.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1034%2Fj.1399-0004.2003.00115.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=12919132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD3svjslKguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=190-197&author=I.+L.+Cohenauthor=X.+Liuauthor=C.+Schutzauthor=B.+N.+Whiteauthor=E.+C.+Jenkinsauthor=W.+T.+Brownauthor=J.+J.+A.+Holden&title=Association+of+autism+severity+with+a+monoamine+oxidase+A+functional+polymorphism&doi=10.1034%2Fj.1399-0004.2003.00115.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Association of autism severity with a monoamine oxidase A functional polymorphism</span></div><div class="casAuthors">Cohen I L; Liu X; Schutz C; White B N; Jenkins E C; Brown W T; Holden J J A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">190-7</span>
        ISSN:<span class="NLM_cas:issn">0009-9163</span>.
    </div><div class="casAbstract">A functional polymorphism (the upstream variable-number tandem repeat region, or uVNTR) in the monoamine oxidase A (MAOA) promoter region has been reported to be associated with behavioral abnormalities as well as increased serotonergic responsivity.  We examined the relation between MAOA-uVNTR alleles and the phenotypic expression of autism in 41 males younger than 12.6 years of age.  Children with the low-activity MAOA allele had both lower intelligence quotients (IQ) and more severe autistic behavior than children with the high-activity allele.  In follow-up testing of 34 of the males at the 1-year time-point, those with the low-activity allele showed a worsening in IQ but no change in the severity of their autistic behavior.  We conclude that functional MAOA-uVNTR alleles may act as a genetic modifier of the severity of autism in males.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJ4SHrV34LGRKDYG3bNImrfW6udTcc2eYxz_aZWazBYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svjslKguw%253D%253D&md5=d50e6699e788316019d483ca9924ea7e</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1034%2Fj.1399-0004.2003.00115.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1399-0004.2003.00115.x%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DI.%2BL.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSchutz%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DB.%2BN.%26aulast%3DJenkins%26aufirst%3DE.%2BC.%26aulast%3DBrown%26aufirst%3DW.%2BT.%26aulast%3DHolden%26aufirst%3DJ.%2BJ.%2BA.%26atitle%3DAssociation%2520of%2520autism%2520severity%2520with%2520a%2520monoamine%2520oxidase%2520A%2520functional%2520polymorphism%26jtitle%3DClin.%2520Genet.%26date%3D2003%26volume%3D64%26spage%3D190%26epage%3D197%26doi%3D10.1034%2Fj.1399-0004.2003.00115.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Veenstra-VanderWeele, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannangatti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carneiro, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawley, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders-Bush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamoorthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daws, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span> </span><span class="NLM_article-title">Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">5469</span><span class="NLM_x">–</span> <span class="NLM_lpage">5474</span><span class="refDoi"> DOI: 10.1073/pnas.1112345109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.1112345109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22431635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslOjsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=5469-5474&author=J.+Veenstra-VanderWeeleauthor=C.+L.+Mullerauthor=H.+Iwamotoauthor=J.+E.+Sauerauthor=W.+A.+Owensauthor=C.+R.+Shahauthor=J.+Cohenauthor=P.+Mannangattiauthor=T.+Jessenauthor=B.+J.+Thompsonauthor=R.+Yeauthor=T.+M.+Kerrauthor=A.+M.+Carneiroauthor=J.+N.+Crawleyauthor=E.+Sanders-Bushauthor=D.+G.+McMahonauthor=S.+Ramamoorthyauthor=L.+C.+Dawsauthor=J.+S.+Sutcliffeauthor=R.+D.+Blakely&title=Autism+gene+variant+causes+hyperserotonemia%2C+serotonin+receptor+hypersensitivity%2C+social+impairment+and+repetitive+behavior&doi=10.1073%2Fpnas.1112345109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior</span></div><div class="casAuthors">Veenstra-Vanderweele, Jeremy; Muller, Christopher L.; Iwamoto, Hideki; Sauer, Jennifer E.; Owens, W. Anthony; Shah, Charisma R.; Cohen, Jordan; Mannangatti, Padmanabhan; Jessen, Tammy; Thompson, Brent J.; Ye, Ran; Kerr, Travis M.; Carneiro, Ana M.; Crawley, Jacqueline N.; Sanders-Bush, Elaine; McMahon, Douglas G.; Ramamoorthy, Sammanda; Daws, Lynette C.; Sutcliffe, James S.; Blakely, Randy D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5469-5474, S5469/1-S5469/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Fifty years ago, increased whole-blood serotonin levels, or hyperserotonemia, first linked disrupted 5-HT homeostasis to Autism Spectrum Disorders (ASDs).  The 5-HT transporter (SERT) gene (SLC6A4) was assocd. with whole blood 5-HT levels and ASD susceptibility.  Previously, we identified multiple gain-of-function SERT coding variants in children with ASD.  Here we establish that transgenic mice expressing the most common of these variants, SERT Ala56, exhibit elevated, p38 MAPK-dependent transporter phosphorylation, enhanced 5-HT clearance rates and hyperserotonemia.  These effects are accompanied by altered basal firing of raphe 5-HT neurons, as well as 5HT1A and 5HT2A receptor hypersensitivity.  Strikingly, SERT Ala56 mice display alterations in social function, communication, and repetitive behavior.  Our efforts provide strong support for the hypothesis that altered 5-HT homeostasis can impact risk for ASD traits and provide a model with construct and face validity that can support further anal. of ASD mechanisms and potentially novel treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqVZ2XOarfFrVg90H21EOLACvtfcHk0lh3oMjUaK7_uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslOjsbY%253D&md5=28c4378da3e1dfef11efbe786b5af66e</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1112345109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1112345109%26sid%3Dliteratum%253Aachs%26aulast%3DVeenstra-VanderWeele%26aufirst%3DJ.%26aulast%3DMuller%26aufirst%3DC.%2BL.%26aulast%3DIwamoto%26aufirst%3DH.%26aulast%3DSauer%26aufirst%3DJ.%2BE.%26aulast%3DOwens%26aufirst%3DW.%2BA.%26aulast%3DShah%26aufirst%3DC.%2BR.%26aulast%3DCohen%26aufirst%3DJ.%26aulast%3DMannangatti%26aufirst%3DP.%26aulast%3DJessen%26aufirst%3DT.%26aulast%3DThompson%26aufirst%3DB.%2BJ.%26aulast%3DYe%26aufirst%3DR.%26aulast%3DKerr%26aufirst%3DT.%2BM.%26aulast%3DCarneiro%26aufirst%3DA.%2BM.%26aulast%3DCrawley%26aufirst%3DJ.%2BN.%26aulast%3DSanders-Bush%26aufirst%3DE.%26aulast%3DMcMahon%26aufirst%3DD.%2BG.%26aulast%3DRamamoorthy%26aufirst%3DS.%26aulast%3DDaws%26aufirst%3DL.%2BC.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BS.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26atitle%3DAutism%2520gene%2520variant%2520causes%2520hyperserotonemia%252C%2520serotonin%2520receptor%2520hypersensitivity%252C%2520social%2520impairment%2520and%2520repetitive%2520behavior%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D5469%26epage%3D5474%26doi%3D10.1073%2Fpnas.1112345109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Bortolato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godar, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzghoul, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darling, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellman, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, J. C.</span><span> </span><span class="NLM_article-title">Monoamine oxidase A and A/B knockout mice display autistic-like features</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span><span class="refDoi"> DOI: 10.1017/S1461145712000715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1017%2FS1461145712000715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22850464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFOisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=869-888&author=M.+Bortolatoauthor=S.+C.+Godarauthor=L.+Alzghoulauthor=J.+Zhangauthor=R.+D.+Darlingauthor=K.+L.+Simpsonauthor=V.+Biniauthor=K.+Chenauthor=C.+L.+Wellmanauthor=R.+C.+Linauthor=J.+C.+Shih&title=Monoamine+oxidase+A+and+A%2FB+knockout+mice+display+autistic-like+features&doi=10.1017%2FS1461145712000715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase A and A/B knockout mice display autistic-like features</span></div><div class="casAuthors">Bortolato, Marco; Godar, Sean C.; Alzghoul, Loai; Zhang, Junlin; Darling, Ryan D.; Simpson, Kimberly L.; Bini, Valentina; Chen, Kevin; Wellman, Cara L.; Lin, Rick C. S.; Shih, Jean C.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">869-888</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Converging lines of evidence show that a sizable subset of autism-spectrum disorders (ASDs) is characterized by increased blood levels of serotonin (5-hydroxytryptamine, 5-HT), yet the mechanistic link between these two phenomena remains unclear.  The enzymic degrdn. of brain 5-HT is mainly mediated by monoamine oxidase (MAO)A and, in the absence of this enzyme, by its cognate isoenzyme MAOB.  MAOA and A/B knockout (KO) mice display high 5-HT levels, particularly during early developmental stages.  Here we show that both mutant lines exhibit numerous behavioral hallmarks of ASDs, such as social and communication impairments, perseverative and stereotypical responses, behavioral inflexibility, as well as subtle tactile and motor deficits.  Furthermore, both MAOA and A/B KO mice displayed neuropathol. alterations reminiscent of typical ASD features, including reduced thickness of the corpus callosum, increased dendritic arborization of pyramidal neurons in the prefrontal cortex and disrupted microarchitecture of the cerebellum.  The severity of repetitive responses and neuropathol. aberrances was generally greater in MAOA/B KO animals.  These findings suggest that the neurochem. imbalances induced by MAOA deficiency (either by itself or in conjunction with lack of MAOB) may result in an array of abnormalities similar to those obsd. in ASDs.  Thus, MAOA and A/B KO mice may afford valuable models to help elucidate the neurobiol. bases of these disorders and related neurodevelopmental problems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_vfDwK0U56rVg90H21EOLACvtfcHk0lhcTfUETNr3mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFOisL8%253D&md5=f5cb41b10049afdd6113ac3c4c61c4ce</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1017%2FS1461145712000715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145712000715%26sid%3Dliteratum%253Aachs%26aulast%3DBortolato%26aufirst%3DM.%26aulast%3DGodar%26aufirst%3DS.%2BC.%26aulast%3DAlzghoul%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDarling%26aufirst%3DR.%2BD.%26aulast%3DSimpson%26aufirst%3DK.%2BL.%26aulast%3DBini%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DWellman%26aufirst%3DC.%2BL.%26aulast%3DLin%26aufirst%3DR.%2BC.%26aulast%3DShih%26aufirst%3DJ.%2BC.%26atitle%3DMonoamine%2520oxidase%2520A%2520and%2520A%252FB%2520knockout%2520mice%2520display%2520autistic-like%2520features%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2013%26volume%3D16%26spage%3D869%26epage%3D888%26doi%3D10.1017%2FS1461145712000715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Muller, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anacker, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veenstra-VanderWeele, J.</span><span> </span><span class="NLM_article-title">The serotonin system in autism spectrum disorder: from biomarker to animal models</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2015.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuroscience.2015.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26577932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVChsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2016&pages=24-41&author=C.+L.+Mullerauthor=A.+M.+Anackerauthor=J.+Veenstra-VanderWeele&title=The+serotonin+system+in+autism+spectrum+disorder%3A+from+biomarker+to+animal+models&doi=10.1016%2Fj.neuroscience.2015.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">The serotonin system in autism spectrum disorder: From biomarker to animal models</span></div><div class="casAuthors">Muller, C. L.; Anacker, A. M. J.; Veenstra-VanderWeele, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-41</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Elevated whole blood serotonin, or hyperserotonemia, was the first biomarker identified in autism spectrum disorder (ASD) and is present in more than 25% of affected children.  The serotonin system is a logical candidate for involvement in ASD due to its pleiotropic role across multiple brain systems both dynamically and across development.  Tantalizing clues connect this peripheral biomarker with changes in brain and behavior in ASD, but the contribution of the serotonin system to ASD pathophysiol. remains incompletely understood.  Studies of whole blood serotonin levels in ASD and in a large founder population indicate greater heritability than for the disorder itself and suggest an assocn. with recurrence risk.  Emerging data from both neuroimaging and postmortem samples also indicate changes in the brain serotonin system in ASD.  Genetic linkage and assocn. studies of both whole blood serotonin levels and of ASD risk point to the chromosomal region contg. the serotonin transporter (SERT) gene in males but not in females.  In ASD families with evidence of linkage to this region, multiple rare SERT amino acid variants lead to a convergent increase in serotonin uptake in cell models.  A knock-in mouse model of one of these variants, SERT Gly56Ala, recapitulates the hyperserotonemia biomarker and shows increased brain serotonin clearance, increased serotonin receptor sensitivity, and altered social, communication, and repetitive behaviors.  Data from other rodent models also suggest an important role for the serotonin system in social behavior, in cognitive flexibility, and in sensory development.  Recent work indicates that reciprocal interactions between serotonin and other systems, such as oxytocin, may be particularly important for social behavior.  Collectively, these data point to the serotonin system as a prime candidate for treatment development in a subgroup of children defined by a robust, heritable biomarker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHmqEwuDqonbVg90H21EOLACvtfcHk0lhcTfUETNr3mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVChsbzI&md5=c63627331693d2b166a433571ad88a17</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2015.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2015.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DC.%2BL.%26aulast%3DAnacker%26aufirst%3DA.%2BM.%26aulast%3DVeenstra-VanderWeele%26aufirst%3DJ.%26atitle%3DThe%2520serotonin%2520system%2520in%2520autism%2520spectrum%2520disorder%253A%2520from%2520biomarker%2520to%2520animal%2520models%26jtitle%3DNeuroscience%26date%3D2016%26volume%3D321%26spage%3D24%26epage%3D41%26doi%3D10.1016%2Fj.neuroscience.2015.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brignell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silove, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazell, P.</span><span> </span><span class="NLM_article-title">Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD004677</span><span class="refDoi"> DOI: 10.1002/14651858.CD004677.pub3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2F14651858.CD004677.pub3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=CD004677&author=K.+Williamsauthor=A.+Brignellauthor=M.+Randallauthor=N.+Siloveauthor=P.+Hazell&title=Selective+serotonin+reuptake+inhibitors+%28SSRIs%29+for+autism+spectrum+disorders+%28ASD%29&doi=10.1002%2F14651858.CD004677.pub3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD004677.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD004677.pub3%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DBrignell%26aufirst%3DA.%26aulast%3DRandall%26aufirst%3DM.%26aulast%3DSilove%26aufirst%3DN.%26aulast%3DHazell%26aufirst%3DP.%26atitle%3DSelective%2520serotonin%2520reuptake%2520inhibitors%2520%2528SSRIs%2529%2520for%2520autism%2520spectrum%2520disorders%2520%2528ASD%2529%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2013%26spage%3DCD004677%26doi%3D10.1002%2F14651858.CD004677.pub3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Hollander, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soorya, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anagnostou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferretti, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasserman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settipani, C.</span><span> </span><span class="NLM_article-title">A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span><span class="refDoi"> DOI: 10.1176/appi.ajp.2011.10050764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1176%2Fappi.ajp.2011.10050764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22193531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC383pvFCnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2012&pages=292-299&author=E.+Hollanderauthor=L.+Sooryaauthor=W.+Chaplinauthor=E.+Anagnostouauthor=B.+P.+Taylorauthor=C.+J.+Ferrettiauthor=S.+Wassermanauthor=E.+Swansonauthor=C.+Settipani&title=A+double-blind+placebo-controlled+trial+of+fluoxetine+for+repetitive+behaviors+and+global+severity+in+adult+autism+spectrum+disorders&doi=10.1176%2Fappi.ajp.2011.10050764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders</span></div><div class="casAuthors">Hollander Eric; Soorya Latha; Chaplin William; Anagnostou Evdokia; Taylor Bonnie P; Ferretti Casara J; Wasserman Stacey; Swanson Erika; Settipani Cara</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">292-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  The effects of fluoxetine and placebo on repetitive behaviors and global severity were compared in adults with autism spectrum disorders (ASDs).  METHOD:  Adults with ASDs were enrolled in a 12-week double-blind placebo-controlled fluoxetine trial.  Thirty-seven were randomly assigned to fluoxetine (N=22) or placebo (N=15).  Dosage followed a fixed schedule, starting at 10 mg/day and increasing as tolerated up to 80 mg/day.  Repetitive behaviors were measured with the compulsion subscale of the Yale-Brown Obsessive Compulsive Scale; the Clinical Global Impression (CGI) improvement scale was used to rate improvement in obsessive-compulsive symptoms and overall severity.  RESULTS:  There was a significant treatment-by-time interaction indicating a significantly greater reduction in repetitive behaviors across time for fluoxetine than for placebo.  With overall response defined as a CGI global improvement score of 2 or less, there were significantly more responders at week 12 in the fluoxetine group than in the placebo group.  The risk ratio was 1.5 for CGI global improvement (responders: fluoxetine, 35%; placebo, 0%) and 1.8 for CGI-rated improvement in obsessive-compulsive symptoms (responders: fluoxetine, 50%; placebo, 8%).  Only mild and moderate side effects were observed.  CONCLUSIONS:  Fluoxetine treatment, compared to placebo, resulted in significantly greater improvement in repetitive behaviors, according to both the Yale-Brown compulsion subscale and CGI rating of obsessive-compulsive symptoms, as well as on the CGI overall improvement rating.  Fluoxetine appeared to be well tolerated.  These findings stand in contrast to findings in a trial of citalopram for childhood autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6wMPYGfAiJTAEfvC7EH1LfW6udTcc2ebvQ5-JN64ECLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383pvFCnsA%253D%253D&md5=027bc4110863f52a9b8356c66413c315</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2011.10050764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2011.10050764%26sid%3Dliteratum%253Aachs%26aulast%3DHollander%26aufirst%3DE.%26aulast%3DSoorya%26aufirst%3DL.%26aulast%3DChaplin%26aufirst%3DW.%26aulast%3DAnagnostou%26aufirst%3DE.%26aulast%3DTaylor%26aufirst%3DB.%2BP.%26aulast%3DFerretti%26aufirst%3DC.%2BJ.%26aulast%3DWasserman%26aufirst%3DS.%26aulast%3DSwanson%26aufirst%3DE.%26aulast%3DSettipani%26aufirst%3DC.%26atitle%3DA%2520double-blind%2520placebo-controlled%2520trial%2520of%2520fluoxetine%2520for%2520repetitive%2520behaviors%2520and%2520global%2520severity%2520in%2520adult%2520autism%2520spectrum%2520disorders%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2012%26volume%3D169%26spage%3D292%26epage%3D299%26doi%3D10.1176%2Fappi.ajp.2011.10050764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Chugani, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chugani, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiznitzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nass, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janisse, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon-Thomas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothermel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzik, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirtz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivaswamy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhilber, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roeder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katusin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supula, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halverson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gjolaj, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakraborty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigeluk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosqueda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBoard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolinski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naguib, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe-Christensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQueeney, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinlicht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toltzis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosolowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banchy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlake, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabro, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tacket, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchheit, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepper, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speicher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frohnapfel, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browning, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreischer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blubaugh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garver, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merryman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherrod, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perryman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorduy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angkustsiri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plumer, L.B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siy Leigh, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacalman, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roa, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Govindappa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brule, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarwary, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cargill, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steindorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrykowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Root, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanzel, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwilling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellatly, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberfield, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedland, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coimbre, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posey, D.</span><span> </span><span class="NLM_article-title">Efficacy of low-dose buspirone for restricted and repetitive behavior in young children with autism spectrum disorder: a randomized trial</span> <span class="citation_source-journal">J. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1016/j.jpeds.2015.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.jpeds.2015.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26746121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28Xis12lsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2016&pages=45-53&author=D.+C.+Chuganiauthor=H.+T.+Chuganiauthor=M.+Wiznitzerauthor=S.+Parikhauthor=P.+A.+Evansauthor=R.+L.+Hansenauthor=R.+Nassauthor=J.+J.+Janisseauthor=P.+Dixon-Thomasauthor=M.+Behenauthor=R.+Rothermelauthor=J.+S.+Parkerauthor=A.+Kumarauthor=O.+Muzikauthor=D.+J.+Edwardsauthor=D.+Hirtzauthor=H.+Jiangauthor=L.+Sivaswamyauthor=G.+Steinhilberauthor=K.+Kennedyauthor=K.+Pawlikauthor=R.+Roederauthor=M.+Malianauthor=H.+Turnerauthor=A.+Hannaauthor=J.+Katusinauthor=D.+Supulaauthor=S.+Halversonauthor=W.+Guyauthor=N.+Gjolajauthor=T.+Mangnerauthor=P.+Chakrabortyauthor=A.+Wigelukauthor=G.+Pattersonauthor=A.+Mosquedaauthor=M.+Burkettauthor=A.+DeBoardauthor=J.+Cornettauthor=M.-L.+Leeauthor=X.+Luauthor=C.+Germainauthor=M.+Majkowskiauthor=B.+Frenchauthor=A.+Stolinskiauthor=S.+Naguibauthor=C.+Wolfe-Christensenauthor=S.+Taylorauthor=J.+Ameliauthor=J.+K.+McQueeneyauthor=M.+Rubinlichtauthor=B.+Gorkaauthor=E.+Zacharskiauthor=J.+L.+Blumerauthor=K.+Maxwellauthor=C.+Tasiauthor=P.+Toltzisauthor=J.+Kalicauthor=D.+Morusauthor=J.+Paulettauthor=B.+Rosolowskiauthor=M.+Banchyauthor=K.+Westlakeauthor=B.+Calabroauthor=C.+Tacketauthor=I.+Adkinsauthor=K.+Buchheitauthor=K.+Hepperauthor=D.+Speicherauthor=S.+Bergantauthor=J.+Hakyauthor=M.+B.+Frohnapfelauthor=C.+Schaeferauthor=A.+Browningauthor=R.+Bauerauthor=R.+Embacherauthor=J.+Knappauthor=S.+Levyauthor=D.+Daviesauthor=D.+Lachauthor=J.+Petrichauthor=S.+Kreischerauthor=P.+Blubaughauthor=M.+A.+Morrisauthor=C.+Garverauthor=M.+Andersenauthor=M.+Greeneauthor=A.+Richardsauthor=M.+Rochaauthor=R.+Merrymanauthor=S.+Gollaauthor=A.+Lorenzenauthor=J.+L.+Sherrodauthor=P.+Perrymanauthor=K.+Lorduyauthor=K.+Angkustsiriauthor=L.B.+Plumerauthor=M.+J.+Siy+Leighauthor=S.+C.+Bacalmanauthor=D.+L.+Roaauthor=K.+Govindappaauthor=G.+Mahajanauthor=E.+Bickelauthor=N.+Bruleauthor=E.+Hareauthor=N.+Sarwaryauthor=D.+Cargillauthor=J.+Leeauthor=S.+Homauthor=D.+Steindorfauthor=M.+Pietrykowskiauthor=K.+Rootauthor=S.+Coffeyauthor=E.+P.+Hanzelauthor=A.+Santanaauthor=C.+Ramirezauthor=S.+Berciauthor=N.+Gabrielauthor=G.+Hirschauthor=E.+Robertsauthor=A.+Zwillingauthor=R.+Gellatlyauthor=D.+Levyauthor=S.+Leeauthor=J.+Rodmanauthor=A.+Hannaauthor=N.+Oberfieldauthor=S.+Friedlandauthor=C.+Lordauthor=R.+Kozloffauthor=C.+Crouseauthor=S.+Millenauthor=A.+J.+Coimbreauthor=K.+L.+McCarterauthor=D.+Posey&title=Efficacy+of+low-dose+buspirone+for+restricted+and+repetitive+behavior+in+young+children+with+autism+spectrum+disorder%3A+a+randomized+trial&doi=10.1016%2Fj.jpeds.2015.11.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of Low-Dose Buspirone for Restricted and Repetitive Behavior in Young Children with Autism Spectrum Disorder: A Randomized Trial</span></div><div class="casAuthors">Chugani, Diane C.; Chugani, Harry T.; Wiznitzer, Max; Parikh, Sumit; Evans, Patricia A.; Hansen, Robin L.; Nass, Ruth; Janisse, James J.; Dixon-Thomas, Pamela; Behen, Michael; Rothermel, Robert; Parker, Jacqueline S.; Kumar, Ajay; Muzik, Otto; Edwards, David J.; Hirtz, Deborah</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pediatrics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45-53.e4</span>CODEN:
                <span class="NLM_cas:coden">JOPDAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3476</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">To det. safety and efficacy of the 5HT1A serotonin partial agonist buspirone on core autism and assocd. features in children with autism spectrum disorder (ASD).  Children 2-6 years of age with ASD (N = 166) were randomized to receive placebo or 2.5 or 5.0 mg of buspirone twice daily.  The primary objective was to evaluate the effects of 24 wk of buspirone on the Autism Diagnostic Observation Schedule (ADOS) Composite Total Score.  Secondary objectives included evaluating the effects of buspirone on social competence, repetitive behaviors, language, sensory dysfunction, and anxiety and to assess side effects.  Positron emission tomog. measures of tryptophan metab. and blood serotonin concns. were assessed as predictors of buspirone efficacy.  There was no difference in the ADOS Composite Total Score between baseline and 24 wk among the 3 treatment groups (P = .400); however, the ADOS Restricted and Repetitive Behavior score showed a time-by-treatment effect (P = .006); the 2.5-mg buspirone group showed significant improvement (P = .003), whereas placebo and 5.0-mg buspirone groups showed no change.  Children in the 2.5-mg buspirone group were more likely to improve if they had fewer foci of increased brain tryptophan metab. on positron emission tomog. (P = .018) or if they showed normal levels of blood serotonin (P = .044).  Adverse events did not differ significantly among treatment groups.  Treatment with 2.5 mg of buspirone in young children with ASD might be a useful adjunct therapy to target restrictive and repetitive behaviors in conjunction with behavioral interventions.  ClinicalTrials.gov: NCT00873509.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAPUV06l84yrVg90H21EOLACvtfcHk0lhla4z-kD-inA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xis12lsQ%253D%253D&md5=ac77f3940dde32cce96b05719bbf65a9</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.jpeds.2015.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpeds.2015.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DChugani%26aufirst%3DD.%2BC.%26aulast%3DChugani%26aufirst%3DH.%2BT.%26aulast%3DWiznitzer%26aufirst%3DM.%26aulast%3DParikh%26aufirst%3DS.%26aulast%3DEvans%26aufirst%3DP.%2BA.%26aulast%3DHansen%26aufirst%3DR.%2BL.%26aulast%3DNass%26aufirst%3DR.%26aulast%3DJanisse%26aufirst%3DJ.%2BJ.%26aulast%3DDixon-Thomas%26aufirst%3DP.%26aulast%3DBehen%26aufirst%3DM.%26aulast%3DRothermel%26aufirst%3DR.%26aulast%3DParker%26aufirst%3DJ.%2BS.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DMuzik%26aufirst%3DO.%26aulast%3DEdwards%26aufirst%3DD.%2BJ.%26aulast%3DHirtz%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DSivaswamy%26aufirst%3DL.%26aulast%3DSteinhilber%26aufirst%3DG.%26aulast%3DKennedy%26aufirst%3DK.%26aulast%3DPawlik%26aufirst%3DK.%26aulast%3DRoeder%26aufirst%3DR.%26aulast%3DMalian%26aufirst%3DM.%26aulast%3DTurner%26aufirst%3DH.%26aulast%3DHanna%26aufirst%3DA.%26aulast%3DKatusin%26aufirst%3DJ.%26aulast%3DSupula%26aufirst%3DD.%26aulast%3DHalverson%26aufirst%3DS.%26aulast%3DGuy%26aufirst%3DW.%26aulast%3DGjolaj%26aufirst%3DN.%26aulast%3DMangner%26aufirst%3DT.%26aulast%3DChakraborty%26aufirst%3DP.%26aulast%3DWigeluk%26aufirst%3DA.%26aulast%3DPatterson%26aufirst%3DG.%26aulast%3DMosqueda%26aufirst%3DA.%26aulast%3DBurkett%26aufirst%3DM.%26aulast%3DDeBoard%26aufirst%3DA.%26aulast%3DCornett%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.-L.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DGermain%26aufirst%3DC.%26aulast%3DMajkowski%26aufirst%3DM.%26aulast%3DFrench%26aufirst%3DB.%26aulast%3DStolinski%26aufirst%3DA.%26aulast%3DNaguib%26aufirst%3DS.%26aulast%3DWolfe-Christensen%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DAmeli%26aufirst%3DJ.%26aulast%3DMcQueeney%26aufirst%3DJ.%2BK.%26aulast%3DRubinlicht%26aufirst%3DM.%26aulast%3DGorka%26aufirst%3DB.%26aulast%3DZacharski%26aufirst%3DE.%26aulast%3DBlumer%26aufirst%3DJ.%2BL.%26aulast%3DMaxwell%26aufirst%3DK.%26aulast%3DTasi%26aufirst%3DC.%26aulast%3DToltzis%26aufirst%3DP.%26aulast%3DKalic%26aufirst%3DJ.%26aulast%3DMorus%26aufirst%3DD.%26aulast%3DPaulett%26aufirst%3DJ.%26aulast%3DRosolowski%26aufirst%3DB.%26aulast%3DBanchy%26aufirst%3DM.%26aulast%3DWestlake%26aufirst%3DK.%26aulast%3DCalabro%26aufirst%3DB.%26aulast%3DTacket%26aufirst%3DC.%26aulast%3DAdkins%26aufirst%3DI.%26aulast%3DBuchheit%26aufirst%3DK.%26aulast%3DHepper%26aufirst%3DK.%26aulast%3DSpeicher%26aufirst%3DD.%26aulast%3DBergant%26aufirst%3DS.%26aulast%3DHaky%26aufirst%3DJ.%26aulast%3DFrohnapfel%26aufirst%3DM.%2BB.%26aulast%3DSchaefer%26aufirst%3DC.%26aulast%3DBrowning%26aufirst%3DA.%26aulast%3DBauer%26aufirst%3DR.%26aulast%3DEmbacher%26aufirst%3DR.%26aulast%3DKnapp%26aufirst%3DJ.%26aulast%3DLevy%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DD.%26aulast%3DLach%26aufirst%3DD.%26aulast%3DPetrich%26aufirst%3DJ.%26aulast%3DKreischer%26aufirst%3DS.%26aulast%3DBlubaugh%26aufirst%3DP.%26aulast%3DMorris%26aufirst%3DM.%2BA.%26aulast%3DGarver%26aufirst%3DC.%26aulast%3DAndersen%26aufirst%3DM.%26aulast%3DGreene%26aufirst%3DM.%26aulast%3DRichards%26aufirst%3DA.%26aulast%3DRocha%26aufirst%3DM.%26aulast%3DMerryman%26aufirst%3DR.%26aulast%3DGolla%26aufirst%3DS.%26aulast%3DLorenzen%26aufirst%3DA.%26aulast%3DSherrod%26aufirst%3DJ.%2BL.%26aulast%3DPerryman%26aufirst%3DP.%26aulast%3DLorduy%26aufirst%3DK.%26aulast%3DAngkustsiri%26aufirst%3DK.%26aulast%3DPlumer%26aufirst%3DL.B.%26aulast%3DSiy%2BLeigh%26aufirst%3DM.%2BJ.%26aulast%3DBacalman%26aufirst%3DS.%2BC.%26aulast%3DRoa%26aufirst%3DD.%2BL.%26aulast%3DGovindappa%26aufirst%3DK.%26aulast%3DMahajan%26aufirst%3DG.%26aulast%3DBickel%26aufirst%3DE.%26aulast%3DBrule%26aufirst%3DN.%26aulast%3DHare%26aufirst%3DE.%26aulast%3DSarwary%26aufirst%3DN.%26aulast%3DCargill%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DHom%26aufirst%3DS.%26aulast%3DSteindorf%26aufirst%3DD.%26aulast%3DPietrykowski%26aufirst%3DM.%26aulast%3DRoot%26aufirst%3DK.%26aulast%3DCoffey%26aufirst%3DS.%26aulast%3DHanzel%26aufirst%3DE.%2BP.%26aulast%3DSantana%26aufirst%3DA.%26aulast%3DRamirez%26aufirst%3DC.%26aulast%3DBerci%26aufirst%3DS.%26aulast%3DGabriel%26aufirst%3DN.%26aulast%3DHirsch%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DZwilling%26aufirst%3DA.%26aulast%3DGellatly%26aufirst%3DR.%26aulast%3DLevy%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DRodman%26aufirst%3DJ.%26aulast%3DHanna%26aufirst%3DA.%26aulast%3DOberfield%26aufirst%3DN.%26aulast%3DFriedland%26aufirst%3DS.%26aulast%3DLord%26aufirst%3DC.%26aulast%3DKozloff%26aufirst%3DR.%26aulast%3DCrouse%26aufirst%3DC.%26aulast%3DMillen%26aufirst%3DS.%26aulast%3DCoimbre%26aufirst%3DA.%2BJ.%26aulast%3DMcCarter%26aufirst%3DK.%2BL.%26aulast%3DPosey%26aufirst%3DD.%26atitle%3DEfficacy%2520of%2520low-dose%2520buspirone%2520for%2520restricted%2520and%2520repetitive%2520behavior%2520in%2520young%2520children%2520with%2520autism%2520spectrum%2520disorder%253A%2520a%2520randomized%2520trial%26jtitle%3DJ.%2520Pediatr.%26date%3D2016%26volume%3D170%26spage%3D45%26epage%3D53%26doi%3D10.1016%2Fj.jpeds.2015.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Gould, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensler, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benno, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onaivi, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daws, L. C.</span><span> </span><span class="NLM_article-title">Density and function of central serotonin (5-HT) transporters, 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2010.07104.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1111%2Fj.1471-4159.2010.07104.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21070242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2011&pages=291-303&author=G.+G.+Gouldauthor=J.+G.+Henslerauthor=T.+F.+Burkeauthor=R.+H.+Bennoauthor=E.+S.+Onaiviauthor=L.+C.+Daws&title=Density+and+function+of+central+serotonin+%285-HT%29+transporters%2C+5-HT1A+and+5-HT2A+receptors%2C+and+effects+of+their+targeting+on+BTBR+T%2Btf%2FJ+mouse+social+behavior&doi=10.1111%2Fj.1471-4159.2010.07104.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior</span></div><div class="casAuthors">Gould, Georgianna G.; Hensler, Julie G.; Burke, Teresa F.; Benno, Robert H.; Onaivi, Emmanuel S.; Daws, Lynette C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">291-303</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">BTBR mice are potentially useful tools for autism research because their behavior parallels core social interaction impairments and restricted-repetitive behaviors.  Altered regulation of central serotonin (5-HT) neurotransmission may underlie such behavioral deficits.  To test this, we compared 5-HT transporter (SERT), 5-HT1A and 5-HT2A receptor densities among BTBR and C57 strains.  Autoradiog. [3H] cyanoimipramine (1 nM) binding to SERT was 20-30% lower throughout the adult BTBR brain as compared to C57BL/10J mice.  In hippocampal membrane homogenates, [3H] citalopram maximal binding (Bmax) to SERT was 95 fmol/mg protein in BTBR and 171 fmol/mg protein in C57BL/6J mice, and the BTBR dissocn. const. (KD) was 2.0 nM vs. 1.1 in C57BL/6J mice.  Hippocampal 5-HT1A and 5-HT2A receptor binding was similar among strains.  However, 8-OH-DPAT-stimulated [35S] GTPγS binding in the BTBR hippocampal CA1 region was 28% higher, indicating elevated 5-HT1A capacity to activate G-proteins.  In BTBR mice, the SERT blocker, fluoxetine (10 mg/kg) and the 5-HT1A receptor partial-agonist, buspirone (2 mg/kg) enhanced social interactions.  The D2/5-HT2 receptor antagonist, risperidone (0.1 mg/kg) reduced marble burying, but failed to improve sociability.  Overall, altered SERT and/or 5-HT1A functionality in hippocampus could contribute to the relatively low sociability of BTBR mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7g_18Lb-yXbVg90H21EOLACvtfcHk0lgTXOXGVklOpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGqtbc%253D&md5=fe417d31e44b476c2789fa4371fbbc47</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2010.07104.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2010.07104.x%26sid%3Dliteratum%253Aachs%26aulast%3DGould%26aufirst%3DG.%2BG.%26aulast%3DHensler%26aufirst%3DJ.%2BG.%26aulast%3DBurke%26aufirst%3DT.%2BF.%26aulast%3DBenno%26aufirst%3DR.%2BH.%26aulast%3DOnaivi%26aufirst%3DE.%2BS.%26aulast%3DDaws%26aufirst%3DL.%2BC.%26atitle%3DDensity%2520and%2520function%2520of%2520central%2520serotonin%2520%25285-HT%2529%2520transporters%252C%25205-HT1A%2520and%25205-HT2A%2520receptors%252C%2520and%2520effects%2520of%2520their%2520targeting%2520on%2520BTBR%2520T%252Btf%252FJ%2520mouse%2520social%2520behavior%26jtitle%3DJ.%2520Neurochem.%26date%3D2011%26volume%3D116%26spage%3D291%26epage%3D303%26doi%3D10.1111%2Fj.1471-4159.2010.07104.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Chadman, K. K.</span><span> </span><span class="NLM_article-title">Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">586</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span><span class="refDoi"> DOI: 10.1016/j.pbb.2010.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.pbb.2010.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20863848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGgsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2011&pages=586-594&author=K.+K.+Chadman&title=Fluoxetine+but+not+risperidone+increases+sociability+in+the+BTBR+mouse+model+of+autism&doi=10.1016%2Fj.pbb.2010.09.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism</span></div><div class="casAuthors">Chadman, Kathryn K.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">586-594</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Autism, a neurodevelopmental disorder, is characterized by abnormal social interactions, impaired social communication and repetitive behaviors and/or restricted interests, along with several assocd. symptoms including irritability and anxiety.  Risperidone is approved for the irritability and self-injurious behaviors found in autism.  Fluoxetine is under evaluation for the repetitive behaviors and anxiety assocd. with autism.  These two drugs were evaluated in the BTBR T + tf/J (BTBR) mouse model of autism and C57BL/6J (B6) mice by using the three-chambered social approach test and elevated plus maze to det. effects on sociability and anxiety.  Fluoxetine increased sociability, defined as time spent with a stranger mouse, in the BTBR mice without affecting anxiety-like behavior in the elevated plus maze.  Fluoxetine did not significantly change either behavior in the B6 mice.  Risperidone did not affect sociability or anxiety-like behaviors and had a sedative-like effect at higher doses.  These findings suggest that fluoxetine may have some therapeutic efficacy for treating the social behaviors in autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9hPVBKhcsR7Vg90H21EOLACvtfcHk0lgTXOXGVklOpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGgsrjL&md5=444c92fc7db9f205599b7ff10ad6e4c4</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2010.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2010.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DChadman%26aufirst%3DK.%2BK.%26atitle%3DFluoxetine%2520but%2520not%2520risperidone%2520increases%2520sociability%2520in%2520the%2520BTBR%2520mouse%2520model%2520of%2520autism%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2011%26volume%3D97%26spage%3D586%26epage%3D594%26doi%3D10.1016%2Fj.pbb.2010.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">File, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, N.</span><span> </span><span class="NLM_article-title">Comparative study of pre- and postsynaptic 5-HT<sub>1A</sub> receptor modulation of anxiety in two ethological animal tests</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4810</span><span class="NLM_x">–</span> <span class="NLM_lpage">4815</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1523%2FJNEUROSCI.16-15-04810.1996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=8764667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADyaK28XksFWisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=4810-4815&author=S.+E.+Fileauthor=L.+E.+Gonzalezauthor=N.+Andrews&title=Comparative+study+of+pre-+and+postsynaptic+5-HT1A+receptor+modulation+of+anxiety+in+two+ethological+animal+tests"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative study of pre- and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests</span></div><div class="casAuthors">File, Sandra E.; Gonzalez, Luis E.; Andrews, Nick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4810-4815</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The purpose of this study was to det. the roles of the presynaptic 5-HT1A receptors in the median raphe nucleus (MRN) and of the postsynaptic 5-HT1A receptors in its projection area of the dorsal hippocampus in the social interaction and elevated plus-maze tests of anxiety.  Direct administration of the 5-HT1A receptor agonist (±)-8-hydroxy-dipropylaminotetralin (8-OH-DPAT, 200 ng) into the MRN had significant anxiolytic effects in all three test situations examd. (social interaction, plus-maze trials 1 and 2).  These anxiolytic effects were antagonized by a silent dose (200 ng) of the 5-HT1A receptor antagonist WAY 100635, confirming that they were mediated by 5-HT1A receptors.  In contrast, after bilateral administration to the dorsal hippocampus, 8-OH-DPAT (100 ng) had significant anxiogenic effects in the social interaction test and in plus-maze trial 2.  These anxiogenic effects were antagonized by silent doses of 5-HT1A receptor antagonists [(+)WAY 100135, 10 mg/kg s.c., and intrahippocampal (±)tertatolol, 3 μg, resp.], confirming mediation by 5-HT1A receptors.  In rats naive to the plus-maze, neither 8-OH-DPAT (50, 100, or 200 ng) nor the 5-HT1A receptor antagonist (±)tertatolol (3 μg) had any significant effect when administered to the dorsal hippocampus.  This demonstrates that previous experience of a rat in the plus-maze has a major effect on the sensitivity of dorsal hippocampal 5-HT1A receptors, as the authors have demonstrated previously for the 5-HT1A receptors in the dorsal raphe nucleus.  Overall, the results provide evidence that stimulation of the presynaptic 5-HT1A receptors in the MRN results in an anxiolytic action, whereas stimulation of the postsynaptic 5-HT1A receptors in its projection area results in an anxiogenic effect.  These results are consistent with an overall redn. in 5-HT neurotransmission in the dorsal hippocampus having an anxiolytic effect, and they explain the relatively weak anxiolytic profile detected when 5-HT1A receptor agonists are given systemically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorxA5nL19fvrVg90H21EOLACvtfcHk0lgTXOXGVklOpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XksFWisrs%253D&md5=a948423eeeec17d71ae0759c1968fc19</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.16-15-04810.1996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.16-15-04810.1996%26sid%3Dliteratum%253Aachs%26aulast%3DFile%26aufirst%3DS.%2BE.%26aulast%3DGonzalez%26aufirst%3DL.%2BE.%26aulast%3DAndrews%26aufirst%3DN.%26atitle%3DComparative%2520study%2520of%2520pre-%2520and%2520postsynaptic%25205-HT1A%2520receptor%2520modulation%2520of%2520anxiety%2520in%2520two%2520ethological%2520animal%2520tests%26jtitle%3DJ.%2520Neurosci.%26date%3D1996%26volume%3D16%26spage%3D4810%26epage%3D4815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Boulougouris, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, T. W.</span><span> </span><span class="NLM_article-title">Enhancement of spatial reversal learning by 5-HT<sub>2C</sub> receptor antagonism is neuroanatomically specific</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4312-09.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1523%2FJNEUROSCI.4312-09.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20089901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC3c%252Fks1WmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=930-938&author=V.+Boulougourisauthor=T.+W.+Robbins&title=Enhancement+of+spatial+reversal+learning+by+5-HT2C+receptor+antagonism+is+neuroanatomically+specific&doi=10.1523%2FJNEUROSCI.4312-09.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of spatial reversal learning by 5-HT2C receptor antagonism is neuroanatomically specific</span></div><div class="casAuthors">Boulougouris Vasileios; Robbins Trevor W</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of neuroscience : the official journal of the Society for Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">930-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We have recently demonstrated that systemic administration of 5-HT(2C) and 5-HT(2A) receptor antagonists significantly enhanced and impaired spatial reversal learning, respectively.  In this study, the role of 5-HT(2C) and 5-HT(2A) receptor subtypes in the mediation of these opposing effects was further investigated with respect to neuroanatomical specificity.  The roles of 5-HT(2C) and 5-HT(2A) receptors were examined within some of the brain regions implicated in cognitive flexibility, namely the orbitofrontal cortex (OFC), medial prefrontal cortex (mPFC), and nucleus accumbens (NAc), by means of targeted infusions of selective 5-HT(2C) and 5-HT(2A) receptor antagonists (SB 242084 and M100907, respectively).  Intra-OFC 5-HT(2C) receptor antagonism produced dose-dependent effects similar to those of systemic administration, i.e., improved spatial reversal learning by reducing the number of trials (all doses: 0.1, 0.3, and 1.0 microg) and perseverative errors to criterion (0.3 and 1.0 microg) compared with controls.  However, the highest dose (1.0 microg) showed a nonselective effect, as it also affected retention preceding the reversal phase and decreased learning errors.  Intracerebral infusions of SB 242084 into the mPFC or NAc produced no significant effects on any behavioral measures.  Similarly, no significant differences were observed with intra-OFC, -mPFC, or -NAc infusions of M100907.  These data suggest that the improved performance in reversal learning observed after 5-HT(2C) receptor antagonism is mediated within the OFC.  These data also bear on the issue of whether 5-HT(2C) receptor antagonism within the OFC might help elucidate the biological substrate of obsessive-compulsive disorder, offering the potential for therapeutic application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcROq2wl2Nnf8xJ5E29YNGvQfW6udTcc2eYvuCZ071j_mLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c%252Fks1WmtQ%253D%253D&md5=112e4f66f6fa39dcbdc35a6117c52e5a</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4312-09.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4312-09.2010%26sid%3Dliteratum%253Aachs%26aulast%3DBoulougouris%26aufirst%3DV.%26aulast%3DRobbins%26aufirst%3DT.%2BW.%26atitle%3DEnhancement%2520of%2520spatial%2520reversal%2520learning%2520by%25205-HT2C%2520receptor%2520antagonism%2520is%2520neuroanatomically%2520specific%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D930%26epage%3D938%26doi%3D10.1523%2FJNEUROSCI.4312-09.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Amodeo, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragozzino, M. E.</span><span> </span><span class="NLM_article-title">Risperidone and the 5-HT<sub>2A</sub> receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf/J mice</span> <span class="citation_source-journal">Autism Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span><span class="refDoi"> DOI: 10.1002/aur.1395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2Faur.1395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24894823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2cjovFajtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=555-567&author=D.+A.+Amodeoauthor=J.+H.+Jonesauthor=J.+A.+Sweeneyauthor=M.+E.+Ragozzino&title=Risperidone+and+the+5-HT2A+receptor+antagonist+M100907+improve+probabilistic+reversal+learning+in+BTBR+T+%2B+tf%2FJ+mice&doi=10.1002%2Faur.1395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf/J mice</span></div><div class="casAuthors">Amodeo Dionisio A; Jones Joshua H; Sweeney John A; Ragozzino Michael E</div><div class="citationInfo"><span class="NLM_cas:title">Autism research : official journal of the International Society for Autism Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">555-67</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impaired social interactions with restricted interests and repetitive behaviors (RRBs).  RRBs can severely limit daily living and be particularly stressful to family members.  To date, there are limited options for treating this feature in ASD.  Risperidone, an atypical antipsychotic, is approved to treat irritability in ASD, but less is known about whether it is effective in treating "higher order" RRBs, for example cognitive inflexibility.  Risperidone also has multiple receptor targets in which only a subset may be procognitive and others induce cognitive impairment. 5HT2A receptor blockade represents one promising and more targeted approach, as various preclinical studies have shown that 5HT2A receptor antagonists improve cognition.  The present study investigated whether risperidone and/or M100907, a 5HT2A receptor antagonist, improved probabilistic reversal learning performance in the BTBR T + tf/J (BTBR) mouse model of autism.  The effects of these treatments were also investigated in C57BL/6J (B6) mice as a comparison strain.  Using a spatial reversal learning test with 80/20 probabilistic feedback, similar to one in which ASD individuals exhibit impairments, both risperidone (0.125 mg) and M100907 (0.01 and 0.1 mg) improved reversal learning in BTBR mice.  Risperidone (0.125 mg) impaired reversal learning in B6 mice.  Improvement in probabilistic reversal learning performance resulted from treatments enhancing the maintenance of the newly correct choice pattern.  Because risperidone can lead to unwanted side effects, treatment with a specific 5HT2A receptor antagonist may improve cognitive flexibility in individuals with ASD while also minimizing unwanted side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcD2MeuvJF536HPRus0rAafW6udTcc2eYvuCZ071j_mLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjovFajtQ%253D%253D&md5=07b743b7a123ff77954564d2d7f7e0e2</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1002%2Faur.1395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Faur.1395%26sid%3Dliteratum%253Aachs%26aulast%3DAmodeo%26aufirst%3DD.%2BA.%26aulast%3DJones%26aufirst%3DJ.%2BH.%26aulast%3DSweeney%26aufirst%3DJ.%2BA.%26aulast%3DRagozzino%26aufirst%3DM.%2BE.%26atitle%3DRisperidone%2520and%2520the%25205-HT2A%2520receptor%2520antagonist%2520M100907%2520improve%2520probabilistic%2520reversal%2520learning%2520in%2520BTBR%2520T%2520%252B%2520tf%252FJ%2520mice%26jtitle%3DAutism%2520Res.%26date%3D2014%26volume%3D7%26spage%3D555%26epage%3D567%26doi%3D10.1002%2Faur.1395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Amodeo, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragozzino, M. E.</span><span> </span><span class="NLM_article-title">M100907 attenuates elevated grooming behavior in the BTBR mouse</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1016/j.bbr.2016.06.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bbr.2016.06.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27378338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1aisLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2016&pages=67-70&author=D.+A.+Amodeoauthor=E.+Riveraauthor=J.+T.+Dunnauthor=M.+E.+Ragozzino&title=M100907+attenuates+elevated+grooming+behavior+in+the+BTBR+mouse&doi=10.1016%2Fj.bbr.2016.06.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">M100907 attenuates elevated grooming behavior in the BTBR mouse</span></div><div class="casAuthors">Amodeo, Dionisio A.; Rivera, Elaine; Dunn, Jeffrey T.; Ragozzino, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">67-70</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Individuals with autism spectrum disorder (ASD) exhibit social-communication deficits along with restricted interests and repetitive behaviors (RRBs).  To date, there is a lack of effective treatments to alleviate RRBs.  A recent study found that treatment with the 5HT2A receptor antagonist M100907 attenuates a reversal learning deficit in the BTBR mouse model of autism.  The BTBR mouse also exhibits elevated grooming behavior which may model stereotyped motor behaviors also obsd. in ASD.  The present study examd. whether 5HT2A receptor blockade with M100907 at either 0.01 or 0.1 mg/kg can reduce repetitive grooming in BTBR mice compared to that of vehicle-treated BTBR and C57BL6/J (B6) mice.  M100907 at 0.1 mg/kg, but not 0.01 mg/kg, significantly attenuated repetitive grooming in BTBR mice compared to that of vehicle-treated BTBR mice.  M100907 at either dose did not affect grooming behavior in B6 mice.  To det. whether 0.1 mg/kg M100907 had a more general effect on activity in BTBR mice, a second expt. detd. whether M100907 at 0.1 mg/kg affected locomotor activity in BTBR mice.  M100907 treatment in BTBR and B6 mice did not alter locomotor activity compared to that of vehicle-treated BTBR and B6 mice.  The present findings taken together with past results suggest that treatment with a 5HT2A receptor antagonist may be effective in ameliorating RRBs in ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1N0hqADZmDbVg90H21EOLACvtfcHk0lg2-rPjOjtOUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1aisLjP&md5=59027c99b3f84c67e7154a1b5f82c22a</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2016.06.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2016.06.064%26sid%3Dliteratum%253Aachs%26aulast%3DAmodeo%26aufirst%3DD.%2BA.%26aulast%3DRivera%26aufirst%3DE.%26aulast%3DDunn%26aufirst%3DJ.%2BT.%26aulast%3DRagozzino%26aufirst%3DM.%2BE.%26atitle%3DM100907%2520attenuates%2520elevated%2520grooming%2520behavior%2520in%2520the%2520BTBR%2520mouse%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2016%26volume%3D313%26spage%3D67%26epage%3D70%26doi%3D10.1016%2Fj.bbr.2016.06.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Amodeo, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, E. H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragozzino, M. E.</span><span> </span><span class="NLM_article-title">5-HT<sub>2A</sub> receptor blockade in dorsomedial striatum reduces repetitive behaviors in BTBR mice</span> <span class="citation_source-journal">Genes, Brain Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span><span class="refDoi"> DOI: 10.1111/gbb.12343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1111%2Fgbb.12343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27717169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsFCmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=342-351&author=D.+A.+Amodeoauthor=E.+Riveraauthor=E.+H.+Cookauthor=J.+A.+Sweeneyauthor=M.+E.+Ragozzino&title=5-HT2A+receptor+blockade+in+dorsomedial+striatum+reduces+repetitive+behaviors+in+BTBR+mice&doi=10.1111%2Fgbb.12343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">5HT2A receptor blockade in dorsomedial striatum reduces repetitive behaviors in BTBR mice</span></div><div class="casAuthors">Amodeo, D. A.; Rivera, E.; Cook, E. H., Jr.; Sweeney, J. A.; Ragozzino, M. E.</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Brain and Behavior</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">342-351</span>CODEN:
                <span class="NLM_cas:coden">GBBEAO</span>;
        ISSN:<span class="NLM_cas:issn">1601-183X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Restricted and repetitive behaviors are a defining feature of autism, which can be expressed as a cognitive flexibility deficit or stereotyped, motor behaviors.  There is limited knowledge about the underlying neuropathophysiol. contributing to these behaviors.  Previous findings suggest that central 5HT2A receptor activity is altered in autism, while recent work indicates that systemic 5HT2A receptor antagonist treatment reduces repetitive behaviors in an idiopathic model of autism.  5HT2A receptors are expressed in the orbitofrontal cortex and striatum.  These two regions have been shown to be altered in autism.  The present study investigated whether 5HT2A receptor blockade in the dorsomedial striatum or orbitofrontal cortex in the BTBR mouse strain, an idiopathic model of autism, affects the phenotype related to restricted and repetitive behaviors.  Microinfusion of the 5HT2A receptor antagonist, M100907 into the dorsomedial striatum alleviated a reversal learning impairment and attenuated grooming behavior.  M100907 infusion into the orbitofrontal cortex increased perseveration during reversal learning and potentiated grooming.  These findings suggest that increased 5HT2A receptor activity in the dorsomedial striatum may contribute to behavioral inflexibility and stereotyped behaviors in the BTBR mouse.  The 5HT2A receptor signaling in the orbitofrontal cortex may be crit. for inhibiting a previously learned response during reversal learning and expression of stereotyped behavior.  The present results suggest which brain areas exhibit abnormalities underlying repetitive behaviors in an idiopathic mouse model of autism, as well as which brain areas systemic treatment with M100907 may principally act on in BTBR mice to attenuate repetitive behaviors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoLK-d9UGL8rVg90H21EOLACvtfcHk0ljI5TRQ687jQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsFCmurw%253D&md5=9042e327b431566410c7ccf9a0934bab</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1111%2Fgbb.12343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fgbb.12343%26sid%3Dliteratum%253Aachs%26aulast%3DAmodeo%26aufirst%3DD.%2BA.%26aulast%3DRivera%26aufirst%3DE.%26aulast%3DCook%26aufirst%3DE.%2BH.%26aulast%3DSweeney%26aufirst%3DJ.%2BA.%26aulast%3DRagozzino%26aufirst%3DM.%2BE.%26atitle%3D5-HT2A%2520receptor%2520blockade%2520in%2520dorsomedial%2520striatum%2520reduces%2520repetitive%2520behaviors%2520in%2520BTBR%2520mice%26jtitle%3DGenes%252C%2520Brain%2520Behav.%26date%3D2017%26volume%3D16%26spage%3D342%26epage%3D351%26doi%3D10.1111%2Fgbb.12343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Kvachnina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dityatev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dityateva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voyno-Yasenetskaya, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponimaskin, E. G.</span><span> </span><span class="NLM_article-title">5-HT<sub>7</sub> receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">7821</span><span class="NLM_x">–</span> <span class="NLM_lpage">7830</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1790-05.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1523%2FJNEUROSCI.1790-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=16120784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvVKgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=7821-7830&author=E.+Kvachninaauthor=G.+Liuauthor=A.+Dityatevauthor=U.+Rennerauthor=A.+Dumuisauthor=D.+W.+Richterauthor=G.+Dityatevaauthor=M.+Schachnerauthor=T.+A.+Voyno-Yasenetskayaauthor=E.+G.+Ponimaskin&title=5-HT7+receptor+is+coupled+to+G+alpha+subunits+of+heterotrimeric+G12-protein+to+regulate+gene+transcription+and+neuronal+morphology&doi=10.1523%2FJNEUROSCI.1790-05.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT7 receptor is coupled to Gα subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology</span></div><div class="casAuthors">Kvachnina, Elena; Liu, Guoquan; Dityatev, Alexander; Renner, Ute; Dumuis, Aline; Richter, Diethelm W.; Dityateva, Galina; Schachner, Melitta; Voyno-Yasenetskaya, Tatyana A.; Ponimaskin, Evgeni G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">7821-7830</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The neurotransmitter serotonin (5-HT) plays an important role in the regulation of multiple events in the CNS.  The authors demonstrated recently a coupling between the 5-HT4 receptor and the heterotrimeric G13-protein resulting in RhoA-dependent neurite retraction and cell rounding.  In the present study, the authors identified G12 as an addnl. G-protein that can be activated by another member of serotonin receptors, the 5-HT7 receptor.  Expression of 5-HT7 receptor induced constitutive and agonist-dependent activation of a serum response element-mediated gene transcription through G12-mediated activation of small GTPases.  In NIH3T3 cells, activation of the 5-HT7 receptor induced filopodia formation via a Cdc42-mediated pathway correlating with RhoA-dependent cell rounding.  In mouse hippocampal neurons, activation of the endogenous 5-HT7 receptors significantly increased neurite length, whereas stimulation of 5-HT4 receptors led to a decrease in the length and no. of neurites.  These data demonstrate distinct roles for 5-HT7R/G12 and 5-HT4R/G13 signaling pathways in neurite outgrowth and retraction, suggesting that serotonin plays a prominent role in regulating the neuronal cytoarchitecture in addn. to its classical role as neurotransmitter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYY4-5ryShm7Vg90H21EOLACvtfcHk0ljI5TRQ687jQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvVKgu7c%253D&md5=46861cf8fcd57de268bfa8f7450cac69</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1790-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1790-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DKvachnina%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DDityatev%26aufirst%3DA.%26aulast%3DRenner%26aufirst%3DU.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DRichter%26aufirst%3DD.%2BW.%26aulast%3DDityateva%26aufirst%3DG.%26aulast%3DSchachner%26aufirst%3DM.%26aulast%3DVoyno-Yasenetskaya%26aufirst%3DT.%2BA.%26aulast%3DPonimaskin%26aufirst%3DE.%2BG.%26atitle%3D5-HT7%2520receptor%2520is%2520coupled%2520to%2520G%2520alpha%2520subunits%2520of%2520heterotrimeric%2520G12-protein%2520to%2520regulate%2520gene%2520transcription%2520and%2520neuronal%2520morphology%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D7821%26epage%3D7830%26doi%3D10.1523%2FJNEUROSCI.1790-05.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Kobe, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guseva, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medrihan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerholz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzog, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radyushkin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kordi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenreich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusakov, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponimaskin, E. G.</span><span> </span><span class="NLM_article-title">5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2915</span><span class="NLM_x">–</span> <span class="NLM_lpage">2930</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.2765-11.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1523%2FJNEUROSCI.2765-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22378867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XjslKjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=2915-2930&author=F.+Kobeauthor=D.+Gusevaauthor=T.+P.+Jensenauthor=A.+Wirthauthor=U.+Rennerauthor=D.+Hessauthor=M.+M%C3%BCllerauthor=L.+Medrihanauthor=W.+Zhangauthor=M.+Zhangauthor=K.+Braunauthor=S.+Westerholzauthor=A.+Herzogauthor=K.+Radyushkinauthor=A.+El-Kordiauthor=H.+Ehrenreichauthor=D.+W.+Richterauthor=D.+A.+Rusakovauthor=E.+G.+Ponimaskin&title=5-HT7R%2FG12+signaling+regulates+neuronal+morphology+and+function+in+an+age-dependent+manner&doi=10.1523%2FJNEUROSCI.2765-11.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner</span></div><div class="casAuthors">Kobe, Fritz; Guseva, Daria; Jensen, Thomas P.; Wirth, Alexander; Renner, Ute; Hess, Dietmar; Mueller, Michael; Medrihan, Lucian; Zhang, Weiqi; Zhang, Mingyue; Braun, Katharina; Westerholz, Soeren; Herzog, Andreas; Radyushkin, Konstantin; El-Kordi, Ahmed; Ehrenreich, Hannelore; Richter, Diethelm W.; Rusakov, Dmitri A.; Ponimaskin, Evgeni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2915-2930</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The common neurotransmitter serotonin controls different aspects of early neuronal differentiation, although the underlying mechanisms are poorly understood.  Here we report that activation of the serotonin 5-HT7 receptor promotes synaptogenesis and enhances synaptic activity in hippocampal neurons at early postnatal stages.  An anal. of Gα12-deficient mice reveals a crit. role of G12-protein for 5-HT7 receptor-mediated effects in neurons.  In organotypic prepns. from the hippocampus of juvenile mice, stimulation of 5-HT7R/G12 signaling potentiates formation of dendritic spines, increases neuronal excitability, and modulates synaptic plasticity.  In contrast, in older neuronal prepns., morphogenetic and synaptogenic effects of 5-HT7/G12 signaling are abolished.  Moreover, inhibition of 5-HT7 receptor had no effect on synaptic plasticity in hippocampus of adult animals.  Expression anal. reveals that the prodn. of 5-HT7 and Gα12-proteins in the hippocampus undergoes strong regulation with a pronounced transient increase during early postnatal stages.  Thus, regulated expression of 5-HT7 receptor and Gα12-protein may represent a mol. mechanism by which serotonin specifically modulates formation of initial neuronal networks during early postnatal development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcV8lb4lfGdbVg90H21EOLACvtfcHk0ljI5TRQ687jQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjslKjt7Y%253D&md5=4cd2f5bc8e09e3d14962a60d37175bdf</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2765-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2765-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DKobe%26aufirst%3DF.%26aulast%3DGuseva%26aufirst%3DD.%26aulast%3DJensen%26aufirst%3DT.%2BP.%26aulast%3DWirth%26aufirst%3DA.%26aulast%3DRenner%26aufirst%3DU.%26aulast%3DHess%26aufirst%3DD.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DMedrihan%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DBraun%26aufirst%3DK.%26aulast%3DWesterholz%26aufirst%3DS.%26aulast%3DHerzog%26aufirst%3DA.%26aulast%3DRadyushkin%26aufirst%3DK.%26aulast%3DEl-Kordi%26aufirst%3DA.%26aulast%3DEhrenreich%26aufirst%3DH.%26aulast%3DRichter%26aufirst%3DD.%2BW.%26aulast%3DRusakov%26aufirst%3DD.%2BA.%26aulast%3DPonimaskin%26aufirst%3DE.%2BG.%26atitle%3D5-HT7R%252FG12%2520signaling%2520regulates%2520neuronal%2520morphology%2520and%2520function%2520in%2520an%2520age-dependent%2520manner%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D2915%26epage%3D2930%26doi%3D10.1523%2FJNEUROSCI.2765-11.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Speranza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambery, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Domenico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crispino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severino, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpicelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellenchi, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Porzio, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone-Capano, C.</span><span> </span><span class="NLM_article-title">The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuropharm.2012.10.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=155-167&author=L.+Speranzaauthor=A.+Chamberyauthor=M.+Di+Domenicoauthor=M.+Crispinoauthor=V.+Severinoauthor=F.+Volpicelliauthor=M.+Leopoldoauthor=G.+C.+Bellenchiauthor=U.+di+Porzioauthor=C.+Perrone-Capano&title=The+serotonin+receptor+7+promotes+neurite+outgrowth+via+ERK+and+Cdk5+signaling+pathways&doi=10.1016%2Fj.neuropharm.2012.10.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DSperanza%26aufirst%3DL.%26aulast%3DChambery%26aufirst%3DA.%26aulast%3DDi%2BDomenico%26aufirst%3DM.%26aulast%3DCrispino%26aufirst%3DM.%26aulast%3DSeverino%26aufirst%3DV.%26aulast%3DVolpicelli%26aufirst%3DF.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DBellenchi%26aufirst%3DG.%2BC.%26aulast%3Ddi%2BPorzio%26aufirst%3DU.%26aulast%3DPerrone-Capano%26aufirst%3DC.%26atitle%3DThe%2520serotonin%2520receptor%25207%2520promotes%2520neurite%2520outgrowth%2520via%2520ERK%2520and%2520Cdk5%2520signaling%2520pathways%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D67%26spage%3D155%26epage%3D167%26doi%3D10.1016%2Fj.neuropharm.2012.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Speranza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpicelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Stefano, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambery, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellenchi, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Porzio, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crispino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone-Capano, C.</span><span> </span><span class="NLM_article-title">Activation of 5-HT<sub>7</sub> receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics</span> <span class="citation_source-journal">Front. Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="refDoi"> DOI: 10.3389/fnbeh.2015.00062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3389%2Ffnbeh.2015.00062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25814944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsV2ht7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=62&author=L.+Speranzaauthor=T.+Giulianoauthor=F.+Volpicelliauthor=M.+E.+De+Stefanoauthor=L.+Lombardiauthor=A.+Chamberyauthor=E.+Lacivitaauthor=M.+Leopoldoauthor=G.+C.+Bellenchiauthor=U.+di+Porzioauthor=M.+Crispinoauthor=C.+Perrone-Capano&title=Activation+of+5-HT7+receptor+stimulates+neurite+elongation+through+mTOR%2C+Cdc42+and+actin+filaments+dynamics&doi=10.3389%2Ffnbeh.2015.00062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of 5-HT7 receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics</span></div><div class="casAuthors">Speranza, Luisa; Giuliano, Teresa; Volpicelli, Floriana; De Stefano, M. Egle; Lombardi, Loredana; Chambery, Angela; Lacivita, Enza; Leopoldo, Marcello; Bellenchi, Gian C.; di Porzio, Umberto; Crispino, Marianna; Perrone-Capano, Carla</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">62/1-62/14</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Recent studies have indicated that the serotonin receptor subtype 7 (5-HT7R) plays a crucial role in shaping neuronal morphol. during embryonic and early postnatal life.  Here we show that pharmacol. stimulation of 5-HT7R using a highly selective agonist, LP-211, enhances neurite outgrowth in neuronal primary cultures from the cortex, hippocampus and striatal complex of embryonic mouse brain, through multiple signal transduction pathways.  All these signaling systems, involving mTOR, the Rho GTPase Cdc42, Cdk5, and ERK, are known to converge on the reorganization of cytoskeletal proteins that subserve neurite outgrowth.  Indeed, our data indicate that neurite elongation stimulated by 5-HT7R is modulated by drugs affecting actin polymn.  In addn., we show, by 2D Western blot analyses, that treatment of neuronal cultures with LP-211 alters the expression profile of cofilin, an actin binding protein involved in microfilaments dynamics.  Furthermore, by using microfluidic chambers that phys. sep. axons from the soma and dendrites, we demonstrate that agonist-dependent activation of 5-HT7R stimulates axonal elongation.  Our results identify for the first time several signal transduction pathways, activated by stimulation of 5-HT7R, that converge to promote cytoskeleton reorganization and consequent modulation of axonal elongation.  Therefore, the activation of 5-HT7R might represent one of the key elements regulating CNS connectivity and plasticity during development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbp2mV1sLJ9LVg90H21EOLACvtfcHk0lhH1yqE19PRgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2ht7bK&md5=d55b03d0f3f833977f459818e4dafea6</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2015.00062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2015.00062%26sid%3Dliteratum%253Aachs%26aulast%3DSperanza%26aufirst%3DL.%26aulast%3DGiuliano%26aufirst%3DT.%26aulast%3DVolpicelli%26aufirst%3DF.%26aulast%3DDe%2BStefano%26aufirst%3DM.%2BE.%26aulast%3DLombardi%26aufirst%3DL.%26aulast%3DChambery%26aufirst%3DA.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DBellenchi%26aufirst%3DG.%2BC.%26aulast%3Ddi%2BPorzio%26aufirst%3DU.%26aulast%3DCrispino%26aufirst%3DM.%26aulast%3DPerrone-Capano%26aufirst%3DC.%26atitle%3DActivation%2520of%25205-HT7%2520receptor%2520stimulates%2520neurite%2520elongation%2520through%2520mTOR%252C%2520Cdc42%2520and%2520actin%2520filaments%2520dynamics%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2015%26volume%3D9%26spage%3D62%26doi%3D10.3389%2Ffnbeh.2015.00062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Speranza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpicelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guseva, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellenchi, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Porzio, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bijata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone-Capano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponimaskin, E. G.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>7</sub> receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span><span class="refDoi"> DOI: 10.1111/jnc.13962</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1111%2Fjnc.13962" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=28122114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvVWisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2017&pages=647-661&author=L.+Speranzaauthor=J.+Labusauthor=F.+Volpicelliauthor=D.+Gusevaauthor=E.+Lacivitaauthor=M.+Leopoldoauthor=G.+C.+Bellenchiauthor=U.+di+Porzioauthor=M.+Bijataauthor=C.+Perrone-Capanoauthor=E.+G.+Ponimaskin&title=Serotonin+5-HT7+receptor+increases+the+density+of+dendritic+spines+and+facilitates+synaptogenesis+in+forebrain+neurons&doi=10.1111%2Fjnc.13962"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT7 receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons</span></div><div class="casAuthors">Speranza, Luisa; Labus, Josephine; Volpicelli, Floriana; Guseva, Daria; Lacivita, Enza; Leopoldo, Marcello; Bellenchi, Gian Carlo; di Porzio, Umberto; Bijata, Monika; Perrone-Capano, Carla; Ponimaskin, Evgeni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">647-661</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Precise control of dendritic spine d. and synapse formation is crit. for normal and pathol. brain functions.  Therefore, signaling pathways influencing dendrite outgrowth and remodeling remain a subject of extensive investigations.  Here, we report that prolonged activation of the serotonin 5-HT7 receptor (5-HT7R) with selective agonist LP-211 promotes formation of dendritic spines and facilitates synaptogenesis in postnatal cortical and striatal neurons.  Crit. role of 5-HT7R in neuronal morphogenesis was confirmed by anal. of neurons isolated from 5-HT7R-deficient mice and by pharmacol. inactivation of the receptor.  Acute activation of 5-HT7R results in pronounced neurite elongation in postnatal striatal and cortical neurons, thus extending previous data on the morphogenic role of 5-HT7R in embryonic and hippocampal neurons.  We also obsd. decreased no. of spines in neurons with either genetically (i.e. 5-HT7R-knock-out) or pharmacol. (i.e. antagonist treatment) blocked 5-HT7R, suggesting that constitutive 5-HT7R activity is critically involved in the spinogenesis.  Moreover, cyclin-dependent kinase 5 and small GTPase Cdc42 were identified as important downstream effectors mediating morphogenic effects of 5-HT7R in neurons.  Altogether, our data suggest that the 5-HT7R-mediated structural reorganization during the postnatal development might have a crucial role for the development and plasticity of forebrain areas such as cortex and striatum, and thereby can be implicated in regulation of the higher cognitive functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocjTpuuLOBcrVg90H21EOLACvtfcHk0liVb7E06c9Z6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvVWisL8%253D&md5=f9925d4fa2ebe414faec1234364a1e8f</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13962%26sid%3Dliteratum%253Aachs%26aulast%3DSperanza%26aufirst%3DL.%26aulast%3DLabus%26aufirst%3DJ.%26aulast%3DVolpicelli%26aufirst%3DF.%26aulast%3DGuseva%26aufirst%3DD.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DBellenchi%26aufirst%3DG.%2BC.%26aulast%3Ddi%2BPorzio%26aufirst%3DU.%26aulast%3DBijata%26aufirst%3DM.%26aulast%3DPerrone-Capano%26aufirst%3DC.%26aulast%3DPonimaskin%26aufirst%3DE.%2BG.%26atitle%3DSerotonin%25205-HT7%2520receptor%2520increases%2520the%2520density%2520of%2520dendritic%2520spines%2520and%2520facilitates%2520synaptogenesis%2520in%2520forebrain%2520neurons%26jtitle%3DJ.%2520Neurochem.%26date%3D2017%26volume%3D141%26spage%3D647%26epage%3D661%26doi%3D10.1111%2Fjnc.13962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Vizuete, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venero, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traiffort, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machado, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano, J.</span><span> </span><span class="NLM_article-title">Expression of 5-HT<sub>7</sub> receptor mRNA in rat brain during postnatal development</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">227</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/S0304-3940(97)00302-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0304-3940%2897%2900302-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=1997&pages=53-56&author=M.+L.+Vizueteauthor=J.+L.+Veneroauthor=E.+Traiffortauthor=C.+Vargasauthor=A.+Machadoauthor=J.+Cano&title=Expression+of+5-HT7+receptor+mRNA+in+rat+brain+during+postnatal+development&doi=10.1016%2FS0304-3940%2897%2900302-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2897%2900302-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252897%252900302-9%26sid%3Dliteratum%253Aachs%26aulast%3DVizuete%26aufirst%3DM.%2BL.%26aulast%3DVenero%26aufirst%3DJ.%2BL.%26aulast%3DTraiffort%26aufirst%3DE.%26aulast%3DVargas%26aufirst%3DC.%26aulast%3DMachado%26aufirst%3DA.%26aulast%3DCano%26aufirst%3DJ.%26atitle%3DExpression%2520of%25205-HT7%2520receptor%2520mRNA%2520in%2520rat%2520brain%2520during%2520postnatal%2520development%26jtitle%3DNeurosci.%2520Lett.%26date%3D1997%26volume%3D227%26spage%3D53%26epage%3D56%26doi%3D10.1016%2FS0304-3940%2897%2900302-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Leo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adriani, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavaliere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Porzio, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone-Capano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laviola, G.</span><span> </span><span class="NLM_article-title">Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology</span> <span class="citation_source-journal">Genes, Brain Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span><span class="refDoi"> DOI: 10.1111/j.1601-183X.2009.00486.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1111%2Fj.1601-183X.2009.00486.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=19243449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtFeis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=356-368&author=D.+Leoauthor=W.+Adrianiauthor=C.+Cavaliereauthor=G.+Cirilloauthor=E.+M.+Marcoauthor=E.+Romanoauthor=U.+di+Porzioauthor=M.+Papaauthor=C.+Perrone-Capanoauthor=G.+Laviola&title=Methylphenidate+to+adolescent+rats+drives+enduring+changes+of+accumbal+Htr7+expression%3A+implications+for+impulsive+behavior+and+neuronal+morphology&doi=10.1111%2Fj.1601-183X.2009.00486.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology</span></div><div class="casAuthors">Leo, D.; Adriani, W.; Cavaliere, C.; Cirillo, G.; Marco, E. M.; Romano, E.; Di Porzio, U.; Papa, M.; Perrone-Capano, C.; Laviola, G.</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Brain and Behavior</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">356-368</span>CODEN:
                <span class="NLM_cas:coden">GBBEAO</span>;
        ISSN:<span class="NLM_cas:issn">1601-1848</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Methylphenidate (MPH) administration to adolescent rodents produces persistent region-specific changes in brain reward circuits and alterations of reward-based behavior.  We show that these modifications include a marked increment of serotonin (5-hydroxy-tryptamine) receptor type 7 (Htr7) expression and synaptic contacts, mainly in the nucleus accumbens, and a redn. of basal behavioral impulsivity.  We show that neural and behavioral consequences are functionally related: administration of a selective Htr7 antagonist fully counteracts the MPH-reduced impulsive behavior and enhances impulsivity when administered alone in naive rats.  Agonist-induced activation of endogenous Htr7 significantly increases neurite length in striatal neuron primary cultures, thus suggesting plastic remodeling of neuronal morphol.  The mixed Htr (1a/7) agonist, 8-OH-DPAT, reduces impulsive behavior in adolescent rats and in naive adults, whose impulsivity is enhanced by the Htr7 antagonist.  In summary, behavioral pharmacol. expts. show that Htr7 mediates self-control behavior, and brain primary cultures expts. indicate that this receptor may be involved in the underlying neural plasticity, through changes in neuronal cytoarchitecture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojF4CMhcNITbVg90H21EOLACvtfcHk0liVb7E06c9Z6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtFeis70%253D&md5=f7238775c5ba3b2f49a76f85b5a369e6</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1111%2Fj.1601-183X.2009.00486.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1601-183X.2009.00486.x%26sid%3Dliteratum%253Aachs%26aulast%3DLeo%26aufirst%3DD.%26aulast%3DAdriani%26aufirst%3DW.%26aulast%3DCavaliere%26aufirst%3DC.%26aulast%3DCirillo%26aufirst%3DG.%26aulast%3DMarco%26aufirst%3DE.%2BM.%26aulast%3DRomano%26aufirst%3DE.%26aulast%3Ddi%2BPorzio%26aufirst%3DU.%26aulast%3DPapa%26aufirst%3DM.%26aulast%3DPerrone-Capano%26aufirst%3DC.%26aulast%3DLaviola%26aufirst%3DG.%26atitle%3DMethylphenidate%2520to%2520adolescent%2520rats%2520drives%2520enduring%2520changes%2520of%2520accumbal%2520Htr7%2520expression%253A%2520implications%2520for%2520impulsive%2520behavior%2520and%2520neuronal%2520morphology%26jtitle%3DGenes%252C%2520Brain%2520Behav.%26date%3D2009%26volume%3D8%26spage%3D356%26epage%3D368%26doi%3D10.1111%2Fj.1601-183X.2009.00486.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">De Filippis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nativio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricceri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adriani, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passarelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laviola, G.</span><span> </span><span class="NLM_article-title">Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2506</span><span class="NLM_x">–</span> <span class="NLM_lpage">2518</span><span class="refDoi"> DOI: 10.1038/npp.2014.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnpp.2014.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24809912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVGru7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=2506-2518&author=B.+De+Filippisauthor=P.+Nativioauthor=A.+Fabbriauthor=L.+Ricceriauthor=W.+Adrianiauthor=E.+Lacivitaauthor=M.+Leopoldoauthor=F.+Passarelliauthor=A.+Fusoauthor=G.+Laviola&title=Pharmacological+stimulation+of+the+brain+serotonin+receptor+7+as+a+novel+therapeutic+approach+for+Rett+syndrome&doi=10.1038%2Fnpp.2014.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Stimulation of the Brain Serotonin Receptor 7 as a Novel Therapeutic Approach for Rett Syndrome</span></div><div class="casAuthors">De Filippis, Bianca; Nativio, Paola; Fabbri, Alessia; Ricceri, Laura; Adriani, Walter; Lacivita, Enza; Leopoldo, Marcello; Passarelli, Francesca; Fuso, Andrea; Laviola, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2506-2518</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a rare neurodevelopmental disorder, characterized by severe behavioral and physiol. symptoms.  Mutations in the Me CpG-binding protein 2 gene (MECP2) cause >95% of classic cases, and currently there is no cure for this devastating disorder.  The serotonin receptor 7 (5-HT7R) is linked to neuro-physiol. regulation of circadian rhythm, mood, cognition, and synaptic plasticity.  We presently report that 5-HT7R d. is consistently reduced in cortical and hippocampal brain areas of symptomatic MeCP2-308 male mice, a RTT model.  Systemic repeated treatment with LP-211 (0.25 mg/kg once/day for 7 days), a brain-penetrant selective 5-HT7R agonist, was able to rescue RTT-related defective performance: anxiety-related profiles in a Light/Dark test, motor abilities in a Dowel test, the exploratory behavior in the Marble Burying test, as well as memory in the Novelty Preference task.  In the brain of RTT mice, LP-211 also reversed the abnormal activation of PAK and cofilin (key regulators of actin cytoskeleton dynamics) and of the ribosomal protein (rp) S6, whose reduced activation in MECP2 mutant neurons by mTOR is responsible for the altered protein translational control.  Present findings indicate that pharmacol. targeting of 5-HT7R improves specific behavioral and mol. manifestations of RTT, thus representing a first step toward the validation of an innovative systemic treatment.  Beyond RTT, the latter might be extended to other disorders assocd. with intellectual disability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnrsCidW_X5rVg90H21EOLACvtfcHk0lgXq4KHC5K5Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVGru7s%253D&md5=3ca5c55ceaee5c6091033f92eb30a60d</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2014.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2014.105%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFilippis%26aufirst%3DB.%26aulast%3DNativio%26aufirst%3DP.%26aulast%3DFabbri%26aufirst%3DA.%26aulast%3DRicceri%26aufirst%3DL.%26aulast%3DAdriani%26aufirst%3DW.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DPassarelli%26aufirst%3DF.%26aulast%3DFuso%26aufirst%3DA.%26aulast%3DLaviola%26aufirst%3DG.%26atitle%3DPharmacological%2520stimulation%2520of%2520the%2520brain%2520serotonin%2520receptor%25207%2520as%2520a%2520novel%2520therapeutic%2520approach%2520for%2520Rett%2520syndrome%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D2506%26epage%3D2518%26doi%3D10.1038%2Fnpp.2014.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">De Filippis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiodi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adriani, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domenici, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laviola, G.</span><span> </span><span class="NLM_article-title">Long-lasting beneficial effects of central serotonin receptor 7 stimulation in female mice modeling Rett syndrome</span> <span class="citation_source-journal">Front. Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="refDoi"> DOI: 10.3389/fnbeh.2015.00086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3389%2Ffnbeh.2015.00086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25926782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsV2htL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=86&author=B.+De+Filippisauthor=V.+Chiodiauthor=W.+Adrianiauthor=E.+Lacivitaauthor=C.+Mallozziauthor=M.+Leopoldoauthor=M.+R.+Domeniciauthor=A.+Fusoauthor=G.+Laviola&title=Long-lasting+beneficial+effects+of+central+serotonin+receptor+7+stimulation+in+female+mice+modeling+Rett+syndrome&doi=10.3389%2Ffnbeh.2015.00086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Long-lasting beneficial effects of central serotonin receptor 7 stimulation in female mice modeling Rett syndrome</span></div><div class="casAuthors">De Filippis, Bianca; Chiodi, Valentina; Adriani, Walter; Lacivita, Enza; Mallozzi, Cinzia; Leopoldo, Marcello; Domenici, Maria Rosaria; Fuso, Andrea; Laviola, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86/1-86/11</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a rare neurodevelopmental disorder, characterized by severe behavioral and physiol. symptoms.  Mutations in the Me CpG binding protein 2 gene (MECP2) cause more than 95% of classic cases, and currently there is no cure for this devastating disorder.  Recently we have demonstrated that specific behavioral and brain mol. alterations can be rescued in MeCP2-308 male mice, a RTT mouse model, by pharmacol. stimulation of the brain serotonin receptor 7 (5-HT7R).  This member of the serotonin receptor family-crucially involved in the regulation of brain structural plasticity and cognitive processes-can be stimulated by systemic repeated treatment with LP-211, a brain-penetrant selective 5-HT7R agonist.  The present study extends previous findings by demonstrating that the LP-211 treatment (0.25 mg/kg, once per day for 7 days) rescues RTT-related phenotypic alterations, motor coordination (Dowel test), spatial ref. memory (Barnes maze test) and synaptic plasticity (hippocampal long-term-potentiation) in MeCP2-308 heterozygous female mice, the genetic and hormonal milieu that resembles that of RTT patients.  LP-211 also restores the activation of the ribosomal protein (rp) S6, the downstream target of mTOR and S6 kinase, in the hippocampus of RTT female mice.  Notably, the beneficial effects on neurobehavioral and mol. parameters of a seven-day long treatment with LP-211 were evident up to 2 mo after the last injection, thus suggesting long-lasting effects on RTT-related impairments.  Taken together with our previous study, these results provide compelling preclin. evidence of the potential therapeutic value for RTT of a pharmacol. approach targeting the brain 5-HT7R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmp6k2rYlzgrVg90H21EOLACvtfcHk0lgXq4KHC5K5Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2htL7N&md5=2ceb672cfb7eaadae64c42e68412f818</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2015.00086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2015.00086%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFilippis%26aufirst%3DB.%26aulast%3DChiodi%26aufirst%3DV.%26aulast%3DAdriani%26aufirst%3DW.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DMallozzi%26aufirst%3DC.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DDomenici%26aufirst%3DM.%2BR.%26aulast%3DFuso%26aufirst%3DA.%26aulast%3DLaviola%26aufirst%3DG.%26atitle%3DLong-lasting%2520beneficial%2520effects%2520of%2520central%2520serotonin%2520receptor%25207%2520stimulation%2520in%2520female%2520mice%2520modeling%2520Rett%2520syndrome%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2015%26volume%3D9%26spage%3D86%26doi%3D10.3389%2Ffnbeh.2015.00086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Valenti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laviola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Filippis, B.</span><span> </span><span class="NLM_article-title">Stimulation of the brain serotonin receptor 7 rescues mitochondrial dysfunction in female mice from two models of Rett syndrome</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.04.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuropharm.2017.04.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=28419872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntVKqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2017&pages=79-88&author=D.+Valentiauthor=L.+de+Bariauthor=D.+Vigliauthor=E.+Lacivitaauthor=M.+Leopoldoauthor=G.+Laviolaauthor=R.+A.+Vaccaauthor=B.+De+Filippis&title=Stimulation+of+the+brain+serotonin+receptor+7+rescues+mitochondrial+dysfunction+in+female+mice+from+two+models+of+Rett+syndrome&doi=10.1016%2Fj.neuropharm.2017.04.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of the brain serotonin receptor 7 rescues mitochondrial dysfunction in female mice from two models of Rett syndrome</span></div><div class="casAuthors">Valenti, Daniela; de Bari, Lidia; Vigli, Daniele; Lacivita, Enza; Leopoldo, Marcello; Laviola, Giovanni; Vacca, Rosa Anna; De Filippis, Bianca</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a rare neurodevelopmental disorder, characterized by severe behavioral and physiol. symptoms.  Mutations in the Me CpG binding protein 2 gene (MECP2) cause more than 95% of classic cases, and currently there is no cure for this devastating disorder.  Recently we have demonstrated that neurobehavioral and brain mol. alterations can be rescued in a RTT mouse model, by pharmacol. stimulation of the brain serotonin receptor 7 (5-HT7R).  This member of the serotonin receptor family, crucially involved in the regulation of brain structural plasticity and cognitive processes, can be stimulated by systemic repeated treatment with LP-211, a brain-penetrant selective agonist.  The present study extends previous findings by demonstrating that LP-211 treatment (0.25 mg/kg, once per day for 7 days) rescues mitochondrial respiratory chain impairment, oxidative phosphorylation deficiency and the reduced energy status in the brain of heterozygous female mice from two highly validated mouse models of RTT (MeCP2-308 and MeCP2-Bird mice).  Moreover, LP-211 treatment completely restored the radical species overprodn. by brain mitochondria in the MeCP2-308 model and partially recovered the oxidative imbalance in the more severely affected MeCP2-Bird model.  These results provide the first evidence that RTT brain mitochondrial dysfunction can be rescued targeting the brain 5-HT7R and add compelling preclin. evidence of the potential therapeutic value of LP-211 as a pharmacol. approach for this devastating neurodevelopmental disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcGf0zr-8zC7Vg90H21EOLACvtfcHk0lgXTUOSmHGDuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntVKqtbc%253D&md5=e9afc4ce248190af567dc4f38099601e</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.04.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.04.024%26sid%3Dliteratum%253Aachs%26aulast%3DValenti%26aufirst%3DD.%26aulast%3Dde%2BBari%26aufirst%3DL.%26aulast%3DVigli%26aufirst%3DD.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLaviola%26aufirst%3DG.%26aulast%3DVacca%26aufirst%3DR.%2BA.%26aulast%3DDe%2BFilippis%26aufirst%3DB.%26atitle%3DStimulation%2520of%2520the%2520brain%2520serotonin%2520receptor%25207%2520rescues%2520mitochondrial%2520dysfunction%2520in%2520female%2520mice%2520from%2520two%2520models%2520of%2520Rett%2520syndrome%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D121%26spage%3D79%26epage%3D88%26doi%3D10.1016%2Fj.neuropharm.2017.04.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Costa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sardone, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciranna, L.</span><span> </span><span class="NLM_article-title">Novel agonists for serotonin 5-HT<sub>7</sub> receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X syndrome</span> <span class="citation_source-journal">Front. Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="refDoi"> DOI: 10.3389/fnbeh.2015.00065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3389%2Ffnbeh.2015.00065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25814945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsV2htLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=65&author=L.+Costaauthor=L.+M.+Sardoneauthor=E.+Lacivitaauthor=M.+Leopoldoauthor=L.+Ciranna&title=Novel+agonists+for+serotonin+5-HT7+receptors+reverse+metabotropic+glutamate+receptor-mediated+long-term+depression+in+the+hippocampus+of+wild-type+and+Fmr1+KO+mice%2C+a+model+of+Fragile+X+syndrome&doi=10.3389%2Ffnbeh.2015.00065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome</span></div><div class="casAuthors">Costa, Lara; Sardone, Lara M.; Lacivita, Enza; Leopoldo, Marcello; Ciranna, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">65/1-65/11</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Serotonin 5-HT7 receptors are expressed in the hippocampus and modulate the excitability of hippocampal neurons.  We have previously shown that 5-HT7 receptors modulate glutamate-mediated hippocampal synaptic transmission and long-term synaptic plasticity.  In particular, we have shown that activation of 5-HT7 receptors reversed metabotropic glutamate receptor-mediated long-term depression (mGluR-LTD) in wild-type (wt) and in Fmr1 KO mice, a mouse model of Fragile X Syndrome in which mGluR-LTD is abnormally enhanced, suggesting that 5-HT7 receptor agonists might be envisaged as a novel therapeutic strategy for Fragile X Syndrome.  In this perspective, we have characterized the basic in vitro pharmacokinetic properties of novel mols. with high binding affinity and selectivity for 5-HT7 receptors and we have tested their effects on synaptic plasticity using patch clamp on acute hippocampal slices.  Here we show that LP-211, a high affinity selective agonist of 5-HT7 receptors, reverses mGluR-LTD in wt and Fmr1 KO mice, correcting a synaptic malfunction in the mouse model of Fragile X Syndrome.  Among novel putative agonists of 5-HT7 receptors, the compd. BA-10 displayed improved affinity and selectivity for 5-HT7 receptors and improved in vitro pharmacokinetic properties with respect to LP-211.  BA-10 significantly reversed mGluR-LTD in the CA3-CA1 synapse in wt and Fmr1KO mice, indicating that BA-10 behaved as a highly effective agonist of 5-HT7 receptors and reduced exaggerated mGluR-LTD in a mouse model of Fragile X Syndrome.  On the other side, the compds. RA-7 and PM-20, resp. arising from in vivo metab. of LP-211 and BA-10, had no effect on mGluR-LTD thus did not behave as agonists of 5-HT7 receptors in our conditions.  The present results provide information about the structure-activity relationship of novel 5-HT7 receptor agonists and indicate that LP-211 and BA-10 might be used as novel pharmacol. tools for the therapy of Fragile X Syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5rRoHOX7O4LVg90H21EOLACvtfcHk0lgXTUOSmHGDuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2htLbP&md5=88255a5469d17074e2eea5b7670158f4</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2015.00065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2015.00065%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DL.%26aulast%3DSardone%26aufirst%3DL.%2BM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DCiranna%26aufirst%3DL.%26atitle%3DNovel%2520agonists%2520for%2520serotonin%25205-HT7%2520receptors%2520reverse%2520metabotropic%2520glutamate%2520receptor-mediated%2520long-term%2520depression%2520in%2520the%2520hippocampus%2520of%2520wild-type%2520and%2520Fmr1%2520KO%2520mice%252C%2520a%2520model%2520of%2520Fragile%2520X%2520syndrome%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2015%26volume%3D9%26spage%3D65%26doi%3D10.3389%2Ffnbeh.2015.00065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Costa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spatuzza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Antoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaccorso, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trovato, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musumeci, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catania, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciranna, L.</span><span> </span><span class="NLM_article-title">Activation of 5-HT<sub>7</sub> serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X syndrome</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">924</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2012.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.biopsych.2012.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22817866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVykt7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=924-933&author=L.+Costaauthor=M.+Spatuzzaauthor=S.+D%E2%80%99Antoniauthor=C.+M.+Bonaccorsoauthor=C.+Trovatoauthor=S.+A.+Musumeciauthor=M.+Leopoldoauthor=E.+Lacivitaauthor=M.+V.+Cataniaauthor=L.+Ciranna&title=Activation+of+5-HT7+serotonin+receptors+reverses+metabotropic+glutamate+receptor-mediated+synaptic+plasticity+in+wild-type+and+Fmr1+knockout+mice%2C+a+model+of+Fragile+X+syndrome&doi=10.1016%2Fj.biopsych.2012.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of 5-HT7 Serotonin Receptors Reverses Metabotropic Glutamate Receptor-Mediated Synaptic Plasticity in Wild-Type and Fmr1 Knockout Mice, a Model of Fragile X Syndrome</span></div><div class="casAuthors">Costa, Lara; Spatuzza, Michela; D'Antoni, Simona; Bonaccorso, Carmela M.; Trovato, Chiara; Musumeci, Sebastiano A.; Leopoldo, Marcello; Lacivita, Enza; Catania, Maria V.; Ciranna, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">924-933</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Fragile X syndrome (FXS) is a genetic cause of intellectual disability and autism.  Fmr1 knockout (Fmr1 KO) mice, an animal model of FXS, exhibit spatial memory impairment and synapse malfunctioning in the hippocampus, with abnormal enhancement of long-term depression mediated by metabotropic glutamate receptors (mGluR-LTD).  The neurotransmitter serotonin (5-HT) modulates hippocampal-dependent learning through serotonin 1A (5-HT1A) and serotonin 7 (5-HT7) receptors; the underlying mechanisms are unknown.  We used electrophysiol. to test the effects of 5-HT on mGluR-LTD in wild-type and Fmr1 KO mice and immunocytochem. and biotinylation assay to study related changes of 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)propanoic acid (AMPA) glutamate receptor surface expression.  Application of 5-HT or 8-OH-DPAT (a mixed 5-HT1A/5-HT7 agonist) reversed mGluR-LTD in hippocampal slices.  Reversal of mGluR-LTD by 8-OH-DPAT persisted in the presence of the 5-HT1A receptor antagonist WAY-100635, was abolished by SB-269970 (5-HT7 receptor antagonist), and was mimicked by LP-211, a novel selective 5-HT7 receptor agonist.  Consistently, 8-OH-DPAT decreased mGluR-mediated redn. of AMPA glutamate receptor 2 (GluR2) subunit surface expression in hippocampal slices and cultured hippocampal neurons, an effect mimicked by LP-211 and blocked by SB-269970.  In Fmr1 KO mice, mGluR-LTD was abnormally enhanced; similarly to wild-type, 8-OH-DPAT reversed mGluR-LTD and decreased mGluR-induced redn. of surface AMPA receptors, an effect antagonized by SB-269970.  Serotonin 7 receptor activation reverses metabotropic glutamate receptor-induced AMPA receptor internalization and LTD both in wild-type and in Fmr1 KO mice, correcting excessive mGluR-LTD.  Therefore, selective activation of 5-HT7 receptors may represent a novel strategy in the therapy of FXS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8gBMnQibSXbVg90H21EOLACvtfcHk0lgXTUOSmHGDuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVykt7%252FJ&md5=b4d75fe1118b739b111f7e7f29a32c24</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2012.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2012.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DL.%26aulast%3DSpatuzza%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Antoni%26aufirst%3DS.%26aulast%3DBonaccorso%26aufirst%3DC.%2BM.%26aulast%3DTrovato%26aufirst%3DC.%26aulast%3DMusumeci%26aufirst%3DS.%2BA.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DCatania%26aufirst%3DM.%2BV.%26aulast%3DCiranna%26aufirst%3DL.%26atitle%3DActivation%2520of%25205-HT7%2520serotonin%2520receptors%2520reverses%2520metabotropic%2520glutamate%2520receptor-mediated%2520synaptic%2520plasticity%2520in%2520wild-type%2520and%2520Fmr1%2520knockout%2520mice%252C%2520a%2520model%2520of%2520Fragile%2520X%2520syndrome%26jtitle%3DBiol.%2520Psychiatry%26date%3D2012%26volume%3D72%26spage%3D924%26epage%3D933%26doi%3D10.1016%2Fj.biopsych.2012.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Canal, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsing, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vemula, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, R. G.</span><span> </span><span class="NLM_article-title">An orally active phenylaminotetralin-chemotype serotonin 5-HT<sub>7</sub> and 5-HT<sub>1A</sub> receptor partial agonist that corrects motor stereotypy in mouse models</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1259</span><span class="NLM_x">–</span> <span class="NLM_lpage">1270</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00099</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00099" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovFKktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1259-1270&author=C.+E.+Canalauthor=D.+E.+Felsingauthor=Y.+Liuauthor=W.+Zhuauthor=J.+T.+Woodauthor=C.+K.+Perryauthor=R.+Vemulaauthor=R.+G.+Booth&title=An+orally+active+phenylaminotetralin-chemotype+serotonin+5-HT7+and+5-HT1A+receptor+partial+agonist+that+corrects+motor+stereotypy+in+mouse+models&doi=10.1021%2Facschemneuro.5b00099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist That Corrects Motor Stereotypy in Mouse Models</span></div><div class="casAuthors">Canal, Clinton E.; Felsing, Daniel E.; Liu, Yue; Zhu, Wanying; Wood, JodiAnne T.; Perry, Charles K.; Vemula, Rajender; Booth, Raymond G.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1259-1270</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stereotypy (e.g., repetitive hand waving) is a key phenotype of autism spectrum disorder, Fragile X and Rett syndromes, and other neuropsychiatric disorders, and its severity correlates with cognitive and attention deficits.  There are no effective treatments, however, for stereotypy.  Perturbation of serotonin (5-HT) neurotransmission contributes to stereotypy, suggesting that distinct 5-HT receptors may be pharmacotherapeutic targets to treat stereotypy and related neuropsychiatric symptoms.  For example, preclin. studies indicate that 5-HT7 receptor activation corrects deficits in mouse models of Fragile X and Rett syndromes, and clin. trials for autism are underway with buspirone, a 5-HT1A partial agonist with relevant affinity at 5-HT7 receptors.  Herein, we report the synthesis, in vitro mol. pharmacol., behavioral pharmacol., and pharmacokinetic parameters in mice after s.c. and oral administration of (+)-5-(2'-fluorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine ((+)-5-FPT), a new, dual partial agonist targeting both 5-HT7 (Ki = 5.8 nM, EC50 = 34 nM) and 5-HT1A (Ki = 22 nM, EC50 = 40 nM) receptors.  Three unique, heterogeneous mouse models were used to assess the efficacy of (+)-5-FPT to reduce stereotypy: idiopathic jumping in C58/J mice, repetitive body rotations in C57BL/6J mice treated with the NMDA antagonist, MK-801, and repetitive head twitching in C57BL/6J mice treated with the 5-HT2 agonist, DOI.  Systemic (+)-5-FPT potently and efficaciously reduced or eliminated stereotypy in each of the mouse models without altering locomotor behavior on its own, and addnl. tests showed that (+)-5-FPT, at the highest behaviorally active dose tested, enhanced social interaction and did not cause behaviors indicative of serotonin syndrome.  These data suggest that (+)-5-FPT is a promising medication for treating stereotypy in psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzYBDCOy-y8rVg90H21EOLACvtfcHk0ljd38gaYxfZmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovFKktbo%253D&md5=029bb904bf625875d069f2a937a22efa</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00099%26sid%3Dliteratum%253Aachs%26aulast%3DCanal%26aufirst%3DC.%2BE.%26aulast%3DFelsing%26aufirst%3DD.%2BE.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DWood%26aufirst%3DJ.%2BT.%26aulast%3DPerry%26aufirst%3DC.%2BK.%26aulast%3DVemula%26aufirst%3DR.%26aulast%3DBooth%26aufirst%3DR.%2BG.%26atitle%3DAn%2520orally%2520active%2520phenylaminotetralin-chemotype%2520serotonin%25205-HT7%2520and%25205-HT1A%2520receptor%2520partial%2520agonist%2520that%2520corrects%2520motor%2520stereotypy%2520in%2520mouse%2520models%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D1259%26epage%3D1270%26doi%3D10.1021%2Facschemneuro.5b00099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Mohler, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gannon, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shacham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragozzino, M. E.</span><span> </span><span class="NLM_article-title">The effects of PRX-07034, a novel 5-HT<sub>6</sub> antagonist, on cognitive flexibility and working memory in rats</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">220</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span><span class="refDoi"> DOI: 10.1007/s00213-011-2518-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs00213-011-2518-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21989804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC38zmsVWguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=2012&pages=687-696&author=E.+G.+Mohlerauthor=P.+M.+Bakerauthor=K.+S.+Gannonauthor=S.+S.+Jonesauthor=S.+Shachamauthor=J.+A.+Sweeneyauthor=M.+E.+Ragozzino&title=The+effects+of+PRX-07034%2C+a+novel+5-HT6+antagonist%2C+on+cognitive+flexibility+and+working+memory+in+rats&doi=10.1007%2Fs00213-011-2518-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats</span></div><div class="casAuthors">Mohler Eric G; Baker Phillip M; Gannon Kimberly S; Jones Simon S; Shacham Sharon; Sweeney John A; Ragozzino Michael E</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">220</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">687-96</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">RATIONALE:  Accumulating evidence indicates that schizophrenia and autism spectrum disorder patients are marked by cognitive deficits in working memory and strategy switching.  There is accumulating evidence that 5-hydroxytryptamine (5-HT)(6) receptors may serve as a useful target to improve cognitive functioning.  OBJECTIVES:  In the present experiments, the novel 5-HT(6) antagonist, PRX-07034, was examined for its selectivity of the 5-HT(6) receptor, as well as its effect on delayed spontaneous alternation and strategy switching.  METHODS:  The binding affinity of PRX-07034 to the 5-HT(6) receptor, other 5-HT receptors, as well as other G-protein coupled receptors, ion channels, and transporters was evaluated.  Cyclic AMP production was measured from transfected HEK-293 cells.  In separate behavioral experiments, rats received different doses of PRX-07034 (0.1, 1, or 3 mg/kg, i.p.) 30 min prior to delayed spontaneous alternation testing or prior to the acquisition and switch phases in a place-response switch test.  RESULTS:  The results indicated that PRX-07034 is both a potent (Ki = 4-8 nM) and highly selective 5-HT(6) receptor antagonist (≥100-fold selectivity for the 5-HT(6) receptor compared to 68 other GPCRs, ion channels, and transporters, except D(3) (Ki = 71 nM) and 5-HT(1B) (Ki = 260 nM) receptors.  For cyclic AMP quantification, PRX-07034 demonstrated antagonist activity (IC(50) = 19 nM) without an effect on basal levels and did not show any agonist activity up to 10 μM.  PRX-07034 at 1 and 3 mg/kg (but not 0.1 mg/kg) significantly enhanced delayed spontaneous alternation.  The drug at 1 and 3 mg/kg also enhanced switching between a place and response strategy, but did not affect initial learning of either a place or response discrimination.  CONCLUSIONS:  These findings demonstrate that PRX-07034 is a selective 5-HT(6) receptor antagonist that may represent a novel treatment for enhancing working memory and cognitive flexibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkGoJom5qmh8K3uFsUIZtkfW6udTcc2eZPWQd2TAMSpbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zmsVWguw%253D%253D&md5=8327d396edea80aee527b7e3ffdc4905</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1007%2Fs00213-011-2518-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-011-2518-7%26sid%3Dliteratum%253Aachs%26aulast%3DMohler%26aufirst%3DE.%2BG.%26aulast%3DBaker%26aufirst%3DP.%2BM.%26aulast%3DGannon%26aufirst%3DK.%2BS.%26aulast%3DJones%26aufirst%3DS.%2BS.%26aulast%3DShacham%26aufirst%3DS.%26aulast%3DSweeney%26aufirst%3DJ.%2BA.%26aulast%3DRagozzino%26aufirst%3DM.%2BE.%26atitle%3DThe%2520effects%2520of%2520PRX-07034%252C%2520a%2520novel%25205-HT6%2520antagonist%252C%2520on%2520cognitive%2520flexibility%2520and%2520working%2520memory%2520in%2520rats%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2012%26volume%3D220%26spage%3D687%26epage%3D696%26doi%3D10.1007%2Fs00213-011-2518-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Dayer, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobshagen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaumont-Dubel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marin, P.</span><span> </span><span class="NLM_article-title">5-HT<sub>6</sub> receptor: a new player controlling the development of neural circuits</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span><span class="refDoi"> DOI: 10.1021/cn500326z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500326z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVOhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=951-960&author=A.+G.+Dayerauthor=M.+Jacobshagenauthor=S.+Chaumont-Dubelauthor=P.+Marin&title=5-HT6+receptor%3A+a+new+player+controlling+the+development+of+neural+circuits&doi=10.1021%2Fcn500326z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT6 Receptor: A New Player Controlling the Development of Neural Circuits</span></div><div class="casAuthors">Dayer, Alexandre G.; Jacobshagen, Moritz; Chaumont-Dubel, Severine; Marin, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">951-960</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  5-HT6 receptor (5-HT6R) is a G protein-coupled receptor that has recently emerged as a new regulator of neural development.  In addn. to the canonical Gs adenylyl cyclase pathway, recent proteomics approaches reveal that 5-HT6R is able to engage key developmental signaling pathways controlling neuronal circuit formation, neuronal connectivity, and psychiatric-relevant behaviors.  For example, at early stages of neuronal development, expression of 5-HT6R constitutively regulates the activity of the cyclin-dependent kinase (Cdk)5 and, through this mechanism, controls cellular processes involved in circuit formation, including neuronal migration and neurite outgrowth.  In addn. to the Cdk5 pathway, 5-HT6R modulates a variety of key developmental targets such as Fyn, Jab1, and mammalian target of rapamycin (mTOR).  Engagement of developmental pathways through 5-HT6R pharmacol. manipulation has led to interesting new therapeutic perspectives in the field of psychiatric-related disorders.  Indeed, 5-HT6R blockade can rescue a pathol. overactivation of the mTOR pathway induced by early life insults in rodents and normalizes the assocd. social and episodic memory deficits.  Here, we review recent evidence supporting the notion that 5-HT6R is at the interface of key developmental signaling pathways and a novel actor in the orchestration of neural circuit formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEHxmpdYBG_7Vg90H21EOLACvtfcHk0lisZEmEKYZDKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVOhug%253D%253D&md5=6cf3566bebb39ebd1e4b121f79d1ac5a</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Fcn500326z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500326z%26sid%3Dliteratum%253Aachs%26aulast%3DDayer%26aufirst%3DA.%2BG.%26aulast%3DJacobshagen%26aufirst%3DM.%26aulast%3DChaumont-Dubel%26aufirst%3DS.%26aulast%3DMarin%26aufirst%3DP.%26atitle%3D5-HT6%2520receptor%253A%2520a%2520new%2520player%2520controlling%2520the%2520development%2520of%2520neural%2520circuits%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D951%26epage%3D960%26doi%3D10.1021%2Fcn500326z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Duhr, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Déléris, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Séveno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morisset-Lopez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannoury la Cour, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaumont-Dubel, S.</span><span> </span><span class="NLM_article-title">Cdk5 induces constitutive activation of 5-HT<sub>6</sub> receptors to promote neurite growth</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">590</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span><span class="refDoi"> DOI: 10.1038/nchembio.1547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnchembio.1547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24880860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFCgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=590-597&author=F.+Duhrauthor=P.+D%C3%A9l%C3%A9risauthor=F.+Raynaudauthor=M.+S%C3%A9venoauthor=S.+Morisset-Lopezauthor=C.+Mannoury+la+Courauthor=M.+J.+Millanauthor=J.+Bockaertauthor=P.+Marinauthor=S.+Chaumont-Dubel&title=Cdk5+induces+constitutive+activation+of+5-HT6+receptors+to+promote+neurite+growth&doi=10.1038%2Fnchembio.1547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growth</span></div><div class="casAuthors">Duhr, Fanny; Deleris, Paul; Raynaud, Fabrice; Seveno, Martial; Morisset-Lopez, Severine; Mannoury la Cour, Clotilde; Millan, Mark J.; Bockaert, Joel; Marin, Philippe; Chaumont-Dubel, Severine</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">590-597</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The serotonin6 receptor (5-HT6R) is a promising target for treating cognitive deficits of schizophrenia often linked to alterations of neuronal development.  This receptor controls neurodevelopmental processes, but the signaling mechanisms involved remain poorly understood.  Using a proteomic strategy, we show that 5-HT6Rs constitutively interact with cyclin-dependent kinase 5 (Cdk5).  Expression of 5-HT6Rs in NG108-15 cells induced neurite growth and expression of voltage-gated Ca2+ channels, two hallmarks of neuronal differentiation.  5-HT6R-elicited neurite growth was agonist independent and prevented by the 5-HT6R antagonist SB258585, which behaved as an inverse agonist.  Moreover, it required receptor phosphorylation at Ser350 by Cdk5 and Cdc42 activity.  Supporting a role of native 5-HT6Rs in neuronal differentiation, neurite growth of primary neurons was reduced by SB258585, by silencing 5-HT6R expression or by mutating Ser350 into alanine.  These results reveal a functional interplay between Cdk5 and a G protein-coupled receptor to control neuronal differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnZu_0TtuhmrVg90H21EOLACvtfcHk0lisZEmEKYZDKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFCgt7s%253D&md5=8a4b4db83cffe9361f5c4ba5b27f25ba</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1547%26sid%3Dliteratum%253Aachs%26aulast%3DDuhr%26aufirst%3DF.%26aulast%3DD%25C3%25A9l%25C3%25A9ris%26aufirst%3DP.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DS%25C3%25A9veno%26aufirst%3DM.%26aulast%3DMorisset-Lopez%26aufirst%3DS.%26aulast%3DMannoury%2Bla%2BCour%26aufirst%3DC.%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DMarin%26aufirst%3DP.%26aulast%3DChaumont-Dubel%26aufirst%3DS.%26atitle%3DCdk5%2520induces%2520constitutive%2520activation%2520of%25205-HT6%2520receptors%2520to%2520promote%2520neurite%2520growth%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D590%26epage%3D597%26doi%3D10.1038%2Fnchembio.1547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Caliendo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorino, F.</span><span> </span><span class="NLM_article-title">Derivatives as 5HT<sub>1A</sub> receptor ligands–past and present</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1721</span><span class="NLM_x">–</span> <span class="NLM_lpage">1753</span><span class="refDoi"> DOI: 10.2174/0929867054367220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.2174%2F0929867054367220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=16029144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD2MXls1Wisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=1721-1753&author=G.+Caliendoauthor=V.+Santagadaauthor=E.+Perissuttiauthor=F.+Fiorino&title=Derivatives+as+5HT1A+receptor+ligands%E2%80%93past+and+present&doi=10.2174%2F0929867054367220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Derivatives as 5HT1A receptor ligands-past and present</span></div><div class="casAuthors">Caliendo, G.; Santagada, V.; Perissutti, E.; Fiorino, F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1721-1753</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Serotonin is a neuromediator, well-know for its implication in mood regulation, anxiety, depression and, insomnia as well as in normal human function such as sleep, sexual activity and appetite.  In this way, serotonin (5-hydroxytryptamine, 5-HT) is one of the most attractive targets for medicinal chemists and pharmaceutical companies.  Among 5-HTRs, the 5-HT1A subtype is the best studied, and it is generally accepted that it is involved in psychiatric disorders such as anxiety and depression.  Several structurally different compds. are known to bind 5-HT1A receptor sites such as aminotetralins, ergolines, arylpiperazines, indolylalkylamines, aporphines and aryloxyalkylamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNq1YopI8Ho7Vg90H21EOLACvtfcHk0lhTOa_PZy3VwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXls1Wisrg%253D&md5=42c78fb99de63e801880ae4577fe3583</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.2174%2F0929867054367220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867054367220%26sid%3Dliteratum%253Aachs%26aulast%3DCaliendo%26aufirst%3DG.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DFiorino%26aufirst%3DF.%26atitle%3DDerivatives%2520as%25205HT1A%2520receptor%2520ligands%25E2%2580%2593past%2520and%2520present%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D1721%26epage%3D1753%26doi%3D10.2174%2F0929867054367220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tricklebank, M. D.</span><span> </span><span class="NLM_article-title">Centrally active 5-HT receptor agonists and antagonists</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1016/S0149-7634(05)80054-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0149-7634%2805%2980054-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1992&pages=75-82&author=D.+N.+Middlemissauthor=M.+D.+Tricklebank&title=Centrally+active+5-HT+receptor+agonists+and+antagonists&doi=10.1016%2FS0149-7634%2805%2980054-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1016%2FS0149-7634%2805%2980054-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0149-7634%252805%252980054-5%26sid%3Dliteratum%253Aachs%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DTricklebank%26aufirst%3DM.%2BD.%26atitle%3DCentrally%2520active%25205-HT%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D1992%26volume%3D16%26spage%3D75%26epage%3D82%26doi%3D10.1016%2FS0149-7634%2805%2980054-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Leysen, J. E.</span><span> </span><span class="NLM_article-title">5-HT<sub>2</sub> receptors</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.2174/1568007043482598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.2174%2F1568007043482598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=14965241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=11-26&author=J.+E.+Leysen&title=5-HT2+receptors&doi=10.2174%2F1568007043482598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2 receptors</span></div><div class="casAuthors">Leysen, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-26</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  5-HT2 receptors are G-protein coupled receptors that currently comprise 3 subtypes: 5-HT2A, 5-HT2B, and 5-HT2C receptors.  The subtypes are related in their mol. structure, amino acid sequence, and signaling properties.  5-HT2A and 5-HT2C receptors have a widespread distribution and function in the central nervous system.  5-HT2A and 5-HT2C receptor antagonism is a property of certain antipsychotic and antidepressant drugs.  5-HT2B receptors have a restricted expression in the central nervous system.  They have an important role in embryogenesis and in the periphery.  In this article, selected aspects of 5-HT2 receptor research are reviewed for each subtype under 3 main headings: (1) genes, protein structure, and receptor signaling; (2) receptor localization with emphasis on the CNS, and (3) compds.  The general discussion reflects on the reasons for the limited success in the clinic of 5-HT2 receptor subtype selective drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAGTjJwjn8erVg90H21EOLACvtfcHk0lhTOa_PZy3VwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWksrk%253D&md5=9f7316c92e674a8c1cf7b13f48d9711a</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.2174%2F1568007043482598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043482598%26sid%3Dliteratum%253Aachs%26aulast%3DLeysen%26aufirst%3DJ.%2BE.%26atitle%3D5-HT2%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D11%26epage%3D26%26doi%3D10.2174%2F1568007043482598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Benhamú, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martín-Fontecha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vázquez-Villa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Rodríguez, M. L.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>6</sub> receptor antagonists for the treatment of cognitive deficiency in Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7160</span><span class="NLM_x">–</span> <span class="NLM_lpage">7181</span><span class="refDoi"> DOI: 10.1021/jm5003952</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5003952" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVWjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7160-7181&author=B.+Benham%C3%BAauthor=M.+Mart%C3%ADn-Fontechaauthor=H.+V%C3%A1zquez-Villaauthor=L.+Pardoauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&title=Serotonin+5-HT6+receptor+antagonists+for+the+treatment+of+cognitive+deficiency+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm5003952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT6 Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer's Disease</span></div><div class="casAuthors">Benhamu, Bellinda; Martin-Fontecha, Mar; Vazquez-Villa, Henar; Pardo, Leonardo; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7160-7181</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is one of the most frequent causes of death and disability worldwide and has a significant clin. and socioeconomic impact.  In the search for novel therapeutic strategies, serotonin 5-HT6 receptor (5-HT6R) has been proposed as a promising drug target for cognition enhancement in AD.  This manuscript reviews the compelling evidence for the implication of this receptor in learning and memory processes.  We have summarized the current status of the medicinal chem. of 5-HT6R antagonists and the encouraging preclin. findings that demonstrate their significant procognitive behavioral effects in a no. of learning paradigms, probably acting through modulation of multiple neurotransmitter systems and signaling pathways.  The results of the ongoing clin. trials are eagerly awaited to shed some light on the validation of 5-HT6R antagonists as a new drug class for the treatment of symptomatic cognitive impairment in AD, either as stand-alone therapy or in combination with established agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeTO6_2THvaLVg90H21EOLACvtfcHk0liDjfWbBBqX5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVWjs7c%253D&md5=bf8d2cba73f72e04a5caf8b295647064</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1021%2Fjm5003952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5003952%26sid%3Dliteratum%253Aachs%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DMart%25C3%25ADn-Fontecha%26aufirst%3DM.%26aulast%3DV%25C3%25A1zquez-Villa%26aufirst%3DH.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DSerotonin%25205-HT6%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520cognitive%2520deficiency%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7160%26epage%3D7181%26doi%3D10.1021%2Fjm5003952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>7</sub> receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2010.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.pharmthera.2010.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20923682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVantQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2011&pages=120-148&author=M.+Leopoldoauthor=E.+Lacivitaauthor=F.+Berardiauthor=R.+Perroneauthor=P.+B.+Hedlund&title=Serotonin+5-HT7+receptor+agents%3A+Structure-activity+relationships+and+potential+therapeutic+applications+in+central+nervous+system+disorders&doi=10.1016%2Fj.pharmthera.2010.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders</span></div><div class="casAuthors">Leopoldo, Marcello; Lacivita, Enza; Berardi, Francesco; Perrone, Roberto; Hedlund, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">120-148</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Since its discovery in the 1940s in serum, the mammalian intestinal mucosa, and in the central nervous system, serotonin (5-HT) has been shown to be involved in virtually all cognitive and behavioral human functions, and alterations in its neurochem. have been implicated in the etiol. of a plethora of neuropsychiatric disorders.  The cloning of 5-HT receptor subtypes has been of importance in enabling them to be classified as specific protein mols. encoded by specific genes.  The 5-HT7 receptor is the most recently classified member of the serotonin receptor family.  Since its identification, it has been the subject of intense research efforts driven by its presence in functionally relevant regions of the brain.  The availability of some selective antagonists and agonists, in combination with genetically modified mice lacking the 5-HT7 receptor, has allowed for a better understanding of the pathophysiol. role of this receptor.  This paper reviews data on localization and pharmacol. properties of the 5-HT7 receptor, and summarizes the results of structure-activity relationship studies aimed at the discovery of selective 5-HT7 receptor ligands.  Addnl., an overview of the potential therapeutic applications of 5-HT7 receptor agonists and antagonists in central nervous system disorders is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWPpaPQfXAkrVg90H21EOLACvtfcHk0ljvKmdpdZ4C0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVantQ%253D%253D&md5=060ef6a028b4f9a2b6f842a2accdae2c</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2010.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2010.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26atitle%3DSerotonin%25205-HT7%2520receptor%2520agents%253A%2520Structure-activity%2520relationships%2520and%2520potential%2520therapeutic%2520applications%2520in%2520central%2520nervous%2520system%2520disorders%26jtitle%3DPharmacol.%2520Ther.%26date%3D2011%26volume%3D129%26spage%3D120%26epage%3D148%26doi%3D10.1016%2Fj.pharmthera.2010.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group">Karvat, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimchi, T.</span><span> </span><span class="NLM_article-title">Acetylcholine elevation relieves cognitive rigidity and social deficiency in a mouse model of autism</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">840</span><span class="refDoi"> DOI: 10.1038/npp.2013.274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnpp.2013.274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24096295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslajsrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=831-840&author=G.+Karvatauthor=T.+Kimchi&title=Acetylcholine+elevation+relieves+cognitive+rigidity+and+social+deficiency+in+a+mouse+model+of+autism&doi=10.1038%2Fnpp.2013.274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholine Elevation Relieves Cognitive Rigidity and Social Deficiency in a Mouse Model of Autism</span></div><div class="casAuthors">Karvat, Golan; Kimchi, Tali</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">831-840</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autism spectrum disorders (ASD) are defined by behavioral deficits in social interaction and communication, repetitive stereotyped behaviors, and restricted interests/cognitive rigidity.  Recent studies in humans and animal-models suggest that dysfunction of the cholinergic system may underlie autism-related behavioral symptoms.  Here we tested the hypothesis that augmentation of acetylcholine (ACh) in the synaptic cleft by inhibiting acetylcholinesterase may ameliorate autistic phenotypes.  We first administered the acetylcholinesterase inhibitor (AChEI) Donepezil systemically by i.p. (i.p.) injections.  Second, the drug was injected directly into the rodent homolog of the caudate nucleus, the dorsomedial striatum (DMS), of the inbred mouse strain BTBR T+tf/J (BTBR), a commonly-used model presenting all core autism-related phenotypes and expressing low brain ACh levels.  We found that i.p. injection of AChEI to BTBR mice significantly relieved autism-relevant phenotypes, including decreasing cognitive rigidity, improving social preference, and enhancing social interaction, in a dose-dependent manner.  Microinjection of the drug directly into the DMS, but not into the ventromedial striatum, led to significant amelioration of the cognitive-rigidity and social-deficiency phenotypes.  Taken together, these findings provide evidence of the key role of the cholinergic system and the DMS in the etiol. of ASD, and suggest that elevated cognitive flexibility may result in enhanced social attention.  The potential therapeutic effect of AChEIs in ASD patients is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBinNVK7MHerVg90H21EOLACvtfcHk0ljvKmdpdZ4C0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslajsrbO&md5=bc0d5545c633d39211738897307d0a9c</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2013.274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2013.274%26sid%3Dliteratum%253Aachs%26aulast%3DKarvat%26aufirst%3DG.%26aulast%3DKimchi%26aufirst%3DT.%26atitle%3DAcetylcholine%2520elevation%2520relieves%2520cognitive%2520rigidity%2520and%2520social%2520deficiency%2520in%2520a%2520mouse%2520model%2520of%2520autism%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D831%26epage%3D840%26doi%3D10.1038%2Fnpp.2013.274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group">Deutsch, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burket, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbano, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, A. D.</span><span> </span><span class="NLM_article-title">The α7 nicotinic acetylcholine receptor: a mediator of pathogenesis and therapeutic target in autism spectrum disorders and Down syndrome</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span><span class="refDoi"> DOI: 10.1016/j.bcp.2015.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bcp.2015.06.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=363-377&author=S.+I.+Deutschauthor=J.+A.+Burketauthor=M.+R.+Urbanoauthor=A.+D.+Benson&title=The+%CE%B17+nicotinic+acetylcholine+receptor%3A+a+mediator+of+pathogenesis+and+therapeutic+target+in+autism+spectrum+disorders+and+Down+syndrome&doi=10.1016%2Fj.bcp.2015.06.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2015.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2015.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DDeutsch%26aufirst%3DS.%2BI.%26aulast%3DBurket%26aufirst%3DJ.%2BA.%26aulast%3DUrbano%26aufirst%3DM.%2BR.%26aulast%3DBenson%26aufirst%3DA.%2BD.%26atitle%3DThe%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%253A%2520a%2520mediator%2520of%2520pathogenesis%2520and%2520therapeutic%2520target%2520in%2520autism%2520spectrum%2520disorders%2520and%2520Down%2520syndrome%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2015%26volume%3D97%26spage%3D363%26epage%3D377%26doi%3D10.1016%2Fj.bcp.2015.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group">Deutsch, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbano, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burket, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herndon, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winebarger, E. E.</span><span> </span><span class="NLM_article-title">Pharmacotherapeutic implications of the association between genomic instability at chromosome 15q13.3 and autism spectrum disorders</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span><span class="refDoi"> DOI: 10.1097/WNF.0b013e31823a1247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1097%2FWNF.0b013e31823a1247" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2011&pages=203-205&author=S.+I.+Deutschauthor=M.+R.+Urbanoauthor=J.+A.+Burketauthor=A.+L.+Herndonauthor=E.+E.+Winebarger&title=Pharmacotherapeutic+implications+of+the+association+between+genomic+instability+at+chromosome+15q13.3+and+autism+spectrum+disorders&doi=10.1097%2FWNF.0b013e31823a1247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1097%2FWNF.0b013e31823a1247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWNF.0b013e31823a1247%26sid%3Dliteratum%253Aachs%26aulast%3DDeutsch%26aufirst%3DS.%2BI.%26aulast%3DUrbano%26aufirst%3DM.%2BR.%26aulast%3DBurket%26aufirst%3DJ.%2BA.%26aulast%3DHerndon%26aufirst%3DA.%2BL.%26aulast%3DWinebarger%26aufirst%3DE.%2BE.%26atitle%3DPharmacotherapeutic%2520implications%2520of%2520the%2520association%2520between%2520genomic%2520instability%2520at%2520chromosome%252015q13.3%2520and%2520autism%2520spectrum%2520disorders%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2011%26volume%3D34%26spage%3D203%26epage%3D205%26doi%3D10.1097%2FWNF.0b013e31823a1247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudweeks, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakel, J. L.</span><span> </span><span class="NLM_article-title">Nicotinic receptors in the brain: correlating physiology with function</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span><span class="refDoi"> DOI: 10.1016/S0166-2236(99)01471-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0166-2236%2899%2901471-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10542436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADyaK1MXntlegtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1999&pages=555-561&author=S.+Jonesauthor=S.+Sudweeksauthor=J.+L.+Yakel&title=Nicotinic+receptors+in+the+brain%3A+correlating+physiology+with+function&doi=10.1016%2FS0166-2236%2899%2901471-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptors in the brain: correlating physiology with function</span></div><div class="casAuthors">Jones, S.; Sudweeks, S.; Yakel, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">555-561</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 69 refs.  Nicotinic ACh receptors (nAChRs) have been implicated in a variety of brain functions, including neuronal development, learning and memory formation, and reward.  Although there are substantial data indicating that nAChR subunits are found in many brain regions, the precise cellular roles of these subunits in neuronal functions have remained elusive.  Until recently, nAChRs were thought primarily to serve a modulatory role in the brain by regulating neurotransmitter release from nerve terminals.  However, new evidence has revealed that nAChRs also function in a postsynaptic role by mediating fast ACh-mediated synaptic transmission in the hippocampus and in the sensory cortex, and are found at somatodendritic as well as nerve terminal sites in the reward system.  It is possible that presynaptic and postsynaptic nAChRs mediate changes in the efficacy of synaptic transmission in these brain regions.  These changes could underlie the proposed functions of nAChRs in cognitive functions of the hippocampus and cerebral cortex, in neuronal development in the sensory cortex, and in reward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXA9Bxc8k8kbVg90H21EOLACvtfcHk0ljjMmvTZFjNSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntlegtbg%253D&md5=a099fd4c62c8bd6eb3a658ed606680eb</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1016%2FS0166-2236%2899%2901471-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-2236%252899%252901471-X%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%26aulast%3DSudweeks%26aufirst%3DS.%26aulast%3DYakel%26aufirst%3DJ.%2BL.%26atitle%3DNicotinic%2520receptors%2520in%2520the%2520brain%253A%2520correlating%2520physiology%2520with%2520function%26jtitle%3DTrends%2520Neurosci.%26date%3D1999%26volume%3D22%26spage%3D555%26epage%3D561%26doi%3D10.1016%2FS0166-2236%2899%2901471-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group">Beinat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banister, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrera, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span> </span><span class="NLM_article-title">The recent development of α7 nicotinic acetylcholine receptor (nAChR) ligands as therapeutic candidates for the treatment of central nervous system (CNS) diseases</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2134</span><span class="NLM_x">–</span> <span class="NLM_lpage">2151</span><span class="refDoi"> DOI: 10.2174/1381612822666160127114125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.2174%2F1381612822666160127114125" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=2134-2151&author=C.+Beinatauthor=S.+D.+Banisterauthor=M.+Herreraauthor=M.+Kassiou&title=The+recent+development+of+%CE%B17+nicotinic+acetylcholine+receptor+%28nAChR%29+ligands+as+therapeutic+candidates+for+the+treatment+of+central+nervous+system+%28CNS%29+diseases&doi=10.2174%2F1381612822666160127114125"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.2174%2F1381612822666160127114125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612822666160127114125%26sid%3Dliteratum%253Aachs%26aulast%3DBeinat%26aufirst%3DC.%26aulast%3DBanister%26aufirst%3DS.%2BD.%26aulast%3DHerrera%26aufirst%3DM.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DThe%2520recent%2520development%2520of%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520%2528nAChR%2529%2520ligands%2520as%2520therapeutic%2520candidates%2520for%2520the%2520treatment%2520of%2520central%2520nervous%2520system%2520%2528CNS%2529%2520diseases%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2016%26volume%3D22%26spage%3D2134%26epage%3D2151%26doi%3D10.2174%2F1381612822666160127114125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span> </span><span class="NLM_article-title">Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1038/npp.2011.199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnpp.2011.199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21956443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ejsrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=16-42&author=C.+K.+Jonesauthor=N.+Byunauthor=M.+Bubser&title=Muscarinic+and+nicotinic+acetylcholine+receptor+agonists+and+allosteric+modulators+for+the+treatment+of+schizophrenia&doi=10.1038%2Fnpp.2011.199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of Schizophrenia</span></div><div class="casAuthors">Jones, Carrie K.; Byun, Nellie; Bubser, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-42</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Muscarinic and nicotinic acetylcholine (ACh) receptors (mAChRs and nAChRs) are emerging as important targets for the development of novel treatments for the symptoms assocd. with schizophrenia.  Preclin. and early proof-of-concept clin. studies have provided strong evidence that activators of specific mAChR (M1 and M4) and nAChR (α7 and α2β4) subtypes are effective in animal models of antipsychotic-like activity and/or cognitive enhancement, and in the treatment of pos. and cognitive symptoms in patients with schizophrenia.  While early attempts to develop selective mAChR and nAChR agonists provided important preliminary findings, these compds. have ultimately failed in clin. development due to a lack of true subtype selectivity and subsequent dose-limiting adverse effects.  In recent years, there have been major advances in the discovery of highly selective activators for the different mAChR and nAChR subtypes with suitable properties for optimization as potential candidates for clin. trials.  One novel strategy has been to identify ligands that activate a specific receptor subtype through actions at sites that are distinct from the highly conserved ACh-binding site, termed allosteric sites.  These allosteric activators, both allosteric agonists and pos. allosteric modulators, of mAChR and nAChR subtypes demonstrate unique mechanisms of action and high selectivity in vivo, and may provide innovative treatment strategies for schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-WrW81ixmbrVg90H21EOLACvtfcHk0lhwkx8thojgYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ejsrfP&md5=75e618b3697dba8e8bd3b3b5e6deecaa</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.199%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DByun%26aufirst%3DN.%26aulast%3DBubser%26aufirst%3DM.%26atitle%3DMuscarinic%2520and%2520nicotinic%2520acetylcholine%2520receptor%2520agonists%2520and%2520allosteric%2520modulators%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D16%26epage%3D42%26doi%3D10.1038%2Fnpp.2011.199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajós, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raggenbass, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higdon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford-Root, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkenpas, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allaman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span> </span><span class="NLM_article-title">A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4396</span><span class="NLM_x">–</span> <span class="NLM_lpage">4405</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.5269-04.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1523%2FJNEUROSCI.5269-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=15858066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFKgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=4396-4405&author=R.+S.+Hurstauthor=M.+Haj%C3%B3sauthor=M.+Raggenbassauthor=T.+M.+Wallauthor=N.+R.+Higdonauthor=J.+A.+Lawsonauthor=K.+L.+Rutherford-Rootauthor=M.+B.+Berkenpasauthor=W.+E.+Hoffmannauthor=D.+W.+Piotrowskiauthor=V.+E.+Groppiauthor=G.+Allamanauthor=R.+Ogierauthor=S.+Bertrandauthor=D.+Bertrandauthor=S.+P.+Arneric&title=A+novel+positive+allosteric+modulator+of+the+alpha7+neuronal+nicotinic+acetylcholine+receptor%3A+in+vitro+and+in+vivo+characterization&doi=10.1523%2FJNEUROSCI.5269-04.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">A novel positive allosteric modulator of the α7 neuronal nicotinic acetylcholine receptor: In vitro and in vivo characterization</span></div><div class="casAuthors">Hurst, Raymond S.; Hajos, Mihaly; Raggenbass, Mario; Wall, Theron M.; Higdon, Nicole R.; Lawson, Judy A.; Rutherford-Root, Karen L.; Berkenpas, Mitchell B.; Hoffmann, W. E.; Piotrowski, David W.; Groppi, Vincent E.; Allaman, Geraldine; Ogier, Roch; Bertrand, Sonia; Bertrand, Daniel; Arneric, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4396-4405</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Several lines of evidence suggest a link between the α7 neuronal nicotinic acetylcholine receptor (nAChR) and brain disorders including schizophrenia, Alzheimer's disease, and traumatic brain injury.  The present work describes a novel mol., 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(5-methyl-isoxazol-3-yl)-urea (PNU-120596), which acts as a powerful pos. allosteric modulator of the α7 nAChR.  Discovered in a high-throughput screen, PNU-120596 increased agonist-evoked calcium flux mediated by an engineered variant of the human α7 nAChR.  Electrophysiol. studies confirmed that PNU-120596 increased peak agonist-evoked currents mediated by wild-type receptors and also demonstrated a pronounced prolongation of the evoked response in the continued presence of agonist.  In contrast, PNU-120596 produced no detectable change in currents mediated by α4β2, α3β4, and α9α10 nAChRs.  PNU-120596 increased the channel mean open time of α7 nAChRs but had no effect on ion selectivity and relatively little, if any, effect on unitary conductance.  When applied to acute hippocampal slices, PNU-120596 increased the frequency of ACh-evoked GABAergic postsynaptic currents measured in pyramidal neurons; this effect was suppressed by TTX, suggesting that PNU-120596 modulated the function of α7 nAChRs located on the somatodendritic membrane of hippocampal interneurons.  Accordingly, PNU-120596 greatly enhanced the ACh-evoked inward currents in these interneurons.  Systemic administration of PNU-120596 to rats improved the auditory gating deficit caused by amphetamine, a model proposed to reflect a circuit level disturbance assocd. with schizophrenia.  Together, these results suggest that PNU-120596 represents a new class of mol. that enhances α7 nAChR function and thus has the potential to treat psychiatric and neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq26WDVJ3sdGLVg90H21EOLACvtfcHk0lhwkx8thojgYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFKgtLo%253D&md5=39dd78bcd96ebff54a2beb7d67b68e33</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5269-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5269-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DHaj%25C3%25B3s%26aufirst%3DM.%26aulast%3DRaggenbass%26aufirst%3DM.%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DHigdon%26aufirst%3DN.%2BR.%26aulast%3DLawson%26aufirst%3DJ.%2BA.%26aulast%3DRutherford-Root%26aufirst%3DK.%2BL.%26aulast%3DBerkenpas%26aufirst%3DM.%2BB.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DAllaman%26aufirst%3DG.%26aulast%3DOgier%26aufirst%3DR.%26aulast%3DBertrand%26aufirst%3DS.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26atitle%3DA%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520the%2520alpha7%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520characterization%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D4396%26epage%3D4405%26doi%3D10.1523%2FJNEUROSCI.5269-04.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gronlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetterstrand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarris, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gfesser, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kouhen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radek, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3377</span><span class="NLM_x">–</span> <span class="NLM_lpage">3384</span><span class="refDoi"> DOI: 10.1021/jm9003818</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9003818" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3377-3384&author=R.+Faghihauthor=S.+M.+Gopalakrishnanauthor=J.+H.+Gronlienauthor=J.+Malyszauthor=C.+A.+Briggsauthor=C.+Wetterstrandauthor=H.+Weenauthor=M.+P.+Curtisauthor=K.+A.+Sarrisauthor=G.+A.+Gfesserauthor=R.+El-Kouhenauthor=H.+M.+Robbauthor=R.+J.+Radekauthor=K.+C.+Marshauthor=W.+H.+Bunnelleauthor=M.+Gopalakrishnan&title=Discovery+of+4-%285-%284-chlorophenyl%29-2-methyl-3-propionyl-1H-pyrrol-1-yl%29benzenesulfonamide+%28A-867744%29+as+a+novel+positive+allosteric+modulator+of+the+alpha7+nicotinic+acetylcholine+receptor&doi=10.1021%2Fjm9003818"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1021%2Fjm9003818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9003818%26sid%3Dliteratum%253Aachs%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DGopalakrishnan%26aufirst%3DS.%2BM.%26aulast%3DGronlien%26aufirst%3DJ.%2BH.%26aulast%3DMalysz%26aufirst%3DJ.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DWetterstrand%26aufirst%3DC.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DCurtis%26aufirst%3DM.%2BP.%26aulast%3DSarris%26aufirst%3DK.%2BA.%26aulast%3DGfesser%26aufirst%3DG.%2BA.%26aulast%3DEl-Kouhen%26aufirst%3DR.%26aulast%3DRobb%26aufirst%3DH.%2BM.%26aulast%3DRadek%26aufirst%3DR.%2BJ.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25204-%25285-%25284-chlorophenyl%2529-2-methyl-3-propionyl-1H-pyrrol-1-yl%2529benzenesulfonamide%2520%2528A-867744%2529%2520as%2520a%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520the%2520alpha7%2520nicotinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3377%26epage%3D3384%26doi%3D10.1021%2Fjm9003818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group">Carter, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witt, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insel, T. R.</span><span> </span><span class="NLM_article-title">Oxytocin and social bonding</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">652</span><span class="NLM_x">, </span> <span class="NLM_fpage">204</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span><span class="refDoi"> DOI: 10.1111/j.1749-6632.1992.tb34356.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1111%2Fj.1749-6632.1992.tb34356.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=652&publication_year=1992&pages=204-211&author=C.+S.+Carterauthor=J.+R.+Williamsauthor=D.+M.+Wittauthor=T.+R.+Insel&title=Oxytocin+and+social+bonding&doi=10.1111%2Fj.1749-6632.1992.tb34356.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.1992.tb34356.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.1992.tb34356.x%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DC.%2BS.%26aulast%3DWilliams%26aufirst%3DJ.%2BR.%26aulast%3DWitt%26aufirst%3DD.%2BM.%26aulast%3DInsel%26aufirst%3DT.%2BR.%26atitle%3DOxytocin%2520and%2520social%2520bonding%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1992%26volume%3D652%26spage%3D204%26epage%3D211%26doi%3D10.1111%2Fj.1749-6632.1992.tb34356.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group">Insel, T. R.</span><span> </span><span class="NLM_article-title">A neurobiological basis of social attachment</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">735</span><span class="refDoi"> DOI: 10.1176/ajp.154.6.726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1176%2Fajp.154.6.726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=9167498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADyaK2szhtVegsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=1997&pages=726-735&author=T.+R.+Insel&title=A+neurobiological+basis+of+social+attachment&doi=10.1176%2Fajp.154.6.726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">A neurobiological basis of social attachment</span></div><div class="casAuthors">Insel T R</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">726-35</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Although an inability to form normal social attachments characterizes many forms of psychopathology, there has been little study of the neural basis of social bond formation.  The primary purpose of this article is to describe a novel approach to the neurobiology of attachment.  METHOD:  The author reviews animal research on two closely related neuropeptides, oxytocin and vasopressin, implicated in the central mediation of attachment behaviors.  These neuropeptides appear to be important for the initiation of pair bonds and parental behaviors as well as the infant's response to social separation.  RESULTS:  Both cellular and molecular studies have begun to reveal the mechanisms by which oxytocin and vasopressin neural pathways are regulated, leading to a preliminary understanding of how these hormones act within the brain to influence complex social behaviors.  CONCLUSIONS:  Although their function in the human brain has yet to be demonstrated, the available evidence suggests that oxytocin and vasopressin may prove to be important in the pathophysiology of clinical disorders, such as autism, characterized by an inability to form normal social attachments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXx1ktA_8fRHO4gDb7JggCfW6udTcc2eb5KHReuG22_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2szhtVegsw%253D%253D&md5=2175549d30474a0c51c4757df1b9949c</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1176%2Fajp.154.6.726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fajp.154.6.726%26sid%3Dliteratum%253Aachs%26aulast%3DInsel%26aufirst%3DT.%2BR.%26atitle%3DA%2520neurobiological%2520basis%2520of%2520social%2520attachment%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D1997%26volume%3D154%26spage%3D726%26epage%3D735%26doi%3D10.1176%2Fajp.154.6.726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group">Modahl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterhouse, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, H.</span><span> </span><span class="NLM_article-title">Plasma oxytocin levels in autistic children</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span><span class="refDoi"> DOI: 10.1016/S0006-3223(97)00439-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0006-3223%2897%2900439-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=9513736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADyaK1c7nsV2hsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1998&pages=270-277&author=C.+Modahlauthor=L.+Greenauthor=D.+Feinauthor=M.+Morrisauthor=L.+Waterhouseauthor=C.+Feinsteinauthor=H.+Levin&title=Plasma+oxytocin+levels+in+autistic+children&doi=10.1016%2FS0006-3223%2897%2900439-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma oxytocin levels in autistic children</span></div><div class="casAuthors">Modahl C; Green L; Fein D; Morris M; Waterhouse L; Feinstein C; Levin H</div><div class="citationInfo"><span class="NLM_cas:title">Biological psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">270-7</span>
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    </div><div class="casAbstract">BACKGROUND:  Social impairments are central to the syndrome of autism.  The neuropeptide oxytocin (OT) has been implicated in the regulation of social behavior in animals but has not yet been examined in autistic subjects.  METHODS:  To determine whether autistic children have abnormalities in OT, midday plasma samples from 29 autistic and 30 age-matched normal children, all prepubertal, were analyzed by radioimmunoassay for levels of OT.  RESULTS:  Despite individual variability and overlapping group distributions, the autistic group had significantly lower plasma OT levels than the normal group.  OT increased with age in the normal but not the autistic children.  Elevated OT was associated with higher scores on social and developmental measures for the normal children, but was associated with lower scores for the autistic children.  These relationships were strongest in a subset of autistic children identified as aloof.  CONCLUSIONS:  Although making inferences to central OT functioning from peripheral measurement is difficult, the data suggest that OT abnormalities may exist in autism, and that more direct investigation of central nervous system OT function is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkrIn8D9W2z2LFM_lbR1VmfW6udTcc2eYQd8GVsSRpwbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c7nsV2hsQ%253D%253D&md5=36ba0a757dc1cfee81be20d30132122b</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2897%2900439-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252897%252900439-3%26sid%3Dliteratum%253Aachs%26aulast%3DModahl%26aufirst%3DC.%26aulast%3DGreen%26aufirst%3DL.%26aulast%3DFein%26aufirst%3DD.%26aulast%3DMorris%26aufirst%3DM.%26aulast%3DWaterhouse%26aufirst%3DL.%26aulast%3DFeinstein%26aufirst%3DC.%26aulast%3DLevin%26aufirst%3DH.%26atitle%3DPlasma%2520oxytocin%2520levels%2520in%2520autistic%2520children%26jtitle%3DBiol.%2520Psychiatry%26date%3D1998%26volume%3D43%26spage%3D270%26epage%3D277%26doi%3D10.1016%2FS0006-3223%2897%2900439-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group">Green, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modahl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterhouse, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M.</span><span> </span><span class="NLM_article-title">Oxytocin and autistic disorder: alterations in peptide forms</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span><span class="refDoi"> DOI: 10.1016/S0006-3223(01)01139-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0006-3223%2801%2901139-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=11690596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvFGqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=609-613&author=L.+Greenauthor=D.+Feinauthor=C.+Modahlauthor=C.+Feinsteinauthor=L.+Waterhouseauthor=M.+Morris&title=Oxytocin+and+autistic+disorder%3A+alterations+in+peptide+forms&doi=10.1016%2FS0006-3223%2801%2901139-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin and autistic disorder: alterations in peptide forms</span></div><div class="casAuthors">Green, LeeAnne; Fein, Deborah; Modahl, Charlotte; Feinstein, Carl; Waterhouse, Lynn; Morris, Mariana</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">609-613</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Oxytocin (OT) is synthesized as a prohormone that is sequentially processed to peptides.  These peptides are the bioactive amidated form (OT) and the C-terminal extended peptides, OT-Gly, OT-Gly-Lys and OT-Gly-Lys-Arg, which are designated together as OT-X.  As an extension of our previous study finding decreased plasma OT in autism, studies were conducted to det. whether there were changes in OT peptide forms in autistic children.  28 Male subjects (97 ± 20 mo; range, 70-139 mo), diagnosed with DSM-IV autistic disorder through observation and semi-structured interview, were compared with 31 age-matched nonpsychiatric control subjects (106 ± 22 mo; range, 74-140 mo).  Using OT antisera with different specificity for the peptide forms, the authors measured plasma OT and OT-X in each group.  T tests showed that there was a decrease in plasma OT (t = 4.4, p < .0001), an increase in OT-X (t = 2.3, p < .03) and an increase in the ratio of OT-X/OT (t = 4.5, p < .0001) in the autistic sample, compared with control subjects.  The results suggest that children with autistic disorder show alterations in the endocrine OT system.  Deficits in OT peptide processing in children with autism may be important in the development of this syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy-zzsrIaaKbVg90H21EOLACvtfcHk0lhKZOSMKHCKVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvFGqsLc%253D&md5=50b8f68beebf1d162e59b8f4e5f8132e</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2801%2901139-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252801%252901139-8%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DL.%26aulast%3DFein%26aufirst%3DD.%26aulast%3DModahl%26aufirst%3DC.%26aulast%3DFeinstein%26aufirst%3DC.%26aulast%3DWaterhouse%26aufirst%3DL.%26aulast%3DMorris%26aufirst%3DM.%26atitle%3DOxytocin%2520and%2520autistic%2520disorder%253A%2520alterations%2520in%2520peptide%2520forms%26jtitle%3DBiol.%2520Psychiatry%26date%3D2001%26volume%3D50%26spage%3D609%26epage%3D613%26doi%3D10.1016%2FS0006-3223%2801%2901139-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group">LoParo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, I. D.</span><span> </span><span class="NLM_article-title">The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: a meta-analysis</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span><span class="refDoi"> DOI: 10.1038/mp.2014.77</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fmp.2014.77" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25092245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2cbovVSmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=640-646&author=D.+LoParoauthor=I.+D.+Waldman&title=The+oxytocin+receptor+gene+%28OXTR%29+is+associated+with+autism+spectrum+disorder%3A+a+meta-analysis&doi=10.1038%2Fmp.2014.77"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: a meta-analysis</span></div><div class="casAuthors">LoParo D; Waldman I D</div><div class="citationInfo"><span class="NLM_cas:title">Molecular psychiatry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">640-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The oxytocin receptor gene (OXTR) has been studied as a risk factor for autism spectrum disorder (ASD) owing to converging evidence from multiple levels of analysis that oxytocin (OXT) has an important role in the regulation of affiliative behavior and social bonding in both nonhuman mammals and humans.  Inconsistency in the effect sizes of the OXTR variants included in association studies render it unclear whether OXTR is truly associated with ASD, and, if so, which OXTR single-nucleotide polymorphisms (SNPs) are associated.  Thus, a meta-analytic review of extant studies is needed to determine whether OXTR shows association with ASD, and to elucidate which specific SNPs have a significant effect on ASD.  The current meta-analysis of 16 OXTR SNPs included 3941 individuals with ASD from 11 independent samples, although analyses of each individual SNP included a subset of this total.  We found significant associations between ASD and the SNPs rs7632287, rs237887, rs2268491 and rs2254298.  OXTR was also significantly associated with ASD in a gene-based test.  The current meta-analysis is the largest and most comprehensive investigation of the association of OXTR with ASD and the findings suggest directions for future studies of the etiology of ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXbTryRKs-MBjv2lLSLOxFfW6udTcc2ea_38YoROSfpLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbovVSmsA%253D%253D&md5=c4f507ef2ccd3c7a208b654e2bc69bcb</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1038%2Fmp.2014.77&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2014.77%26sid%3Dliteratum%253Aachs%26aulast%3DLoParo%26aufirst%3DD.%26aulast%3DWaldman%26aufirst%3DI.%2BD.%26atitle%3DThe%2520oxytocin%2520receptor%2520gene%2520%2528OXTR%2529%2520is%2520associated%2520with%2520autism%2520spectrum%2520disorder%253A%2520a%2520meta-analysis%26jtitle%3DMol.%2520Psychiatry%26date%3D2015%26volume%3D20%26spage%3D640%26epage%3D646%26doi%3D10.1038%2Fmp.2014.77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group">Jin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torashima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopatina, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shnayder, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seike, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takasawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munesue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashida, H.</span><span> </span><span class="NLM_article-title">CD38 is critical for social behaviour by regulating oxytocin secretion</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">446</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1038/nature05526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnature05526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=17287729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1arsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2007&pages=41-45&author=D.+Jinauthor=H.+X.+Liuauthor=H.+Hiraiauthor=T.+Torashimaauthor=T.+Nagaiauthor=O.+Lopatinaauthor=N.+A.+Shnayderauthor=K.+Yamadaauthor=M.+Nodaauthor=T.+Seikeauthor=K.+Fujitaauthor=S.+Takasawaauthor=S.+Yokoyamaauthor=K.+Koizumiauthor=Y.+Shiraishiauthor=S.+Tanakaauthor=M.+Hashiiauthor=T.+Yoshiharaauthor=K.+Higashidaauthor=M.+S.+Islamauthor=N.+Yamadaauthor=K.+Hayashiauthor=N.+Noguchiauthor=I.+Katoauthor=H.+Okamotoauthor=A.+Matsushimaauthor=A.+Salminaauthor=T.+Munesueauthor=N.+Shimizuauthor=S.+Mochidaauthor=M.+Asanoauthor=H.+Higashida&title=CD38+is+critical+for+social+behaviour+by+regulating+oxytocin+secretion&doi=10.1038%2Fnature05526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">CD38 is critical for social behavior by regulating oxytocin secretion</span></div><div class="casAuthors">Jin, Duo; Liu, Hong-Xiang; Hirai, Hirokazu; Torashima, Takashi; Nagai, Taku; Lopatina, Olga; Shnayder, Natalia A.; Yamada, Kiyofumi; Noda, Mami; Seike, Toshihiro; Fujita, Kyota; Takasawa, Shin; Yokoyama, Shigeru; Koizumi, Keita; Shiraishi, Yoshitake; Tanaka, Shigenori; Hashii, Minako; Yoshihara, Toru; Higashida, Kazuhiro; Islam, Mohammad Saharul; Yamada, Nobuaki; Hayashi, Kenshi; Noguchi, Naoya; Kato, Ichiro; Okamoto, Hiroshi; Matsushima, Akihiro; Salmina, Alla; Munesue, Toshio; Shimizu, Nobuaki; Mochida, Sumiko; Asano, Masahide; Higashida, Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">446</span>
        (<span class="NLM_cas:issue">7131</span>),
    <span class="NLM_cas:pages">41-45</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">CD38, a transmembrane glycoprotein with ADP-Ribosyl cyclase activity, catalyzes the formation of Ca2+ signaling mols., but its role in the neuroendocrine system is unknown.  Here we show that adult CD38 knockout (CD38-/-) female and male mice show marked defects in maternal nurturing and social behavior, resp., with higher locomotor activity.  Consistently, the plasma level of oxytocin (OT), but not vasopressin, was strongly decreased in CD38-/- mice.  Replacement of OT by s.c. injection or lentiviral-vector-mediated delivery of human CD38 in the hypothalamus rescued social memory and maternal care in CD38-/- mice.  Depolarization-induced OT secretion and Ca2+ elevation in oxytocinergic neurohypophysial axon terminals were disrupted in CD38-/- mice; this was mimicked by CD38 metabolite antagonists in CD38+/+ mice.  These results reveal that CD38 has a key role in neuropeptide release, thereby critically regulating maternal and social behaviors, and may be an element in neuro-developmental disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplMtCpmjbVNrVg90H21EOLACvtfcHk0lhu1LTf7srLjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1arsLw%253D&md5=f9e5a484caaeefd77260e712553d915f</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1038%2Fnature05526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05526%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DH.%2BX.%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DTorashima%26aufirst%3DT.%26aulast%3DNagai%26aufirst%3DT.%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DShnayder%26aufirst%3DN.%2BA.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DNoda%26aufirst%3DM.%26aulast%3DSeike%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DTakasawa%26aufirst%3DS.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DKoizumi%26aufirst%3DK.%26aulast%3DShiraishi%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DHashii%26aufirst%3DM.%26aulast%3DYoshihara%26aufirst%3DT.%26aulast%3DHigashida%26aufirst%3DK.%26aulast%3DIslam%26aufirst%3DM.%2BS.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DNoguchi%26aufirst%3DN.%26aulast%3DKato%26aufirst%3DI.%26aulast%3DOkamoto%26aufirst%3DH.%26aulast%3DMatsushima%26aufirst%3DA.%26aulast%3DSalmina%26aufirst%3DA.%26aulast%3DMunesue%26aufirst%3DT.%26aulast%3DShimizu%26aufirst%3DN.%26aulast%3DMochida%26aufirst%3DS.%26aulast%3DAsano%26aufirst%3DM.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DCD38%2520is%2520critical%2520for%2520social%2520behaviour%2520by%2520regulating%2520oxytocin%2520secretion%26jtitle%3DNature%26date%3D2007%26volume%3D446%26spage%3D41%26epage%3D45%26doi%3D10.1038%2Fnature05526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group">Preti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellante, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doneddu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadda, R.</span><span> </span><span class="NLM_article-title">Oxytocin and autism: a systematic review of randomized controlled trials</span> <span class="citation_source-journal">J. Child Adolesc. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1089/cap.2013.0040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1089%2Fcap.2013.0040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24679173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltlaltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=54-68&author=A.+Pretiauthor=M.+Melisauthor=S.+Siddiauthor=M.+Vellanteauthor=G.+Donedduauthor=R.+Fadda&title=Oxytocin+and+autism%3A+a+systematic+review+of+randomized+controlled+trials&doi=10.1089%2Fcap.2013.0040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin and Autism: A Systematic Review of Randomized Controlled Trials</span></div><div class="casAuthors">Preti, Antonio; Melis, Mariangela; Siddi, Sara; Vellante, Marcello; Doneddu, Giuseppe; Fadda, Roberta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Child and Adolescent Psychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">54-68</span>CODEN:
                <span class="NLM_cas:coden">JADPET</span>;
        ISSN:<span class="NLM_cas:issn">1044-5463</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Objective: Little is known about the effectiveness of pharmacol. interventions on autism spectrum disorder (ASD).  This is a systematic review of the randomized controlled trials (RCTs) of oxytocin interventions in autism, made from Jan. 1990 to Sept. 2013.  Method: A search of computerized databases was supplemented by manual search in the bibliogs. of key publications.  The methodol. quality of the studies included in the review was evaluated independently by two researchers, according to a set of formal criteria.  Discrepancies in scoring were resolved through discussion.  Results: The review yielded seven RCTs, including 101 subjects with ASD (males=95) and 8 males with Fragile X syndrome.  The main categories of target symptoms tested in the studies were repetitive behaviors, eye gaze, and emotion recognition.  The studies had a medium to high risk of bias.  Most studies had small samples (median=15).  All the studies but one reported statistically significant between-group differences on at least one outcome variable.  Most findings were characterized by medium effect size.  Only one study had evidence that the improvement in emotion recognition was maintained after 6 wk of treatment with intranasal oxytocin.  Overall, oxytocin was well tolerated and side effects, when present, were generally rated as mild; however, restlessness, increased irritability, and increased energy occurred more often under oxytocin.  Conclusions: RCTs of oxytocin interventions in autism yielded potentially promising findings in measures of emotion recognition and eye gaze, which are impaired early in the course of the ASD condition and might disrupt social skills learning in developing children.  There is a need for larger, more methodol. rigorous RCTs in this area.  Future studies should be better powered to est. outcomes with medium to low effect size, and should try to enroll female participants, who were rarely considered in previous studies.  Risk of bias should be minimized.  Human long-term administration studies are necessary before clin. recommendations can be made.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyfGFQSxkhqLVg90H21EOLACvtfcHk0lgIUJcjJB1X1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltlaltbg%253D&md5=4fcb80d475afc80e0bc1b110102bd809</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1089%2Fcap.2013.0040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcap.2013.0040%26sid%3Dliteratum%253Aachs%26aulast%3DPreti%26aufirst%3DA.%26aulast%3DMelis%26aufirst%3DM.%26aulast%3DSiddi%26aufirst%3DS.%26aulast%3DVellante%26aufirst%3DM.%26aulast%3DDoneddu%26aufirst%3DG.%26aulast%3DFadda%26aufirst%3DR.%26atitle%3DOxytocin%2520and%2520autism%253A%2520a%2520systematic%2520review%2520of%2520randomized%2520controlled%2520trials%26jtitle%3DJ.%2520Child%2520Adolesc.%2520Psychopharmacol.%26date%3D2014%26volume%3D24%26spage%3D54%26epage%3D68%26doi%3D10.1089%2Fcap.2013.0040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group">Leng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, M.</span><span> </span><span class="NLM_article-title">Intranasal oxytocin: myths and delusions</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2015.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.biopsych.2015.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26049207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsFegsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=243-250&author=G.+Lengauthor=M.+Ludwig&title=Intranasal+oxytocin%3A+myths+and+delusions&doi=10.1016%2Fj.biopsych.2015.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Intranasal Oxytocin: Myths and Delusions</span></div><div class="casAuthors">Leng, Gareth; Ludwig, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">243-250</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Despite widespread reports that intranasal application of oxytocin has a variety of behavioral effects, very little of the huge amts. applied intranasally appears to reach the cerebrospinal fluid.  However, peripheral concns. are increased to supraphysiol. levels, with likely effects on diverse targets including the gastrointestinal tract, heart, and reproductive tract.  The wish to believe in the effectiveness of intranasal oxytocin appears to be widespread and needs to be guarded against with scepticism and rigor.  Preregistering trials, declaring primary and secondary outcomes in advance, specifying the statistical methods to be applied, and making all data openly available should minimize problems of publication bias and questionable post hoc analyses.  Effects of intranasal oxytocin also need proper dose-response studies, and such studies need to include control subjects for peripheral effects, by administering oxytocin peripherally and by blocking peripheral actions with antagonists.  Reports in the literature of oxytocin measurements include many that have been made with discredited methodol.  Claims that peripheral measurements of oxytocin reflect central release are questionable at best.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoATjOPiHPO2bVg90H21EOLACvtfcHk0lioUu3qclgm1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsFegsrk%253D&md5=16d266108339c1e0d37e9f2ee2cb4ffb</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2015.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2015.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DLeng%26aufirst%3DG.%26aulast%3DLudwig%26aufirst%3DM.%26atitle%3DIntranasal%2520oxytocin%253A%2520myths%2520and%2520delusions%26jtitle%3DBiol.%2520Psychiatry%26date%3D2016%26volume%3D79%26spage%3D243%26epage%3D250%26doi%3D10.1016%2Fj.biopsych.2015.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group">Wiśniewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alagarsamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galyean, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tariga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiśniewska, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croston, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laporte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivière, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schteingart, C. D.</span><span> </span><span class="NLM_article-title">New, potent, and selective peptidic oxytocin receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5306</span><span class="NLM_x">–</span> <span class="NLM_lpage">5317</span><span class="refDoi"> DOI: 10.1021/jm500365s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500365s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVWhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5306-5317&author=K.+Wi%C5%9Bniewskiauthor=S.+Alagarsamyauthor=R.+Galyeanauthor=H.+Tarigaauthor=D.+Thompsonauthor=B.+Lyauthor=H.+Wi%C5%9Bniewskaauthor=S.+Qiauthor=G.+Crostonauthor=R.+Laporteauthor=P.+J.+Rivi%C3%A8reauthor=C.+D.+Schteingart&title=New%2C+potent%2C+and+selective+peptidic+oxytocin+receptor+agonists&doi=10.1021%2Fjm500365s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">New, Potent, and Selective Peptidic Oxytocin Receptor Agonists</span></div><div class="casAuthors">Wisniewski, Kazimierz; Alagarsamy, Sudarkodi; Galyean, Robert; Tariga, Hiroe; Thompson, Dorain; Ly, Brian; Wisniewska, Halina; Qi, Steve; Croston, Glenn; Laporte, Regent; Riviere, Pierre J.-M.; Schteingart, Claudio D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5306-5317</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mothers of preterm babies frequently have difficulty establishing or maintaining lactation, thought to be due to interference with the milk ejection reflex.  Administration of exogenous oxytocin can produce alveolar contraction and adequate breast emptying resulting in establishment of successful lactation.  The natural hormone oxytocin is not receptor-selective and may cause hyponatremia via V2 receptor mediated antidiuresis.  We have designed a series of potent oxytocin analogs contg. N-alkylglycines in position 7 with excellent selectivity vs. the related V1a, V1b, and V2 vasopressin receptors and short half-life: agonists 31([2-ThiMeGly7]dOT), 47 (carba-6-[Phe2,BuGly7]dOT), 55 (carba-6-[3-MeBzlGly7]dOT), and 57 (carba-1-[4-FBzlGly7]dOT) have EC50 values at hOTR < 0.1 nM, selectivity ratios vs. related human vasopressin receptors of >2000, IC50 at hV1aR > 500 nM, and total clearance in rats in the range of 60-80 mL min-1 kg-1.  Compd. 57 (FE 202767) is currently in clin. development for the treatment of preterm mothers requiring lactation support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_ykZz5KXVXbVg90H21EOLACvtfcHk0lioUu3qclgm1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVWhs78%253D&md5=8076f2bbeb06371908b462d1c8f25321</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1021%2Fjm500365s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500365s%26sid%3Dliteratum%253Aachs%26aulast%3DWi%25C5%259Bniewski%26aufirst%3DK.%26aulast%3DAlagarsamy%26aufirst%3DS.%26aulast%3DGalyean%26aufirst%3DR.%26aulast%3DTariga%26aufirst%3DH.%26aulast%3DThompson%26aufirst%3DD.%26aulast%3DLy%26aufirst%3DB.%26aulast%3DWi%25C5%259Bniewska%26aufirst%3DH.%26aulast%3DQi%26aufirst%3DS.%26aulast%3DCroston%26aufirst%3DG.%26aulast%3DLaporte%26aufirst%3DR.%26aulast%3DRivi%25C3%25A8re%26aufirst%3DP.%2BJ.%26aulast%3DSchteingart%26aufirst%3DC.%2BD.%26atitle%3DNew%252C%2520potent%252C%2520and%2520selective%2520peptidic%2520oxytocin%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5306%26epage%3D5317%26doi%3D10.1021%2Fjm500365s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group">Ashworth, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batt, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broqua, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigh, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeney, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laporte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartar, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yea, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, M. B.</span><span> </span><span class="NLM_article-title">Nonpeptide oxytocin agonists</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span><span class="refDoi"> DOI: 10.1358/dof.2006.031.04.980655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1358%2Fdof.2006.031.04.980655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVyltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=345-354&author=D.+M.+Ashworthauthor=A.+R.+Battauthor=A.+J.+Baxterauthor=P.+Broquaauthor=R.+M.+Haighauthor=P.+Hudsonauthor=C.+M.+Heeneyauthor=R.+Laporteauthor=A.+M.+Pensonauthor=G.+R.+Pittauthor=P.+A.+Robsonauthor=D.+P.+Rookerauthor=A.+L.+Tartarauthor=C.+M.+Yeaauthor=M.+B.+Roe&title=Nonpeptide+oxytocin+agonists&doi=10.1358%2Fdof.2006.031.04.980655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptide oxytocin agonists</span></div><div class="casAuthors">Ashworth, Doreen M.; Batt, Andrzej R.; Baxter, Andrew J.; Broqua, Pierre; Haigh, Robert M.; Hudson, Peter; Heeney, Celine M. S.; Laporte, Regent; Penson, Andrew; Pitt, Gary R. W.; Robson, Peter A.; Rooker, David P.; Tartar, Andre L.; Yea, Chris M.; Roe, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">345-353</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Oxytocin is a neurohypophyseal hormone that acts at the oxytocin receptor localized both peripherally and centrally and is particularly highly expressed in the pregnant human myometrium.  Synthetic oxytocin has long been used to induce labor and oxytocin antagonists have been introduced for the treatment of preterm labor.  New compds. are described that are potent, selective and efficacious oxytocin receptor agonists with potential utility in promoting labor and for the treatment of conditions such as male and female sexual dysfunction.  These new agents may also be useful as tools for further elucidating the roles of the oxytocin receptor system.  Furthermore, as they are nonpeptidic in nature, they may offer advantages over peptide oxytocin analogs in terms of oral availability and central penetration.  This article describes the various approaches that have been used to discover such compds.  Compds. such as 27, the first nonpeptide oxytocin agonists reported, are currently being investigated as pharmacol. tools in animal models of oxytocin activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxThz83ckUprVg90H21EOLACvtfcHk0ljGLnuh_aPBnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVyltr4%253D&md5=398b1bc9e09f4682997567457d6905c8</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.04.980655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.04.980655%26sid%3Dliteratum%253Aachs%26aulast%3DAshworth%26aufirst%3DD.%2BM.%26aulast%3DBatt%26aufirst%3DA.%2BR.%26aulast%3DBaxter%26aufirst%3DA.%2BJ.%26aulast%3DBroqua%26aufirst%3DP.%26aulast%3DHaigh%26aufirst%3DR.%2BM.%26aulast%3DHudson%26aufirst%3DP.%26aulast%3DHeeney%26aufirst%3DC.%2BM.%26aulast%3DLaporte%26aufirst%3DR.%26aulast%3DPenson%26aufirst%3DA.%2BM.%26aulast%3DPitt%26aufirst%3DG.%2BR.%26aulast%3DRobson%26aufirst%3DP.%2BA.%26aulast%3DRooker%26aufirst%3DD.%2BP.%26aulast%3DTartar%26aufirst%3DA.%2BL.%26aulast%3DYea%26aufirst%3DC.%2BM.%26aulast%3DRoe%26aufirst%3DM.%2BB.%26atitle%3DNonpeptide%2520oxytocin%2520agonists%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D345%26epage%3D354%26doi%3D10.1358%2Fdof.2006.031.04.980655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group">Ring, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwyer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platt, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulicicchio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logue, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span> </span><span class="NLM_article-title">Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2009.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuropharm.2009.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=19615387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD1Mjjs1GqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=69-77&author=R.+H.+Ringauthor=L.+E.+Schechterauthor=S.+K.+Leonardauthor=J.+M.+Dwyerauthor=B.+J.+Plattauthor=R.+Grafauthor=S.+Grauerauthor=C.+Pulicicchioauthor=L.+Resnickauthor=Z.+Rahmanauthor=S.+J.+Sukoff+Rizzoauthor=B.+Luoauthor=C.+E.+Beyerauthor=S.+F.+Logueauthor=K.+L.+Marquisauthor=Z.+A.+Hughesauthor=S.+Rosenzweig-Lipson&title=Receptor+and+behavioral+pharmacology+of+WAY-267464%2C+a+non-peptide+oxytocin+receptor+agonist&doi=10.1016%2Fj.neuropharm.2009.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist</span></div><div class="casAuthors">Ring Robert H; Schechter Lee E; Leonard Sarah K; Dwyer Jason M; Platt Brian J; Graf Radka; Grauer Steven; Pulicicchio Claudine; Resnick Lynn; Rahman Zia; Sukoff Rizzo Stacey J; Luo Bin; Beyer Chad E; Logue Sheree F; Marquis Karen L; Hughes Zoe A; Rosenzweig-Lipson Sharon</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The widely reported effects of oxytocin (OT) on CNS function has generated considerable interest in the therapeutic potential for targeting this system for a variety of human psychiatric diseases, including anxiety disorders, autism, schizophrenia, and depression.  The utility of synthetic OT, as both a research tool and neurotherapeutic, is limited by the physiochemical properties inherent in most neuropeptides, notably its short half-life and poor blood brain barrier penetration.  Subsequently, the discovery and development of non-peptide molecules that act as selective agonists of the oxytocin receptor (OTR) has been an important goal of the field.  In this study, we report the receptor and behavioral pharmacology of WAY-267464, a first generation small-molecule OTR agonist.  WAY-267464 is a high-affinity, potent, and selective (vs.  V1a, V2, V1b) agonist of the OTR.  In assays measuring both behavioral (four-plate test, elevated zero maze) and autonomic (stress-induced hyperthermia) parameters of the anxiety response, WAY-267464 exhibits an anxiolytic-like profile similar to OT.  We have demonstrated that the anxiolytic-like profile of WAY-267464 is mediated through central sites of action.  WAY-267464 also significantly reverses disruption in prepulse inhibition of the acoustic startle reflex induced by either MK-801 or amphetamine, similar to the antipsychotic-like effects previously reported for OT.  Interestingly, in the mouse tail suspension test, WAY-267464 failed to produce changes in immobility that are seen with OT, raising the question of whether the antidepressant-like activity of OT may be working independently of the OTR.  A selective OTR antagonist also failed to block the effects of OT on immobility in the TST.  The significance of these findings for shaping the clinical development of OTR agonists is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8S-KlSxighgMthz5_Rx5rfW6udTcc2eafqrzVkGxvR7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mjjs1GqsQ%253D%253D&md5=699434bd2c444cd29345d24db54fbbb5</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2009.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2009.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DRing%26aufirst%3DR.%2BH.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DLeonard%26aufirst%3DS.%2BK.%26aulast%3DDwyer%26aufirst%3DJ.%2BM.%26aulast%3DPlatt%26aufirst%3DB.%2BJ.%26aulast%3DGraf%26aufirst%3DR.%26aulast%3DGrauer%26aufirst%3DS.%26aulast%3DPulicicchio%26aufirst%3DC.%26aulast%3DResnick%26aufirst%3DL.%26aulast%3DRahman%26aufirst%3DZ.%26aulast%3DSukoff%2BRizzo%26aufirst%3DS.%2BJ.%26aulast%3DLuo%26aufirst%3DB.%26aulast%3DBeyer%26aufirst%3DC.%2BE.%26aulast%3DLogue%26aufirst%3DS.%2BF.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DReceptor%2520and%2520behavioral%2520pharmacology%2520of%2520WAY-267464%252C%2520a%2520non-peptide%2520oxytocin%2520receptor%2520agonist%26jtitle%3DNeuropharmacology%26date%3D2010%26volume%3D58%26spage%3D69%26epage%3D77%26doi%3D10.1016%2Fj.neuropharm.2009.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group">Pitt, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batt, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigh, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartar, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trim, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yea, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, M. B.</span><span> </span><span class="NLM_article-title">Non-peptide oxytocin agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4585</span><span class="NLM_x">–</span> <span class="NLM_lpage">4589</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2004.04.107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bmcl.2004.04.107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4585-4589&author=G.+R.+Pittauthor=A.+R.+Battauthor=R.+M.+Haighauthor=A.+M.+Pensonauthor=P.+A.+Robsonauthor=D.+P.+Rookerauthor=A.+L.+Tartarauthor=J.+E.+Trimauthor=C.+M.+Yeaauthor=M.+B.+Roe&title=Non-peptide+oxytocin+agonists&doi=10.1016%2Fj.bmcl.2004.04.107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.04.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.04.107%26sid%3Dliteratum%253Aachs%26aulast%3DPitt%26aufirst%3DG.%2BR.%26aulast%3DBatt%26aufirst%3DA.%2BR.%26aulast%3DHaigh%26aufirst%3DR.%2BM.%26aulast%3DPenson%26aufirst%3DA.%2BM.%26aulast%3DRobson%26aufirst%3DP.%2BA.%26aulast%3DRooker%26aufirst%3DD.%2BP.%26aulast%3DTartar%26aufirst%3DA.%2BL.%26aulast%3DTrim%26aufirst%3DJ.%2BE.%26aulast%3DYea%26aufirst%3DC.%2BM.%26aulast%3DRoe%26aufirst%3DM.%2BB.%26atitle%3DNon-peptide%2520oxytocin%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4585%26epage%3D4589%26doi%3D10.1016%2Fj.bmcl.2004.04.107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group">Frantz, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boudier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span> </span><span class="NLM_article-title">Subtlety of the structure-affinity and structure-efficacy relationships around a nonpeptide oxytocin receptor agonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1546</span><span class="NLM_x">–</span> <span class="NLM_lpage">1562</span><span class="refDoi"> DOI: 10.1021/jm901084f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901084f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1546-1562&author=M.+C.+Frantzauthor=J.+Rodrigoauthor=L.+Boudierauthor=T.+Durrouxauthor=B.+Mouillacauthor=M.+Hibert&title=Subtlety+of+the+structure-affinity+and+structure-efficacy+relationships+around+a+nonpeptide+oxytocin+receptor+agonist&doi=10.1021%2Fjm901084f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1021%2Fjm901084f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901084f%26sid%3Dliteratum%253Aachs%26aulast%3DFrantz%26aufirst%3DM.%2BC.%26aulast%3DRodrigo%26aufirst%3DJ.%26aulast%3DBoudier%26aufirst%3DL.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DHibert%26aufirst%3DM.%26atitle%3DSubtlety%2520of%2520the%2520structure-affinity%2520and%2520structure-efficacy%2520relationships%2520around%2520a%2520nonpeptide%2520oxytocin%2520receptor%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1546%26epage%3D1562%26doi%3D10.1021%2Fjm901084f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group">Bissantz, C.; Grundschober, C.; Nettekoven, M.; Plancher, J. M.; Vifian, W.</span><span> </span><span class="NLM_article-title">Oxytocin Receptor Agonists for the Treatment of CNS Diseases</span>. WIPO Patent WO2014111356,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+Bissantz&author=C.+Grundschober&author=M.+Nettekoven&author=J.+M.+Plancher&author=W.+Vifian&title=Oxytocin+Receptor+Agonists+for+the+Treatment+of+CNS+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26atitle%3DOxytocin%2520Receptor%2520Agonists%2520for%2520the%2520Treatment%2520of%2520CNS%2520Diseases%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group">Izdebska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciosek, J.</span><span> </span><span class="NLM_article-title">Galanin influences on vasopressin and oxytocin release: in vitro studies</span> <span class="citation_source-journal">Neuropeptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span><span class="refDoi"> DOI: 10.1016/j.npep.2010.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.npep.2010.04.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2010&pages=341-348&author=K.+Izdebskaauthor=J.+Ciosek&title=Galanin+influences+on+vasopressin+and+oxytocin+release%3A+in+vitro+studies&doi=10.1016%2Fj.npep.2010.04.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1016%2Fj.npep.2010.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.npep.2010.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DIzdebska%26aufirst%3DK.%26aulast%3DCiosek%26aufirst%3DJ.%26atitle%3DGalanin%2520influences%2520on%2520vasopressin%2520and%2520oxytocin%2520release%253A%2520in%2520vitro%2520studies%26jtitle%3DNeuropeptides%26date%3D2010%26volume%3D44%26spage%3D341%26epage%3D348%26doi%3D10.1016%2Fj.npep.2010.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group">Riebold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankuta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Israel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemanov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monakhov, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yirmiya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malavasi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebstein, R. P.</span><span> </span><span class="NLM_article-title">All-trans retinoic acid upregulates reduced CD38 transcription in lymphoblastoid cell lines from autism spectrum disorder</span> <span class="citation_source-journal">Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">806</span><span class="refDoi"> DOI: 10.2119/molmed.2011.00080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.2119%2Fmolmed.2011.00080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21528155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVemurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=799-806&author=M.+Rieboldauthor=D.+Mankutaauthor=E.+Lererauthor=S.+Israelauthor=S.+Zhongauthor=L.+Nemanovauthor=M.+V.+Monakhovauthor=S.+Leviauthor=N.+Yirmiyaauthor=M.+Yaariauthor=F.+Malavasiauthor=R.+P.+Ebstein&title=All-trans+retinoic+acid+upregulates+reduced+CD38+transcription+in+lymphoblastoid+cell+lines+from+autism+spectrum+disorder&doi=10.2119%2Fmolmed.2011.00080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">All-trans retinoic acid upregulates reduced CD38 transcription in lymphoblastoid cell lines from Autism spectrum disorder</span></div><div class="casAuthors">Riebold, Mathias; Mankuta, David; Lerer, Elad; Israel, Salomon; Zhong, Songfa; Nemanov, Luba; Monakhov, Mikhail V.; Levi, Shlomit; Yirmiya, Nurit; Yaari, Maya; Malavasi, Fabio; Ebstein, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">799-806</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">Deficits in social behavior in mice lacking the CD38 gene were attributed to impaired secretion of oxytocin.  In humans, similar deficits in social behavior are assocd. with autistic spectrum disorder (ASD), for which genetic variants of CD38 were pinpointed as provisional risk factors.  We sought to explore, in an in vitro model, the feasibility of the theory that restoring the level of CD38 in ASD patients could be of potential clin. benefit.  CD38 transcription is highly sensitive to several cytokines and vitamins.  One of these, all-trans retinoic acid (ATRA), a known inducer of CD38, was added during cell culture and tested on a large sample of N = 120 lymphoblastoid cell (LBC) lines from ASD patients and their parents.  Anal. of CD38 mRNA levels shows that ATRA has an upmodulatory potential on LBC derived from ASD patients as well as from their parents.  The next crucial issue addressed in this study was the relationship between levels of CD38 expression and psychol. parameters.  The results obtained indicate a pos. correlation between CD38 expression levels and patient scores on the Vineland Adaptive Behavior Scale.  In addn., anal. of the role of genetic polymorphisms in the dynamics of the mol. revealed that the genotype of a single-nucleotide polymorphism (rs6449182; C>G variation) in the CpG island of intron 1, harboring the retinoic-acid response element, exerts differential roles in CD38 expression in ASD and in parental LBC.  In conclusion,these results provide an empirical basis for the development of a pharmacol. ASD treatment strategy based on retinoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriy61GX2kvIbVg90H21EOLACvtfcHk0lhiMfPfINfpWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVemurrM&md5=363c795fd0c65ed45b756143003ca8b9</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2011.00080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2011.00080%26sid%3Dliteratum%253Aachs%26aulast%3DRiebold%26aufirst%3DM.%26aulast%3DMankuta%26aufirst%3DD.%26aulast%3DLerer%26aufirst%3DE.%26aulast%3DIsrael%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DS.%26aulast%3DNemanov%26aufirst%3DL.%26aulast%3DMonakhov%26aufirst%3DM.%2BV.%26aulast%3DLevi%26aufirst%3DS.%26aulast%3DYirmiya%26aufirst%3DN.%26aulast%3DYaari%26aufirst%3DM.%26aulast%3DMalavasi%26aufirst%3DF.%26aulast%3DEbstein%26aufirst%3DR.%2BP.%26atitle%3DAll-trans%2520retinoic%2520acid%2520upregulates%2520reduced%2520CD38%2520transcription%2520in%2520lymphoblastoid%2520cell%2520lines%2520from%2520autism%2520spectrum%2520disorder%26jtitle%3DMol.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D799%26epage%3D806%26doi%3D10.2119%2Fmolmed.2011.00080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group">Sabatier, N.</span><span> </span><span class="NLM_article-title">Alpha-melanocyte-stimulating hormone and oxytocin: a peptide signalling cascade in the hypothalamus</span> <span class="citation_source-journal">J. Neuroendocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span><span class="refDoi"> DOI: 10.1111/j.1365-2826.2006.01464.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1111%2Fj.1365-2826.2006.01464.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=16879169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1Srt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=703-710&author=N.+Sabatier&title=Alpha-melanocyte-stimulating+hormone+and+oxytocin%3A+a+peptide+signalling+cascade+in+the+hypothalamus&doi=10.1111%2Fj.1365-2826.2006.01464.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">α-Melanocyte-stimulating hormone and oxytocin: a peptide signalling cascade in the hypothalamus</span></div><div class="casAuthors">Sabatier, N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroendocrinology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">703-710</span>CODEN:
                <span class="NLM_cas:coden">JOUNE2</span>;
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  α-MSH (α-MSH) and oxytocin share remarkable similarities of effects on behavior in rats; in particular, they both inhibit feeding behavior and stimulate sexual behavior.  Recently, we showed that α-MSH interacts with the magnocellular oxytocin system in the supraoptic nucleus; α-MSH induces the release of oxytocin from the dendrites of magnocellular neurons but it inhibits the secretion of oxytocin from their nerve terminals in the posterior pituitary.  This effect of α-MSH on supraoptic nucleus oxytocin neurons is remarkable for two reasons.  First, it illustrates the capacity of magnocellular neurons to differentially regulate peptide release from dendrites and axons and, second, it emphasizes the putative role of magnocellular neurons as a major source of central oxytocin release, and as a likely substrate of some oxytocin-mediated behaviors.  The ability of peptides to differentially control secretion from different compartments of their targets indicates one way by which peptide signals might have a particularly significant effect on neuronal circuitry.  This suggests a possible explanation for the striking way in which some peptides can influence specific, complex behaviors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD9oIng0TALbVg90H21EOLACvtfcHk0lhiMfPfINfpWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1Srt7Y%253D&md5=c0775a098f5cce02d8725ce8153d416d</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2826.2006.01464.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2826.2006.01464.x%26sid%3Dliteratum%253Aachs%26aulast%3DSabatier%26aufirst%3DN.%26atitle%3DAlpha-melanocyte-stimulating%2520hormone%2520and%2520oxytocin%253A%2520a%2520peptide%2520signalling%2520cascade%2520in%2520the%2520hypothalamus%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D2006%26volume%3D18%26spage%3D703%26epage%3D710%26doi%3D10.1111%2Fj.1365-2826.2006.01464.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group">Peñagarikano, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lázaro, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peles, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maidment, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golshani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwind, D. H.</span><span> </span><span class="NLM_article-title">Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">271ra8</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3010257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1126%2Fscitranslmed.3010257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25609168" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=271ra8&author=O.+Pe%C3%B1agarikanoauthor=M.+T.+L%C3%A1zaroauthor=X.+H.+Luauthor=A.+Gordonauthor=H.+Dongauthor=H.+A.+Lamauthor=E.+Pelesauthor=N.+T.+Maidmentauthor=N.+P.+Murphyauthor=X.+W.+Yangauthor=P.+Golshaniauthor=D.+H.+Geschwind&title=Exogenous+and+evoked+oxytocin+restores+social+behavior+in+the+Cntnap2+mouse+model+of+autism&doi=10.1126%2Fscitranslmed.3010257"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3010257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3010257%26sid%3Dliteratum%253Aachs%26aulast%3DPe%25C3%25B1agarikano%26aufirst%3DO.%26aulast%3DL%25C3%25A1zaro%26aufirst%3DM.%2BT.%26aulast%3DLu%26aufirst%3DX.%2BH.%26aulast%3DGordon%26aufirst%3DA.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DH.%2BA.%26aulast%3DPeles%26aufirst%3DE.%26aulast%3DMaidment%26aufirst%3DN.%2BT.%26aulast%3DMurphy%26aufirst%3DN.%2BP.%26aulast%3DYang%26aufirst%3DX.%2BW.%26aulast%3DGolshani%26aufirst%3DP.%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26atitle%3DExogenous%2520and%2520evoked%2520oxytocin%2520restores%2520social%2520behavior%2520in%2520the%2520Cntnap2%2520mouse%2520model%2520of%2520autism%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D271ra8%26doi%3D10.1126%2Fscitranslmed.3010257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group">Jørgensen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knigge, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kjaer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warberg, J.</span><span> </span><span class="NLM_article-title">Serotonin receptors involved in vasopressin and oxytocin secretion</span> <span class="citation_source-journal">J. Neuroendocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">242</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1046/j.1365-2826.2003.00978.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1046%2Fj.1365-2826.2003.00978.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=12588512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFyqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=242-249&author=H.+J%C3%B8rgensenauthor=M.+Riisauthor=U.+Kniggeauthor=A.+Kjaerauthor=J.+Warberg&title=Serotonin+receptors+involved+in+vasopressin+and+oxytocin+secretion&doi=10.1046%2Fj.1365-2826.2003.00978.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin receptors involved in vasopressin and oxytocin secretion</span></div><div class="casAuthors">Jorgensen, H.; Riis, M.; Knigge, U.; Kjaer, A.; Warberg, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroendocrinology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">242-249</span>CODEN:
                <span class="NLM_cas:coden">JOUNE2</span>;
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Serotonin (5-HT), 5-HT agonists, the 5-HT precursor 5-hydroxytryptophan, 5-HT-releasers and -reuptake inhibitors stimulate the release of vasopressin and oxytocin.  The authors investigated the involvement of 5-HT receptors in the serotonergic regulation of vasopressin and oxytocin secretion.  Vasopressin and oxytocin secretion was stimulated by 5-HT, the 5-HT1A+1B+5A+7 agonist 5-carboxamidotryptamine (5-CT), the 5-HT2A+2C agonist DOI, the 5-HT2C+2A agonist mCPP, the 5-HT2C agonist MK-212, the 5-HT3 agonist SR 57277 and the 5-HT4 agonist RS 67506.  The 5-HT1A agonist 8-OH-DPAT, which had no effect on vasopressin secretion, stimulated oxytocin secretion.  The 5-HT-induced release of vasopressin and oxytocin was inhibited by central infusion of the 5-HT antagonists WAY 100635 (5-HT1A), LY 53857 (5-HT2A+2C), ICS 205-930 (5-HT3+4) and RS 23597 (5-HT4).  The 5-HT2+6+7 antagonist metergoline in combination with the 5-HT1A+2+7 antagonist methysergide inhibited the stimulatory effect of 5-CT on both hormones, whereas the 5-HT1A+1B antagonist cyanopindolol only inhibited the oxytocin response.  The 5-HT2A antagonist 4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine oxalate had no effect on DOI-induced hormone response.  The 5-HT2C antagonist Y 25130 partly inhibited the stimulating effect of MK-212.  ICS 205-930 and RS 23597 inhibited vasopressin and oxytocin secretion induced by RS 67506.  WAY 100635 inhibited 8-OH-DPAT-induced oxytocin secretion.  The authors conclude that 5-HT-induced vasopressin secretion primarily is mediated via 5-HT2C, 5-HT4 and 5-HT7 receptors, whereas 5-HT2A, 5-HT3 and 5-HT5A receptors seem to be of minor importance.  5-HT-induced oxytocin secretion involves 5-HT1A, 5-HT2C and 5-HT4 receptors; in addn. an involvement of 5-HT1B, 5-HT5A and 5-HT7 receptors seems likely, whereas 5-HT2A and 5-HT3 receptors seem to be less important.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTxnVa0HG29bVg90H21EOLACvtfcHk0lhP9W8wXh_Ttw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFyqs74%253D&md5=dad2cd3529a09c2670927796b8ffeddb</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2826.2003.00978.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2826.2003.00978.x%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DH.%26aulast%3DRiis%26aufirst%3DM.%26aulast%3DKnigge%26aufirst%3DU.%26aulast%3DKjaer%26aufirst%3DA.%26aulast%3DWarberg%26aufirst%3DJ.%26atitle%3DSerotonin%2520receptors%2520involved%2520in%2520vasopressin%2520and%2520oxytocin%2520secretion%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D2003%26volume%3D15%26spage%3D242%26epage%3D249%26doi%3D10.1046%2Fj.1365-2826.2003.00978.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group">Bagdy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalogeras, K. T.</span><span> </span><span class="NLM_article-title">Stimulation of 5-HT<sub>1A</sub> and 5-HT<sub>2</sub>/5-HT<sub>1C</sub> receptors induce oxytocin release in the male rat</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">611</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span><span class="refDoi"> DOI: 10.1016/0006-8993(93)90521-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2F0006-8993%2893%2990521-N" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=8334526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADyaK3sXltV2nsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=611&publication_year=1993&pages=330-332&author=G.+Bagdyauthor=K.+T.+Kalogeras&title=Stimulation+of+5-HT1A+and+5-HT2%2F5-HT1C+receptors+induce+oxytocin+release+in+the+male+rat&doi=10.1016%2F0006-8993%2893%2990521-N"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat</span></div><div class="casAuthors">Bagdy, Gyorgy; Kalogeras, Konstantine T.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">611</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">330-2</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">Plasma oxytocin responses to the 5-HT1A receptor agonists 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), buspirone and ipsapirone, and the 5-HT2/5-HT1C receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) have been studied in conscious, freely moving male rats.  All four compds. caused dose-related increases in plasma oxytocin concns. after i.v. administration.  Oxytocin responses to 8-OH-DPAT were attenuated by pretreatment with the 5-HT1A receptor antagonist NAN-190 while responses to DOI were blocked by pretreatment with 5-HT2/5-HT1C receptor antagonist ritanserin.  Since vasopressin concn. did not change despite the marked elevation in plasma oxytocin, these results suggest that 5-HT1A and 5-HT2/5-HT1C receptors all stimulate oxytocin secretion, and this effect does not reflect a general neurohydrophyseal hormone release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCl_rrMz4e2rVg90H21EOLACvtfcHk0lhP9W8wXh_Ttw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltV2nsLk%253D&md5=419254d6856d5aa32b89f5359818f742</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2893%2990521-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252893%252990521-N%26sid%3Dliteratum%253Aachs%26aulast%3DBagdy%26aufirst%3DG.%26aulast%3DKalogeras%26aufirst%3DK.%2BT.%26atitle%3DStimulation%2520of%25205-HT1A%2520and%25205-HT2%252F5-HT1C%2520receptors%2520induce%2520oxytocin%2520release%2520in%2520the%2520male%2520rat%26jtitle%3DBrain%2520Res.%26date%3D1993%26volume%3D611%26spage%3D330%26epage%3D332%26doi%3D10.1016%2F0006-8993%2893%2990521-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group">Uvnäs-Moberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillegaart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alster, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlenius, S.</span><span> </span><span class="NLM_article-title">Effects of 5-HT agonists, selective for different receptor subtypes, on oxytocin, CCK, gastrin and somatostatin plasma levels in the rat</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1635</span><span class="NLM_x">–</span> <span class="NLM_lpage">1640</span><span class="refDoi"> DOI: 10.1016/S0028-3908(96)00078-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0028-3908%2896%2900078-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1996&pages=1635-1640&author=K.+Uvn%C3%A4s-Mobergauthor=V.+Hillegaartauthor=P.+Alsterauthor=S.+Ahlenius&title=Effects+of+5-HT+agonists%2C+selective+for+different+receptor+subtypes%2C+on+oxytocin%2C+CCK%2C+gastrin+and+somatostatin+plasma+levels+in+the+rat&doi=10.1016%2FS0028-3908%2896%2900078-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2896%2900078-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252896%252900078-0%26sid%3Dliteratum%253Aachs%26aulast%3DUvn%25C3%25A4s-Moberg%26aufirst%3DK.%26aulast%3DHillegaart%26aufirst%3DV.%26aulast%3DAlster%26aufirst%3DP.%26aulast%3DAhlenius%26aufirst%3DS.%26atitle%3DEffects%2520of%25205-HT%2520agonists%252C%2520selective%2520for%2520different%2520receptor%2520subtypes%252C%2520on%2520oxytocin%252C%2520CCK%252C%2520gastrin%2520and%2520somatostatin%2520plasma%2520levels%2520in%2520the%2520rat%26jtitle%3DNeuropharmacology%26date%3D1996%26volume%3D35%26spage%3D1635%26epage%3D1640%26doi%3D10.1016%2FS0028-3908%2896%2900078-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group">Lawson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woehrle, N. S.</span><span> </span><span class="NLM_article-title">Effects of oxytocin on serotonin 1B agonist-induced autism-like behavior in mice</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1016/j.bbr.2016.07.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bbr.2016.07.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27439030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWgu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2016&pages=52-64&author=S.+K.+Lawsonauthor=A.+C.+Grayauthor=N.+S.+Woehrle&title=Effects+of+oxytocin+on+serotonin+1B+agonist-induced+autism-like+behavior+in+mice&doi=10.1016%2Fj.bbr.2016.07.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of oxytocin on serotonin 1B agonist-induced autism-like behavior in mice</span></div><div class="casAuthors">Lawson, Sarah K.; Gray, Andrew C.; Woehrle, Nancy S.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">52-64</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Social impairments in autism remain poorly understood and without approved pharmacotherapies.  Novel animals models are needed to elucidate mechanisms and evaluate novel treatments for the social deficits in autism.  Recently, serotonin 1B receptor (5-HT1B) agonist challenge in mice was shown to induce autism-like behaviors including perseveration, reduced prepulse inhibition, and delayed alternation deficits.  However, the effects of 5-HT1B agonists on autism-related social behaviors in mice remain unknown.  Here, we examine the effects of 5-HT1B agonist challenge on sociability and preference for social novelty in mice.  We also examine the effects of 5-HT1B agonist treatment on av. rearing duration, a putative rodent measure of non-selective attention.  Non-selective attention is an assocd. feature of autism that is also not well understood.  We show that 5-HT1B receptor activation reduces sociability, preference for social novelty, and rearing in mice.  In addn., we examine the ability of oxytocin, an off-label treatment for the social impairments in autism, to reverse 5-HT1B agonist-induced social and attention deficits in mice.  We show that oxytocin restores social novelty preference in mice treated with a 5-HT1B agonist.  We also show that oxytocin attenuates 5-HT1B agonist-induced sociability and rearing deficits in mice.  Our results suggest that 5-HT1B agonist challenge provides a useful pharmacol. mouse model for aspects of autism, and implicate 5-HT1B in autism social and attention deficits.  Moreover, our findings suggest that oxytocin may treat the social deficits in autism through a mechanism involving 5-HT1B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8v6bF2Nb-qLVg90H21EOLACvtfcHk0liHLaoQgnAn8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWgu7jI&md5=8e635f07885eb30c7b77c1f9437249b1</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2016.07.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2016.07.027%26sid%3Dliteratum%253Aachs%26aulast%3DLawson%26aufirst%3DS.%2BK.%26aulast%3DGray%26aufirst%3DA.%2BC.%26aulast%3DWoehrle%26aufirst%3DN.%2BS.%26atitle%3DEffects%2520of%2520oxytocin%2520on%2520serotonin%25201B%2520agonist-induced%2520autism-like%2520behavior%2520in%2520mice%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2016%26volume%3D314%26spage%3D52%26epage%3D64%26doi%3D10.1016%2Fj.bbr.2016.07.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group">Matsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruoka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, M.</span><span> </span><span class="NLM_article-title">Expression of placental leucine aminopeptidase/oxytocinase in neuronal cells and its action on neuronal peptides</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">3259</span><span class="NLM_x">–</span> <span class="NLM_lpage">3266</span><span class="refDoi"> DOI: 10.1046/j.1432-1327.2001.02221.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1046%2Fj.1432-1327.2001.02221.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=11389728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlSgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2001&pages=3259-3266&author=H.+Matsumotoauthor=T.+Nagasakaauthor=A.+Hattoriauthor=T.+Rogiauthor=N.+Tsuruokaauthor=S.+Mizutaniauthor=M.+Tsujimoto&title=Expression+of+placental+leucine+aminopeptidase%2Foxytocinase+in+neuronal+cells+and+its+action+on+neuronal+peptides&doi=10.1046%2Fj.1432-1327.2001.02221.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of placental leucine aminopeptidase/oxytocinase in neuronal cells and its action on neuronal peptides</span></div><div class="casAuthors">Matsumoto, Hideko; Nagasaka, Tetsuro; Hattori, Akira; Rogi, Tomohiro; Tsuruoka, Nobuo; Mizutani, Shigehiko; Tsujimoto, Masafumi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3259-3266</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The placental leucine aminopeptidase (P-LAP)/oxytocinase whose serum level increases with gestation is thought to contribute to the maintenance of normal pregnancy.  P-LAP mRNAs are expressed in various tissues other than the placenta.  In this study, the authors identified P-LAP protein in the brain.  In contrast with the placenta where a significant portion of P-LAP is released, the enzyme was localized in the membrane fraction in brain and PC12 cells and no sol. form of the enzyme was detected.  When PC12 cells were differentiated into neuronal cells by nerve growth factor (NGF), a significant increase in the expression level of P-LAP in the cell was obsd.  As in the case of insulin treatment of 3T3-L1 adipocytes, treatment of PC12 cells with forskolin caused the translocation of the enzyme from intracellular vesicle to the cell surface plasma membrane.  In addn., P-LAP was shown to degrade several bioactive neuropeptides such as Met-enkephalin and dynorphin A (1-8).  These results suggest that P-LAP plays an important role in the regulation of neuronal cell function in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQAXE2HPT4wrVg90H21EOLACvtfcHk0liHLaoQgnAn8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlSgsbo%253D&md5=5ec358847231dc556121be6b18c71c46</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2001.02221.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2001.02221.x%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DH.%26aulast%3DNagasaka%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DA.%26aulast%3DRogi%26aufirst%3DT.%26aulast%3DTsuruoka%26aufirst%3DN.%26aulast%3DMizutani%26aufirst%3DS.%26aulast%3DTsujimoto%26aufirst%3DM.%26atitle%3DExpression%2520of%2520placental%2520leucine%2520aminopeptidase%252Foxytocinase%2520in%2520neuronal%2520cells%2520and%2520its%2520action%2520on%2520neuronal%2520peptides%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2001%26volume%3D268%26spage%3D3259%26epage%3D3266%26doi%3D10.1046%2Fj.1432-1327.2001.02221.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group">Albiston, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diwakarla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernando, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mountford, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeatman, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holien, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, S. Y.</span><span> </span><span class="NLM_article-title">Identification and development of specific inhibitors for insulin-regulated aminopeptidase as a new class of cognitive enhancers</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01402.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1111%2Fj.1476-5381.2011.01402.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21470200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOlurfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2011&pages=37-47&author=A.+L.+Albistonauthor=S.+Diwakarlaauthor=R.+N.+Fernandoauthor=S.+J.+Mountfordauthor=H.+R.+Yeatmanauthor=B.+Morganauthor=V.+Phamauthor=J.+K.+Holienauthor=M.+W.+Parkerauthor=P.+E.+Thompsonauthor=S.+Y.+Chai&title=Identification+and+development+of+specific+inhibitors+for+insulin-regulated+aminopeptidase+as+a+new+class+of+cognitive+enhancers&doi=10.1111%2Fj.1476-5381.2011.01402.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and development of specific inhibitors for insulin-regulated aminopeptidase as a new class of cognitive enhancers</span></div><div class="casAuthors">Albiston, Anthony L.; Diwakarla, Shanti; Fernando, Ruani N.; Mountford, Simon J.; Yeatman, Holly R.; Morgan, Broden; Pham, Vi; Holien, Jessica K.; Parker, Michael W.; Thompson, Philip E.; Chai, Siew Yeen</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-47</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Two structurally distinct peptides, angiotensin IV and LVV-haemorphin 7, both competitive high-affinity inhibitors of insulin-regulated aminopeptidase (IRAP), were found to enhance aversion-assocd. and spatial memory in normal rats and to improve performance in a no. of memory tasks in rat deficits models.  These findings provide compelling support for the development of specific, high-affinity inhibitors of the enzyme as new cognitive enhancing agents.  Different classes of IRAP inhibitors were developed including peptidomimetics and small mol. wt. compds. identified through in silico screening with a homol. model of the catalytic domain of IRAP.  The proof of principal that inhibition of IRAP activity results in facilitation of memory was obtained by the demonstration that the small-mol. IRAP inhibitors also exhibit memory-enhancing properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP4XSnUxmUbrVg90H21EOLACvtfcHk0lisd2OYYsIiXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOlurfE&md5=0c9ab209bd0b6cde5bff0c86fe737538</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01402.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01402.x%26sid%3Dliteratum%253Aachs%26aulast%3DAlbiston%26aufirst%3DA.%2BL.%26aulast%3DDiwakarla%26aufirst%3DS.%26aulast%3DFernando%26aufirst%3DR.%2BN.%26aulast%3DMountford%26aufirst%3DS.%2BJ.%26aulast%3DYeatman%26aufirst%3DH.%2BR.%26aulast%3DMorgan%26aufirst%3DB.%26aulast%3DPham%26aufirst%3DV.%26aulast%3DHolien%26aufirst%3DJ.%2BK.%26aulast%3DParker%26aufirst%3DM.%2BW.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26aulast%3DChai%26aufirst%3DS.%2BY.%26atitle%3DIdentification%2520and%2520development%2520of%2520specific%2520inhibitors%2520for%2520insulin-regulated%2520aminopeptidase%2520as%2520a%2520new%2520class%2520of%2520cognitive%2520enhancers%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D164%26spage%3D37%26epage%3D47%26doi%3D10.1111%2Fj.1476-5381.2011.01402.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group">Insel, T. R.</span><span> </span><span class="NLM_article-title">The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">768</span><span class="NLM_x">–</span> <span class="NLM_lpage">779</span><span class="refDoi"> DOI: 10.1016/j.neuron.2010.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuron.2010.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20346754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1KmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2010&pages=768-779&author=T.+R.+Insel&title=The+challenge+of+translation+in+social+neuroscience%3A+a+review+of+oxytocin%2C+vasopressin%2C+and+affiliative+behavior&doi=10.1016%2Fj.neuron.2010.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior</span></div><div class="casAuthors">Insel, Thomas R.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">768-779</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Social neuroscience is rapidly exploring the complex territory between perception and action where recognition, value, and meaning are instantiated.  This review follows the trail of research on oxytocin and vasopressin as an exemplar of one path for exploring the "dark matter" of social neuroscience.  Studies across vertebrate species suggest that these neuropeptides are important for social cognition, with gender- and steroid-dependent effects.  Comparative research in voles yields a model based on interspecies and intraspecies variation of the geog. of oxytocin receptors and vasopressin V1a receptors in the forebrain.  Highly affiliative species have receptors in brain circuits related to reward or reinforcement.  The neuroanatomical distribution of these receptors may be guided by variations in the regulatory regions of their resp. genes.  This review describes the promises and problems of extrapolating these findings to human social cognition, with specific ref. to the social deficits of autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrre0O9VbZrSLVg90H21EOLACvtfcHk0ljfOEBuIVb6Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1KmtLs%253D&md5=92d1b922874d4c759523a5658e740c98</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2010.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2010.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DInsel%26aufirst%3DT.%2BR.%26atitle%3DThe%2520challenge%2520of%2520translation%2520in%2520social%2520neuroscience%253A%2520a%2520review%2520of%2520oxytocin%252C%2520vasopressin%252C%2520and%2520affiliative%2520behavior%26jtitle%3DNeuron%26date%3D2010%26volume%3D65%26spage%3D768%26epage%3D779%26doi%3D10.1016%2Fj.neuron.2010.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group">Ebner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wotjak, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landgraf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelmann, M.</span><span> </span><span class="NLM_article-title">Forced swimming triggers vasopressin release within the amygdala to modulate stress-coping strategies in rats</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span><span class="refDoi"> DOI: 10.1046/j.0953-816x.2001.01869.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1046%2Fj.0953-816x.2001.01869.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=11849304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD387ltVymtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=384-388&author=K.+Ebnerauthor=C.+T.+Wotjakauthor=R.+Landgrafauthor=M.+Engelmann&title=Forced+swimming+triggers+vasopressin+release+within+the+amygdala+to+modulate+stress-coping+strategies+in+rats&doi=10.1046%2Fj.0953-816x.2001.01869.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Forced swimming triggers vasopressin release within the amygdala to modulate stress-coping strategies in rats</span></div><div class="casAuthors">Ebner Karl; Wotjak Carsten T; Landgraf Rainer; Engelmann Mario</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">384-8</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Previously, we have demonstrated that forced swimming triggers the release of arginine vasopressin (AVP) within the septum of rats, where AVP modulates stress-coping strategies.  The present study was designed to examine the effects of forced swimming on the release of AVP within the amygdala.  Therefore, adult male Wistar rats were chronically implanted with a microdialysis probe aimed at the amygdala to monitor the local release of AVP under both resting and stress conditions.  A 10-min forced swimming session caused a significant increase in the extracellular AVP concentration (to 366 +/- 90% of baseline; P < 0.05) within this brain area.  In a subsequent experiment we investigated the physiological impact of the stressor-induced release of AVP by administrating the AVP V1 receptor antagonist d(CH2)5Tyr(Me)AVP into the amygdala via inverse microdialysis.  Bilateral antagonist treatment modulated the behavioural response acutely by increasing the time the animals spent struggling and by reducing the time the animals floated.  Our results demonstrate a significant activation of the vasopressinergic system within the amygdala in response to forced swimming.  AVP released within the amygdala seems to be involved in the generation of passive coping strategies in stressful situations.  Taken together with previous findings the results of the present study suggest that AVP is released within septum and amygdala to balance the behavioural response during forced swimming.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQem9MhWlUjNKNc3HjJRoFAfW6udTcc2eaWOu9KK4-ixLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387ltVymtA%253D%253D&md5=4ec2951b4960f54080f6496d844de1b1</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1046%2Fj.0953-816x.2001.01869.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0953-816x.2001.01869.x%26sid%3Dliteratum%253Aachs%26aulast%3DEbner%26aufirst%3DK.%26aulast%3DWotjak%26aufirst%3DC.%2BT.%26aulast%3DLandgraf%26aufirst%3DR.%26aulast%3DEngelmann%26aufirst%3DM.%26atitle%3DForced%2520swimming%2520triggers%2520vasopressin%2520release%2520within%2520the%2520amygdala%2520to%2520modulate%2520stress-coping%2520strategies%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2002%26volume%3D15%26spage%3D384%26epage%3D388%26doi%3D10.1046%2Fj.0953-816x.2001.01869.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group">Zink, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempf, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakimi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer-Lindenberg, A.</span><span> </span><span class="NLM_article-title">Vasopressin modulates medial prefrontal cortex–amygdala circuitry during emotion processing in humans</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">7017</span><span class="NLM_x">–</span> <span class="NLM_lpage">7022</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4899-09.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1523%2FJNEUROSCI.4899-09.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20484643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVWmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=7017-7022&author=C.+F.+Zinkauthor=J.+L.+Steinauthor=L.+Kempfauthor=S.+Hakimiauthor=A.+Meyer-Lindenberg&title=Vasopressin+modulates+medial+prefrontal+cortex%E2%80%93amygdala+circuitry+during+emotion+processing+in+humans&doi=10.1523%2FJNEUROSCI.4899-09.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Vasopressin modulates medial prefrontal cortex-amygdala circuitry during emotion processing in humans</span></div><div class="casAuthors">Zink, Caroline F.; Stein, Jason L.; Kempf, Lucas; Hakimi, Shabnam; Meyer-Lindenberg, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7017-7022</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The neuropeptide vasopressin is a modulator of mammalian social behavior and emotion, particularly fear, aggression, and anxiety.  In humans, the neural circuitry underlying behavioral effects of vasopressin is unknown.  Using a double-blind crossover administration of 40 IU of vasopressin or placebo and functional MRI during processing of facial emotions in healthy male volunteers, we show that vasopressin specifically reduces differential activation in the subgenual cingulate cortex.  Structural equation modeling of a previously evaluated circuit between amygdala, subgenual cingulate, and supragenual cingulate revealed altered effective connectivity between subgenual and supragenual cingulate under vasopressin.  Our data demonstrate an impact of vasopressin on activity and connectivity in the cortical component of a medial prefrontal cortex-amygdala circuit implicated in emotional regulation, providing the first data on the neural basis for the effects of vasopressin on social behavior in humans with potential therapeutic significance for mood and anxiety disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRrqFcCp-XArVg90H21EOLACvtfcHk0lgORkg5CN7nlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVWmsro%253D&md5=d2a72abfa835ba262ebe395301a6dd50</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4899-09.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4899-09.2010%26sid%3Dliteratum%253Aachs%26aulast%3DZink%26aufirst%3DC.%2BF.%26aulast%3DStein%26aufirst%3DJ.%2BL.%26aulast%3DKempf%26aufirst%3DL.%26aulast%3DHakimi%26aufirst%3DS.%26aulast%3DMeyer-Lindenberg%26aufirst%3DA.%26atitle%3DVasopressin%2520modulates%2520medial%2520prefrontal%2520cortex%25E2%2580%2593amygdala%2520circuitry%2520during%2520emotion%2520processing%2520in%2520humans%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D7017%26epage%3D7022%26doi%3D10.1523%2FJNEUROSCI.4899-09.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group">Loup, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tribollet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois-Dauphin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreifuss, J. J.</span><span> </span><span class="NLM_article-title">Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">555</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1016/0006-8993(91)90345-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2F0006-8993%2891%2990345-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1657300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADyaK3MXlslGhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=555&publication_year=1991&pages=220-232&author=F.+Loupauthor=E.+Tribolletauthor=M.+Dubois-Dauphinauthor=J.+J.+Dreifuss&title=Localization+of+high-affinity+binding+sites+for+oxytocin+and+vasopressin+in+the+human+brain.+An+autoradiographic+study&doi=10.1016%2F0006-8993%2891%2990345-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain.  An autoradiographic study</span></div><div class="casAuthors">Loup, F.; Tribollet, E.; Dubois-Dauphin, M.; Dreifuss, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">555</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">220-32</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">Sites which bind oxytocin and vasopressin with high affinity were detected in the brain and upper spinal cord of 12 human subjects, using in vitro light microscopic autoradiog.  Tissue sections were incubated with tritiated vasopressin, tritiated oxytocin, or an iodinated oxytocin antagonist.  The ligand specificity of binding was assessed with unlabeled vasopressin or oxytocin in excess, as well as in competition expts. using synthetic structural analogs.  The distribution of vasopressin binding sites differed markedly from that of oxytocin binding sites in the forebrain, while there was overlap in the brain stem.  Vasopressin binding sites were detected in the dorsal part of the lateral septal nucleus, in midline nuclei and adjacent intralaminar nuclei of the thalamus, in the hilus of the dentate gyrus, the dorsolateral part of the basal amygdaloid nucleus and the brain stem.  The distribution of oxytocin binding sites in the brain stem has been recently reported.  Oxytocin binding sites were also obsd. in the basal nucleus of Meynert, the nucleus of the vertical limb of the diagonal band of Broca, the ventral part of the lateral septal nucleus, the preoptic/anterior hypothalamic area, the posterior hypothalamic area, and variably in the globus pallidus and ventral pallidum.  The presence of oxytocin and vasopressin binding sites in limbic and autonomic areas suggests a neurotransmitter or neuromodulator role for these peptides in the human central nervous system.  They may also affect cholinergic transmission in the basal forebrain and consequently play a role in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofbbjy_8Dk0LVg90H21EOLACvtfcHk0lgORkg5CN7nlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlslGhu78%253D&md5=617f37734907b365fc7fab5e5f175c75</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2891%2990345-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252891%252990345-V%26sid%3Dliteratum%253Aachs%26aulast%3DLoup%26aufirst%3DF.%26aulast%3DTribollet%26aufirst%3DE.%26aulast%3DDubois-Dauphin%26aufirst%3DM.%26aulast%3DDreifuss%26aufirst%3DJ.%2BJ.%26atitle%3DLocalization%2520of%2520high-affinity%2520binding%2520sites%2520for%2520oxytocin%2520and%2520vasopressin%2520in%2520the%2520human%2520brain.%2520An%2520autoradiographic%2520study%26jtitle%3DBrain%2520Res.%26date%3D1991%26volume%3D555%26spage%3D220%26epage%3D232%26doi%3D10.1016%2F0006-8993%2891%2990345-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref217"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref217'); return false;" data-citation="" class="refNumLink">217</a></strong><div class="NLM_citation" id="cit217"><span><span class="NLM_contrib-group">Ratni, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundschober, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez Sanchez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnider, P.</span><span> </span><span class="NLM_article-title">Discovery of highly selective brain-penetrant vasopressin 1a antagonists for the potential treatment of autism via a chemogenomic and scaffold hopping approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2275</span><span class="NLM_x">–</span> <span class="NLM_lpage">2289</span><span class="refDoi"> DOI: 10.1021/jm501745f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501745f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Sgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2275-2289&author=H.+Ratniauthor=M.+Rogers-Evansauthor=C.+Bissantzauthor=C.+Grundschoberauthor=J.+L.+Moreauauthor=F.+Schulerauthor=H.+Fischerauthor=R.+Alvarez+Sanchezauthor=P.+Schnider&title=Discovery+of+highly+selective+brain-penetrant+vasopressin+1a+antagonists+for+the+potential+treatment+of+autism+via+a+chemogenomic+and+scaffold+hopping+approach&doi=10.1021%2Fjm501745f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Selective Brain-Penetrant Vasopressin 1a Antagonists for the Potential Treatment of Autism via a Chemogenomic and Scaffold Hopping Approach</span></div><div class="casAuthors">Ratni, Hasane; Rogers-Evans, Mark; Bissantz, Caterina; Grundschober, Christophe; Moreau, Jean-Luc; Schuler, Franz; Fischer, Holger; Alvarez Sanchez, Ruben; Schnider, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2275-2289</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">From a micromolar high throughput screening hit 7, the successful complementary application of a chemogenomic approach and of a scaffold hopping exercise rapidly led to a low single digit nanomolar human vasopressin 1a (hV1a) receptor antagonist 38.  Initial optimization of the mouse V1a activities delivered suitable tool compds. which demonstrated a V1a mediated central in vivo effect.  This novel series was further optimized through parallel synthesis with a focus on balancing lipophilicity to achieve robust aq. soly. while avoiding P-gp mediated efflux.  These efforts led to the discovery of the highly potent and selective brain-penetrant hV1a antagonist RO5028442 (8) suitable for human clin. studies in people with autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpyc3A24J_GLVg90H21EOLACvtfcHk0liY2trEj6IX3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Sgtrc%253D&md5=587fbafaf38372123378586ecd87f10a</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1021%2Fjm501745f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501745f%26sid%3Dliteratum%253Aachs%26aulast%3DRatni%26aufirst%3DH.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DGrundschober%26aufirst%3DC.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DAlvarez%2BSanchez%26aufirst%3DR.%26aulast%3DSchnider%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520highly%2520selective%2520brain-penetrant%2520vasopressin%25201a%2520antagonists%2520for%2520the%2520potential%2520treatment%2520of%2520autism%2520via%2520a%2520chemogenomic%2520and%2520scaffold%2520hopping%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2275%26epage%3D2289%26doi%3D10.1021%2Fjm501745f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref218"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref218'); return false;" data-citation="" class="refNumLink">218</a></strong><div class="NLM_citation" id="cit218"><span><span class="NLM_contrib-group">Umbricht, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Valle Rubido, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCracken, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shic, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scahill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noeldeke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boak, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khwaja, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squassante, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundschober, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kletzl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontoura, P.</span><span> </span><span class="NLM_article-title">A single dose, randomized, controlled proof-of-mechanism study of a novel vasopressin 1a receptor antagonist (RG7713) in high-functioning adults with autism spectrum disorder</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1914</span><span class="NLM_x">–</span> <span class="NLM_lpage">1923</span><span class="refDoi"> DOI: 10.1038/npp.2016.232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnpp.2016.232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27711048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvV2gtLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=1914-1923&author=D.+Umbrichtauthor=M.+Del+Valle+Rubidoauthor=E.+Hollanderauthor=J.+T.+McCrackenauthor=F.+Shicauthor=L.+Scahillauthor=J.+Noeldekeauthor=L.+Boakauthor=O.+Khwajaauthor=L.+Squassanteauthor=C.+Grundschoberauthor=H.+Kletzlauthor=P.+Fontoura&title=A+single+dose%2C+randomized%2C+controlled+proof-of-mechanism+study+of+a+novel+vasopressin+1a+receptor+antagonist+%28RG7713%29+in+high-functioning+adults+with+autism+spectrum+disorder&doi=10.1038%2Fnpp.2016.232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder</span></div><div class="casAuthors">Umbricht, Daniel; del Valle Rubido, Marta; Hollander, Eric; McCracken, James T.; Shic, Frederick; Scahill, Lawrence; Noeldeke, Jana; Boak, Lauren; Khwaja, Omar; Squassante, Lisa; Grundschober, Christophe; Kletzl, Heidemarie; Fontoura, Paulo</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1914-1923</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The core symptoms of autism spectrum disorder (ASD) include impaired social communication, repetitive behaviors, and restricted interests.  No effective pharmacotherapy for these core deficits exists.  Within the domain of social communication, the vasopressin system is implicated in social cognition and social signaling deficits of ASD, and represents a potential therapeutic target.  We assessed the effects of a single 20 mg i.v. dose of the arginine vasopressin receptor 1A (V1a) antagonist, RG7713, on exploratory biomarkers (eye tracking), behavioral and clin. measures of social cognition and communication (affective speech recognition (ASR), reading the mind in the eyes, olfactory identification, scripted interaction), and safety and tolerability in a multicenter, randomized, double-blind, placebo-controlled, cross-over study of 19 high-functioning adult male subjects with DSM-IV Autistic Disorder (age 18-45 years; full scale IQ >70; ABC-Irritability subscale ≤13).  Eye-tracking showed an increase in biol. motion orienting preference with RG7713 (ES=0.8, p=0.047) and a non-significant improvement in the composite score (ES=0.2, p=0.29).  RG7713 reduced ability to detect lust (ES=-0.8, p=0.03) and fear (ES=-0.7, p=0.07) in ASR.  However, when all eight individual emotion subscales were combined into an overall ASR performance score, the redn. was non-significant (ES=-0.1, p=0.59).  Thirteen adverse events were reported in 10 subjects; all were of mild (11/13) or moderate (2/13) severity.  Although interpretation should be cautious due to multiple comparisons and small sample size, these results provide preliminary evidence from exptl. and behavioral biomarkers, that blockade of the V1a receptor may improve social communication in adults with high-functioning ASD.  ClinicalTrials.gov identifier: NCT01474278 A Study of RO5028442 in Adult Male High-Functioning Autistic Patients.  Available at: https://clinicaltrials.gov/ct2/show/NCT01474278.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAsg9CGg4pmLVg90H21EOLACvtfcHk0liY2trEj6IX3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvV2gtLvE&md5=c0cfa97b338f184d08a073f21ab0fe7c</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2016.232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2016.232%26sid%3Dliteratum%253Aachs%26aulast%3DUmbricht%26aufirst%3DD.%26aulast%3DDel%2BValle%2BRubido%26aufirst%3DM.%26aulast%3DHollander%26aufirst%3DE.%26aulast%3DMcCracken%26aufirst%3DJ.%2BT.%26aulast%3DShic%26aufirst%3DF.%26aulast%3DScahill%26aufirst%3DL.%26aulast%3DNoeldeke%26aufirst%3DJ.%26aulast%3DBoak%26aufirst%3DL.%26aulast%3DKhwaja%26aufirst%3DO.%26aulast%3DSquassante%26aufirst%3DL.%26aulast%3DGrundschober%26aufirst%3DC.%26aulast%3DKletzl%26aufirst%3DH.%26aulast%3DFontoura%26aufirst%3DP.%26atitle%3DA%2520single%2520dose%252C%2520randomized%252C%2520controlled%2520proof-of-mechanism%2520study%2520of%2520a%2520novel%2520vasopressin%25201a%2520receptor%2520antagonist%2520%2528RG7713%2529%2520in%2520high-functioning%2520adults%2520with%2520autism%2520spectrum%2520disorder%26jtitle%3DNeuropsychopharmacology%26date%3D2017%26volume%3D42%26spage%3D1914%26epage%3D1923%26doi%3D10.1038%2Fnpp.2016.232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref219"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref219'); return false;" data-citation="" class="refNumLink">219</a></strong><div class="NLM_citation" id="cit219"><span><span class="NLM_contrib-group">O’Dushlaine, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">The Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium</span><span> </span><span class="NLM_article-title">Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span><span class="refDoi"> DOI: 10.1038/nn.3922</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnn.3922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25599223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKjsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=199-209&author=C.+O%E2%80%99Dushlaineauthor=The+Network+and+Pathway+Analysis+Subgroup+of+the+Psychiatric+Genomics+Consortium&title=Psychiatric+genome-wide+association+study+analyses+implicate+neuronal%2C+immune+and+histone+pathways&doi=10.1038%2Fnn.3922"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways</span></div><div class="casAuthors">O'Dushlaine, Colm; Rossin, Lizzy; Lee, Phil H.; Duncan, Laramie; Parikshak, Neelroop N.; Newhouse, Stephen; Ripke, Stephan; Neale, Benjamin M.; Purcell, Shaun M.; Posthuma, Danielle; Nurnberger, John I.; Lee, S. Hong; Faraone, Stephen V.; Perlis, Roy H.; Mowry, Bryan J.; Thapar, Anita; Goddard, Michael E.; Witte, John S.; Absher, Devin; Agartz, Ingrid; Akil, Huda; Amin, Farooq; Andreassen, Ole A.; Anjorin, Adebayo; Anney, Richard; Anttila, Verneri; Arking, Dan E.; Asherson, Philip; Azevedo, Maria H.; Backlund, Lena; Badner, Judith A.; Bailey, Anthony J.; Banaschewski, Tobias; Barchas, Jack D.; Barnes, Michael R.; Barrett, Thomas B.; Bass, Nicholas; Battaglia, Agatino; Bauer, Michael; Bayes, Monica; Bellivier, Frank; Bergen, Sarah E.; Berrettini, Wade; Betancur, Catalina; Bettecken, Thomas; Biederman, Joseph; Binder, Elisabeth B.; Black, Donald W.; Blackwood, Douglas H. R.; Bloss, Cinnamon S.; Boehnke, Michael; Boomsma, Dorret I.; Breuer, Rene; Bruggeman, Richard; Cormican, Paul; Buccola, Nancy G.; Buitelaar, Jan K.; Bunney, William E.; Buxbaum, Joseph D.; Byerley, William F.; Byrne, Enda M.; Caesar, Sian; Cahn, Wiepke; Cantor, Rita M.; Casas, Miguel; Chakravarti, Aravinda; Chambert, Kimberly; Choudhury, Khalid; Cichon, Sven; Mattheisen, Manuel; Cloninger, C. Robert; Collier, David A.; Cook, Edwin H.; Coon, Hilary; Cormand, Bru; Corvin, Aiden; Coryell, William H.; Craig, David W.; Craig, Ian W.; Crosbie, Jennifer; Cuccaro, Michael L.; Curtis, David; Czamara, Darina; Datta, Susmita; Dawson, Geraldine; Day, Richard; De Geus, Eco J.; Degenhardt, Franziska; Djurovic, Srdjan; Donohoe, Gary J.; Doyle, Alysa E.; Duan, Jubao; Dudbridge, Frank; Duketis, Eftichia; Ebstein, Richard P.; Edenberg, Howard J.; Elia, Josephine; Ennis, Sean; Etain, Bruno; Fanous, Ayman; Farmer, Anne E.; Ferrier, I. Nicol; Flickinger, Matthew; Fombonne, Eric; Foroud, Tatiana; Frank, Josef; Franke, Barbara; Fraser, Christine; Freedman, Robert; Freimer, Nelson B.; Freitag, Christine M.; Friedl, Marion; Frisen, Louise; Gallagher, Louise; Gejman, Pablo V.; Georgieva, Lyudmila; Gershon, Elliot S.; Giegling, Ina; Gill, Michael; Gordon, Scott D.; Gordon-Smith, Katherine; Green, Elaine K.; Greenwood, Tiffany A.; Grice, Dorothy E.; Gross, Magdalena; Grozeva, Detelina; Guan, Weihua; Gurling, Hugh; De Haan, Lieuwe; Haines, Jonathan L.; Hakonarson, Hakon; Hallmayer, Joachim; Hamilton, Steven P.; Hamshere, Marian L.; Hansen, Thomas F.; Hartmann, Annette M.; Hautzinger, Martin; Heath, Andrew C.; Henders, Anjali K.; Herms, Stefan; Hickie, Ian B.; Hipolito, Maria; Hoefels, Susanne; Holsboer, Florian; Hoogendijk, Witte J.; Hottenga, Jouke-Jan; Hultman, Christina M.; Hus, Vanessa; Ingason, Andres; Ising, Marcus; Jamain, Stephane; Jones, Edward G.; Jones, Ian; Jones, Lisa; Tzeng, Jung-Ying; Kahler, Anna K.; Kahn, Rene S.; Kandaswamy, Radhika; Keller, Matthew C.; Kennedy, James L.; Kenny, Elaine; Kent, Lindsey; Kim, Yunjung; Kirov, George K.; Klauck, Sabine M.; Klei, Lambertus; Knowles, James A.; Kohli, Martin A.; Koller, Daniel L.; Konte, Bettina; Korszun, Ania; Krabbendam, Lydia; Krasucki, Robert; Kuntsi, Jonna; Kwan, Phoenix; Landen, Mikael; Langstrom, Niklas; Lathrop, Mark; Lawrence, Jacob; Lawson, William B.; Leboyer, Marion; Ledbetter, David H.; Lencz, Todd; Lesch, Klaus-Peter; Levinson, Douglas F.; Lewis, Cathryn M.; Li, Jun; Lichtenstein, Paul; Lieberman, Jeffrey A.; Lin, Dan-Yu; Linszen, Don H.; Liu, Chunyu; Lohoff, Falk W.; Loo, Sandra K.; Lord, Catherine; Lowe, Jennifer K.; Lucae, Susanne; MacIntyre, Donald J.; Madden, Pamela A. F.; Maestrini, Elena; Magnusson, Patrik K. E.; Mahon, Pamela B.; Maier, Wolfgang; Malhotra, Anil K.; Mane, Shrikant M.; Martin, Christa L.; Martin, Nicholas G.; Matthews, Keith; Mattingsdal, Morten; McCarroll, Steven A.; McGhee, Kevin A.; McGough, James J.; McGrath, Patrick J.; McGuffin, Peter; McInnis, Melvin G.; McIntosh, Andrew; McKinney, Rebecca; McLean, Alan W.; McMahon, Francis J.; McMahon, William M.; McQuillin, Andrew; Medeiros, Helena; Medland, Sarah E.; Meier, Sandra; Melle, Ingrid; Meng, Fan; Meyer, Jobst; Middeldorp, Christel M.; Middleton, Lefkos; Milanova, Vihra; Miranda, Ana; Monaco, Anthony P.; Montgomery, Grant W.; Moran, Jennifer L.; Moreno-De-Luca, Daniel; Morken, Gunnar; Morris, Derek W.; Morrow, Eric M.; Moskvina, Valentina; Muglia, Pierandrea; Muhleisen, Thomas W.; Muir, Walter J.; Muller-Myhsok, Bertram; Murtha, Michael; Myers, Richard M.; Myin-Germeys, Inez; Neale, Michael C.; Nelson, Stan F.; Nievergelt, Caroline M.; Nikolov, Ivan; Nimgaonkar, Vishwajit; Nolen, Willem A.; Nothen, Markus M.; Nwulia, Evaristus A.; Nyholt, Dale R.; Oades, Robert D.; Olincy, Ann; Oliveira, Guiomar; Olsen, Line; Ophoff, Roel A.; Osby, Urban; Owen, Michael J.; Palotie, Aarno; Parr, Jeremy R.; Paterson, Andrew D.; Pato, Carlos N.; Pato, Michele T.; Penninx, Brenda W.; Pergadia, Michele L.; Pericak-Vance, Margaret A.; Pickard, Benjamin S.; Pimm, Jonathan; Piven, Joseph; Potash, James B.; Poustka, Fritz; Propping, Peter; Puri, Vinay; Quested, Digby J.; Quinn, Emma M.; Ramos-Quiroga, Josep Antoni; Rasmussen, Henrik B.; Raychaudhuri, Soumya; Rehnstrom, Karola; Reif, Andreas; Ribases, Marta; Rice, John P.; Rietschel, Marcella; Roeder, Kathryn; Roeyers, Herbert; Rothenberger, Aribert; Rouleau, Guy; Ruderfer, Douglas; Rujescu, Dan; Sanders, Alan R.; Sanders, Stephan J.; Santangelo, Susan L.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-209</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Genome-wide assocn. studies (GWAS) of psychiatric disorders have identified multiple genetic assocns. with such disorders, but better methods are needed to derive the underlying biol. mechanisms that these signals indicate.  We sought to identify biol. pathways in GWAS data from over 60,000 participants from the Psychiatric Genomics Consortium.  We developed an anal. framework to rank pathways that requires only summary statistics.  We combined this score across disorders to find common pathways across three adult psychiatric disorders: schizophrenia, major depression and bipolar disorder.  Histone methylation processes showed the strongest assocn., and we also found statistically significant evidence for assocns. with multiple immune and neuronal signaling pathways and with the postsynaptic d.  Our study indicates that risk variants for psychiatric disorders aggregate in particular biol. pathways and that these pathways are frequently shared between disorders.  Our results confirm known mechanisms and suggest several novel insights into the etiol. of psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB_fSmQorh1bVg90H21EOLACvtfcHk0lh40CWRt9rnSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKjsL4%253D&md5=d1f6b3127f32d006bc01a85486edb6cd</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1038%2Fnn.3922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3922%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Dushlaine%26aufirst%3DC.%26aulast%3D%26atitle%3DPsychiatric%2520genome-wide%2520association%2520study%2520analyses%2520implicate%2520neuronal%252C%2520immune%2520and%2520histone%2520pathways%26jtitle%3DNat.%2520Neurosci.%26date%3D2015%26volume%3D18%26spage%3D199%26epage%3D209%26doi%3D10.1038%2Fnn.3922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref220"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref220'); return false;" data-citation="" class="refNumLink">220</a></strong><div class="NLM_citation" id="cit220"><span><span class="NLM_contrib-group">Merrill, J. E.</span><span> </span><span class="NLM_article-title">Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological</span> <span class="citation_source-journal">Dev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><span class="refDoi"> DOI: 10.1159/000111642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1159%2F000111642" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1-10&author=J.+E.+Merrill&title=Tumor+necrosis+factor+alpha%2C+interleukin+1+and+related+cytokines+in+brain+development%3A+normal+and+pathological&doi=10.1159%2F000111642"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1159%2F000111642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000111642%26sid%3Dliteratum%253Aachs%26aulast%3DMerrill%26aufirst%3DJ.%2BE.%26atitle%3DTumor%2520necrosis%2520factor%2520alpha%252C%2520interleukin%25201%2520and%2520related%2520cytokines%2520in%2520brain%2520development%253A%2520normal%2520and%2520pathological%26jtitle%3DDev.%2520Neurosci.%26date%3D2004%26volume%3D14%26spage%3D1%26epage%3D10%26doi%3D10.1159%2F000111642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref221"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref221'); return false;" data-citation="" class="refNumLink">221</a></strong><div class="NLM_citation" id="cit221"><span><span class="NLM_contrib-group">Miller, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoPreste, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaller, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinarello, C. A.</span><span> </span><span class="NLM_article-title">Neonatal interleukin- 1 beta, interleukin-6, and tumor necrosis factor: cord blood levels and cellular production</span> <span class="citation_source-journal">J. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">965</span><span class="refDoi"> DOI: 10.1016/S0022-3476(05)80145-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0022-3476%2805%2980145-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=2246700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADyaK3M%252FmtFajtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1990&pages=961-965&author=L.+C.+Millerauthor=S.+Isaauthor=G.+LoPresteauthor=J.+G.+Schallerauthor=C.+A.+Dinarello&title=Neonatal+interleukin-+1+beta%2C+interleukin-6%2C+and+tumor+necrosis+factor%3A+cord+blood+levels+and+cellular+production&doi=10.1016%2FS0022-3476%2805%2980145-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">Neonatal interleukin-1 beta, interleukin-6, and tumor necrosis factor: cord blood levels and cellular production</span></div><div class="casAuthors">Miller L C; Isa S; LoPreste G; Schaller J G; Dinarello C A</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pediatrics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">961-5</span>
        ISSN:<span class="NLM_cas:issn">0022-3476</span>.
    </div><div class="casAbstract">In a prospective study, levels of interleukin-1 beta (IL-1 beta), interleukin-6) (IL-6), and tumor necrosis factor (TNF) were measured in a blind fashion in cord blood plasma from 92 neonates by specific immunoassays, and were correlated with the clinical courses of the infants, including type of delivery and perinatal complications.  Plasma IL-1 beta concentration was undetectable in infants born by normal vaginal delivery or elective cesarean section but was significantly increased in infants born after induced vaginal deliveries (142 +/- 68 pg/ml) or urgent cesarean section (290 +/- 21 pg/ml; both p less than 0.05 compared with normal deliveries).  The IL-1 beta levels were elevated in infants with severe perinatal complications (282 +/- 116 pg/ml; p less than 0.001), whereas TNF and IL-6 levels were not related to these complications.  Infants with isolated perinatal infectious complications had elevated levels of plasma IL-6 compared with those of sick neonates without infection (p less than 0.001).  In contrast, TNF plasma levels and IL-1 beta production by cord blood leukocytes were decreased in infants with infectious complications alone (both p less than 0.05).  These studies suggest that the levels of IL-1 beta, IL-6, and TNF in the cord plasma relate differentially to clinical complications in the perinatal period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqVm9mR4XMqAyMywPm6HgQfW6udTcc2eZpLJ6gVtFUjbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M%252FmtFajtQ%253D%253D&md5=414fc57e3f069ea19b88fa9becc18c80</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1016%2FS0022-3476%2805%2980145-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-3476%252805%252980145-3%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BC.%26aulast%3DIsa%26aufirst%3DS.%26aulast%3DLoPreste%26aufirst%3DG.%26aulast%3DSchaller%26aufirst%3DJ.%2BG.%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26atitle%3DNeonatal%2520interleukin-%25201%2520beta%252C%2520interleukin-6%252C%2520and%2520tumor%2520necrosis%2520factor%253A%2520cord%2520blood%2520levels%2520and%2520cellular%2520production%26jtitle%3DJ.%2520Pediatr.%26date%3D1990%26volume%3D117%26spage%3D961%26epage%3D965%26doi%3D10.1016%2FS0022-3476%2805%2980145-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref222"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref222'); return false;" data-citation="" class="refNumLink">222</a></strong><div class="NLM_citation" id="cit222"><span><span class="NLM_contrib-group">Yoon, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syu, H. C.</span><span> </span><span class="NLM_article-title">Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity</span> <span class="citation_source-journal">Am. J. Obstet. Gynecol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">960</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span><span class="refDoi"> DOI: 10.1016/0002-9378(95)90028-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2F0002-9378%2895%2990028-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=7892891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADyaK2MXltFCjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=1995&pages=960-970&author=B.+H.+Yoonauthor=R.+Romeroauthor=C.+J.+Kimauthor=J.+K.+Junauthor=R.+Gomezauthor=J.+H.+Choiauthor=H.+C.+Syu&title=Amniotic+fluid+interleukin-6%3A+a+sensitive+test+for+antenatal+diagnosis+of+acute+inflammatory+lesions+of+preterm+placenta+and+prediction+of+perinatal+morbidity&doi=10.1016%2F0002-9378%2895%2990028-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity</span></div><div class="casAuthors">Yoon, Bo Hyun; Romero, Roberto; Kim, Chong Jai; Jun, Jong Kwan; Gomez, Ricardo; Choi, Jung-Hwan; Syn, Hee Chul</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Obstetrics and Gynecology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">960-70</span>CODEN:
                <span class="NLM_cas:coden">AJOGAH</span>;
        ISSN:<span class="NLM_cas:issn">0002-9378</span>.
    </div><div class="casAbstract">Our purpose was to det. whether amniotic fluid concns. of interleukin-6 are of value in the antenatal diagnosis of acute inflammatory lesions (histol. chorioamnionitis) of preterm placenta and in the prediction of perinatal morbidity and mortality.  The relation among placental histol. findings, perinatal outcome, and amniotic fluid interleukin-6 concns. was examd. in 50 consecutive patients who delivered preterm neonates within 72 h after amniocentesis.  Interleukin-6 was detd. by enzyme-linked immunosorbent assays.  Receiver-operator characteristic curve was used for anal.  Patients with acute histol. chorioamnionitis had significantly higher median amniotic fluid interleukin-6 concns. than patients without histol. chorioamnionitis (median 70.8 ng/mL, range 0.7 to 499.2 ng/mL vs median 2.9 ng/mL, range 0.8 to 16.0 ng/mL, resp.).  An amniotic fluid interleukin-6 concn. > 17 ng/mL had a sensitivity of 79% (23/29) and a specificity of 100% (21/21) in the diagnosis of acute histol. chorioamnionitis and a sensitivity of 69% (18/26) and a specificity of 79% (19/24) in the prediction of significant neonatal morbidity (defined as neonatal sepsis, respiratory distress syndrome, pneumonia, intraventricular hemorrhage, bronchopulmonary dysplasia, or necrotizing enterocolitis) and mortality.  These sensitivities were significantly higher than those of amniotic fluid culture (79% vs 38%; 69% vs 27%, resp.).  Amniotic fluid interleukin-6 is a sensitive test for the prospective diagnosis of acute histol. chorioamnionitis and the identification of neonates at risk for significant morbidity and mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEDT-icDrJGbVg90H21EOLACvtfcHk0liIpPYJVFSexA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXltFCjt70%253D&md5=14e6e2ef17014f65847c247ecf6697ba</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1016%2F0002-9378%2895%2990028-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0002-9378%252895%252990028-4%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DB.%2BH.%26aulast%3DRomero%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DC.%2BJ.%26aulast%3DJun%26aufirst%3DJ.%2BK.%26aulast%3DGomez%26aufirst%3DR.%26aulast%3DChoi%26aufirst%3DJ.%2BH.%26aulast%3DSyu%26aufirst%3DH.%2BC.%26atitle%3DAmniotic%2520fluid%2520interleukin-6%253A%2520a%2520sensitive%2520test%2520for%2520antenatal%2520diagnosis%2520of%2520acute%2520inflammatory%2520lesions%2520of%2520preterm%2520placenta%2520and%2520prediction%2520of%2520perinatal%2520morbidity%26jtitle%3DAm.%2520J.%2520Obstet.%2520Gynecol.%26date%3D1995%26volume%3D172%26spage%3D960%26epage%3D970%26doi%3D10.1016%2F0002-9378%2895%2990028-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref223"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref223'); return false;" data-citation="" class="refNumLink">223</a></strong><div class="NLM_citation" id="cit223"><span><span class="NLM_contrib-group">Abbott, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patabendige, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolman, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yusof, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begley, D. J.</span><span> </span><span class="NLM_article-title">Structure and function of the blood-brain barrier</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/j.nbd.2009.07.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.nbd.2009.07.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=19664713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGms73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=13-25&author=N.+J.+Abbottauthor=A.+A.+Patabendigeauthor=D.+E.+Dolmanauthor=S.+R.+Yusofauthor=D.+J.+Begley&title=Structure+and+function+of+the+blood-brain+barrier&doi=10.1016%2Fj.nbd.2009.07.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of the blood-brain barrier</span></div><div class="casAuthors">Abbott, N. Joan; Patabendige, Adjanie A. K.; Dolman, Diana E. M.; Yusof, Siti R.; Begley, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-25</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neural signalling within the central nervous system (CNS) requires a highly controlled microenvironment.  Cells at three key interfaces form barriers between the blood and the CNS: the blood-brain barrier (BBB), blood-CSF barrier and the arachnoid barrier.  The BBB at the level of brain microvessel endothelium is the major site of blood-CNS exchange.  The structure and function of the BBB is summarized, the phys. barrier formed by the endothelial tight junctions, and the transport barrier resulting from membrane transporters and vesicular mechanisms.  The roles of assocd. cells are outlined, esp. the end feet of astrocytic glial cells, and pericytes and microglia.  The embryonic development of the BBB, and changes in pathol. are described.  The BBB is subject to short and long-term regulation, which may be disturbed in pathol.  Any program for drug discovery or delivery, to target or avoid the CNS, needs to consider the special features of the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLiRwl4gXHmbVg90H21EOLACvtfcHk0liIpPYJVFSexA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGms73P&md5=fa08cd39c1350b4c845121c21a174ad8</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.07.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.07.030%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DN.%2BJ.%26aulast%3DPatabendige%26aufirst%3DA.%2BA.%26aulast%3DDolman%26aufirst%3DD.%2BE.%26aulast%3DYusof%26aufirst%3DS.%2BR.%26aulast%3DBegley%26aufirst%3DD.%2BJ.%26atitle%3DStructure%2520and%2520function%2520of%2520the%2520blood-brain%2520barrier%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2010%26volume%3D37%26spage%3D13%26epage%3D25%26doi%3D10.1016%2Fj.nbd.2009.07.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref224"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref224'); return false;" data-citation="" class="refNumLink">224</a></strong><div class="NLM_citation" id="cit224"><span><span class="NLM_contrib-group">Malik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheikh, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spivack, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span> </span><span class="NLM_article-title">Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects</span> <span class="citation_source-journal">Immunobiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">216</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span><span class="refDoi"> DOI: 10.1016/j.imbio.2010.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.imbio.2010.03.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2011&pages=80-85&author=M.+Malikauthor=A.+M.+Sheikhauthor=G.+Wenauthor=W.+Spivackauthor=W.+T.+Brownauthor=X.+Li&title=Expression+of+inflammatory+cytokines%2C+Bcl2+and+cathepsin+D+are+altered+in+lymphoblasts+of+autistic+subjects&doi=10.1016%2Fj.imbio.2010.03.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1016%2Fj.imbio.2010.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imbio.2010.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DMalik%26aufirst%3DM.%26aulast%3DSheikh%26aufirst%3DA.%2BM.%26aulast%3DWen%26aufirst%3DG.%26aulast%3DSpivack%26aufirst%3DW.%26aulast%3DBrown%26aufirst%3DW.%2BT.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DExpression%2520of%2520inflammatory%2520cytokines%252C%2520Bcl2%2520and%2520cathepsin%2520D%2520are%2520altered%2520in%2520lymphoblasts%2520of%2520autistic%2520subjects%26jtitle%3DImmunobiology%26date%3D2011%26volume%3D216%26spage%3D80%26epage%3D85%26doi%3D10.1016%2Fj.imbio.2010.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref225"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref225'); return false;" data-citation="" class="refNumLink">225</a></strong><div class="NLM_citation" id="cit225"><span><span class="NLM_contrib-group">Depino, A. M.</span><span> </span><span class="NLM_article-title">Peripheral and central inflammation in autism spectrum disorders</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1016/j.mcn.2012.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.mcn.2012.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=23069728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1CjsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=69-76&author=A.+M.+Depino&title=Peripheral+and+central+inflammation+in+autism+spectrum+disorders&doi=10.1016%2Fj.mcn.2012.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral and central inflammation in autism spectrum disorders</span></div><div class="casAuthors">Depino, Amaicha Mara</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">69-76</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Recent reports have given a central role to environmental factors in the etiol. of autism spectrum disorders (ASD).  However, most proposed perinatal factors seem to converge into the activation of the immune system, suggesting that an early inflammatory response could be a unifying factor in the etiol. ASD.  Here the author reviews the evidence of early immune activation in individuals with ASD, and the chronic peripheral and central alterations obsd. in the inflammatory response in ASD.  This evidence shows that ASD is assocd. with altered neuroinflammatory processes and abnormal immune responses in adulthood.  How these immune alterations can affect developmental programming of adult behavior or directly affect behavior later in life is discussed in the context of both clin. and animal models of research.  Recent studies in rodents clearly support a role of elevated cytokines in the behavioral symptoms of ASD, both during development and in adulthood.  This article is part of a Special Issue entitled "Neuroinflammation in neurodegeneration and neurodysfunction".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0RarwsUHoHLVg90H21EOLACvtfcHk0lg7fW6zLLnLVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1CjsL%252FL&md5=b30aa1b679c82fbf6942de6d994281f9</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2012.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2012.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DDepino%26aufirst%3DA.%2BM.%26atitle%3DPeripheral%2520and%2520central%2520inflammation%2520in%2520autism%2520spectrum%2520disorders%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2013%26volume%3D53%26spage%3D69%26epage%3D76%26doi%3D10.1016%2Fj.mcn.2012.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref226"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref226'); return false;" data-citation="" class="refNumLink">226</a></strong><div class="NLM_citation" id="cit226"><span><span class="NLM_contrib-group">Auld, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robitaille, R.</span><span> </span><span class="NLM_article-title">Glial cells and neurotransmission: an inclusive view of synaptic function</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span><span class="refDoi"> DOI: 10.1016/S0896-6273(03)00607-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0896-6273%2803%2900607-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2003&pages=389-400&author=D.+S.+Auldauthor=R.+Robitaille&title=Glial+cells+and+neurotransmission%3A+an+inclusive+view+of+synaptic+function&doi=10.1016%2FS0896-6273%2803%2900607-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2803%2900607-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252803%252900607-X%26sid%3Dliteratum%253Aachs%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DRobitaille%26aufirst%3DR.%26atitle%3DGlial%2520cells%2520and%2520neurotransmission%253A%2520an%2520inclusive%2520view%2520of%2520synaptic%2520function%26jtitle%3DNeuron%26date%3D2003%26volume%3D40%26spage%3D389%26epage%3D400%26doi%3D10.1016%2FS0896-6273%2803%2900607-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref227"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref227'); return false;" data-citation="" class="refNumLink">227</a></strong><div class="NLM_citation" id="cit227"><span><span class="NLM_contrib-group">Steinmetz, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buard, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claudepierre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nägler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfrieger, F. W.</span><span> </span><span class="NLM_article-title">Regional variations in the glial influence on synapse development in the mouse CNS</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">577</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><span class="refDoi"> DOI: 10.1113/jphysiol.2006.117358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1113%2Fjphysiol.2006.117358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=16959855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yqsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=577&publication_year=2006&pages=249-261&author=C.+C.+Steinmetzauthor=I.+Buardauthor=T.+Claudepierreauthor=K.+N%C3%A4glerauthor=F.+W.+Pfrieger&title=Regional+variations+in+the+glial+influence+on+synapse+development+in+the+mouse+CNS&doi=10.1113%2Fjphysiol.2006.117358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">Regional variations in the glial influence on synapse development in the mouse CNS</span></div><div class="casAuthors">Steinmetz, C. C.; Buard, I.; Claudepierre, T.; Nagler, K.; Pfrieger, F. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">577</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">249-261</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">There is increasing evidence that synapse function depends on interactions with glial cells, namely astrocytes.  Studies on specific neurons of the central nervous system (CNS) indicated that glial signals also control synapse development, but it remained unclear whether this is a general principle that applies to other neuronal cell types.  To address this question, we developed new methods to immunoisolate neurons from different brain regions of postnatal mice and to culture them in a chem. defined medium.  Electrophysiol. recordings and immunocytochem. staining revealed vigorous synaptogenesis in hippocampal and cerebellar neurons, but not in retinal ganglion cells (RGCs) in the absence of glial cells.  Co-culture with glia promoted synapse formation in RGCs as indicated by a strong increase in the incidence and frequency of action potential-independent miniature synaptic currents, but showed no such effects in hippocampal or cerebellar neurons.  On the other hand, glial signals promoted the efficacy of excitatory synapses in all regions as indicated by an increase in the size of spontaneous synaptic events in cerebellar cultures and of miniature synaptic currents in hippocampal neurons and RGCs.  Inhibitory synaptic currents remained largely unaffected by glia.  Our results indicate that in the mammalian CNS, the way that glial signals promote the development of excitatory synapses depends on the type of neuron.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKKHQwseRSz7Vg90H21EOLACvtfcHk0lg7fW6zLLnLVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yqsLzE&md5=5253934761dd77d0c6138d60b7f04516</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2006.117358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2006.117358%26sid%3Dliteratum%253Aachs%26aulast%3DSteinmetz%26aufirst%3DC.%2BC.%26aulast%3DBuard%26aufirst%3DI.%26aulast%3DClaudepierre%26aufirst%3DT.%26aulast%3DN%25C3%25A4gler%26aufirst%3DK.%26aulast%3DPfrieger%26aufirst%3DF.%2BW.%26atitle%3DRegional%2520variations%2520in%2520the%2520glial%2520influence%2520on%2520synapse%2520development%2520in%2520the%2520mouse%2520CNS%26jtitle%3DJ.%2520Physiol.%26date%3D2006%26volume%3D577%26spage%3D249%26epage%3D261%26doi%3D10.1113%2Fjphysiol.2006.117358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref228"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref228'); return false;" data-citation="" class="refNumLink">228</a></strong><div class="NLM_citation" id="cit228"><span><span class="NLM_contrib-group">Verkhratsky, A.</span><span> </span><span class="NLM_article-title">Physiology of neuronal–glial networking</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span><span class="refDoi"> DOI: 10.1016/j.neuint.2010.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuint.2010.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20144673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFamtLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2010&pages=332-343&author=A.+Verkhratsky&title=Physiology+of+neuronal%E2%80%93glial+networking&doi=10.1016%2Fj.neuint.2010.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit228R"><div class="casContent"><span class="casTitleNuber">228</span><div class="casTitle"><span class="NLM_cas:atitle">Physiology of neuronal-glial networking</span></div><div class="casAuthors">Verkhratsky, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">332-343</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Neuronal-glial networks are the substrate for the brain function.  Evolution of the nervous system resulted in the appearance of highly specialized neuronal web optimized for rapid information transfer.  This neuronal web is embedded into glial syncytium, thereby creating sophisticated neuronal-glial circuitry were both types of neural cells are working in concert, ensuring amplification of brain computational power.  In addn. neuroglial cells are fundamental for control of brain homeostasis and they represent the intrinsic brain defense system, being thus intimately involved in pathogenesis of neurol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIh_jgfgnn4rVg90H21EOLACvtfcHk0lgZL-dNYX66oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFamtLbI&md5=6ff41045607260073fccc3035e580ba9</span></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2010.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2010.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DVerkhratsky%26aufirst%3DA.%26atitle%3DPhysiology%2520of%2520neuronal%25E2%2580%2593glial%2520networking%26jtitle%3DNeurochem.%2520Int.%26date%3D2010%26volume%3D57%26spage%3D332%26epage%3D343%26doi%3D10.1016%2Fj.neuint.2010.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref229"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref229'); return false;" data-citation="" class="refNumLink">229</a></strong><div class="NLM_citation" id="cit229"><span><span class="NLM_contrib-group">Minghetti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnevale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, R.</span><span> </span><span class="NLM_article-title">Microglia–neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">388</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span><span class="refDoi"> DOI: 10.2174/187152707783399193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.2174%2F187152707783399193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=18220778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitF2kurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=388-397&author=L.+Minghettiauthor=D.+Carnevaleauthor=R.+De+Simone&title=Microglia%E2%80%93neuron+interaction+in+inflammatory+and+degenerative+diseases%3A+role+of+cholinergic+and+noradrenergic+systems&doi=10.2174%2F187152707783399193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems</span></div><div class="casAuthors">Carnevale, D.; De Simone, R.; Minghetti, L.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">388-397</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Reciprocal interactions between glia and neurons are essential for many crit. functions in brain health and disease.  Microglial cells, the brain resident macrophages, and astrocytes, the most prevalent type of cell in brain, are actively involved in the control of neuronal activities both in developing and adult organisms.  At the same time, neurons influence glial functions, through direct cell-to-cell interactions as well as the release of sol. mediators.  Among signals from neurons that may have an active role in controlling glial activation are two major neurotransmitters: acetylcholine and noradrenaline.  Several studies indicate that microglia and astrocytes express adrenergic receptors, whose activation influences the release of pro-inflammatory mediators, controlling the extent of glial reactivity.  Acetylcholine receptors are also expressed by glial cells.  In particular, microglial cells express the nicotinic receptor α7 and its activation attenuates the pro-inflammatory response of microglial cultures, suggesting that acetylcholine may control brain inflammation, in analogy to what demonstrated in peripheral tissues.  Deficiencies of noradrenergic and cholinergic systems are linked to important neurodegenerative diseases such as Parkinson's disease (PD) and Alzheimer's disease (AD) and it has been suggested that in addn. to impairing neuron-to-neuron transmission, noradrenergic and cholinergic hypofunction may contribute to dysregulation of the normal neuron-glia interaction, abnormal glial reaction and, eventually, neurodegeneration.  A deeper knowledge of role of cholinergic and noradrenergic systems in controlling neuron-glia interactions may offer new avenues for disease treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptyib6PWJY37Vg90H21EOLACvtfcHk0lgZL-dNYX66oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitF2kurc%253D&md5=ef8d528d8cdf6b749aab73da9e3943ea</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.2174%2F187152707783399193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152707783399193%26sid%3Dliteratum%253Aachs%26aulast%3DMinghetti%26aufirst%3DL.%26aulast%3DCarnevale%26aufirst%3DD.%26aulast%3DDe%2BSimone%26aufirst%3DR.%26atitle%3DMicroglia%25E2%2580%2593neuron%2520interaction%2520in%2520inflammatory%2520and%2520degenerative%2520diseases%253A%2520role%2520of%2520cholinergic%2520and%2520noradrenergic%2520systems%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2007%26volume%3D6%26spage%3D388%26epage%3D397%26doi%3D10.2174%2F187152707783399193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref230"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref230'); return false;" data-citation="" class="refNumLink">230</a></strong><div class="NLM_citation" id="cit230"><span><span class="NLM_contrib-group">Byrnes, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoica, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loane, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faden, A. I.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">550</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span><span class="refDoi"> DOI: 10.1002/glia.20783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2Fglia.20783" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2009&pages=550-560&author=K.+R.+Byrnesauthor=B.+Stoicaauthor=D.+J.+Loaneauthor=A.+Riccioauthor=M.+I.+Davisauthor=A.+I.+Faden&title=Metabotropic+glutamate+receptor+5+activation+inhibits+microglial+associated+inflammation+and+neurotoxicity&doi=10.1002%2Fglia.20783"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1002%2Fglia.20783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.20783%26sid%3Dliteratum%253Aachs%26aulast%3DByrnes%26aufirst%3DK.%2BR.%26aulast%3DStoica%26aufirst%3DB.%26aulast%3DLoane%26aufirst%3DD.%2BJ.%26aulast%3DRiccio%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DFaden%26aufirst%3DA.%2BI.%26atitle%3DMetabotropic%2520glutamate%2520receptor%25205%2520activation%2520inhibits%2520microglial%2520associated%2520inflammation%2520and%2520neurotoxicity%26jtitle%3DGlia%26date%3D2009%26volume%3D57%26spage%3D550%26epage%3D560%26doi%3D10.1002%2Fglia.20783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref231"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref231'); return false;" data-citation="" class="refNumLink">231</a></strong><div class="NLM_citation" id="cit231"><span><span class="NLM_contrib-group">Loane, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoica, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pajoohesh-Ganji, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrnes, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faden, A. I.</span><span> </span><span class="NLM_article-title">Activation of metabotropic glutamate receptor 5 modulates microglial reactivity and neurotoxicity by inhibiting NADPH oxidase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">15629</span><span class="NLM_x">–</span> <span class="NLM_lpage">15639</span><span class="refDoi"> DOI: 10.1074/jbc.M806139200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1074%2Fjbc.M806139200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=15629-15639&author=D.+J.+Loaneauthor=B.+A.+Stoicaauthor=A.+Pajoohesh-Ganjiauthor=K.+R.+Byrnesauthor=A.+I.+Faden&title=Activation+of+metabotropic+glutamate+receptor+5+modulates+microglial+reactivity+and+neurotoxicity+by+inhibiting+NADPH+oxidase&doi=10.1074%2Fjbc.M806139200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806139200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806139200%26sid%3Dliteratum%253Aachs%26aulast%3DLoane%26aufirst%3DD.%2BJ.%26aulast%3DStoica%26aufirst%3DB.%2BA.%26aulast%3DPajoohesh-Ganji%26aufirst%3DA.%26aulast%3DByrnes%26aufirst%3DK.%2BR.%26aulast%3DFaden%26aufirst%3DA.%2BI.%26atitle%3DActivation%2520of%2520metabotropic%2520glutamate%2520receptor%25205%2520modulates%2520microglial%2520reactivity%2520and%2520neurotoxicity%2520by%2520inhibiting%2520NADPH%2520oxidase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D15629%26epage%3D15639%26doi%3D10.1074%2Fjbc.M806139200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref232"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref232'); return false;" data-citation="" class="refNumLink">232</a></strong><div class="NLM_citation" id="cit232"><span><span class="NLM_contrib-group">Drouin-Ouellet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownell, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saint-Pierre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fasano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emond, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudeau, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicchetti, F.</span><span> </span><span class="NLM_article-title">Neuroinflammation is associated with changes in glial mGluR5 expression and the development of neonatal excitotoxic lesions</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span><span class="refDoi"> DOI: 10.1002/glia.21086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2Fglia.21086" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2011&pages=188-199&author=J.+Drouin-Ouelletauthor=A.+L.+Brownellauthor=M.+Saint-Pierreauthor=C.+Fasanoauthor=V.+Emondauthor=L.+E.+Trudeauauthor=D.+Levesqueauthor=F.+Cicchetti&title=Neuroinflammation+is+associated+with+changes+in+glial+mGluR5+expression+and+the+development+of+neonatal+excitotoxic+lesions&doi=10.1002%2Fglia.21086"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1002%2Fglia.21086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.21086%26sid%3Dliteratum%253Aachs%26aulast%3DDrouin-Ouellet%26aufirst%3DJ.%26aulast%3DBrownell%26aufirst%3DA.%2BL.%26aulast%3DSaint-Pierre%26aufirst%3DM.%26aulast%3DFasano%26aufirst%3DC.%26aulast%3DEmond%26aufirst%3DV.%26aulast%3DTrudeau%26aufirst%3DL.%2BE.%26aulast%3DLevesque%26aufirst%3DD.%26aulast%3DCicchetti%26aufirst%3DF.%26atitle%3DNeuroinflammation%2520is%2520associated%2520with%2520changes%2520in%2520glial%2520mGluR5%2520expression%2520and%2520the%2520development%2520of%2520neonatal%2520excitotoxic%2520lesions%26jtitle%3DGlia%26date%3D2011%26volume%3D59%26spage%3D188%26epage%3D199%26doi%3D10.1002%2Fglia.21086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref233"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref233'); return false;" data-citation="" class="refNumLink">233</a></strong><div class="NLM_citation" id="cit233"><span><span class="NLM_contrib-group">Bergeron, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deslauriers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grignon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortier, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepage, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poyart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sébire, G.</span><span> </span><span class="NLM_article-title">White matter injury and autistic-like behavior predominantly affecting male rat offspring exposed to group B streptococcal maternal inflammation</span> <span class="citation_source-journal">Dev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">504</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span><span class="refDoi"> DOI: 10.1159/000355656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1159%2F000355656" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24246964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2013&pages=504-515&author=J.+D.+Bergeronauthor=J.+Deslauriersauthor=S.+Grignonauthor=L.+C.+Fortierauthor=M.+Lepageauthor=T.+Strohauthor=C.+Poyartauthor=G.+S%C3%A9bire&title=White+matter+injury+and+autistic-like+behavior+predominantly+affecting+male+rat+offspring+exposed+to+group+B+streptococcal+maternal+inflammation&doi=10.1159%2F000355656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">White Matter Injury and Autistic-Like Behavior Predominantly Affecting Male Rat Offspring Exposed to Group B Streptococcal Maternal Inflammation</span></div><div class="casAuthors">Bergeron, J. D. L.; Deslauriers, J.; Grignon, S.; Fortier, L. C.; Lepage, M.; Stroh, T.; Poyart, C.; Sebire, G.</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Neuroscience (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">504-515</span>CODEN:
                <span class="NLM_cas:coden">DENED7</span>;
        ISSN:<span class="NLM_cas:issn">0378-5866</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">The impact of the group B streptococcus (GBS)-induced maternal inflammation on offspring's brain has not yet been investigated despite GBS being one of the most frequent bacteria colonizing or infecting pregnant women.  According to our hypothesis GBS-induced maternal immune activation plays a role in offspring perinatal brain damage and subsequent neurodisabilities such as autism.  Using a new preclin. rat model of maternal inflammation triggered by inactivated GBS, we demonstrated placental, neuropathol. and behavioral impacts on offspring.  GBS-exposed placentas presented cystic lesions and polymorphonuclear infiltration located within the decidual/maternal side of the placenta, contrasting with macrophagic infiltration and necrotic areas located in the labyrinth/fetal compartment of the placenta after lipopolysaccharide-induced maternal inflammation.  Brain damage featured lateral ventricles widening, predominately in the male, redn. of periventricular external capsules thickness, oligodendrocyte loss, and disorganization of frontoparietal subcortical tissue with no glial proliferation.  Autistic hallmarks were found in offspring exposed to GBS, namely deficits in motor behavior, social and communicative impairments, i.e. profound defects in the integration and response to both acoustic and chem. signals that are predominant modes of communication in rats.  Surprisingly, only male offspring were affected by these combined autistic-like traits.  Our results show for the first time that materno-fetal inflammatory response to GBS plays a role in the induction of placental and cerebral insults, remarkably recapitulating cardinal features of human autism such as gender dichotomy and neurobehavioral traits.  Unlike other models of prenatal inflammatory brain damage (induced by viral/toll-like receptor 3 (TLR3) or Gram-neg./TLR4), maternal inflammation resulting from GBS/TLR2 interactions induced a distinctive pattern of chorioamnionitis and cerebral injuries.  These results also provide important evidence that beyond genetic influences, modifiable environmental factors play a role in both the occurrence of autism and its gender imbalance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpre6eNH1YETbVg90H21EOLACvtfcHk0lixBMOTm3km1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltb%252FP&md5=de45ce51362af222453044dfb3d47f90</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1159%2F000355656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000355656%26sid%3Dliteratum%253Aachs%26aulast%3DBergeron%26aufirst%3DJ.%2BD.%26aulast%3DDeslauriers%26aufirst%3DJ.%26aulast%3DGrignon%26aufirst%3DS.%26aulast%3DFortier%26aufirst%3DL.%2BC.%26aulast%3DLepage%26aufirst%3DM.%26aulast%3DStroh%26aufirst%3DT.%26aulast%3DPoyart%26aufirst%3DC.%26aulast%3DS%25C3%25A9bire%26aufirst%3DG.%26atitle%3DWhite%2520matter%2520injury%2520and%2520autistic-like%2520behavior%2520predominantly%2520affecting%2520male%2520rat%2520offspring%2520exposed%2520to%2520group%2520B%2520streptococcal%2520maternal%2520inflammation%26jtitle%3DDev.%2520Neurosci.%26date%3D2013%26volume%3D35%26spage%3D504%26epage%3D515%26doi%3D10.1159%2F000355656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref234"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref234'); return false;" data-citation="" class="refNumLink">234</a></strong><div class="NLM_citation" id="cit234"><span><span class="NLM_contrib-group">Le Belle, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghochani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laks, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Aranda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornblum, H. I.</span><span> </span><span class="NLM_article-title">Maternal inflammation contributes to brain overgrowth and autism-associated behaviors through altered redox signaling in stem and progenitor cells</span> <span class="citation_source-journal">Stem Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">734</span><span class="refDoi"> DOI: 10.1016/j.stemcr.2014.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.stemcr.2014.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25418720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslels7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=725-734&author=J.+E.+Le+Belleauthor=J.+Sperryauthor=A.+Ngoauthor=Y.+Ghochaniauthor=D.+R.+Laksauthor=M.+L%C3%B3pez-Arandaauthor=A.+J.+Silvaauthor=H.+I.+Kornblum&title=Maternal+inflammation+contributes+to+brain+overgrowth+and+autism-associated+behaviors+through+altered+redox+signaling+in+stem+and+progenitor+cells&doi=10.1016%2Fj.stemcr.2014.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">Maternal Inflammation Contributes to Brain Overgrowth and Autism-Associated Behaviors through Altered Redox Signaling in Stem and Progenitor Cells</span></div><div class="casAuthors">Le Belle, Janel E.; Sperry, Jantzen; Ngo, Amy; Ghochani, Yasmin; Laks, Dan R.; Lopez-Aranda, Manuel; Silva, Alcino J.; Kornblum, Harley I.</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">725-734</span>CODEN:
                <span class="NLM_cas:coden">SCRTFL</span>;
        ISSN:<span class="NLM_cas:issn">2213-6711</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A period of mild brain overgrowth with an unknown etiol. has been identified as one of the most common phenotypes in autism.  Here, we test the hypothesis that maternal inflammation during crit. periods of embryonic development can cause brain overgrowth and autism-assocd. behaviors as a result of altered neural stem cell function.  Pregnant mice treated with low-dose lipopolysaccharide at embryonic day 9 had offspring with brain overgrowth, with a more pronounced effect in PTEN heterozygotes.  Exposure to maternal inflammation also enhanced NADPH oxidase (NOX)-PI3K pathway signaling, stimulated the hyperproliferation of neural stem and progenitor cells, increased forebrain microglia, and produced abnormal autism-assocd. behaviors in affected pups.  Our evidence supports the idea that a prenatal neuroinflammatory dysregulation in neural stem cell redox signaling can act in concert with underlying genetic susceptibilities to affect cellular responses to environmentally altered cellular levels of reactive oxygen species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzZDIUze4eM7Vg90H21EOLACvtfcHk0lhOFk_ZFuOdyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslels7vJ&md5=a8f7b2de67a5f7c79c0e978030452c8b</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=10.1016%2Fj.stemcr.2014.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stemcr.2014.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BBelle%26aufirst%3DJ.%2BE.%26aulast%3DSperry%26aufirst%3DJ.%26aulast%3DNgo%26aufirst%3DA.%26aulast%3DGhochani%26aufirst%3DY.%26aulast%3DLaks%26aufirst%3DD.%2BR.%26aulast%3DL%25C3%25B3pez-Aranda%26aufirst%3DM.%26aulast%3DSilva%26aufirst%3DA.%2BJ.%26aulast%3DKornblum%26aufirst%3DH.%2BI.%26atitle%3DMaternal%2520inflammation%2520contributes%2520to%2520brain%2520overgrowth%2520and%2520autism-associated%2520behaviors%2520through%2520altered%2520redox%2520signaling%2520in%2520stem%2520and%2520progenitor%2520cells%26jtitle%3DStem%2520Cell%2520Rep.%26date%3D2014%26volume%3D3%26spage%3D725%26epage%3D734%26doi%3D10.1016%2Fj.stemcr.2014.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref235"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref235'); return false;" data-citation="" class="refNumLink">235</a></strong><div class="NLM_citation" id="cit235"><span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persidsky, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, W.</span><span> </span><span class="NLM_article-title">TLR3 activation efficiency by high or low molecular mass poly I:C</span> <span class="citation_source-journal">Innate Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span><span class="refDoi"> DOI: 10.1177/1753425912459975</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1177%2F1753425912459975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=23035017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVKrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=184-192&author=Y.+Zhouauthor=M.+Guoauthor=X.+Wangauthor=J.+Liauthor=Y.+Wangauthor=L.+Yeauthor=M.+Daiauthor=L.+Zhouauthor=Y.+Persidskyauthor=W.+Ho&title=TLR3+activation+efficiency+by+high+or+low+molecular+mass+poly+I%3AC&doi=10.1177%2F1753425912459975"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">TLR3 activation efficiency by high or low molecular mass poly I:C</span></div><div class="casAuthors">Zhou, Yu; Guo, Ming; Wang, Xu; Li, Jielang; Wang, Yizhong; Ye, Li; Dai, Ming; Zhou, Li; Persidsky, Yuri; Ho, Wenzhe</div><div class="citationInfo"><span class="NLM_cas:title">Innate Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-192, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">IINMCB</span>;
        ISSN:<span class="NLM_cas:issn">1753-4259</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Toll-like receptor 3 (TLR3) plays a crit. role in initiating type I IFN-mediated innate immunity against viral infections.  TLR3 recognizes various forms of double stranded (ds) RNA, including viral dsRNA and a synthetic mimic of dsRNA, poly I:C, which has been used extensively as a TLR3 ligand to induce antiviral immunity.  The activation efficiency of TLR3 by poly I:C is influenced by various factors, including size of the ligands, delivery methods and cell types.  In this study, we examd. the stimulatory effect of two com.-available poly I:Cs [high mol. mass (HMM) and low mol. mass (LMM)] on TLR3 activation in various human cell types by detg. the induction of type I and type III IFNs, as well as the antiviral effect.  We demonstrated that the direct addn. of both HMM- and LMM-poly I:C to the cultures of primary macrophages or a neuroblastoma cell line could activate TLR3.  However, the transfection of poly I:C was necessary to induce TLR3 activation in other cell types studied.  In all the cell lines tested, the efficiency of TLR3 activation by HMM-poly I:C was significantly higher than that by LMM-poly I:C.  These observations indicate the importance and necessity of developing effective TLR3 ligands for antiviral therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQjVOxHGbQlbVg90H21EOLACvtfcHk0lhOFk_ZFuOdyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVKrsrs%253D&md5=59824992b1cad7e8cdc94e74c6418593</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.1177%2F1753425912459975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1753425912459975%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DDai%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DPersidsky%26aufirst%3DY.%26aulast%3DHo%26aufirst%3DW.%26atitle%3DTLR3%2520activation%2520efficiency%2520by%2520high%2520or%2520low%2520molecular%2520mass%2520poly%2520I%253AC%26jtitle%3DInnate%2520Immun.%26date%3D2013%26volume%3D19%26spage%3D184%26epage%3D192%26doi%3D10.1177%2F1753425912459975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref236"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref236'); return false;" data-citation="" class="refNumLink">236</a></strong><div class="NLM_citation" id="cit236"><span><span class="NLM_contrib-group">Holm, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draeby, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, T.</span><span> </span><span class="NLM_article-title">Microglia are required for astroglial Toll-like receptor 4 response and for optimal TLR2 and TLR3 response</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span><span class="refDoi"> DOI: 10.1002/glia.22296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2Fglia.22296" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=630-638&author=T.+H.+Holmauthor=D.+Draebyauthor=T.+Owens&title=Microglia+are+required+for+astroglial+Toll-like+receptor+4+response+and+for+optimal+TLR2+and+TLR3+response&doi=10.1002%2Fglia.22296"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.1002%2Fglia.22296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.22296%26sid%3Dliteratum%253Aachs%26aulast%3DHolm%26aufirst%3DT.%2BH.%26aulast%3DDraeby%26aufirst%3DD.%26aulast%3DOwens%26aufirst%3DT.%26atitle%3DMicroglia%2520are%2520required%2520for%2520astroglial%2520Toll-like%2520receptor%25204%2520response%2520and%2520for%2520optimal%2520TLR2%2520and%2520TLR3%2520response%26jtitle%3DGlia%26date%3D2012%26volume%3D60%26spage%3D630%26epage%3D638%26doi%3D10.1002%2Fglia.22296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref237"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref237'); return false;" data-citation="" class="refNumLink">237</a></strong><div class="NLM_citation" id="cit237"><span><span class="NLM_contrib-group">Nadeem, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakheet, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Harbi, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Ayadhi, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attia, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoheir, K. M.</span><span> </span><span class="NLM_article-title">Toll-like receptor 4 signaling is associated with upregulated NADPH oxidase expression in peripheral T cells of children with autism</span> <span class="citation_source-journal">Brain, Behav., Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span><span class="refDoi"> DOI: 10.1016/j.bbi.2016.12.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bbi.2016.12.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=146-154&author=A.+Nadeemauthor=S.+F.+Ahmadauthor=S.+A.+Bakheetauthor=N.+O.+Al-Harbiauthor=L.+Y.+Al-Ayadhiauthor=S.+M.+Attiaauthor=K.+M.+Zoheir&title=Toll-like+receptor+4+signaling+is+associated+with+upregulated+NADPH+oxidase+expression+in+peripheral+T+cells+of+children+with+autism&doi=10.1016%2Fj.bbi.2016.12.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1016%2Fj.bbi.2016.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbi.2016.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DNadeem%26aufirst%3DA.%26aulast%3DAhmad%26aufirst%3DS.%2BF.%26aulast%3DBakheet%26aufirst%3DS.%2BA.%26aulast%3DAl-Harbi%26aufirst%3DN.%2BO.%26aulast%3DAl-Ayadhi%26aufirst%3DL.%2BY.%26aulast%3DAttia%26aufirst%3DS.%2BM.%26aulast%3DZoheir%26aufirst%3DK.%2BM.%26atitle%3DToll-like%2520receptor%25204%2520signaling%2520is%2520associated%2520with%2520upregulated%2520NADPH%2520oxidase%2520expression%2520in%2520peripheral%2520T%2520cells%2520of%2520children%2520with%2520autism%26jtitle%3DBrain%252C%2520Behav.%252C%2520Immun.%26date%3D2017%26volume%3D61%26spage%3D146%26epage%3D154%26doi%3D10.1016%2Fj.bbi.2016.12.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref238"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref238'); return false;" data-citation="" class="refNumLink">238</a></strong><div class="NLM_citation" id="cit238"><span><span class="NLM_contrib-group">Naik, U. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbagani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagalla, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manna, S. K.</span><span> </span><span class="NLM_article-title">A study of nuclear transcription factor-kappa B in childhood autism</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e19488</span><span class="refDoi"> DOI: 10.1371/journal.pone.0019488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1371%2Fjournal.pone.0019488" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e19488&author=U.+S.+Naikauthor=C.+Gangadharanauthor=K.+Abbaganiauthor=B.+Nagallaauthor=N.+Dasariauthor=S.+K.+Manna&title=A+study+of+nuclear+transcription+factor-kappa+B+in+childhood+autism&doi=10.1371%2Fjournal.pone.0019488"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0019488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0019488%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DU.%2BS.%26aulast%3DGangadharan%26aufirst%3DC.%26aulast%3DAbbagani%26aufirst%3DK.%26aulast%3DNagalla%26aufirst%3DB.%26aulast%3DDasari%26aufirst%3DN.%26aulast%3DManna%26aufirst%3DS.%2BK.%26atitle%3DA%2520study%2520of%2520nuclear%2520transcription%2520factor-kappa%2520B%2520in%2520childhood%2520autism%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De19488%26doi%3D10.1371%2Fjournal.pone.0019488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref239"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref239'); return false;" data-citation="" class="refNumLink">239</a></strong><div class="NLM_citation" id="cit239"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csakai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span> </span><span class="NLM_article-title">Therapeutic developments targeting Toll-like receptor-4-mediated neuroinflammation</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span><span class="refDoi"> DOI: 10.1002/cmdc.201500188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2Fcmdc.201500188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26136385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWmtL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=154-165&author=J.+Liauthor=A.+Csakaiauthor=J.+Jinauthor=F.+Zhangauthor=H.+Yin&title=Therapeutic+developments+targeting+Toll-like+receptor-4-mediated+neuroinflammation&doi=10.1002%2Fcmdc.201500188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation</span></div><div class="casAuthors">Li, Jing; Csakai, Adam; Jin, Jialin; Zhang, Fengchun; Yin, Hang</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">154-165</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Toll-like receptors (TLRs) have been shown to play an important role in the immune system, which warrants study of their remarkable potential as pharmacol. targets.  Activation of TLRs requires participation from specific pathogen-assocd. mol. patterns (PAMPs) and accessory proteins such as myeloid differentiation protein 2 (MD2), lipopolysaccharide binding protein (LBP), and cluster differentiation antigen 14 (CD14).  Assembly of the TLR4-MD2-LPS complex is essential in TLR4 activation.  Recent studies have revealed that TLR4 activation is a significant trigger of signal transmission pathways in the nervous system, which could result in chronic pain as well as opioid tolerance and dependence.  Researchers of the mol. structure of TLRs and their accessory proteins have opened a door to syntheses of TLRs agonists and antagonists, such as eritoran.  Small-mol. modulators of TLR4, such as MD2-I and tricyclic antidepressants, offer more promising prospects than peptides, given their convenience in oral administration and lower cost.  Herein we mainly discuss the mechanisms and clin. prospects of TLR4 agonists and antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqteb9IWqhr6bVg90H21EOLACvtfcHk0lgwjotPNm-6aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWmtL7K&md5=53e86dd94e664aeba8734a6de9ab45dc</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500188%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCsakai%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DYin%26aufirst%3DH.%26atitle%3DTherapeutic%2520developments%2520targeting%2520Toll-like%2520receptor-4-mediated%2520neuroinflammation%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D154%26epage%3D165%26doi%3D10.1002%2Fcmdc.201500188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref240"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref240'); return false;" data-citation="" class="refNumLink">240</a></strong><div class="NLM_citation" id="cit240"><span><span class="NLM_contrib-group">Gárate, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Bueno, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madrigal, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caso, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez-Lus, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leza, J. C.</span><span> </span><span class="NLM_article-title">Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="refDoi"> DOI: 10.1186/1742-2094-11-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2F1742-2094-11-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24410883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12hur3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=8&author=I.+G%C3%A1rateauthor=B.+Garc%C3%ADa-Buenoauthor=J.+L.+Madrigalauthor=J.+R.+Casoauthor=L.+Alouauthor=M.+L.+G%C3%B3mez-Lusauthor=J.+C.+Leza&title=Toll-like+4+receptor+inhibitor+TAK-242+decreases+neuroinflammation+in+rat+brain+frontal+cortex+after+stress&doi=10.1186%2F1742-2094-11-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress</span></div><div class="casAuthors">Garate, Iciar; Garcia-Bueno, Borja; Madrigal, Jose Luis Munoz; Caso, Javier R.; Alou, Luis; Gomez-Lus, Maria Luisa; Leza, Juan Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8/1-8/14, 14</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The innate immune response is the first line of defense against invading microorganisms and it is also activated in different neurol./neurodegenerative pathol. scenarios.  As a result, the family of the innate immune toll-like receptors (TLRs) and, in particular, the genetic/pharmacol. manipulation of the TLR-4 signalling pathway emerges as a potential therapeutic strategy.  Growing evidence relates stress exposure with altered immune responses, but the precise role of TLR-4 remains partly unknown.  Methods: The present study aimed to elucidate whether the elements of the TLR-4 signalling pathway are activated after acute stress exposure in rat brain frontal cortex and its role in the regulation of the stress-induced neuroinflammatory response, by means of its pharmacol. modulation with the i.v. administration of the TLR-4 specific inhibitor TAK-242.  Considering that TLR-4 responds predominantly to lipopolysaccharide from gram-neg. bacteria, we checked whether increased intestinal permeability and a resultant bacterial translocation is a potential regulatory mechanism of stress-induced TLR-4 activation.  Results: Acute restraint stress exposure upregulates TLR-4 expression both at the mRNA and protein level.  Stress-induced TLR-4 upregulation is prevented by the protocol of antibiotic intestinal decontamination made to reduce indigenous gastrointestinal microflora, suggesting a role for bacterial translocation on TLR-4 signalling pathway activation.  TAK-242 pre-stress administration prevents the accumulation of potentially deleterious inflammatory and oxidative/nitrosative mediators in the brain frontal cortex of rats.  Conclusions: The use of TAK-242 or other TLR-4 signalling pathway inhibitory compds. could be considered as a potential therapeutic adjuvant strategy to constrain the inflammatory process taking place after stress exposure and in stress-related neuropsychiatric diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpApSuLWy4znrVg90H21EOLACvtfcHk0lh9ikO3IsNyJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12hur3P&md5=35a7e69518b16a61e8cb209ff8022aac</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-11-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-11-8%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25A1rate%26aufirst%3DI.%26aulast%3DGarc%25C3%25ADa-Bueno%26aufirst%3DB.%26aulast%3DMadrigal%26aufirst%3DJ.%2BL.%26aulast%3DCaso%26aufirst%3DJ.%2BR.%26aulast%3DAlou%26aufirst%3DL.%26aulast%3DG%25C3%25B3mez-Lus%26aufirst%3DM.%2BL.%26aulast%3DLeza%26aufirst%3DJ.%2BC.%26atitle%3DToll-like%25204%2520receptor%2520inhibitor%2520TAK-242%2520decreases%2520neuroinflammation%2520in%2520rat%2520brain%2520frontal%2520cortex%2520after%2520stress%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2014%26volume%3D11%26spage%3D8%26doi%3D10.1186%2F1742-2094-11-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref241"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref241'); return false;" data-citation="" class="refNumLink">241</a></strong><div class="NLM_citation" id="cit241"><span><span class="NLM_contrib-group">Hutchinson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loram, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shridhar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezvani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkelhammer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phipps, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landgraf, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falke, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, L. R.</span><span> </span><span class="NLM_article-title">Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">563</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2010.03.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuroscience.2010.03.067" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2010&pages=551-563&author=M.+R.+Hutchinsonauthor=L.+C.+Loramauthor=Y.+Zhangauthor=M.+Shridharauthor=N.+Rezvaniauthor=D.+Berkelhammerauthor=S.+Phippsauthor=P.+S.+Fosterauthor=K.+Landgrafauthor=J.+J.+Falkeauthor=K.+C.+Riceauthor=S.+F.+Maierauthor=H.+Yinauthor=L.+R.+Watkins&title=Evidence+that+tricyclic+small+molecules+may+possess+toll-like+receptor+and+myeloid+differentiation+protein+2+activity&doi=10.1016%2Fj.neuroscience.2010.03.067"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2010.03.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2010.03.067%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DM.%2BR.%26aulast%3DLoram%26aufirst%3DL.%2BC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DShridhar%26aufirst%3DM.%26aulast%3DRezvani%26aufirst%3DN.%26aulast%3DBerkelhammer%26aufirst%3DD.%26aulast%3DPhipps%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DP.%2BS.%26aulast%3DLandgraf%26aufirst%3DK.%26aulast%3DFalke%26aufirst%3DJ.%2BJ.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DMaier%26aufirst%3DS.%2BF.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DWatkins%26aufirst%3DL.%2BR.%26atitle%3DEvidence%2520that%2520tricyclic%2520small%2520molecules%2520may%2520possess%2520toll-like%2520receptor%2520and%2520myeloid%2520differentiation%2520protein%25202%2520activity%26jtitle%3DNeuroscience%26date%3D2010%26volume%3D168%26spage%3D551%26epage%3D563%26doi%3D10.1016%2Fj.neuroscience.2010.03.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref242"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref242'); return false;" data-citation="" class="refNumLink">242</a></strong><div class="NLM_citation" id="cit242"><span><span class="NLM_contrib-group">Jaiswal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohanakumar, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamma, U.</span><span> </span><span class="NLM_article-title">Serotonin mediated immunoregulation and neural functions: complicity in the aetiology of autism spectrum disorders</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/j.neubiorev.2015.05.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neubiorev.2015.05.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=413-431&author=P.+Jaiswalauthor=K.+P.+Mohanakumarauthor=U.+Rajamma&title=Serotonin+mediated+immunoregulation+and+neural+functions%3A+complicity+in+the+aetiology+of+autism+spectrum+disorders&doi=10.1016%2Fj.neubiorev.2015.05.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2015.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2015.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DJaiswal%26aufirst%3DP.%26aulast%3DMohanakumar%26aufirst%3DK.%2BP.%26aulast%3DRajamma%26aufirst%3DU.%26atitle%3DSerotonin%2520mediated%2520immunoregulation%2520and%2520neural%2520functions%253A%2520complicity%2520in%2520the%2520aetiology%2520of%2520autism%2520spectrum%2520disorders%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2015%26volume%3D55%26spage%3D413%26epage%3D431%26doi%3D10.1016%2Fj.neubiorev.2015.05.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref243"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref243'); return false;" data-citation="" class="refNumLink">243</a></strong><div class="NLM_citation" id="cit243"><span><span class="NLM_contrib-group">Cloez-Tayarani, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petit-Bertron, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venters, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavaillon, J. M.</span><span> </span><span class="NLM_article-title">Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors</span> <span class="citation_source-journal">Int. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span><span class="refDoi"> DOI: 10.1093/intimm/dxg027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1093%2Fintimm%2Fdxg027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=12578853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitFKls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=233-240&author=I.+Cloez-Tayaraniauthor=A.+F.+Petit-Bertronauthor=H.+D.+Ventersauthor=J.+M.+Cavaillon&title=Differential+effect+of+serotonin+on+cytokine+production+in+lipopolysaccharide-stimulated+human+peripheral+blood+mononuclear+cells%3A+involvement+of+5-hydroxytryptamine2A+receptors&doi=10.1093%2Fintimm%2Fdxg027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors</span></div><div class="casAuthors">Cloez-Tayarani, Isabelle; Petit-Bertron, Anne-France; Venters, Homer D.; Cavaillon, Jean-Marc</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-240</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">0953-8178</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">In order to provide addnl. insight into the in vivo significance of serotonin [5-hydroxytryptamine (5-HT)] in inflammation, we examd. its effect on the prodn. of tumor necrosis factor (TNF)-α, IL-1α, IL-1β, IL-6, IL-10 and IL-1 receptor antagonist in lipopolysaccharide (LPS)-stimulated human peripheral blood mononuclear cells (PBMC). 5-HT inhibited TNF-α prodn. and increased IL-1β prodn. in PBMC.  The level of IL-1β-converting enzyme/caspase-1 remained unchanged, suggesting that the effect of 5-HT is not directly related to the IL-1β maturation process.  TNF-α mRNA and IL-1β mRNA content did not change in the presence of 5-HT. 5-HT did not have any effect on the prodn. of other cytokines studied.  The inhibitory effect of 5-HT on TNF-α prodn. was antagonized by ketanserin, a selective 5-HT2A antagonist, and mimicked by DOI, a selective 5-HT2A/2C agonist.  These findings suggest that the inhibition of TNF-α prodn. by 5-HT involves the participation of the 5-HT2A receptor subtypes in PBMC.  Accordingly, we detected the presence of 5-HT2A receptors in PBMC by Western blot anal.  Our data support a role of 5-HT in inflammation through its effect on cytokine prodn. in PBMC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraHIWsUpNabrVg90H21EOLACvtfcHk0lj26j--qJytBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitFKls7w%253D&md5=5b1d68e182481ed1180e06b39dbb69a4</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2Fdxg027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252Fdxg027%26sid%3Dliteratum%253Aachs%26aulast%3DCloez-Tayarani%26aufirst%3DI.%26aulast%3DPetit-Bertron%26aufirst%3DA.%2BF.%26aulast%3DVenters%26aufirst%3DH.%2BD.%26aulast%3DCavaillon%26aufirst%3DJ.%2BM.%26atitle%3DDifferential%2520effect%2520of%2520serotonin%2520on%2520cytokine%2520production%2520in%2520lipopolysaccharide-stimulated%2520human%2520peripheral%2520blood%2520mononuclear%2520cells%253A%2520involvement%2520of%25205-hydroxytryptamine2A%2520receptors%26jtitle%3DInt.%2520Immunol.%26date%3D2003%26volume%3D15%26spage%3D233%26epage%3D240%26doi%3D10.1093%2Fintimm%2Fdxg027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref244"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref244'); return false;" data-citation="" class="refNumLink">244</a></strong><div class="NLM_citation" id="cit244"><span><span class="NLM_contrib-group">Baganz, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span> </span><span class="NLM_article-title">A dialogue between the immune system and brain, spoken in the language of serotonin</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1021/cn300186b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300186b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSjurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=48-63&author=N.+L.+Baganzauthor=R.+D.+Blakely&title=A+dialogue+between+the+immune+system+and+brain%2C+spoken+in+the+language+of+serotonin&doi=10.1021%2Fcn300186b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">A Dialogue between the Immune System and Brain, Spoken in the Language of Serotonin</span></div><div class="casAuthors">Baganz, Nicole L.; Blakely, Randy D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-63</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Neuropsychiatric disorders have long been linked to both immune system activation and alterations in serotonin (5-HT) signaling.  In the CNS, the contributions of 5-HT modulate a broad range of targets, most notably, hypothalamic, limbic and cortical circuits linked to the control of mood and mood disorders.  In the periphery, many are aware of the prodn. and actions of 5-HT in the gut but are unaware that the mol. and its receptors are also present in the immune system where evidence suggests they contribute to the both innate and adaptive responses.  In addn., there is clear evidence that the immune system communicates to the brain via both humoral and neuronal mechanisms, and that CNS 5-HT neurons are a direct or indirect target for these actions.  Following a brief primer on the immune system, the authors describe the authors' current understanding of the synthesis, release, and actions of 5-HT in modulating immune function, including the expression of 5-HT biosynthetic enzymes, receptors, and transporters that are typically studied with respect to the roles in the CNS.  The authors then orient the authors' presentation to recent findings that pro-inflammatory cytokines can modulate CNS 5-HT signaling, leading to a conceptualization that among the many roles of 5-HT in the body is an integrated physiol. and behavioral response to inflammatory events and pathogens.  From this perspective, altered 5-HT/immune conversations are likely to contribute to risk for neurobehavioral disorders historically linked to compromised 5-HT function or ameliorated by 5-HT targeted medications, including depression and anxiety disorders, obsessive-compulsive disorder (OCD), and autism.  The authors' review raises the question as to whether genetic variation impacting 5-HT signaling genes may contribute to maladaptive behavior as much through perturbed immune system modulation as through altered brain mechanisms.  Conversely, targeting the immune system for therapeutic development may provide an important opportunity to treat mental illness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBV_HdnFzQaLVg90H21EOLACvtfcHk0lhGCSv3_HJFAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSjurjJ&md5=cf19718241e2bed04cec00624e043a8f</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.1021%2Fcn300186b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300186b%26sid%3Dliteratum%253Aachs%26aulast%3DBaganz%26aufirst%3DN.%2BL.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26atitle%3DA%2520dialogue%2520between%2520the%2520immune%2520system%2520and%2520brain%252C%2520spoken%2520in%2520the%2520language%2520of%2520serotonin%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D48%26epage%3D63%26doi%3D10.1021%2Fcn300186b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref245"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref245'); return false;" data-citation="" class="refNumLink">245</a></strong><div class="NLM_citation" id="cit245"><span><span class="NLM_contrib-group">Zhu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carneiro, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dostmann, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewlett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span> </span><span class="NLM_article-title">p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">15649</span><span class="NLM_x">–</span> <span class="NLM_lpage">15658</span><span class="refDoi"> DOI: 10.1074/jbc.M410858200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1074%2Fjbc.M410858200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=15649-15658&author=C.+B.+Zhuauthor=A.+M.+Carneiroauthor=W.+R.+Dostmannauthor=W.+A.+Hewlettauthor=R.+D.+Blakely&title=p38+MAPK+activation+elevates+serotonin+transport+activity+via+a+trafficking-independent%2C+protein+phosphatase+2A-dependent+process&doi=10.1074%2Fjbc.M410858200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit245&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M410858200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M410858200%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%2BB.%26aulast%3DCarneiro%26aufirst%3DA.%2BM.%26aulast%3DDostmann%26aufirst%3DW.%2BR.%26aulast%3DHewlett%26aufirst%3DW.%2BA.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26atitle%3Dp38%2520MAPK%2520activation%2520elevates%2520serotonin%2520transport%2520activity%2520via%2520a%2520trafficking-independent%252C%2520protein%2520phosphatase%25202A-dependent%2520process%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D15649%26epage%3D15658%26doi%3D10.1074%2Fjbc.M410858200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref246"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref246'); return false;" data-citation="" class="refNumLink">246</a></strong><div class="NLM_citation" id="cit246"><span><span class="NLM_contrib-group">Angelidou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasiadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alysandratos, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theoharides, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lykouras, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalogeromitros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theoharides, T. C.</span><span> </span><span class="NLM_article-title">Neurotensin is increased in serum of young children with autistic disorder</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="refDoi"> DOI: 10.1186/1742-2094-7-48</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2F1742-2094-7-48" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20731814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC3cfht1GhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=48&author=A.+Angelidouauthor=K.+Francisauthor=M.+Vasiadiauthor=K.+D.+Alysandratosauthor=B.+Zhangauthor=A.+Theoharidesauthor=L.+Lykourasauthor=K.+Sideriauthor=D.+Kalogeromitrosauthor=T.+C.+Theoharides&title=Neurotensin+is+increased+in+serum+of+young+children+with+autistic+disorder&doi=10.1186%2F1742-2094-7-48"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit246R"><div class="casContent"><span class="casTitleNuber">246</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin is increased in serum of young children with autistic disorder</span></div><div class="casAuthors">Angelidou Asimenia; Francis Konstantinos; Vasiadi Magdalini; Alysandratos Konstantinos-Dionysios; Zhang Bodi; Theoharides Athanasios; Lykouras Lefteris; Sideri Kyriaki; Kalogeromitros Dimitrios; Theoharides Theoharis C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autism spectrum disorders (ASD) are a group of pervasive neurodevelopmental disorders diagnosed in early childhood.  They are associated with a set of "core symptoms" that include disabilities in social interaction skills, verbal and non-verbal communication, as well as repetitive and stereotypic behaviors.  There is no definite pathogenetic mechanism or diagnostic tests.  Many children with ASD also have "allergic-like" symptoms, but test negative implying mast cell activation by non-allergic triggers.  We measured by Milliplex arrays serum levels of 3 neuropeptides that could stimulate mast cells in children with autistic disorder (n = 19; 16 males and 3 females; mean age 3.0 ± 0.4 years) and healthy, unrelated controls (n = 16; 13 males and 3 females; mean age 3 ± 1.2 years).  Only neurotensin (NT) was significantly increased from 60.5 ± 6.0 pg/ml in controls to 105.6 ± 12.4 pg/ml in autistic disorder (p = 0.004).  There was no statistically significant difference in the serum levels of β-endorphin or substance P (SP).  NT could stimulate immune cells, especially mast cells, and/or have direct effects on brain inflammation and ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_hk3m1QAJhsK3uFsUIZtkfW6udTcc2eZ_gs7HzuNGDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfht1GhsQ%253D%253D&md5=f54cc29bd477e5167713a3536ca63c10</span></div><a href="/servlet/linkout?suffix=cit246&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-7-48&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-7-48%26sid%3Dliteratum%253Aachs%26aulast%3DAngelidou%26aufirst%3DA.%26aulast%3DFrancis%26aufirst%3DK.%26aulast%3DVasiadi%26aufirst%3DM.%26aulast%3DAlysandratos%26aufirst%3DK.%2BD.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DTheoharides%26aufirst%3DA.%26aulast%3DLykouras%26aufirst%3DL.%26aulast%3DSideri%26aufirst%3DK.%26aulast%3DKalogeromitros%26aufirst%3DD.%26aulast%3DTheoharides%26aufirst%3DT.%2BC.%26atitle%3DNeurotensin%2520is%2520increased%2520in%2520serum%2520of%2520young%2520children%2520with%2520autistic%2520disorder%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2010%26volume%3D7%26spage%3D48%26doi%3D10.1186%2F1742-2094-7-48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref247"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref247'); return false;" data-citation="" class="refNumLink">247</a></strong><div class="NLM_citation" id="cit247"><span><span class="NLM_contrib-group">Patel, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsilioni, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeman, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theoharides, T. C.</span><span> </span><span class="NLM_article-title">Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">E7049</span><span class="NLM_x">–</span> <span class="NLM_lpage">E7058</span><span class="refDoi"> DOI: 10.1073/pnas.1604992113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.1604992113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E7049-E7058&author=A.+B.+Patelauthor=I.+Tsilioniauthor=S.+E.+Leemanauthor=T.+C.+Theoharides&title=Neurotensin+stimulates+sortilin+and+mTOR+in+human+microglia+inhibitable+by+methoxyluteolin%2C+a+potential+therapeutic+target+for+autism&doi=10.1073%2Fpnas.1604992113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit247&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1604992113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1604992113%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DA.%2BB.%26aulast%3DTsilioni%26aufirst%3DI.%26aulast%3DLeeman%26aufirst%3DS.%2BE.%26aulast%3DTheoharides%26aufirst%3DT.%2BC.%26atitle%3DNeurotensin%2520stimulates%2520sortilin%2520and%2520mTOR%2520in%2520human%2520microglia%2520inhibitable%2520by%2520methoxyluteolin%252C%2520a%2520potential%2520therapeutic%2520target%2520for%2520autism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3DE7049%26epage%3DE7058%26doi%3D10.1073%2Fpnas.1604992113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref248"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref248'); return false;" data-citation="" class="refNumLink">248</a></strong><div class="NLM_citation" id="cit248"><span><span class="NLM_contrib-group">Nykjaer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willnow, T. E.</span><span> </span><span class="NLM_article-title">Sortilin: a receptor to regulate neuronal viability and function</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span><span class="refDoi"> DOI: 10.1016/j.tins.2012.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.tins.2012.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22341525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XivFygs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=261-270&author=A.+Nykjaerauthor=T.+E.+Willnow&title=Sortilin%3A+a+receptor+to+regulate+neuronal+viability+and+function&doi=10.1016%2Fj.tins.2012.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit248R"><div class="casContent"><span class="casTitleNuber">248</span><div class="casTitle"><span class="NLM_cas:atitle">Sortilin: a receptor to regulate neuronal viability and function</span></div><div class="casAuthors">Nykjaer, Anders; Willnow, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">261-270</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sortilin is a type-1 receptor expressed in neurons of the central and peripheral nervous systems.  Initially considered a rather peculiar receptor resembling an intracellular sorting protein in yeast, sortilin has emerged as a key player in the regulation of neuronal viability and function.  It acts as a receptor of neurotrophic factors and neuropeptides, but also as a co-receptor to cytokine receptors, tyrosine receptor kinases, G-protein coupled receptors and ion-channels.  Here, we review recent findings that identified multiple roles for sortilin in the cellular transport and signaling.  Furthermore, we discuss how sortilin contributes not only to the functional integrity of the nervous system during physiol. conditions but also plays an important role during neuronal injury and disease processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtew6HXcTIybVg90H21EOLACvtfcHk0lhfxGAUIAugrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivFygs7s%253D&md5=923da52421a21e3d2c1b850811173281</span></div><a href="/servlet/linkout?suffix=cit248&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2012.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2012.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DNykjaer%26aufirst%3DA.%26aulast%3DWillnow%26aufirst%3DT.%2BE.%26atitle%3DSortilin%253A%2520a%2520receptor%2520to%2520regulate%2520neuronal%2520viability%2520and%2520function%26jtitle%3DTrends%2520Neurosci.%26date%3D2012%26volume%3D35%26spage%3D261%26epage%3D270%26doi%3D10.1016%2Fj.tins.2012.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref249"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref249'); return false;" data-citation="" class="refNumLink">249</a></strong><div class="NLM_citation" id="cit249"><span><span class="NLM_contrib-group">Hermans-Borgmeyer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nykjaer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaller, C.</span><span> </span><span class="NLM_article-title">Expression of the 100-kDa neurotensin receptor sortilin during mouse embryonal development</span> <span class="citation_source-journal">Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span><span class="refDoi"> DOI: 10.1016/S0169-328X(99)00022-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0169-328X%2899%2900022-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10064893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADyaK1MXhtFeju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1999&pages=216-219&author=I.+Hermans-Borgmeyerauthor=G.+Hermeyauthor=A.+Nykjaerauthor=C.+Schaller&title=Expression+of+the+100-kDa+neurotensin+receptor+sortilin+during+mouse+embryonal+development&doi=10.1016%2FS0169-328X%2899%2900022-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit249R"><div class="casContent"><span class="casTitleNuber">249</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the 100-kDa neurotensin receptor sortilin during mouse embryonal development</span></div><div class="casAuthors">Hermans-Borgmeyer, Irm; Hermey, Guido; Nykjaer, Anders; Schaller, Chica</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">216-219</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Recently, sortilin a non G-protein-coupled receptor has been identified as the 100-kDa neurotensin receptor.  In this paper we describe the expression of its gene during mouse embryonal development.  We show that the nervous system is the main location of sortilin gene expression and that with ongoing development the forebrain exhibits the highest accumulation of transcripts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj2OZQmHqXeLVg90H21EOLACvtfcHk0lhvjP8t5uy2Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtFeju7s%253D&md5=8faa197df61c33eec68f5b2b4cd8378c</span></div><a href="/servlet/linkout?suffix=cit249&amp;dbid=16384&amp;doi=10.1016%2FS0169-328X%2899%2900022-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-328X%252899%252900022-4%26sid%3Dliteratum%253Aachs%26aulast%3DHermans-Borgmeyer%26aufirst%3DI.%26aulast%3DHermey%26aufirst%3DG.%26aulast%3DNykjaer%26aufirst%3DA.%26aulast%3DSchaller%26aufirst%3DC.%26atitle%3DExpression%2520of%2520the%2520100-kDa%2520neurotensin%2520receptor%2520sortilin%2520during%2520mouse%2520embryonal%2520development%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D1999%26volume%3D65%26spage%3D216%26epage%3D219%26doi%3D10.1016%2FS0169-328X%2899%2900022-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref250"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref250'); return false;" data-citation="" class="refNumLink">250</a></strong><div class="NLM_citation" id="cit250"><span><span class="NLM_contrib-group">Theoharides, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akin, C.</span><span> </span><span class="NLM_article-title">Mast cells, mastocytosis, and related disorders</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span><span class="refDoi"> DOI: 10.1056/NEJMra1409760</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1056%2FNEJMra1409760" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26154789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12qu77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=163-172&author=T.+C.+Theoharidesauthor=P.+Valentauthor=C.+Akin&title=Mast+cells%2C+mastocytosis%2C+and+related+disorders&doi=10.1056%2FNEJMra1409760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit250R"><div class="casContent"><span class="casTitleNuber">250</span><div class="casTitle"><span class="NLM_cas:atitle">Mast cells, mastocytosis, and related disorders</span></div><div class="casAuthors">Theoharides, Theoharis C.; Valent, Peter; Akin, Cem</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-172</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Pathol. conditions involving mast cells appear to be more common than once thought.  The diagnosis and treatment of such disorders are challenging, given protean symptoms and the presence of coexisting conditions.  In patients with severe symptoms or those with allergies to hymenoptera venom, the investigation of mast-cell monoclonality may provide the diagnosis.  Identification and avoidance of triggers, including emotional or phys. stress, may be helpful.  Most symptoms can be managed with histamine-receptor antagonists or other drugs that interfere with mast-cell mediators, along with blockers of mast-cell activation.  Patients with aggressive mastocytosis may require addnl. drugs to interfere with the proliferation and survival of mast cells.  Data are lacking to identify reliable biomarkers of mast-cell activation, signaling steps through which many triggers converge, drugs with dual inhibitory activity against mast-cell proliferation and mast-cell activation, and methods for delivering drugs specifically to mast cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC9RqY9NlQgrVg90H21EOLACvtfcHk0lhvjP8t5uy2Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12qu77I&md5=4be41091da0b611fac401a2fd22aba6e</span></div><a href="/servlet/linkout?suffix=cit250&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1409760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1409760%26sid%3Dliteratum%253Aachs%26aulast%3DTheoharides%26aufirst%3DT.%2BC.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DAkin%26aufirst%3DC.%26atitle%3DMast%2520cells%252C%2520mastocytosis%252C%2520and%2520related%2520disorders%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D163%26epage%3D172%26doi%3D10.1056%2FNEJMra1409760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref251"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref251'); return false;" data-citation="" class="refNumLink">251</a></strong><div class="NLM_citation" id="cit251"><span><span class="NLM_contrib-group">Wilson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naves, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lalloué, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jauberteau, M. O.</span><span> </span><span class="NLM_article-title">The implications of sortilin/vps10p domain receptors in neurological and human diseases</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1354</span><span class="NLM_x">–</span> <span class="NLM_lpage">1365</span><span class="refDoi"> DOI: 10.2174/1871527313666141023151642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.2174%2F1871527313666141023151642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25345507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2rtr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=1354-1365&author=C.+M.+Wilsonauthor=T.+Navesauthor=S.+Saadaauthor=S.+Pinetauthor=F.+Vincentauthor=F.+Lallou%C3%A9author=M.+O.+Jauberteau&title=The+implications+of+sortilin%2Fvps10p+domain+receptors+in+neurological+and+human+diseases&doi=10.2174%2F1871527313666141023151642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit251R"><div class="casContent"><span class="casTitleNuber">251</span><div class="casTitle"><span class="NLM_cas:atitle">The Implications of Sortilin/Vps10p Domain Receptors in Neurological and Human Diseases</span></div><div class="casAuthors">Wilson, Cornelia M.; Naves, Thomas; Saada, Sofiane; Pinet, Sandra; Vincent, Francois; Lalloue, Fabrice; Jauberteau, Marie-Odile</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1354-1365</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The neurotensin receptor-3 also known as sortilin is part of the new receptor family of vacuolar protein sorting 10 protein domain.  Growing evidence show that the vacuolar protein sorting 10 protein domain family is implicated as a genetic risk factor for neurodegenerative diseases such as Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease, in addn. to links assocd. with type 2 diabetes mellitus, lysosomal disorders, cardiovascular disease and atherosclerosis.  In fact, sortilin expression is elevated in many human cell lines controlling the trafficking and release of neurotrophins.  Hence, not surprisingly the imbalance of neurotrophin signaling is implicated in several human diseases.  The fine regulation of the growth factor, brain derived nerve factor by sortilin mediates both neuronal and tumor cell survival, whereas in Alzheimer's disease sortilin mediated beta secretase-1 trafficking increases the cleavage of the beta-amyloid precursor protein.  Perturbation of the autocrine/paracrine loop of neurotrophins in combination with the cell surface interaction of sortilin with neurotensin receptor 1 or 2 or tyrosine kinase receptor A or B are dramatically upregulated in both neurodegenerative diseases and cancer.  In cardiovascular diseases, the circulatory low-d. lipoprotein is closely correlated with sortilin expression in hepatocytes.  Herein, this review discusses the multifaceted role played by sortilin and its interacting partners in human disease which could be interesting novel target(s) in drug discovery.  Nevertheless, completely challenging the function of sortilin could prove unfavorable given the important universal role of sortilin plays in the body.  Hence, metab. disorders could be relieved with specific targeted therapeutic challenge of sortilin function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR441ZsnG8gbVg90H21EOLACvtfcHk0lhvjP8t5uy2Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2rtr3O&md5=621f31a9b409d2b99b0d461d7afa3312</span></div><a href="/servlet/linkout?suffix=cit251&amp;dbid=16384&amp;doi=10.2174%2F1871527313666141023151642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871527313666141023151642%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DC.%2BM.%26aulast%3DNaves%26aufirst%3DT.%26aulast%3DSaada%26aufirst%3DS.%26aulast%3DPinet%26aufirst%3DS.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DLallou%25C3%25A9%26aufirst%3DF.%26aulast%3DJauberteau%26aufirst%3DM.%2BO.%26atitle%3DThe%2520implications%2520of%2520sortilin%252Fvps10p%2520domain%2520receptors%2520in%2520neurological%2520and%2520human%2520diseases%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2014%26volume%3D13%26spage%3D1354%26epage%3D1365%26doi%3D10.2174%2F1871527313666141023151642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref252"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref252'); return false;" data-citation="" class="refNumLink">252</a></strong><div class="NLM_citation" id="cit252"><span><span class="NLM_contrib-group">Schrøder, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langgård, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltas, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskildsen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagmose, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonsen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biilmann Rønn, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egebjerg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavenhagen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strandbygård, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thirup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uppalanchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervaram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasturi, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eradi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakumudi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span> </span><span class="NLM_article-title">The identification of AF38469: an orally bioavailable inhibitor of the VPS10P family sorting receptor Sortilin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.11.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bmcl.2013.11.046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=177-180&author=T.+J.+Schr%C3%B8derauthor=S.+Christensenauthor=S.+Lindbergauthor=M.+Langg%C3%A5rdauthor=L.+Davidauthor=P.+J.+Maltasauthor=J.+Eskildsenauthor=J.+Jacobsenauthor=L.+Tagmoseauthor=K.+B.+Simonsenauthor=L.+C.+Biilmann+R%C3%B8nnauthor=I.+E.+de+Jongauthor=I.+J.+Malikauthor=J.+J.+Karlssonauthor=C.+Bundgaardauthor=J.+Egebjergauthor=J.+B.+Stavenhagenauthor=D.+Strandbyg%C3%A5rdauthor=S.+Thirupauthor=J.+L.+Andersenauthor=S.+Uppalanchiauthor=S.+Pervaramauthor=S.+P.+Kasturiauthor=P.+Eradiauthor=D.+R.+Sakumudiauthor=S.+P.+Watson&title=The+identification+of+AF38469%3A+an+orally+bioavailable+inhibitor+of+the+VPS10P+family+sorting+receptor+Sortilin&doi=10.1016%2Fj.bmcl.2013.11.046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit252&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.11.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.11.046%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B8der%26aufirst%3DT.%2BJ.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DLindberg%26aufirst%3DS.%26aulast%3DLangg%25C3%25A5rd%26aufirst%3DM.%26aulast%3DDavid%26aufirst%3DL.%26aulast%3DMaltas%26aufirst%3DP.%2BJ.%26aulast%3DEskildsen%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DJ.%26aulast%3DTagmose%26aufirst%3DL.%26aulast%3DSimonsen%26aufirst%3DK.%2BB.%26aulast%3DBiilmann%2BR%25C3%25B8nn%26aufirst%3DL.%2BC.%26aulast%3Dde%2BJong%26aufirst%3DI.%2BE.%26aulast%3DMalik%26aufirst%3DI.%2BJ.%26aulast%3DKarlsson%26aufirst%3DJ.%2BJ.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DEgebjerg%26aufirst%3DJ.%26aulast%3DStavenhagen%26aufirst%3DJ.%2BB.%26aulast%3DStrandbyg%25C3%25A5rd%26aufirst%3DD.%26aulast%3DThirup%26aufirst%3DS.%26aulast%3DAndersen%26aufirst%3DJ.%2BL.%26aulast%3DUppalanchi%26aufirst%3DS.%26aulast%3DPervaram%26aufirst%3DS.%26aulast%3DKasturi%26aufirst%3DS.%2BP.%26aulast%3DEradi%26aufirst%3DP.%26aulast%3DSakumudi%26aufirst%3DD.%2BR.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26atitle%3DThe%2520identification%2520of%2520AF38469%253A%2520an%2520orally%2520bioavailable%2520inhibitor%2520of%2520the%2520VPS10P%2520family%2520sorting%2520receptor%2520Sortilin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D177%26epage%3D180%26doi%3D10.1016%2Fj.bmcl.2013.11.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref253"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref253'); return false;" data-citation="" class="refNumLink">253</a></strong><div class="NLM_citation" id="cit253"><span><span class="NLM_contrib-group">Andersen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langgård, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltas, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rønn, L. C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strandbygaard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thirup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span> </span><span class="NLM_article-title">The identification of novel acid isostere based inhibitors of the VPS10P family sorting receptor sortilin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2629</span><span class="NLM_x">–</span> <span class="NLM_lpage">2633</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2017.02.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bmcl.2017.02.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2629-2633&author=J.+L.+Andersenauthor=S.+Lindbergauthor=M.+Langg%C3%A5rdauthor=P.+J.+Maltasauthor=L.+C.+B.+R%C3%B8nnauthor=C.+Bundgaardauthor=D.+Strandbygaardauthor=S.+Thirupauthor=S.+P.+Watson&title=The+identification+of+novel+acid+isostere+based+inhibitors+of+the+VPS10P+family+sorting+receptor+sortilin&doi=10.1016%2Fj.bmcl.2017.02.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit253&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.02.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.02.028%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DJ.%2BL.%26aulast%3DLindberg%26aufirst%3DS.%26aulast%3DLangg%25C3%25A5rd%26aufirst%3DM.%26aulast%3DMaltas%26aufirst%3DP.%2BJ.%26aulast%3DR%25C3%25B8nn%26aufirst%3DL.%2BC.%2BB.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DStrandbygaard%26aufirst%3DD.%26aulast%3DThirup%26aufirst%3DS.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26atitle%3DThe%2520identification%2520of%2520novel%2520acid%2520isostere%2520based%2520inhibitors%2520of%2520the%2520VPS10P%2520family%2520sorting%2520receptor%2520sortilin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2629%26epage%3D2633%26doi%3D10.1016%2Fj.bmcl.2017.02.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref254"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref254'); return false;" data-citation="" class="refNumLink">254</a></strong><div class="NLM_citation" id="cit254"><span><span class="NLM_contrib-group">Peng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, H. J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases: a review of their structure and role in systemic sclerosis</span> <span class="citation_source-journal">J. Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1409</span><span class="NLM_x">–</span> <span class="NLM_lpage">1414</span><span class="refDoi"> DOI: 10.1007/s10875-012-9735-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs10875-012-9735-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22767184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFSnsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=1409-1414&author=W.+Pengauthor=J.+Yanauthor=Y.+Wanauthor=B.+B.+Wangauthor=J.+Taoauthor=G.+Yangauthor=H.+J.+W.+Panauthor=J.+Wang&title=Matrix+metalloproteinases%3A+a+review+of+their+structure+and+role+in+systemic+sclerosis&doi=10.1007%2Fs10875-012-9735-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit254R"><div class="casContent"><span class="casTitleNuber">254</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix Metalloproteinases: A Review of Their Structure and Role in Systemic Sclerosis</span></div><div class="casAuthors">Peng, Wen-jia; Yan, Jun-wei; Wan, Ya-nan; Wang, Bing-xiang; Tao, Jin-hui; Yang, Guo-jun; Pan, Hai-feng; Wang, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1409-1414</span>CODEN:
                <span class="NLM_cas:coden">JCIMDO</span>;
        ISSN:<span class="NLM_cas:issn">0271-9142</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are the main enzymes involved in arterial wall extracellular matrix (ECM) degrdn. and remodeling, whose activity has been involved in various normal and pathol. processes, such as inflammation, fibrosis.  As a result, the MMPs have come to consider as both therapeutic targets and diagnostic tools for the treatment and diagnosis of autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis.  Systemic sclerosis (SSc) is a rare autoimmune disease of unknown etiol. characterized by an excessive over-prodn. of collagen and other ECM, resulting in skin thickening and fibrosis of internal organs.  In recent years, abnormal expression of MMPs has been demonstrated with the pathogenesis of SSc, and the assocn. of different polymorphisms on MMPs genes with SSc has been extensively studied.  This review describes the structure, function and regulation of MMPs and shortly summarizes current understanding on exptl. findings, genetic assocns. of MMPs in SSc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9enZZRy-u7bVg90H21EOLACvtfcHk0lhqVe-fDR4OlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFSnsLzE&md5=603fb4bd8b021ad0db40e4ba07d2fb4c</span></div><a href="/servlet/linkout?suffix=cit254&amp;dbid=16384&amp;doi=10.1007%2Fs10875-012-9735-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10875-012-9735-7%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%2BB.%26aulast%3DTao%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DPan%26aufirst%3DH.%2BJ.%2BW.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DMatrix%2520metalloproteinases%253A%2520a%2520review%2520of%2520their%2520structure%2520and%2520role%2520in%2520systemic%2520sclerosis%26jtitle%3DJ.%2520Clin.%2520Immunol.%26date%3D2012%26volume%3D32%26spage%3D1409%26epage%3D1414%26doi%3D10.1007%2Fs10875-012-9735-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref255"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref255'); return false;" data-citation="" class="refNumLink">255</a></strong><div class="NLM_citation" id="cit255"><span><span class="NLM_contrib-group">Abdallah, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, T. M.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases in autism spectrum disorders</span> <span class="citation_source-journal">J. Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="refDoi"> DOI: 10.1186/2049-9256-1-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2F2049-9256-1-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25408909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2MzovFaiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2013&pages=16&author=M.+W.+Abdallahauthor=T.+M.+Michel&title=Matrix+metalloproteinases+in+autism+spectrum+disorders&doi=10.1186%2F2049-9256-1-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit255R"><div class="casContent"><span class="casTitleNuber">255</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases in autism spectrum disorders</span></div><div class="casAuthors">Abdallah Morsi W; Michel Tanja M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of molecular psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autism Spectrum Disorders (ASD) are group of developmental disabilities with a complex neurobiological basis including putative changes in the immune system.  They are characterized by pervasive qualitative abnormalities in social interactions, communication, and stereotyped behaviour.  Matrix metalloproteinases (MMPs) represent a group of proteases which play an important role in neuroinflammation and neurodevelopment.  Therefore, they possibly have a crucial function in the etiopathology of ASD.  In this review, we summarize the plausibility of the hypothesis that MMPs are involved in the neuropathology of ASD.  Possible pathways through which MMPs can contribute to the pathogenesis of ASD are discussed including neuroinflammatory mechanisms inclusive of mediating neuropathological effects of infections, the associations between MMPs and other biomarkers such as cytokines, chemokines and neurotrophic factors.  Despite sufficient evidence for such an involvement of MMPs in the neuropathology of ASD, they have not yet been extensively studied in this context.  Thus, further research in this field is not only urgently needed but also very promising and may also lead to new therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTN5srQYW2OKMzK395ZObgVfW6udTcc2eZxBsk_9gyO37ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzovFaiug%253D%253D&md5=60bdd45e470cffb53308f392d2503338</span></div><a href="/servlet/linkout?suffix=cit255&amp;dbid=16384&amp;doi=10.1186%2F2049-9256-1-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2049-9256-1-16%26sid%3Dliteratum%253Aachs%26aulast%3DAbdallah%26aufirst%3DM.%2BW.%26aulast%3DMichel%26aufirst%3DT.%2BM.%26atitle%3DMatrix%2520metalloproteinases%2520in%2520autism%2520spectrum%2520disorders%26jtitle%3DJ.%2520Mol.%2520Psychiatry%26date%3D2013%26volume%3D1%26spage%3D16%26doi%3D10.1186%2F2049-9256-1-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref256"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref256'); return false;" data-citation="" class="refNumLink">256</a></strong><div class="NLM_citation" id="cit256"><span><span class="NLM_contrib-group">Bilousova, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charles, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethell, I. M.</span><span> </span><span class="NLM_article-title">Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model</span> <span class="citation_source-journal">J. Med. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span><span class="refDoi"> DOI: 10.1136/jmg.2008.061796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1136%2Fjmg.2008.061796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=18835858" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=94-102&author=T.+V.+Bilousovaauthor=L.+Dansieauthor=M.+Ngoauthor=J.+Ayeauthor=J.+R.+Charlesauthor=D.+W.+Ethellauthor=I.+M.+Ethell&title=Minocycline+promotes+dendritic+spine+maturation+and+improves+behavioural+performance+in+the+fragile+X+mouse+model&doi=10.1136%2Fjmg.2008.061796"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit256&amp;dbid=16384&amp;doi=10.1136%2Fjmg.2008.061796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjmg.2008.061796%26sid%3Dliteratum%253Aachs%26aulast%3DBilousova%26aufirst%3DT.%2BV.%26aulast%3DDansie%26aufirst%3DL.%26aulast%3DNgo%26aufirst%3DM.%26aulast%3DAye%26aufirst%3DJ.%26aulast%3DCharles%26aufirst%3DJ.%2BR.%26aulast%3DEthell%26aufirst%3DD.%2BW.%26aulast%3DEthell%26aufirst%3DI.%2BM.%26atitle%3DMinocycline%2520promotes%2520dendritic%2520spine%2520maturation%2520and%2520improves%2520behavioural%2520performance%2520in%2520the%2520fragile%2520X%2520mouse%2520model%26jtitle%3DJ.%2520Med.%2520Genet.%26date%3D2008%26volume%3D46%26spage%3D94%26epage%3D102%26doi%3D10.1136%2Fjmg.2008.061796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref257"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref257'); return false;" data-citation="" class="refNumLink">257</a></strong><div class="NLM_citation" id="cit257"><span><span class="NLM_contrib-group">Dziembowska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pretto, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janusz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaczmarek, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leigh, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durbin-Johnson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagerman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tassone, F.</span><span> </span><span class="NLM_article-title">High MMP-9 activity levels in fragile X syndrome are lowered by minocycline</span> <span class="citation_source-journal">Am. J. Med. Genet., Part A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">1897</span><span class="NLM_x">–</span> <span class="NLM_lpage">1903</span><span class="refDoi"> DOI: 10.1002/ajmg.a.36023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2Fajmg.a.36023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFyht7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2013&pages=1897-1903&author=M.+Dziembowskaauthor=D.+I.+Prettoauthor=A.+Januszauthor=L.+Kaczmarekauthor=M.+J.+Leighauthor=N.+Gabrielauthor=B.+Durbin-Johnsonauthor=R.+J.+Hagermanauthor=F.+Tassone&title=High+MMP-9+activity+levels+in+fragile+X+syndrome+are+lowered+by+minocycline&doi=10.1002%2Fajmg.a.36023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit257R"><div class="casContent"><span class="casTitleNuber">257</span><div class="casTitle"><span class="NLM_cas:atitle">High MMP-9 activity levels in fragile X syndrome are lowered by minocycline</span></div><div class="casAuthors">Dziembowska, Magdalena; Pretto, Dalyir I.; Janusz, Aleksandra; Kaczmarek, Leszek; Leigh, Mary Jacena; Gabriel, Nielsen; Durbin-Johnson, Blythe; Hagerman, Randi J.; Tassone, Flora</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medical Genetics, Part A</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1897-1903</span>CODEN:
                <span class="NLM_cas:coden">AJMGB8</span>;
        ISSN:<span class="NLM_cas:issn">1552-4825</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Fragile X syndrome (FXS) is a neurodevelopmental disorder characterized by lack of the FMR1 protein, FMRP, a translational repressor.  Its absence leads to up-regulation of locally translated proteins involved in synaptic transmission and plasticity, including the matrix metalloproteinase-9 (MMP-9).  In the Fmr1 knock-out (KO), a mouse model of FXS, an abnormal elevated expression of MMP-9 in the brain was pharmacol. down-regulated after treatment with the tetracycline deriv. minocycline.  Moreover, the rescue of immature dendritic spine morphol. and a significant improvement of abnormal behavior were assocd. with down-regulation of MMP-9.  Here, we report on high plasma activity of MMP-9 in individuals with FXS.  In addn., we investigate MMP-9 changes in patients with FXS who have gone through a minocycline controlled clin. trial and correlate MMP-9 activity to clin. observations.  The results of this study suggest that, in humans, activity levels of MMP-9 are lowered by minocycline and that, in some cases, changes in MMP-9 activity are pos. assocd. with improvement based on clin. measures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe_bjRm7_wxrVg90H21EOLACvtfcHk0lh4aIRzd5yH5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFyht7zK&md5=c97c45c77933683aa2869fc612a86d23</span></div><a href="/servlet/linkout?suffix=cit257&amp;dbid=16384&amp;doi=10.1002%2Fajmg.a.36023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fajmg.a.36023%26sid%3Dliteratum%253Aachs%26aulast%3DDziembowska%26aufirst%3DM.%26aulast%3DPretto%26aufirst%3DD.%2BI.%26aulast%3DJanusz%26aufirst%3DA.%26aulast%3DKaczmarek%26aufirst%3DL.%26aulast%3DLeigh%26aufirst%3DM.%2BJ.%26aulast%3DGabriel%26aufirst%3DN.%26aulast%3DDurbin-Johnson%26aufirst%3DB.%26aulast%3DHagerman%26aufirst%3DR.%2BJ.%26aulast%3DTassone%26aufirst%3DF.%26atitle%3DHigh%2520MMP-9%2520activity%2520levels%2520in%2520fragile%2520X%2520syndrome%2520are%2520lowered%2520by%2520minocycline%26jtitle%3DAm.%2520J.%2520Med.%2520Genet.%252C%2520Part%2520A%26date%3D2013%26volume%3D161%26spage%3D1897%26epage%3D1903%26doi%3D10.1002%2Fajmg.a.36023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref258"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref258'); return false;" data-citation="" class="refNumLink">258</a></strong><div class="NLM_citation" id="cit258"><span><span class="NLM_contrib-group">Geschwind, D. H.</span><span> </span><span class="NLM_article-title">Autism: many genes, common pathways?</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span><span class="refDoi"> DOI: 10.1016/j.cell.2008.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.cell.2008.10.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2008&pages=391-395&author=D.+H.+Geschwind&title=Autism%3A+many+genes%2C+common+pathways%3F&doi=10.1016%2Fj.cell.2008.10.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit258&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2008.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2008.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26atitle%3DAutism%253A%2520many%2520genes%252C%2520common%2520pathways%253F%26jtitle%3DCell%26date%3D2008%26volume%3D135%26spage%3D391%26epage%3D395%26doi%3D10.1016%2Fj.cell.2008.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref259"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref259'); return false;" data-citation="" class="refNumLink">259</a></strong><div class="NLM_citation" id="cit259"><span><span class="NLM_contrib-group">Lim, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaang, B. K.</span><span> </span><span class="NLM_article-title">Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients</span> <span class="citation_source-journal">Mol. Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="refDoi"> DOI: 10.1186/s13041-015-0146-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2Fs13041-015-0146-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26419846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1yqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=57&author=C.+S.+Limauthor=J.+E.+Yangauthor=Y.+K.+Leeauthor=K.+Leeauthor=J.+A.+Leeauthor=B.+K.+Kaang&title=Understanding+the+molecular+basis+of+autism+in+a+dish+using+hiPSCs-derived+neurons+from+ASD+patients&doi=10.1186%2Fs13041-015-0146-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit259R"><div class="casContent"><span class="casTitleNuber">259</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients</span></div><div class="casAuthors">Lim, Chae-Seok; Yang, Jung-eun; Lee, You-Kyung; Lee, Kyungmin; Lee, Jin-A.; Kaang, Bong-Kiun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57/1-57/17</span>CODEN:
                <span class="NLM_cas:coden">MBORAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-6606</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by deficits in social cognition, language development, and repetitive/restricted behaviors.  Due to the complexity and heterogeneity of ASD and lack of a proper human cellular model system, the pathophysiol. mechanism of ASD during the developmental process is largely unknown.  However, recent progress in induced pluripotent stem cell (iPSC) technol. as well as in vitro neural differentiation techniques have allowed us to functionally characterize neurons and analyze cortical development during neural differentiation.  These tech. advances will increase our understanding of the pathogenic mechanisms of heterogeneous ASD and help identify mol. biomarkers for patient stratification as well as personalized medicine.  In this review, we summarize our current knowledge of iPSC generation, differentiation of specific neuronal subtypes from iPSCs, and phenotypic characterizations of human ASD patient-derived iPSC models.  Finally, we discuss the current limitations of iPSC technol. and future directions of ASD pathophysiol. studies using iPSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW56H-bUqsA7Vg90H21EOLACvtfcHk0lh4aIRzd5yH5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1yqsr8%253D&md5=f1816ab17d0e23550b41799b8c7e0f5d</span></div><a href="/servlet/linkout?suffix=cit259&amp;dbid=16384&amp;doi=10.1186%2Fs13041-015-0146-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13041-015-0146-6%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DYang%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DY.%2BK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DKaang%26aufirst%3DB.%2BK.%26atitle%3DUnderstanding%2520the%2520molecular%2520basis%2520of%2520autism%2520in%2520a%2520dish%2520using%2520hiPSCs-derived%2520neurons%2520from%2520ASD%2520patients%26jtitle%3DMol.%2520Brain%26date%3D2015%26volume%3D8%26spage%3D57%26doi%3D10.1186%2Fs13041-015-0146-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref260"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref260'); return false;" data-citation="" class="refNumLink">260</a></strong><div class="NLM_citation" id="cit260"><span><span class="NLM_contrib-group">Nargund, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strack, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, T. M.</span><span> </span><span class="NLM_article-title">Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4035</span><span class="NLM_x">–</span> <span class="NLM_lpage">4043</span><span class="refDoi"> DOI: 10.1021/jm058241a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058241a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4035-4043&author=R.+P.+Nargundauthor=A.+M.+Strackauthor=T.+M.+Fong&title=Melanocortin-4+receptor+%28MC4R%29+agonists+for+the+treatment+of+obesity&doi=10.1021%2Fjm058241a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit260&amp;dbid=16384&amp;doi=10.1021%2Fjm058241a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058241a%26sid%3Dliteratum%253Aachs%26aulast%3DNargund%26aufirst%3DR.%2BP.%26aulast%3DStrack%26aufirst%3DA.%2BM.%26aulast%3DFong%26aufirst%3DT.%2BM.%26atitle%3DMelanocortin-4%2520receptor%2520%2528MC4R%2529%2520agonists%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4035%26epage%3D4043%26doi%3D10.1021%2Fjm058241a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref261"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref261'); return false;" data-citation="" class="refNumLink">261</a></strong><div class="NLM_citation" id="cit261"><span><span class="NLM_contrib-group">King, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabbani, N.</span><span> </span><span class="NLM_article-title">Alpha 7 nicotinic receptor coupling to heterotrimeric G proteins modulates RhoA activation, cytoskeletal motility, and structural growth</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">532</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span><span class="refDoi"> DOI: 10.1111/jnc.13660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1111%2Fjnc.13660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27167578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsVyjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=532-545&author=J.+R.+Kingauthor=N.+Kabbani&title=Alpha+7+nicotinic+receptor+coupling+to+heterotrimeric+G+proteins+modulates+RhoA+activation%2C+cytoskeletal+motility%2C+and+structural+growth&doi=10.1111%2Fjnc.13660"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit261R"><div class="casContent"><span class="casTitleNuber">261</span><div class="casTitle"><span class="NLM_cas:atitle">Alpha 7 nicotinic receptor coupling to heterotrimeric G proteins modulates RhoA activation, cytoskeletal motility, and structural growth</span></div><div class="casAuthors">King, Justin R.; Kabbani, Nadine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">532-545</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) modulate the growth and structure of neurons throughout the nervous system.  Ligand stimulation of the α7 nAChR has been shown to regulate the large heterotrimeric GTP-binding protein (G protein) signaling in various types of cells.  Here, we demonstrate a role for α7 nAChR/G protein interaction in the activation of the small (monomeric) RhoA GTPase leading to cytoskeletal changes during neurite growth.  Treatment of PC12 cells with the α7 nAChR agonist choline or PNU-282987 was assocd. with an increase in RhoA activity and an inhibition in neurite growth.  Specifically, choline treatment was found to attenuate the velocity of microtubule growth at the growth cone and decrease the rate of actin polymn. throughout the cell.  The effects of α7 nAChR activation were abolished by expression of a dominant neg. α7 nAChR (α7345-348A) deficient in G protein coupling.  Proteomic anal. of immunopptd. α7 nAChR complexes from differentiating PC12 cells and synaptic fractions of the developing mouse hippocampus revealed the existence of Rho GTPase-regulating guanine nucleotide exchange factors within α7 nAChR interactomes.  These findings underscore the role of α7 nAChR/G protein in cytoskeletal regulation during neurite growth.  This image depicts the hypothesized interaction of the traditionally ionotropic α7 nicotinic acetylcholine receptor (α7 nAChR) and its ability to interact and signal through both large and small G proteins, leading to the regulation of cytoskeletal growth.  Using differentiated PC12 cells, and the specific agonist choline, it was shown that α7 nAChR/G protein interactions mediate both short- and long-term neurite growth dynamics through increased RhoA activation.  Activation of RhoA was shown to decrease actin polymn., and lead to an overall decrease in neurite growth via regulation of the microtubule network.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri7JwZpevyVbVg90H21EOLACvtfcHk0lgOgljkvyDR-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsVyjtL4%253D&md5=c5ba0e25ca364e425c1f905ec5c27136</span></div><a href="/servlet/linkout?suffix=cit261&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13660%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DJ.%2BR.%26aulast%3DKabbani%26aufirst%3DN.%26atitle%3DAlpha%25207%2520nicotinic%2520receptor%2520coupling%2520to%2520heterotrimeric%2520G%2520proteins%2520modulates%2520RhoA%2520activation%252C%2520cytoskeletal%2520motility%252C%2520and%2520structural%2520growth%26jtitle%3DJ.%2520Neurochem.%26date%3D2016%26volume%3D138%26spage%3D532%26epage%3D545%26doi%3D10.1111%2Fjnc.13660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref262"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref262'); return false;" data-citation="" class="refNumLink">262</a></strong><div class="NLM_citation" id="cit262"><span><span class="NLM_contrib-group">Loth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span> </span><span class="NLM_article-title">Defining precision medicine approaches to autism spectrum disorders: concepts and challenges</span> <span class="citation_source-journal">Front. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="refDoi"> DOI: 10.3389/fpsyt.2016.00188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3389%2Ffpsyt.2016.00188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27965598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC1c%252FjvVGqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=188&author=E.+Lothauthor=D.+G.+Murphyauthor=W.+Spooren&title=Defining+precision+medicine+approaches+to+autism+spectrum+disorders%3A+concepts+and+challenges&doi=10.3389%2Ffpsyt.2016.00188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit262R"><div class="casContent"><span class="casTitleNuber">262</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Precision Medicine Approaches to Autism Spectrum Disorders: Concepts and Challenges</span></div><div class="casAuthors">Loth Eva; Murphy Declan G; Spooren Will</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">188</span>
        ISSN:<span class="NLM_cas:issn">1664-0640</span>.
    </div><div class="casAbstract">The tremendous clinical and etiological variability between individuals with autism spectrum disorder (ASD) has made precision medicine the most promising treatment approach.  It aims to combine new pathophysiologically based treatments with objective tests (stratification biomarkers) to predict which treatment may be beneficial for a particular person.  Here we discuss significant advances and current challenges for this approach: rare monogenic forms of ASD have provided a major breakthrough for the identification of treatment targets by providing a means to trace causal links from a gene to specific molecular alterations and biological pathways.  To estimate whether treatment targets thus identified may be useful for larger patient groups we need a better understanding of whether different etiologies (i.e., genetic and environmental risk factors acting at different critical time points) lead to convergent or divergent molecular mechanisms, and how they map onto differences in circuit-level brain and cognitive development, and behavioral symptom profiles.  Several recently failed clinical trials with syndromic forms of ASD provide valuable insights into conceptual and methodological issues linked to limitations in the translatability from animal models to humans, placebo effects, and a need for mechanistically plausible, objective outcome measures.  To identify stratification biomarkers that enrich participant selection in clinical trials, large-scale multi-modal longitudinal observational studies are underway.  Addressing these different factors in the next generation of research studies requires a translatable developmental perspective and multidisciplinary, collaborative efforts, with a commitment to sharing protocols and data, to increase transparency and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0sPuNApGhP0EksK8CslK8fW6udTcc2ebh0b89d-OcL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c%252FjvVGqtg%253D%253D&md5=febaa73b23ecc415d6c121a402c6ed51</span></div><a href="/servlet/linkout?suffix=cit262&amp;dbid=16384&amp;doi=10.3389%2Ffpsyt.2016.00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffpsyt.2016.00188%26sid%3Dliteratum%253Aachs%26aulast%3DLoth%26aufirst%3DE.%26aulast%3DMurphy%26aufirst%3DD.%2BG.%26aulast%3DSpooren%26aufirst%3DW.%26atitle%3DDefining%2520precision%2520medicine%2520approaches%2520to%2520autism%2520spectrum%2520disorders%253A%2520concepts%2520and%2520challenges%26jtitle%3DFront.%2520Psychiatry%26date%3D2016%26volume%3D7%26spage%3D188%26doi%3D10.3389%2Ffpsyt.2016.00188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216'],'ref217':['cit217'],'ref218':['cit218'],'ref219':['cit219'],'ref220':['cit220'],'ref221':['cit221'],'ref222':['cit222'],'ref223':['cit223'],'ref224':['cit224'],'ref225':['cit225'],'ref226':['cit226'],'ref227':['cit227'],'ref228':['cit228'],'ref229':['cit229'],'ref230':['cit230'],'ref231':['cit231'],'ref232':['cit232'],'ref233':['cit233'],'ref234':['cit234'],'ref235':['cit235'],'ref236':['cit236'],'ref237':['cit237'],'ref238':['cit238'],'ref239':['cit239'],'ref240':['cit240'],'ref241':['cit241'],'ref242':['cit242'],'ref243':['cit243'],'ref244':['cit244'],'ref245':['cit245'],'ref246':['cit246'],'ref247':['cit247'],'ref248':['cit248'],'ref249':['cit249'],'ref250':['cit250'],'ref251':['cit251'],'ref252':['cit252'],'ref253':['cit253'],'ref254':['cit254'],'ref255':['cit255'],'ref256':['cit256'],'ref257':['cit257'],'ref258':['cit258'],'ref259':['cit259'],'ref260':['cit260'],'ref261':['cit261'],'ref262':['cit262']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 29 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jieon Lee, Rina Kwag, Soyeon Lee, Doyoung Kim, Jiwan Woo, Yakdol Cho, Hak Joong Kim, Jeongjin Kim, Byungsun Jeon, <span class="NLM_string-name hlFld-ContribAuthor">Hyunah Choo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of G Protein-Biased Ligands against 5-HT7R. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7453-7467. <a href="https://doi.org/10.1021/acs.jmedchem.1c00110" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00110%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BG%252BProtein-Biased%252BLigands%252Bagainst%252B5-HT7R%26aulast%3DLee%26aufirst%3DJieon%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21012021%26date%3D25052021%26volume%3D64%26issue%3D11%26spage%3D7453%26epage%3D7467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Enza Lacivita, Mauro Niso, Margherita Mastromarino, Andrea Garcia Silva, Cibell Resch, Andre Zeug, María I. Loza, Marián Castro, Evgeni Ponimaskin, <span class="NLM_string-name hlFld-ContribAuthor">Marcello Leopoldo</span>. </span><span class="cited-content_cbyCitation_article-title">Knowledge-Based Design of Long-Chain Arylpiperazine Derivatives Targeting Multiple Serotonin Receptors as Potential Candidates for Treatment of Autism Spectrum Disorder. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (8)
                                     , 1313-1327. <a href="https://doi.org/10.1021/acschemneuro.0c00647" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00647</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00647%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DKnowledge-Based%252BDesign%252Bof%252BLong-Chain%252BArylpiperazine%252BDerivatives%252BTargeting%252BMultiple%252BSerotonin%252BReceptors%252Bas%252BPotential%252BCandidates%252Bfor%252BTreatment%252Bof%252BAutism%252BSpectrum%252BDisorder%26aulast%3DLacivita%26aufirst%3DEnza%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D09102020%26date%3D24032021%26date%3D01042021%26volume%3D12%26issue%3D8%26spage%3D1313%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wataru Ichinose, Stanislav M. Cherepanov, Anna A. Shabalova, Shigeru Yokoyama, Teruko Yuhi, Hiroaki Yamaguchi, Ayu Watanabe, Yasuhiko Yamamoto, Hiroshi Okamoto, Shinichi Horike, Junpei Terakawa, Takiko Daikoku, Mizuki Watanabe, Nariyasu Mano, Haruhiro Higashida, <span class="NLM_string-name hlFld-ContribAuthor">Satoshi Shuto</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Highly Potent Analogue and a Long-Acting Analogue of Oxytocin for the Treatment of Social Impairment-Like Behaviors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3297-3310. <a href="https://doi.org/10.1021/acs.jmedchem.8b01691" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01691</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01691%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ba%252BHighly%252BPotent%252BAnalogue%252Band%252Ba%252BLong-Acting%252BAnalogue%252Bof%252BOxytocin%252Bfor%252Bthe%252BTreatment%252Bof%252BSocial%252BImpairment-Like%252BBehaviors%26aulast%3DIchinose%26aufirst%3DWataru%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D31102018%26date%3D02042019%26date%3D21032019%26volume%3D62%26issue%3D7%26spage%3D3297%26epage%3D3310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maria
N. Modica, Enza Lacivita, Sebastiano Intagliata, Loredana Salerno, Giuseppe Romeo, Valeria Pittalà, <span class="NLM_string-name hlFld-ContribAuthor">Marcello Leopoldo</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships and Therapeutic Potentials of 5-HT7 Receptor Ligands: An Update. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (19)
                                     , 8475-8503. <a href="https://doi.org/10.1021/acs.jmedchem.7b01898" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01898</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01898%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Band%252BTherapeutic%252BPotentials%252Bof%252B5-HT7%252BReceptor%252BLigands%25253A%252BAn%252BUpdate%26aulast%3DModica%26aufirst%3DMaria%2BN.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D22122017%26date%3D05062018%26date%3D16052018%26volume%3D61%26issue%3D19%26spage%3D8475%26epage%3D8503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marie-Céline Frantz, Lucie P. Pellissier, Elsa Pflimlin, Stéphanie Loison, Jorge Gandía, Claire Marsol, Thierry Durroux, Bernard Mouillac, Jérôme A. J. Becker, Julie Le Merrer, Christel Valencia, Pascal Villa, Dominique Bonnet, <span class="NLM_string-name hlFld-ContribAuthor">Marcel Hibert</span>. </span><span class="cited-content_cbyCitation_article-title">LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (19)
                                     , 8670-8692. <a href="https://doi.org/10.1021/acs.jmedchem.8b00697" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00697%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLIT-001%25252C%252Bthe%252BFirst%252BNonpeptide%252BOxytocin%252BReceptor%252BAgonist%252Bthat%252BImproves%252BSocial%252BInteraction%252Bin%252Ba%252BMouse%252BModel%252Bof%252BAutism%26aulast%3DFrantz%26aufirst%3DMarie-C%25C3%25A9line%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D02052018%26date%3D24092018%26date%3D10092018%26volume%3D61%26issue%3D19%26spage%3D8670%26epage%3D8692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Loreto  Arrieta-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Daniela  Espinoza-Rosales</span>, <span class="hlFld-ContribAuthor ">Gonzalo  Vera</span>, <span class="hlFld-ContribAuthor ">Young Hwa  Cho</span>, <span class="hlFld-ContribAuthor ">David  Cabezas</span>, <span class="hlFld-ContribAuthor ">David  Vásquez-Velásquez</span>, <span class="hlFld-ContribAuthor ">Jaime  Mella-Raipán</span>, <span class="hlFld-ContribAuthor ">Carlos F.  Lagos</span>, <span class="hlFld-ContribAuthor ">Gonzalo  Recabarren-Gajardo</span>. </span><span class="cited-content_cbyCitation_article-title">Novel N-Arylsulfonylindoles Targeted as Ligands of the 5-HT6 Receptor. Insights on the Influence of C-5 Substitution on Ligand Affinity. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (6)
                                     , 528. <a href="https://doi.org/10.3390/ph14060528" title="DOI URL">https://doi.org/10.3390/ph14060528</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14060528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14060528%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DNovel%252BN-Arylsulfonylindoles%252BTargeted%252Bas%252BLigands%252Bof%252Bthe%252B5-HT6%252BReceptor.%252BInsights%252Bon%252Bthe%252BInfluence%252Bof%252BC-5%252BSubstitution%252Bon%252BLigand%252BAffinity%26aulast%3DArrieta-Rodr%25C3%25ADguez%26aufirst%3DLoreto%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D6%26spage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donald E.  Greydanus</span>, <span class="hlFld-ContribAuthor ">Dilip R.  Patel</span>, <span class="hlFld-ContribAuthor ">Dustin C.  Rowland</span>. </span><span class="cited-content_cbyCitation_article-title">Autism Spectrum Disorder. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-820472-6.00085-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-820472-6.00085-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820472-6.00085-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820472-6.00085-2%26sid%3Dliteratum%253Aachs%26atitle%3DAutism%252BSpectrum%252BDisorder%26aulast%3DGreydanus%26aufirst%3DDonald%2BE.%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BBiomedical%252BSciences%26date%3D2021%26volume%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gahan  Pandina</span>, <span class="hlFld-ContribAuthor ">Robert H.  Ring</span>, <span class="hlFld-ContribAuthor ">Abigail  Bangerter</span>, <span class="hlFld-ContribAuthor ">Seth  Ness</span>. </span><span class="cited-content_cbyCitation_article-title">Current Approaches to the Pharmacologic Treatment of Core Symptoms Across the Lifespan of Autism Spectrum Disorder. </span><span class="cited-content_cbyCitation_journal-name">Psychiatric Clinics of North America</span><span> <strong>2020,</strong> <em>43 </em>
                                    (4)
                                     , 629-645. <a href="https://doi.org/10.1016/j.psc.2020.08.003" title="DOI URL">https://doi.org/10.1016/j.psc.2020.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.psc.2020.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.psc.2020.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychiatric%2520Clinics%2520of%2520North%2520America%26atitle%3DCurrent%252BApproaches%252Bto%252Bthe%252BPharmacologic%252BTreatment%252Bof%252BCore%252BSymptoms%252BAcross%252Bthe%252BLifespan%252Bof%252BAutism%252BSpectrum%252BDisorder%26aulast%3DPandina%26aufirst%3DGahan%26date%3D2020%26volume%3D43%26issue%3D4%26spage%3D629%26epage%3D645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monireh  Mansouri</span>, <span class="hlFld-ContribAuthor ">Hamidreza  Pouretemad</span>, <span class="hlFld-ContribAuthor ">Mehrdad  Roghani</span>, <span class="hlFld-ContribAuthor ">Gregers  Wegener</span>, <span class="hlFld-ContribAuthor ">Maryam  Ardalan</span>. </span><span class="cited-content_cbyCitation_article-title">Autistic-like behaviours and associated brain structural plasticity are modulated by oxytocin in maternally separated rats. </span><span class="cited-content_cbyCitation_journal-name">Behavioural Brain Research</span><span> <strong>2020,</strong> <em>393 </em>, 112756. <a href="https://doi.org/10.1016/j.bbr.2020.112756" title="DOI URL">https://doi.org/10.1016/j.bbr.2020.112756</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbr.2020.112756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbr.2020.112756%26sid%3Dliteratum%253Aachs%26jtitle%3DBehavioural%2520Brain%2520Research%26atitle%3DAutistic-like%252Bbehaviours%252Band%252Bassociated%252Bbrain%252Bstructural%252Bplasticity%252Bare%252Bmodulated%252Bby%252Boxytocin%252Bin%252Bmaternally%252Bseparated%252Brats%26aulast%3DMansouri%26aufirst%3DMonireh%26date%3D2020%26volume%3D393%26spage%3D112756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosa  Savino</span>, <span class="hlFld-ContribAuthor ">Marco  Carotenuto</span>, <span class="hlFld-ContribAuthor ">Anna Nunzia  Polito</span>, <span class="hlFld-ContribAuthor ">Sofia  Di Noia</span>, <span class="hlFld-ContribAuthor ">Marzia  Albenzio</span>, <span class="hlFld-ContribAuthor ">Alessia  Scarinci</span>, <span class="hlFld-ContribAuthor ">Antonio  Ambrosi</span>, <span class="hlFld-ContribAuthor ">Francesco  Sessa</span>, <span class="hlFld-ContribAuthor ">Nicola  Tartaglia</span>, <span class="hlFld-ContribAuthor ">Giovanni  Messina</span>. </span><span class="cited-content_cbyCitation_article-title">Analyzing the Potential Biological Determinants of Autism Spectrum Disorder: From Neuroinflammation to the Kynurenine Pathway. </span><span class="cited-content_cbyCitation_journal-name">Brain Sciences</span><span> <strong>2020,</strong> <em>10 </em>
                                    (9)
                                     , 631. <a href="https://doi.org/10.3390/brainsci10090631" title="DOI URL">https://doi.org/10.3390/brainsci10090631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/brainsci10090631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbrainsci10090631%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Sciences%26atitle%3DAnalyzing%252Bthe%252BPotential%252BBiological%252BDeterminants%252Bof%252BAutism%252BSpectrum%252BDisorder%25253A%252BFrom%252BNeuroinflammation%252Bto%252Bthe%252BKynurenine%252BPathway%26aulast%3DSavino%26aufirst%3DRosa%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D9%26spage%3D631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amber M.  Muehlmann</span>, <span class="hlFld-ContribAuthor ">Sebastian  Maletz</span>, <span class="hlFld-ContribAuthor ">Michael A.  King</span>, <span class="hlFld-ContribAuthor ">Mark H.  Lewis</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological targeting of striatal indirect pathway neurons improves subthalamic nucleus dysfunction and reduces repetitive behaviors in C58 mice. </span><span class="cited-content_cbyCitation_journal-name">Behavioural Brain Research</span><span> <strong>2020,</strong> <em>391 </em>, 112708. <a href="https://doi.org/10.1016/j.bbr.2020.112708" title="DOI URL">https://doi.org/10.1016/j.bbr.2020.112708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbr.2020.112708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbr.2020.112708%26sid%3Dliteratum%253Aachs%26jtitle%3DBehavioural%2520Brain%2520Research%26atitle%3DPharmacological%252Btargeting%252Bof%252Bstriatal%252Bindirect%252Bpathway%252Bneurons%252Bimproves%252Bsubthalamic%252Bnucleus%252Bdysfunction%252Band%252Breduces%252Brepetitive%252Bbehaviors%252Bin%252BC58%252Bmice%26aulast%3DMuehlmann%26aufirst%3DAmber%2BM.%26date%3D2020%26volume%3D391%26spage%3D112708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Enza  Lacivita</span>, <span class="hlFld-ContribAuthor ">Mauro  Niso</span>, <span class="hlFld-ContribAuthor ">Madia Letizia  Stama</span>, <span class="hlFld-ContribAuthor ">Anna  Arzuaga</span>, <span class="hlFld-ContribAuthor ">Concetta  Altamura</span>, <span class="hlFld-ContribAuthor ">Lara  Costa</span>, <span class="hlFld-ContribAuthor ">Jean-François  Desaphy</span>, <span class="hlFld-ContribAuthor ">Michael E.  Ragozzino</span>, <span class="hlFld-ContribAuthor ">Lucia  Ciranna</span>, <span class="hlFld-ContribAuthor ">Marcello  Leopoldo</span>. </span><span class="cited-content_cbyCitation_article-title">Privileged scaffold-based design to identify a novel drug-like 5-HT7 receptor-preferring agonist to target Fragile X syndrome. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>199 </em>, 112395. <a href="https://doi.org/10.1016/j.ejmech.2020.112395" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112395%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPrivileged%252Bscaffold-based%252Bdesign%252Bto%252Bidentify%252Ba%252Bnovel%252Bdrug-like%252B5-HT7%252Breceptor-preferring%252Bagonist%252Bto%252Btarget%252BFragile%252BX%252Bsyndrome%26aulast%3DLacivita%26aufirst%3DEnza%26date%3D2020%26volume%3D199%26spage%3D112395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Waqas  Haider</span>, <span class="hlFld-ContribAuthor ">Wei‐Feng  Xu</span>, <span class="hlFld-ContribAuthor ">Min  Liu</span>, <span class="hlFld-ContribAuthor ">Yan‐Wei  Wu</span>, <span class="hlFld-ContribAuthor ">Yan‐Fei  Tang</span>, <span class="hlFld-ContribAuthor ">Mei‐Yan  Wei</span>, <span class="hlFld-ContribAuthor ">Chang‐Yun  Wang</span>, <span class="hlFld-ContribAuthor ">Ling  Lu</span>, <span class="hlFld-ContribAuthor ">Chang‐Lun  Shao</span>. </span><span class="cited-content_cbyCitation_article-title">Structure‐Activity Relationships and Potent Cytotoxic Activities of Terphenyllin Derivatives from a Small Compound Library. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2020,</strong> <em>17 </em>
                                    (7)
                                     <a href="https://doi.org/10.1002/cbdv.202000207" title="DOI URL">https://doi.org/10.1002/cbdv.202000207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.202000207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.202000207%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DStructure%2525E2%252580%252590Activity%252BRelationships%252Band%252BPotent%252BCytotoxic%252BActivities%252Bof%252BTerphenyllin%252BDerivatives%252Bfrom%252Ba%252BSmall%252BCompound%252BLibrary%26aulast%3DHaider%26aufirst%3DWaqas%26date%3D2020%26date%3D2020%26volume%3D17%26issue%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gahan  Pandina</span>, <span class="hlFld-ContribAuthor ">Robert H.  Ring</span>, <span class="hlFld-ContribAuthor ">Abigail  Bangerter</span>, <span class="hlFld-ContribAuthor ">Seth  Ness</span>. </span><span class="cited-content_cbyCitation_article-title">Current Approaches to the Pharmacologic Treatment of Core Symptoms Across the Lifespan of Autism Spectrum Disorder. </span><span class="cited-content_cbyCitation_journal-name">Child and Adolescent Psychiatric Clinics of North America</span><span> <strong>2020,</strong> <em>29 </em>
                                    (2)
                                     , 301-317. <a href="https://doi.org/10.1016/j.chc.2019.12.004" title="DOI URL">https://doi.org/10.1016/j.chc.2019.12.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chc.2019.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chc.2019.12.004%26sid%3Dliteratum%253Aachs%26jtitle%3DChild%2520and%2520Adolescent%2520Psychiatric%2520Clinics%2520of%2520North%2520America%26atitle%3DCurrent%252BApproaches%252Bto%252Bthe%252BPharmacologic%252BTreatment%252Bof%252BCore%252BSymptoms%252BAcross%252Bthe%252BLifespan%252Bof%252BAutism%252BSpectrum%252BDisorder%26aulast%3DPandina%26aufirst%3DGahan%26date%3D2020%26volume%3D29%26issue%3D2%26spage%3D301%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe  Romeo</span>, <span class="hlFld-ContribAuthor ">Loredana  Salerno</span>, <span class="hlFld-ContribAuthor ">Valeria  Pittalà</span>, <span class="hlFld-ContribAuthor ">Marialuisa  Candido</span>, <span class="hlFld-ContribAuthor ">Sebastiano  Intagliata</span>, <span class="hlFld-ContribAuthor ">Emanuele  Amata</span>, <span class="hlFld-ContribAuthor ">Mario  Salmona</span>, <span class="hlFld-ContribAuthor ">Alfredo  Cagnotto</span>, <span class="hlFld-ContribAuthor ">Antonio  Rescifina</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Floresta</span>, <span class="hlFld-ContribAuthor ">Maria Nunziata  Modica</span>. </span><span class="cited-content_cbyCitation_article-title">[1]Benzothieno[3,2-d]pyrimidine derivatives as ligands for the serotonergic 5-HT7 receptor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>183 </em>, 111690. <a href="https://doi.org/10.1016/j.ejmech.2019.111690" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111690</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111690%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%25255B1%25255DBenzothieno%25255B3%25252C2-d%25255Dpyrimidine%252Bderivatives%252Bas%252Bligands%252Bfor%252Bthe%252Bserotonergic%252B5-HT7%252Breceptor%26aulast%3DRomeo%26aufirst%3DGiuseppe%26date%3D2019%26volume%3D183%26spage%3D111690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dae-Wook  Kang</span>, <span class="hlFld-ContribAuthor ">James B.  Adams</span>, <span class="hlFld-ContribAuthor ">Devon M.  Coleman</span>, <span class="hlFld-ContribAuthor ">Elena L.  Pollard</span>, <span class="hlFld-ContribAuthor ">Juan  Maldonado</span>, <span class="hlFld-ContribAuthor ">Sharon  McDonough-Means</span>, <span class="hlFld-ContribAuthor ">J. Gregory  Caporaso</span>, <span class="hlFld-ContribAuthor ">Rosa  Krajmalnik-Brown</span>. </span><span class="cited-content_cbyCitation_article-title">Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-42183-0" title="DOI URL">https://doi.org/10.1038/s41598-019-42183-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-42183-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-42183-0%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DLong-term%252Bbenefit%252Bof%252BMicrobiota%252BTransfer%252BTherapy%252Bon%252Bautism%252Bsymptoms%252Band%252Bgut%252Bmicrobiota%26aulast%3DKang%26aufirst%3DDae-Wook%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul J.  Goldsmith</span>. </span><span class="cited-content_cbyCitation_article-title">NMDAR PAMs: Multiple Chemotypes for Multiple Binding Sites. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (24)
                                     , 2239-2253. <a href="https://doi.org/10.2174/1568026619666191011095341" title="DOI URL">https://doi.org/10.2174/1568026619666191011095341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666191011095341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666191011095341%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DNMDAR%252BPAMs%25253A%252BMultiple%252BChemotypes%252Bfor%252BMultiple%252BBinding%252BSites%26aulast%3DGoldsmith%26aufirst%3DPaul%2BJ.%26date%3D2019%26volume%3D19%26issue%3D24%26spage%3D2239%26epage%3D2253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Liu</span>, <span class="hlFld-ContribAuthor ">Jin-Feng  Chen</span>, <span class="hlFld-ContribAuthor ">Yue  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Guo</span>, <span class="hlFld-ContribAuthor ">Qin-Mei  Zhou</span>, <span class="hlFld-ContribAuthor ">Cheng  Peng</span>, <span class="hlFld-ContribAuthor ">Liang  Xiong</span>. </span><span class="cited-content_cbyCitation_article-title">Cytotoxicity of lanostane-type triterpenoids and ergosteroids isolated from Omphalia lapidescens on MDA-MB-231 and HGC-27 cells. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2019,</strong> <em>118 </em>, 109273. <a href="https://doi.org/10.1016/j.biopha.2019.109273" title="DOI URL">https://doi.org/10.1016/j.biopha.2019.109273</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2019.109273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2019.109273%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DCytotoxicity%252Bof%252Blanostane-type%252Btriterpenoids%252Band%252Bergosteroids%252Bisolated%252Bfrom%252BOmphalia%252Blapidescens%252Bon%252BMDA-MB-231%252Band%252BHGC-27%252Bcells%26aulast%3DLiu%26aufirst%3DFei%26date%3D2019%26volume%3D118%26spage%3D109273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yulong  Cai</span>, <span class="hlFld-ContribAuthor ">Lian  Wang</span>, <span class="hlFld-ContribAuthor ">Ivan  Nalvarte</span>, <span class="hlFld-ContribAuthor ">Rui  Xiao</span>, <span class="hlFld-ContribAuthor ">Xin  Li</span>, <span class="hlFld-ContribAuthor ">Xiaotang  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Citalopram attenuates social behavior deficits in the BTBR T+Itpr3tf/J mouse model of autism. </span><span class="cited-content_cbyCitation_journal-name">Brain Research Bulletin</span><span> <strong>2019,</strong> <em>150 </em>, 75-85. <a href="https://doi.org/10.1016/j.brainresbull.2019.04.026" title="DOI URL">https://doi.org/10.1016/j.brainresbull.2019.04.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainresbull.2019.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainresbull.2019.04.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%2520Bulletin%26atitle%3DCitalopram%252Battenuates%252Bsocial%252Bbehavior%252Bdeficits%252Bin%252Bthe%252BBTBR%252BT%25252BItpr3tf%25252FJ%252Bmouse%252Bmodel%252Bof%252Bautism%26aulast%3DCai%26aufirst%3DYulong%26date%3D2019%26volume%3D150%26spage%3D75%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Md Rafi  Haider</span>, <span class="hlFld-ContribAuthor ">Kamal  Ahmad</span>, <span class="hlFld-ContribAuthor ">Nadeem  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Zulphikar  Ali</span>, <span class="hlFld-ContribAuthor ">Md Jawaid  Akhtar</span>, <span class="hlFld-ContribAuthor ">Neeraj  Fuloria</span>, <span class="hlFld-ContribAuthor ">Shivkanya  Fuloria</span>, <span class="hlFld-ContribAuthor ">Manickam  Ravichandran</span>, <span class="hlFld-ContribAuthor ">M. Shahar  Yar</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 9-(2-(1-arylethylidene)hydrazinyl)acridine derivatives: Target Topoisomerase 1 and growth inhibition of HeLa cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>88 </em>, 102962. <a href="https://doi.org/10.1016/j.bioorg.2019.102962" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.102962</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.102962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.102962%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252B9-%2525282-%2525281-arylethylidene%252529hydrazinyl%252529acridine%252Bderivatives%25253A%252BTarget%252BTopoisomerase%252B1%252Band%252Bgrowth%252Binhibition%252Bof%252BHeLa%252Bcancer%252Bcells%26aulast%3DHaider%26aufirst%3DMd%2BRafi%26date%3D2019%26volume%3D88%26spage%3D102962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruu-Fen  Tzang</span>, <span class="hlFld-ContribAuthor ">Chuan-Hsin  Chang</span>, <span class="hlFld-ContribAuthor ">Yue-Cune  Chang</span>, <span class="hlFld-ContribAuthor ">Hsien-Yuan  Lane</span>. </span><span class="cited-content_cbyCitation_article-title">Autism Associated With Anti-NMDAR Encephalitis: Glutamate-Related Therapy. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Psychiatry</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fpsyt.2019.00440" title="DOI URL">https://doi.org/10.3389/fpsyt.2019.00440</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fpsyt.2019.00440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffpsyt.2019.00440%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Psychiatry%26atitle%3DAutism%252BAssociated%252BWith%252BAnti-NMDAR%252BEncephalitis%25253A%252BGlutamate-Related%252BTherapy%26aulast%3DTzang%26aufirst%3DRuu-Fen%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying  Chen</span>, <span class="hlFld-ContribAuthor ">Bolin  Wu</span>, <span class="hlFld-ContribAuthor ">Yameng  Hao</span>, <span class="hlFld-ContribAuthor ">Yunqi  Liu</span>, <span class="hlFld-ContribAuthor ">Zhili  Zhang</span>, <span class="hlFld-ContribAuthor ">Chao  Tian</span>, <span class="hlFld-ContribAuthor ">Xianling  Ning</span>, <span class="hlFld-ContribAuthor ">Ying  Guo</span>, <span class="hlFld-ContribAuthor ">Junyi  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationship studies of (E)-3,4-dihydroxystyryl alkyl sulfones as novel neuroprotective agents based on improved antioxidant, anti-inflammatory activities and BBB permeability. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>171 </em>, 420-433. <a href="https://doi.org/10.1016/j.ejmech.2019.03.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationship%252Bstudies%252Bof%252B%252528E%252529-3%25252C4-dihydroxystyryl%252Balkyl%252Bsulfones%252Bas%252Bnovel%252Bneuroprotective%252Bagents%252Bbased%252Bon%252Bimproved%252Bantioxidant%25252C%252Banti-inflammatory%252Bactivities%252Band%252BBBB%252Bpermeability%26aulast%3DChen%26aufirst%3DYing%26date%3D2019%26volume%3D171%26spage%3D420%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Huang</span>, <span class="hlFld-ContribAuthor ">Jingjing  Wu</span>, <span class="hlFld-ContribAuthor ">Dongjian  Chen</span>, <span class="hlFld-ContribAuthor ">Jie  Jin</span>, <span class="hlFld-ContribAuthor ">Yue  Wu</span>, <span class="hlFld-ContribAuthor ">Zhuo  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of sulforaphane in the central nervous system. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2019,</strong> <em>853 </em>, 153-168. <a href="https://doi.org/10.1016/j.ejphar.2019.03.010" title="DOI URL">https://doi.org/10.1016/j.ejphar.2019.03.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2019.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2019.03.010%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DEffects%252Bof%252Bsulforaphane%252Bin%252Bthe%252Bcentral%252Bnervous%252Bsystem%26aulast%3DHuang%26aufirst%3DChao%26date%3D2019%26volume%3D853%26spage%3D153%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark H.  Lewis</span>, <span class="hlFld-ContribAuthor ">Christopher T.  Primiani</span>, <span class="hlFld-ContribAuthor ">Amber M.  Muehlmann</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Dopamine D
              2
              , Adenosine A
              2A
              , and Glutamate mGlu
              5
              Receptors to Reduce Repetitive Behaviors in Deer Mice. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2019,</strong> <em>369 </em>
                                    (1)
                                     , 88-97. <a href="https://doi.org/10.1124/jpet.118.256081" title="DOI URL">https://doi.org/10.1124/jpet.118.256081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.118.256081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.118.256081%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DTargeting%252BDopamine%252BD%252B2%252B%25252C%252BAdenosine%252BA%252B2A%252B%25252C%252Band%252BGlutamate%252BmGlu%252B5%252BReceptors%252Bto%252BReduce%252BRepetitive%252BBehaviors%252Bin%252BDeer%252BMice%26aulast%3DLewis%26aufirst%3DMark%2BH.%26date%3D2019%26date%3D2019%26volume%3D369%26issue%3D1%26spage%3D88%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kendy Eduardo  Urdaneta</span>, <span class="hlFld-ContribAuthor ">María Andrea  Castillo</span>, <span class="hlFld-ContribAuthor ">Nola  Montiel</span>, <span class="hlFld-ContribAuthor ">Neomar  Semprún-Hernández</span>, <span class="hlFld-ContribAuthor ">Nicola  Antonucci</span>, <span class="hlFld-ContribAuthor ">Dario  Siniscalco</span>. </span><span class="cited-content_cbyCitation_article-title">Autism Spectrum Disorders: Potential Neuro-Psychopharmacotherapeutic Plant-Based Drugs. </span><span class="cited-content_cbyCitation_journal-name">ASSAY and Drug Development Technologies</span><span> <strong>2018,</strong> <em>16 </em>
                                    (8)
                                     , 433-444. <a href="https://doi.org/10.1089/adt.2018.848" title="DOI URL">https://doi.org/10.1089/adt.2018.848</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/adt.2018.848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fadt.2018.848%26sid%3Dliteratum%253Aachs%26jtitle%3DASSAY%2520and%2520Drug%2520Development%2520Technologies%26atitle%3DAutism%252BSpectrum%252BDisorders%25253A%252BPotential%252BNeuro-Psychopharmacotherapeutic%252BPlant-Based%252BDrugs%26aulast%3DUrdaneta%26aufirst%3DKendy%2BEduardo%26date%3D2018%26volume%3D16%26issue%3D8%26spage%3D433%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lian  Wang</span>, <span class="hlFld-ContribAuthor ">Yulong  Cai</span>, <span class="hlFld-ContribAuthor ">Xiaotang  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Metformin Administration During Early Postnatal Life Rescues Autistic-Like Behaviors in the BTBR T+ Itpr3tf/J Mouse Model of Autism. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Behavioral Neuroscience</span><span> <strong>2018,</strong> <em>12 </em><a href="https://doi.org/10.3389/fnbeh.2018.00290" title="DOI URL">https://doi.org/10.3389/fnbeh.2018.00290</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnbeh.2018.00290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnbeh.2018.00290%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Behavioral%2520Neuroscience%26atitle%3DMetformin%252BAdministration%252BDuring%252BEarly%252BPostnatal%252BLife%252BRescues%252BAutistic-Like%252BBehaviors%252Bin%252Bthe%252BBTBR%252BT%25252B%252BItpr3tf%25252FJ%252BMouse%252BModel%252Bof%252BAutism%26aulast%3DWang%26aufirst%3DLian%26date%3D2018%26date%3D2018%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara M.  Freeman</span>, <span class="hlFld-ContribAuthor ">Julie  Ngo</span>, <span class="hlFld-ContribAuthor ">Bhavdeep  Singh</span>, <span class="hlFld-ContribAuthor ">Megan  Masnaghetti</span>, <span class="hlFld-ContribAuthor ">Karen L.  Bales</span>, <span class="hlFld-ContribAuthor ">James E.  Blevins</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of Chronic Oxytocin Administration and Diet Composition on Oxytocin and Vasopressin 1a Receptor Binding in the Rat Brain. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience</span><span> <strong>2018,</strong> <em>392 </em>, 241-251. <a href="https://doi.org/10.1016/j.neuroscience.2018.07.037" title="DOI URL">https://doi.org/10.1016/j.neuroscience.2018.07.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuroscience.2018.07.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuroscience.2018.07.037%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%26atitle%3DEffects%252Bof%252BChronic%252BOxytocin%252BAdministration%252Band%252BDiet%252BComposition%252Bon%252BOxytocin%252Band%252BVasopressin%252B1a%252BReceptor%252BBinding%252Bin%252Bthe%252BRat%252BBrain%26aulast%3DFreeman%26aufirst%3DSara%2BM.%26date%3D2018%26volume%3D392%26spage%3D241%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kamal  Ahmad</span>, <span class="hlFld-ContribAuthor ">Zubair Bin  Hafeez</span>, <span class="hlFld-ContribAuthor ">Abdul Roof  Bhat</span>, <span class="hlFld-ContribAuthor ">Moshahid Alam  Rizvi</span>, <span class="hlFld-ContribAuthor ">Sonu C.  Thakur</span>, <span class="hlFld-ContribAuthor ">Amir  Azam</span>, <span class="hlFld-ContribAuthor ">Fareeda  Athar</span>. </span><span class="cited-content_cbyCitation_article-title">Antioxidant and apoptotic effects of Callistemon lanceolatus leaves and their compounds against human cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2018,</strong> <em>106 </em>, 1195-1209. <a href="https://doi.org/10.1016/j.biopha.2018.07.016" title="DOI URL">https://doi.org/10.1016/j.biopha.2018.07.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2018.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2018.07.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DAntioxidant%252Band%252Bapoptotic%252Beffects%252Bof%252BCallistemon%252Blanceolatus%252Bleaves%252Band%252Btheir%252Bcompounds%252Bagainst%252Bhuman%252Bcancer%252Bcells%26aulast%3DAhmad%26aufirst%3DKamal%26date%3D2018%26volume%3D106%26spage%3D1195%26epage%3D1209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samata R.  Sharma</span>, <span class="hlFld-ContribAuthor ">Xenia  Gonda</span>, <span class="hlFld-ContribAuthor ">Frank I.  Tarazi</span>. </span><span class="cited-content_cbyCitation_article-title">Autism Spectrum Disorder: Classification, diagnosis and therapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2018,</strong> <em>190 </em>, 91-104. <a href="https://doi.org/10.1016/j.pharmthera.2018.05.007" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2018.05.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2018.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2018.05.007%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DAutism%252BSpectrum%252BDisorder%25253A%252BClassification%25252C%252Bdiagnosis%252Band%252Btherapy%26aulast%3DSharma%26aufirst%3DSamata%2BR.%26date%3D2018%26volume%3D190%26spage%3D91%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Antipsychotis and antidepressant drugs that are currently used in pharmacological treatment of ASD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Psychotropic drugs that have been studied for ASD treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Structure of mGlu<sub>5</sub> NAMs that have been studied in ASD models. (B) Structure of mGlu<sub>5</sub> PAMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of orthosteric agonists and antagonists of mGlu<sub>2/3</sub> receptors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of mGlu<sub>2/3</sub> PAMs and NAMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) NMDA antagonists that have studied in ASD animal models. (B) New NMDA antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Drugs modulating GABA transmission that have been subjected to clinical trials for ASD treatment. (B) Structure of a GABA<sub>B</sub> PAM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of GSK-3β inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structures of mTOR inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of compounds <b>65</b> and <b>66</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structure of the ROCK inhibitors that can modulate dendritic spines morphology.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Serotonergic drugs and ligands that have been studied in ASD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. (A) Structures of α7 nACh agonists. (B) Structures of α7 nACh PAMs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Peptidic and nonpeptidic oxytonergic ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. (A) Modulators of oxytonergic transmission. (B) Structure of the brain penetrant V1a antagonist <b>86</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. (A) Structures of TLR4 agonists. (B) Tricyclic antidepressants that can inhibit TLR4 activation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Structures of sortilin inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/medium/jm-2017-00965h_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structure of compound <b>96</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-22/acs.jmedchem.7b00965/20171117/images/large/jm-2017-00965h_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00965&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22254" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22254" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 262 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span> <span class="citation_source-book">Diagnostic and Statistical Manual of Mental Disorders</span>, <span class="NLM_edition">5th</span> ed.; <span class="NLM_publisher-name">American Psychiatric Association</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Diagnostic+and+Statistical+Manual+of+Mental+Disorders%2C+5th+ed.%3B+American+Psychiatric+Association%3A+Washington%2C+DC%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DDiagnostic%2520and%2520Statistical%2520Manual%2520of%2520Mental%2520Disorders%26pub%3DAmerican%2520Psychiatric%2520Association%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Gotham, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickles, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C.</span><span> </span><span class="NLM_article-title">The autism diagnostic observation schedule: revised algorithms for improved diagnostic validity</span> <span class="citation_source-journal">J. Autism Dev. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">627</span><span class="refDoi"> DOI: 10.1007/s10803-006-0280-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs10803-006-0280-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=17180459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD2s3ns1Clug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=613-627&author=K.+Gothamauthor=S.+Risiauthor=A.+Picklesauthor=C.+Lord&title=The+autism+diagnostic+observation+schedule%3A+revised+algorithms+for+improved+diagnostic+validity&doi=10.1007%2Fs10803-006-0280-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The Autism Diagnostic Observation Schedule: revised algorithms for improved diagnostic validity</span></div><div class="casAuthors">Gotham Katherine; Risi Susan; Pickles Andrew; Lord Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autism and developmental disorders</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">613-27</span>
        ISSN:<span class="NLM_cas:issn">0162-3257</span>.
    </div><div class="casAbstract">Autism Diagnostic Observation Schedule (ADOS) Modules 1-3 item and domain total distributions were reviewed for 1,630 assessments of children aged 14 months to 16 years with an autism spectrum disorder (ASD) or with heterogeneous non-spectrum disorders.  Children were divided by language level and age to yield more homogeneous cells.  Items were chosen that best differentiated between diagnoses and were arranged into domains on the basis of multi-factor item-response analysis.  Reflecting recent research, the revised algorithm now consists of two new domains, Social Affect and Restricted, Repetitive Behaviors (RRB), combined to one score to which thresholds are applied, resulting in generally improved predictive value.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSA4BbJKIYMTxdUSIfHIn4FfW6udTcc2eZ12pmxo9VsBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3ns1Clug%253D%253D&md5=97db507b15d46bd380221cd1a855a87e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs10803-006-0280-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10803-006-0280-1%26sid%3Dliteratum%253Aachs%26aulast%3DGotham%26aufirst%3DK.%26aulast%3DRisi%26aufirst%3DS.%26aulast%3DPickles%26aufirst%3DA.%26aulast%3DLord%26aufirst%3DC.%26atitle%3DThe%2520autism%2520diagnostic%2520observation%2520schedule%253A%2520revised%2520algorithms%2520for%2520improved%2520diagnostic%2520validity%26jtitle%3DJ.%2520Autism%2520Dev.%2520Disord.%26date%3D2007%26volume%3D37%26spage%3D613%26epage%3D627%26doi%3D10.1007%2Fs10803-006-0280-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Rutter, M.; Le Couter, A.; Lord, C.</span> <span class="citation_source-book">ADI-R, Autism Diagnostic Interview: Revised</span>. <span class="NLM_publisher-name">Western Psychological Services</span>, <span class="NLM_publisher-loc">Los Angeles, CA</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=M.+Rutter&author=A.+Le+Couter&author=C.+Lord&title=ADI-R%2C+Autism+Diagnostic+Interview%3A+Revised"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRutter%26aufirst%3DM.%26btitle%3DADI-R%252C%2520Autism%2520Diagnostic%2520Interview%253A%2520Revised%26pub%3DWestern%2520Psychological%2520Services%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Maski, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeste, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, S. J.</span><span> </span><span class="NLM_article-title">Common neurological co-morbidities in autism spectrum disorders</span> <span class="citation_source-journal">Curr. Opin. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span><span class="refDoi"> DOI: 10.1097/MOP.0b013e32834c9282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1097%2FMOP.0b013e32834c9282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21970828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlGqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2011&pages=609-615&author=K.+P.+Maskiauthor=S.+S.+Jesteauthor=S.+J.+Spence&title=Common+neurological+co-morbidities+in+autism+spectrum+disorders&doi=10.1097%2FMOP.0b013e32834c9282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Common neurological co-morbidities in autism spectrum disorders</span></div><div class="casAuthors">Maski, Kiran P.; Jeste, Shafali S.; Spence, Sarah J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pediatrics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">609-615</span>CODEN:
                <span class="NLM_cas:coden">COPEE9</span>;
        ISSN:<span class="NLM_cas:issn">1040-8703</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose of review Autism spectrum disorders (ASDs) are heterogeneous neurodevelopmental disorders assocd. with various co-morbidities.  Neurol. co-morbidities include motor impairments, epilepsy, and sleep dysfunction.  These impairments have been receiving more attention recently, perhaps because of their significant impact on the behavior and cognitive function of children with ASDs.  Here, we review the epidemiol., etiol., and clin. approach to these neurol. co-morbidities and highlight future research directions.  Recent findings Motor impairments include stereotypies, motor delays, and deficits, such as dyspraxia, incoordination, and gait problems.  Sleep dysfunction typically presents as difficulty with sleep onset and prolonged awakenings during the night.  Recent data suggest that abnormalities in melatonin may affect sleep and may be a potential treatment target.  There is no classic epilepsy syndrome assocd. with ASDs.  Intellectual disability, syndromic autism, and female sex are specific risk factors.  Recent research has focused on identifying the overlapping pathways between these neurol. co-morbidities and the core deficits in ASDs, which may have direct and powerful implications for treatment and prognosis.  Summary Motor impairment, epilepsy, and sleep dysfunction are common neurol. co-morbidities in ASDs.  Clinicians should be aware that recognition and treatment of these issues may improve the function and outcome of children with ASDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpShlkIg__v17Vg90H21EOLACvtfcHk0ljz4B7eU1ohKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlGqtrk%253D&md5=462fa6735c100bc77861eaa42b784880</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1097%2FMOP.0b013e32834c9282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMOP.0b013e32834c9282%26sid%3Dliteratum%253Aachs%26aulast%3DMaski%26aufirst%3DK.%2BP.%26aulast%3DJeste%26aufirst%3DS.%2BS.%26aulast%3DSpence%26aufirst%3DS.%2BJ.%26atitle%3DCommon%2520neurological%2520co-morbidities%2520in%2520autism%2520spectrum%2520disorders%26jtitle%3DCurr.%2520Opin.%2520Pediatr.%26date%3D2011%26volume%3D23%26spage%3D609%26epage%3D615%26doi%3D10.1097%2FMOP.0b013e32834c9282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Leyfer, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folstein, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacalman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tager-Flusberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lainhart, J. E.</span><span> </span><span class="NLM_article-title">Comorbid psychiatric disorders in children with autism: interview development and rates of disorders</span> <span class="citation_source-journal">J. Autism Dev. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">849</span><span class="NLM_x">–</span> <span class="NLM_lpage">861</span><span class="refDoi"> DOI: 10.1007/s10803-006-0123-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs10803-006-0123-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=16845581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD28rmsVOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=849-861&author=O.+T.+Leyferauthor=S.+E.+Folsteinauthor=S.+Bacalmanauthor=N.+O.+Davisauthor=E.+Dinhauthor=J.+Morganauthor=H.+Tager-Flusbergauthor=J.+E.+Lainhart&title=Comorbid+psychiatric+disorders+in+children+with+autism%3A+interview+development+and+rates+of+disorders&doi=10.1007%2Fs10803-006-0123-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Comorbid psychiatric disorders in children with autism: interview development and rates of disorders</span></div><div class="casAuthors">Leyfer Ovsanna T; Folstein Susan E; Bacalman Susan; Davis Naomi O; Dinh Elena; Morgan Jubel; Tager-Flusberg Helen; Lainhart Janet E</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autism and developmental disorders</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">849-61</span>
        ISSN:<span class="NLM_cas:issn">0162-3257</span>.
    </div><div class="casAbstract">The Kiddie Schedule for Affective Disorders and Schizophrenia was modified for use in children and adolescents with autism by developing additional screening questions and coding options that reflect the presentation of psychiatric disorders in autism spectrum disorders.  The modified instrument, the Autism Comorbidity Interview-Present and Lifetime Version (ACI-PL), was piloted and frequently diagnosed disorders, depression, ADHD, and OCD, were tested for reliability and validity.  The ACI-PL provides reliable DSM diagnoses that are valid based on clinical psychiatric diagnosis and treatment history.  The sample demonstrated a high prevalence of specific phobia, obsessive compulsive disorder, and ADHD.  The rates of psychiatric disorder in autism are high and are associated with functional impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSpMuQiMCKOH8KL0FlyGHDofW6udTcc2eYxyf-0PzW0Brntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rmsVOruw%253D%253D&md5=c702c2edbf7fd36d9fef757a97e25872</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs10803-006-0123-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10803-006-0123-0%26sid%3Dliteratum%253Aachs%26aulast%3DLeyfer%26aufirst%3DO.%2BT.%26aulast%3DFolstein%26aufirst%3DS.%2BE.%26aulast%3DBacalman%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DN.%2BO.%26aulast%3DDinh%26aufirst%3DE.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DTager-Flusberg%26aufirst%3DH.%26aulast%3DLainhart%26aufirst%3DJ.%2BE.%26atitle%3DComorbid%2520psychiatric%2520disorders%2520in%2520children%2520with%2520autism%253A%2520interview%2520development%2520and%2520rates%2520of%2520disorders%26jtitle%3DJ.%2520Autism%2520Dev.%2520Disord.%26date%3D2006%26volume%3D36%26spage%3D849%26epage%3D861%26doi%3D10.1007%2Fs10803-006-0123-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Persico, A. M.</span><span> </span><span class="NLM_article-title">Autisms</span>. In  <span class="citation_source-book">Neural Circuit Development and Function in the Healthy and Diseased Brain: Comprehensive Developmental Neuroscience</span>; Vol.  <span class="NLM_volume">3</span>; <span class="NLM_contrib-group">Rakic, P.; Rubenstein, J.</span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">694</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FB978-0-12-397267-5.00045-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=651-694&author=A.+M.+Persicoauthor=P.+Rakic&author=J.+Rubenstein&title=Neural+Circuit+Development+and+Function+in+the+Healthy+and+Diseased+Brain%3A+Comprehensive+Developmental+Neuroscience"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-397267-5.00045-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-397267-5.00045-5%26sid%3Dliteratum%253Aachs%26aulast%3DPersico%26aufirst%3DA.%2BM.%26atitle%3DAutisms%26btitle%3DNeural%2520Circuit%2520Development%2520and%2520Function%2520in%2520the%2520Healthy%2520and%2520Diseased%2520Brain%253A%2520Comprehensive%2520Developmental%2520Neuroscience%26volume%3D3%26aulast%3DRakic%26aufirst%3DP.%26pub%3DElsevier%26date%3D2013%26spage%3D651%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Baio, J.</span><span> </span><span class="NLM_article-title">Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2010</span> <span class="citation_source-journal">MMWR Surveill. Summ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">21</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=1-21&author=J.+Baio&title=Prevalence+of+autism+spectrum+disorder+among+children+aged+8+years%E2%80%94autism+and+developmental+disabilities+monitoring+network%2C+11+sites%2C+United+States%2C+2010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaio%26aufirst%3DJ.%26atitle%3DPrevalence%2520of%2520autism%2520spectrum%2520disorder%2520among%2520children%2520aged%25208%2520years%25E2%2580%2594autism%2520and%2520developmental%2520disabilities%2520monitoring%2520network%252C%252011%2520sites%252C%2520United%2520States%252C%25202010%26jtitle%3DMMWR%2520Surveill.%2520Summ.%26date%3D2014%26volume%3D63%26spage%3D1%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Levy, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandell, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, R. T.</span><span> </span><span class="NLM_article-title">Autism</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">374</span><span class="NLM_x">, </span> <span class="NLM_fpage">1627</span><span class="NLM_x">–</span> <span class="NLM_lpage">1638</span><span class="refDoi"> DOI: 10.1016/S0140-6736(09)61376-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0140-6736%2809%2961376-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2009&pages=1627-1638&author=S.+E.+Levyauthor=D.+S.+Mandellauthor=R.+T.+Schultz&title=Autism&doi=10.1016%2FS0140-6736%2809%2961376-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2809%2961376-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252809%252961376-3%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DS.%2BE.%26aulast%3DMandell%26aufirst%3DD.%2BS.%26aulast%3DSchultz%26aufirst%3DR.%2BT.%26atitle%3DAutism%26jtitle%3DLancet%26date%3D2009%26volume%3D374%26spage%3D1627%26epage%3D1638%26doi%3D10.1016%2FS0140-6736%2809%2961376-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">DiCicco-Bloom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwaigenbaum, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courchesne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dager, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. J.</span><span> </span><span class="NLM_article-title">The developmental neurobiology of autism spectrum disorder</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">6897</span><span class="NLM_x">–</span> <span class="NLM_lpage">6906</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1712-06.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1523%2FJNEUROSCI.1712-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=16807320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVGqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=6897-6906&author=E.+DiCicco-Bloomauthor=C.+Lordauthor=L.+Zwaigenbaumauthor=E.+Courchesneauthor=S.+R.+Dagerauthor=C.+Schmitzauthor=R.+T.+Schultzauthor=J.+Crawleyauthor=L.+J.+Young&title=The+developmental+neurobiology+of+autism+spectrum+disorder&doi=10.1523%2FJNEUROSCI.1712-06.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The developmental neurobiology of autism spectrum disorder</span></div><div class="casAuthors">DiCicco-Bloom, Emanuel; Lord, Catherine; Zwaigenbaum, Lonnie; Courchesne, Eric; Dager, Stephen R.; Schmitz, Christoph; Schultz, Robert T.; Crawley, Jacqueline; Young, Larry J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">6897-6906</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  Autism spectrum disorder (ASD) is a devastating childhood disorder that affects about 1 in 166 children.  ASD comprises several different disorders as defined by deficits in social behaviors and interactions that prevent the development of normal interpersonal relationships of affected patients with their parents, siblings, and other children.  Studies of the ASD brain using structural and functional imaging and neuropathol. techniques have revealed macroscopic and microscopic abnormalities of development.  Children with ASD show an increased postnatal brain growth trajectory, with the greatest differences occurring in rostral cerebral cortex, amygdala, and cerebellar hemispheres and reflecting greater changes in white than gray matter.  However, the underlying etiol. of ASD remains unclear.  Given the developmental origins of ASD and the identification of early behavioral and brain growth abnormalities, sensitive tools may soon become available to diagnose the disease during the first year of life.  Furthermore, genetic discoveries might also focus attention on a no. of developmental regulators and processes, neurotransmitter and synaptic components and possibly novel genetic mechanisms that contribute to ASD susceptibility in the context of specific environmental factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMUMN4iHT1IbVg90H21EOLACvtfcHk0ljz4B7eU1ohKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVGqtr0%253D&md5=9c0870580b94dc56518a676323e6d8da</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1712-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1712-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DDiCicco-Bloom%26aufirst%3DE.%26aulast%3DLord%26aufirst%3DC.%26aulast%3DZwaigenbaum%26aufirst%3DL.%26aulast%3DCourchesne%26aufirst%3DE.%26aulast%3DDager%26aufirst%3DS.%2BR.%26aulast%3DSchmitz%26aufirst%3DC.%26aulast%3DSchultz%26aufirst%3DR.%2BT.%26aulast%3DCrawley%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DL.%2BJ.%26atitle%3DThe%2520developmental%2520neurobiology%2520of%2520autism%2520spectrum%2520disorder%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D6897%26epage%3D6906%26doi%3D10.1523%2FJNEUROSCI.1712-06.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Bauman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemper, T. L.</span><span> </span><span class="NLM_article-title">Neuroanatomic observations of the brain in autism: a review and future directions</span> <span class="citation_source-journal">Int. J. Dev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">183</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span><span class="refDoi"> DOI: 10.1016/j.ijdevneu.2004.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.ijdevneu.2004.09.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=183-187&author=M.+L.+Baumanauthor=T.+L.+Kemper&title=Neuroanatomic+observations+of+the+brain+in+autism%3A+a+review+and+future+directions&doi=10.1016%2Fj.ijdevneu.2004.09.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ijdevneu.2004.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijdevneu.2004.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DBauman%26aufirst%3DM.%2BL.%26aulast%3DKemper%26aufirst%3DT.%2BL.%26atitle%3DNeuroanatomic%2520observations%2520of%2520the%2520brain%2520in%2520autism%253A%2520a%2520review%2520and%2520future%2520directions%26jtitle%3DInt.%2520J.%2520Dev.%2520Neurosci.%26date%3D2005%26volume%3D23%26spage%3D183%26epage%3D187%26doi%3D10.1016%2Fj.ijdevneu.2004.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Rice, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barone, S.,  Jr.</span><span> </span><span class="NLM_article-title">Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models</span> <span class="citation_source-journal">Environ. Health Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span><span class="refDoi"> DOI: 10.2307/3454543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.2307%2F3454543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10852851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252FhtVKktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2000&pages=511-533&author=D.+Riceauthor=S.+Barone&title=Critical+periods+of+vulnerability+for+the+developing+nervous+system%3A+evidence+from+humans+and+animal+models&doi=10.2307%2F3454543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models</span></div><div class="casAuthors">Rice D; Barone S Jr</div><div class="citationInfo"><span class="NLM_cas:title">Environmental health perspectives</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">108 Suppl 3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">511-33</span>
        ISSN:<span class="NLM_cas:issn">0091-6765</span>.
    </div><div class="casAbstract">Vulnerable periods during the development of the nervous system are sensitive to environmental insults because they are dependent on the temporal and regional emergence of critical developmental processes (i.e., proliferation, migration, differentiation, synaptogenesis, myelination, and apoptosis).  Evidence from numerous sources demonstrates that neural development extends from the embryonic period through adolescence.  In general, the sequence of events is comparable among species, although the time scales are considerably different.  Developmental exposure of animals or humans to numerous agents (e.g., X-ray irradiation, methylazoxymethanol, ethanol, lead, methyl mercury, or chlorpyrifos) demonstrates that interference with one or more of these developmental processes can lead to developmental neurotoxicity.  Different behavioral domains (e.g., sensory, motor, and various cognitive functions) are subserved by different brain areas.  Although there are important differences between the rodent and human brain, analogous structures can be identified.  Moreover, the ontogeny of specific behaviors can be used to draw inferences regarding the maturation of specific brain structures or neural circuits in rodents and primates, including humans.  Furthermore, various clinical disorders in humans (e.g., schizophrenia, dyslexia, epilepsy, and autism) may also be the result of interference with normal ontogeny of developmental processes in the nervous system.  Of critical concern is the possibility that developmental exposure to neurotoxicants may result in an acceleration of age-related decline in function.  This concern is compounded by the fact that developmental neurotoxicity that results in small effects can have a profound societal impact when amortized across the entire population and across the life span of humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7SmmI3YHPTx0LsK7uFuY7fW6udTcc2eab86LUq2Pny7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252FhtVKktQ%253D%253D&md5=88c1a16d6a945fbd0cc9485e49210bc9</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2307%2F3454543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2307%252F3454543%26sid%3Dliteratum%253Aachs%26aulast%3DRice%26aufirst%3DD.%26aulast%3DBarone%26aufirst%3DS.%26atitle%3DCritical%2520periods%2520of%2520vulnerability%2520for%2520the%2520developing%2520nervous%2520system%253A%2520evidence%2520from%2520humans%2520and%2520animal%2520models%26jtitle%3DEnviron.%2520Health%2520Perspect.%26date%3D2000%26volume%3D108%26spage%3D511%26epage%3D533%26doi%3D10.2307%2F3454543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Geschwind, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levitt, P.</span><span> </span><span class="NLM_article-title">Autism spectrum disorders: developmental disconnection syndromes</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span><span class="refDoi"> DOI: 10.1016/j.conb.2007.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.conb.2007.01.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=103-111&author=D.+H.+Geschwindauthor=P.+Levitt&title=Autism+spectrum+disorders%3A+developmental+disconnection+syndromes&doi=10.1016%2Fj.conb.2007.01.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.conb.2007.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.conb.2007.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26aulast%3DLevitt%26aufirst%3DP.%26atitle%3DAutism%2520spectrum%2520disorders%253A%2520developmental%2520disconnection%2520syndromes%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D2007%26volume%3D17%26spage%3D103%26epage%3D111%26doi%3D10.1016%2Fj.conb.2007.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Hahamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malach, R.</span><span> </span><span class="NLM_article-title">The idiosyncratic brain: distortion of spontaneous connectivity patterns in autism spectrum disorder</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span><span class="refDoi"> DOI: 10.1038/nn.3919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnn.3919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25599222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=302-309&author=A.+Hahamyauthor=M.+Behrmannauthor=R.+Malach&title=The+idiosyncratic+brain%3A+distortion+of+spontaneous+connectivity+patterns+in+autism+spectrum+disorder&doi=10.1038%2Fnn.3919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The idiosyncratic brain: distortion of spontaneous connectivity patterns in autism spectrum disorder</span></div><div class="casAuthors">Hahamy, Avital; Behrmann, Marlene; Malach, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">302-309</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autism spectrum disorder (ASD) has been assocd. with a redn. in resting state functional connectivity, though this assertion has recently been challenged by reports of increased connectivity in ASD.  To address these contradictory findings, we examd. both inter- and intrahemispheric functional connectivity in several resting state data sets acquired from adults with high-functioning ASD and matched control participants.  Our results reveal areas of both increased and decreased connectivity in multiple ASD groups as compared to control groups.  We propose that this heterogeneity stems from a previously unrecognized ASD characteristic: idiosyncratic distortions of the functional connectivity pattern relative to the typical, canonical template.  The magnitude of an individual's pattern distortion in homotopic interhemispheric connectivity correlated significantly with behavioral symptoms of ASD.  We propose that individualized alterations in functional connectivity organization are a core characteristic of high-functioning ASD, and that this may account for previous discrepant findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtc-acXprjL7Vg90H21EOLACvtfcHk0lhMa2QcC2xkKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKjsL8%253D&md5=bfbcd937350f17a93291e509125326eb</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnn.3919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3919%26sid%3Dliteratum%253Aachs%26aulast%3DHahamy%26aufirst%3DA.%26aulast%3DBehrmann%26aufirst%3DM.%26aulast%3DMalach%26aufirst%3DR.%26atitle%3DThe%2520idiosyncratic%2520brain%253A%2520distortion%2520of%2520spontaneous%2520connectivity%2520patterns%2520in%2520autism%2520spectrum%2520disorder%26jtitle%3DNat.%2520Neurosci.%26date%3D2015%26volume%3D18%26spage%3D302%26epage%3D309%26doi%3D10.1038%2Fnn.3919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Geschwind, D. H.</span><span> </span><span class="NLM_article-title">Genetics of autism spectrum disorders</span> <span class="citation_source-journal">Trends Cognit. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span><span class="refDoi"> DOI: 10.1016/j.tics.2011.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.tics.2011.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21855394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC3MjptlOhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=409-416&author=D.+H.+Geschwind&title=Genetics+of+autism+spectrum+disorders&doi=10.1016%2Fj.tics.2011.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Genetics of autism spectrum disorders</span></div><div class="casAuthors">Geschwind Daniel H</div><div class="citationInfo"><span class="NLM_cas:title">Trends in cognitive sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">409-16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Characterized by a combination of abnormalities in language, social cognition and mental flexibility, autism is not a single disorder but a neurodevelopmental syndrome commonly referred to as autism spectrum disorder (ASD).  Several dozen ASD susceptibility genes have been identified in the past decade, collectively accounting for 10-20% of ASD cases.  These findings, although demonstrating that ASD is etiologically heterogeneous, provide important clues about its pathophysiology.  Diverse genetic and genomic approaches provide evidence converging on disruption of key biological pathways, many of which are also implicated in other allied neurodevelopmental disorders.  Knowing the genes involved in ASD provides us with a crucial tool to probe both the specificity of ASD and the shared neurobiological and cognitive features across what are considered clinically distinct disorders, with the goal of linking gene to brain circuits to cognitive function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8jry8eEXXtTjk2McQZ6XmfW6udTcc2ebJiKTXYuopl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjptlOhtA%253D%253D&md5=8eebec6732562f1379bcdbdce8c22415</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tics.2011.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tics.2011.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26atitle%3DGenetics%2520of%2520autism%2520spectrum%2520disorders%26jtitle%3DTrends%2520Cognit.%2520Sci.%26date%3D2011%26volume%3D15%26spage%3D409%26epage%3D416%26doi%3D10.1016%2Fj.tics.2011.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Persico, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merelli, S.</span><span> </span><span class="NLM_article-title">Environmental factors and autism spectrum disorder</span> <span class="citation_source-journal">Curr. Dev. Disord. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span><span class="refDoi"> DOI: 10.1007/s40474-013-0002-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs40474-013-0002-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=8-19&author=A.+M.+Persicoauthor=S.+Merelli&title=Environmental+factors+and+autism+spectrum+disorder&doi=10.1007%2Fs40474-013-0002-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs40474-013-0002-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40474-013-0002-2%26sid%3Dliteratum%253Aachs%26aulast%3DPersico%26aufirst%3DA.%2BM.%26aulast%3DMerelli%26aufirst%3DS.%26atitle%3DEnvironmental%2520factors%2520and%2520autism%2520spectrum%2520disorder%26jtitle%3DCurr.%2520Dev.%2520Disord.%2520Rep.%26date%3D2014%26volume%3D1%26spage%3D8%26epage%3D19%26doi%3D10.1007%2Fs40474-013-0002-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Young, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabarti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suckling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron-Cohen, S.</span><span> </span><span class="NLM_article-title">From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition</span> <span class="citation_source-journal">Mol. Autism</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="refDoi"> DOI: 10.1186/s13229-016-0068-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2Fs13229-016-0068-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26793298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslKgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=9&author=A.+M.+Youngauthor=B.+Chakrabartiauthor=D.+Robertsauthor=M.+C.+Laiauthor=J.+Sucklingauthor=S.+Baron-Cohen&title=From+molecules+to+neural+morphology%3A+understanding+neuroinflammation+in+autism+spectrum+condition&doi=10.1186%2Fs13229-016-0068-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition</span></div><div class="casAuthors">Young, Adam M. H.; Chakrabarti, Bhismadev; Roberts, David; Lai, Meng-Chuan; Suckling, John; Baron-Cohen, Simon</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Autism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9/1-9/8</span>CODEN:
                <span class="NLM_cas:coden">MAOUBR</span>;
        ISSN:<span class="NLM_cas:issn">2040-2392</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Growing evidence points toward a crit. role for early (prenatal) atypical neurodevelopmental processes in the etiol. of autism spectrum condition (ASC).  One such process that could impact early neural development is inflammation.  We review the evidence for atypical expression of mol. markers in the amniotic fluid, serum, cerebrospinal fluid (CSF), and the brain parenchyma that suggest a role for inflammation in the emergence of ASC.  This is complemented with a no. of neuroimaging and neuropathol. studies describing microglial activation.  Implications for treatment are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojpUDM7nzEJrVg90H21EOLACvtfcHk0lh1NTAOkgoijA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslKgsLY%253D&md5=19d6c2f2a023cdf8d40f6edbe5434a60</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1186%2Fs13229-016-0068-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13229-016-0068-x%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DA.%2BM.%26aulast%3DChakrabarti%26aufirst%3DB.%26aulast%3DRoberts%26aufirst%3DD.%26aulast%3DLai%26aufirst%3DM.%2BC.%26aulast%3DSuckling%26aufirst%3DJ.%26aulast%3DBaron-Cohen%26aufirst%3DS.%26atitle%3DFrom%2520molecules%2520to%2520neural%2520morphology%253A%2520understanding%2520neuroinflammation%2520in%2520autism%2520spectrum%2520condition%26jtitle%3DMol.%2520Autism%26date%3D2016%26volume%3D7%26spage%3D9%26doi%3D10.1186%2Fs13229-016-0068-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ji, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findling, R. L.</span><span> </span><span class="NLM_article-title">An update on pharmacotherapy for autism spectrum disorder in children and adolescents</span> <span class="citation_source-journal">Curr. Opin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">101</span><span class="refDoi"> DOI: 10.1097/YCO.0000000000000132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1097%2FYCO.0000000000000132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25602248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2Mvns1yiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2015&pages=91-101&author=N.+Jiauthor=R.+L.+Findling&title=An+update+on+pharmacotherapy+for+autism+spectrum+disorder+in+children+and+adolescents&doi=10.1097%2FYCO.0000000000000132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">An update on pharmacotherapy for autism spectrum disorder in children and adolescents</span></div><div class="casAuthors">Ji Na  Young; Findling Robert L</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in psychiatry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-101</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  Although there is no known efficacious pharmacotherapy for core symptoms of autism spectrum disorder (ASD), psychotropic medications are commonly prescribed for behavioral/emotional symptoms associated with ASD.  We reviewed current evidence-based pharmacotherapy options and updates from recent noteworthy studies.  RECENT FINDINGS:  Atypical antipsychotics, particularly risperidone and aripiprazole, are effective in reducing irritability, stereotypy and hyperactivity.  Metabolic adverse events, including weight gain and dyslipidemia, are common.  Methylphenidate is effective in reducing attention-deficit hyperactivity disorder (ADHD) symptoms.  Atomoxetine and alpha-2 agonists appear effective in reducing ADHD symptoms.  Selective serotonin reuptake inhibitors are not effective in improving repetitive behaviors in children with ASD, and frequently cause activating adverse events.  Efficacy of antiepileptic drugs is inconclusive.  Overall, efficacy and tolerability of pharmacotherapy in children with ASD are less favorable than data seen in typically developing children with similar symptoms.  Newer agents, including glutamatergic agents and oxytocin, appear promising albeit with mixed results.  SUMMARY:  Current evidence-based pharmacotherapy options in children with ASD are very limited, and many have substantial adverse events.  Clinicians should use pharmacotherapy as a part of comprehensive treatment, and judiciously weigh risks and benefits.  New pharmacotherapy options for core symptoms as well as co-occurring symptoms of ASD are in urgent need.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7z98uqLHqqtXdcedVHT5tfW6udTcc2ebJiKTXYuopl7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mvns1yiug%253D%253D&md5=84b1b3c456e743b6f7ac916a87189fab</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1097%2FYCO.0000000000000132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FYCO.0000000000000132%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DN.%26aulast%3DFindling%26aufirst%3DR.%2BL.%26atitle%3DAn%2520update%2520on%2520pharmacotherapy%2520for%2520autism%2520spectrum%2520disorder%2520in%2520children%2520and%2520adolescents%26jtitle%3DCurr.%2520Opin.%2520Psychiatry%26date%3D2015%26volume%3D28%26spage%3D91%26epage%3D101%26doi%3D10.1097%2FYCO.0000000000000132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Matera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmieri, V. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagaria, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margari, F.</span><span> </span><span class="NLM_article-title">Risperidone and cardiometabolic risk in children and adolescents: clinical and instrumental issues</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span><span class="refDoi"> DOI: 10.1097/JCP.0000000000000688</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1097%2FJCP.0000000000000688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=28338545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvF2qurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2017&pages=302-309&author=E.+Materaauthor=L.+Margariauthor=V.+O.+Palmieriauthor=G.+Zagariaauthor=R.+Palumbiauthor=F.+Margari&title=Risperidone+and+cardiometabolic+risk+in+children+and+adolescents%3A+clinical+and+instrumental+issues&doi=10.1097%2FJCP.0000000000000688"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Risperidone and Cardiometabolic Risk in Children and Adolescents: Clinical and Instrumental Issues</span></div><div class="casAuthors">Matera, Emilia; Margari, Lucia; Palmieri, Vincenzo Ostilio; Zagaria, Giuseppina; Palumbi, Roberto; Margari, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">302-309</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Purpose/background: Although second-generation antipsychotics are used to treat and manage symptoms for several psychiatric disorders, data about their adverse effects in developmental age are limited.  The aim of this prospective observational study was to verify the cardiovascular and metabolic risk in a sample of antipsychotic-naive children/adolescent patients starting risperidone therapy.  Methods: Twenty-two patients, younger than 18 years, were recruited.  The assessment included anthropometric data, cardiovascular parameters, blood tests, and ultrasonog. abdominal study.  Results: After an av. follow-up period of 7.6 mo, statistically significant increases in mean values of waist circumference, body mass index (BMI), BMI percentile, BMI z score, total cholesterol, and prolactin were found.  Other cardiometabolic parameters showed an upward trend in time.  Subjects in pubertal/postpubertal stage and female patients were more susceptible to developing cardiometabolic changes.  Moreover, significant correlations between changes in anthropometric and several metabolic parameters were found.  A tendency to change in constitution of the liver parenchyma and distribution of the abdominal fat mass with ultrasonog. abdominal study was also evident.  Conclusions: In our sample, several metabolic parameters showed a sensitivity to risperidone treatment.  Because most of these parameters are age dependent, metabolic syndrome criteria used for adults were inappropriate in children and adolescents.  Periodic clin. and instrumental evaluations and guidelines for monitoring of any metabolic, lab., and instrumental complications are necessary in the perspective of even long-time second-generation antipsychotics treatment in children and adolescents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt1k9nAYP1GrVg90H21EOLACvtfcHk0liORs_O__2jNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvF2qurw%253D&md5=9cb2b034b9aaff17922c9f4622657dd6</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1097%2FJCP.0000000000000688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJCP.0000000000000688%26sid%3Dliteratum%253Aachs%26aulast%3DMatera%26aufirst%3DE.%26aulast%3DMargari%26aufirst%3DL.%26aulast%3DPalmieri%26aufirst%3DV.%2BO.%26aulast%3DZagaria%26aufirst%3DG.%26aulast%3DPalumbi%26aufirst%3DR.%26aulast%3DMargari%26aufirst%3DF.%26atitle%3DRisperidone%2520and%2520cardiometabolic%2520risk%2520in%2520children%2520and%2520adolescents%253A%2520clinical%2520and%2520instrumental%2520issues%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2017%26volume%3D37%26spage%3D302%26epage%3D309%26doi%3D10.1097%2FJCP.0000000000000688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Margari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petruzzelli, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamanna, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmieri, V. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margari, F.</span><span> </span><span class="NLM_article-title">Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span><span class="refDoi"> DOI: 10.1097/YIC.0000000000000063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1097%2FYIC.0000000000000063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25514607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2MznvFKqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2015&pages=103-108&author=L.+Margariauthor=E.+Materaauthor=M.+G.+Petruzzelliauthor=M.+Simoneauthor=A.+L.+Lamannaauthor=A.+Pastoreauthor=V.+O.+Palmieriauthor=F.+Margari&title=Prolactin+variations+during+risperidone+therapy+in+a+sample+of+drug-naive+children+and+adolescents&doi=10.1097%2FYIC.0000000000000063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents</span></div><div class="casAuthors">Margari Lucia; Matera Emilia; Petruzzelli Maria G; Simone Marta; Lamanna Anna L; Pastore Adriana; Palmieri Vincenzo O; Margari Francesco</div><div class="citationInfo"><span class="NLM_cas:title">International clinical psychopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">103-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The aim of this prospective observational study was to investigate the variations of serum prolactin hormone (PRL) in a sample of 34 drug-naive patients (mean age 13 years) who started risperidone therapy assuming that several factors may favor the increase in serum PRL.  Serum PRL and hyperprolactinemia clinical signs were examined at baseline (T0) and after almost 3 months of treatment (T1).  We considered sex, pubertal status, risperidone dosage, psychiatric diagnosis, and any personal/family history of autoimmune diseases.  The mean serum PRL value increased between T0 and T1 (P=0.004).  The mean serum PRL was higher in females in the pubertal/postpubertal stage and for risperidone dosage up 1 mg/day.  Hyperprolactinemia was found in 20% of patients at T0 and in 38% of patients at T1 (P=0.03).  The mean serum PRL increase was greater in early-onset schizophrenia spectrum psychosis patients compared with no-early-onset schizophrenia spectrum psychosis patients (P=0.04).  The increase in PRL was higher in patients with a personal and a family history of autoimmune diseases.  This study suggests that the increase in serum PRL in patients treated with risperidone may be linked not only to the drug and its dosage but also to several risk factors such as sex, pubertal stage, psychiatric disease, and autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRWhnKWAUjbzLxanA7vODO6fW6udTcc2eYJUAmkqi0Am7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MznvFKqtA%253D%253D&md5=11ff8f08314d95c90ce390623c25bb7f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1097%2FYIC.0000000000000063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FYIC.0000000000000063%26sid%3Dliteratum%253Aachs%26aulast%3DMargari%26aufirst%3DL.%26aulast%3DMatera%26aufirst%3DE.%26aulast%3DPetruzzelli%26aufirst%3DM.%2BG.%26aulast%3DSimone%26aufirst%3DM.%26aulast%3DLamanna%26aufirst%3DA.%2BL.%26aulast%3DPastore%26aufirst%3DA.%26aulast%3DPalmieri%26aufirst%3DV.%2BO.%26aulast%3DMargari%26aufirst%3DF.%26atitle%3DProlactin%2520variations%2520during%2520risperidone%2520therapy%2520in%2520a%2520sample%2520of%2520drug-naive%2520children%2520and%2520adolescents%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D2015%26volume%3D30%26spage%3D103%26epage%3D108%26doi%3D10.1097%2FYIC.0000000000000063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Margari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petruzzelli, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmieri, V. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margari, F.</span><span> </span><span class="NLM_article-title">Tolerability and safety profile of risperidone in a sample of children and adolescents</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">183</span><span class="refDoi"> DOI: 10.1097/YIC.0b013e328362497b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1097%2FYIC.0b013e328362497b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=23689836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC3snlt1Cktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=177-183&author=L.+Margariauthor=E.+Materaauthor=F.+Craigauthor=M.+G.+Petruzzelliauthor=V.+O.+Palmieriauthor=A.+Pastoreauthor=F.+Margari&title=Tolerability+and+safety+profile+of+risperidone+in+a+sample+of+children+and+adolescents&doi=10.1097%2FYIC.0b013e328362497b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Tolerability and safety profile of risperidone in a sample of children and adolescents</span></div><div class="casAuthors">Margari Lucia; Matera Emilia; Craig Francesco; Petruzzelli Maria G; Palmieri Vincenzo O; Pastore Adriana; Margari Francesco</div><div class="citationInfo"><span class="NLM_cas:title">International clinical psychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">177-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The aim of this prospective observational study was to verify the tolerability and safety profile of risperidone in a sample of antipsychotic-naive children/adolescent patients having a different psychiatric diagnosis.  Twenty-two (mean age of 12±3.2) antipsychotic-naive patients who started therapy with risperidone were recruited.  The assessment involved anthropometric data (weight, height, BMI, BMI z-score and BMI percentile), cardiovascular parameters (blood pressure and QTc interval) and blood tests (levels of glucose, triglycerides, total cholesterol, glutamic oxaloacetic and pyruvic transaminases, γ-glutamyl transferase, prolactin, free triiodothyronine, free thyroxine, thyroid-stimulating hormone, thyroglobulin, antithyroid peroxidase and antithyroglobulin).  After an average follow-up of 6 months of risperidone therapy, a statistically significant increase in weight and body composition was observed.  Furthermore, an increase in serum levels of prolactin was observed in 50% of patients.  No other significant changes in metabolic and cardiovascular parameters were found.  Although an increase in these parameters was detected, it remained in the normal range.  This study suggests the use of specific protocols for monitoring children/adolescents treated with second-generation antipsychotics to manage the metabolic long-term complications and progression to more severe disease states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRsLI4Tm6tClpNiNltV31zlfW6udTcc2eYJUAmkqi0Am7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3snlt1Cktg%253D%253D&md5=9975ded4a704989f8bf80c43b2ba78f1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1097%2FYIC.0b013e328362497b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FYIC.0b013e328362497b%26sid%3Dliteratum%253Aachs%26aulast%3DMargari%26aufirst%3DL.%26aulast%3DMatera%26aufirst%3DE.%26aulast%3DCraig%26aufirst%3DF.%26aulast%3DPetruzzelli%26aufirst%3DM.%2BG.%26aulast%3DPalmieri%26aufirst%3DV.%2BO.%26aulast%3DPastore%26aufirst%3DA.%26aulast%3DMargari%26aufirst%3DF.%26atitle%3DTolerability%2520and%2520safety%2520profile%2520of%2520risperidone%2520in%2520a%2520sample%2520of%2520children%2520and%2520adolescents%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D2013%26volume%3D28%26spage%3D177%26epage%3D183%26doi%3D10.1097%2FYIC.0b013e328362497b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">McDougle, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stigler, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posey, D. J.</span><span> </span><span class="NLM_article-title">Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=18533764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD1cXot1WqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2008&pages=15-20&issue=Suppl+4&author=C.+J.+McDougleauthor=K.+A.+Stiglerauthor=C.+A.+Ericksonauthor=D.+J.+Posey&title=Atypical+antipsychotics+in+children+and+adolescents+with+autistic+and+other+pervasive+developmental+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders</span></div><div class="casAuthors">McDougle, Christopher J.; Stigler, Kimberly A.; Erickson, Craig A.; Posey, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry (Memphis, TN, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">Suppl. 4</span>),
    <span class="NLM_cas:pages">15-20</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review.  Atypical antipsychotics are emerging as the first-line pharmacol. treatment for irritability (i.e., aggression, self-injurious behavior, and severe tantrums) in children and adolescents with autistic and other pervasive developmental disorders.  Results from placebo-controlled and open-label studies of clozapine, risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole in this subject population are reviewed.  Addnl. placebo-controlled trials and studies of longer-term safety and tolerability are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsFmS7i1CdW7Vg90H21EOLACvtfcHk0liaczyCZtwryw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXot1WqsL4%253D&md5=edb581577b458cbeb8c2b2f33cd671ec</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcDougle%26aufirst%3DC.%2BJ.%26aulast%3DStigler%26aufirst%3DK.%2BA.%26aulast%3DErickson%26aufirst%3DC.%2BA.%26aulast%3DPosey%26aufirst%3DD.%2BJ.%26atitle%3DAtypical%2520antipsychotics%2520in%2520children%2520and%2520adolescents%2520with%2520autistic%2520and%2520other%2520pervasive%2520developmental%2520disorders%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2008%26volume%3D69%26issue%3DSuppl%25204%26spage%3D15%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">McCracken, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGough, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aman, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsay, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollway, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDougle, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swiezy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scahill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenig, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lancor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tierney, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghuman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grados, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitiello, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, D.</span><span> </span><span class="NLM_article-title">Research units on pediatric psychopharmacology autism network. Risperidone in children with autism and serious behavioral problems</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span><span class="refDoi"> DOI: 10.1056/NEJMoa013171</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1056%2FNEJMoa013171" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=12151468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD38XlslWqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2002&pages=314-321&author=J.+T.+McCrackenauthor=J.+McGoughauthor=B.+Shahauthor=P.+Croninauthor=D.+Hongauthor=M.+G.+Amanauthor=L.+E.+Arnoldauthor=R.+Lindsayauthor=P.+Nashauthor=J.+Hollwayauthor=C.+J.+McDougleauthor=D.+Poseyauthor=N.+Swiezyauthor=A.+Kohnauthor=L.+Scahillauthor=A.+Martinauthor=K.+Koenigauthor=F.+Volkmarauthor=D.+Carrollauthor=A.+Lancorauthor=E.+Tierneyauthor=J.+Ghumanauthor=N.+M.+Gonzalezauthor=M.+Gradosauthor=B.+Vitielloauthor=L.+Ritzauthor=M.+Daviesauthor=J.+Robinsonauthor=D.+McMahon&title=Research+units+on+pediatric+psychopharmacology+autism+network.+Risperidone+in+children+with+autism+and+serious+behavioral+problems&doi=10.1056%2FNEJMoa013171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Risperidone in children with autism and serious behavioral problems</span></div><div class="casAuthors">McCracken, James T.; McGough, James; Shah, Bhavik; Cronin, Pegeen; Hong, Daniel; Aman, Michael G.; Arnold, L. Eugene; Lindsay, Ronald; Nash, Patricia; Hollway, Jill; McDougle, Christopher J.; Posey, David; Swiezy, Naomi; Kohn, Arlene; Schaill, Lawrence; Martin, Andres; Koenig, Kathleen; Volkmar, Fred; Carroll, Deirdre; Lancor, Allison; Tierney, Elaine; Ghuman, Jaswinder; Gonzalez, Nilda M.; Grados, Marco; Vitiello, Benedetto; Ritz, Louise; Davies, Mark; Robinson, James; McMahon, Don</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">314-321</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Atypical antipsychotic agents, which block postsynaptic dopamine and serotonin receptors, have advantages over traditional antipsychotic medications in the treatment of adults with schizophrenia and may be beneficial in children with autistic disorder who have serious behavioral disturbances.  However, data on the safety and efficacy of atypical antipsychotic agents in children are limited.  We conducted a multisite, randomized, double-blind trial of risperidone as compared with placebo for the treatment of autistic disorder accompanied by severe tantrums, aggression, or self-injurious behavior in children 5 to 17 yr old.  The primary outcome measures were the score on the Irritability sub-scale of the Aberrant Behavior Checklist and the rating on the Clin. Global Impressions-Improvement (CGI-I) scale at eight weeks.  A total of 101 children (82 boys and 19 girls; mean [SD] age, 8.82.7 yr) were randomly assigned to receive risperidone (49 children) or placebo (52).  Treatment with risperidone for eight weeks (dose range, 0.5 to 3.5 mg per day) resulted in a 56.9 % redn. in the Irritability score, as compared with a 14.1 % decrease in the placebo group (P<0.001).  The rate of a pos. response, defined as at least a 25 % decrease in the Irritability score and a rating of much improved or very much improved on the CGI-I scale, was 69 % in the risperidone group (34 of 49 children had a pos. response) and 12 % in the placebo group (6 of 52, P<0.001).  Risperidone therapy was assocd. with an av. wt. gain of 2.72.9 kg, as compared with 0.82.2 kg with placebo (P<0.001).  Increased appetite, fatigue, drowsiness, dizziness, and drooling were more common in the risperidone group than in the placebo group (P< 0.05 for each comparison).  In two thirds of the children with a pos. response to risperidone at eight weeks (23 of 34), the benefit was maintained at six months.  Risperidone was effective and well tolerated for the treatment of tantrums, aggression, or self-injurious behavior in children with autistic disorder.  The short period of this trial limits inferences about adverse effects such as tardive dyskinesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqldDtdrxrpnrVg90H21EOLACvtfcHk0liaczyCZtwryw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlslWqt7Y%253D&md5=01efa8c7a2285ceae5a0cd646c165626</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa013171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa013171%26sid%3Dliteratum%253Aachs%26aulast%3DMcCracken%26aufirst%3DJ.%2BT.%26aulast%3DMcGough%26aufirst%3DJ.%26aulast%3DShah%26aufirst%3DB.%26aulast%3DCronin%26aufirst%3DP.%26aulast%3DHong%26aufirst%3DD.%26aulast%3DAman%26aufirst%3DM.%2BG.%26aulast%3DArnold%26aufirst%3DL.%2BE.%26aulast%3DLindsay%26aufirst%3DR.%26aulast%3DNash%26aufirst%3DP.%26aulast%3DHollway%26aufirst%3DJ.%26aulast%3DMcDougle%26aufirst%3DC.%2BJ.%26aulast%3DPosey%26aufirst%3DD.%26aulast%3DSwiezy%26aufirst%3DN.%26aulast%3DKohn%26aufirst%3DA.%26aulast%3DScahill%26aufirst%3DL.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DKoenig%26aufirst%3DK.%26aulast%3DVolkmar%26aufirst%3DF.%26aulast%3DCarroll%26aufirst%3DD.%26aulast%3DLancor%26aufirst%3DA.%26aulast%3DTierney%26aufirst%3DE.%26aulast%3DGhuman%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DN.%2BM.%26aulast%3DGrados%26aufirst%3DM.%26aulast%3DVitiello%26aufirst%3DB.%26aulast%3DRitz%26aufirst%3DL.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DMcMahon%26aufirst%3DD.%26atitle%3DResearch%2520units%2520on%2520pediatric%2520psychopharmacology%2520autism%2520network.%2520Risperidone%2520in%2520children%2520with%2520autism%2520and%2520serious%2520behavioral%2520problems%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D347%26spage%3D314%26epage%3D321%26doi%3D10.1056%2FNEJMoa013171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Moore, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichner, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. R.</span><span> </span><span class="NLM_article-title">Treating functional impairment of autism with selective serotonin-reuptake inhibitors</span> <span class="citation_source-journal">Ann. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1519</span><span class="refDoi"> DOI: 10.1345/aph.1D543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1345%2Faph.1D543" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2004&pages=1515-1519&author=M.+L.+Mooreauthor=S.+F.+Eichnerauthor=J.+R.+Jones&title=Treating+functional+impairment+of+autism+with+selective+serotonin-reuptake+inhibitors&doi=10.1345%2Faph.1D543"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1345%2Faph.1D543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1345%252Faph.1D543%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DM.%2BL.%26aulast%3DEichner%26aufirst%3DS.%2BF.%26aulast%3DJones%26aufirst%3DJ.%2BR.%26atitle%3DTreating%2520functional%2520impairment%2520of%2520autism%2520with%2520selective%2520serotonin-reuptake%2520inhibitors%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2004%26volume%3D38%26spage%3D1515%26epage%3D1519%26doi%3D10.1345%2Faph.1D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brignell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silove, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazell, P.</span><span> </span><span class="NLM_article-title">Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD004677</span><span class="refDoi"> DOI: 10.1002/14651858.CD004677.pub3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2F14651858.CD004677.pub3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=CD004677&author=K.+Williamsauthor=A.+Brignellauthor=M.+Randallauthor=N.+Siloveauthor=P.+Hazell&title=Selective+serotonin+reuptake+inhibitors+%28SSRIs%29+for+autism+spectrum+disorders+%28ASD%29&doi=10.1002%2F14651858.CD004677.pub3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD004677.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD004677.pub3%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DBrignell%26aufirst%3DA.%26aulast%3DRandall%26aufirst%3DM.%26aulast%3DSilove%26aufirst%3DN.%26aulast%3DHazell%26aufirst%3DP.%26atitle%3DSelective%2520serotonin%2520reuptake%2520inhibitors%2520%2528SSRIs%2529%2520for%2520autism%2520spectrum%2520disorders%2520%2528ASD%2529%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2013%26volume%3D8%26spage%3DCD004677%26doi%3D10.1002%2F14651858.CD004677.pub3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Hurwitz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackmore, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolfenden, S.</span><span> </span><span class="NLM_article-title">Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD008372</span><span class="refDoi"> DOI: 10.1002/14651858.CD008372.pub2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2F14651858.CD008372.pub2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=CD008372&author=R.+Hurwitzauthor=R.+Blackmoreauthor=P.+Hazellauthor=K.+Williamsauthor=S.+Woolfenden&title=Tricyclic+antidepressants+for+autism+spectrum+disorders+%28ASD%29+in+children+and+adolescents&doi=10.1002%2F14651858.CD008372.pub2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD008372.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD008372.pub2%26sid%3Dliteratum%253Aachs%26aulast%3DHurwitz%26aufirst%3DR.%26aulast%3DBlackmore%26aufirst%3DR.%26aulast%3DHazell%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DWoolfenden%26aufirst%3DS.%26atitle%3DTricyclic%2520antidepressants%2520for%2520autism%2520spectrum%2520disorders%2520%2528ASD%2529%2520in%2520children%2520and%2520adolescents%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2012%26volume%3D3%26spage%3DCD008372%26doi%3D10.1002%2F14651858.CD008372.pub2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Hirota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veenstra-Vanderweele, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishi, T.</span><span> </span><span class="NLM_article-title">Antiepileptic medications in autism spectrum disorder: a systematic review and meta-analysis</span> <span class="citation_source-journal">J. Autism Dev. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">948</span><span class="NLM_x">–</span> <span class="NLM_lpage">957</span><span class="refDoi"> DOI: 10.1007/s10803-013-1952-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs10803-013-1952-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24077782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FitFemsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2014&pages=948-957&author=T.+Hirotaauthor=J.+Veenstra-Vanderweeleauthor=E.+Hollanderauthor=T.+Kishi&title=Antiepileptic+medications+in+autism+spectrum+disorder%3A+a+systematic+review+and+meta-analysis&doi=10.1007%2Fs10803-013-1952-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Antiepileptic medications in autism spectrum disorder: a systematic review and meta-analysis</span></div><div class="casAuthors">Hirota Tomoya; Veenstra-Vanderweele Jeremy; Hollander Eric; Kishi Taro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autism and developmental disorders</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">948-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Electroencephalogram-recorded epileptiform activity is common in children with autism spectrum disorder (ASD), even without clinical seizures.  A systematic literature search identified 7 randomized, placebo-controlled trials of antiepileptic drugs (AEDs) in ASD (total n = 171), including three of valproate, and one each of lamotrigine, levetiracetam, and topiramate.  Meta-analysis revealed no significant difference between medication and placebo in four studies targeting irritability/agitation and three studies investigating global improvement, although limitations include lack of power and different medications with diverse actions.  Across all seven studies, there was no significant difference in discontinuation rate between two groups.  AEDs do not appear to have a large effect size to treat behavioral symptoms in ASD, but further research is needed, particularly in the subgroup of patients with epileptiform abnormalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRWoKJoTs3QNuxsqfvU0ziafW6udTcc2eZIZlU0VGjrXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FitFemsw%253D%253D&md5=c3ff2944874d87b611e8d221d272c4b2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs10803-013-1952-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10803-013-1952-2%26sid%3Dliteratum%253Aachs%26aulast%3DHirota%26aufirst%3DT.%26aulast%3DVeenstra-Vanderweele%26aufirst%3DJ.%26aulast%3DHollander%26aufirst%3DE.%26aulast%3DKishi%26aufirst%3DT.%26atitle%3DAntiepileptic%2520medications%2520in%2520autism%2520spectrum%2520disorder%253A%2520a%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DJ.%2520Autism%2520Dev.%2520Disord.%26date%3D2014%26volume%3D44%26spage%3D948%26epage%3D957%26doi%3D10.1007%2Fs10803-013-1952-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Perry, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Ruiz, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Court, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volsen, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folly, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iversen, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenk, G. L.</span><span> </span><span class="NLM_article-title">Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1058</span><span class="NLM_x">–</span> <span class="NLM_lpage">1066</span><span class="refDoi"> DOI: 10.1176/appi.ajp.158.7.1058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1176%2Fappi.ajp.158.7.1058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=11431227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD3MznsVegtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2001&pages=1058-1066&author=E.+K.+Perryauthor=M.+L.+Leeauthor=C.+M.+Martin-Ruizauthor=J.+A.+Courtauthor=S.+G.+Volsenauthor=J.+Merritauthor=E.+Follyauthor=P.+E.+Iversenauthor=M.+L.+Baumanauthor=R.+H.+Perryauthor=G.+L.+Wenk&title=Cholinergic+activity+in+autism%3A+abnormalities+in+the+cerebral+cortex+and+basal+forebrain&doi=10.1176%2Fappi.ajp.158.7.1058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain</span></div><div class="casAuthors">Perry E K; Lee M L; Martin-Ruiz C M; Court J A; Volsen S G; Merrit J; Folly E; Iversen P E; Bauman M L; Perry R H; Wenk G L</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1058-66</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Measures of cholinergic transmitter activity were investigated in patients with autism because of reported neuropathological abnormalities in cholinergic nuclei in the basal forebrain.  METHOD:  Levels of cholinergic enzyme and receptor activity were measured in the frontal and parietal cerebral cortex of deceased autistic adults, similarly aged normal adults without mental retardation, and nonautistic mentally retarded adults.  The immunoreactivity levels of brain-derived neurotrophic factor and nerve growth factor were measured in the basal forebrain.  RESULTS:  There were no differences between the autistic and comparison groups in choline acetyltransferase or acetylcholinesterase activity in the cerebral cortex and basal forebrain or in muscarinic M(2) receptor or alpha-bungarotoxin binding within the cortex.  Cortical M(1) receptor binding was up to 30% lower than normal in the autistic subjects, and the difference reached significance in the parietal cortex.  In both the parietal and frontal cortices, differences in nicotinic receptors assessed by [(3)H]epibatidine binding were significant and extensive (65%-73% lower in the autistic group than in the normal subjects); there were no differences in nicotine binding in the basal forebrain.  Immunochemical analysis indicated lower levels of both the alpha(4) and beta(2) nicotinic receptor subunits in the parietal cortex.  The M(1) receptor abnormality was not evident in the nonautistic group with mental retardation, although the lower [(3)H]epibatidine binding was apparent.  In the basal forebrain, the level of brain-derived neurotrophic factor in the autistic group was three times as high as the level of the normal group.  CONCLUSIONS:  These neurochemical abnormalities implicate the cholinergic system in developmental disorders such as autism and suggest the potential for intervention based on cholinergic receptor modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcx_1FDHwS4RpyrDyM_m9cfW6udTcc2eZIZlU0VGjrXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MznsVegtA%253D%253D&md5=d0533418769a83b9d842b4baedaee4cd</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.158.7.1058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.158.7.1058%26sid%3Dliteratum%253Aachs%26aulast%3DPerry%26aufirst%3DE.%2BK.%26aulast%3DLee%26aufirst%3DM.%2BL.%26aulast%3DMartin-Ruiz%26aufirst%3DC.%2BM.%26aulast%3DCourt%26aufirst%3DJ.%2BA.%26aulast%3DVolsen%26aufirst%3DS.%2BG.%26aulast%3DMerrit%26aufirst%3DJ.%26aulast%3DFolly%26aufirst%3DE.%26aulast%3DIversen%26aufirst%3DP.%2BE.%26aulast%3DBauman%26aufirst%3DM.%2BL.%26aulast%3DPerry%26aufirst%3DR.%2BH.%26aulast%3DWenk%26aufirst%3DG.%2BL.%26atitle%3DCholinergic%2520activity%2520in%2520autism%253A%2520abnormalities%2520in%2520the%2520cerebral%2520cortex%2520and%2520basal%2520forebrain%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2001%26volume%3D158%26spage%3D1058%26epage%3D1066%26doi%3D10.1176%2Fappi.ajp.158.7.1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Rossignol, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, R. E.</span><span> </span><span class="NLM_article-title">The use of medications approved for Alzheimer’s disease in autism spectrum disorder: a systematic review</span> <span class="citation_source-journal">Front. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="refDoi"> DOI: 10.3389/fped.2014.00087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3389%2Ffped.2014.00087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25202686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252Fps1ahtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=87&author=D.+A.+Rossignolauthor=R.+E.+Frye&title=The+use+of+medications+approved+for+Alzheimer%E2%80%99s+disease+in+autism+spectrum+disorder%3A+a+systematic+review&doi=10.3389%2Ffped.2014.00087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review</span></div><div class="casAuthors">Rossignol Daniel A; Frye Richard E</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pediatrics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autism spectrum disorder (ASD) is a neurodevelopmental disorder that affects 1 in 68 children in the United States.  Even though it is a common disorder, only two medications (risperidone and aripiprazole) are approved by the U.S.  Food and Drug Administration (FDA) to treat symptoms associated with ASD.  However, these medications are approved to treat irritability, which is not a core symptom of ASD.  A number of novel medications, which have not been approved by the FDA to treat ASD have been used off-label in some studies to treat ASD symptoms, including medications approved for Alzheimer's disease.  Interestingly, some of these studies are high-quality, double-blind, placebo-controlled (DBPC) studies.  This article systematically reviews studies published through April, 2014, which examined the use of Alzheimer's medications in ASD, including donepezil (seven studies, two were DBPC, five out of seven reported improvements), galantamine (four studies, two were DBPC, all reported improvements), rivastigmine (one study reporting improvements), tacrine (one study reporting improvements), and memantine (nine studies, one was DBPC, eight reported improvements).  An evidence-based scale was used to rank each medication.  Collectively, these studies reported improvements in expressive language and communication, receptive language, social interaction, irritability, hyperactivity, attention, eye contact, emotional lability, repetitive or self-stimulatory behaviors, motor planning, disruptive behaviors, obsessive-compulsive symptoms, lethargy, overall ASD behaviors, and increased REM sleep.  Reported side effects are reviewed and include irritability, gastrointestinal problems, verbal or behavioral regression, headaches, irritability, rash, tremor, sedation, vomiting, and speech problems.  Both galantamine and memantine had sufficient evidence ranking for improving both core and associated symptoms of ASD.  Given the lack of medications approved to treat ASD, further studies on novel medications, including Alzheimer's disease medications, are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVuIz0BrbXQXqj_yg7twvpfW6udTcc2eZIZlU0VGjrXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252Fps1ahtA%253D%253D&md5=f1ed3002839bfe400cb142be50d85e38</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.3389%2Ffped.2014.00087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffped.2014.00087%26sid%3Dliteratum%253Aachs%26aulast%3DRossignol%26aufirst%3DD.%2BA.%26aulast%3DFrye%26aufirst%3DR.%2BE.%26atitle%3DThe%2520use%2520of%2520medications%2520approved%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520autism%2520spectrum%2520disorder%253A%2520a%2520systematic%2520review%26jtitle%3DFront.%2520Pediatr.%26date%3D2014%26volume%3D2%26spage%3D87%26doi%3D10.3389%2Ffped.2014.00087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Pearson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casat, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loveland, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukstein, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerger, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Factor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanwoerden, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleveland, L. A.</span><span> </span><span class="NLM_article-title">Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms</span> <span class="citation_source-journal">J. Child Adolesc. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span><span class="refDoi"> DOI: 10.1089/cap.2012.0096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1089%2Fcap.2012.0096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=23782128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVOkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=337-351&author=D.+Pearsonauthor=C.+Santosauthor=M.+Amanauthor=L.+E.+Arnoldauthor=C.+D.+Casatauthor=R.+Mansourauthor=D.+M.+Laneauthor=K.+A.+Lovelandauthor=O.+G.+Buksteinauthor=S.+W.+Jergerauthor=P.+Factorauthor=S.+Vanwoerdenauthor=E.+Perezauthor=L.+A.+Cleveland&title=Effects+of+extended+release+methylphenidate+treatment+on+ratings+of+attention-deficit%2Fhyperactivity+disorder+%28ADHD%29+and+associated+behavior+in+children+with+autism+spectrum+disorders+and+ADHD+symptoms&doi=10.1089%2Fcap.2012.0096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Extended Release Methylphenidate Treatment on Ratings of Attention-Deficit/Hyperactivity Disorder (ADHD) and Associated Behavior in Children with Autism Spectrum Disorders and ADHD Symptoms</span></div><div class="casAuthors">Pearson, Deborah A.; Santos, Cynthia W.; Aman, Michael G.; Arnold, L. Eugene; Casat, Charles D.; Mansour, Rosleen; Lane, David M.; Loveland, Katherine A.; Bukstein, Oscar G.; Jerger, Susan W.; Factor, Perry; Vanwoerden, Salome; Perez, Evelyn; Cleveland, Lynne A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Child and Adolescent Psychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">337-351</span>CODEN:
                <span class="NLM_cas:coden">JADPET</span>;
        ISSN:<span class="NLM_cas:issn">1044-5463</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Objective: The purpose of this study was to examine the behavioral effects of four doses of psychostimulant medication, combining extended-release methylphenidate (MPH) in the morning with immediate-release MPH in the afternoon.  Method: The sample comprised 24 children (19 boys; 5 girls) who met American Psychiatric Assocn., Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV-TR) criteria for an autism spectrum disorder (ASD) on the Autism Diagnostic Interview-Revised (ADI-R) and the Autism Diagnostic Observation Schedule (ADOS), and had significant symptoms of attention-deficit/hyperactivity disorder (ADHD).  This sample consisted of elementary school-age, community-based children (mean chronol. age=8.8 years, SD=1.7; mean intelligence quotient [IQ]=85; SD=16.8).  Effects of four dose levels of MPH on parent and teacher behavioral ratings were investigated using a within-subject, crossover, placebo-controlled design.  Results: MPH treatment was assocd. with significant declines in hyperactive and impulsive behavior at both home and school.  Parents noted significant declines in inattentive and oppositional behavior, and improvements in social skills.  No exacerbation of stereotypies was noted, and side effects were similar to those seen in typically developing children with ADHD.  Dose response was primarily linear in the dose range studied.  Conclusions: The results of this study suggest that MPH formulations are efficacious and well-tolerated for children with ASD and significant ADHD symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxublQ8_Ne37Vg90H21EOLACvtfcHk0lhdD5yMZPIOlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVOkur0%253D&md5=2c1679c9a3f03acafdd2feef51f28673</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1089%2Fcap.2012.0096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcap.2012.0096%26sid%3Dliteratum%253Aachs%26aulast%3DPearson%26aufirst%3DD.%26aulast%3DSantos%26aufirst%3DC.%26aulast%3DAman%26aufirst%3DM.%26aulast%3DArnold%26aufirst%3DL.%2BE.%26aulast%3DCasat%26aufirst%3DC.%2BD.%26aulast%3DMansour%26aufirst%3DR.%26aulast%3DLane%26aufirst%3DD.%2BM.%26aulast%3DLoveland%26aufirst%3DK.%2BA.%26aulast%3DBukstein%26aufirst%3DO.%2BG.%26aulast%3DJerger%26aufirst%3DS.%2BW.%26aulast%3DFactor%26aufirst%3DP.%26aulast%3DVanwoerden%26aufirst%3DS.%26aulast%3DPerez%26aufirst%3DE.%26aulast%3DCleveland%26aufirst%3DL.%2BA.%26atitle%3DEffects%2520of%2520extended%2520release%2520methylphenidate%2520treatment%2520on%2520ratings%2520of%2520attention-deficit%252Fhyperactivity%2520disorder%2520%2528ADHD%2529%2520and%2520associated%2520behavior%2520in%2520children%2520with%2520autism%2520spectrum%2520disorders%2520and%2520ADHD%2520symptoms%26jtitle%3DJ.%2520Child%2520Adolesc.%2520Psychopharmacol.%26date%3D2013%26volume%3D23%26spage%3D337%26epage%3D351%26doi%3D10.1089%2Fcap.2012.0096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Panksepp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensing, P.</span><span> </span><span class="NLM_article-title">Brief report: a synopsis of an open-trial of naltrexone treatment of autism with four children</span> <span class="citation_source-journal">J. Autism Dev. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1007/BF02284764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2FBF02284764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1864831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADyaK3MzisVaqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1991&pages=243-249&author=J.+Pankseppauthor=P.+Lensing&title=Brief+report%3A+a+synopsis+of+an+open-trial+of+naltrexone+treatment+of+autism+with+four+children&doi=10.1007%2FBF02284764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Brief report: a synopsis of an open-trial of naltrexone treatment of autism with four children</span></div><div class="casAuthors">Panksepp J; Lensing P</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autism and developmental disorders</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-9</span>
        ISSN:<span class="NLM_cas:issn">0162-3257</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRsN3ZR_oy622hHGZei4OW9fW6udTcc2eZlzEws5VMP5Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3MzisVaqtg%253D%253D&md5=34bb0fd0a345abb9d88d0f24f969bf02</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2FBF02284764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02284764%26sid%3Dliteratum%253Aachs%26aulast%3DPanksepp%26aufirst%3DJ.%26aulast%3DLensing%26aufirst%3DP.%26atitle%3DBrief%2520report%253A%2520a%2520synopsis%2520of%2520an%2520open-trial%2520of%2520naltrexone%2520treatment%2520of%2520autism%2520with%2520four%2520children%26jtitle%3DJ.%2520Autism%2520Dev.%2520Disord.%26date%3D1991%26volume%3D21%26spage%3D243%26epage%3D249%26doi%3D10.1007%2FBF02284764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Eichaar, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maisch, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augusto, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehring, H. J.</span><span> </span><span class="NLM_article-title">Efficacy and safety of naltrexone use in pediatric patients with autistic disorder</span> <span class="citation_source-journal">Ann. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span><span class="refDoi"> DOI: 10.1345/aph.1G499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1345%2Faph.1G499" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2006&pages=1086-1095&author=G.+M.+Eichaarauthor=N.+M.+Maischauthor=L.+M.+Augustoauthor=H.+J.+Wehring&title=Efficacy+and+safety+of+naltrexone+use+in+pediatric+patients+with+autistic+disorder&doi=10.1345%2Faph.1G499"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1345%2Faph.1G499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1345%252Faph.1G499%26sid%3Dliteratum%253Aachs%26aulast%3DEichaar%26aufirst%3DG.%2BM.%26aulast%3DMaisch%26aufirst%3DN.%2BM.%26aulast%3DAugusto%26aufirst%3DL.%2BM.%26aulast%3DWehring%26aufirst%3DH.%2BJ.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520naltrexone%2520use%2520in%2520pediatric%2520patients%2520with%2520autistic%2520disorder%26jtitle%3DAnn.%2520Pharmacother.%26date%3D2006%26volume%3D40%26spage%3D1086%26epage%3D1095%26doi%3D10.1345%2Faph.1G499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Varghese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshav, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacot-Descombes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wicinski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickstein, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harony-Nicolas, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Rubeis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drapeau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buxbaum, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, P. R.</span><span> </span><span class="NLM_article-title">Autism spectrum disorder: neuropathology and animal models</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span><span class="refDoi"> DOI: 10.1007/s00401-017-1736-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs00401-017-1736-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2017&pages=537-566&author=M.+Vargheseauthor=N.+Keshavauthor=S.+Jacot-Descombesauthor=T.+Wardaauthor=B.+Wicinskiauthor=D.+L.+Dicksteinauthor=H.+Harony-Nicolasauthor=S.+De+Rubeisauthor=E.+Drapeauauthor=J.+D.+Buxbaumauthor=P.+R.+Hof&title=Autism+spectrum+disorder%3A+neuropathology+and+animal+models&doi=10.1007%2Fs00401-017-1736-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs00401-017-1736-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-017-1736-4%26sid%3Dliteratum%253Aachs%26aulast%3DVarghese%26aufirst%3DM.%26aulast%3DKeshav%26aufirst%3DN.%26aulast%3DJacot-Descombes%26aufirst%3DS.%26aulast%3DWarda%26aufirst%3DT.%26aulast%3DWicinski%26aufirst%3DB.%26aulast%3DDickstein%26aufirst%3DD.%2BL.%26aulast%3DHarony-Nicolas%26aufirst%3DH.%26aulast%3DDe%2BRubeis%26aufirst%3DS.%26aulast%3DDrapeau%26aufirst%3DE.%26aulast%3DBuxbaum%26aufirst%3DJ.%2BD.%26aulast%3DHof%26aufirst%3DP.%2BR.%26atitle%3DAutism%2520spectrum%2520disorder%253A%2520neuropathology%2520and%2520animal%2520models%26jtitle%3DActa%2520Neuropathol.%26date%3D2017%26volume%3D134%26spage%3D537%26epage%3D566%26doi%3D10.1007%2Fs00401-017-1736-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Sztainberg, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, H. Y.</span><span> </span><span class="NLM_article-title">Lessons learned from studying syndromic autism spectrum disorders</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1408</span><span class="NLM_x">–</span> <span class="NLM_lpage">1417</span><span class="refDoi"> DOI: 10.1038/nn.4420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnn.4420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27786181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslGgsLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2016&pages=1408-1417&author=Y.+Sztainbergauthor=H.+Y.+Zoghbi&title=Lessons+learned+from+studying+syndromic+autism+spectrum+disorders&doi=10.1038%2Fnn.4420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons learned from studying syndromic autism spectrum disorders</span></div><div class="casAuthors">Sztainberg, Yehezkel; Zoghbi, Huda Y.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1408-1417</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Syndromic autism spectrum disorders represent a group of childhood neurol. conditions, typically assocd. with chromosomal abnormalities or mutations in a single gene.  The discovery of their genetic causes has increased our understanding of the mol. pathways crit. for normal cognitive and social development.  Human studies have revealed that the brain is particularly sensitive to changes in dosage of various proteins from transcriptional and translational regulators to synaptic proteins.  Investigations of these disorders in animals have shed light on previously unknown pathogenic mechanisms leading to the identification of potential targets for therapeutic intervention.  The demonstration of reversibility of several phenotypes in adult mice is encouraging, and brings hope that with novel therapies, skills and functionality might improve in affected children and young adults.  As new research reveals points of convergence between syndromic and nonsyndromic autism spectrum disorders, we believe there will be opportunities for shared therapeutics for this class of conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreBCusjuxzr7Vg90H21EOLACvtfcHk0lgSvVu_bw2G9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslGgsLfL&md5=e5a8a2784ac4e9943fe909fefc66bd72</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnn.4420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.4420%26sid%3Dliteratum%253Aachs%26aulast%3DSztainberg%26aufirst%3DY.%26aulast%3DZoghbi%26aufirst%3DH.%2BY.%26atitle%3DLessons%2520learned%2520from%2520studying%2520syndromic%2520autism%2520spectrum%2520disorders%26jtitle%3DNat.%2520Neurosci.%26date%3D2016%26volume%3D19%26spage%3D1408%26epage%3D1417%26doi%3D10.1038%2Fnn.4420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Jacquemont, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagerman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagerman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leehey, M. A.</span><span> </span><span class="NLM_article-title">Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span><span class="refDoi"> DOI: 10.1016/S1474-4422(06)70676-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS1474-4422%2806%2970676-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=17166801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpslWmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=45-55&author=S.+Jacquemontauthor=R.+J.+Hagermanauthor=P.+J.+Hagermanauthor=M.+A.+Leehey&title=Fragile-X+syndrome+and+fragile+X-associated+tremor%2Fataxia+syndrome%3A+two+faces+of+FMR1&doi=10.1016%2FS1474-4422%2806%2970676-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1</span></div><div class="casAuthors">Jacquemont, Sebastien; Hagerman, Randi; Hagerman, Paul; Leehey, Maureen A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-55</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent advances in our understanding of the clin. and mol. features of the fragile-X mental-retardation 1 gene, FMR1, highlight the importance of single-gene disorders.  15 Years after its discovery, FMR1 continues to reveal new and unexpected clin. presentations and mol. mechanisms.  Loss of function of FMR1 is a model for neurodevelopmental and behavioral disorders, including mental retardation, autism, anxiety, and mood instability.  In addn., overexpression and CNS toxicity of FMR1 mRNA causes a late-onset neurodegenerative disorder, the fragile-X-assocd. tremor/ataxia syndrome (FXTAS).  A similar mechanism is probably involved in premature ovarian failure, which affects up to 20% of female carriers of an altered FMR1 gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJhuRo1JnBLbVg90H21EOLACvtfcHk0lgSvVu_bw2G9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpslWmuw%253D%253D&md5=3063996e801ef74f42d95e7d91ae3906</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2806%2970676-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252806%252970676-7%26sid%3Dliteratum%253Aachs%26aulast%3DJacquemont%26aufirst%3DS.%26aulast%3DHagerman%26aufirst%3DR.%2BJ.%26aulast%3DHagerman%26aufirst%3DP.%2BJ.%26aulast%3DLeehey%26aufirst%3DM.%2BA.%26atitle%3DFragile-X%2520syndrome%2520and%2520fragile%2520X-associated%2520tremor%252Fataxia%2520syndrome%253A%2520two%2520faces%2520of%2520FMR1%26jtitle%3DLancet%2520Neurol.%26date%3D2007%26volume%3D6%26spage%3D45%26epage%3D55%26doi%3D10.1016%2FS1474-4422%2806%2970676-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Huber, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bear, M. F.</span><span> </span><span class="NLM_article-title">Altered synaptic plasticity in a mouse model of fragile X mental retardation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">7746</span><span class="NLM_x">–</span> <span class="NLM_lpage">7750</span><span class="refDoi"> DOI: 10.1073/pnas.122205699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.122205699" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=7746-7750&author=K.+M.+Huberauthor=S.+M.+Gallagherauthor=S.+T.+Warrenauthor=M.+F.+Bear&title=Altered+synaptic+plasticity+in+a+mouse+model+of+fragile+X+mental+retardation&doi=10.1073%2Fpnas.122205699"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1073%2Fpnas.122205699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.122205699%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DK.%2BM.%26aulast%3DGallagher%26aufirst%3DS.%2BM.%26aulast%3DWarren%26aufirst%3DS.%2BT.%26aulast%3DBear%26aufirst%3DM.%2BF.%26atitle%3DAltered%2520synaptic%2520plasticity%2520in%2520a%2520mouse%2520model%2520of%2520fragile%2520X%2520mental%2520retardation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D7746%26epage%3D7750%26doi%3D10.1073%2Fpnas.122205699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Irwin, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenough, W. T.</span><span> </span><span class="NLM_article-title">Dendritic spine structural anomalies in fragile-X mental retardation syndrome</span> <span class="citation_source-journal">Cereb. Cortex</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1038</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span><span class="refDoi"> DOI: 10.1093/cercor/10.10.1038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1093%2Fcercor%2F10.10.1038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=11007554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD3M%252FgvV2lsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=1038-1044&author=S.+A.+Irwinauthor=R.+Galvezauthor=W.+T.+Greenough&title=Dendritic+spine+structural+anomalies+in+fragile-X+mental+retardation+syndrome&doi=10.1093%2Fcercor%2F10.10.1038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Dendritic spine structural anomalies in fragile-X mental retardation syndrome</span></div><div class="casAuthors">Irwin S A; Galvez R; Greenough W T</div><div class="citationInfo"><span class="NLM_cas:title">Cerebral cortex (New York, N.Y. : 1991)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1038-44</span>
        ISSN:<span class="NLM_cas:issn">1047-3211</span>.
    </div><div class="casAbstract">Fragile-X syndrome is the most common single-gene inherited form of mental retardation.  Morphological studies suggest a possible failure of the synapse maturation process.  Cerebral cortical spine morphology in fragile-X syndrome and in a knockout mouse model of it appears immature, with long, thin spines much more common than the stubby and mushroom-shaped spines more characteristic of normal development.  In human fragile-X syndrome there is also a higher density of spines along dendrites, suggesting a possible failure of synapse elimination.  While variously misshapen spines are characteristic of a number of mental retardation syndromes, the overabundance of spines seen in fragile-X syndrome is unusual.  Taken with evidence of neurotransmitter activation of the synthesis of the fragile-X protein (FMRP) at synapses in vitro and evidence for behaviorally induced FMRP expression in vivo, and with evidence compatible with a role for FMRP in regulating the synthesis of other proteins, it is possible that FMRP serves as an 'immediate early protein' at the synapse that orchestrates aspects of synaptic development and plasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS0jfkd5cHPJ7mQt-ICR3qNfW6udTcc2eZhgURYObMykLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M%252FgvV2lsw%253D%253D&md5=2a1323b8a564ac437846daeb964c73ef</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1093%2Fcercor%2F10.10.1038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcercor%252F10.10.1038%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DS.%2BA.%26aulast%3DGalvez%26aufirst%3DR.%26aulast%3DGreenough%26aufirst%3DW.%2BT.%26atitle%3DDendritic%2520spine%2520structural%2520anomalies%2520in%2520fragile-X%2520mental%2520retardation%2520syndrome%26jtitle%3DCereb.%2520Cortex%26date%3D2000%26volume%3D10%26spage%3D1038%26epage%3D1044%26doi%3D10.1093%2Fcercor%2F10.10.1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Bear, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, S. T.</span><span> </span><span class="NLM_article-title">The mGluR theory of fragile X mental retardation</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span><span class="refDoi"> DOI: 10.1016/j.tins.2004.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.tins.2004.04.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=370-377&author=M.+F.+Bearauthor=K.+M.+Huberauthor=S.+T.+Warren&title=The+mGluR+theory+of+fragile+X+mental+retardation&doi=10.1016%2Fj.tins.2004.04.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2004.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2004.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DBear%26aufirst%3DM.%2BF.%26aulast%3DHuber%26aufirst%3DK.%2BM.%26aulast%3DWarren%26aufirst%3DS.%2BT.%26atitle%3DThe%2520mGluR%2520theory%2520of%2520fragile%2520X%2520mental%2520retardation%26jtitle%3DTrends%2520Neurosci.%26date%3D2004%26volume%3D27%26spage%3D370%26epage%3D377%26doi%3D10.1016%2Fj.tins.2004.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Paluszkiewicz, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntsman, M. M.</span><span> </span><span class="NLM_article-title">Fragile X syndrome: the GABAergic system and circuit dysfunction</span> <span class="citation_source-journal">Dev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1159/000329420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1159%2F000329420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21934270" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1GktbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2011&pages=349-364&author=S.+M.+Paluszkiewiczauthor=B.+S.+Martinauthor=M.+M.+Huntsman&title=Fragile+X+syndrome%3A+the+GABAergic+system+and+circuit+dysfunction&doi=10.1159%2F000329420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Fragile X syndrome: the GABAergic system and circuit dysfunction</span></div><div class="casAuthors">Paluszkiewicz, Scott M.; Martin, Brandon S.; Huntsman, Molly M.</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Neuroscience (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">349-364</span>CODEN:
                <span class="NLM_cas:coden">DENED7</span>;
        ISSN:<span class="NLM_cas:issn">0378-5866</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Fragile X syndrome (FXS) is a neurodevelopmental disorder characterized by intellectual disability, sensory hypersensitivity, and high incidences of autism spectrum disorders and epilepsy.  These phenotypes are suggestive of defects in neural circuit development and imbalances in excitatory glutamatergic and inhibitory GABAergic neurotransmission.  While alterations in excitatory synapse function and plasticity are well-established in Fmr1 knockout (KO) mouse models of FXS, a no. of recent electrophysiol. and mol. studies now identify prominent defects in inhibitory GABAergic transmission in behaviorally relevant forebrain regions such as the amygdala, cortex, and hippocampus.  In this review, the authors summarize evidence for GABAergic system dysfunction in FXS patients and Fmr1 KO mouse models alike.  The authors then discuss some of the known developmental roles of GABAergic signaling, as well as the development and refinement of GABAergic synapses as a framework for understanding potential causes of mature circuit dysfunction.  Finally, the authors highlight the GABAergic system as a relevant target for the treatment of FXS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3C3Y8B-1_T7Vg90H21EOLACvtfcHk0ljjJ0i0uAoqPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1GktbrO&md5=7077c1b74771767305a35bb5203e0e99</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1159%2F000329420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000329420%26sid%3Dliteratum%253Aachs%26aulast%3DPaluszkiewicz%26aufirst%3DS.%2BM.%26aulast%3DMartin%26aufirst%3DB.%2BS.%26aulast%3DHuntsman%26aufirst%3DM.%2BM.%26atitle%3DFragile%2520X%2520syndrome%253A%2520the%2520GABAergic%2520system%2520and%2520circuit%2520dysfunction%26jtitle%3DDev.%2520Neurosci.%26date%3D2011%26volume%3D33%26spage%3D349%26epage%3D364%26doi%3D10.1159%2F000329420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Chahrour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, H. Y.</span><span> </span><span class="NLM_article-title">The story of Rett syndrome: from clinic to neurobiology</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span><span class="refDoi"> DOI: 10.1016/j.neuron.2007.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuron.2007.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=17988628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2007&pages=422-437&author=M.+Chahrourauthor=H.+Y.+Zoghbi&title=The+story+of+Rett+syndrome%3A+from+clinic+to+neurobiology&doi=10.1016%2Fj.neuron.2007.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The story of Rett syndrome: from clinic to neurobiology</span></div><div class="casAuthors">Chahrour, Maria; Zoghbi, Huda Y.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">422-437</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Mutations in the gene encoding methyl-CpG binding protein 2 (MeCP2), a transcriptional repressor involved in chromatin remodeling and the modulation of RNA splicing.  MECP2 aberrations result in a constellation of neuropsychiatric abnormalities, whereby both loss of function and gain in MECP2 dosage lead to similar neurol. phenotypes.  Recent studies demonstrate disease reversibility in RTT mouse models, suggesting that the neurol. defects in MECP2 disorders are not permanent.  To investigate the potential for restoring neuronal function in RTT patients, it is essential to identify MeCP2 targets or modifiers of the phenotype that can be therapeutically modulated.  Moreover, deciphering the mol. underpinnings of RTT is likely to contribute to the understanding of the pathogenesis of a broader class of neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopG5K6_7b0rrVg90H21EOLACvtfcHk0ljjJ0i0uAoqPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWitrvP&md5=95dd875581895cb15bd31e65d6eb4002</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2007.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2007.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DChahrour%26aufirst%3DM.%26aulast%3DZoghbi%26aufirst%3DH.%2BY.%26atitle%3DThe%2520story%2520of%2520Rett%2520syndrome%253A%2520from%2520clinic%2520to%2520neurobiology%26jtitle%3DNeuron%26date%3D2007%26volume%3D56%26spage%3D422%26epage%3D437%26doi%3D10.1016%2Fj.neuron.2007.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Chao, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samaco, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chahrour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neul, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heintz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubenstein, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noebels, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenmund, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoghbi, H. Y.</span><span> </span><span class="NLM_article-title">Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1038/nature09582</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnature09582" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=263-269&author=H.+T.+Chaoauthor=H.+Chenauthor=R.+C.+Samacoauthor=M.+Xueauthor=M.+Chahrourauthor=J.+Yooauthor=J.+L.+Neulauthor=S.+Gongauthor=H.+C.+Luauthor=N.+Heintzauthor=M.+Ekkerauthor=J.+L.+Rubensteinauthor=J.+L.+Noebelsauthor=C.+Rosenmundauthor=H.+Y.+Zoghbi&title=Dysfunction+in+GABA+signalling+mediates+autism-like+stereotypies+and+Rett+syndrome+phenotypes&doi=10.1038%2Fnature09582"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnature09582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09582%26sid%3Dliteratum%253Aachs%26aulast%3DChao%26aufirst%3DH.%2BT.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSamaco%26aufirst%3DR.%2BC.%26aulast%3DXue%26aufirst%3DM.%26aulast%3DChahrour%26aufirst%3DM.%26aulast%3DYoo%26aufirst%3DJ.%26aulast%3DNeul%26aufirst%3DJ.%2BL.%26aulast%3DGong%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DH.%2BC.%26aulast%3DHeintz%26aufirst%3DN.%26aulast%3DEkker%26aufirst%3DM.%26aulast%3DRubenstein%26aufirst%3DJ.%2BL.%26aulast%3DNoebels%26aufirst%3DJ.%2BL.%26aulast%3DRosenmund%26aufirst%3DC.%26aulast%3DZoghbi%26aufirst%3DH.%2BY.%26atitle%3DDysfunction%2520in%2520GABA%2520signalling%2520mediates%2520autism-like%2520stereotypies%2520and%2520Rett%2520syndrome%2520phenotypes%26jtitle%3DNature%26date%3D2010%26volume%3D468%26spage%3D263%26epage%3D269%26doi%3D10.1038%2Fnature09582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Jeste, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploubidis, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, A.</span><span> </span><span class="NLM_article-title">Characterization of autism in young children with tuberous sclerosis complex</span> <span class="citation_source-journal">J. Child Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span><span class="refDoi"> DOI: 10.1177/0883073807309788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1177%2F0883073807309788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=18160549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD1c3osVemtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=520-525&author=S.+S.+Jesteauthor=M.+Sahinauthor=P.+Boltonauthor=J.+B.+Ploubidisauthor=A.+Humphrey&title=Characterization+of+autism+in+young+children+with+tuberous+sclerosis+complex&doi=10.1177%2F0883073807309788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of autism in young children with tuberous sclerosis complex</span></div><div class="casAuthors">Jeste Shafali S; Sahin Mustafa; Bolton Patrick; Ploubidis George B; Humphrey Ayla</div><div class="citationInfo"><span class="NLM_cas:title">Journal of child neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">520-5</span>
        ISSN:<span class="NLM_cas:issn">0883-0738</span>.
    </div><div class="casAbstract">Both cognitive impairment and autism are common in the tuberous sclerosis complex, but the relationship between the 2 diagnoses has not been formally explored.  The authors evaluated 20 clinic-referred children with tuberous sclerosis complex at ages 18, 24, 36, and 60 months and classified them as autism, autism spectrum disorder, or normal on the basis of the Autism Diagnostic Observation Schedule.  Using the Mullen Scale of Early Learning, cognitive function in each subgroup was assessed.  The authors then analyzed the subscores of the Autism Diagnostic Observation Schedule in children with autism.  Children with autism showed significantly more global cognitive impairment than those without autism.  In addition, all children had some baseline cognitive impairment and the majority had deficits in play scores.  The authors conclude that clinic-referred children with tuberous sclerosis complex and autism are at considerable risk for cognitive impairment.  These characteristics may help to guide more tailored services for these high-risk children.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSb4glqw3lXMbYtC3U5jeOifW6udTcc2eYHMNSQkeqB8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3osVemtg%253D%253D&md5=bbc3eb9869325f2a671ea9d8b02a667b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1177%2F0883073807309788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0883073807309788%26sid%3Dliteratum%253Aachs%26aulast%3DJeste%26aufirst%3DS.%2BS.%26aulast%3DSahin%26aufirst%3DM.%26aulast%3DBolton%26aufirst%3DP.%26aulast%3DPloubidis%26aufirst%3DJ.%2BB.%26aulast%3DHumphrey%26aufirst%3DA.%26atitle%3DCharacterization%2520of%2520autism%2520in%2520young%2520children%2520with%2520tuberous%2520sclerosis%2520complex%26jtitle%3DJ.%2520Child%2520Neurol.%26date%3D2008%26volume%3D23%26spage%3D520%26epage%3D525%26doi%3D10.1177%2F0883073807309788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Han, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahin, M.</span><span> </span><span class="NLM_article-title">TSC1/TSC2 signaling in the CNS</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">585</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">980</span><span class="refDoi"> DOI: 10.1016/j.febslet.2011.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.febslet.2011.02.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=585&publication_year=2011&pages=973-980&author=J.+M.+Hanauthor=M.+Sahin&title=TSC1%2FTSC2+signaling+in+the+CNS&doi=10.1016%2Fj.febslet.2011.02.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2011.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2011.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DJ.%2BM.%26aulast%3DSahin%26aufirst%3DM.%26atitle%3DTSC1%252FTSC2%2520signaling%2520in%2520the%2520CNS%26jtitle%3DFEBS%2520Lett.%26date%3D2011%26volume%3D585%26spage%3D973%26epage%3D980%26doi%3D10.1016%2Fj.febslet.2011.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Rubenstein, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merzenich, M. M.</span><span> </span><span class="NLM_article-title">Model of autism: increased ratio of excitation/inhibition in key neural systems</span> <span class="citation_source-journal">Genes, Brain Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span><span class="refDoi"> DOI: 10.1034/j.1601-183X.2003.00037.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1034%2Fj.1601-183X.2003.00037.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=14606691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD3srivVKnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=255-267&author=J.+L.+Rubensteinauthor=M.+M.+Merzenich&title=Model+of+autism%3A+increased+ratio+of+excitation%2Finhibition+in+key+neural+systems&doi=10.1034%2Fj.1601-183X.2003.00037.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Model of autism: increased ratio of excitation/inhibition in key neural systems</span></div><div class="casAuthors">Rubenstein J L R; Merzenich M M</div><div class="citationInfo"><span class="NLM_cas:title">Genes, brain, and behavior</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">255-67</span>
        ISSN:<span class="NLM_cas:issn">1601-1848</span>.
    </div><div class="casAbstract">Autism is a severe neurobehavioral syndrome, arising largely as an inherited disorder, which can arise from several diseases.  Despite recent advances in identifying some genes that can cause autism, its underlying neurological mechanisms are uncertain.  Autism is best conceptualized by considering the neural systems that may be defective in autistic individuals.  Recent advances in understanding neural systems that process sensory information, various types of memories and social and emotional behaviors are reviewed and compared with known abnormalities in autism.  Then, specific genetic abnormalities that are linked with autism are examined.  Synthesis of this information leads to a model that postulates that some forms of autism are caused by an increased ratio of excitation/inhibition in sensory, mnemonic, social and emotional systems.  The model further postulates that the increased ratio of excitation/inhibition can be caused by combinatorial effects of genetic and environmental variables that impinge upon a given neural system.  Furthermore, the model suggests potential therapeutic interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQjdvqZKnV9JqNc3HjJRoFAfW6udTcc2eYHMNSQkeqB8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3srivVKnug%253D%253D&md5=b446351fe4c91902c5da1bcbdcb9048e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1034%2Fj.1601-183X.2003.00037.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1601-183X.2003.00037.x%26sid%3Dliteratum%253Aachs%26aulast%3DRubenstein%26aufirst%3DJ.%2BL.%26aulast%3DMerzenich%26aufirst%3DM.%2BM.%26atitle%3DModel%2520of%2520autism%253A%2520increased%2520ratio%2520of%2520excitation%252Finhibition%2520in%2520key%2520neural%2520systems%26jtitle%3DGenes%252C%2520Brain%2520Behav.%26date%3D2003%26volume%3D2%26spage%3D255%26epage%3D267%26doi%3D10.1034%2Fj.1601-183X.2003.00037.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Uzunova, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallanti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, E.</span><span> </span><span class="NLM_article-title">Excitatory/inhibitory imbalance in autism spectrum disorders: implications for interventions and therapeutics</span> <span class="citation_source-journal">World J. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.3109/15622975.2015.1085597</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3109%2F15622975.2015.1085597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26469219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC28zhvFehsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=174-186&author=G.+Uzunovaauthor=S.+Pallantiauthor=E.+Hollander&title=Excitatory%2Finhibitory+imbalance+in+autism+spectrum+disorders%3A+implications+for+interventions+and+therapeutics&doi=10.3109%2F15622975.2015.1085597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics</span></div><div class="casAuthors">Uzunova Genoveva; Pallanti Stefano; Hollander Eric; Pallanti Stefano; Pallanti Stefano; Pallanti Stefano</div><div class="citationInfo"><span class="NLM_cas:title">The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">174-86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  Imbalance between excitation and inhibition and increased excitatory-inhibitory (E-I) ratio is a common mechanism in autism spectrum disorders (ASD) that is responsible for the learning and memory, cognitive, sensory, motor deficits, and seizures occurring in these disorders.  ASD are very heterogeneous and better understanding of E-I imbalance in brain will lead to better diagnosis and treatments.  METHODS:  We perform a critical literature review of the causes and presentations of E-I imbalance in ASD.  RESULTS:  E-I imbalance in ASD is due primarily to abnormal glutamatergic and GABAergic neurotransmission in key brain regions such as neocortex, hippocampus, amygdala, and cerebellum.  Other causes are due to dysfunction of neuropeptides (oxytocin), synaptic proteins (neuroligins), and immune system molecules (cytokines).  At the neuropathological level E-I imbalance in ASD is presented as a "minicolumnopathy".  E-I imbalance alters the manner by which the brain processes information and regulates behaviour.  New developments for investigating E-I imbalance such as optogenetics and transcranial magnetic stimulation (TMS) are presented.  Non-invasive brain stimulation methods such as TMS for treatment of the core symptoms of ASD are discussed.  CONCLUSIONS:  Understanding E-I imbalance has important implications for developing better pharmacological and behavioural treatments for ASD, including TMS, new drugs, biomarkers and patient stratification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8n37XrrY07_69nzq6467DfW6udTcc2eZEtauM54MQJ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zhvFehsA%253D%253D&md5=0b0fb016f04f52ac9caeb8a39de6d467</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3109%2F15622975.2015.1085597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F15622975.2015.1085597%26sid%3Dliteratum%253Aachs%26aulast%3DUzunova%26aufirst%3DG.%26aulast%3DPallanti%26aufirst%3DS.%26aulast%3DHollander%26aufirst%3DE.%26atitle%3DExcitatory%252Finhibitory%2520imbalance%2520in%2520autism%2520spectrum%2520disorders%253A%2520implications%2520for%2520interventions%2520and%2520therapeutics%26jtitle%3DWorld%2520J.%2520Biol.%2520Psychiatry%26date%3D2016%26volume%3D17%26spage%3D174%26epage%3D186%26doi%3D10.3109%2F15622975.2015.1085597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Yizhar, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenno, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prigge, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goshen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paz, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehfest, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fudim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramakrishnan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huguenard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegemann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deisseroth, K.</span><span> </span><span class="NLM_article-title">Neocortical excitation/inhibition balance in information processing and social dysfunction</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">477</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span><span class="refDoi"> DOI: 10.1038/nature10360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnature10360" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=477&publication_year=2011&pages=171-178&author=O.+Yizharauthor=L.+E.+Fennoauthor=M.+Priggeauthor=F.+Schneiderauthor=T.+J.+Davidsonauthor=D.+J.+O%E2%80%99Sheaauthor=V.+S.+Sohalauthor=I.+Goshenauthor=J.+Finkelsteinauthor=J.+T.+Pazauthor=K.+Stehfestauthor=R.+Fudimauthor=C.+Ramakrishnanauthor=J.+R.+Huguenardauthor=P.+Hegemannauthor=K.+Deisseroth&title=Neocortical+excitation%2Finhibition+balance+in+information+processing+and+social+dysfunction&doi=10.1038%2Fnature10360"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnature10360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10360%26sid%3Dliteratum%253Aachs%26aulast%3DYizhar%26aufirst%3DO.%26aulast%3DFenno%26aufirst%3DL.%2BE.%26aulast%3DPrigge%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DF.%26aulast%3DDavidson%26aufirst%3DT.%2BJ.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DD.%2BJ.%26aulast%3DSohal%26aufirst%3DV.%2BS.%26aulast%3DGoshen%26aufirst%3DI.%26aulast%3DFinkelstein%26aufirst%3DJ.%26aulast%3DPaz%26aufirst%3DJ.%2BT.%26aulast%3DStehfest%26aufirst%3DK.%26aulast%3DFudim%26aufirst%3DR.%26aulast%3DRamakrishnan%26aufirst%3DC.%26aulast%3DHuguenard%26aufirst%3DJ.%2BR.%26aulast%3DHegemann%26aufirst%3DP.%26aulast%3DDeisseroth%26aufirst%3DK.%26atitle%3DNeocortical%2520excitation%252Finhibition%2520balance%2520in%2520information%2520processing%2520and%2520social%2520dysfunction%26jtitle%3DNature%26date%3D2011%26volume%3D477%26spage%3D171%26epage%3D178%26doi%3D10.1038%2Fnature10360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Dani, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turrigiano, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaenisch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, S. B.</span><span> </span><span class="NLM_article-title">Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">12560</span><span class="NLM_x">–</span> <span class="NLM_lpage">12565</span><span class="refDoi"> DOI: 10.1073/pnas.0506071102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.0506071102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=12560-12565&author=V.+S.+Daniauthor=Q.+Changauthor=A.+Maffeiauthor=G.+G.+Turrigianoauthor=R.+Jaenischauthor=S.+B.+Nelson&title=Reduced+cortical+activity+due+to+a+shift+in+the+balance+between+excitation+and+inhibition+in+a+mouse+model+of+Rett+syndrome&doi=10.1073%2Fpnas.0506071102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0506071102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0506071102%26sid%3Dliteratum%253Aachs%26aulast%3DDani%26aufirst%3DV.%2BS.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DMaffei%26aufirst%3DA.%26aulast%3DTurrigiano%26aufirst%3DG.%2BG.%26aulast%3DJaenisch%26aufirst%3DR.%26aulast%3DNelson%26aufirst%3DS.%2BB.%26atitle%3DReduced%2520cortical%2520activity%2520due%2520to%2520a%2520shift%2520in%2520the%2520balance%2520between%2520excitation%2520and%2520inhibition%2520in%2520a%2520mouse%2520model%2520of%2520Rett%2520syndrome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D12560%26epage%3D12565%26doi%3D10.1073%2Fpnas.0506071102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Pop, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levenga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buijsen, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieuwenhuizen, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasparini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oostra, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willemsen, R.</span><span> </span><span class="NLM_article-title">Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">1227</span><span class="NLM_x">–</span> <span class="NLM_lpage">1235</span><span class="refDoi"> DOI: 10.1007/s00213-012-2947-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs00213-012-2947-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=23254376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKgtbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=2014&pages=1227-1235&author=A.+S.+Popauthor=J.+Levengaauthor=C.+E.+de+Eschauthor=R.+A.+Buijsenauthor=I.+M.+Nieuwenhuizenauthor=T.+Liauthor=A.+Isaacsauthor=F.+Gaspariniauthor=B.+A.+Oostraauthor=R.+Willemsen&title=Rescue+of+dendritic+spine+phenotype+in+Fmr1+KO+mice+with+the+mGluR5+antagonist+AFQ056%2FMavoglurant&doi=10.1007%2Fs00213-012-2947-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant</span></div><div class="casAuthors">Pop, Andreea S.; Levenga, Josien; de Esch, Celine E. F.; Buijsen, Ronald A. M.; Nieuwenhuizen, Ingeborg M.; Li, Tracy; Isaacs, Aaron; Gasparini, Fabrizio; Oostra, Ben A.; Willemsen, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">231</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1227-1235</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Fragile X syndrome (FXS) is the leading monogenic cause of intellectual disability and autism.  The disease is a result of lack of expression of the fragile X mental retardation protein.  Brain tissues of patients with FXS and mice with FMRP deficiency have shown an abnormal dendritic spine phenotype.  We investigated the dendritic spine length and d. of hippocampal CA1 pyramidal neurons in 2-, 10-, and 25-wk-old Fmr1 knockout (KO).  Next, we studied the effects of long-term treatment with an mGluR5 antagonist, AFQ056/Mavoglurant, on the spine phenotype in adult Fmr1 KO mice.  We obsd. alterations in the spine phenotype during development, with a decreased spine length in 2-wk-old Fmr1 KO mice compared with age-match wild-type littermates, but with increased spine length in Fmr1 KO mice compared with 10- and 25-wk-old wild-type controls.  No difference was found in spine d. at any age.  We report a rescue of the abnormal spine length in adult Fmr1 KO mice after a long-term treatment with AFQ056/Mavoglurant.  This finding suggests that long-term treatment at later stage is sufficient to reverse the structural spine abnormalities and represents a starting point for future studies aimed at improving treatments for FXS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt2oI77gxPsrVg90H21EOLACvtfcHk0ljsSUXueUvFPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKgtbrN&md5=f27f7213f095d039cab261855c8c54c4</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1007%2Fs00213-012-2947-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-012-2947-y%26sid%3Dliteratum%253Aachs%26aulast%3DPop%26aufirst%3DA.%2BS.%26aulast%3DLevenga%26aufirst%3DJ.%26aulast%3Dde%2BEsch%26aufirst%3DC.%2BE.%26aulast%3DBuijsen%26aufirst%3DR.%2BA.%26aulast%3DNieuwenhuizen%26aufirst%3DI.%2BM.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DIsaacs%26aufirst%3DA.%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DOostra%26aufirst%3DB.%2BA.%26aulast%3DWillemsen%26aufirst%3DR.%26atitle%3DRescue%2520of%2520dendritic%2520spine%2520phenotype%2520in%2520Fmr1%2520KO%2520mice%2520with%2520the%2520mGluR5%2520antagonist%2520AFQ056%252FMavoglurant%26jtitle%3DPsychopharmacology%26date%3D2014%26volume%3D231%26spage%3D1227%26epage%3D1235%26doi%3D10.1007%2Fs00213-012-2947-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmitte, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Practical strategies and concepts in GPCR allosteric modulator discovery: recent advances with metabotropic glutamate receptors</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">6707</span><span class="NLM_x">–</span> <span class="NLM_lpage">6741</span><span class="refDoi"> DOI: 10.1021/acs.chemrev.5b00656</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.5b00656" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFahsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=6707-6741&author=C.+W.+Lindsleyauthor=K.+A.+Emmitteauthor=C.+R.+Hopkinsauthor=T.+M.+Bridgesauthor=K.+J.+Gregoryauthor=C.+M.+Niswenderauthor=P.+J.+Conn&title=Practical+strategies+and+concepts+in+GPCR+allosteric+modulator+discovery%3A+recent+advances+with+metabotropic+glutamate+receptors&doi=10.1021%2Facs.chemrev.5b00656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors</span></div><div class="casAuthors">Lindsley, Craig W.; Emmitte, Kyle A.; Hopkins, Corey R.; Bridges, Thomas M.; Gregory, Karen J.; Niswender, Colleen M.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6707-6741</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Allosteric modulation of GPCRs has initiated a new era of basic and translational discovery, filled with therapeutic promise yet fraught with caveats.  Allosteric ligands stabilize unique conformations of the GPCR that afford fundamentally new receptors, capable of novel pharmacol., unprecedented subtype selectivity, and unique signal bias.  This review provides a comprehensive overview of the basics of GPCR allosteric pharmacol., medicinal chem., drug metab., and validated approaches to address each of the major challenges and caveats.  Then, the review narrows focus to highlight recent advances in the discovery of allosteric ligands for metabotropic glutamate receptor subtypes 1-5 and 7 (mGlu1-5,7) highlighting key concepts ("mol. switches", signal bias, heterodimers) and practical solns. to enable the development of tool compds. and clin. candidates.  The review closes with a section on late-breaking new advances with allosteric ligands for other GPCRs and emerging data for endogenous allosteric modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq18XJrjVel-7Vg90H21EOLACvtfcHk0lgzWKV79ZDFcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFahsr8%253D&md5=c12704b6602b6c50add92e7fd9350382</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.5b00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.5b00656%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DPractical%2520strategies%2520and%2520concepts%2520in%2520GPCR%2520allosteric%2520modulator%2520discovery%253A%2520recent%2520advances%2520with%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DChem.%2520Rev.%26date%3D2016%26volume%3D116%26spage%3D6707%26epage%3D6741%26doi%3D10.1021%2Facs.chemrev.5b00656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Silverman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolu, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barkan, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawley, J. N.</span><span> </span><span class="NLM_article-title">Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">976</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span><span class="refDoi"> DOI: 10.1038/npp.2009.201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnpp.2009.201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20032969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslOju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=976-989&author=J.+L.+Silvermanauthor=S.+S.+Toluauthor=C.+L.+Barkanauthor=J.+N.+Crawley&title=Repetitive+self-grooming+behavior+in+the+BTBR+mouse+model+of+autism+is+blocked+by+the+mGluR5+antagonist+MPEP&doi=10.1038%2Fnpp.2009.201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Repetitive Self-Grooming Behavior in the BTBR Mouse Model of Autism is Blocked by the mGluR5 Antagonist MPEP</span></div><div class="casAuthors">Silverman, Jill L.; Tolu, Seda S.; Barkan, Charlotte L.; Crawley, Jacqueline N.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">976-989</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autism is a neurodevelopmental disorder characterized by abnormal reciprocal social interactions, communication deficits, and repetitive behaviors with restricted interests.  BTBR T+tf/J (BTBR) is an inbred mouse strain that shows robust behavioral phenotypes with analogies to all three of the diagnostic symptoms of autism, including well-replicated deficits in reciprocal social interactions and social approach, unusual patterns of ultrasonic vocalization, and high levels of repetitive self-grooming.  These phenotypes offer straightforward behavioral assays for translational investigations of pharmacol. compds.  Two suggested treatments for autism were evaluated in the BTBR mouse model.  Methyl-6-phenylethynyl-pyridine (MPEP), an antagonist of the mGluR5 metabotropic glutamate receptor, blocks aberrant phenotypes in the Fmr1 mouse model of Fragile X, a comorbid neurodevelopmental disorder with autistic features.  Risperidone has been approved by the United States Food and Drug Administration for the treatment of irritability, tantrums, and self-injurious behavior in autistic individuals.  We evaluated the actions of MPEP and risperidone on two BTBR phenotypes, low sociability and high repetitive self-grooming.  Open field activity served as an independent control for non-social exploratory activity and motor functions.  C57BL/6J (B6), an inbred strain with high sociability and low self-grooming, served as the strain control.  MPEP significantly reduced repetitive self-grooming in BTBR, at doses that had no sedating effects on open field activity.  Risperidone reduced repetitive self-grooming in BTBR, but only at doses that induced sedation in both strains.  No overall improvements in sociability were detected in BTBR after treatment with either MPEP or risperidone.  Our findings suggest that antagonists of mGluR5 receptors may have selective therapeutic efficacy in treating repetitive behaviors in autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXnIAZEZ9t_LVg90H21EOLACvtfcHk0lgzWKV79ZDFcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslOju7Y%253D&md5=173070defb6ae57acd383e335fcb1013</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2009.201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2009.201%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DJ.%2BL.%26aulast%3DTolu%26aufirst%3DS.%2BS.%26aulast%3DBarkan%26aufirst%3DC.%2BL.%26aulast%3DCrawley%26aufirst%3DJ.%2BN.%26atitle%3DRepetitive%2520self-grooming%2520behavior%2520in%2520the%2520BTBR%2520mouse%2520model%2520of%2520autism%2520is%2520blocked%2520by%2520the%2520mGluR5%2520antagonist%2520MPEP%26jtitle%3DNeuropsychopharmacology%26date%3D2010%26volume%3D35%26spage%3D976%26epage%3D989%26doi%3D10.1038%2Fnpp.2009.201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Silverman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karras, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolu, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawley, J. N.</span><span> </span><span class="NLM_article-title">Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">131ra51</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3003501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1126%2Fscitranslmed.3003501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22539775" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=131ra51&author=J.+L.+Silvermanauthor=D.+G.+Smithauthor=S.+J.+Rizzoauthor=M.+N.+Karrasauthor=S.+M.+Turnerauthor=S.+S.+Toluauthor=D.+K.+Bryceauthor=D.+L.+Smithauthor=K.+Fonsecaauthor=R.+H.+Ringauthor=J.+N.+Crawley&title=Negative+allosteric+modulation+of+the+mGluR5+receptor+reduces+repetitive+behaviors+and+rescues+social+deficits+in+mouse+models+of+autism&doi=10.1126%2Fscitranslmed.3003501"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003501%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DJ.%2BL.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DRizzo%26aufirst%3DS.%2BJ.%26aulast%3DKarras%26aufirst%3DM.%2BN.%26aulast%3DTurner%26aufirst%3DS.%2BM.%26aulast%3DTolu%26aufirst%3DS.%2BS.%26aulast%3DBryce%26aufirst%3DD.%2BK.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DFonseca%26aufirst%3DK.%26aulast%3DRing%26aufirst%3DR.%2BH.%26aulast%3DCrawley%26aufirst%3DJ.%2BN.%26atitle%3DNegative%2520allosteric%2520modulation%2520of%2520the%2520mGluR5%2520receptor%2520reduces%2520repetitive%2520behaviors%2520and%2520rescues%2520social%2520deficits%2520in%2520mouse%2520models%2520of%2520autism%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D131ra51%26doi%3D10.1126%2Fscitranslmed.3003501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Seese, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maske, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gall, C. M.</span><span> </span><span class="NLM_article-title">Long-term memory deficits are associated with elevated synaptic ERK1/2 activation and reversed by mGluR5 antagonism in an animal model of autism</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1664</span><span class="NLM_x">–</span> <span class="NLM_lpage">1673</span><span class="refDoi"> DOI: 10.1038/npp.2014.13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnpp.2014.13" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=1664-1673&author=R.+R.+Seeseauthor=A.+R.+Maskeauthor=G.+Lynchauthor=C.+M.+Gall&title=Long-term+memory+deficits+are+associated+with+elevated+synaptic+ERK1%2F2+activation+and+reversed+by+mGluR5+antagonism+in+an+animal+model+of+autism&doi=10.1038%2Fnpp.2014.13"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2014.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2014.13%26sid%3Dliteratum%253Aachs%26aulast%3DSeese%26aufirst%3DR.%2BR.%26aulast%3DMaske%26aufirst%3DA.%2BR.%26aulast%3DLynch%26aufirst%3DG.%26aulast%3DGall%26aufirst%3DC.%2BM.%26atitle%3DLong-term%2520memory%2520deficits%2520are%2520associated%2520with%2520elevated%2520synaptic%2520ERK1%252F2%2520activation%2520and%2520reversed%2520by%2520mGluR5%2520antagonism%2520in%2520an%2520animal%2520model%2520of%2520autism%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D1664%26epage%3D1673%26doi%3D10.1038%2Fnpp.2014.13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Mehta, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandal, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, S. J.</span><span> </span><span class="NLM_article-title">mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e26077</span><span class="refDoi"> DOI: 10.1371/journal.pone.0026077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1371%2Fjournal.pone.0026077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e26077&author=M.+V.+Mehtaauthor=M.+J.+Gandalauthor=S.+J.+Siegel&title=mGluR5-antagonist+mediated+reversal+of+elevated+stereotyped%2C+repetitive+behaviors+in+the+VPA+model+of+autism&doi=10.1371%2Fjournal.pone.0026077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0026077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0026077%26sid%3Dliteratum%253Aachs%26aulast%3DMehta%26aufirst%3DM.%2BV.%26aulast%3DGandal%26aufirst%3DM.%2BJ.%26aulast%3DSiegel%26aufirst%3DS.%2BJ.%26atitle%3DmGluR5-antagonist%2520mediated%2520reversal%2520of%2520elevated%2520stereotyped%252C%2520repetitive%2520behaviors%2520in%2520the%2520VPA%2520model%2520of%2520autism%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De26077%26doi%3D10.1371%2Fjournal.pone.0026077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Rocher, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boléa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lütjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epping-Jordan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessis, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutel, V.</span><span> </span><span class="NLM_article-title">mGluR5 negative allosteric modulators overview: a medicinal chemistry approach towards a series of novel therapeutic agents</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">680</span><span class="NLM_x">–</span> <span class="NLM_lpage">695</span><span class="refDoi"> DOI: 10.2174/1568026611109060680</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.2174%2F1568026611109060680" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21261592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSmsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=680-695&author=J.+P.+Rocherauthor=B.+Bonnetauthor=C.+Bol%C3%A9aauthor=R.+L%C3%BCtjensauthor=E.+Le+Poulauthor=S.+Poliauthor=M.+Epping-Jordanauthor=A.+S.+Bessisauthor=B.+Ludwigauthor=V.+Mutel&title=mGluR5+negative+allosteric+modulators+overview%3A+a+medicinal+chemistry+approach+towards+a+series+of+novel+therapeutic+agents&doi=10.2174%2F1568026611109060680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">mGluR5 negative allosteric modulators overview: a medicinal chemistry approach towards a series of novel therapeutic agents</span></div><div class="casAuthors">Rocher, Jean-Philippe; Bonnet, Beatrice; Bolea, Christelle; Lutjens, Robert; Le Poul, Emmanuel; Poli, Sonia; Epping-Jordan, Mark; Bessis, Anne-Sophie; Ludwig, Bernard; Mutel, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">680-695</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Allosteric modulators of metabotropic glutamate receptors (mGluRs) subtypes 1-8 have been shown to offer a valid way to develop small mol. non aminoacid-like therapeutics that can be administered orally and that readily cross the blood-brain barrier.  Allosteric modulators of glutamatergic receptors and in particular mGluR5 have emerged as a novel and highly desirable class of compds. for the treatment of central nervous system (CNS) disorders and peripheral disorders.  This article provides medicinal chem. highlights around the chem. classes of potent and highly selective mGluR5 neg. allosteric modulators (NAMs) and their therapeutic potential.  In addn., it describes the medicinal chem. approach from the discovery to the clin. candidate selection of a new series of heteroaryl-butynylpyridines targeting mGluR5.  The multiparametric optimization of the initial starting point which ended in the selection of potential clin. candidates combining the best pharmacophoric features is presented.  The pharmacol. properties are reported and support the interest of these agents for new therapeutic approaches.  Furthermore, a summary of the diverse mGluR5 Positron Emission Tomog. (PET) radioligands is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeXrv5HnHG77Vg90H21EOLACvtfcHk0liJuDj6q0-_ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSmsrw%253D&md5=aab29725fa93c1895f32f7dbe93a16f1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.2174%2F1568026611109060680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026611109060680%26sid%3Dliteratum%253Aachs%26aulast%3DRocher%26aufirst%3DJ.%2BP.%26aulast%3DBonnet%26aufirst%3DB.%26aulast%3DBol%25C3%25A9a%26aufirst%3DC.%26aulast%3DL%25C3%25BCtjens%26aufirst%3DR.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DEpping-Jordan%26aufirst%3DM.%26aulast%3DBessis%26aufirst%3DA.%2BS.%26aulast%3DLudwig%26aufirst%3DB.%26aulast%3DMutel%26aufirst%3DV.%26atitle%3DmGluR5%2520negative%2520allosteric%2520modulators%2520overview%253A%2520a%2520medicinal%2520chemistry%2520approach%2520towards%2520a%2520series%2520of%2520novel%2520therapeutic%2520agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D680%26epage%3D695%26doi%3D10.2174%2F1568026611109060680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Emmitte, K. A.</span><span> </span><span class="NLM_article-title">Recent advances in the design and development of novel negative allosteric modulators of mGlu5</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span><span class="refDoi"> DOI: 10.1021/cn2000266</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn2000266" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVWjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=411-432&author=K.+A.+Emmitte&title=Recent+advances+in+the+design+and+development+of+novel+negative+allosteric+modulators+of+mGlu5&doi=10.1021%2Fcn2000266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the design and development of novel negative allosteric modulators of mGlu5</span></div><div class="casAuthors">Emmitte, Kyle A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">411-432</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Neg. allosteric modulators (NAMs) of metabotropic glutamate receptor subtype 5 (mGlu5) have remained attractive to researchers as potential therapies for a no. of central nervous system related diseases, including anxiety, pain, gastroesophageal reflux disease (GERD), addiction, Parkinson's disease (PD), and fragile X syndrome (FXS).  In addn. to the many publications with supportive preclin. data with key tool mols., recent pos. reports from the clinic have bolstered the confidence in this approach.  During the 2 yr time span from 2009 through 2010, a no. of new mGlu5 NAM chemotypes have been disclosed and discussed in the primary and patent literature.  A summary of several efforts representing many diverse chemotypes are presented here, along with a discussion of representative structure-activity relationships (SAR) and synthetic approaches to the templates where possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs7RmgtM8r7LVg90H21EOLACvtfcHk0liJuDj6q0-_ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVWjsbs%253D&md5=ac71bcd9a9deb35fbfbfa4b26edcd3cf</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fcn2000266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn2000266%26sid%3Dliteratum%253Aachs%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26atitle%3DRecent%2520advances%2520in%2520the%2520design%2520and%2520development%2520of%2520novel%2520negative%2520allosteric%2520modulators%2520of%2520mGlu5%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D411%26epage%3D432%26doi%3D10.1021%2Fcn2000266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">de Vrij, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levenga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Linde, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koekkoek, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Zeeuw, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oostra, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willemsen, R.</span><span> </span><span class="NLM_article-title">Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1016/j.nbd.2008.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.nbd.2008.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=18571098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsF2ltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2008&pages=127-132&author=F.+M.+de+Vrijauthor=J.+Levengaauthor=H.+C.+van+der+Lindeauthor=S.+K.+Koekkoekauthor=C.+I.+De+Zeeuwauthor=D.+L.+Nelsonauthor=B.+A.+Oostraauthor=R.+Willemsen&title=Rescue+of+behavioral+phenotype+and+neuronal+protrusion+morphology+in+Fmr1+KO+mice&doi=10.1016%2Fj.nbd.2008.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice</span></div><div class="casAuthors">de Vrij, Femke M. S.; Levenga, Josien; van der Linde, Herma C.; Koekkoek, Sebastiaan K.; De Zeeuw, Chris I.; Nelson, David L.; Oostra, Ben A.; Willemsen, Rob</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Lack of fragile X mental retardation protein (FMRP) causes Fragile X Syndrome, the most common form of inherited mental retardation.  FMRP is an RNA-binding protein and is a component of messenger ribonucleoprotein complexes, assocd. with brain polyribosomes, including dendritic polysomes.  FMRP is therefore thought to be involved in translational control of specific mRNAs at synaptic sites.  In mice lacking FMRP, protein synthesis-dependent synaptic plasticity is altered and structural malformations of dendritic protrusions occur.  One hypothesized cause of the disease mechanism is based on exaggerated group I mGluR receptor activation.  In this study, we examd. the effect of the mGluR5 antagonist MPEP on Fragile X related behavior in Fmr1 KO mice.  Our results demonstrate a clear defect in prepulse inhibition of startle in Fmr1 KO mice, that could be rescued by MPEP.  Moreover, we show for the first time a structural rescue of Fragile X related protrusion morphol. with two independent mGluR5 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8B9SAxzKhy7Vg90H21EOLACvtfcHk0liJuDj6q0-_ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsF2ltrc%253D&md5=a643f104d26db67e7a6020bddc31fbe4</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2008.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2008.04.002%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVrij%26aufirst%3DF.%2BM.%26aulast%3DLevenga%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BLinde%26aufirst%3DH.%2BC.%26aulast%3DKoekkoek%26aufirst%3DS.%2BK.%26aulast%3DDe%2BZeeuw%26aufirst%3DC.%2BI.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DOostra%26aufirst%3DB.%2BA.%26aulast%3DWillemsen%26aufirst%3DR.%26atitle%3DRescue%2520of%2520behavioral%2520phenotype%2520and%2520neuronal%2520protrusion%2520morphology%2520in%2520Fmr1%2520KO%2520mice%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2008%26volume%3D31%26spage%3D127%26epage%3D132%26doi%3D10.1016%2Fj.nbd.2008.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Ceccarelli, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeschke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buettelmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huwyler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolczewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinssen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span> </span><span class="NLM_article-title">Rational design, synthesis, and structure-activity relationship of benzoxazolones: new potent mGlu5 receptor antagonists based on the fenobam structure</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1302</span><span class="NLM_x">–</span> <span class="NLM_lpage">1306</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bmcl.2006.12.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1302-1306&author=S.+M.+Ceccarelliauthor=G.+Jaeschkeauthor=B.+Buettelmannauthor=J.+Huwylerauthor=S.+Kolczewskiauthor=J.+U.+Petersauthor=E.+Prinssenauthor=R.+Porterauthor=W.+Spoorenauthor=E.+Vieira&title=Rational+design%2C+synthesis%2C+and+structure-activity+relationship+of+benzoxazolones%3A+new+potent+mGlu5+receptor+antagonists+based+on+the+fenobam+structure&doi=10.1016%2Fj.bmcl.2006.12.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DCeccarelli%26aufirst%3DS.%2BM.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DBuettelmann%26aufirst%3DB.%26aulast%3DHuwyler%26aufirst%3DJ.%26aulast%3DKolczewski%26aufirst%3DS.%26aulast%3DPeters%26aufirst%3DJ.%2BU.%26aulast%3DPrinssen%26aufirst%3DE.%26aulast%3DPorter%26aufirst%3DR.%26aulast%3DSpooren%26aufirst%3DW.%26aulast%3DVieira%26aufirst%3DE.%26atitle%3DRational%2520design%252C%2520synthesis%252C%2520and%2520structure-activity%2520relationship%2520of%2520benzoxazolones%253A%2520new%2520potent%2520mGlu5%2520receptor%2520antagonists%2520based%2520on%2520the%2520fenobam%2520structure%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1302%26epage%3D1306%26doi%3D10.1016%2Fj.bmcl.2006.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Vranesic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ofner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flor, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilbe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouhelal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desrayaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasparini, F.</span><span> </span><span class="NLM_article-title">AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: identification, SAR and pharmacological characterization</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5790</span><span class="NLM_x">–</span> <span class="NLM_lpage">5803</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bmc.2014.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25316499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslGns7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=5790-5803&author=I.+Vranesicauthor=S.+Ofnerauthor=P.+J.+Florauthor=G.+Bilbeauthor=R.+Bouhelalauthor=A.+Enzauthor=S.+Desrayaudauthor=K.+McAllisterauthor=R.+Kuhnauthor=F.+Gasparini&title=AFQ056%2Fmavoglurant%2C+a+novel+clinically+effective+mGluR5+antagonist%3A+identification%2C+SAR+and+pharmacological+characterization&doi=10.1016%2Fj.bmc.2014.09.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: Identification, SAR and pharmacological characterization</span></div><div class="casAuthors">Vranesic, Ivo; Ofner, Silvio; Flor, Peter Josef; Bilbe, Graeme; Bouhelal, Rochdi; Enz, Albert; Desrayaud, Sandrine; McAllister, Kevin; Kuhn, Rainer; Gasparini, Fabrizio</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5790-5803</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here we describe the identification, structure-activity relation and the initial pharmacol. characterization of AFQ056/mavoglurant, a structurally novel, non-competitive mGlu5 receptor antagonist.  AFQ056/mavoglurant was identified by chem. derivatization of a lead compd. discovered in a HTS campaign.  In vitro, AFQ056/mavoglurant had an IC50 of 30 nM in a functional assay with human mGluR5 and was selective over the other mGluR subtypes, iGluRs and a panel of 238 CNS relevant receptors, transporter or enzymes.  In vivo, AFQ056/mavoglurant showed an improved pharmacokinetic profile in rat and efficacy in the stress-induced hyperthermia test in mice as compared to the prototypic mGluR5 antagonist MPEP.  The efficacy of AFQ056/mavoglurant in humans has been assessed in L-dopa induced dyskinesia in Parkinson's disease and Fragile X syndrome in proof of principle clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomfnTAWNW_RbVg90H21EOLACvtfcHk0ljqm2RHZHYx0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslGns7bJ&md5=a34ab6585a186730f2fbf09d8c97180c</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DVranesic%26aufirst%3DI.%26aulast%3DOfner%26aufirst%3DS.%26aulast%3DFlor%26aufirst%3DP.%2BJ.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DBouhelal%26aufirst%3DR.%26aulast%3DEnz%26aufirst%3DA.%26aulast%3DDesrayaud%26aufirst%3DS.%26aulast%3DMcAllister%26aufirst%3DK.%26aulast%3DKuhn%26aufirst%3DR.%26aulast%3DGasparini%26aufirst%3DF.%26atitle%3DAFQ056%252Fmavoglurant%252C%2520a%2520novel%2520clinically%2520effective%2520mGluR5%2520antagonist%253A%2520identification%252C%2520SAR%2520and%2520pharmacological%2520characterization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D5790%26epage%3D5803%26doi%3D10.1016%2Fj.bmc.2014.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Scharf, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeschke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettstein, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindemann, L.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptor 5 as drug target for Fragile X syndrome</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">124</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span><span class="refDoi"> DOI: 10.1016/j.coph.2014.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.coph.2014.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25488569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVWrsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=124-134&author=S.+H.+Scharfauthor=G.+Jaeschkeauthor=J.+G.+Wettsteinauthor=L.+Lindemann&title=Metabotropic+glutamate+receptor+5+as+drug+target+for+Fragile+X+syndrome&doi=10.1016%2Fj.coph.2014.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic glutamate receptor 5 as drug target for Fragile X syndrome</span></div><div class="casAuthors">Scharf, Sebastian H.; Jaeschke, Georg; Wettstein, Joseph G.; Lindemann, Lothar</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">124-134</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Fragile X syndrome (FXS) is the most common monogenic form of inherited mental retardation caused by a trinucleotid repeat expansion and transcriptional shutdown of the FMR1 gene.  FXS patients present a complex and often severe neuropsychiatric phenotype yet have mild somatic symptoms, normal life expectancies, and no indications of neurodegeneration.  The therapeutic potential of mGlu5 inhibitors was proposed in the 'mGluR theory of FXS' based on early insights into the mol. pathophysiol. of FXS.  Studies in Fragile X mental retardation 1 (Fmr1) knock-out mice, a widely used disease model, demonstrated that mGlu5 inhibitors can correct a broad range of disease-related phenotypes.  Recent clin. trials, however, with two different mGlu5 inhibitors (basimglurant and mavoglurant) showed no therapeutic benefit in FXS patients for reasons as yet unclear.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbD6x0TJKC0rVg90H21EOLACvtfcHk0ljqm2RHZHYx0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVWrsb7E&md5=242f124e6c5e0100b197e29d8f70865a</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2014.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2014.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DScharf%26aufirst%3DS.%2BH.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26aulast%3DLindemann%26aufirst%3DL.%26atitle%3DMetabotropic%2520glutamate%2520receptor%25205%2520as%2520drug%2520target%2520for%2520Fragile%2520X%2520syndrome%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2015%26volume%3D20%26spage%3D124%26epage%3D134%26doi%3D10.1016%2Fj.coph.2014.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Jaeschke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolczewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitter-Stoll, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boissin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büttelmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccarelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huwyler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuratli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niederhauser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pähler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinssen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurr, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tännler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettstein, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindemann, L.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1<i>H</i>-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1358</span><span class="NLM_x">–</span> <span class="NLM_lpage">1371</span><span class="refDoi"> DOI: 10.1021/jm501642c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501642c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1358-1371&author=G.+Jaeschkeauthor=S.+Kolczewskiauthor=W.+Spoorenauthor=E.+Vieiraauthor=N.+Bitter-Stollauthor=P.+Boissinauthor=E.+Borroniauthor=B.+B%C3%BCttelmannauthor=S.+Ceccarelliauthor=N.+Clemannauthor=B.+Davidauthor=C.+Funkauthor=W.+Gubaauthor=A.+Harrisonauthor=T.+Hartungauthor=M.+Honerauthor=J.+Huwylerauthor=M.+Kuratliauthor=U.+Niederhauserauthor=A.+P%C3%A4hlerauthor=J.+U.+Petersauthor=A.+Petersenauthor=E.+Prinssenauthor=A.+Ricciauthor=D.+Rueherauthor=M.+Rueherauthor=M.+Schneiderauthor=P.+Spurrauthor=T.+Stollauthor=D.+T%C3%A4nnlerauthor=J.+Wichmannauthor=R.+H.+Porterauthor=J.+G.+Wettsteinauthor=L.+Lindemann&title=Metabotropic+glutamate+receptor+5+negative+allosteric+modulators%3A+discovery+of+2-chloro-4-%5B1-%284-fluorophenyl%29-2%2C5-dimethyl-1H-imidazol-4-ylethynyl%5Dpyridine+%28basimglurant%2C+RO4917523%29%2C+a+promising+novel+medicine+for+psychiatric+diseases&doi=10.1021%2Fjm501642c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm501642c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501642c%26sid%3Dliteratum%253Aachs%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DKolczewski%26aufirst%3DS.%26aulast%3DSpooren%26aufirst%3DW.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DBitter-Stoll%26aufirst%3DN.%26aulast%3DBoissin%26aufirst%3DP.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DB%25C3%25BCttelmann%26aufirst%3DB.%26aulast%3DCeccarelli%26aufirst%3DS.%26aulast%3DClemann%26aufirst%3DN.%26aulast%3DDavid%26aufirst%3DB.%26aulast%3DFunk%26aufirst%3DC.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DHarrison%26aufirst%3DA.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DHoner%26aufirst%3DM.%26aulast%3DHuwyler%26aufirst%3DJ.%26aulast%3DKuratli%26aufirst%3DM.%26aulast%3DNiederhauser%26aufirst%3DU.%26aulast%3DP%25C3%25A4hler%26aufirst%3DA.%26aulast%3DPeters%26aufirst%3DJ.%2BU.%26aulast%3DPetersen%26aufirst%3DA.%26aulast%3DPrinssen%26aufirst%3DE.%26aulast%3DRicci%26aufirst%3DA.%26aulast%3DRueher%26aufirst%3DD.%26aulast%3DRueher%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DSpurr%26aufirst%3DP.%26aulast%3DStoll%26aufirst%3DT.%26aulast%3DT%25C3%25A4nnler%26aufirst%3DD.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DPorter%26aufirst%3DR.%2BH.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26aulast%3DLindemann%26aufirst%3DL.%26atitle%3DMetabotropic%2520glutamate%2520receptor%25205%2520negative%2520allosteric%2520modulators%253A%2520discovery%2520of%25202-chloro-4-%255B1-%25284-fluorophenyl%2529-2%252C5-dimethyl-1H-imidazol-4-ylethynyl%255Dpyridine%2520%2528basimglurant%252C%2520RO4917523%2529%252C%2520a%2520promising%2520novel%2520medicine%2520for%2520psychiatric%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1358%26epage%3D1371%26doi%3D10.1021%2Fjm501642c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Munshi, K.; Pawlowski, K.; Gonzalez-Heydrich, J.; Picker, J. D.</span><span> </span><span class="NLM_article-title">Review of salient investigational drugs for the treatment of fragile X syndrome</span>.  <span class="citation_source-journal">J. Child Adolesc. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1089/cap.2016.0200</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1089%2Fcap.2016.0200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=28475355" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=K.+Munshi&author=K.+Pawlowski&author=J.+Gonzalez-Heydrich&author=J.+D.+Picker&title=Review+of+salient+investigational+drugs+for+the+treatment+of+fragile+X+syndrome&doi=10.1089%2Fcap.2016.0200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1089%2Fcap.2016.0200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcap.2016.0200%26sid%3Dliteratum%253Aachs%26aulast%3DMunshi%26aufirst%3DK.%26atitle%3DReview%2520of%2520salient%2520investigational%2520drugs%2520for%2520the%2520treatment%2520of%2520fragile%2520X%2520syndrome%26jtitle%3DJ.%2520Child%2520Adolesc.%2520Psychopharmacol.%26date%3D2017%26doi%3D10.1089%2Fcap.2016.0200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manka, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">A novel metabotropic glutamate receptor 5 positive allosteric modulator acts at a unique site and confers stimulus bias to mGlu5 signaling</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">847</span><span class="refDoi"> DOI: 10.1124/mol.112.082891</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1124%2Fmol.112.082891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=23348500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsVyrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2013&pages=835-847&author=M.+J.+Noetzelauthor=K.+J.+Gregoryauthor=P.+N.+Vinsonauthor=J.+T.+Mankaauthor=S.+R.+Staufferauthor=C.+W.+Lindsleyauthor=C.+M.+Niswenderauthor=Z.+Xiangauthor=P.+J.+Conn&title=A+novel+metabotropic+glutamate+receptor+5+positive+allosteric+modulator+acts+at+a+unique+site+and+confers+stimulus+bias+to+mGlu5+signaling&doi=10.1124%2Fmol.112.082891"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">A novel metabotropic glutamate receptor 5 positive allosteric modulator acts at a unique site and confers stimulus bias to mGlu5 signaling</span></div><div class="casAuthors">Noetzel, M. J.; Gregory, K. J.; Vinson, P. N.; Manka, J. T.; Stauffer, S. R.; Lindsley, C. W.; Niswender, C. M.; Xiang, Z.; Conn, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">835-847</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Metabotropic glutamate receptor 5 (mGlu5) is a target for the treatment of central nervous system (CNS) disorders, such as schizophrenia and Alzheimer's disease.  Furthermore, mGlu5 has been shown to play an important role in hippocampal synaptic plasticity, specifically in long-term depression (LTD) and long-term potentiation (LTP), which is thought to be involved in cognition.  Multiple mGlu5-pos. allosteric modulators (PAMs) have been developed from a variety of different scaffolds.  Previous work has extensively characterized a common allosteric site on mGlu5, termed the MPEP (2-Methyl-6-(phenylethynyl)pyridine) binding site.  However, one mGlu5 PAM, CPPHA (N-(4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl)-2-hydroxybenzamide), interacts with a sep. allosteric site on mGlu5.  Using cell-based assays and brain slice prepns., we characterized the interaction of a potent and efficacious mGlu5 PAM from the CPPHA series termed NCFP (N-(4-chloro-2-((4-fluoro-1,3-dioxoisoindolin-2-yl)methyl)phenyl)picolinamide).  NCFP binds to the CPPHA site on mGlu5 and potentiates mGlu5-mediated responses in both recombinant and native systems.  However, NCFP provides greater mGlu5 subtype selectivity than does CPPHA, making it more suitable for studies of effects on mGlu5 in CNS prepns.  Of interest, NCFP does not potentiate responses involved in hippocampal synaptic plasticity (LTD/LTP), setting it apart from other previously characterized MPEP site PAMs.  This suggests that although mGlu5 PAMs may have similar responses in some systems, they can induce differential effects on mGlu5-mediated physiol. responses in the CNS.  Such stimulus bias by mGlu5 PAMs may complicate drug discovery efforts but would also allow for specifically tailored therapies, if pharmacol. biases can be attributed to different therapeutic outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrBH7IPviPNbVg90H21EOLACvtfcHk0lhIFLjnX4rnvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsVyrt7s%253D&md5=175d8e7aef535a8df57a73420200c8b0</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1124%2Fmol.112.082891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.112.082891%26sid%3Dliteratum%253Aachs%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DManka%26aufirst%3DJ.%2BT.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DA%2520novel%2520metabotropic%2520glutamate%2520receptor%25205%2520positive%2520allosteric%2520modulator%2520acts%2520at%2520a%2520unique%2520site%2520and%2520confers%2520stimulus%2520bias%2520to%2520mGlu5%2520signaling%26jtitle%3DMol.%2520Pharmacol.%26date%3D2013%26volume%3D83%26spage%3D835%26epage%3D847%26doi%3D10.1124%2Fmol.112.082891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Rook, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noetzel, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pouliot, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogliotti, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manka, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudek, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Unique signaling profiles of positive allosteric modulators of mGlu5 determine differences in in vivo activity</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2012.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.biopsych.2012.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=23140665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GktLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=501-509&author=J.+M.+Rookauthor=M.+J.+Noetzelauthor=W.+A.+Pouliotauthor=T.+M.+Bridgesauthor=P.+N.+Vinsonauthor=H.+P.+Choauthor=Y.+Zhouauthor=R.+D.+Gogliottiauthor=J.+T.+Mankaauthor=K.+J.+Gregoryauthor=S.+R.+Staufferauthor=F.+E.+Dudekauthor=Z.+Xiangauthor=C.+M.+Niswenderauthor=J.+S.+Danielsauthor=C.+K.+Jonesauthor=C.+W.+Lindsleyauthor=P.+J.+Conn&title=Unique+signaling+profiles+of+positive+allosteric+modulators+of+mGlu5+determine+differences+in+in+vivo+activity&doi=10.1016%2Fj.biopsych.2012.09.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Unique Signaling Profiles of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Determine Differences in In Vivo Activity</span></div><div class="casAuthors">Rook, Jerri M.; Noetzel, Meredith J.; Pouliot, Wendy A.; Bridges, Thomas M.; Vinson, Paige N.; Cho, Hyekyung P.; Zhou, Ya; Gogliotti, Rocco D.; Manka, Jason T.; Gregory, Karen J.; Stauffer, Shaun R.; Dudek, F. Edward; Xiang, Zixiu; Niswender, Colleen M.; Daniels, J. Scott; Jones, Carrie K.; Lindsley, Craig W.; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">501-509</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Metabotropic glutamate receptor subtype 5 (mGlu5) activators have emerged as a novel approach to the treatment of schizophrenia.  Pos. allosteric modulators (PAMs) of mGlu5 have generated tremendous excitement and fueled major drug discovery efforts.  Although mGlu5 PAMs have robust efficacy in preclin. models of schizophrenia, preliminary reports suggest that these compds. may induce seizure activity.  Prototypical mGlu5 PAMs do not activate mGlu5 directly but selectively potentiate activation of mGlu5 by glutamate.  This mechanism may be crit. to maintaining normal activity-dependence of mGlu5 activation and achieving optimal in vivo effects.Using specially engineered mGlu5 cell lines incorporating point mutations within the allosteric and orthosteric binding sites, as well as brain slice electrophysiol. and in vivo electroencephalog. and behavioral pharmacol., we found that some mGlu5 PAMs have intrinsic allosteric agonist activity in the absence of glutamate.  Both in vitro mutagenesis and in vivo pharmacol. studies demonstrate that VU0422465 is an agonist PAM that induces epileptiform activity and behavioral convulsions in rodents.  In contrast, VU0361747, an mGlu5 PAMs optimized to eliminate allosteric agonist activity, has robust in vivo efficacy and does not induce adverse effects at doses that yield high brain concns.Loss of the abs. dependence of mGlu5 PAMs on glutamate release for their activity can lead to severe adverse effects.  The finding that closely related mGlu5 PAMs can differ in their intrinsic agonist activity provides crit. new insights that is essential for advancing these mols. through clin. development for treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEnfOyxRj5nrVg90H21EOLACvtfcHk0liMtNoop9CtDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GktLrM&md5=f8aba766e4ddf4fb28b3e3166ce8cd8c</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2012.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2012.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DNoetzel%26aufirst%3DM.%2BJ.%26aulast%3DPouliot%26aufirst%3DW.%2BA.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DCho%26aufirst%3DH.%2BP.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGogliotti%26aufirst%3DR.%2BD.%26aulast%3DManka%26aufirst%3DJ.%2BT.%26aulast%3DGregory%26aufirst%3DK.%2BJ.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DDudek%26aufirst%3DF.%2BE.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DUnique%2520signaling%2520profiles%2520of%2520positive%2520allosteric%2520modulators%2520of%2520mGlu5%2520determine%2520differences%2520in%2520in%2520vivo%2520activity%26jtitle%3DBiol.%2520Psychiatry%26date%3D2013%26volume%3D73%26spage%3D501%26epage%3D509%26doi%3D10.1016%2Fj.biopsych.2012.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Conde-Ceide, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Viturro, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Barrantes, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinson, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rook, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Megens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niswender, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steckler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolomé-Nebreda, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Discovery of VU0409551/JNJ-46778212: an mGlu5 positive allosteric modulator clinical candidate targeting schizophrenia</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">716</span><span class="NLM_x">–</span> <span class="NLM_lpage">720</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00181</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00181" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovVSgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=716-720&author=S.+Conde-Ceideauthor=C.+M.+Martinez-Viturroauthor=J.+Alcazarauthor=P.+M.+Garcia-Barrantesauthor=H.+Lavreysenauthor=C.+Mackieauthor=P.+N.+Vinsonauthor=J.+M.+Rookauthor=T.+M.+Bridgesauthor=S.+J.+Danielsauthor=A.+Megensauthor=X.+Langloisauthor=W.+H.+Drinkenburgauthor=A.+Ahnaouauthor=C.+K.+Niswenderauthor=C.+K.+Jonesauthor=G.+J.+Macdonaldauthor=T.+Stecklerauthor=P.+J.+Connauthor=S.+R.+Staufferauthor=J.+M.+Bartolom%C3%A9-Nebredaauthor=C.+W.+Lindsley&title=Discovery+of+VU0409551%2FJNJ-46778212%3A+an+mGlu5+positive+allosteric+modulator+clinical+candidate+targeting+schizophrenia&doi=10.1021%2Facsmedchemlett.5b00181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of VU0409551/JNJ-46778212: An mGlu5 Positive Allosteric Modulator Clinical Candidate Targeting Schizophrenia</span></div><div class="casAuthors">Conde-Ceide, Susana; Martinez-Viturro, Carlos M.; Alcazar, Jesus; Garcia-Barrantes, Pedro M.; Lavreysen, Hilde; Mackie, Claire; Vinson, Paige N.; Rook, Jerri M.; Bridges, Thomas M.; Daniels, J. Scott; Megens, Anton; Langlois, Xavier; Drinkenburg, Wilhelmus H.; Ahnaou, Abdellah; Niswender, Colleen M.; Jones, Carrie K.; Macdonald, Gregor J.; Steckler, Thomas; Conn, P. Jeffrey; Stauffer, Shaun R.; Bartolome-Nebreda, Jose Manuel; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">716-720</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, the authors report the structure-activity relationship of a novel series of potent, selective, and orally bioavailable metabotropic glutamate receptor subtype 5 (mGlu5) pos. allosteric modulators.  On the basis of its robust in vitro potency and in vivo efficacy in multiple preclin. models of multiple domains of schizophrenia, coupled with a good DMPK profile and an acceptable therapeutic window, I (VU0409551/JNJ-46778212) was selected as a candidate for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz4F4S2MCNz7Vg90H21EOLACvtfcHk0lgk5jtdSLSDOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovVSgu78%253D&md5=d92cd4c79b31d664deb53cafee809798</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00181%26sid%3Dliteratum%253Aachs%26aulast%3DConde-Ceide%26aufirst%3DS.%26aulast%3DMartinez-Viturro%26aufirst%3DC.%2BM.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DGarcia-Barrantes%26aufirst%3DP.%2BM.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DVinson%26aufirst%3DP.%2BN.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DBridges%26aufirst%3DT.%2BM.%26aulast%3DDaniels%26aufirst%3DS.%2BJ.%26aulast%3DMegens%26aufirst%3DA.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DDrinkenburg%26aufirst%3DW.%2BH.%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DNiswender%26aufirst%3DC.%2BK.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DSteckler%26aufirst%3DT.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DBartolom%25C3%25A9-Nebreda%26aufirst%3DJ.%2BM.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520VU0409551%252FJNJ-46778212%253A%2520an%2520mGlu5%2520positive%2520allosteric%2520modulator%2520clinical%2520candidate%2520targeting%2520schizophrenia%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D716%26epage%3D720%26doi%3D10.1021%2Facsmedchemlett.5b00181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Chen, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gean, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. S.</span><span> </span><span class="NLM_article-title">Activation of mGluR2/3 underlies the effects of N-acetylcystein on amygdala-associated autism-like phenotypes in a valproate-induced rat model of autism</span> <span class="citation_source-journal">Front. Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="refDoi"> DOI: 10.3389/fnbeh.2014.00219</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3389%2Ffnbeh.2014.00219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24987341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1GjsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=219&author=Y.+W.+Chenauthor=H.+C.+Linauthor=M.+C.+Ngauthor=Y.+H.+Hsiaoauthor=C.+C.+Wangauthor=P.+W.+Geanauthor=P.+S.+Chen&title=Activation+of+mGluR2%2F3+underlies+the+effects+of+N-acetylcystein+on+amygdala-associated+autism-like+phenotypes+in+a+valproate-induced+rat+model+of+autism&doi=10.3389%2Ffnbeh.2014.00219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of mGluR2/3 underlies the effects of N-acetylcystein on amygdala-associated autism-like phenotypes in a valproate-induced rat model of autism</span></div><div class="casAuthors">Chen, Yu-Wen; Lin, Hui-Ching; Ng, Ming-Chong; Hsiao, Ya-Hsin; Wang, Chao-Chuan; Gean, Po-Wu; Chen, Po See</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">219/1-219/9, 9</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Autism-like phenotypes in male valproate (VPA)-exposed offspring have been linked to high glutamatergic neurotransmission in the thalamic-amygdala pathway.  Glial cystine/glutamate exchange (system Xc-), which exchanges extracellular cystine for intracellular glutamate, plays a significant role in the maintenance of extracellular glutamate.  N-acetylcysteine (NAC) is a cystine prodrug that restores extracellular glutamate by stimulating system Xc-.  In this study, we examd. the effects of NAC on autism-like phenotypes and neurotransmission in the thalamic-amygdala synapses, as well as the involvement of metabotropic glutamate receptors 2/3 (mGluR2/3).  Valproate-treated rats received a single i.p. injection of 500 mg/kg NaVPA on E12.5.  On postnatal day 21 (P21), NAC or saline was administered once daily for 10 days.  From day 8 to 10, NAC was given 1/2 h prior to behavioral testing.  Chronic administration of NAC restored the duration and frequency of social interaction and ameliorated anxiety-like behaviors in VPA-exposed offspring.  In amygdala slices, NAC treatment normalized the increased frequency of mEPSCs and decreased the paired pulse facilitation (PPF) induced by VPA exposure.  The effects of NAC on social interaction and anxiety-like behavior in the VPA-exposed offspring were blocked after intra-amygdala infusion of mGluR2/3 antagonist LY341495.  The expressions of mGluR2/3 protein and mGluR2 mRNA were significantly lower in the VPA-exposed offspring.  In contrast, the mGluR3 mRNA level did not differ between the saline- and VPA-exposed offspring.  These results provide the first evidence that the disruption of social interaction and enhanced presynaptic excitatory transmission in VPA-exposed offspring could be rescued by NAC, which depends on the activation of mGluR2/3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLdBNsuTo9KLVg90H21EOLACvtfcHk0lgk5jtdSLSDOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1GjsrvK&md5=7d5a98724a4b1e1cd726fcde5db3e5ab</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2014.00219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2014.00219%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BW.%26aulast%3DLin%26aufirst%3DH.%2BC.%26aulast%3DNg%26aufirst%3DM.%2BC.%26aulast%3DHsiao%26aufirst%3DY.%2BH.%26aulast%3DWang%26aufirst%3DC.%2BC.%26aulast%3DGean%26aufirst%3DP.%2BW.%26aulast%3DChen%26aufirst%3DP.%2BS.%26atitle%3DActivation%2520of%2520mGluR2%252F3%2520underlies%2520the%2520effects%2520of%2520N-acetylcystein%2520on%2520amygdala-associated%2520autism-like%2520phenotypes%2520in%2520a%2520valproate-induced%2520rat%2520model%2520of%2520autism%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D219%26doi%3D10.3389%2Ffnbeh.2014.00219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valli, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kress, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wepsiec, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harkness, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grutsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andis, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffey, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tizzano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1040</span><span class="refDoi"> DOI: 10.1021/jm980616n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980616n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADyaK1MXhtlOlurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1027-1040&author=J.+A.+Monnauthor=M.+J.+Valliauthor=S.+M.+Masseyauthor=M.+M.+Hansenauthor=T.+J.+Kressauthor=J.+P.+Wepsiecauthor=A.+R.+Harknessauthor=J.+L.+Grutschauthor=R.+A.+Wrightauthor=B.+G.+Johnsonauthor=S.+L.+Andisauthor=A.+Kingstonauthor=R.+Tomlinsonauthor=R.+Lewisauthor=K.+R.+Griffeyauthor=J.+P.+Tizzanoauthor=D.+D.+Schoepp&title=Synthesis%2C+pharmacological+characterization%2C+and+molecular+modeling+of+heterobicyclic+amino+acids+related+to+%28%2B%29-2-aminobicyclo%5B3.1.0%5Dhexane-2%2C6-dicarboxylic+acid+%28LY354740%29%3A+identification+of+two+new+potent%2C+selective%2C+and+systemically+active+agonists+for+group+II+metabotropic+glutamate+receptors&doi=10.1021%2Fjm980616n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Pharmacological Characterization, and Molecular Modeling of Heterobicyclic Amino Acids Related to (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740): Identification of Two New Potent, Selective, and Systemically Active Agonists for Group II Metabotropic Glutamate Receptors</span></div><div class="casAuthors">Monn, James A.; Valli, Matthew J.; Massey, Steven M.; Hansen, Marvin M.; Kress, Thomas J.; Wepsiec, James P.; Harkness, Allen R.; Grutsch, John L., Jr.; Wright, Rebecca A.; Johnson, Bryan G.; Andis, Sherri L.; Kingston, Ann; Tomlinson, Rosemarie; Lewis, Richard; Griffey, Kelly R.; Tizzano, Joseph P.; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1027-1040</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of an ongoing research program aimed at the identification of highly potent, selective, and systemically active agonists for group II metabotropic glutamate (mGlu) receptors, novel heterobicyclic amino acids (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268, I) and (-)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795, II) have been prepd.  I and II are structurally related to the previously described nanomolar potency group II mGlu receptor agonist, (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate monohydrate (LY354740 monohydrate, III), with the C(4)-methylene unit of III being replaced with either an oxygen atom or a sulfur atom.  I and II potently and stereospecifically displaced specific binding of the mGlu2/3 receptor antagonist ([3H]LY341495) in rat cerebral cortical homogenates, displaying IC50 values of 15 ± 4 and 8.4 ± 0.8 nM, resp., while having no effect up to 100,000 nM on radioligand binding to the glutamate recognition site on NMDA, AMPA, or kainate receptors.  I and II also potently displaced [3H]LY341495 binding from membranes expressing recombinant human group II mGlu receptor subtypes: I Ki = 14.1 ± 1.4 nM at mGlu2 and 5.8 ± 0.64 nM at mGlu3; II Ki = 40.6 ± 3.7 nM at mGlu2 and 4.7 ± 1.2 nM at mGlu3.  Evaluation of the functional effects of I and II on second-messenger responses in nonneuronal cells expressing human mGlu receptor subtypes demonstrated each to be a highly potent agonist for group II mGlu receptors: I EC50 = 2.69 ± 0.26 nM at mGlu2 and 4.58 ± 0.04 nM at mGlu3; II EC50 = 3.91 ± 0.81 nM at mGlu2 and 7.63 ± 2.08 nM at mGlu3.  In contrast, neither compd. (up to 10,000 nM) displayed either agonist or antagonist activity in cells expressing recombinant human mGlu1a, mGlu5a, mGlu4a, or mGlu7a receptors.  The agonist effects of I and II at group II mGlu receptors were not totally specific, however, as mGlu6 agonist activity was obsd. at high nanomolar concns. for I (EC50 = 401 ± 46 nM) and at micromolar concns. (EC50 = 2 430 ± 600 nM) for II; furthermore, each activated mGlu8 receptors at micromolar concns. (EC50 = 1 690 ± 130 and 7 340 ± 2 720 nM, resp.).  I.p. administration of either I or II in the mouse resulted in a dose-related blockade of limbic seizure activity produced by the nonselective group I/group II mGluR agonist (1S,3R)-ACPD (I ED50 = 19 mg/kg, II ED50 = 14 mg/kg), indicating that these mols. effectively cross the blood-brain barrier following systemic administration and suppress group I mGluR-mediated limbic excitation.  Thus, I and II are novel pharmacol. tools useful for exploring the functions of mGlu receptors in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJB67CSyXWlrVg90H21EOLACvtfcHk0lgk5jtdSLSDOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtlOlurk%253D&md5=6770c78b85dd10620b87ce6c9b4b5fe5</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm980616n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980616n%26sid%3Dliteratum%253Aachs%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DValli%26aufirst%3DM.%2BJ.%26aulast%3DMassey%26aufirst%3DS.%2BM.%26aulast%3DHansen%26aufirst%3DM.%2BM.%26aulast%3DKress%26aufirst%3DT.%2BJ.%26aulast%3DWepsiec%26aufirst%3DJ.%2BP.%26aulast%3DHarkness%26aufirst%3DA.%2BR.%26aulast%3DGrutsch%26aufirst%3DJ.%2BL.%26aulast%3DWright%26aufirst%3DR.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DAndis%26aufirst%3DS.%2BL.%26aulast%3DKingston%26aufirst%3DA.%26aulast%3DTomlinson%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DGriffey%26aufirst%3DK.%2BR.%26aulast%3DTizzano%26aufirst%3DJ.%2BP.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DSynthesis%252C%2520pharmacological%2520characterization%252C%2520and%2520molecular%2520modeling%2520of%2520heterobicyclic%2520amino%2520acids%2520related%2520to%2520%2528%252B%2529-2-aminobicyclo%255B3.1.0%255Dhexane-2%252C6-dicarboxylic%2520acid%2520%2528LY354740%2529%253A%2520identification%2520of%2520two%2520new%2520potent%252C%2520selective%252C%2520and%2520systemically%2520active%2520agonists%2520for%2520group%2520II%2520metabotropic%2520glutamate%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1027%26epage%3D1040%26doi%3D10.1021%2Fjm980616n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Ornstein, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleisch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tizzano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helton, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hérin, M.</span><span> </span><span class="NLM_article-title">2-Substituted (2SR)-2-amino-2-((1SR,2SR)-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span><span class="refDoi"> DOI: 10.1021/jm970498o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970498o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=358-378&author=P.+L.+Ornsteinauthor=T.+J.+Bleischauthor=M.+B.+Arnoldauthor=J.+H.+Kennedyauthor=R.+A.+Wrightauthor=B.+G.+Johnsonauthor=J.+P.+Tizzanoauthor=D.+R.+Heltonauthor=M.+J.+Kallmanauthor=D.+D.+Schoeppauthor=M.+H%C3%A9rin&title=2-Substituted+%282SR%29-2-amino-2-%28%281SR%2C2SR%29-carboxycycloprop-1-yl%29glycines+as+potent+and+selective+antagonists+of+group+II+metabotropic+glutamate+receptors.+2.+Effects+of+aromatic+substitution%2C+pharmacological+characterization%2C+and+bioavailability&doi=10.1021%2Fjm970498o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm970498o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970498o%26sid%3Dliteratum%253Aachs%26aulast%3DOrnstein%26aufirst%3DP.%2BL.%26aulast%3DBleisch%26aufirst%3DT.%2BJ.%26aulast%3DArnold%26aufirst%3DM.%2BB.%26aulast%3DKennedy%26aufirst%3DJ.%2BH.%26aulast%3DWright%26aufirst%3DR.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DTizzano%26aufirst%3DJ.%2BP.%26aulast%3DHelton%26aufirst%3DD.%2BR.%26aulast%3DKallman%26aufirst%3DM.%2BJ.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26aulast%3DH%25C3%25A9rin%26aufirst%3DM.%26atitle%3D2-Substituted%2520%25282SR%2529-2-amino-2-%2528%25281SR%252C2SR%2529-carboxycycloprop-1-yl%2529glycines%2520as%2520potent%2520and%2520selective%2520antagonists%2520of%2520group%2520II%2520metabotropic%2520glutamate%2520receptors.%25202.%2520Effects%2520of%2520aromatic%2520substitution%252C%2520pharmacological%2520characterization%252C%2520and%2520bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D358%26epage%3D378%26doi%3D10.1021%2Fjm970498o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Chaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimizu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuhara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakagami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakazato, A.</span><span> </span><span class="NLM_article-title">MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2003.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuropharm.2003.10.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2004&pages=457-467&author=S.+Chakiauthor=R.+Yoshikawaauthor=S.+Hirotaauthor=T.+Shimazakiauthor=M.+Maedaauthor=N.+Kawashimaauthor=T.+Yoshimizuauthor=A.+Yasuharaauthor=K.+Sakagamiauthor=S.+Okuyamaauthor=S.+Nakanishiauthor=A.+Nakazato&title=MGS0039%3A+a+potent+and+selective+group+II+metabotropic+glutamate+receptor+antagonist+with+antidepressant-like+activity&doi=10.1016%2Fj.neuropharm.2003.10.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2003.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2003.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DChaki%26aufirst%3DS.%26aulast%3DYoshikawa%26aufirst%3DR.%26aulast%3DHirota%26aufirst%3DS.%26aulast%3DShimazaki%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DKawashima%26aufirst%3DN.%26aulast%3DYoshimizu%26aufirst%3DT.%26aulast%3DYasuhara%26aufirst%3DA.%26aulast%3DSakagami%26aufirst%3DK.%26aulast%3DOkuyama%26aufirst%3DS.%26aulast%3DNakanishi%26aufirst%3DS.%26aulast%3DNakazato%26aufirst%3DA.%26atitle%3DMGS0039%253A%2520a%2520potent%2520and%2520selective%2520group%2520II%2520metabotropic%2520glutamate%2520receptor%2520antagonist%2520with%2520antidepressant-like%2520activity%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D46%26spage%3D457%26epage%3D467%26doi%3D10.1016%2Fj.neuropharm.2003.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Johnson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagdmann, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britton, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Large, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callagaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tizzano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-yl-methylamine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3189</span><span class="NLM_x">–</span> <span class="NLM_lpage">3192</span><span class="refDoi"> DOI: 10.1021/jm034015u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm034015u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3189-3192&author=M.+P.+Johnsonauthor=M.+Baezauthor=G.+E.+Jagdmannauthor=T.+C.+Brittonauthor=T.+H.+Largeauthor=D.+O.+Callagaroauthor=J.+P.+Tizzanoauthor=J.+A.+Monnauthor=D.+D.+Schoepp&title=Discovery+of+allosteric+potentiators+for+the+metabotropic+glutamate+2+receptor%3A+synthesis+and+subtype+selectivity+of+N-%284-%282-methoxyphenoxy%29phenyl%29-N-%282%2C2%2C2-trifluoroethylsulfonyl%29pyrid-3-yl-methylamine&doi=10.1021%2Fjm034015u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm034015u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm034015u%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DM.%2BP.%26aulast%3DBaez%26aufirst%3DM.%26aulast%3DJagdmann%26aufirst%3DG.%2BE.%26aulast%3DBritton%26aufirst%3DT.%2BC.%26aulast%3DLarge%26aufirst%3DT.%2BH.%26aulast%3DCallagaro%26aufirst%3DD.%2BO.%26aulast%3DTizzano%26aufirst%3DJ.%2BP.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DDiscovery%2520of%2520allosteric%2520potentiators%2520for%2520the%2520metabotropic%2520glutamate%25202%2520receptor%253A%2520synthesis%2520and%2520subtype%2520selectivity%2520of%2520N-%25284-%25282-methoxyphenoxy%2529phenyl%2529-N-%25282%252C2%252C2-trifluoroethylsulfonyl%2529pyrid-3-yl-methylamine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3189%26epage%3D3192%26doi%3D10.1021%2Fjm034015u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Galici, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hempstapat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echemendia, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Paulis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2 has antipsychotic-and anxiolytic-like effects in mice</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">318</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span><span class="refDoi"> DOI: 10.1124/jpet.106.102046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1124%2Fjpet.106.102046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=16608916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsFymsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2006&pages=173-185&author=R.+Galiciauthor=C.+K.+Jonesauthor=K.+Hempstapatauthor=Y.+Nongauthor=N.+G.+Echemendiaauthor=L.+G.+Williamsauthor=T.+de+Paulisauthor=P.+J.+Conn&title=Biphenyl-indanone+A%2C+a+positive+allosteric+modulator+of+the+metabotropic+glutamate+receptor+subtype+2+has+antipsychotic-and+anxiolytic-like+effects+in+mice&doi=10.1124%2Fjpet.106.102046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice</span></div><div class="casAuthors">Galici, Ruggero; Jonas, Carrie K.; Hemstapat, Kamondanai; Nong, Yi; Echemendia, Nicholas G.; Williams, Lilly C.; de Paulis, Tomas; Conn, P. Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">318</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">173-185</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Previous studies indicate that agonists of the group II metabotropic glutamate receptors (mGluRs), mGluR2 and mGluR3, may provide a novel approach for the treatment of anxiety disorders and schizophrenia.  However, the relative contributions of the mGluR2 and mGluR3 subtypes to the effects of the group II mGluR agonists remain unclear.  In the present study, we describe an alternate synthesis and further pharmacol. characterization of a recently reported pos. allosteric modulator of mGluR2 termed biphenyl-indanone A (BINA).  In recombinant systems, BINA produced a robust and selective potentiation of the response of mGluR2 to glutamate with no effect on the glutamate response of other mGluR subtypes.  In hippocampal brain slices, BINA (1 μM) significantly potentiated the mGluR2/3 agonist-induced inhibition of excitatory synaptic transmission at the medial perforant path-dentate gyrus synapse.  BINA was also efficacious in several models predictive of antipsychotic- and anxiolytic-like activity in mice.  The behavioral effects of BINA were blocked by the mGluR2/3 antagonist LY341495, suggesting that the in vivo effects of BINA are mediated by increased activation of mGluR2.  Collectively, these results indicate that BINA is a selective mGluR2 pos. allosteric modulator and provide further support for the growing evidence that selective allosteric potentiators of mGluR2 mimic many of the in vivo actions of mGluR2/3 agonists that may predict therapeutic utility of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-1EIY1aXPUrVg90H21EOLACvtfcHk0lgzrIIgXZN8RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsFymsbc%253D&md5=e51f1d1df8831b32c5b91a62c0919875</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.102046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.102046%26sid%3Dliteratum%253Aachs%26aulast%3DGalici%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DHempstapat%26aufirst%3DK.%26aulast%3DNong%26aufirst%3DY.%26aulast%3DEchemendia%26aufirst%3DN.%2BG.%26aulast%3DWilliams%26aufirst%3DL.%2BG.%26aulast%3Dde%2BPaulis%26aufirst%3DT.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DBiphenyl-indanone%2520A%252C%2520a%2520positive%2520allosteric%2520modulator%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%2520subtype%25202%2520has%2520antipsychotic-and%2520anxiolytic-like%2520effects%2520in%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D318%26spage%3D173%26epage%3D185%26doi%3D10.1124%2Fjpet.106.102046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Hiyoshi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marumo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hikichi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomishima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuhara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karasawa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaki, S.</span><span> </span><span class="NLM_article-title">Neurophysiologic and antipsychotic profiles of TASP0433864, a novel positive allosteric modulator of metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">642</span><span class="NLM_x">–</span> <span class="NLM_lpage">653</span><span class="refDoi"> DOI: 10.1124/jpet.114.218651</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1124%2Fjpet.114.218651" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25277141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWhtLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2014&pages=642-653&author=T.+Hiyoshiauthor=T.+Marumoauthor=H.+Hikichiauthor=Y.+Tomishimaauthor=H.+Urabeauthor=T.+Tamitaauthor=I.+Iidaauthor=A.+Yasuharaauthor=J.+Karasawaauthor=S.+Chaki&title=Neurophysiologic+and+antipsychotic+profiles+of+TASP0433864%2C+a+novel+positive+allosteric+modulator+of+metabotropic+glutamate+2+receptor&doi=10.1124%2Fjpet.114.218651"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Neurophysiologic and antipsychotic profiles of TASP0433864, a novel positive allosteric modulator of metabotropic glutamate 2 receptor</span></div><div class="casAuthors">Hiyoshi, Tetsuaki; Marumo, Toshiyuki; Hikichi, Hirohiko; Tomishima, Yasumitsu; Urabe, Hiroki; Tamita, Tomoko; Iida, Izumi; Yasuhara, Akito; Karasawa, Jun-ichi; Chaki, Shigeyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">642-653, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Excess glutamatergic neurotransmission has been implicated in the pathophysiol. of schizophrenia, and the activation of metabotropic glutamate 2 (mGlu2) receptor may exert antipsychotic effects by normalizing glutamate transmission.  In the present study, we investigated the neurophysiol. and antipsychotic profiles of TASP0433864 [(2S)-2-[(4-tert-butylphenoxy)methyl]-5-methyl-2,3-dihydroimidazo[2,1-b][1,3]oxazole-6-carboxamide], a newly synthesized pos. allosteric modulator (PAM) of mGlu2 receptor.  TASP0433864 exhibited PAM activity at human and rat mGlu2 receptors with EC50 values of 199 and 206 nM, resp., without exerting agonist activity at rat mGlu2 receptor.  TASP0433864 produced a leftward and upward shift in the concn.-response curve of glutamate-increased guanosine 5'-O-(3-[35S]thio)triphosphate binding to mGlu2 receptor.  In contrast, TASP0433864 had negligible activities for other mGlu receptors, including mGlu3 receptor, and did not have any affinity for other receptors or transporters.  In hippocampal slices, TASP0433864 potentiated an inhibitory effect of DCG-IV [(2S,2'R,3'R)-2-(2',3'-dicarboxylcyclopropyl)glycine], a mGlu2/3 receptor agonist, on the field excitatory postsynaptic potentials in the dentate gyrus, indicating that TASP0433864 potentiates the mGlu2 receptor-mediated presynaptic inhibition of glutamate release.  Moreover, TASP0433864 inhibited both MK-801 [(5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate]- and ketamine-increased cortical γ band oscillation in the rat cortical EEG, which have been considered to reflect the excess activation of cortical pyramidal neurons.  The inhibitory effect of TASP0433864 on cortical activation was also obsd. in the mouse 2-deoxy-glucose uptake study.  In a behavioral study, TASP0433864 significantly inhibited both ketamine- and methamphetamine-increased locomotor activities in mice and rats, resp.  Collectively, these findings indicate that TASP0433864 is a selective mGlu2 receptor PAM with antipsychotic activity, and the attenuation of excess glutamatergic neurotransmission may be involved in the action of TASP0433864.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ZCE3A5-e6rVg90H21EOLACvtfcHk0lg1m_ggtKKrLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWhtLbN&md5=975913a2781961123c4171ca71c0638c</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.218651&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.218651%26sid%3Dliteratum%253Aachs%26aulast%3DHiyoshi%26aufirst%3DT.%26aulast%3DMarumo%26aufirst%3DT.%26aulast%3DHikichi%26aufirst%3DH.%26aulast%3DTomishima%26aufirst%3DY.%26aulast%3DUrabe%26aufirst%3DH.%26aulast%3DTamita%26aufirst%3DT.%26aulast%3DIida%26aufirst%3DI.%26aulast%3DYasuhara%26aufirst%3DA.%26aulast%3DKarasawa%26aufirst%3DJ.%26aulast%3DChaki%26aufirst%3DS.%26atitle%3DNeurophysiologic%2520and%2520antipsychotic%2520profiles%2520of%2520TASP0433864%252C%2520a%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D351%26spage%3D642%26epage%3D653%26doi%3D10.1124%2Fjpet.114.218651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahnaou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pype, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Discovery of 1-butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1<i>H</i>)-pyridone (JNJ-40411813): a novel positive allosteric modulator of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6495</span><span class="NLM_x">–</span> <span class="NLM_lpage">6512</span><span class="refDoi"> DOI: 10.1021/jm500496m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500496m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFyitLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6495-6512&author=J.+M.+Cidauthor=G.+Tresadernauthor=G.+Duveyauthor=R.+Lutjensauthor=T.+Finnauthor=J.+P.+Rocherauthor=S.+Poliauthor=J.+A.+Vegaauthor=A.+I.+de+Lucasauthor=E.+Matesanzauthor=M.+L.+Linaresauthor=J.+I.+Andr%C3%A9sauthor=J.+Alcazarauthor=J.+M.+Alonsoauthor=G.+J.+Macdonaldauthor=D.+Oehlrichauthor=H.+Lavreysenauthor=A.+Ahnaouauthor=W.+Drinkenburgauthor=C.+Mackieauthor=S.+Pypeauthor=D.+Gallacherauthor=A.+A.+Trabanco&title=Discovery+of+1-butyl-3-chloro-4-%284-phenyl-1-piperidinyl%29-%281H%29-pyridone+%28JNJ-40411813%29%3A+a+novel+positive+allosteric+modulator+of+the+metabotropic+glutamate+2+receptor&doi=10.1021%2Fjm500496m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1-Butyl-3-chloro-4-(4-phenyl-1-piperidinyl)-(1H)-pyridone (JNJ-40411813): A Novel Positive Allosteric Modulator of the Metabotropic Glutamate 2 Receptor</span></div><div class="casAuthors">Cid, Jose Maria; Tresadern, Gary; Duvey, Guillaume; Lutjens, Robert; Finn, Terry; Rocher, Jean-Philippe; Poli, Sonia; Vega, Juan Antonio; de Lucas, Ana Isabel; Matesanz, Encarnacion; Linares, Maria Lourdes; Andres, Jose Ignacio; Alcazar, Jesus; Alonso, Jose Manuel; Macdonald, Gregor J.; Oehlrich, Daniel; Lavreysen, Hilde; Ahnaou, Abdelah; Drinkenburg, Wilhelmus; Mackie, Claire; Pype, Stefan; Gallacher, David; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6495-6512</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors previously reported the discovery of 4-aryl-substituted pyridones with mGlu2 PAM activity starting from the HTS hit I.  In this article, the authors describe a different exploration I from that led to the discovery of a novel subseries of phenylpiperidine-substituted pyridones.  The optimization strategy involved the introduction of different spacers between the pyridone core and the Ph ring of I.  The fine tuning of metab. and hERG followed by differentiation of advanced leads that were identified on the basis of PK profiles and in vivo potency converged on lead compd. II (JNJ-40411813).  Full in vitro and in vivo profiles indicate that II displayed an optimal interplay between potency, selectivity, favorable ADMET/PK and cardiovascular safety profile, and central EEG activity.  Compd. II has been investigated in the clinic for schizophrenia and anxious depression disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWE5azCuzrDbVg90H21EOLACvtfcHk0lg1m_ggtKKrLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFyitLfO&md5=d485ac63ceea50eaf8864f08bf903350</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm500496m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500496m%26sid%3Dliteratum%253Aachs%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DFinn%26aufirst%3DT.%26aulast%3DRocher%26aufirst%3DJ.%2BP.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3Dde%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DAhnaou%26aufirst%3DA.%26aulast%3DDrinkenburg%26aufirst%3DW.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DPype%26aufirst%3DS.%26aulast%3DGallacher%26aufirst%3DD.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DDiscovery%2520of%25201-butyl-3-chloro-4-%25284-phenyl-1-piperidinyl%2529-%25281H%2529-pyridone%2520%2528JNJ-40411813%2529%253A%2520a%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6495%26epage%3D6512%26doi%3D10.1021%2Fjm500496m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Cook, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">March, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satterthwaite, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span> </span><span class="NLM_article-title">Lessons learned from the fate of AstraZeneca’s drug pipeline: a five dimensional framework</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1038/nrd4309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnrd4309" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=419-431&author=D.+Cookauthor=D.+Brownauthor=R.+Alexanderauthor=R.+Marchauthor=P.+Morganauthor=G.+Satterthwaiteauthor=M.+N.+Pangalos&title=Lessons+learned+from+the+fate+of+AstraZeneca%E2%80%99s+drug+pipeline%3A+a+five+dimensional+framework&doi=10.1038%2Fnrd4309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fnrd4309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4309%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMarch%26aufirst%3DR.%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DSatterthwaite%26aufirst%3DG.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26atitle%3DLessons%2520learned%2520from%2520the%2520fate%2520of%2520AstraZeneca%25E2%2580%2599s%2520drug%2520pipeline%253A%2520a%2520five%2520dimensional%2520framework%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D419%26epage%3D431%26doi%3D10.1038%2Fnrd4309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Campo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalinichev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yacoubi, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Royer-Urios, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legrand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parron, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessif, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaugeois, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celanire, S.</span><span> </span><span class="NLM_article-title">Characterization of an mGluR2/3 negative allosteric modulator in rodent models of depression</span> <span class="citation_source-journal">J. Neurogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span><span class="refDoi"> DOI: 10.3109/01677063.2011.627485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3109%2F01677063.2011.627485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22091727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=152-166&author=B.+Campoauthor=M.+Kalinichevauthor=N.+Lambengauthor=M.+E.+Yacoubiauthor=I.+Royer-Uriosauthor=M.+Schneiderauthor=C.+Legrandauthor=D.+Parronauthor=F.+Girardauthor=A.+Bessifauthor=S.+Poliauthor=J.+M.+Vaugeoisauthor=E.+Le+Poulauthor=S.+Celanire&title=Characterization+of+an+mGluR2%2F3+negative+allosteric+modulator+in+rodent+models+of+depression&doi=10.3109%2F01677063.2011.627485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of an mGluR2/3 Negative Allosteric Modulator in Rodent Models of Depression</span></div><div class="casAuthors">Campo, Brice; Kalinichev, Mikhail; Lambeng, Nathalie; El Yacoubi, M.; Royer-Urios, Isabelle; Schneider, Manfred; Legrand, Coline; Parron, Delphine; Girard, Francoise; Bessif, Abdelhak; Poli, Sonia; Vaugeois, Jean-Marie; Le Poul, Emmanuel; Celanire, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">152-166</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">There is growing evidence suggesting that antagonists of group II metabotropic glutamate receptors (mGluR2/3) exhibit antidepressant-like properties in several preclin. models of depression.  However, all those studies have been performed using competitive group II non-selective orthosteric antagonists.  In this study we extensively characterized a group II selective neg. allosteric modulator (4-[3-(2,6-Dimethylpyridin-4-yl)phenyl]-7-methyl-8-trifluoromethyl-1,3-dihydrobenzo[b][1,4]diazepin-2-one, namely RO4491533, Woltering et al., 2010) in several in vitro biochem. assays and in vivo models of depression.  In vitro, RO4491533 completely blocked the glutamate-induced Ca2 ++ mobilization and the glutamate-induced accumulation in [35S]GTPγS binding in cells expressing recombinant human or rat mGluR2 and in native tissues.  Results from Schild plot expts. and reversibility test at the target on both cellular and membrane-based assays confirmed the neg. allosteric modulator properties of the compd.  RO4491533 was equipotent on mGluR2 and mGluR3 receptors but not active on any other mGluRs.  RO4491533 has acceptable PK properties in mice and rats, is bioavailable following oral gavage (F == 30%) and brain-penetrant (CSF conc/total plasma conc ratio == 0.8%).  RO4491533 appeared to engage the central mGluR2 and mGluR3 receptors since the compd. reversed the hypolocomotor effect of an mGluR2/3 orthosteric agonist LY379268 in a target-specific manner, as did the group II orthosteric mGluR2/3 antagonist LY341495.  RO4491533 and LY341495 dose-dependently reduced immobility time of C57Bl6/J mice in the forced swim test.  Also, RO4491533 and LY341495 were active in the tail suspension test in a line of Helpless (H) mice, a putative genetic model of depression.  These data suggest that mGluR2/3 receptors are viable targets for development of novel pharmacotherapies for depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovnqA5cdGksrVg90H21EOLACvtfcHk0liPheAk5QxXzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7fI&md5=86c0560136504ae513418a2b1fe0c9e1</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.3109%2F01677063.2011.627485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2011.627485%26sid%3Dliteratum%253Aachs%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DKalinichev%26aufirst%3DM.%26aulast%3DLambeng%26aufirst%3DN.%26aulast%3DYacoubi%26aufirst%3DM.%2BE.%26aulast%3DRoyer-Urios%26aufirst%3DI.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DLegrand%26aufirst%3DC.%26aulast%3DParron%26aufirst%3DD.%26aulast%3DGirard%26aufirst%3DF.%26aulast%3DBessif%26aufirst%3DA.%26aulast%3DPoli%26aufirst%3DS.%26aulast%3DVaugeois%26aufirst%3DJ.%2BM.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DCelanire%26aufirst%3DS.%26atitle%3DCharacterization%2520of%2520an%2520mGluR2%252F3%2520negative%2520allosteric%2520modulator%2520in%2520rodent%2520models%2520of%2520depression%26jtitle%3DJ.%2520Neurogenet.%26date%3D2011%26volume%3D25%26spage%3D152%26epage%3D166%26doi%3D10.3109%2F01677063.2011.627485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Homayoun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefani, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamagan, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moghaddam, B.</span><span> </span><span class="NLM_article-title">Functional interaction between NMDA and mGlu5 receptors: effects on working memory, instrumental learning, motor behaviors, and dopamine release</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1259</span><span class="NLM_x">–</span> <span class="NLM_lpage">1269</span><span class="refDoi"> DOI: 10.1038/sj.npp.1300417</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fsj.npp.1300417" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=1259-1269&author=H.+Homayounauthor=M.+R.+Stefaniauthor=B.+W.+Adamsauthor=G.+D.+Tamaganauthor=B.+Moghaddam&title=Functional+interaction+between+NMDA+and+mGlu5+receptors%3A+effects+on+working+memory%2C+instrumental+learning%2C+motor+behaviors%2C+and+dopamine+release&doi=10.1038%2Fsj.npp.1300417"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1300417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1300417%26sid%3Dliteratum%253Aachs%26aulast%3DHomayoun%26aufirst%3DH.%26aulast%3DStefani%26aufirst%3DM.%2BR.%26aulast%3DAdams%26aufirst%3DB.%2BW.%26aulast%3DTamagan%26aufirst%3DG.%2BD.%26aulast%3DMoghaddam%26aufirst%3DB.%26atitle%3DFunctional%2520interaction%2520between%2520NMDA%2520and%2520mGlu5%2520receptors%253A%2520effects%2520on%2520working%2520memory%252C%2520instrumental%2520learning%252C%2520motor%2520behaviors%252C%2520and%2520dopamine%2520release%26jtitle%3DNeuropsychopharmacology%26date%3D2004%26volume%3D29%26spage%3D1259%26epage%3D1269%26doi%3D10.1038%2Fsj.npp.1300417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Chung, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhim, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E.</span><span> </span><span class="NLM_article-title">Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span><span class="refDoi"> DOI: 10.1038/nn.3927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnn.3927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25622145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVehtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=435-443&author=W.+Chungauthor=S.+Y.+Choiauthor=E.+Leeauthor=H.+Parkauthor=J.+Kangauthor=H.+Parkauthor=Y.+Choiauthor=D.+Leeauthor=S.+G.+Parkauthor=R.+Kimauthor=Y.+S.+Choauthor=J.+Choiauthor=M.+H.+Kimauthor=J.+W.+Leeauthor=S.+Leeauthor=I.+Rhimauthor=M.+W.+Jungauthor=D.+Kimauthor=Y.+C.+Baeauthor=E.+Kim&title=Social+deficits+in+IRSp53+mutant+mice+improved+by+NMDAR+and+mGluR5+suppression&doi=10.1038%2Fnn.3927"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression</span></div><div class="casAuthors">Chung, Woosuk; Choi, Su Yeon; Lee, Eunee; Park, Haram; Kang, Jaeseung; Park, Hanwool; Choi, Yeonsoo; Lee, Dongsoo; Park, Sae-Geun; Kim, Ryunhee; Cho, Yi Sul; Choi, Jeonghoon; Kim, Myoung-Hwan; Lee, Jong Won; Lee, Seungjoon; Rhim, Issac; Jung, Min Whan; Kim, Daesoo; Bae, Yong Chul; Kim, Eunjoon</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">435-443</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Social deficits are obsd. in diverse psychiatric disorders, including autism spectrum disorders and schizophrenia.  We found that mice lacking the excitatory synaptic signaling scaffold IRSp53 (also known as BAIAP2) showed impaired social interaction and communication.  Treatment of IRSp53-/- mice, which display enhanced NMDA receptor (NMDAR) function in the hippocampus, with memantine, an NMDAR antagonist, or MPEP, a metabotropic glutamate receptor 5 antagonist that indirectly inhibits NMDAR function, normalized social interaction.  This social rescue was accompanied by normalization of NMDAR function and plasticity in the hippocampus and neuronal firing in the medial prefrontal cortex.  These results, together with the reduced NMDAR function implicated in social impairments, suggest that deviation of NMDAR function in either direction leads to social deficits and that correcting the deviation has beneficial effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDO8pL-0S9orVg90H21EOLACvtfcHk0liPheAk5QxXzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVehtL4%253D&md5=c63781b5bcec5d3ecb14f79a53508d63</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fnn.3927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3927%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DW.%26aulast%3DChoi%26aufirst%3DS.%2BY.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DS.%2BG.%26aulast%3DKim%26aufirst%3DR.%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DM.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DRhim%26aufirst%3DI.%26aulast%3DJung%26aufirst%3DM.%2BW.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DBae%26aufirst%3DY.%2BC.%26aulast%3DKim%26aufirst%3DE.%26atitle%3DSocial%2520deficits%2520in%2520IRSp53%2520mutant%2520mice%2520improved%2520by%2520NMDAR%2520and%2520mGluR5%2520suppression%26jtitle%3DNat.%2520Neurosci.%26date%3D2015%26volume%3D18%26spage%3D435%26epage%3D443%26doi%3D10.1038%2Fnn.3927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Won, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mah, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaang, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E.</span><span> </span><span class="NLM_article-title">Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">486</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1038/nature11208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnature11208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22699620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1emtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=486&publication_year=2012&pages=261-265&author=H.+Wonauthor=H.+R.+Leeauthor=H.+Y.+Geeauthor=W.+Mahauthor=J.+I.+Kimauthor=J.+Leeauthor=S.+Haauthor=C.+Chungauthor=E.+S.+Jungauthor=Y.+S.+Choauthor=S.+G.+Parkauthor=J.+S.+Leeauthor=K.+Leeauthor=D.+Kimauthor=Y.+C.+Baeauthor=B.+K.+Kaangauthor=M.+G.+Leeauthor=E.+Kim&title=Autistic-like+social+behaviour+in+Shank2-mutant+mice+improved+by+restoring+NMDA+receptor+function&doi=10.1038%2Fnature11208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Autistic-like social behavior in Shank2-mutant mice improved by restoring NMDA receptor function</span></div><div class="casAuthors">Won, Hyejung; Lee, Hye-Ryeon; Gee, Heon Yung; Mah, Won; Kim, Jae-Ick; Lee, Jiseok; Ha, Seungmin; Chung, Changuk; Jung, Eun Suk; Cho, Yi Sul; Park, Sae-Geun; Lee, Jung-Soo; Lee, Kyungmin; Kim, Daesoo; Bae, Yong Chul; Kaang, Bong-Kiun; Lee, Min Goo; Kim, Eunjoon</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">486</span>
        (<span class="NLM_cas:issue">7402</span>),
    <span class="NLM_cas:pages">261-265</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autism spectrum disorder (ASD) is a group of conditions characterized by impaired social interaction and communication, and restricted and repetitive behaviors.  ASD is a highly heritable disorder involving various genetic determinants.  Shank2 (also known as ProSAP1) is a multi-domain scaffolding protein and signaling adaptor enriched at excitatory neuronal synapses, and mutations in the human SHANK2 gene have recently been assocd. with ASD and intellectual disablility.  Although ASD-assocd. genes are being increasingly identified and studied using various approaches, including mouse genetics, further efforts are required to delineate important causal mechanisms with the potential for therapeutic application.  Here we show that Shank2-mutant (Shank2-/-) mice carrying a mutation identical to the ASD-assocd. microdeletion in the human SHANK2 gene exhibit ASD-like behaviors including reduced social interaction, reduced social communication by ultrasonic vocalizations, and repetitive jumping.  These mice show a marked decrease in NMDA (N-methyl-d-aspartate) glutamate receptor (NMDAR) function.  Direct stimulation of NMDARs with d-cycloserine, a partial agonist of NMDARs, normalizes NMDAR function and improves social interaction in Shank2-/- mice.  Furthermore, treatment of Shank2-/- mice with a pos. allosteric modulator of metabotropic glutamate receptor 5 (mGluR5), which enhances NMDAR function via mGluR5 activation, also normalizes NMDAR function and markedly enhances social interaction.  These results suggest that reduced NMDAR function may contribute to the development of ASD-like phenotypes in Shank2-/- mice, and mGluR modulation of NMDARs offers a potential strategy to treat ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLS1qTT4nQELVg90H21EOLACvtfcHk0li0wvkFi3qMDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1emtrw%253D&md5=0d5478d17f8b572074040b9fe70b64a3</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2Fnature11208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11208%26sid%3Dliteratum%253Aachs%26aulast%3DWon%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DH.%2BR.%26aulast%3DGee%26aufirst%3DH.%2BY.%26aulast%3DMah%26aufirst%3DW.%26aulast%3DKim%26aufirst%3DJ.%2BI.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DHa%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DE.%2BS.%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DPark%26aufirst%3DS.%2BG.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DBae%26aufirst%3DY.%2BC.%26aulast%3DKaang%26aufirst%3DB.%2BK.%26aulast%3DLee%26aufirst%3DM.%2BG.%26aulast%3DKim%26aufirst%3DE.%26atitle%3DAutistic-like%2520social%2520behaviour%2520in%2520Shank2-mutant%2520mice%2520improved%2520by%2520restoring%2520NMDA%2520receptor%2520function%26jtitle%3DNature%26date%3D2012%26volume%3D486%26spage%3D261%26epage%3D265%26doi%3D10.1038%2Fnature11208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Urbano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okwara, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herndon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutsch, S. I.</span><span> </span><span class="NLM_article-title">A trial of D-cycloserine to treat stereotypies in older adolescents and young adults with autism spectrum disorder</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1097/WNF.0000000000000033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1097%2FWNF.0000000000000033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2014&pages=69-72&author=M.+Urbanoauthor=L.+Okwaraauthor=P.+Manserauthor=K.+Hartmannauthor=A.+Herndonauthor=S.+I.+Deutsch&title=A+trial+of+D-cycloserine+to+treat+stereotypies+in+older+adolescents+and+young+adults+with+autism+spectrum+disorder&doi=10.1097%2FWNF.0000000000000033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1097%2FWNF.0000000000000033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWNF.0000000000000033%26sid%3Dliteratum%253Aachs%26aulast%3DUrbano%26aufirst%3DM.%26aulast%3DOkwara%26aufirst%3DL.%26aulast%3DManser%26aufirst%3DP.%26aulast%3DHartmann%26aufirst%3DK.%26aulast%3DHerndon%26aufirst%3DA.%26aulast%3DDeutsch%26aufirst%3DS.%2BI.%26atitle%3DA%2520trial%2520of%2520D-cycloserine%2520to%2520treat%2520stereotypies%2520in%2520older%2520adolescents%2520and%2520young%2520adults%2520with%2520autism%2520spectrum%2520disorder%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2014%26volume%3D37%26spage%3D69%26epage%3D72%26doi%3D10.1097%2FWNF.0000000000000033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Urbano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okwara, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manser, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutsch, S. I.</span><span> </span><span class="NLM_article-title">A trial of d-cycloserine to treat the social deficit in older adolescents and young adults with autism spectrum disorders</span> <span class="citation_source-journal">J. Neuropsychiatry Clin. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span><span class="refDoi"> DOI: 10.1176/appi.neuropsych.13070155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1176%2Fappi.neuropsych.13070155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25923852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2Mjpt12lsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=133-138&author=M.+Urbanoauthor=L.+Okwaraauthor=P.+Manserauthor=K.+Hartmannauthor=S.+I.+Deutsch&title=A+trial+of+d-cycloserine+to+treat+the+social+deficit+in+older+adolescents+and+young+adults+with+autism+spectrum+disorders&doi=10.1176%2Fappi.neuropsych.13070155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">A trial of d-cycloserine to treat the social deficit in older adolescents and young adults with autism spectrum disorders</span></div><div class="casAuthors">Urbano Maria; Okwara Leonore; Manser Paul; Hartmann Kathrin; Deutsch Stephen I</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of neuropsychiatry and clinical neurosciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autism spectrum disorders are difficult for older adolescents and young adults as impaired social communication affects the transition to adult life. d-Cycloserine, a partial glycine agonist at the N-methyl-d-aspartic acid receptor, was tested in a double-blind randomized trial in 20 older adolescents and young adults with autism spectrum disorders using two dosing strategies (50 mg daily versus 50 mg weekly) for 8 weeks with a 2-week follow-up after discontinuation. d-Cycloserine caused statistically and clinically significant improvement with no differentiation between dosing strategies on the Social Responsiveness Scale and the Aberrant Behavior Checklist before and after d-cycloserine administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR1U-PhdIV87JZoeNcnHOQ9fW6udTcc2eZJOwkHb3xDFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mjpt12lsg%253D%253D&md5=3f01021d59b473902beef0e4b12a3735</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1176%2Fappi.neuropsych.13070155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.neuropsych.13070155%26sid%3Dliteratum%253Aachs%26aulast%3DUrbano%26aufirst%3DM.%26aulast%3DOkwara%26aufirst%3DL.%26aulast%3DManser%26aufirst%3DP.%26aulast%3DHartmann%26aufirst%3DK.%26aulast%3DDeutsch%26aufirst%3DS.%2BI.%26atitle%3DA%2520trial%2520of%2520d-cycloserine%2520to%2520treat%2520the%2520social%2520deficit%2520in%2520older%2520adolescents%2520and%2520young%2520adults%2520with%2520autism%2520spectrum%2520disorders%26jtitle%3DJ.%2520Neuropsychiatry%2520Clin.%2520Neurosci.%26date%3D2015%26volume%3D27%26spage%3D133%26epage%3D138%26doi%3D10.1176%2Fappi.neuropsych.13070155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Volkmann, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanger, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirivolu, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paschetto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virginio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleyzes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buisson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steidl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mierau, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagiolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span> </span><span class="NLM_article-title">MPX-004 and MPX-007: new pharmacological tools to study the physiology of NMDA receptors containing the GluN2A subunit</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0148129</span><span class="refDoi"> DOI: 10.1371/journal.pone.0148129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1371%2Fjournal.pone.0148129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26829109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlWrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0148129&author=R.+A.+Volkmannauthor=C.+M.+Fangerauthor=D.+R.+Andersonauthor=V.+R.+Sirivoluauthor=K.+Paschettoauthor=E.+Gordonauthor=C.+Virginioauthor=M.+Gleyzesauthor=B.+Buissonauthor=E.+Steidlauthor=S.+B.+Mierauauthor=M.+Fagioliniauthor=F.+S.+Menniti&title=MPX-004+and+MPX-007%3A+new+pharmacological+tools+to+study+the+physiology+of+NMDA+receptors+containing+the+GluN2A+subunit&doi=10.1371%2Fjournal.pone.0148129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">MPX-004 and MPX-007: new pharmacological tools to study the physiology of nmda receptors containing the GluN2A subunit</span></div><div class="casAuthors">Volkmann, Robert A.; Fanger, Christopher M.; Anderson, David R.; Sirivolu, Venkata Ramana; Paschetto, Kathy; Gordon, Earl; Virginio, Caterina; Gleyzes, Melanie; Buisson, Bruno; Steidl, Esther; Mierau, Susanna B.; Fagiolini, Michela; Menniti, Frank S.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0148129/1-e0148129/20</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">GluN2A is the most abundant of the GluN2 NMDA receptor subunits in the mammalian CNS.  Physiol. and genetic evidence implicate GluN2A-contg. receptors in susceptibility to autism, schizophrenia, childhood epilepsy and neurodevelopmental disorders such as Rett Syndrome.  However, GluN2A-selective pharmacol. probes to explore the therapeutic potential of targeting these receptors have been lacking.  Here we disclose a novel series of pyrazine-contg. GluN2A antagonists exemplified byMPX-004 (5-(((3-chloro-4-fluorophenyl) sulfonamido)methyl)-N-((2-methylthiazol-5-yl)methyl)pyrazine-2-carboxamide) and MPX- 007 (5-(((3-fluoro-4-fluorophenyl)sulfonamido)methyl)-N-((2-methylthiazol-5-yl)methyl) methylpyrazine-2-carboxamide).  MPX-004 and MPX-007 inhibit GluN2A-contg. NMDA receptors expressed in HEK cells with IC50s of 79 nM and 27 nM, resp.  In contrast, at concns. that completely inhibited GluN2A activity these compds. have no inhibitory effect on GluN2B or GluN2D receptor-mediated responses in similar HEK cell-based assays.  Potency and selectivity were confirmed in electrophysiol. assays in Xenopus oocytes expressing GluN2A-D receptor subtypes.  Maximal concns. of MPX-004 and MPX-007 inhibited ∼30%of the whole-cell current in rat pyramidal neurons in primary culture and MPX- 004 inhibited ∼60% of the total NMDA receptor-mediated EPSP in rat hippocampal slices.  GluN2A-selectivity at native receptors was confirmed by the finding that MPX-004 had no inhibitory effect on NMDA receptor mediated synaptic currents in cortical slices from GRIN2A knock out mice.  Thus, MPX-004 and MPX-007 offer highly selective pharmacol. tools to probe GluN2A physiol. and involvement in neuropsychiatric and developmental disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFtzNEu3OcX7Vg90H21EOLACvtfcHk0lhjpe-V07r8cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlWrsrk%253D&md5=975f42be516fd25eb8e9a66605c93a67</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0148129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0148129%26sid%3Dliteratum%253Aachs%26aulast%3DVolkmann%26aufirst%3DR.%2BA.%26aulast%3DFanger%26aufirst%3DC.%2BM.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DSirivolu%26aufirst%3DV.%2BR.%26aulast%3DPaschetto%26aufirst%3DK.%26aulast%3DGordon%26aufirst%3DE.%26aulast%3DVirginio%26aufirst%3DC.%26aulast%3DGleyzes%26aufirst%3DM.%26aulast%3DBuisson%26aufirst%3DB.%26aulast%3DSteidl%26aufirst%3DE.%26aulast%3DMierau%26aufirst%3DS.%2BB.%26aulast%3DFagiolini%26aufirst%3DM.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26atitle%3DMPX-004%2520and%2520MPX-007%253A%2520new%2520pharmacological%2520tools%2520to%2520study%2520the%2520physiology%2520of%2520NMDA%2520receptors%2520containing%2520the%2520GluN2A%2520subunit%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0148129%26doi%3D10.1371%2Fjournal.pone.0148129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Hussman, J. P.</span><span> </span><span class="NLM_article-title">Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism</span> <span class="citation_source-journal">J. Autism Dev. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span><span class="refDoi"> DOI: 10.1023/A:1010715619091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1023%2FA%3A1010715619091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=11450824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD38%252FitVCgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2001&pages=247-248&author=J.+P.+Hussman&title=Suppressed+GABAergic+inhibition+as+a+common+factor+in+suspected+etiologies+of+autism&doi=10.1023%2FA%3A1010715619091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism</span></div><div class="casAuthors">Hussman J P</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autism and developmental disorders</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-8</span>
        ISSN:<span class="NLM_cas:issn">0162-3257</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSlJwwv75--L9XdcedVHT5tfW6udTcc2eZ6cxzmCY54T7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252FitVCgtg%253D%253D&md5=7cb9b3b41aad2cedf841003ca452aa93</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1023%2FA%3A1010715619091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1010715619091%26sid%3Dliteratum%253Aachs%26aulast%3DHussman%26aufirst%3DJ.%2BP.%26atitle%3DSuppressed%2520GABAergic%2520inhibition%2520as%2520a%2520common%2520factor%2520in%2520suspected%2520etiologies%2520of%2520autism%26jtitle%3DJ.%2520Autism%2520Dev.%2520Disord.%26date%3D2001%26volume%3D31%26spage%3D247%26epage%3D248%26doi%3D10.1023%2FA%3A1010715619091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Olsen, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sieghart, W.</span><span> </span><span class="NLM_article-title">International union of pharmacology. LXX. Subtypes of gamma-aminobutyric acid receptors: classification on the basis of subunit composition, pharmacology, and function. Update</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span><span class="refDoi"> DOI: 10.1124/pr.108.00505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1124%2Fpr.108.00505" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=243-260&author=R.+W.+Olsenauthor=W.+Sieghart&title=International+union+of+pharmacology.+LXX.+Subtypes+of+gamma-aminobutyric+acid+receptors%3A+classification+on+the+basis+of+subunit+composition%2C+pharmacology%2C+and+function.+Update&doi=10.1124%2Fpr.108.00505"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1124%2Fpr.108.00505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.108.00505%26sid%3Dliteratum%253Aachs%26aulast%3DOlsen%26aufirst%3DR.%2BW.%26aulast%3DSieghart%26aufirst%3DW.%26atitle%3DInternational%2520union%2520of%2520pharmacology.%2520LXX.%2520Subtypes%2520of%2520gamma-aminobutyric%2520acid%2520receptors%253A%2520classification%2520on%2520the%2520basis%2520of%2520subunit%2520composition%252C%2520pharmacology%252C%2520and%2520function.%2520Update%26jtitle%3DPharmacol.%2520Rev.%26date%3D2008%26volume%3D60%26spage%3D243%26epage%3D260%26doi%3D10.1124%2Fpr.108.00505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Coghlan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inkster, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nutt, D. J.</span><span> </span><span class="NLM_article-title">GABA system dysfunction in autism and related disorders: from synapse to symptoms</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">2044</span><span class="NLM_x">–</span> <span class="NLM_lpage">2055</span><span class="refDoi"> DOI: 10.1016/j.neubiorev.2012.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neubiorev.2012.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22841562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVCisr7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2012&pages=2044-2055&author=S.+Coghlanauthor=J.+Horderauthor=B.+Inksterauthor=M.+A.+Mendezauthor=D.+G.+Murphyauthor=D.+J.+Nutt&title=GABA+system+dysfunction+in+autism+and+related+disorders%3A+from+synapse+to+symptoms&doi=10.1016%2Fj.neubiorev.2012.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">GABA system dysfunction in autism and related disorders: From synapse to symptoms</span></div><div class="casAuthors">Coghlan, Suzanne; Horder, Jamie; Inkster, Becky; Mendez, M. Andreina; Murphy, Declan G.; Nutt, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience & Biobehavioral Reviews</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2044-2055</span>CODEN:
                <span class="NLM_cas:coden">NBREDE</span>;
        ISSN:<span class="NLM_cas:issn">0149-7634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Autism spectrum disorders (ASDs) are neurodevelopmental syndromes characterized by repetitive behaviors and restricted interests, impairments in social behavior and relations, and in language and communication.  These symptoms are also obsd. in a no. of developmental disorders of known origin, including Fragile X Syndrome, Rett Syndrome, and Fetal Anticonvulsant Syndrome.  While these conditions have diverse etiologies, and poorly understood pathologies, emerging evidence suggests that they may all be linked to dysfunction in particular aspects of GABAergic inhibitory signalling in the brain.  We review evidence from genetics, mol. neurobiol. and systems neuroscience relating to the role of GABA in these conditions.  We conclude by discussing how these deficits may relate to the specific symptoms obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz5Bzy3mDXfrVg90H21EOLACvtfcHk0lhjpe-V07r8cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVCisr7P&md5=573508a9d1da4d1802b00265386755ee</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2012.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2012.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DCoghlan%26aufirst%3DS.%26aulast%3DHorder%26aufirst%3DJ.%26aulast%3DInkster%26aufirst%3DB.%26aulast%3DMendez%26aufirst%3DM.%2BA.%26aulast%3DMurphy%26aufirst%3DD.%2BG.%26aulast%3DNutt%26aufirst%3DD.%2BJ.%26atitle%3DGABA%2520system%2520dysfunction%2520in%2520autism%2520and%2520related%2520disorders%253A%2520from%2520synapse%2520to%2520symptoms%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2012%26volume%3D36%26spage%3D2044%26epage%3D2055%26doi%3D10.1016%2Fj.neubiorev.2012.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Cellot, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherubini, E.</span><span> </span><span class="NLM_article-title">GABAergic signaling as therapeutic target for autism spectrum disorders</span> <span class="citation_source-journal">Front. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="refDoi"> DOI: 10.3389/fped.2014.00070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3389%2Ffped.2014.00070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25072038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2cbntVaisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=70&author=G.+Cellotauthor=E.+Cherubini&title=GABAergic+signaling+as+therapeutic+target+for+autism+spectrum+disorders&doi=10.3389%2Ffped.2014.00070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">GABAergic signaling as therapeutic target for autism spectrum disorders</span></div><div class="casAuthors">Cellot Giada; Cherubini Enrico</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in pediatrics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">70</span>
        ISSN:<span class="NLM_cas:issn">2296-2360</span>.
    </div><div class="casAbstract">γ-Aminobutyric acid (GABA), the main inhibitory neurotransmitter in the adult brain, early in postnatal life exerts a depolarizing and excitatory action.  This depends on accumulation of chloride inside the cell via the cation-chloride importer NKCC1, being the expression of the chloride exporter KCC2 very low at birth.  The developmentally regulated expression of KCC2 results in extrusion of chloride with age and a shift of GABA from the depolarizing to the hyperpolarizing direction.  The depolarizing action of GABA leads to intracellular calcium rise through voltage-dependent calcium channels and/or N-methyl-d-aspartate receptors.  GABA-mediated calcium signals regulate a variety of developmental processes from cell proliferation migration, differentiation, synapse maturation, and neuronal wiring.  Therefore, it is not surprising that some forms of neuro-developmental disorders such as autism spectrum disorders (ASDs) are associated with alterations of GABAergic signaling and impairment of the excitatory/inhibitory balance in selective neuronal circuits.  In this review, we will discuss how changes of GABAA-mediated neurotransmission affect several forms of ASDs including the Fragile X, the Angelman, and Rett syndromes.  Then, we will describe various animal models of ASDs with GABAergic dysfunctions, highlighting their behavioral deficits and the possibility to rescue them by targeting selective components of the GABAergic synapse.  In particular, we will discuss how in some cases, reverting the polarity of GABA responses from the depolarizing to the hyperpolarizing direction with the diuretic bumetanide, a selective blocker of NKCC1, may have beneficial effects on ASDs, thus opening new therapeutic perspectives for the treatment of these devastating disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0z4QEAiZ7iDslzEEsg76ufW6udTcc2eZBuYUatao9Zbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbntVaisA%253D%253D&md5=1797a2fb6cc036689777ca1bed7ac7c4</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.3389%2Ffped.2014.00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffped.2014.00070%26sid%3Dliteratum%253Aachs%26aulast%3DCellot%26aufirst%3DG.%26aulast%3DCherubini%26aufirst%3DE.%26atitle%3DGABAergic%2520signaling%2520as%2520therapeutic%2520target%2520for%2520autism%2520spectrum%2520disorders%26jtitle%3DFront.%2520Pediatr.%26date%3D2014%26volume%3D2%26spage%3D70%26doi%3D10.3389%2Ffped.2014.00070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheuer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catterall, W. A.</span><span> </span><span class="NLM_article-title">Enhancement of inhibitory neurotransmission by GABAA receptors having α2,3-subunits ameliorates behavioral deficits in a mouse model of autism</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">1282</span><span class="NLM_x">–</span> <span class="NLM_lpage">1289</span><span class="refDoi"> DOI: 10.1016/j.neuron.2014.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuron.2014.01.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2014&pages=1282-1289&author=S.+Hanauthor=C.+Taiauthor=C.+J.+Jonesauthor=T.+Scheuerauthor=W.+A.+Catterall&title=Enhancement+of+inhibitory+neurotransmission+by+GABAA+receptors+having+%CE%B12%2C3-subunits+ameliorates+behavioral+deficits+in+a+mouse+model+of+autism&doi=10.1016%2Fj.neuron.2014.01.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2014.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2014.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DTai%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DC.%2BJ.%26aulast%3DScheuer%26aufirst%3DT.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26atitle%3DEnhancement%2520of%2520inhibitory%2520neurotransmission%2520by%2520GABAA%2520receptors%2520having%2520%25CE%25B12%252C3-subunits%2520ameliorates%2520behavioral%2520deficits%2520in%2520a%2520mouse%2520model%2520of%2520autism%26jtitle%3DNeuron%26date%3D2014%26volume%3D81%26spage%3D1282%26epage%3D1289%26doi%3D10.1016%2Fj.neuron.2014.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Alhambra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damewood, J. R.,  Jr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dembofsky, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurley, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzog, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horchler, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnmacht, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmiesing, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribadeneira, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knappenberger, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maciag, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christian, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arriza, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapdelaine, M. J.</span><span> </span><span class="NLM_article-title">Development and SAR of functionally selective allosteric modulators of GABAA receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2927</span><span class="NLM_x">–</span> <span class="NLM_lpage">2938</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.03.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bmc.2011.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21498079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltFOrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2927-2938&author=C.+Alhambraauthor=C.+Beckerauthor=T.+Blakeauthor=A.+H.+Changauthor=J.+R.+Damewoodauthor=T.+Danielsauthor=B.+T.+Dembofskyauthor=D.+A.+Gurleyauthor=J.+E.+Hallauthor=K.+J.+Herzogauthor=C.+L.+Horchlerauthor=C.+J.+Ohnmachtauthor=R.+J.+Schmiesingauthor=A.+Dudleyauthor=M.+D.+Ribadeneiraauthor=K.+S.+Knappenbergerauthor=C.+Maciagauthor=M.+M.+Steinauthor=M.+Chopraauthor=X.+F.+Liuauthor=E.+P.+Christianauthor=J.+L.+Arrizaauthor=M.+J.+Chapdelaine&title=Development+and+SAR+of+functionally+selective+allosteric+modulators+of+GABAA+receptors&doi=10.1016%2Fj.bmc.2011.03.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Development and SAR of functionally selective allosteric modulators of GABAA receptors</span></div><div class="casAuthors">Alhambra, Cristobal; Becker, Chris; Blake, Timothy; Chang, Amy; Damewood, James R., Jr.; Daniels, Thalia; Dembofsky, Bruce T.; Gurley, David A.; Hall, James E.; Herzog, Keith J.; Horchler, Carey L.; Ohnmacht, Cyrus J.; Schmiesing, Richard Jon; Dudley, Adam; Ribadeneira, Maria D.; Knappenberger, Katherine S.; Maciag, Carla; Stein, Mark M.; Chopra, Maninder; Liu, Xiaodong F.; Christian, Edward P.; Arriza, Jeffrey L.; Chapdelaine, Marc J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2927-2938</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pos. modulators at the benzodiazepine site of α2- and α3-contg. GABAA receptors are believed to be anxiolytic.  Through oocyte voltage clamp studies, two series of compds. have been discovered that are pos. modulators at α2-/α3-contg. GABAA receptors and that show no functional activity at α1-contg. GABAA receptors.  Studies to improve this functional selectivity and ultimately deliver clin. candidates are reported.  The functional SAR of cinnolines and quinolines that are pos. allosteric modulators of the α2- and α3-contg. GABAA receptors, while simultaneously neutral antagonists at α1-contg. GABAA receptors, is described.  Such functionally selective modulators of GABAA receptors are expected to be useful in the treatment of anxiety and other psychiatric illnesses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVYzfPtmlNCrVg90H21EOLACvtfcHk0ljMVW5ekB9kMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltFOrsbg%253D&md5=24eaa34a5d28e2c7e2cfce14f02267fc</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DAlhambra%26aufirst%3DC.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DBlake%26aufirst%3DT.%26aulast%3DChang%26aufirst%3DA.%2BH.%26aulast%3DDamewood%26aufirst%3DJ.%2BR.%26aulast%3DDaniels%26aufirst%3DT.%26aulast%3DDembofsky%26aufirst%3DB.%2BT.%26aulast%3DGurley%26aufirst%3DD.%2BA.%26aulast%3DHall%26aufirst%3DJ.%2BE.%26aulast%3DHerzog%26aufirst%3DK.%2BJ.%26aulast%3DHorchler%26aufirst%3DC.%2BL.%26aulast%3DOhnmacht%26aufirst%3DC.%2BJ.%26aulast%3DSchmiesing%26aufirst%3DR.%2BJ.%26aulast%3DDudley%26aufirst%3DA.%26aulast%3DRibadeneira%26aufirst%3DM.%2BD.%26aulast%3DKnappenberger%26aufirst%3DK.%2BS.%26aulast%3DMaciag%26aufirst%3DC.%26aulast%3DStein%26aufirst%3DM.%2BM.%26aulast%3DChopra%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%2BF.%26aulast%3DChristian%26aufirst%3DE.%2BP.%26aulast%3DArriza%26aufirst%3DJ.%2BL.%26aulast%3DChapdelaine%26aufirst%3DM.%2BJ.%26atitle%3DDevelopment%2520and%2520SAR%2520of%2520functionally%2520selective%2520allosteric%2520modulators%2520of%2520GABAA%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2927%26epage%3D2938%26doi%3D10.1016%2Fj.bmc.2011.03.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Brondino, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusar-Poli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panisi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damiani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barale, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Politi, P.</span><span> </span><span class="NLM_article-title">Pharmacological modulation of GABA function in autism spectrum disorders: a systematic review of human studies</span> <span class="citation_source-journal">J. Autism Dev. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span><span class="refDoi"> DOI: 10.1007/s10803-015-2619-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs10803-015-2619-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26443675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC283psVSntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2016&pages=825-839&author=N.+Brondinoauthor=L.+Fusar-Poliauthor=C.+Panisiauthor=S.+Damianiauthor=F.+Baraleauthor=P.+Politi&title=Pharmacological+modulation+of+GABA+function+in+autism+spectrum+disorders%3A+a+systematic+review+of+human+studies&doi=10.1007%2Fs10803-015-2619-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Modulation of GABA Function in Autism Spectrum Disorders: A Systematic Review of Human Studies</span></div><div class="casAuthors">Brondino Natascia; Fusar-Poli Laura; Panisi Cristina; Damiani Stefano; Barale Francesco; Politi Pierluigi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autism and developmental disorders</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">825-39</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autism spectrum disorders are an emerging health problem worldwide, but little is known about their pathogenesis.  It has been hypothesized that autism may result from an imbalance between excitatory glutamatergic and inhibitory GABAergic pathways.  Commonly used medications such as valproate, acamprosate, and arbaclofen may act on the GABAergic system and be a potential treatment for people with ASD.  The present systematic review aimed at evaluating the state-of-the-art of clinical trials of GABA modulators in autism.  To date there is insufficient evidence to suggest the use of these drugs in autistic subjects, even if data are promising.  Of note, short-term use of all the reviewed medications appears to be safe.  Future well designed trials are needed to elucidate these preliminary findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTbyy_tCw2eHHtlzo9xastyfW6udTcc2eYIOgCYc6074bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC283psVSntA%253D%253D&md5=1fa93f6a5519e87e4825e57a9274bb0f</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2Fs10803-015-2619-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10803-015-2619-y%26sid%3Dliteratum%253Aachs%26aulast%3DBrondino%26aufirst%3DN.%26aulast%3DFusar-Poli%26aufirst%3DL.%26aulast%3DPanisi%26aufirst%3DC.%26aulast%3DDamiani%26aufirst%3DS.%26aulast%3DBarale%26aufirst%3DF.%26aulast%3DPoliti%26aufirst%3DP.%26atitle%3DPharmacological%2520modulation%2520of%2520GABA%2520function%2520in%2520autism%2520spectrum%2520disorders%253A%2520a%2520systematic%2520review%2520of%2520human%2520studies%26jtitle%3DJ.%2520Autism%2520Dev.%2520Disord.%26date%3D2016%26volume%3D46%26spage%3D825%26epage%3D839%26doi%3D10.1007%2Fs10803-015-2619-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Berry-Kravis, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hessl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathmell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarevics, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherubini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton-Bowen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Heydrich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bear, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagerman, R. J.</span><span> </span><span class="NLM_article-title">Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">152ra127</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3004214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1126%2Fscitranslmed.3004214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22993294" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=152ra127&author=E.+M.+Berry-Kravisauthor=D.+Hesslauthor=B.+Rathmellauthor=P.+Zarevicsauthor=M.+Cherubiniauthor=K.+Walton-Bowenauthor=Y.+Muauthor=D.+V.+Nguyenauthor=J.+Gonzalez-Heydrichauthor=P.+P.+Wangauthor=R.+L.+Carpenterauthor=M.+F.+Bearauthor=R.+J.+Hagerman&title=Effects+of+STX209+%28arbaclofen%29+on+neurobehavioral+function+in+children+and+adults+with+fragile+X+syndrome%3A+a+randomized%2C+controlled%2C+phase+2+trial&doi=10.1126%2Fscitranslmed.3004214"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3004214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3004214%26sid%3Dliteratum%253Aachs%26aulast%3DBerry-Kravis%26aufirst%3DE.%2BM.%26aulast%3DHessl%26aufirst%3DD.%26aulast%3DRathmell%26aufirst%3DB.%26aulast%3DZarevics%26aufirst%3DP.%26aulast%3DCherubini%26aufirst%3DM.%26aulast%3DWalton-Bowen%26aufirst%3DK.%26aulast%3DMu%26aufirst%3DY.%26aulast%3DNguyen%26aufirst%3DD.%2BV.%26aulast%3DGonzalez-Heydrich%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%2BP.%26aulast%3DCarpenter%26aufirst%3DR.%2BL.%26aulast%3DBear%26aufirst%3DM.%2BF.%26aulast%3DHagerman%26aufirst%3DR.%2BJ.%26atitle%3DEffects%2520of%2520STX209%2520%2528arbaclofen%2529%2520on%2520neurobehavioral%2520function%2520in%2520children%2520and%2520adults%2520with%2520fragile%2520X%2520syndrome%253A%2520a%2520randomized%252C%2520controlled%252C%2520phase%25202%2520trial%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D152ra127%26doi%3D10.1126%2Fscitranslmed.3004214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Veenstra-VanderWeele, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarevics, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherubini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton-Bowen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bear, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, R. L.</span><span> </span><span class="NLM_article-title">Arbaclofen in children and adolescents with autism spectrum disorder: a randomized, controlled, Phase 2 trial</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1390</span><span class="NLM_x">–</span> <span class="NLM_lpage">1398</span><span class="refDoi"> DOI: 10.1038/npp.2016.237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnpp.2016.237" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=1390-1398&author=J.+Veenstra-VanderWeeleauthor=E.+H.+Cookauthor=B.+H.+Kingauthor=P.+Zarevicsauthor=M.+Cherubiniauthor=K.+Walton-Bowenauthor=M.+F.+Bearauthor=P.+P.+Wangauthor=R.+L.+Carpenter&title=Arbaclofen+in+children+and+adolescents+with+autism+spectrum+disorder%3A+a+randomized%2C+controlled%2C+Phase+2+trial&doi=10.1038%2Fnpp.2016.237"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2016.237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2016.237%26sid%3Dliteratum%253Aachs%26aulast%3DVeenstra-VanderWeele%26aufirst%3DJ.%26aulast%3DCook%26aufirst%3DE.%2BH.%26aulast%3DKing%26aufirst%3DB.%2BH.%26aulast%3DZarevics%26aufirst%3DP.%26aulast%3DCherubini%26aufirst%3DM.%26aulast%3DWalton-Bowen%26aufirst%3DK.%26aulast%3DBear%26aufirst%3DM.%2BF.%26aulast%3DWang%26aufirst%3DP.%2BP.%26aulast%3DCarpenter%26aufirst%3DR.%2BL.%26atitle%3DArbaclofen%2520in%2520children%2520and%2520adolescents%2520with%2520autism%2520spectrum%2520disorder%253A%2520a%2520randomized%252C%2520controlled%252C%2520Phase%25202%2520trial%26jtitle%3DNeuropsychopharmacology%26date%3D2017%26volume%3D42%26spage%3D1390%26epage%3D1398%26doi%3D10.1038%2Fnpp.2016.237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Brown, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hockerman, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerksen, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colby, D. A.</span><span> </span><span class="NLM_article-title">Activation of the γ-aminobutyric acid type B (GABAB) receptor by agonists and positive allosteric modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6336</span><span class="NLM_x">–</span> <span class="NLM_lpage">6347</span><span class="refDoi"> DOI: 10.1021/jm5018913</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5018913" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtlant7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6336-6347&author=K.+M.+Brownauthor=K.+K.+Royauthor=G.+H.+Hockermanauthor=R.+J.+Doerksenauthor=D.+A.+Colby&title=Activation+of+the+%CE%B3-aminobutyric+acid+type+B+%28GABAB%29+receptor+by+agonists+and+positive+allosteric+modulators&doi=10.1021%2Fjm5018913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of the γ-Aminobutyric Acid Type B (GABAB) Receptor by Agonists and Positive Allosteric Modulators</span></div><div class="casAuthors">Brown, Katie M.; Roy, Kuldeep K.; Hockerman, Gregory H.; Doerksen, Robert J.; Colby, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6336-6347</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Since the discovery of the GABAB agonist and muscle relaxant baclofen, there have been substantial advancements in the development of compds. that activate the GABAB receptor as agonists or pos. allosteric modulators.  For the agonists, most of the existing structure-activity data apply to understanding the role of substituents on the backbone of GABA as well as replacing the carboxylic acid and amine groups.  In the cases of the pos. allosteric modulators, the allosteric binding site(s) and structure-activity relationships are less well-defined; however, multiple classes of mols. have been discovered.  The recent report of the X-ray structure of the GABAB receptor with bound agonists and antagonists provides new insights for the development of compds. that bind the orthosteric site of this receptor.  From a therapeutic perspective, these data have enabled efforts in drug discovery in areas of addiction-related behavior, the treatment of anxiety, and the control of muscle contractility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcDXupO8aPDbVg90H21EOLACvtfcHk0lhBDSV3ayiXTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtlant7Y%253D&md5=90940cf9ded118c6ba931005a97b4f86</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Fjm5018913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5018913%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DK.%2BM.%26aulast%3DRoy%26aufirst%3DK.%2BK.%26aulast%3DHockerman%26aufirst%3DG.%2BH.%26aulast%3DDoerksen%26aufirst%3DR.%2BJ.%26aulast%3DColby%26aufirst%3DD.%2BA.%26atitle%3DActivation%2520of%2520the%2520%25CE%25B3-aminobutyric%2520acid%2520type%2520B%2520%2528GABAB%2529%2520receptor%2520by%2520agonists%2520and%2520positive%2520allosteric%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6336%26epage%3D6347%26doi%3D10.1021%2Fjm5018913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Kalinichev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haddouk, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouillier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riguet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Royer-Urios, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lütjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poli, S.</span><span> </span><span class="NLM_article-title">The drug candidate, ADX71441, is a novel, potent and selective positive allosteric modulator of the GABAB receptor with a potential for treatment of anxiety, pain and spasticity</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2016.11.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuropharm.2016.11.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=34-47&author=M.+Kalinichevauthor=F.+Girardauthor=H.+Haddoukauthor=M.+Rouillierauthor=E.+Riguetauthor=I.+Royer-Uriosauthor=V.+Mutelauthor=R.+L%C3%BCtjensauthor=S.+Poli&title=The+drug+candidate%2C+ADX71441%2C+is+a+novel%2C+potent+and+selective+positive+allosteric+modulator+of+the+GABAB+receptor+with+a+potential+for+treatment+of+anxiety%2C+pain+and+spasticity&doi=10.1016%2Fj.neuropharm.2016.11.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2016.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2016.11.016%26sid%3Dliteratum%253Aachs%26aulast%3DKalinichev%26aufirst%3DM.%26aulast%3DGirard%26aufirst%3DF.%26aulast%3DHaddouk%26aufirst%3DH.%26aulast%3DRouillier%26aufirst%3DM.%26aulast%3DRiguet%26aufirst%3DE.%26aulast%3DRoyer-Urios%26aufirst%3DI.%26aulast%3DMutel%26aufirst%3DV.%26aulast%3DL%25C3%25BCtjens%26aufirst%3DR.%26aulast%3DPoli%26aufirst%3DS.%26atitle%3DThe%2520drug%2520candidate%252C%2520ADX71441%252C%2520is%2520a%2520novel%252C%2520potent%2520and%2520selective%2520positive%2520allosteric%2520modulator%2520of%2520the%2520GABAB%2520receptor%2520with%2520a%2520potential%2520for%2520treatment%2520of%2520anxiety%252C%2520pain%2520and%2520spasticity%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D114%26spage%3D34%26epage%3D47%26doi%3D10.1016%2Fj.neuropharm.2016.11.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Caracci, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ávila, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Ferrari, G. V.</span><span> </span><span class="NLM_article-title">Synaptic Wnt/GSK3β signaling hub in autism</span> <span class="citation_source-journal">Neural Plast.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">2016</span><span class="NLM_x">, </span> <span class="NLM_fpage">9603751</span><span class="refDoi"> DOI: 10.1155/2016/9603751</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1155%2F2016%2F9603751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26881141" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC28jhtVylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=9603751&author=M.+O.+Caracciauthor=M.+E.+%C3%81vilaauthor=G.+V.+De+Ferrari&title=Synaptic+Wnt%2FGSK3%CE%B2+signaling+hub+in+autism&doi=10.1155%2F2016%2F9603751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Synaptic Wnt/GSK3β Signaling Hub in Autism</span></div><div class="casAuthors">Caracci Mario O; Avila Miguel E; De Ferrari Giancarlo V</div><div class="citationInfo"><span class="NLM_cas:title">Neural plasticity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2016</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9603751</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hundreds of genes have been associated with autism spectrum disorders (ASDs) and the interaction of weak and de novo variants derive from distinct autistic phenotypes thus making up the "spectrum." The convergence of these variants in networks of genes associated with synaptic function warrants the study of cell signaling pathways involved in the regulation of the synapse.  The Wnt/β-catenin signaling pathway plays a central role in the development and regulation of the central nervous system and several genes belonging to the cascade have been genetically associated with ASDs.  In the present paper, we review basic information regarding the role of Wnt/β-catenin signaling in excitatory/inhibitory balance (E/I balance) through the regulation of pre- and postsynaptic compartments.  Furthermore, we integrate information supporting the role of the glycogen synthase kinase 3β (GSK3β) in the onset/development of ASDs through direct modulation of Wnt/β-catenin signaling.  Finally, given GSK3β activity as key modulator of synaptic plasticity, we explore the potential of this kinase as a therapeutic target for ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRFS7HBs9MUsjl5L8hwNX0fW6udTcc2ebwti6rEZ-_Trntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jhtVylsg%253D%253D&md5=8dde53877c01a9674e7ad26ab99a8653</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1155%2F2016%2F9603751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F9603751%26sid%3Dliteratum%253Aachs%26aulast%3DCaracci%26aufirst%3DM.%2BO.%26aulast%3D%25C3%2581vila%26aufirst%3DM.%2BE.%26aulast%3DDe%2BFerrari%26aufirst%3DG.%2BV.%26atitle%3DSynaptic%2520Wnt%252FGSK3%25CE%25B2%2520signaling%2520hub%2520in%2520autism%26jtitle%3DNeural%2520Plast.%26date%3D2016%26volume%3D2016%26spage%3D9603751%26doi%3D10.1155%2F2016%2F9603751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Mulligan, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheyette, B. N.</span><span> </span><span class="NLM_article-title">Neurodevelopmental perspectives on Wnt signaling in psychiatry</span> <span class="citation_source-journal">Mol. Neuropsychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">246</span><span class="refDoi"> DOI: 10.1159/000453266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1159%2F000453266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=28277568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC1czks1WitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=219-246&author=K.+A.+Mulliganauthor=B.+N.+Cheyette&title=Neurodevelopmental+perspectives+on+Wnt+signaling+in+psychiatry&doi=10.1159%2F000453266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Neurodevelopmental Perspectives on Wnt Signaling in Psychiatry</span></div><div class="casAuthors">Mulligan Kimberly A; Cheyette Benjamin N R</div><div class="citationInfo"><span class="NLM_cas:title">Molecular neuropsychiatry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">219-246</span>
        ISSN:<span class="NLM_cas:issn">2296-9209</span>.
    </div><div class="casAbstract">Mounting evidence indicates that Wnt signaling is relevant to pathophysiology of diverse mental illnesses including schizophrenia, bipolar disorder, and autism spectrum disorder.  In the 35 years since Wnt ligands were first described, animal studies have richly explored how downstream Wnt signaling pathways affect an array of neurodevelopmental processes and how their disruption can lead to both neurological and behavioral phenotypes.  Recently, human induced pluripotent stem cell (hiPSC) models have begun to contribute to this literature while pushing it in increasingly translational directions.  Simultaneously, large-scale human genomic studies are providing evidence that sequence variation in Wnt signal pathway genes contributes to pathogenesis in several psychiatric disorders.  This article reviews neurodevelopmental and postneurodevelopmental functions of Wnt signaling, highlighting mechanisms, whereby its disruption might contribute to psychiatric illness, and then reviews the most reliable recent genetic evidence supporting that mutations in Wnt pathway genes contribute to psychiatric illness.  We are proponents of the notion that studies in animal and hiPSC models informed by the human genetic data combined with the deep knowledge base and tool kits generated over the last several decades of basic neurodevelopmental research will yield near-term tangible advances in neuropsychiatry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRbMbL0-sgHr9Hxxy173TfNfW6udTcc2eYL_vTpSWHEdrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czks1WitQ%253D%253D&md5=cfbfef2ae9c8e4cea3abff7dbf2031f6</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1159%2F000453266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000453266%26sid%3Dliteratum%253Aachs%26aulast%3DMulligan%26aufirst%3DK.%2BA.%26aulast%3DCheyette%26aufirst%3DB.%2BN.%26atitle%3DNeurodevelopmental%2520perspectives%2520on%2520Wnt%2520signaling%2520in%2520psychiatry%26jtitle%3DMol.%2520Neuropsychiatry%26date%3D2017%26volume%3D2%26spage%3D219%26epage%3D246%26doi%3D10.1159%2F000453266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Klein, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melton, D. A.</span><span> </span><span class="NLM_article-title">A molecular mechanism for the effect of lithium on development</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">8455</span><span class="NLM_x">–</span> <span class="NLM_lpage">8459</span><span class="refDoi"> DOI: 10.1073/pnas.93.16.8455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.93.16.8455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=8710892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADyaK28XkvFyksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=8455-8459&author=P.+S.+Kleinauthor=D.+A.+Melton&title=A+molecular+mechanism+for+the+effect+of+lithium+on+development&doi=10.1073%2Fpnas.93.16.8455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">A molecular mechanism for the effect of lithium on development</span></div><div class="casAuthors">Klein, Peter S.; Melton, Douglas A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8455-8459</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Lithium, one of the most effective drugs for the treatment of bipolar (manic-depressive) disorder, also has dramatic effects on morphogenesis in the early development of numerous organisms.  How lithium exerts these diverse effects is unclear, but the favored hypothesis is that lithium acts through inhibition of inositol monophosphatase (IMPase).  We show here that complete inhibition of IMPase has no effect on the morphogenesis of Xenopus embryos and present a different hypothesis to explain the broad action of lithium.  Our results suggest that lithium acts through inhibition of glycogen synthase kinase-3β (GSK-3β), which regulates cell fate detn. in diverse organisms including dictyostelium, Drosophila, and Xenopus.  Lithium potently inhibits GSK-3β activity (Ki = 2 mM), but is not a general inhibitor of other protein kinases.  In support of this hypothesis, lithium treatment phenocopies loss of GSK-3β function of Xenopus and Dictyostelium.  These observations help explain the effect of lithium on cell-fate detn. and could provide insights into the pathogenesis and treatment of bipolar disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwmgF9XN0PabVg90H21EOLACvtfcHk0lg59wYhJACdig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFyksLY%253D&md5=611ae73b9ec411df9ff84da5fdaffcfc</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.16.8455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.16.8455%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DP.%2BS.%26aulast%3DMelton%26aufirst%3DD.%2BA.%26atitle%3DA%2520molecular%2520mechanism%2520for%2520the%2520effect%2520of%2520lithium%2520on%2520development%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D8455%26epage%3D8459%26doi%3D10.1073%2Fpnas.93.16.8455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Cerpa, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godoy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfaro, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farías, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalfe, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuentealba, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonansco, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span> </span><span class="NLM_article-title">Wnt-7a modulates the synaptic vesicle cycle and synaptic transmission in hippocampal neurons</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">5918</span><span class="NLM_x">–</span> <span class="NLM_lpage">5927</span><span class="refDoi"> DOI: 10.1074/jbc.M705943200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1074%2Fjbc.M705943200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=5918-5927&author=W.+Cerpaauthor=J.+A.+Godoyauthor=I.+Alfaroauthor=G.+G.+Far%C3%ADasauthor=M.+J.+Metcalfeauthor=R.+Fuentealbaauthor=C.+Bonanscoauthor=N.+C.+Inestrosa&title=Wnt-7a+modulates+the+synaptic+vesicle+cycle+and+synaptic+transmission+in+hippocampal+neurons&doi=10.1074%2Fjbc.M705943200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M705943200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M705943200%26sid%3Dliteratum%253Aachs%26aulast%3DCerpa%26aufirst%3DW.%26aulast%3DGodoy%26aufirst%3DJ.%2BA.%26aulast%3DAlfaro%26aufirst%3DI.%26aulast%3DFar%25C3%25ADas%26aufirst%3DG.%2BG.%26aulast%3DMetcalfe%26aufirst%3DM.%2BJ.%26aulast%3DFuentealba%26aufirst%3DR.%26aulast%3DBonansco%26aufirst%3DC.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DWnt-7a%2520modulates%2520the%2520synaptic%2520vesicle%2520cycle%2520and%2520synaptic%2520transmission%2520in%2520hippocampal%2520neurons%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D5918%26epage%3D5927%26doi%3D10.1074%2Fjbc.M705943200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Ahmad-Annuar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeonidis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herreros, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredj, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosso, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brickley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salinas, P. C.</span><span> </span><span class="NLM_article-title">Signaling across the synapse: a role for Wnt and Dishevelled in presynaptic assembly and neurotransmitter release</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">174</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span><span class="refDoi"> DOI: 10.1083/jcb.200511054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1083%2Fjcb.200511054" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2006&pages=127-139&author=A.+Ahmad-Annuarauthor=L.+Cianiauthor=I.+Simeonidisauthor=J.+Herrerosauthor=N.+B.+Fredjauthor=S.+B.+Rossoauthor=A.+Hallauthor=S.+Brickleyauthor=P.+C.+Salinas&title=Signaling+across+the+synapse%3A+a+role+for+Wnt+and+Dishevelled+in+presynaptic+assembly+and+neurotransmitter+release&doi=10.1083%2Fjcb.200511054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200511054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200511054%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad-Annuar%26aufirst%3DA.%26aulast%3DCiani%26aufirst%3DL.%26aulast%3DSimeonidis%26aufirst%3DI.%26aulast%3DHerreros%26aufirst%3DJ.%26aulast%3DFredj%26aufirst%3DN.%2BB.%26aulast%3DRosso%26aufirst%3DS.%2BB.%26aulast%3DHall%26aufirst%3DA.%26aulast%3DBrickley%26aufirst%3DS.%26aulast%3DSalinas%26aufirst%3DP.%2BC.%26atitle%3DSignaling%2520across%2520the%2520synapse%253A%2520a%2520role%2520for%2520Wnt%2520and%2520Dishevelled%2520in%2520presynaptic%2520assembly%2520and%2520neurotransmitter%2520release%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2006%26volume%3D174%26spage%3D127%26epage%3D139%26doi%3D10.1083%2Fjcb.200511054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Ciani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickins, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahores, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anane, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibb, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salinas, P. C.</span><span> </span><span class="NLM_article-title">Wnt7a signaling promotes dendritic spine growth and synaptic strength through Ca<sup>2</sup><sup>+</sup>/Calmodulin-dependent protein kinase II</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">10732</span><span class="NLM_x">–</span> <span class="NLM_lpage">10737</span><span class="refDoi"> DOI: 10.1073/pnas.1018132108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.1018132108" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=10732-10737&author=L.+Cianiauthor=K.+A.+Boyleauthor=E.+Dickinsauthor=M.+Sahoresauthor=D.+Ananeauthor=D.+M.+Lopesauthor=A.+J.+Gibbauthor=P.+C.+Salinas&title=Wnt7a+signaling+promotes+dendritic+spine+growth+and+synaptic+strength+through+Ca2%2B%2FCalmodulin-dependent+protein+kinase+II&doi=10.1073%2Fpnas.1018132108"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1018132108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1018132108%26sid%3Dliteratum%253Aachs%26aulast%3DCiani%26aufirst%3DL.%26aulast%3DBoyle%26aufirst%3DK.%2BA.%26aulast%3DDickins%26aufirst%3DE.%26aulast%3DSahores%26aufirst%3DM.%26aulast%3DAnane%26aufirst%3DD.%26aulast%3DLopes%26aufirst%3DD.%2BM.%26aulast%3DGibb%26aufirst%3DA.%2BJ.%26aulast%3DSalinas%26aufirst%3DP.%2BC.%26atitle%3DWnt7a%2520signaling%2520promotes%2520dendritic%2520spine%2520growth%2520and%2520synaptic%2520strength%2520through%2520Ca2%252B%252FCalmodulin-dependent%2520protein%2520kinase%2520II%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D10732%26epage%3D10737%26doi%3D10.1073%2Fpnas.1018132108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Latapy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rioux, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guitton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, J. M.</span><span> </span><span class="NLM_article-title">Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviour</span> <span class="citation_source-journal">Philos. Trans. R. Soc., B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">2460</span><span class="NLM_x">–</span> <span class="NLM_lpage">2474</span><span class="refDoi"> DOI: 10.1098/rstb.2012.0094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1098%2Frstb.2012.0094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22826345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlCqt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=2012&pages=2460-2474&author=C.+Latapyauthor=V.+Riouxauthor=M.+J.+Guittonauthor=J.+M.+Beaulieu&title=Selective+deletion+of+forebrain+glycogen+synthase+kinase+3%CE%B2+reveals+a+central+role+in+serotonin-sensitive+anxiety+and+social+behaviour&doi=10.1098%2Frstb.2012.0094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviour</span></div><div class="casAuthors">Latapy, Camille; Rioux, Veronique; Guitton, Matthieu J.; Beaulieu, Jean-Martin</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical Transactions of the Royal Society, B: Biological Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">1601</span>),
    <span class="NLM_cas:pages">2460-2474</span>CODEN:
                <span class="NLM_cas:coden">PTRBAE</span>;
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">Serotonin (5-HT) neurotransmission is thought to underlie mental illnesses, such as bipolar disorder, depression, autism and schizophrenia.  Independent studies have indicated that 5-HT or drugs acting on 5-HT neurotransmission regulate the serine/threonine kinase glycogen synthase kinase 3β (GSK3β).  Furthermore, GSK3β inhibition rescues behavioral abnormalities in 5-HT-deficient mice with a loss-of-function mutation equiv. to the human variant (R441H) of tryptophan hydroxylase 2.  In an effort to define neuroanatomical correlates of GSK3β activity in the regulation of behavior, we generated CamKIIcre-floxGSK3β mice in which the gsk3b gene is post-natally inactivated in forebrain pyramidal neurons.  Behavioral characterization showed that suppression of GSK3β in these brain areas has anxiolytic and pro-social effects.  However, while a global redn. of GSK2β expression reduced responsiveness to amphetamine and increased resilience to social defeat, these behavioral effects were not found in CamKIIcre-floxGSK3β mice.  These findings demonstrate a dissocn. of behavioral effects related to GSK3 inhibition, with forebrain GSK3β being involved in the regulation of anxiety and sociability while social preference, resilience and responsiveness to psychostimulants would involve a function of this kinase in subcortical areas such as the hippocampus and striatum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmnqQN3YIHSbVg90H21EOLACvtfcHk0lhf7hdlIBLoTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlCqt77F&md5=de74e57a27df0f415d84531ba980acb4</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1098%2Frstb.2012.0094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2012.0094%26sid%3Dliteratum%253Aachs%26aulast%3DLatapy%26aufirst%3DC.%26aulast%3DRioux%26aufirst%3DV.%26aulast%3DGuitton%26aufirst%3DM.%2BJ.%26aulast%3DBeaulieu%26aufirst%3DJ.%2BM.%26atitle%3DSelective%2520deletion%2520of%2520forebrain%2520glycogen%2520synthase%2520kinase%25203%25CE%25B2%2520reveals%2520a%2520central%2520role%2520in%2520serotonin-sensitive%2520anxiety%2520and%2520social%2520behaviour%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2012%26volume%3D367%26spage%3D2460%26epage%3D2474%26doi%3D10.1098%2Frstb.2012.0094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Hernàndez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guaza, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J. J.</span><span> </span><span class="NLM_article-title">Spatial learning deficit in transgenic mice that conditionally overexpress GSK-3β in the brain but do not form tau filaments</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1529</span><span class="NLM_x">–</span> <span class="NLM_lpage">1533</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.01269.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1046%2Fj.1471-4159.2002.01269.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=12472906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsFym" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2002&pages=1529-1533&author=F.+Hern%C3%A0ndezauthor=J.+Borrellauthor=C.+Guazaauthor=J.+Avilaauthor=J.+J.+Lucas&title=Spatial+learning+deficit+in+transgenic+mice+that+conditionally+overexpress+GSK-3%CE%B2+in+the+brain+but+do+not+form+tau+filaments&doi=10.1046%2Fj.1471-4159.2002.01269.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Spatial learning deficit in transgenic mice that conditionally over-express GSK-3β in the brain but do not form tau filaments</span></div><div class="casAuthors">Hernandez, Felix; Borrell, Jose; Guaza, Carmen; Avila, Jesus; Lucas, Jose J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1529-1533</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">Deregulation of glycogen synthase kinase-3 (GSK-3) activity in neurons has been postulated as a key feature in Alzheimer's disease (AD) pathogenesis.  This was further supported by our recent characterization of transgenic mice that conditionally over-express GSK-3β in hippocampal and cortical neurons.  These mice, designated Tet/GSK-3β, showed many of the biochem. and cellular aspects of AD neuropathol. such as tau hyperphosphorylation and somatodendritic localization, decreased nuclear β-catenin, neuronal death and reactive gliosis.  Tet/GSK-3β mice, however, did not show tau filament formation up to the latest tested age of 3 mo at least.  Here we report spatial learning deficits of Tet/GSK-3β mice in the Morris water maze.  In parallel, we also measured the increase in GSK-3 activity while further exploring the possibility of tau filament formation in aged mice.  We found a significant increase in GSK-3 activity in the hippocampus of Tet/GSK-3β mice whereas no tau fibrils could be found even in very old mice.  These data reinforce the hypothesis of GSK-3 deregulation in AD pathogenesis, and suggest that Tet/GSK-3β mice can be used as an AD model and, most remarkably, can be used to test the therapeutic potential of the selective GSK-3 inhibitors that are currently under development.  Addnl., these expts. suggest that destabilization of microtubules and alteration of intracellular metabolic pathways contribute to AD pathogenesis independent of toxicity triggered by the aberrant tau deposits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnmGYVzTRDerVg90H21EOLACvtfcHk0lhf7hdlIBLoTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsFym&md5=2e8597a2cc0e0a97437ddf9351590cb1</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.01269.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.01269.x%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A0ndez%26aufirst%3DF.%26aulast%3DBorrell%26aufirst%3DJ.%26aulast%3DGuaza%26aufirst%3DC.%26aulast%3DAvila%26aufirst%3DJ.%26aulast%3DLucas%26aufirst%3DJ.%2BJ.%26atitle%3DSpatial%2520learning%2520deficit%2520in%2520transgenic%2520mice%2520that%2520conditionally%2520overexpress%2520GSK-3%25CE%25B2%2520in%2520the%2520brain%2520but%2520do%2520not%2520form%2520tau%2520filaments%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D83%26spage%3D1529%26epage%3D1533%26doi%3D10.1046%2Fj.1471-4159.2002.01269.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Siegel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vishnevetsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stedman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. A.</span><span> </span><span class="NLM_article-title">Preliminary investigation of lithium for mood disorder symptoms in children and adolescents with autism spectrum disorder</span> <span class="citation_source-journal">J. Child Adolesc. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span><span class="refDoi"> DOI: 10.1089/cap.2014.0019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1089%2Fcap.2014.0019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25093602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFamsrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=399-402&author=M.+Siegelauthor=C.+A.+Beresfordauthor=M.+Bunkerauthor=M.+Verdiauthor=D.+Vishnevetskyauthor=C.+Karlssonauthor=O.+Teerauthor=A.+Stedmanauthor=K.+A.+Smith&title=Preliminary+investigation+of+lithium+for+mood+disorder+symptoms+in+children+and+adolescents+with+autism+spectrum+disorder&doi=10.1089%2Fcap.2014.0019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Preliminary Investigation of Lithium for Mood Disorder Symptoms in Children and Adolescents with Autism Spectrum Disorder</span></div><div class="casAuthors">Siegel, Matthew; Beresford, Carol A.; Bunker, Madisun; Verdi, Mary; Vishnevetsky, Donna; Karlsson, Cassie; Teer, Olivia; Stedman, Amy; Smith, Kahsi A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Child and Adolescent Psychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">399-402</span>CODEN:
                <span class="NLM_cas:coden">JADPET</span>;
        ISSN:<span class="NLM_cas:issn">1044-5463</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Objective: Children with autism spectrum disorder (ASD) have higher rates of comorbid psychiatric disorders, including mood disorders, than the general child population.  Although children with ASD may experience irritability (aggression, self-injury, and tantrums), a portion also experience symptoms that are typical of a mood disorder, such as euphoria/elevated mood, mania, hypersexuality, paranoia, or decreased need for sleep.  Despite lithium's established efficacy in controlling mood disorder symptoms in the neurotypical population, lithium has been rarely studied in children with ASD.Methods: We performed a retrospective chart review of 30 children and adolescents diagnosed with ASD by the Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision (DSM-IV-TR) criteria who were prescribed lithium in order to assess target symptoms, safety, and tolerability.  Clin. Global Impressions - Improvement (CGI-I) ratings were performed by two board-certified child psychiatrists with expertise in ASD.  CGI-I scores were dichotomized into "improved" (CGI-I score of 1 or 2) or "not improved" (CGI-I score ≥3).Results: Forty-three percent of patients who received lithium were rated as "improved" on the CGI-I.  Seventy-one percent of patients who had two or more pretreatment mood disorder symptoms were rated as "improved.  " The presence of mania (p=0.033) or euphoria/elevated mood (p=0.041) were the pretreatment symptoms significantly assocd. with an "improved" rating.  The mean lithium blood level was 0.70 mEq/L (SD=0.26), and the av. length of lithium treatment was 29.7 days (SD=23.9).  Forty-seven percent of patients were reported to have at least one side effect, most commonly vomiting (13%), tremor (10%), fatigue (10%), irritability (7%), and enuresis (7%).Conclusions: This preliminary assessment of lithium in children and adolescents with ASD suggests that lithium may be a medication of interest for those who exhibit two or more mood disorder symptoms, particularly mania or euphoria/elevated mood.  A relatively high side effect rate merits caution, and these results are limited by the retrospective, uncontrolled study design.  Future study of lithium in a prospective trial with treatment-sensitive outcome measures may be indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl35nuQjFGnbVg90H21EOLACvtfcHk0lhf7hdlIBLoTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFamsrvF&md5=6a361133f71c31a559fd48b72a47ecf4</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1089%2Fcap.2014.0019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcap.2014.0019%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DM.%26aulast%3DBeresford%26aufirst%3DC.%2BA.%26aulast%3DBunker%26aufirst%3DM.%26aulast%3DVerdi%26aufirst%3DM.%26aulast%3DVishnevetsky%26aufirst%3DD.%26aulast%3DKarlsson%26aufirst%3DC.%26aulast%3DTeer%26aufirst%3DO.%26aulast%3DStedman%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DK.%2BA.%26atitle%3DPreliminary%2520investigation%2520of%2520lithium%2520for%2520mood%2520disorder%2520symptoms%2520in%2520children%2520and%2520adolescents%2520with%2520autism%2520spectrum%2520disorder%26jtitle%3DJ.%2520Child%2520Adolesc.%2520Psychopharmacol.%26date%3D2014%26volume%3D24%26spage%3D399%26epage%3D402%26doi%3D10.1089%2Fcap.2014.0019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Z.</span><span> </span><span class="NLM_article-title">Lithium ameliorates autistic-like behaviors induced by neonatal isolation in rats</span> <span class="citation_source-journal">Front. Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">234</span><span class="refDoi"> DOI: 10.3389/fnbeh.2014.00234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3389%2Ffnbeh.2014.00234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25018711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1GltL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=234&author=X.+Wuauthor=Y.+Baiauthor=T.+Tanauthor=H.+Liauthor=S.+Xiaauthor=X.+Changauthor=Z.+Zhouauthor=W.+Zhouauthor=T.+Liauthor=Y.+T.+Wangauthor=Z.+Dong&title=Lithium+ameliorates+autistic-like+behaviors+induced+by+neonatal+isolation+in+rats&doi=10.3389%2Ffnbeh.2014.00234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Lithium ameliorates autistic-like behaviors induced by neonatal isolation in rats</span></div><div class="casAuthors">Wu, Xiaoyan; Bai, Yanrui; Tan, Tao; Li, Hongjie; Xia, Shuting; Chang, Xinxia; Zhou, Zikai; Zhou, Weihui; Li, Tingyu; Wang, Yu Tian; Dong, Zhifang</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">234/1-234/12, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Neonatal isolation is a widely accepted model to study the long-term behavioral changes produced by the early life events.  However, it remains unknown whether neonatal isolation can induce autistic-like behaviors, and if so, whether pharmacol. treatment can overcome it.  Here, we reported that newborn rats subjected to individual isolations from their mother and nest for 1 h per day from postnatal days 1-9 displayed apparent autistic-like symptoms including social deficits, excessive repetitive self-grooming behavior and increased anxiety- and depressive-like behaviors tested in young adult (postnatal days 42-56) compared to normal reared controls.  Furthermore, these behavioral changes were accompanied by impaired adult hippocampal neurogenesis and reduced the ratio of excitatory/inhibitory synaptic transmissions, as reflected by an increase in spontaneous inhibitory postsynaptic current (sIPSC) and normal spontaneous excitatory postsynaptic current (sEPSC) in the hippocampal CA1 pyramidal neuron.  More importantly, chronic administration of lithium, a clin. used mood stabilizer, completely overcame neonatal isolation-induced autistic-like behaviors and restored adult hippocampal neurogenesis as well as the balance between excitatory and inhibitory activities to physiol. levels.  These findings indicate that neonatal isolation may produce autistic-like behaviors and lithium may be a potential therapeutic agent against autism spectrum disorders (ASD) during development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyI2ISniSEILVg90H21EOLACvtfcHk0lgiJP_G3kJQrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1GltL%252FL&md5=9abfba2d6b6b744d1df94458179dcd92</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2014.00234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2014.00234%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DXia%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%2BT.%26aulast%3DDong%26aufirst%3DZ.%26atitle%3DLithium%2520ameliorates%2520autistic-like%2520behaviors%2520induced%2520by%2520neonatal%2520isolation%2520in%2520rats%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2014%26volume%3D8%26spage%3D234%26doi%3D10.3389%2Ffnbeh.2014.00234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Liu, Z.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C. B.</span><span> </span><span class="NLM_article-title">Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1145</span><span class="NLM_x">–</span> <span class="NLM_lpage">1152</span><span class="refDoi"> DOI: 10.1016/j.nbd.2011.12.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.nbd.2011.12.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22227453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XitlGkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=1145-1152&author=Z.-H.+Liuauthor=T.+Huangauthor=C.+B.+Smith&title=Lithium+reverses+increased+rates+of+cerebral+protein+synthesis+in+a+mouse+model+of+fragile+X+syndrome&doi=10.1016%2Fj.nbd.2011.12.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome</span></div><div class="casAuthors">Liu, Zhong-Hua; Huang, Tianjian; Smith, Carolyn Beebe</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1145-1152</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Individuals with fragile X syndrome (FXS), an inherited form of cognitive disability, have a wide range of symptoms including hyperactivity, autistic behavior, seizures and learning deficits.  FXS is caused by silencing of FMR1 and the consequent absence of fragile X mental retardation protein (FMRP).  FMRP is an RNA-binding protein that assocs. with polyribosomes and neg. regulates translation.  In a previous study of a mouse model of FXS (Fmr1 knockout (KO)) we demonstrated that in vivo rates of cerebral protein synthesis (rCPS) were elevated in selective brain regions suggesting that the absence of FMRP in FXS may result in dysregulation of cerebral protein synthesis.  Lithium, a drug used clin. to treat bipolar disorder, has been used to improve mood dysregulation in individuals with FXS.  We reported previously that in the Fmr1 KO mouse chronic dietary lithium treatment reversed or ameliorated both behavioral and morphol. abnormalities.  Herein we report that chronic dietary lithium treatment reversed the increased rCPS in Fmr1 KO mice with little effect on wild type mice.  We also report our results of analyses of key signaling mols. involved in regulation of mRNA translation.  Our analyses indicate that neither effects on the PI3K/Akt nor the MAPK/ERK 1/2 pathway fully account for the effects of lithium treatment on rCPS.  Collectively our findings and those from other labs. on the efficacy of lithium treatment in animal models support further studies in patients with FXS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_xl88jUTRWrVg90H21EOLACvtfcHk0lgiJP_G3kJQrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitlGkt78%253D&md5=49e0e187bc62f9ad0ca17c2514e74a60</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2011.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2011.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.-H.%26aulast%3DHuang%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DC.%2BB.%26atitle%3DLithium%2520reverses%2520increased%2520rates%2520of%2520cerebral%2520protein%2520synthesis%2520in%2520a%2520mouse%2520model%2520of%2520fragile%2520X%2520syndrome%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2012%26volume%3D45%26spage%3D1145%26epage%3D1152%26doi%3D10.1016%2Fj.nbd.2011.12.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Guo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murthy, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaller, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span> </span><span class="NLM_article-title">Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span><span class="refDoi"> DOI: 10.1093/hmg/ddr501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1093%2Fhmg%2Fddr501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22048960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2jurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=681-691&author=W.+Guoauthor=A.+C.+Murthyauthor=L.+Zhangauthor=E.+B.+Johnsonauthor=E.+G.+Schallerauthor=A.+M.+Allanauthor=X.+Zhao&title=Inhibition+of+GSK3%CE%B2+improves+hippocampus-dependent+learning+and+rescues+neurogenesis+in+a+mouse+model+of+fragile+X+syndrome&doi=10.1093%2Fhmg%2Fddr501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome</span></div><div class="casAuthors">Guo, Weixiang; Murthy, Adeline C.; Zhang, Li; Johnson, Eric B.; Schaller, Eric G.; Allan, Andrea M.; Zhao, Xinyu</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">681-691</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Fragile X syndrome (FXS), a common inherited form of intellectual disability with learning deficits, results from a loss of fragile X mental retardation protein (FMRP).  Despite extensive research, treatment options for FXS remain limited.  Since FMRP is known to play an important role in adult hippocampal neurogenesis and hippocampus-dependent learning and FMRP regulates the adult neural stem cell fate through the translational regulation of glycogen synthase kinase 3β (GSK3β), we investigated the effects of a GSK3β inhibitor, SB216763, on Fmr1 knockout mice (Fmr1 KO).  We found that the inhibition of GSK3β could reverse the hippocampus-dependent learning deficits and rescue adult hippocampal neurogenesis at multiple stages in Fmr1 KO mice.  Our results point to GSK3β inhibition as a potential treatment for the learning deficits seen in FXS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZClb5MIi3wLVg90H21EOLACvtfcHk0lgiJP_G3kJQrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2jurc%253D&md5=18d17e5cc75c11223d0f79f84e0648ab</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddr501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddr501%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DMurthy%26aufirst%3DA.%2BC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DE.%2BB.%26aulast%3DSchaller%26aufirst%3DE.%2BG.%26aulast%3DAllan%26aufirst%3DA.%2BM.%26aulast%3DZhao%26aufirst%3DX.%26atitle%3DInhibition%2520of%2520GSK3%25CE%25B2%2520improves%2520hippocampus-dependent%2520learning%2520and%2520rescues%2520neurogenesis%2520in%2520a%2520mouse%2520model%2520of%2520fragile%2520X%2520syndrome%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2012%26volume%3D21%26spage%3D681%26epage%3D691%26doi%3D10.1093%2Fhmg%2Fddr501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ormö, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesäter, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerning, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markgren, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgegård, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nylöf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giménez-Cassina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernández, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Díaz-Nido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span> </span><span class="NLM_article-title">Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">45937</span><span class="NLM_x">–</span> <span class="NLM_lpage">45945</span><span class="refDoi"> DOI: 10.1074/jbc.M306268200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1074%2Fjbc.M306268200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=12928438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosl2itL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=45937-45945&author=R.+Bhatauthor=Y.+Xueauthor=S.+Bergauthor=S.+Hellbergauthor=M.+Orm%C3%B6author=Y.+Nilssonauthor=A.+C.+Rades%C3%A4terauthor=E.+Jerningauthor=P.+O.+Markgrenauthor=T.+Borgeg%C3%A5rdauthor=M.+Nyl%C3%B6fauthor=A.+Gim%C3%A9nez-Cassinaauthor=F.+Hern%C3%A1ndezauthor=J.+J.+Lucasauthor=J.+D%C3%ADaz-Nidoauthor=J.+Avila&title=Structural+insights+and+biological+effects+of+glycogen+synthase+kinase+3-specific+inhibitor+AR-A014418&doi=10.1074%2Fjbc.M306268200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418</span></div><div class="casAuthors">Bhat, Ratan; Xue, Yafeng; Berg, Stefan; Hellberg, Sven; Ormoe, Mats; Nilsson, Yvonne; Radesaeter, Ann-Cathrin; Jerning, Eva; Markgren, Per-Olof; Borgegard, Thomas; Nyloef, Martin; Gimenez-Cassina, Alfredo; Hernandez, Felix; Lucas, Jose J.; Diaz-Nido, Javier; Avila, Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">45937-45945</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Glycogen synthase kinase 3 (GSK3) is a serine/threonine kinase that has been implicated in pathol. conditions such as diabetes and Alzheimer's disease.  We report the characterization of a GSK3 inhibitor, AR-A014418, which inhibits GSK3 (IC50 = 104±27 nM), in an ATP-competitive manner (Ki = 38 nM).  AR-A014418 does not significantly inhibit cdk2 or cdk5 (IC50 > 100 μM) or 26 other kinases demonstrating high specificity for GSK3.  We report the co-crystn. of AR-A014418 with the GSK3β protein and provide a description of the interactions within the ATP pocket, as well as an understanding of the structural basis for the selectivity of AR-A014418.  AR-A014418 inhibits tau phosphorylation at a GSK3-specific site (Ser-396) in cells stably expressing human four-repeat tau protein.  AR-A014418 protects N2A neuroblastoma cells against cell death mediated by inhibition of the phosphatidylinositol 3-kinase/protein kinase B survival pathway.  Furthermore, AR-A014418 inhibits neurodegeneration mediated by β-amyloid peptide in hippocampal slices.  AR-A014418 may thus have important applications as a tool to elucidate the role of GSK3 in cellular signaling and possibly in Alzheimer's disease.  AR-A014418 is the first compd. of a family of specific inhibitors of GSK3 that does not significantly inhibit closely related kinases such as cdk2 or cdk5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVw7LgEHct0LVg90H21EOLACvtfcHk0lhLL-irRhimtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosl2itL0%253D&md5=c52e13ab3dfdcef165620714c3181860</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M306268200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M306268200%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DHellberg%26aufirst%3DS.%26aulast%3DOrm%25C3%25B6%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DY.%26aulast%3DRades%25C3%25A4ter%26aufirst%3DA.%2BC.%26aulast%3DJerning%26aufirst%3DE.%26aulast%3DMarkgren%26aufirst%3DP.%2BO.%26aulast%3DBorgeg%25C3%25A5rd%26aufirst%3DT.%26aulast%3DNyl%25C3%25B6f%26aufirst%3DM.%26aulast%3DGim%25C3%25A9nez-Cassina%26aufirst%3DA.%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DF.%26aulast%3DLucas%26aufirst%3DJ.%2BJ.%26aulast%3DD%25C3%25ADaz-Nido%26aufirst%3DJ.%26aulast%3DAvila%26aufirst%3DJ.%26atitle%3DStructural%2520insights%2520and%2520biological%2520effects%2520of%2520glycogen%2520synthase%2520kinase%25203-specific%2520inhibitor%2520AR-A014418%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D45937%26epage%3D45945%26doi%3D10.1074%2Fjbc.M306268200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Yuskaitis, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mines, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweatt, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jope, R. S.</span><span> </span><span class="NLM_article-title">Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">632</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span><span class="refDoi"> DOI: 10.1016/j.bcp.2009.09.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bcp.2009.09.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=632-646&author=C.+J.+Yuskaitisauthor=M.+A.+Minesauthor=M.+K.+Kingauthor=J.+D.+Sweattauthor=C.+A.+Millerauthor=R.+S.+Jope&title=Lithium+ameliorates+altered+glycogen+synthase+kinase-3+and+behavior+in+a+mouse+model+of+fragile+X+syndrome&doi=10.1016%2Fj.bcp.2009.09.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.09.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.09.023%26sid%3Dliteratum%253Aachs%26aulast%3DYuskaitis%26aufirst%3DC.%2BJ.%26aulast%3DMines%26aufirst%3DM.%2BA.%26aulast%3DKing%26aufirst%3DM.%2BK.%26aulast%3DSweatt%26aufirst%3DJ.%2BD.%26aulast%3DMiller%26aufirst%3DC.%2BA.%26aulast%3DJope%26aufirst%3DR.%2BS.%26atitle%3DLithium%2520ameliorates%2520altered%2520glycogen%2520synthase%2520kinase-3%2520and%2520behavior%2520in%2520a%2520mouse%2520model%2520of%2520fragile%2520X%2520syndrome%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D632%26epage%3D646%26doi%3D10.1016%2Fj.bcp.2009.09.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Maqbool, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobashir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoda, N.</span><span> </span><span class="NLM_article-title">Pivotal role of glycogen synthase kinase-3: a therapeutic target for Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2015.10.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.ejmech.2015.10.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26562543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVWms7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2016&pages=63-81&author=M.+Maqboolauthor=M.+Mobashirauthor=N.+Hoda&title=Pivotal+role+of+glycogen+synthase+kinase-3%3A+a+therapeutic+target+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2015.10.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease</span></div><div class="casAuthors">Maqbool, Mudasir; Mobashir, Mohammad; Hoda, Nasimul</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-81</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Neurodegenerative diseases are among the most challenging diseases with poorly known mechanism of cause and paucity of complete cure.  Out of all the neurodegenerative diseases, Alzheimer's disease is the most devastating and loosening of thinking and judging ability disease that occurs in the old age people.  Many hypotheses came forth in order to explain its causes.  In this review, we have enlightened Glycogen Synthase Kinase-3 which has been considered as a concrete cause for Alzheimer's disease.  Plaques and Tangles (abnormal structures) are the basic suspects in damaging and killing of nerve cells wherein Glycogen Synthase Kinase-3 has a key role in the formation of these fatal accumulations.  Various Glycogen Synthase Kinase-3 inhibitors have been reported to reduce the amt. of amyloid-beta as well as the tau hyperphosphorylation in both neuronal and nonneuronal cells.  Addnl., Glycogen Synthase Kinase-3 inhibitors have been reported to enhance the adult hippocampal neurogenesis in vivo as well as in vitro.  Keeping the chemotype of the reported Glycogen Synthase Kinase-3 inhibitors in consideration, they may be grouped into natural inhibitors, inorg. metal ions, organo-synthetic, and peptide like inhibitors.  On the basis of their mode of binding to the constituent enzyme, they may also be grouped as ATP, nonATP, and allosteric binding sites competitive inhibitors.  ATP competitive inhibitors were known earlier inhibitors but they lack efficient selectivity.  This led to find the new ways for the enzyme inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFXYexXxHIbrVg90H21EOLACvtfcHk0lhLL-irRhimtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVWms7rE&md5=df793f92aef5f445948fed494d9bb96e</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DMaqbool%26aufirst%3DM.%26aulast%3DMobashir%26aufirst%3DM.%26aulast%3DHoda%26aufirst%3DN.%26atitle%3DPivotal%2520role%2520of%2520glycogen%2520synthase%2520kinase-3%253A%2520a%2520therapeutic%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D107%26spage%3D63%26epage%3D81%26doi%3D10.1016%2Fj.ejmech.2015.10.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">van Spronsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoogenraad, C. C.</span><span> </span><span class="NLM_article-title">Synapse pathology in psychiatric and neurologic disease</span> <span class="citation_source-journal">Curr. Neurol. Neurosci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span><span class="refDoi"> DOI: 10.1007/s11910-010-0104-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs11910-010-0104-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20425036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1CjsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=207-214&author=M.+van+Spronsenauthor=C.+C.+Hoogenraad&title=Synapse+pathology+in+psychiatric+and+neurologic+disease&doi=10.1007%2Fs11910-010-0104-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Synapse pathology in psychiatric and neurologic disease</span></div><div class="casAuthors">van Spronsen, Myrrhe; Hoogenraad, Casper C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neurology and Neuroscience Reports</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">207-214</span>CODEN:
                <span class="NLM_cas:coden">CNNRBS</span>;
        ISSN:<span class="NLM_cas:issn">1534-6293</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Inhibitory and excitatory synapses play a fundamental role in information processing in the brain.  Excitatory synapses usually are situated on dendritic spines, small membrane protrusions that harbor glutamate receptors and postsynaptic d. components and help transmit elec. signals.  In recent years, it has become evident that spine morphol. is intimately linked to synapse function-smaller spines have smaller synapses and support reduced synaptic transmission.  The relationship between synaptic signaling, spine shape, and brain function is never more apparent than when the brain becomes dysfunctional.  Many psychiatric and neurol. disorders, ranging from mental retardation and autism to Alzheimer's disease and addiction, are accompanied by alterations in spine morphol. and synapse no.  In this review, we highlight the structure and mol. organization of synapses and discuss functional effects of synapse pathol. in brain disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEWURs9kuUL7Vg90H21EOLACvtfcHk0ljb9g8eq1lVgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1CjsLrO&md5=98c15fc3ed9510610ce16cc962d65d0c</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1007%2Fs11910-010-0104-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11910-010-0104-8%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BSpronsen%26aufirst%3DM.%26aulast%3DHoogenraad%26aufirst%3DC.%2BC.%26atitle%3DSynapse%2520pathology%2520in%2520psychiatric%2520and%2520neurologic%2520disease%26jtitle%3DCurr.%2520Neurol.%2520Neurosci.%2520Rep.%26date%3D2010%26volume%3D10%26spage%3D207%26epage%3D214%26doi%3D10.1007%2Fs11910-010-0104-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Berg, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwind, D. H.</span><span> </span><span class="NLM_article-title">Autism genetics: searching for specificity and convergence</span> <span class="citation_source-journal">Genome Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="refDoi"> DOI: 10.1186/gb-2012-13-7-247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2Fgb-2012-13-7-247" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=247&author=J.+M.+Bergauthor=D.+H.+Geschwind&title=Autism+genetics%3A+searching+for+specificity+and+convergence&doi=10.1186%2Fgb-2012-13-7-247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1186%2Fgb-2012-13-7-247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2012-13-7-247%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DJ.%2BM.%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26atitle%3DAutism%2520genetics%253A%2520searching%2520for%2520specificity%2520and%2520convergence%26jtitle%3DGenome%2520Biol.%26date%3D2012%26volume%3D13%26spage%3D247%26doi%3D10.1186%2Fgb-2012-13-7-247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Hutsler, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1309</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span><span class="refDoi"> DOI: 10.1016/j.brainres.2009.09.120</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.brainres.2009.09.120" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=19896929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFams7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1309&publication_year=2010&pages=83-94&author=J.+J.+Hutslerauthor=H.+Zhang&title=Increased+dendritic+spine+densities+on+cortical+projection+neurons+in+autism+spectrum+disorders&doi=10.1016%2Fj.brainres.2009.09.120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders</span></div><div class="casAuthors">Hutsler, Jeffrey J.; Zhang, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1309</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">83-94</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Multiple types of indirect evidence have been used to support theories of altered cortical connectivity in autism spectrum disorders (ASD).  In other developmental disorders reduced spine expression is commonly found, while conditions such as fragile X syndrome show increased spine densities.  Despite its relevance to theories of altered cortical connectivity, synaptic spine expression has not been systematically explored in ASD.  Here we examine dendritic spines on Golgi-impregnated cortical pyramidal cells in the cortex of ASD subjects and age-matched control cases.  Pyramidal cells were studied within both the superficial and deep cortical layers of frontal, temporal, and parietal lobe regions.  Relative to controls, spine densities were greater in ASD subjects.  In analyses restricted to the apical dendrites of pyramidal cells, greater spine densities were found predominantly within layer II of each cortical location and within layer V of the temporal lobe.  High spine densities were assocd. with decreased brain wts. and were most commonly found in ASD subjects with lower levels of cognitive functioning.  Greater spine densities in ASD subjects provide structural support for recent suggestions of connectional changes within the cerebral cortex that may result in altered cortical computations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJGNeGj8C3KLVg90H21EOLACvtfcHk0ljb9g8eq1lVgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFams7jE&md5=5d41212ee729b19b904c0d20cd8e1638</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2009.09.120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2009.09.120%26sid%3Dliteratum%253Aachs%26aulast%3DHutsler%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DIncreased%2520dendritic%2520spine%2520densities%2520on%2520cortical%2520projection%2520neurons%2520in%2520autism%2520spectrum%2520disorders%26jtitle%3DBrain%2520Res.%26date%3D2010%26volume%3D1309%26spage%3D83%26epage%3D94%26doi%3D10.1016%2Fj.brainres.2009.09.120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Geschwind, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levitt, P.</span><span> </span><span class="NLM_article-title">Autism spectrum disorders: developmental disconnection syndromes</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span><span class="refDoi"> DOI: 10.1016/j.conb.2007.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.conb.2007.01.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=103-111&author=D.+H.+Geschwindauthor=P.+Levitt&title=Autism+spectrum+disorders%3A+developmental+disconnection+syndromes&doi=10.1016%2Fj.conb.2007.01.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.conb.2007.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.conb.2007.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26aulast%3DLevitt%26aufirst%3DP.%26atitle%3DAutism%2520spectrum%2520disorders%253A%2520developmental%2520disconnection%2520syndromes%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D2007%26volume%3D17%26spage%3D103%26epage%3D111%26doi%3D10.1016%2Fj.conb.2007.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Auerbach, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osterweil, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bear, M. F.</span><span> </span><span class="NLM_article-title">Mutations causing syndromic autism define an axis of synaptic pathophysiology</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">480</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1038/nature10658</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnature10658" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=480&publication_year=2011&pages=63-68&author=B.+D.+Auerbachauthor=E.+K.+Osterweilauthor=M.+F.+Bear&title=Mutations+causing+syndromic+autism+define+an+axis+of+synaptic+pathophysiology&doi=10.1038%2Fnature10658"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1038%2Fnature10658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10658%26sid%3Dliteratum%253Aachs%26aulast%3DAuerbach%26aufirst%3DB.%2BD.%26aulast%3DOsterweil%26aufirst%3DE.%2BK.%26aulast%3DBear%26aufirst%3DM.%2BF.%26atitle%3DMutations%2520causing%2520syndromic%2520autism%2520define%2520an%2520axis%2520of%2520synaptic%2520pathophysiology%26jtitle%3DNature%26date%3D2011%26volume%3D480%26spage%3D63%26epage%3D68%26doi%3D10.1038%2Fnature10658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Phillips, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozzo-Miller, L.</span><span> </span><span class="NLM_article-title">Dendritic spine dysgenesis in autism related disorders</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">601</span><span class="NLM_x">, </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span><span class="refDoi"> DOI: 10.1016/j.neulet.2015.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neulet.2015.01.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=601&publication_year=2015&pages=30-40&author=M.+Phillipsauthor=L.+Pozzo-Miller&title=Dendritic+spine+dysgenesis+in+autism+related+disorders&doi=10.1016%2Fj.neulet.2015.01.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2015.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2015.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DM.%26aulast%3DPozzo-Miller%26aufirst%3DL.%26atitle%3DDendritic%2520spine%2520dysgenesis%2520in%2520autism%2520related%2520disorders%26jtitle%3DNeurosci.%2520Lett.%26date%3D2015%26volume%3D601%26spage%3D30%26epage%3D40%26doi%3D10.1016%2Fj.neulet.2015.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Tsai, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahin, M.</span><span> </span><span class="NLM_article-title">Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex</span> <span class="citation_source-journal">Curr. Opin. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1097/WCO.0b013e32834451c4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1097%2FWCO.0b013e32834451c4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21301339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVGitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2011&pages=106-113&author=P.+Tsaiauthor=M.+Sahin&title=Mechanisms+of+neurocognitive+dysfunction+and+therapeutic+considerations+in+tuberous+sclerosis+complex&doi=10.1097%2FWCO.0b013e32834451c4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex</span></div><div class="casAuthors">Tsai, Peter; Sahin, Mustafa</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-113</span>CODEN:
                <span class="NLM_cas:coden">CONEEX</span>;
        ISSN:<span class="NLM_cas:issn">1350-7540</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Mendelian disorders that affect cognition provide a unique opportunity to study the mechanisms of neurodevelopmental disorders through the examn. of genetic defects in animals and development of hypotheses that can be tested in human beings.  Tuberous sclerosis complex (TSC) is a genetic disease that presents with epilepsy, autism, and intellectual disability.  Here we review recent advances in our understanding of TSC pathogenesis and signaling pathways that may be modulated to treat the neurol. symptoms.  Accumulating evidence suggests that TSC patients have nontuber abnormalities that contribute to the development of the neurol. phenotype- in particular, disorganization of axon tracts and deficient myelination.  TSC mouse models have failed to replicate the human neuropathol. entirely, but have shed light on the cellular abnormalities and the neurobehavioral phenotypes.  Most importantly, cell culture and animal models have identified the mTORC1 pathway as a therapeutic target in this disease.  Preclin. data strongly suggest that TSC is a disease of abnormal neuronal connectivity.  The high incidence of neurodevelopmental deficits, early detection of the disease in very young ages, and availability of mTORC1 inhibitors make TSC a model for other Mendelian disorders of neurocognition and an avenue for the mechanism-based treatment trials of neurodevelopmental disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbiN2ECb_DWLVg90H21EOLACvtfcHk0lhnRvWxN4uyrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVGitLg%253D&md5=d0f9a3ce4d33af1424221dcf2d804dc9</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1097%2FWCO.0b013e32834451c4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWCO.0b013e32834451c4%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DP.%26aulast%3DSahin%26aufirst%3DM.%26atitle%3DMechanisms%2520of%2520neurocognitive%2520dysfunction%2520and%2520therapeutic%2520considerations%2520in%2520tuberous%2520sclerosis%2520complex%26jtitle%3DCurr.%2520Opin.%2520Neurol.%26date%3D2011%26volume%3D24%26spage%3D106%26epage%3D113%26doi%3D10.1097%2FWCO.0b013e32834451c4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Ishii, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wataya-Kaneda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canuet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, M.</span><span> </span><span class="NLM_article-title">Everolimus improves behavioral deficits in a patient with autism associated with tuberous sclerosis: a case report</span> <span class="citation_source-journal">Neuropsychiatric Electrophysiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="refDoi"> DOI: 10.1186/s40810-015-0004-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2Fs40810-015-0004-x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2015&pages=6&author=R.+Ishiiauthor=M.+Wataya-Kanedaauthor=L.+Canuetauthor=N.+Nonomuraauthor=Y.+Nakaiauthor=M.+Takeda&title=Everolimus+improves+behavioral+deficits+in+a+patient+with+autism+associated+with+tuberous+sclerosis%3A+a+case+report&doi=10.1186%2Fs40810-015-0004-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1186%2Fs40810-015-0004-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40810-015-0004-x%26sid%3Dliteratum%253Aachs%26aulast%3DIshii%26aufirst%3DR.%26aulast%3DWataya-Kaneda%26aufirst%3DM.%26aulast%3DCanuet%26aufirst%3DL.%26aulast%3DNonomura%26aufirst%3DN.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DTakeda%26aufirst%3DM.%26atitle%3DEverolimus%2520improves%2520behavioral%2520deficits%2520in%2520a%2520patient%2520with%2520autism%2520associated%2520with%2520tuberous%2520sclerosis%253A%2520a%2520case%2520report%26jtitle%3DNeuropsychiatric%2520Electrophysiology%26date%3D2015%26volume%3D1%26spage%3D6%26doi%3D10.1186%2Fs40810-015-0004-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Huber, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa-Mattioli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zukin, R. S.</span><span> </span><span class="NLM_article-title">Dysregulation of mammalian target of rapamycin signaling in mouse models of autism</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">13836</span><span class="NLM_x">–</span> <span class="NLM_lpage">13842</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.2656-15.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1523%2FJNEUROSCI.2656-15.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26468183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVymsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=13836-13842&author=K.+M.+Huberauthor=E.+Klannauthor=M.+Costa-Mattioliauthor=R.+S.+Zukin&title=Dysregulation+of+mammalian+target+of+rapamycin+signaling+in+mouse+models+of+autism&doi=10.1523%2FJNEUROSCI.2656-15.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Dysregulation of mammalian target of rapamycin signaling in mouse models of autism</span></div><div class="casAuthors">Huber, Kimberly M.; Klann, Eric; Costa-Mattioli, Mauro; Zukin, R. Suzanne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">13836-13842</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The mammalian target of rapamycin (mTOR) is a central regulator of a diverse array of cellular processes, including cell growth, proliferation, autophagy, translation, and actin polymn.  Components of the mTOR cascade are present at synapses and influence synaptic plasticity and spine morphogenesis.  A prevailing view is that the study of mTOR and its role in autism spectrum disorders (ASDs) will elucidate the mol. mechanisms by which mTOR regulates neuronal function under physiol. and pathol. conditions.  Although many ASDs arise as a result of mutations in genes with multiple mol. functions, they appear to converge on common biol. pathways that give rise to autism-relevant behaviors.  Dysregulation of mTOR signaling has been identified as a phenotypic feature common to fragile X syndrome, tuberous sclerosis complex 1 and 2, neurofibromatosis 1, phosphatase and tensin homolog, and potentially Rett syndrome.  Below are a summary of topics covered in a symposium that presents dysregulation of mTOR as a unifying theme in a subset of ASDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcajpQX5LkC7Vg90H21EOLACvtfcHk0lhnRvWxN4uyrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVymsLw%253D&md5=09a8e749ff56d8f439f766356087676b</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2656-15.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2656-15.2015%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DK.%2BM.%26aulast%3DKlann%26aufirst%3DE.%26aulast%3DCosta-Mattioli%26aufirst%3DM.%26aulast%3DZukin%26aufirst%3DR.%2BS.%26atitle%3DDysregulation%2520of%2520mammalian%2520target%2520of%2520rapamycin%2520signaling%2520in%2520mouse%2520models%2520of%2520autism%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D13836%26epage%3D13842%26doi%3D10.1523%2FJNEUROSCI.2656-15.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Crino, P. B.</span><span> </span><span class="NLM_article-title">Evolving neurobiology of tuberous sclerosis complex</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span><span class="refDoi"> DOI: 10.1007/s00401-013-1085-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs00401-013-1085-x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2013&pages=317-332&author=P.+B.+Crino&title=Evolving+neurobiology+of+tuberous+sclerosis+complex&doi=10.1007%2Fs00401-013-1085-x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1007%2Fs00401-013-1085-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-013-1085-x%26sid%3Dliteratum%253Aachs%26aulast%3DCrino%26aufirst%3DP.%2BB.%26atitle%3DEvolving%2520neurobiology%2520of%2520tuberous%2520sclerosis%2520complex%26jtitle%3DActa%2520Neuropathol.%26date%3D2013%26volume%3D125%26spage%3D317%26epage%3D332%26doi%3D10.1007%2Fs00401-013-1085-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Burket, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutsch, S. I.</span><span> </span><span class="NLM_article-title">Rapamycin improves sociability in the BTBR T+Itpr3tf/J mouse model of autism spectrum disorders</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span><span class="refDoi"> DOI: 10.1016/j.brainresbull.2013.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.brainresbull.2013.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24295733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisl2gsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2014&pages=70-75&author=J.+A.+Burketauthor=A.+D.+Bensonauthor=A.+H.+Tangauthor=S.+I.+Deutsch&title=Rapamycin+improves+sociability+in+the+BTBR+T%2BItpr3tf%2FJ+mouse+model+of+autism+spectrum+disorders&doi=10.1016%2Fj.brainresbull.2013.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Rapamycin improves sociability in the BTBR T+Itpr3tf/J mouse model of autism spectrum disorders</span></div><div class="casAuthors">Burket, Jessica A.; Benson, Andrew D.; Tang, Amy H.; Deutsch, Stephen I.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">70-75</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Overactivation of the mammalian target of rapamycin (mTOR) has been implicated in the pathogenesis of syndromic forms of autism spectrum disorders (ASDs), such as tuberous sclerosis complex, neurofibromatosis 1, and fragile X syndrome.  Administration of mTORC1 (mTOR complex 1) inhibitors (e.g. rapamycin) in syndromic mouse models of ASDs improved behavior, cognition, and neuropathol.  However, since only a minority of ASDs are due to the effects of single genes (∼10%), there is a need to explore inhibition of mTOR activity in mouse models that may be more relevant to the majority of nonsyndromic presentations, such as the genetically inbred BTBR T+Itpr3tf/J (BTBR) mouse model of ASDs.  BTBR mice have social impairment and exhibit increased stereotypic behavior.  In prior work, D-cycloserine, a partial glycineB site agonist that targets the N-methyl-D-aspartate (NMDA) receptor, was shown to improve sociability in both Balb/c and BTBR mouse models of ASDs.  Importantly, NMDA receptor activation regulates mTOR signaling activity.  The current study investigated the ability of rapamycin (10 mg/kg, i.p. × four days), an mTORC1 inhibitor, to improve sociability and stereotypic behavior in BTBR mice.  Using a std. paradigm to assess mouse social behavior, rapamycin improved several measures of sociability in the BTBR mouse, suggesting that mTOR overactivation represents a therapeutic target that mediates or contributes to impaired sociability in the BTBR mouse model of ASDs.  Interestingly, there was no effect of rapamycin on stereotypic behaviors in this mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHmDEzsomCL7Vg90H21EOLACvtfcHk0lhnRvWxN4uyrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisl2gsQ%253D%253D&md5=47bb7d9c6dddd184aa56554ad5f8a190</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresbull.2013.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresbull.2013.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DBurket%26aufirst%3DJ.%2BA.%26aulast%3DBenson%26aufirst%3DA.%2BD.%26aulast%3DTang%26aufirst%3DA.%2BH.%26aulast%3DDeutsch%26aufirst%3DS.%2BI.%26atitle%3DRapamycin%2520improves%2520sociability%2520in%2520the%2520BTBR%2520T%252BItpr3tf%252FJ%2520mouse%2520model%2520of%2520autism%2520spectrum%2520disorders%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2014%26volume%3D100%26spage%3D70%26epage%3D75%26doi%3D10.1016%2Fj.brainresbull.2013.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Tang, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingras, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonenberg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuman, E. M.</span><span> </span><span class="NLM_article-title">A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">467</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span><span class="refDoi"> DOI: 10.1073/pnas.012605299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.012605299" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=467-472&author=S.+J.+Tangauthor=G.+Reisauthor=H.+Kangauthor=A.+C.+Gingrasauthor=N.+Sonenbergauthor=E.+M.+Schuman&title=A+rapamycin-sensitive+signaling+pathway+contributes+to+long-term+synaptic+plasticity+in+the+hippocampus&doi=10.1073%2Fpnas.012605299"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1073%2Fpnas.012605299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.012605299%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DS.%2BJ.%26aulast%3DReis%26aufirst%3DG.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DGingras%26aufirst%3DA.%2BC.%26aulast%3DSonenberg%26aufirst%3DN.%26aulast%3DSchuman%26aufirst%3DE.%2BM.%26atitle%3DA%2520rapamycin-sensitive%2520signaling%2520pathway%2520contributes%2520to%2520long-term%2520synaptic%2520plasticity%2520in%2520the%2520hippocampus%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D467%26epage%3D472%26doi%3D10.1073%2Fpnas.012605299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Krueger, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Care, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agricola, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangeshkar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byars, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahmoud, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franz, D. N.</span><span> </span><span class="NLM_article-title">Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1801</span><span class="NLM_x">–</span> <span class="NLM_lpage">1811</span><span class="refDoi"> DOI: 10.1056/NEJMoa1001671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1056%2FNEJMoa1001671" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21047224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2gsbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1801-1811&author=D.+A.+Kruegerauthor=M.+M.+Careauthor=K.+Hollandauthor=K.+Agricolaauthor=C.+Tudorauthor=P.+Mangeshkarauthor=K.+A.+Wilsonauthor=A.+Byarsauthor=T.+Sahmoudauthor=D.+N.+Franz&title=Everolimus+for+subependymal+giant-cell+astrocytomas+in+tuberous+sclerosis&doi=10.1056%2FNEJMoa1001671"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis</span></div><div class="casAuthors">Krueger, Darcy A.; Care, Marguerite M.; Holland, Katherine; Agricola, Karen; Tudor, Cynthia; Mangeshkar, Prajakta; Wilson, Kimberly A.; Byars, Anna; Sahmoud, Tarek; Franz, David Neal</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1801-1811</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Neurosurgical resection is the std. treatment for subependymal giant-cell astrocytomas in patients with the tuberous sclerosis complex.  An alternative may be the use of everolimus, which inhibits the mammalian target of rapamycin, a protein regulated by gene products involved in the tuberous sclerosis complex.  METHODS: Patients 3 years of age or older with serial growth of subependymal giant-cell astrocytomas were eligible for this open-label study.  The primary efficacy end point was the change in vol. of subependymal giant-cell astrocytomas between baseline and 6 mo.  We gave everolimus orally, at a dose of 3.0 mg per square meter of body-surface area, to achieve a trough concn. of 5 to 15 ng per mL.  RESULTS: We enrolled 28 patients.  Everolimus therapy was assocd. with a clin. meaningful redn. in vol. of the primary subependymal giant-cell astrocytoma, as assessed on independent central review (P < 0.001 for baseline vs. 6 mo), with a redn. of at least 30% in 21 patients (75%) and at least 50% in 9 patients (32%).  Marked redns. were seen within 3 mo and were sustained.  There were no new lesions, worsening hydrocephalus, evidence of increased intracranial pressure, or necessity for surgical resection or other therapy for subependymal giant-cell astrocytoma.  Of the 16 patients for whom 24-h video electroencephalog. data were available, seizure frequency for the 6-mo study period (vs. the previous 6-mo period) decreased in 9, did not change in 6, and increased in 1 (median change, -1 seizure; P = 0.02).  The mean (± SD) score on the validated Quality-of-Life in Childhood Epilepsy questionnaire (on which scores can range from 0 to 100, with higher scores indicating a better quality of life) was improved at 3 mo (63.4 ± 12.4) and 6 mo (62.1 ± 14.2) over the baseline score (57.8 ± 14.0).  Single cases of grade 3 treatment-related sinusitis, pneumonia, viral bronchitis, tooth infection, stomatitis, and leukopenia were reported.  CONCLUSIONS: Everolimus therapy was assocd. with marked redn. in the vol. of subependymal giant-cell astrocytomas and seizure frequency and may be a potential alternative to neurosurgical resection in some cases, though long-term studies are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzwPOsvrgvibVg90H21EOLACvtfcHk0li3aY7PELWs9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2gsbbP&md5=b2a5b8128167c750fc4f9a8c8d188bcb</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1001671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1001671%26sid%3Dliteratum%253Aachs%26aulast%3DKrueger%26aufirst%3DD.%2BA.%26aulast%3DCare%26aufirst%3DM.%2BM.%26aulast%3DHolland%26aufirst%3DK.%26aulast%3DAgricola%26aufirst%3DK.%26aulast%3DTudor%26aufirst%3DC.%26aulast%3DMangeshkar%26aufirst%3DP.%26aulast%3DWilson%26aufirst%3DK.%2BA.%26aulast%3DByars%26aufirst%3DA.%26aulast%3DSahmoud%26aufirst%3DT.%26aulast%3DFranz%26aufirst%3DD.%2BN.%26atitle%3DEverolimus%2520for%2520subependymal%2520giant-cell%2520astrocytomas%2520in%2520tuberous%2520sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D1801%26epage%3D1811%26doi%3D10.1056%2FNEJMoa1001671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Heffron, T. P.</span><span> </span><span class="NLM_article-title">Small molecule kinase inhibitors for the treatment of brain cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">10030</span><span class="NLM_x">–</span> <span class="NLM_lpage">10066</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00618</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00618" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOjt77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10030-10066&author=T.+P.+Heffron&title=Small+molecule+kinase+inhibitors+for+the+treatment+of+brain+cancer&doi=10.1021%2Facs.jmedchem.6b00618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer</span></div><div class="casAuthors">Heffron, Timothy P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10030-10066</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In addn. to each of the factors that govern the identification of a successful oncol. drug candidate, drug discovery aimed at treating neurol. cancer must also consider the presence of the blood-brain barrier (BBB).  The high level of expression of efflux transporters (e.g., P-glycoprotein (P-gp) and breast cancer resistance protein (Bcrp)) at the BBB limits many small mols. from freely reaching the brain, where neurooncol. malignancies reside.  Furthermore, many of the targets identified for the potential treatment of central nervous system (CNS) malignancies suggest that kinase inhibitors, capable of penetrating the BBB to reach their target, would be desirable.  This Perspective discusses the unmet need for neurooncol. treatments, the appeal of kinase targets in this space, and a summary of what is known about free brain penetration of clin. inhibitors of kinases that are of interest for the treatment of brain cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqij86WIpk16LVg90H21EOLACvtfcHk0lhJYEg-p9C4DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOjt77E&md5=7e184f17a60658174cb44a9fbadc8dfd</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00618%26sid%3Dliteratum%253Aachs%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26atitle%3DSmall%2520molecule%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520brain%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10030%26epage%3D10066%26doi%3D10.1021%2Facs.jmedchem.6b00618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Fernandez, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres-Alemán, I.</span><span> </span><span class="NLM_article-title">The many faces of insulin-like peptide signalling in the brain</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">239</span><span class="refDoi"> DOI: 10.1038/nrn3209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnrn3209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22430016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSgtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=225-239&author=A.+M.+Fernandezauthor=I.+Torres-Alem%C3%A1n&title=The+many+faces+of+insulin-like+peptide+signalling+in+the+brain&doi=10.1038%2Fnrn3209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The many faces of insulin-like peptide signalling in the brain</span></div><div class="casAuthors">Fernandez, Ana M.; Torres-Aleman, Ignacio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">225-239</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Central and peripheral insulin-like peptides (ILPs), which include insulin, insulin-like growth factor 1 (IGF1) and IGF2, exert many effects in the brain.  Through their actions on brain growth and differentiation, ILPs contribute to building circuitries that subserve metabolic and behavioral adaptation to internal and external cues of energy availability.  In the adult brain each ILP has distinct effects, but together their actions ultimately regulate energy homeostasis - they affect nutrient sensing and regulate neuronal plasticity to modulate adaptive behaviors involved in food seeking, including high-level cognitive operations such as spatial memory.  In essence, the multifaceted activity of ILPs in the brain may be viewed as a system organization involved in the control of energy allocation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6fJj_fCXjlbVg90H21EOLACvtfcHk0lhJYEg-p9C4DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSgtr0%253D&md5=e366462795185094b8da0e7c6f8713ec</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1038%2Fnrn3209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3209%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DA.%2BM.%26aulast%3DTorres-Alem%25C3%25A1n%26aufirst%3DI.%26atitle%3DThe%2520many%2520faces%2520of%2520insulin-like%2520peptide%2520signalling%2520in%2520the%2520brain%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2012%26volume%3D13%26spage%3D225%26epage%3D239%26doi%3D10.1038%2Fnrn3209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Dyer, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vahdatpour, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanfeliu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropea, D.</span><span> </span><span class="NLM_article-title">The role of insulin-like growth factor 1 (IGF-1) in brain development, maturation and neuroplasticity</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">325</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2016.03.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuroscience.2016.03.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27038749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsVWms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2016&pages=89-99&author=A.+H.+Dyerauthor=C.+Vahdatpourauthor=A.+Sanfeliuauthor=D.+Tropea&title=The+role+of+insulin-like+growth+factor+1+%28IGF-1%29+in+brain+development%2C+maturation+and+neuroplasticity&doi=10.1016%2Fj.neuroscience.2016.03.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Insulin-Like Growth Factor 1 (IGF-1) in brain development, maturation and neuroplasticity</span></div><div class="casAuthors">Dyer, Adam H.; Vahdatpour, Cyrus; Sanfeliu, Albert; Tropea, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-99</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Insulin-Like Growth Factor 1 (IGF-1) is a phylogenetically ancient neurotrophic hormone with crucial roles to play in CNS development and maturation.  Recently, IGF-1 has been shown to have potent effects on cellular neuroplasticity.  Neuroplasticty refers to the adaptive changes made by the CNS in the face of changing functional demands and is crucial in processes such as learning and memory.  IGF-1, signaling through its glycoprotein receptor (IGF-1R), and canonical signaling pathways such as the PI3K-Akt and Ras-Raf-MAP pathways, has potent effects on cellular neuroplasticity in the CNS.  In the present review, the role of IGF-1 in brain development is reviewed, followed by a detailed discussion of the role played by IGF in cellular neuroplasticity in the CNS.  Findings from models of perturbed and reparative plasticity detailing the role played by IGF-1 are discussed, followed by the electrophysiol., structural and functional evidence supporting this role.  Finally, the post-lesion and post-injury roles played by IGF-1 are briefly evaluated.  We discuss the putative neurobiol. underlying these changes, reviewing recent evidence and highlighting areas for further research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlsJxC9wkq7Vg90H21EOLACvtfcHk0lhJYEg-p9C4DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsVWms7o%253D&md5=7782581e29f0d47fff9c7a8b899ad212</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2016.03.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2016.03.056%26sid%3Dliteratum%253Aachs%26aulast%3DDyer%26aufirst%3DA.%2BH.%26aulast%3DVahdatpour%26aufirst%3DC.%26aulast%3DSanfeliu%26aufirst%3DA.%26aulast%3DTropea%26aufirst%3DD.%26atitle%3DThe%2520role%2520of%2520insulin-like%2520growth%2520factor%25201%2520%2528IGF-1%2529%2520in%2520brain%2520development%252C%2520maturation%2520and%2520neuroplasticity%26jtitle%3DNeuroscience%26date%3D2016%26volume%3D325%26spage%3D89%26epage%3D99%26doi%3D10.1016%2Fj.neuroscience.2016.03.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Cheng, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mervis, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salem, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witters, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bondy, C. A.</span><span> </span><span class="NLM_article-title">Insulin-like growth factor 1 is essential for normal dendritic growth</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1002/jnr.10634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2Fjnr.10634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=12815703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltlSqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2003&pages=1-9&author=C.+M.+Chengauthor=R.+F.+Mervisauthor=S.+L.+Niuauthor=N.+Salemauthor=L.+A.+Wittersauthor=V.+Tsengauthor=R.+Reinhardtauthor=C.+A.+Bondy&title=Insulin-like+growth+factor+1+is+essential+for+normal+dendritic+growth&doi=10.1002%2Fjnr.10634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin-like growth factor 1 is essential for normal dendritic growth</span></div><div class="casAuthors">Cheng, Clara M.; Mervis, Ronald F.; Niu, Shui-Lin; Salem, Norman, Jr.; Witters, Lee A.; Tseng, Victor; Reinhardt, Rickey; Bondy, Carolyn A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">This study evaluated somatic and dendritic growth of neurons in the frontoparietal cortex of lgf1-/- brains.  Pyramidal neuron d. was increased by ∼25% and soma size reduced by ∼10%.  Golgi staining revealed that cortical layer II-III neurons exhibited a significant redn. in dendritic length and complexity in lgf1 null mice.  Dendritic spine d. and presumably synaptic contacts were reduced by 16%.  Similar findings were obtained for cortical layer V and piriform cortex pyramids.  Supporting a redn. in synapses, synaptotagmin levels were reduced by 30% in the lgf1 null brain.  Investigation of factors critically involved in dendritic growth and synaptogenesis showed an ∼50% redn. in cortical CDC42 protein expression and an ∼10% redn. in brain cholesterol levels in lgf1 null mice.  Evidence is presented that lgf1 deletion causes disruptions in lipid and microtubule metab., leading to impaired neuronal somatic and dendritic growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Smtu04QuHLVg90H21EOLACvtfcHk0lgwsV5MRnn1-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltlSqtrk%253D&md5=e58b5c2a6e9ad20038c54fa6733c1bd2</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1002%2Fjnr.10634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.10634%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DC.%2BM.%26aulast%3DMervis%26aufirst%3DR.%2BF.%26aulast%3DNiu%26aufirst%3DS.%2BL.%26aulast%3DSalem%26aufirst%3DN.%26aulast%3DWitters%26aufirst%3DL.%2BA.%26aulast%3DTseng%26aufirst%3DV.%26aulast%3DReinhardt%26aufirst%3DR.%26aulast%3DBondy%26aufirst%3DC.%2BA.%26atitle%3DInsulin-like%2520growth%2520factor%25201%2520is%2520essential%2520for%2520normal%2520dendritic%2520growth%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2003%26volume%3D73%26spage%3D1%26epage%3D9%26doi%3D10.1002%2Fjnr.10634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Baker, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batchelor, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafiee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, J.</span><span> </span><span class="NLM_article-title">Central penetration and stability of N-terminal tripeptide of insulin-like growth factor-I, glycine-proline-glutamate in adult rat</span> <span class="citation_source-journal">Neuropeptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1016/j.npep.2004.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.npep.2004.11.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2005&pages=81-87&author=A.+M.+Bakerauthor=D.+C.+Batchelorauthor=G.+B.+Thomasauthor=J.+Y.+Wenauthor=M.+Rafieeauthor=H.+Linauthor=J.+Guan&title=Central+penetration+and+stability+of+N-terminal+tripeptide+of+insulin-like+growth+factor-I%2C+glycine-proline-glutamate+in+adult+rat&doi=10.1016%2Fj.npep.2004.11.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.npep.2004.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.npep.2004.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DA.%2BM.%26aulast%3DBatchelor%26aufirst%3DD.%2BC.%26aulast%3DThomas%26aufirst%3DG.%2BB.%26aulast%3DWen%26aufirst%3DJ.%2BY.%26aulast%3DRafiee%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DGuan%26aufirst%3DJ.%26atitle%3DCentral%2520penetration%2520and%2520stability%2520of%2520N-terminal%2520tripeptide%2520of%2520insulin-like%2520growth%2520factor-I%252C%2520glycine-proline-glutamate%2520in%2520adult%2520rat%26jtitle%3DNeuropeptides%26date%3D2005%26volume%3D39%26spage%3D81%26epage%3D87%26doi%3D10.1016%2Fj.npep.2004.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Corvin, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molinos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Little, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donohoe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropea, D.</span><span> </span><span class="NLM_article-title">Insulin-like growth factor 1 (IGF1) and its active peptide (1–3)IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">520</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/j.neulet.2012.05.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neulet.2012.05.029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=520&publication_year=2012&pages=51-56&author=A.+P.+Corvinauthor=I.+Molinosauthor=G.+Littleauthor=G.+Donohoeauthor=M.+Gillauthor=D.+W.+Morrisauthor=D.+Tropea&title=Insulin-like+growth+factor+1+%28IGF1%29+and+its+active+peptide+%281%E2%80%933%29IGF1+enhance+the+expression+of+synaptic+markers+in+neuronal+circuits+through+different+cellular+mechanisms&doi=10.1016%2Fj.neulet.2012.05.029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2012.05.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2012.05.029%26sid%3Dliteratum%253Aachs%26aulast%3DCorvin%26aufirst%3DA.%2BP.%26aulast%3DMolinos%26aufirst%3DI.%26aulast%3DLittle%26aufirst%3DG.%26aulast%3DDonohoe%26aufirst%3DG.%26aulast%3DGill%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DD.%2BW.%26aulast%3DTropea%26aufirst%3DD.%26atitle%3DInsulin-like%2520growth%2520factor%25201%2520%2528IGF1%2529%2520and%2520its%2520active%2520peptide%2520%25281%25E2%2580%25933%2529IGF1%2520enhance%2520the%2520expression%2520of%2520synaptic%2520markers%2520in%2520neuronal%2520circuits%2520through%2520different%2520cellular%2520mechanisms%26jtitle%3DNeurosci.%2520Lett.%26date%3D2012%26volume%3D520%26spage%3D51%26epage%3D56%26doi%3D10.1016%2Fj.neulet.2012.05.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Tropea, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giacometti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurry, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flannery, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaenisch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, M.</span><span> </span><span class="NLM_article-title">Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">2029</span><span class="NLM_x">–</span> <span class="NLM_lpage">2034</span><span class="refDoi"> DOI: 10.1073/pnas.0812394106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.0812394106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=2029-2034&author=D.+Tropeaauthor=E.+Giacomettiauthor=N.+R.+Wilsonauthor=C.+Beardauthor=C.+McCurryauthor=D.+D.+Fuauthor=R.+Flanneryauthor=R.+Jaenischauthor=M.+Sur&title=Partial+reversal+of+Rett+syndrome-like+symptoms+in+MeCP2+mutant+mice&doi=10.1073%2Fpnas.0812394106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0812394106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0812394106%26sid%3Dliteratum%253Aachs%26aulast%3DTropea%26aufirst%3DD.%26aulast%3DGiacometti%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DN.%2BR.%26aulast%3DBeard%26aufirst%3DC.%26aulast%3DMcCurry%26aufirst%3DC.%26aulast%3DFu%26aufirst%3DD.%2BD.%26aulast%3DFlannery%26aufirst%3DR.%26aulast%3DJaenisch%26aufirst%3DR.%26aulast%3DSur%26aufirst%3DM.%26atitle%3DPartial%2520reversal%2520of%2520Rett%2520syndrome-like%2520symptoms%2520in%2520MeCP2%2520mutant%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D2029%26epage%3D2034%26doi%3D10.1073%2Fpnas.0812394106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Castro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, R. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwok, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petravicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellios, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropea, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, M.</span><span> </span><span class="NLM_article-title">Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">9941</span><span class="NLM_x">–</span> <span class="NLM_lpage">9946</span><span class="refDoi"> DOI: 10.1073/pnas.1311685111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.1311685111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=9941-9946&author=J.+Castroauthor=R.+I.+Garciaauthor=S.+Kwokauthor=A.+Banerjeeauthor=J.+Petraviczauthor=J.+Woodsonauthor=N.+Melliosauthor=D.+Tropeaauthor=M.+Sur&title=Functional+recovery+with+recombinant+human+IGF1+treatment+in+a+mouse+model+of+Rett+Syndrome&doi=10.1073%2Fpnas.1311685111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1311685111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1311685111%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DJ.%26aulast%3DGarcia%26aufirst%3DR.%2BI.%26aulast%3DKwok%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DPetravicz%26aufirst%3DJ.%26aulast%3DWoodson%26aufirst%3DJ.%26aulast%3DMellios%26aufirst%3DN.%26aulast%3DTropea%26aufirst%3DD.%26aulast%3DSur%26aufirst%3DM.%26atitle%3DFunctional%2520recovery%2520with%2520recombinant%2520human%2520IGF1%2520treatment%2520in%2520a%2520mouse%2520model%2520of%2520Rett%2520Syndrome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D9941%26epage%3D9946%26doi%3D10.1073%2Fpnas.1311685111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Deacon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snape, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altimiras, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biekofsky, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogram, P.</span><span> </span><span class="NLM_article-title">NNZ-2566, a novel analog of (1–3) IGF-1, as a potential therapeutic agent for fragile X syndrome</span> <span class="citation_source-journal">NeuroMol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1007/s12017-015-8341-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs12017-015-8341-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25613838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=71-82&author=R.+M.+Deaconauthor=L.+Glassauthor=M.+Snapeauthor=M.+J.+Hurleyauthor=F.+J.+Altimirasauthor=R.+R.+Biekofskyauthor=P.+Cogram&title=NNZ-2566%2C+a+novel+analog+of+%281%E2%80%933%29+IGF-1%2C+as+a+potential+therapeutic+agent+for+fragile+X+syndrome&doi=10.1007%2Fs12017-015-8341-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">NNZ-2566, a Novel Analog of (1-3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome</span></div><div class="casAuthors">Deacon, Robert M. J.; Glass, Larry; Snape, Mike; Hurley, Michael J.; Altimiras, Francisco J.; Biekofsky, Rodolfo R.; Cogram, Patricia</div><div class="citationInfo"><span class="NLM_cas:title">NeuroMolecular Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-82</span>CODEN:
                <span class="NLM_cas:coden">NMEEAN</span>;
        ISSN:<span class="NLM_cas:issn">1535-1084</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Fragile X syndrome (FXS) is the most common form of inherited intellectual disability.  Previous studies have implicated mGlu5 in the pathogenesis of the disease, and many agents that target the underlying pathophysiol. of FXS have focused on mGluR5 modulation.  In the present work, a novel pharmacol. approach for FXS is investigated.  NNZ-2566, a synthetic analog of a naturally occurring neurotrophic peptide derived from insulin-like growth factor-1 (IGF-1), was administered to fmr1 knockout mice correcting learning and memory deficits, abnormal hyperactivity and social interaction, normalizing aberrant dendritic spine d., overactive ERK and Akt signaling, and macroorchidism.  Altogether, our results indicate a unique disease-modifying potential for NNZ-2566 in FXS.  Most importantly, the present data implicate the IGF-1 mol. pathway in the pathogenesis of FXS.  A clin. trial is under way to ascertain whether these findings translate into clin. effects in FXS patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW2rxzSbk-77Vg90H21EOLACvtfcHk0limvuf7nppLeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCrsbs%253D&md5=fca3c173927ac34c66039ab0df9ac111</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1007%2Fs12017-015-8341-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12017-015-8341-2%26sid%3Dliteratum%253Aachs%26aulast%3DDeacon%26aufirst%3DR.%2BM.%26aulast%3DGlass%26aufirst%3DL.%26aulast%3DSnape%26aufirst%3DM.%26aulast%3DHurley%26aufirst%3DM.%2BJ.%26aulast%3DAltimiras%26aufirst%3DF.%2BJ.%26aulast%3DBiekofsky%26aufirst%3DR.%2BR.%26aulast%3DCogram%26aufirst%3DP.%26atitle%3DNNZ-2566%252C%2520a%2520novel%2520analog%2520of%2520%25281%25E2%2580%25933%2529%2520IGF-1%252C%2520as%2520a%2520potential%2520therapeutic%2520agent%2520for%2520fragile%2520X%2520syndrome%26jtitle%3DNeuroMol.%2520Med.%26date%3D2015%26volume%3D17%26spage%3D71%26epage%3D82%26doi%3D10.1007%2Fs12017-015-8341-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Marchetto, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belinson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freitas, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vadodaria, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beltrao-Braga, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trujillo, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes, A. P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanabhan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunez, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennand, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eichenfield, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pramparo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyler, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courchesne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwind, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynshaw-Boris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muotri, A. R.</span><span> </span><span class="NLM_article-title">Altered proliferation and networks in neural cells derived from idiopathic autistic individuals</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">820</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span><span class="refDoi"> DOI: 10.1038/mp.2016.95</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fmp.2016.95" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27378147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFegtb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=820-835&author=M.+C.+Marchettoauthor=H.+Belinsonauthor=Y.+Tianauthor=B.+C.+Freitasauthor=C.+Fuauthor=K.+C.+Vadodariaauthor=P.+C.+Beltrao-Bragaauthor=C.+A.+Trujilloauthor=A.+P.+D.+Mendesauthor=K.+Padmanabhanauthor=Y.+Nunezauthor=J.+Ouauthor=H.+Ghoshauthor=R.+Wrightauthor=K.+J.+Brennandauthor=K.+Pierceauthor=L.+Eichenfieldauthor=T.+Pramparoauthor=L.+T.+Eylerauthor=C.+C.+Barnesauthor=E.+Courchesneauthor=D.+H.+Geschwindauthor=F.+H.+Gageauthor=A.+Wynshaw-Borisauthor=A.+R.+Muotri&title=Altered+proliferation+and+networks+in+neural+cells+derived+from+idiopathic+autistic+individuals&doi=10.1038%2Fmp.2016.95"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Altered proliferation and networks in neural cells derived from idiopathic autistic individuals</span></div><div class="casAuthors">Marchetto, M. C.; Belinson, H.; Tian, Y.; Freitas, B. C.; Fu, C.; Vadodaria, K. C.; Beltrao-Braga, P. C.; Trujillo, C. A.; Mendes, A. P. D.; Padmanabhan, K.; Nunez, Y.; Ou, J.; Ghosh, H.; Wright, R.; Brennand, K. J.; Pierce, K.; Eichenfield, L.; Pramparo, T.; Eyler, L. T.; Barnes, C. C.; Courchesne, E.; Geschwind, D. H.; Gage, F. H.; Wynshaw-Boris, A.; Muotri, A. R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">820-835</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autism spectrum disorders (ASD) are common, complex and heterogeneous neurodevelopmental disorders.  Cellular and mol. mechanisms responsible for ASD pathogenesis have been proposed based on genetic studies, brain pathol. and imaging, but a major impediment to testing ASD hypotheses is the lack of human cell models.  Here, we reprogrammed fibroblasts to generate induced pluripotent stem cells, neural progenitor cells (NPCs) and neurons from ASD individuals with early brain overgrowth and non-ASD controls with normal brain size.  ASD-derived NPCs display increased cell proliferation because of dysregulation of a β-catenin/BRN2 transcriptional cascade.  ASD-derived neurons display abnormal neurogenesis and reduced synaptogenesis leading to functional defects in neuronal networks.  Interestingly, defects in neuronal networks could be rescued by insulin growth factor 1 (IGF-1), a drug that is currently in clin. trials for ASD.  This work demonstrates that selection of ASD subjects based on endophenotypes unraveled biol. relevant pathway disruption and revealed a potential cellular mechanism for the therapeutic effect of IGF-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYLRk4ASJ8RLVg90H21EOLACvtfcHk0ljq5XmLdG6MIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFegtb3E&md5=42a09737de67b7018f37b4e52abd9406</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1038%2Fmp.2016.95&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2016.95%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetto%26aufirst%3DM.%2BC.%26aulast%3DBelinson%26aufirst%3DH.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DFreitas%26aufirst%3DB.%2BC.%26aulast%3DFu%26aufirst%3DC.%26aulast%3DVadodaria%26aufirst%3DK.%2BC.%26aulast%3DBeltrao-Braga%26aufirst%3DP.%2BC.%26aulast%3DTrujillo%26aufirst%3DC.%2BA.%26aulast%3DMendes%26aufirst%3DA.%2BP.%2BD.%26aulast%3DPadmanabhan%26aufirst%3DK.%26aulast%3DNunez%26aufirst%3DY.%26aulast%3DOu%26aufirst%3DJ.%26aulast%3DGhosh%26aufirst%3DH.%26aulast%3DWright%26aufirst%3DR.%26aulast%3DBrennand%26aufirst%3DK.%2BJ.%26aulast%3DPierce%26aufirst%3DK.%26aulast%3DEichenfield%26aufirst%3DL.%26aulast%3DPramparo%26aufirst%3DT.%26aulast%3DEyler%26aufirst%3DL.%2BT.%26aulast%3DBarnes%26aufirst%3DC.%2BC.%26aulast%3DCourchesne%26aufirst%3DE.%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26aulast%3DGage%26aufirst%3DF.%2BH.%26aulast%3DWynshaw-Boris%26aufirst%3DA.%26aulast%3DMuotri%26aufirst%3DA.%2BR.%26atitle%3DAltered%2520proliferation%2520and%2520networks%2520in%2520neural%2520cells%2520derived%2520from%2520idiopathic%2520autistic%2520individuals%26jtitle%3DMol.%2520Psychiatry%26date%3D2017%26volume%3D22%26spage%3D820%26epage%3D835%26doi%3D10.1038%2Fmp.2016.95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Durand, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betancur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckers, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaste, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauchereau, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nygren, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rastam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillberg, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anckarsäter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sponheim, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goubran-Botros, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delorme, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabane, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouren-Simeoni, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Mas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogé, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Héron, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burglen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leboyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgeron, T.</span><span> </span><span class="NLM_article-title">Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span><span class="refDoi"> DOI: 10.1038/ng1933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fng1933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=17173049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD28jlsF2ntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=25-27&author=C.+M.+Durandauthor=C.+Betancurauthor=T.+M.+Boeckersauthor=J.+Bockmannauthor=P.+Chasteauthor=F.+Fauchereauauthor=G.+Nygrenauthor=M.+Rastamauthor=I.+C.+Gillbergauthor=H.+Anckars%C3%A4terauthor=E.+Sponheimauthor=H.+Goubran-Botrosauthor=R.+Delormeauthor=N.+Chabaneauthor=M.+C.+Mouren-Simeoniauthor=P.+de+Masauthor=E.+Biethauthor=B.+Rog%C3%A9author=D.+H%C3%A9ronauthor=L.+Burglenauthor=C.+Gillbergauthor=M.+Leboyerauthor=T.+Bourgeron&title=Mutations+in+the+gene+encoding+the+synaptic+scaffolding+protein+SHANK3+are+associated+with+autism+spectrum+disorders&doi=10.1038%2Fng1933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders</span></div><div class="casAuthors">Durand Christelle M; Betancur Catalina; Boeckers Tobias M; Bockmann Juergen; Chaste Pauline; Fauchereau Fabien; Nygren Gudrun; Rastam Maria; Gillberg I Carina; Anckarsater Henrik; Sponheim Eili; Goubran-Botros Hany; Delorme Richard; Chabane Nadia; Mouren-Simeoni Marie-Christine; de Mas Philippe; Bieth Eric; Roge Bernadette; Heron Delphine; Burglen Lydie; Gillberg Christopher; Leboyer Marion; Bourgeron Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Nature genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-7</span>
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    </div><div class="casAbstract">SHANK3 (also known as ProSAP2) regulates the structural organization of dendritic spines and is a binding partner of neuroligins; genes encoding neuroligins are mutated in autism and Asperger syndrome.  Here, we report that a mutation of a single copy of SHANK3 on chromosome 22q13 can result in language and/or social communication disorders.  These mutations concern only a small number of individuals, but they shed light on one gene dosage-sensitive synaptic pathway that is involved in autism spectrum disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSHWugWFFBYm70AGQpJZWpJfW6udTcc2eZO5uXaUJnjnrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jlsF2ntw%253D%253D&md5=47996cb8244d84634d201931f3a9ab43</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1038%2Fng1933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1933%26sid%3Dliteratum%253Aachs%26aulast%3DDurand%26aufirst%3DC.%2BM.%26aulast%3DBetancur%26aufirst%3DC.%26aulast%3DBoeckers%26aufirst%3DT.%2BM.%26aulast%3DBockmann%26aufirst%3DJ.%26aulast%3DChaste%26aufirst%3DP.%26aulast%3DFauchereau%26aufirst%3DF.%26aulast%3DNygren%26aufirst%3DG.%26aulast%3DRastam%26aufirst%3DM.%26aulast%3DGillberg%26aufirst%3DI.%2BC.%26aulast%3DAnckars%25C3%25A4ter%26aufirst%3DH.%26aulast%3DSponheim%26aufirst%3DE.%26aulast%3DGoubran-Botros%26aufirst%3DH.%26aulast%3DDelorme%26aufirst%3DR.%26aulast%3DChabane%26aufirst%3DN.%26aulast%3DMouren-Simeoni%26aufirst%3DM.%2BC.%26aulast%3Dde%2BMas%26aufirst%3DP.%26aulast%3DBieth%26aufirst%3DE.%26aulast%3DRog%25C3%25A9%26aufirst%3DB.%26aulast%3DH%25C3%25A9ron%26aufirst%3DD.%26aulast%3DBurglen%26aufirst%3DL.%26aulast%3DGillberg%26aufirst%3DC.%26aulast%3DLeboyer%26aufirst%3DM.%26aulast%3DBourgeron%26aufirst%3DT.%26atitle%3DMutations%2520in%2520the%2520gene%2520encoding%2520the%2520synaptic%2520scaffolding%2520protein%2520SHANK3%2520are%2520associated%2520with%2520autism%2520spectrum%2520disorders%26jtitle%3DNat.%2520Genet.%26date%3D2007%26volume%3D39%26spage%3D25%26epage%3D27%26doi%3D10.1038%2Fng1933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Phelan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saul, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stapleton, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweet, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermid, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claytor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, D. P.</span><span> </span><span class="NLM_article-title">22q13 deletion syndrome</span> <span class="citation_source-journal">Am. J. Med. Genet., Part A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1002/1096-8628(20010615)101:2<91::AID-AJMG1340>3.0.CO;2-C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2F1096-8628%2820010615%29101%3A2%3C91%3A%3AAID-AJMG1340%3E3.0.CO%3B2-C" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2001&pages=91-99&author=M.+C.+Phelanauthor=R.+C.+Rogersauthor=R.+A.+Saulauthor=G.+A.+Stapletonauthor=K.+Sweetauthor=H.+McDermidauthor=S.+R.+Shawauthor=J.+Claytorauthor=J.+Willisauthor=D.+P.+Kelly&title=22q13+deletion+syndrome&doi=10.1002%2F1096-8628%2820010615%29101%3A2%3C91%3A%3AAID-AJMG1340%3E3.0.CO%3B2-C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1002%2F1096-8628%2820010615%29101%3A2%3C91%3A%3AAID-AJMG1340%3E3.0.CO%3B2-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1096-8628%252820010615%2529101%253A2%253C91%253A%253AAID-AJMG1340%253E3.0.CO%253B2-C%26sid%3Dliteratum%253Aachs%26aulast%3DPhelan%26aufirst%3DM.%2BC.%26aulast%3DRogers%26aufirst%3DR.%2BC.%26aulast%3DSaul%26aufirst%3DR.%2BA.%26aulast%3DStapleton%26aufirst%3DG.%2BA.%26aulast%3DSweet%26aufirst%3DK.%26aulast%3DMcDermid%26aufirst%3DH.%26aulast%3DShaw%26aufirst%3DS.%2BR.%26aulast%3DClaytor%26aufirst%3DJ.%26aulast%3DWillis%26aufirst%3DJ.%26aulast%3DKelly%26aufirst%3DD.%2BP.%26atitle%3D22q13%2520deletion%2520syndrome%26jtitle%3DAm.%2520J.%2520Med.%2520Genet.%252C%2520Part%2520A%26date%3D2001%26volume%3D101%26spage%3D91%26epage%3D99%26doi%3D10.1002%2F1096-8628%2820010615%29101%3A2%3C91%3A%3AAID-AJMG1340%3E3.0.CO%3B2-C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Sarowar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grabrucker, A. M.</span><span> </span><span class="NLM_article-title">Actin-dependent alterations of dendritic spine morphology in shankopathies</span> <span class="citation_source-journal">Neural Plast.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">2016</span><span class="NLM_x">, </span> <span class="NLM_fpage">8051861</span><span class="refDoi"> DOI: 10.1155/2016/8051861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1155%2F2016%2F8051861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27795858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2snhtFeqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2016&publication_year=2016&pages=8051861&author=T.+Sarowarauthor=A.+M.+Grabrucker&title=Actin-dependent+alterations+of+dendritic+spine+morphology+in+shankopathies&doi=10.1155%2F2016%2F8051861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Actin-Dependent Alterations of Dendritic Spine Morphology in Shankopathies</span></div><div class="casAuthors">Sarowar Tasnuva; Grabrucker Andreas M</div><div class="citationInfo"><span class="NLM_cas:title">Neural plasticity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2016</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8051861</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Shank proteins (Shank1, Shank2, and Shank3) act as scaffolding molecules in the postsynaptic density of many excitatory neurons.  Mutations in SHANK genes, in particular SHANK2 and SHANK3, lead to autism spectrum disorders (ASD) in both human and mouse models.  Shank3 proteins are made of several domains-the Shank/ProSAP N-terminal (SPN) domain, ankyrin repeats, SH3 domain, PDZ domain, a proline-rich region, and the sterile alpha motif (SAM) domain.  Via various binding partners of these domains, Shank3 is able to bind and interact with a wide range of proteins including modulators of small GTPases such as RICH2, a RhoGAP protein, and βPIX, a RhoGEF protein for Rac1 and Cdc42, actin binding proteins and actin modulators.  Dysregulation of all isoforms of Shank proteins, but especially Shank3, leads to alterations in spine morphogenesis, shape, and activity of the synapse via altering actin dynamics.  Therefore, here, we highlight the role of Shank proteins as modulators of small GTPases and, ultimately, actin dynamics, as found in multiple in vitro and in vivo models.  The failure to mediate this regulatory role might present a shared mechanism in the pathophysiology of autism-associated mutations, which leads to dysregulation of spine morphogenesis and synaptic signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQQO0Kg4IryURLDWw4HIq2sfW6udTcc2eZEBLZsdFB7ULntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snhtFeqsw%253D%253D&md5=f45d0c671761a1900b699643f84c9b0e</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1155%2F2016%2F8051861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2016%252F8051861%26sid%3Dliteratum%253Aachs%26aulast%3DSarowar%26aufirst%3DT.%26aulast%3DGrabrucker%26aufirst%3DA.%2BM.%26atitle%3DActin-dependent%2520alterations%2520of%2520dendritic%2520spine%2520morphology%2520in%2520shankopathies%26jtitle%3DNeural%2520Plast.%26date%3D2016%26volume%3D2016%26spage%3D8051861%26doi%3D10.1155%2F2016%2F8051861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Naisbitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sala, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valtschanoff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worley, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, M.</span><span> </span><span class="NLM_article-title">Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">–</span> <span class="NLM_lpage">582</span><span class="refDoi"> DOI: 10.1016/S0896-6273(00)80809-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0896-6273%2800%2980809-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=569-582&author=S.+Naisbittauthor=E.+Kimauthor=J.+C.+Tuauthor=B.+Xiaoauthor=C.+Salaauthor=J.+Valtschanoffauthor=R.+J.+Weinbergauthor=P.+F.+Worleyauthor=M.+Sheng&title=Shank%2C+a+novel+family+of+postsynaptic+density+proteins+that+binds+to+the+NMDA+receptor%2FPSD-95%2FGKAP+complex+and+cortactin&doi=10.1016%2FS0896-6273%2800%2980809-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980809-0%26sid%3Dliteratum%253Aachs%26aulast%3DNaisbitt%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DTu%26aufirst%3DJ.%2BC.%26aulast%3DXiao%26aufirst%3DB.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DValtschanoff%26aufirst%3DJ.%26aulast%3DWeinberg%26aufirst%3DR.%2BJ.%26aulast%3DWorley%26aufirst%3DP.%2BF.%26aulast%3DSheng%26aufirst%3DM.%26atitle%3DShank%252C%2520a%2520novel%2520family%2520of%2520postsynaptic%2520density%2520proteins%2520that%2520binds%2520to%2520the%2520NMDA%2520receptor%252FPSD-95%252FGKAP%2520complex%2520and%2520cortactin%26jtitle%3DNeuron%26date%3D1999%26volume%3D23%26spage%3D569%26epage%3D582%26doi%3D10.1016%2FS0896-6273%2800%2980809-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Bozdagi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavassoli, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buxbaum, J. D.</span><span> </span><span class="NLM_article-title">Insulin-like growth factor-1 rescues synaptic and motor deficits in mouse model of autism and developmental delay</span> <span class="citation_source-journal">Mol. Autism</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="refDoi"> DOI: 10.1186/2040-2392-4-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2F2040-2392-4-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=23621888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVSgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=9&author=O.+Bozdagiauthor=T.+Tavassoliauthor=J.+D.+Buxbaum&title=Insulin-like+growth+factor-1+rescues+synaptic+and+motor+deficits+in+mouse+model+of+autism+and+developmental+delay&doi=10.1186%2F2040-2392-4-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay</span></div><div class="casAuthors">Bozdagi, Ozlem; Tavassoli, Teresa; Buxbaum, Joseph D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Autism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">9</span>CODEN:
                <span class="NLM_cas:coden">MAOUBR</span>;
        ISSN:<span class="NLM_cas:issn">2040-2392</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Haploinsufficiency of SHANK3, due to either hemizygous gene deletion (termed 22q13 deletion syndrome or Phelan-McDermid syndrome) or to gene mutation, accounts for about 0.5% of the cases of autism spectrum disorder (ASD) and/or developmental delay, and there is evidence for a wider role for SHANK3 and glutamate signaling abnormalities in ASD and related conditions.  Therapeutic approaches that reverse deficits in SHANK3-haploinsufficiency may therefore be broadly beneficial in ASD and in developmental delay.  Findings: We obsd. that daily i.p. injections of human insulin-like growth factor 1 (IGF-1) over a 2-wk period reversed deficits in hippocampal α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) signaling, long-term potentiation (LTP), and motor performance that we had previously reported in Shank3-deficient mice.  Pos. effects were obsd. with an IGF-1 peptide deriv. as well.  Conclusions: We obsd. significant beneficial effects of IGF-1 in a mouse model of ASD and of developmental delay.  Studies in mouse and human neuronal models of Rett syndrome also show benefits with IGF-1, raising the possibility that this compd. may have benefits broadly in ASD and related conditions, even with differing mol. etiol.  Given the extensive safety data for IGF-1 in children with short stature due to primary IGF-1 deficiency, IGF-1 is an attractive candidate for controlled clin. trials in SHANK3-deficiency and in ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPhnl5Spk9LrVg90H21EOLACvtfcHk0ljuat9dBbto1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVSgsL0%253D&md5=cf0e63baecd27fb0e3753efce01349b3</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1186%2F2040-2392-4-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2040-2392-4-9%26sid%3Dliteratum%253Aachs%26aulast%3DBozdagi%26aufirst%3DO.%26aulast%3DTavassoli%26aufirst%3DT.%26aulast%3DBuxbaum%26aufirst%3DJ.%2BD.%26atitle%3DInsulin-like%2520growth%2520factor-1%2520rescues%2520synaptic%2520and%2520motor%2520deficits%2520in%2520mouse%2520model%2520of%2520autism%2520and%2520developmental%2520delay%26jtitle%3DMol.%2520Autism%26date%3D2013%26volume%3D4%26spage%3D9%26doi%3D10.1186%2F2040-2392-4-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Shcheglovitov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shcheglovitova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebastiano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krawisz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froehlich, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernstein, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallmayer, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolmetsch, R. E.</span><span> </span><span class="NLM_article-title">SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">503</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span><span class="refDoi"> DOI: 10.1038/nature12618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnature12618" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=267-271&author=A.+Shcheglovitovauthor=O.+Shcheglovitovaauthor=M.+Yazawaauthor=T.+Portmannauthor=R.+Shuauthor=V.+Sebastianoauthor=A.+Krawiszauthor=W.+Froehlichauthor=J.+A.+Bernsteinauthor=J.+F.+Hallmayerauthor=R.+E.+Dolmetsch&title=SHANK3+and+IGF1+restore+synaptic+deficits+in+neurons+from+22q13+deletion+syndrome+patients&doi=10.1038%2Fnature12618"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1038%2Fnature12618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12618%26sid%3Dliteratum%253Aachs%26aulast%3DShcheglovitov%26aufirst%3DA.%26aulast%3DShcheglovitova%26aufirst%3DO.%26aulast%3DYazawa%26aufirst%3DM.%26aulast%3DPortmann%26aufirst%3DT.%26aulast%3DShu%26aufirst%3DR.%26aulast%3DSebastiano%26aufirst%3DV.%26aulast%3DKrawisz%26aufirst%3DA.%26aulast%3DFroehlich%26aufirst%3DW.%26aulast%3DBernstein%26aufirst%3DJ.%2BA.%26aulast%3DHallmayer%26aufirst%3DJ.%2BF.%26aulast%3DDolmetsch%26aufirst%3DR.%2BE.%26atitle%3DSHANK3%2520and%2520IGF1%2520restore%2520synaptic%2520deficits%2520in%2520neurons%2520from%252022q13%2520deletion%2520syndrome%2520patients%26jtitle%3DNature%26date%3D2013%26volume%3D503%26spage%3D267%26epage%3D271%26doi%3D10.1038%2Fnature12618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Kolevzon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halpern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grodberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rapaport, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavassoli, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soorya, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buxbaum, J. D.</span><span> </span><span class="NLM_article-title">A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome</span> <span class="citation_source-journal">Mol. Autism</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="refDoi"> DOI: 10.1186/2040-2392-5-54</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2F2040-2392-5-54" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25685306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFOjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=54&author=A.+Kolevzonauthor=L.+Bushauthor=A.+T.+Wangauthor=D.+Halpernauthor=Y.+Frankauthor=D.+Grodbergauthor=R.+Rapaportauthor=T.+Tavassoliauthor=W.+Chaplinauthor=L.+Sooryaauthor=J.+D.+Buxbaum&title=A+pilot+controlled+trial+of+insulin-like+growth+factor-1+in+children+with+Phelan-McDermid+syndrome&doi=10.1186%2F2040-2392-5-54"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome</span></div><div class="casAuthors">Kolevzon, Alexander; Bush, Lauren; Wang, A. Ting; Halpern, Danielle; Frank, Yitzchak; Grodberg, David; Rapaport, Robert; Tavassoli, Teresa; Chaplin, William; Soorya, Latha; Buxbaum, Joseph D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Autism</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">54/1-54/18, 18 pp.</span>CODEN:
                <span class="NLM_cas:coden">MAOUBR</span>;
        ISSN:<span class="NLM_cas:issn">2040-2392</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Autism spectrum disorder (ASD) is now understood to have multiple genetic risk genes and one example is SHANK3.  SHANK3 deletions and mutations disrupt synaptic function and result in Phelan-McDermid syndrome (PMS), which causes a monogenic form of ASD with a frequency of at least 0.5% of ASD cases.  Recent evidence from preclin. studies with mouse and human neuronal models of SHANK3 deficiency suggest that insulin-like growth factor-1 (IGF-1) can reverse synaptic plasticity and motor learning deficits.  The objective of this study was to pilot IGF-1 treatment in children with PMS to evaluate safety, tolerability, and efficacy for core deficits of ASD, including social impairment and restricted and repetitive behaviors.  Methods: Nine children with PMS aged 5 to 15 were enrolled in a placebo-controlled, double-blind, crossover design study, with 3 mo of treatment with IGF-1 and 3 mo of placebo in random order, sepd. by a 4-wk wash-out period.  Results: Compared to the placebo phase, the IGF-1 phase was assocd. with significant improvement in both social impairment and restrictive behaviors, as measured by the Aberrant Behavior Checklist and the Repetitive Behavior Scale, resp.  IGF-1 was found to be well tolerated and there were no serious adverse events in any participants.  Conclusions: This study establishes the feasibility of IGF-1 treatment in PMS and contributes pilot data from the first controlled treatment trial in the syndrome.  Results also provide proof of concept to advance knowledge about developing targeted treatments for addnl. causes of ASD assocd. with impaired synaptic development and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIoN-2TAr_8rVg90H21EOLACvtfcHk0lhxG6H3S2wfdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFOjtrw%253D&md5=0c98a02ae3121881b7c14b83058a5d92</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1186%2F2040-2392-5-54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2040-2392-5-54%26sid%3Dliteratum%253Aachs%26aulast%3DKolevzon%26aufirst%3DA.%26aulast%3DBush%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DA.%2BT.%26aulast%3DHalpern%26aufirst%3DD.%26aulast%3DFrank%26aufirst%3DY.%26aulast%3DGrodberg%26aufirst%3DD.%26aulast%3DRapaport%26aufirst%3DR.%26aulast%3DTavassoli%26aufirst%3DT.%26aulast%3DChaplin%26aufirst%3DW.%26aulast%3DSoorya%26aufirst%3DL.%26aulast%3DBuxbaum%26aufirst%3DJ.%2BD.%26atitle%3DA%2520pilot%2520controlled%2520trial%2520of%2520insulin-like%2520growth%2520factor-1%2520in%2520children%2520with%2520Phelan-McDermid%2520syndrome%26jtitle%3DMol.%2520Autism%26date%3D2014%26volume%3D5%26spage%3D54%26doi%3D10.1186%2F2040-2392-5-54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Tu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naisbitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petralia, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brakeman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aakalu, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanahan, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worley, P. F.</span><span> </span><span class="NLM_article-title">Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">592</span><span class="refDoi"> DOI: 10.1016/S0896-6273(00)80810-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0896-6273%2800%2980810-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=583-592&author=J.+C.+Tuauthor=B.+Xiaoauthor=S.+Naisbittauthor=J.+P.+Yuanauthor=R.+S.+Petraliaauthor=P.+Brakemanauthor=A.+Doanauthor=V.+K.+Aakaluauthor=A.+A.+Lanahanauthor=M.+Shengauthor=P.+F.+Worley&title=Coupling+of+mGluR%2FHomer+and+PSD-95+complexes+by+the+Shank+family+of+postsynaptic+density+proteins&doi=10.1016%2FS0896-6273%2800%2980810-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980810-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980810-7%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DJ.%2BC.%26aulast%3DXiao%26aufirst%3DB.%26aulast%3DNaisbitt%26aufirst%3DS.%26aulast%3DYuan%26aufirst%3DJ.%2BP.%26aulast%3DPetralia%26aufirst%3DR.%2BS.%26aulast%3DBrakeman%26aufirst%3DP.%26aulast%3DDoan%26aufirst%3DA.%26aulast%3DAakalu%26aufirst%3DV.%2BK.%26aulast%3DLanahan%26aufirst%3DA.%2BA.%26aulast%3DSheng%26aufirst%3DM.%26aulast%3DWorley%26aufirst%3DP.%2BF.%26atitle%3DCoupling%2520of%2520mGluR%252FHomer%2520and%2520PSD-95%2520complexes%2520by%2520the%2520Shank%2520family%2520of%2520postsynaptic%2520density%2520proteins%26jtitle%3DNeuron%26date%3D1999%26volume%3D23%26spage%3D583%26epage%3D592%26doi%3D10.1016%2FS0896-6273%2800%2980810-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Vicidomini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponzoni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmeisser, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morello, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orellana, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durante, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalmani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantegazza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genazzani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giustetto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabresi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckers, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sala, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verpelli, C.</span><span> </span><span class="NLM_article-title">Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">784</span><span class="refDoi"> DOI: 10.1038/mp.2016.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fmp.2016.70" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27113996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvVSgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=784&author=C.+Vicidominiauthor=L.+Ponzoniauthor=D.+Limauthor=M.+J.+Schmeisserauthor=D.+Reimauthor=N.+Morelloauthor=D.+Orellanaauthor=A.+Tozziauthor=V.+Duranteauthor=P.+Scalmaniauthor=M.+Mantegazzaauthor=A.+A.+Genazzaniauthor=M.+Giustettoauthor=M.+Salaauthor=P.+Calabresiauthor=T.+M.+Boeckersauthor=C.+Salaauthor=C.+Verpelli&title=Pharmacological+enhancement+of+mGlu5+receptors+rescues+behavioral+deficits+in+SHANK3+knock-out+mice&doi=10.1038%2Fmp.2016.70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice [Erratum to document cited in CA166:546730]</span></div><div class="casAuthors">Vicidomini, C.; Ponzoni, L.; Lim, D.; Schmeisser, M. J.; Reim, D.; Morello, N.; Orellana, D.; Tozzi, A.; Durante, V.; Scalmani, P.; Mantegazza, M.; Genazzani, A. A.; Giustetto, M.; Sala, M.; Calabresi, P.; Boeckers, T. M.; Sala, C.; Verpelli, C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">784</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Correction to:Mol. Psychiatry advance online publication 29 March 2016; doi:10.1038/mp.2016.30 Following publication of this paper, the authors noticed that the affiliations for M Giustetto, C Vicidomini, C Sala and C Verpelli were incorrect.  The correct affiliations appear below: C Vicidomini1,2, L Ponzoni, D Lim, MJ Schmeisser, D Reim, N Morello, D Orellana, A Tozzi, V Durante, P Scalmani, M Mantegazza, AA Genazzani, M Giustetto3, M Sala, P Calabresi, TM Boeckers, C Sala1,2 and C Verpelli1,2 1CNR Neuroscience Institute, Milan, Italy; 2BIOMETRA University of Milan, Milan, Italy; 3Department of Neuroscience, University of Turin, Turin, Italy;.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomJ69-dxja3rVg90H21EOLACvtfcHk0lhxG6H3S2wfdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvVSgsrs%253D&md5=931962589e67f96e4cca024bcaa983d0</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1038%2Fmp.2016.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2016.70%26sid%3Dliteratum%253Aachs%26aulast%3DVicidomini%26aufirst%3DC.%26aulast%3DPonzoni%26aufirst%3DL.%26aulast%3DLim%26aufirst%3DD.%26aulast%3DSchmeisser%26aufirst%3DM.%2BJ.%26aulast%3DReim%26aufirst%3DD.%26aulast%3DMorello%26aufirst%3DN.%26aulast%3DOrellana%26aufirst%3DD.%26aulast%3DTozzi%26aufirst%3DA.%26aulast%3DDurante%26aufirst%3DV.%26aulast%3DScalmani%26aufirst%3DP.%26aulast%3DMantegazza%26aufirst%3DM.%26aulast%3DGenazzani%26aufirst%3DA.%2BA.%26aulast%3DGiustetto%26aufirst%3DM.%26aulast%3DSala%26aufirst%3DM.%26aulast%3DCalabresi%26aufirst%3DP.%26aulast%3DBoeckers%26aufirst%3DT.%2BM.%26aulast%3DSala%26aufirst%3DC.%26aulast%3DVerpelli%26aufirst%3DC.%26atitle%3DPharmacological%2520enhancement%2520of%2520mGlu5%2520receptors%2520rescues%2520behavioral%2520deficits%2520in%2520SHANK3%2520knock-out%2520mice%26jtitle%3DMol.%2520Psychiatry%26date%3D2017%26volume%3D22%26spage%3D784%26doi%3D10.1038%2Fmp.2016.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Huang, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, D. F.</span><span> </span><span class="NLM_article-title">Rho GTPase-activating proteins: Regulators of Rho GTPase activity in neuronal development and CNS diseases</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span><span class="refDoi"> DOI: 10.1016/j.mcn.2017.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.mcn.2017.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=28163190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXisVygs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2017&pages=18-31&author=G.+H.+Huangauthor=Z.+L.+Sunauthor=H.+J.+Liauthor=D.+F.+Feng&title=Rho+GTPase-activating+proteins%3A+Regulators+of+Rho+GTPase+activity+in+neuronal+development+and+CNS+diseases&doi=10.1016%2Fj.mcn.2017.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Rho GTPase-activating proteins: Regulators of Rho GTPase activity in neuronal development and CNS diseases</span></div><div class="casAuthors">Huang, Guo-Hui; Sun, Zhao-Liang; Li, Hong-Jiang; Feng, Dong-Fu</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">18-31</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Rho family of small GTPases was considered as mol. switches in regulating multiple cellular events, including cytoskeleton reorganization.  The Rho GTPase-activating proteins (RhoGAPs) are one of the major families of Rho GTPase regulators.  RhoGAPs were initially considered neg. mediators of Rho signaling pathways via their GAP domain.  Recent studies have demonstrated that RhoGAPs also regulate numerous aspects of neuronal development and are related to various neurodegenerative diseases in GAP-dependent and GAP-independent manners.  Moreover, RhoGAPs are regulated through various mechanisms, such as phosphorylation.  To date, approx. 70 RhoGAPs have been identified; however, only a small portion has been thoroughly investigated.  Thus, the characterization of important RhoGAPs in the central nervous system is crucial to understand their spatiotemporal role during different stages of neuronal development.  In this review, we summarize the current knowledge of RhoGAPs in the brain with an emphasis on their mol. function, regulation mechanism and disease implications in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp25T2fg6nbWLVg90H21EOLACvtfcHk0lhxG6H3S2wfdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXisVygs74%253D&md5=eecd38b6eb8989431ba53257c9249d36</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2017.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2017.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DG.%2BH.%26aulast%3DSun%26aufirst%3DZ.%2BL.%26aulast%3DLi%26aufirst%3DH.%2BJ.%26aulast%3DFeng%26aufirst%3DD.%2BF.%26atitle%3DRho%2520GTPase-activating%2520proteins%253A%2520Regulators%2520of%2520Rho%2520GTPase%2520activity%2520in%2520neuronal%2520development%2520and%2520CNS%2520diseases%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2017%26volume%3D80%26spage%3D18%26epage%3D31%26doi%3D10.1016%2Fj.mcn.2017.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Nakagawa, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujisawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishizaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span> </span><span class="NLM_article-title">ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">392</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span><span class="refDoi"> DOI: 10.1016/0014-5793(96)00811-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2F0014-5793%2896%2900811-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=392&publication_year=1996&pages=189-193&author=O.+Nakagawaauthor=K.+Fujisawaauthor=T.+Ishizakiauthor=Y.+Saitoauthor=K.+Nakaoauthor=S.+Narumiya&title=ROCK-I+and+ROCK-II%2C+two+isoforms+of+Rho-associated+coiled-coil+forming+protein+serine%2Fthreonine+kinase+in+mice&doi=10.1016%2F0014-5793%2896%2900811-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2896%2900811-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252896%252900811-3%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DO.%26aulast%3DFujisawa%26aufirst%3DK.%26aulast%3DIshizaki%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DNakao%26aufirst%3DK.%26aulast%3DNarumiya%26aufirst%3DS.%26atitle%3DROCK-I%2520and%2520ROCK-II%252C%2520two%2520isoforms%2520of%2520Rho-associated%2520coiled-coil%2520forming%2520protein%2520serine%252Fthreonine%2520kinase%2520in%2520mice%26jtitle%3DFEBS%2520Lett.%26date%3D1996%26volume%3D392%26spage%3D189%26epage%3D193%26doi%3D10.1016%2F0014-5793%2896%2900811-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Huentelman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talboom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corneveaux, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiman, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bimonte-Nelson, H. A.</span><span> </span><span class="NLM_article-title">Peripheral delivery of a ROCK inhibitor improves learning and working memory</span> <span class="citation_source-journal">Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span><span class="refDoi"> DOI: 10.1037/a0014260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1037%2Fa0014260" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2009&pages=218-223&author=M.+J.+Huentelmanauthor=D.+A.+Stephanauthor=J.+Talboomauthor=J.+J.+Corneveauxauthor=D.+M.+Reimanauthor=J.+D.+Gerberauthor=C.+A.+Barnesauthor=G.+E.+Alexanderauthor=E.+M.+Reimanauthor=H.+A.+Bimonte-Nelson&title=Peripheral+delivery+of+a+ROCK+inhibitor+improves+learning+and+working+memory&doi=10.1037%2Fa0014260"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1037%2Fa0014260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1037%252Fa0014260%26sid%3Dliteratum%253Aachs%26aulast%3DHuentelman%26aufirst%3DM.%2BJ.%26aulast%3DStephan%26aufirst%3DD.%2BA.%26aulast%3DTalboom%26aufirst%3DJ.%26aulast%3DCorneveaux%26aufirst%3DJ.%2BJ.%26aulast%3DReiman%26aufirst%3DD.%2BM.%26aulast%3DGerber%26aufirst%3DJ.%2BD.%26aulast%3DBarnes%26aufirst%3DC.%2BA.%26aulast%3DAlexander%26aufirst%3DG.%2BE.%26aulast%3DReiman%26aufirst%3DE.%2BM.%26aulast%3DBimonte-Nelson%26aufirst%3DH.%2BA.%26atitle%3DPeripheral%2520delivery%2520of%2520a%2520ROCK%2520inhibitor%2520improves%2520learning%2520and%2520working%2520memory%26jtitle%3DBehav.%2520Neurosci.%26date%3D2009%26volume%3D123%26spage%3D218%26epage%3D223%26doi%3D10.1037%2Fa0014260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Swanger, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattheyses, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentry, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herskowitz, J. H.</span><span> </span><span class="NLM_article-title">ROCK1 and ROCK2 inhibition alters dendritic spine morphology in hippocampal neurons</span> <span class="citation_source-journal">Cell Logist.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1133266</span><span class="refDoi"> DOI: 10.1080/21592799.2015.1133266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1080%2F21592799.2015.1133266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27054047" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=e1133266&author=S.+A.+Swangerauthor=A.+L.+Mattheysesauthor=E.+G.+Gentryauthor=J.+H.+Herskowitz&title=ROCK1+and+ROCK2+inhibition+alters+dendritic+spine+morphology+in+hippocampal+neurons&doi=10.1080%2F21592799.2015.1133266"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1080%2F21592799.2015.1133266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21592799.2015.1133266%26sid%3Dliteratum%253Aachs%26aulast%3DSwanger%26aufirst%3DS.%2BA.%26aulast%3DMattheyses%26aufirst%3DA.%2BL.%26aulast%3DGentry%26aufirst%3DE.%2BG.%26aulast%3DHerskowitz%26aufirst%3DJ.%2BH.%26atitle%3DROCK1%2520and%2520ROCK2%2520inhibition%2520alters%2520dendritic%2520spine%2520morphology%2520in%2520hippocampal%2520neurons%26jtitle%3DCell%2520Logist.%26date%3D2015%26volume%3D5%26spage%3De1133266%26doi%3D10.1080%2F21592799.2015.1133266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Alokam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singhal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivathsav, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garigipati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puppala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sriram, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perumal, Y.</span><span> </span><span class="NLM_article-title">Design of dual inhibitors of ROCK-I and NOX2 as potential leads for the treatment of neuroinflammation associated with various neurological diseases including autism spectrum disorder</span> <span class="citation_source-journal">Mol. BioSyst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span><span class="refDoi"> DOI: 10.1039/C4MB00570H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1039%2FC4MB00570H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25465055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFegt77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=607-617&author=R.+Alokamauthor=S.+Singhalauthor=G.+S.+Srivathsavauthor=S.+Garigipatiauthor=S.+Puppalaauthor=D.+Sriramauthor=Y.+Perumal&title=Design+of+dual+inhibitors+of+ROCK-I+and+NOX2+as+potential+leads+for+the+treatment+of+neuroinflammation+associated+with+various+neurological+diseases+including+autism+spectrum+disorder&doi=10.1039%2FC4MB00570H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Design of dual inhibitors of ROCK-I and NOX2 as potential leads for the treatment of neuroinflammation associated with various neurological diseases including autism spectrum disorder</span></div><div class="casAuthors">Alokam, Reshma; Singhal, Sarthak; Srivathsav, Geetha Sai; Garigipati, Sowmya; Puppala, Sripriya; Sriram, Dharmarajan; Perumal, Yogeeswari</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">607-617</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Inhibition of both Rho kinase (ROCK-I) and NADPH oxidase (NOX2) to treat neuroinflammation could be very effective in the treatment of progressive neurol. diseases like Alzheimer's disease, autism spectral disorder, and fragile X syndrome.  NOX2 being a multi-enzyme component is activated during host defense in phagocytes such as microglia, to catalyze the prodn. of superoxide from oxygen, while ROCK is an important mediator of fundamental cell processes like adhesion, proliferation and migration.  Phosphorylated ROCK was found to activate NOX2 assembly via Ras related C3 botulinum toxin substrate (Rac) in disease conditions.  Overexpression of ROCK-I and NOX2 in innate immune cells like microglial cells contribute to progressive neuronal damage early in neurol. disease development.  In the present study we employed a computer-aided methodol. combining pharmacophores and mol. docking to identify new chem. entities that could inhibit ROCK-I as well as NOX2 (p47 phox).  Among the huge dataset of a com. database, top 18 mols. with crucial binding interactions were selected for biol. evaluation.  Seven among the lead mols. exhibited inhibitory potential against ROCK-I and NOX2 with IC50s ranging from 1.588 to 856.2 nM and 0.8942 to 10.24 μM, resp., and emerged as potential hits as dual inhibitors with adequate selectivity index (SI = CC50/GIC50) in cell-based assays.  The most active compd. 3 was further found to show redn. of the pro-inflammatory mediators such as TNFα, interleukin-6 (IL-6) and interleukin-1beta (IL-1β) mRNA expression levels in activated (MeHg treated) human neuroblastoma (IMR32) cell lines.  Hence the present work documented the utility of these dual inhibitors as prototypical leads to be useful for the treatment of neurol. disorders including autism spectrum disorder and Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG4-6HYAydFLVg90H21EOLACvtfcHk0ljvzzuU2rnu1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFegt77I&md5=922bff3bb922854f01651c7195de0327</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1039%2FC4MB00570H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MB00570H%26sid%3Dliteratum%253Aachs%26aulast%3DAlokam%26aufirst%3DR.%26aulast%3DSinghal%26aufirst%3DS.%26aulast%3DSrivathsav%26aufirst%3DG.%2BS.%26aulast%3DGarigipati%26aufirst%3DS.%26aulast%3DPuppala%26aufirst%3DS.%26aulast%3DSriram%26aufirst%3DD.%26aulast%3DPerumal%26aufirst%3DY.%26atitle%3DDesign%2520of%2520dual%2520inhibitors%2520of%2520ROCK-I%2520and%2520NOX2%2520as%2520potential%2520leads%2520for%2520the%2520treatment%2520of%2520neuroinflammation%2520associated%2520with%2520various%2520neurological%2520diseases%2520including%2520autism%2520spectrum%2520disorder%26jtitle%3DMol.%2520BioSyst.%26date%3D2015%26volume%3D11%26spage%3D607%26epage%3D617%26doi%3D10.1039%2FC4MB00570H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoGrasso, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defert, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span> </span><span class="NLM_article-title">Rho kinase (ROCK) inhibitors and their therapeutic potential</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2269</span><span class="NLM_x">–</span> <span class="NLM_lpage">2300</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00683</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00683" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Oqtb%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2269-2300&author=Y.+Fengauthor=P.+V.+LoGrassoauthor=O.+Defertauthor=R.+Li&title=Rho+kinase+%28ROCK%29+inhibitors+and+their+therapeutic+potential&doi=10.1021%2Facs.jmedchem.5b00683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential</span></div><div class="casAuthors">Feng, Yangbo; LoGrasso, Philip V.; Defert, Olivier; Li, Rongshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2269-2300</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Rho kinases (ROCKs) belong to the serine-threonine family, the inhibition of which affects the function of many downstream substrates.  As such, ROCK inhibitors have potential therapeutic applicability in a wide variety of pathol. conditions including asthma, cancer, erectile dysfunction, glaucoma, insulin resistance, kidney failure, neuronal degeneration, and osteoporosis.  To date, two ROCK inhibitors have been approved for clin. use in Japan (fasudil and ripasudil) and one in China (fasudil).  In 1995 fasudil was approved for the treatment of cerebral vasospasm, and more recently, ripasudil was approved for the treatment of glaucoma in 2014.  In this Perspective, we present a comprehensive review of the physiol. and biol. functions for ROCK, the properties and development of over 170 ROCK inhibitors as well as their therapeutic potential, the current status, and future considerations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXh2BorYftcbVg90H21EOLACvtfcHk0ljFi6hAY3BeVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Oqtb%252FJ&md5=99b0e10dca303023b1bf382fcb255771</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00683%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DLoGrasso%26aufirst%3DP.%2BV.%26aulast%3DDefert%26aufirst%3DO.%26aulast%3DLi%26aufirst%3DR.%26atitle%3DRho%2520kinase%2520%2528ROCK%2529%2520inhibitors%2520and%2520their%2520therapeutic%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2269%26epage%3D2300%26doi%3D10.1021%2Facs.jmedchem.5b00683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Hranilovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bujas-Petkovic, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vragovic, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jernej, B.</span><span> </span><span class="NLM_article-title">Hyperserotonemia in adults with autistic disorder</span> <span class="citation_source-journal">J. Autism Dev. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1934</span><span class="NLM_x">–</span> <span class="NLM_lpage">1940</span><span class="refDoi"> DOI: 10.1007/s10803-006-0324-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs10803-006-0324-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=17165147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD2snhs1yjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2007&pages=1934-1940&author=D.+Hranilovicauthor=Z.+Bujas-Petkovicauthor=R.+Vragovicauthor=T.+Vukauthor=K.+Hockauthor=B.+Jernej&title=Hyperserotonemia+in+adults+with+autistic+disorder&doi=10.1007%2Fs10803-006-0324-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperserotonemia in adults with autistic disorder</span></div><div class="casAuthors">Hranilovic Dubravka; Bujas-Petkovic Zorana; Vragovic Renata; Vuk Tomislav; Hock Karlo; Jernej Branimir</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autism and developmental disorders</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1934-40</span>
        ISSN:<span class="NLM_cas:issn">0162-3257</span>.
    </div><div class="casAbstract">Hyperserotonemia is the most consistent serotonin-related finding in autism.  The basis of this phenomenon, and its relationship to the central serotonergic dysfunction remains unclear.  Platelet serotonin level (PSL) in 53 autistic adults and 45 healthy controls was measured.  Mean PSL in autistic group (75.7 +/- 37.4 ng/microL) was significantly higher than the control sample (59.2 +/- 16.2 ng/microL) due to a presence of hyperserotonemic subjects which comprised 32% of the patients.  PSL of autistic subjects did not correlate with the severity of symptoms, as measured by total CARS score, or the degree of mental retardation.  However, significant negative relationship was observed between PSL and speech development, indicating the relationship between the peripheral 5HT concentrations and verbal abilities in autistic subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCYqigiN2N3gxyojvcjibhfW6udTcc2eaKpDsHnwDVvrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snhs1yjtw%253D%253D&md5=47982ccad0da149672b77532afa6ac0d</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1007%2Fs10803-006-0324-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10803-006-0324-6%26sid%3Dliteratum%253Aachs%26aulast%3DHranilovic%26aufirst%3DD.%26aulast%3DBujas-Petkovic%26aufirst%3DZ.%26aulast%3DVragovic%26aufirst%3DR.%26aulast%3DVuk%26aufirst%3DT.%26aulast%3DHock%26aufirst%3DK.%26aulast%3DJernej%26aufirst%3DB.%26atitle%3DHyperserotonemia%2520in%2520adults%2520with%2520autistic%2520disorder%26jtitle%3DJ.%2520Autism%2520Dev.%2520Disord.%26date%3D2007%26volume%3D37%26spage%3D1934%26epage%3D1940%26doi%3D10.1007%2Fs10803-006-0324-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Coutinho, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgadinho, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macedo, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bento, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marques, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ataíde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borges, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente, A. M.</span><span> </span><span class="NLM_article-title">Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">264</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span><span class="refDoi"> DOI: 10.1038/sj.mp.4001409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fsj.mp.4001409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=15094787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhvFCmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=264-271&author=A.+M.+Coutinhoauthor=G.+Oliveiraauthor=T.+Morgadinhoauthor=C.+Feselauthor=T.+R.+Macedoauthor=C.+Bentoauthor=C.+Marquesauthor=A.+Ata%C3%ADdeauthor=T.+Miguelauthor=L.+Borgesauthor=A.+M.+Vicente&title=Variants+of+the+serotonin+transporter+gene+%28SLC6A4%29+significantly+contribute+to+hyperserotonemia+in+autism&doi=10.1038%2Fsj.mp.4001409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism</span></div><div class="casAuthors">Coutinho, A. M.; Oliveira, G.; Morgadinho, T.; Fesel, C.; Macedo, T. R.; Bento, C.; Marques, C.; Ataide, A.; Miguel, T.; Borges, L.; Vicente, A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">264-271</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The role of the serotonin system in the etiol. and pathogenesis of autism spectrum disorders (ASD) is not clearly defined.  High levels of platelet serotonin (5-HT) have been consistently found in a proportion of patients, and it is known that specific 5-HT transporter gene (SLC6A4) variants modulate transporter reuptake function, therefore possibly influencing the occurrence of hyperserotonemia in a subset of autistic patients.  We have examd. the assocn. of platelet serotonin levels with two SLC6A4 polymorphisms, 5-HTT gene-linked polymorphic region (HTTLPR) in the promoter and intron 2 variable no. of tandem repeats (VNTR), in a sample of 105 ASD patients, their parents, and 52 control children.  Quant. transmission disequil. test (QTDT) results showed a significant effect on 5-HT levels of each SLC6A4 marker (P=0.017 for HTTLPR; P=0.047 for intron 2 VNTR) and of haplotypes of the two markers (P=0.017), with a major contribution of the L.Stin2.10 haplotype (P=0.0013).  A 5-HT mean value in the range of hyperserotonemia was assocd. with the homozygous L.Stin2.10 haplotype (H (1,N=97)=7.76, P=0.0054), which occurred in 33% of hyperserotonemic patients against 6% of patients with normal 5-HT levels (Fisher's exact test: P=0.013, OR=8).  Allele interaction at the HTTLPR locus was found, with a significant dominance variance effect on 5-HT levels.  We found no transmission disequil. of any of the SLC6A4 variants in ASD.  Our results show that the SLC6A4 gene is a significant factor in the detn. of 5-HT levels, and that specific SLC6A4 variants are assocd. with an increased risk for hyperserotonemia in our sample of autistic patients.  The biol. mechanism, however, is unlikely to involve the SLC6A4 gene solely.  The assocd. SLC6A4 alleles likely interact with other genes or environmental factors to produce the abnormally high 5-HT levels obsd. in this subset of autistic patients, who possibly represent a sep. etiol. group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCI_1tmZTIHrVg90H21EOLACvtfcHk0ljFi6hAY3BeVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhvFCmsLs%253D&md5=5b856dd5aa3dd5d102e842f802cacb43</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4001409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4001409%26sid%3Dliteratum%253Aachs%26aulast%3DCoutinho%26aufirst%3DA.%2BM.%26aulast%3DOliveira%26aufirst%3DG.%26aulast%3DMorgadinho%26aufirst%3DT.%26aulast%3DFesel%26aufirst%3DC.%26aulast%3DMacedo%26aufirst%3DT.%2BR.%26aulast%3DBento%26aufirst%3DC.%26aulast%3DMarques%26aufirst%3DC.%26aulast%3DAta%25C3%25ADde%26aufirst%3DA.%26aulast%3DMiguel%26aufirst%3DT.%26aulast%3DBorges%26aufirst%3DL.%26aulast%3DVicente%26aufirst%3DA.%2BM.%26atitle%3DVariants%2520of%2520the%2520serotonin%2520transporter%2520gene%2520%2528SLC6A4%2529%2520significantly%2520contribute%2520to%2520hyperserotonemia%2520in%2520autism%26jtitle%3DMol.%2520Psychiatry%26date%3D2004%26volume%3D9%26spage%3D264%26epage%3D271%26doi%3D10.1038%2Fsj.mp.4001409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Cohen, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, J. J. A.</span><span> </span><span class="NLM_article-title">Association of autism severity with a monoamine oxidase A functional polymorphism</span> <span class="citation_source-journal">Clin. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">190</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span><span class="refDoi"> DOI: 10.1034/j.1399-0004.2003.00115.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1034%2Fj.1399-0004.2003.00115.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=12919132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD3svjslKguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=190-197&author=I.+L.+Cohenauthor=X.+Liuauthor=C.+Schutzauthor=B.+N.+Whiteauthor=E.+C.+Jenkinsauthor=W.+T.+Brownauthor=J.+J.+A.+Holden&title=Association+of+autism+severity+with+a+monoamine+oxidase+A+functional+polymorphism&doi=10.1034%2Fj.1399-0004.2003.00115.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Association of autism severity with a monoamine oxidase A functional polymorphism</span></div><div class="casAuthors">Cohen I L; Liu X; Schutz C; White B N; Jenkins E C; Brown W T; Holden J J A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">190-7</span>
        ISSN:<span class="NLM_cas:issn">0009-9163</span>.
    </div><div class="casAbstract">A functional polymorphism (the upstream variable-number tandem repeat region, or uVNTR) in the monoamine oxidase A (MAOA) promoter region has been reported to be associated with behavioral abnormalities as well as increased serotonergic responsivity.  We examined the relation between MAOA-uVNTR alleles and the phenotypic expression of autism in 41 males younger than 12.6 years of age.  Children with the low-activity MAOA allele had both lower intelligence quotients (IQ) and more severe autistic behavior than children with the high-activity allele.  In follow-up testing of 34 of the males at the 1-year time-point, those with the low-activity allele showed a worsening in IQ but no change in the severity of their autistic behavior.  We conclude that functional MAOA-uVNTR alleles may act as a genetic modifier of the severity of autism in males.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJ4SHrV34LGRKDYG3bNImrfW6udTcc2eYLFs57chjtFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svjslKguw%253D%253D&md5=d50e6699e788316019d483ca9924ea7e</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1034%2Fj.1399-0004.2003.00115.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1399-0004.2003.00115.x%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DI.%2BL.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSchutz%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DB.%2BN.%26aulast%3DJenkins%26aufirst%3DE.%2BC.%26aulast%3DBrown%26aufirst%3DW.%2BT.%26aulast%3DHolden%26aufirst%3DJ.%2BJ.%2BA.%26atitle%3DAssociation%2520of%2520autism%2520severity%2520with%2520a%2520monoamine%2520oxidase%2520A%2520functional%2520polymorphism%26jtitle%3DClin.%2520Genet.%26date%3D2003%26volume%3D64%26spage%3D190%26epage%3D197%26doi%3D10.1034%2Fj.1399-0004.2003.00115.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Veenstra-VanderWeele, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannangatti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carneiro, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawley, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders-Bush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramamoorthy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daws, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutcliffe, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span> </span><span class="NLM_article-title">Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">5469</span><span class="NLM_x">–</span> <span class="NLM_lpage">5474</span><span class="refDoi"> DOI: 10.1073/pnas.1112345109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.1112345109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22431635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslOjsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=5469-5474&author=J.+Veenstra-VanderWeeleauthor=C.+L.+Mullerauthor=H.+Iwamotoauthor=J.+E.+Sauerauthor=W.+A.+Owensauthor=C.+R.+Shahauthor=J.+Cohenauthor=P.+Mannangattiauthor=T.+Jessenauthor=B.+J.+Thompsonauthor=R.+Yeauthor=T.+M.+Kerrauthor=A.+M.+Carneiroauthor=J.+N.+Crawleyauthor=E.+Sanders-Bushauthor=D.+G.+McMahonauthor=S.+Ramamoorthyauthor=L.+C.+Dawsauthor=J.+S.+Sutcliffeauthor=R.+D.+Blakely&title=Autism+gene+variant+causes+hyperserotonemia%2C+serotonin+receptor+hypersensitivity%2C+social+impairment+and+repetitive+behavior&doi=10.1073%2Fpnas.1112345109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior</span></div><div class="casAuthors">Veenstra-Vanderweele, Jeremy; Muller, Christopher L.; Iwamoto, Hideki; Sauer, Jennifer E.; Owens, W. Anthony; Shah, Charisma R.; Cohen, Jordan; Mannangatti, Padmanabhan; Jessen, Tammy; Thompson, Brent J.; Ye, Ran; Kerr, Travis M.; Carneiro, Ana M.; Crawley, Jacqueline N.; Sanders-Bush, Elaine; McMahon, Douglas G.; Ramamoorthy, Sammanda; Daws, Lynette C.; Sutcliffe, James S.; Blakely, Randy D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5469-5474, S5469/1-S5469/9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Fifty years ago, increased whole-blood serotonin levels, or hyperserotonemia, first linked disrupted 5-HT homeostasis to Autism Spectrum Disorders (ASDs).  The 5-HT transporter (SERT) gene (SLC6A4) was assocd. with whole blood 5-HT levels and ASD susceptibility.  Previously, we identified multiple gain-of-function SERT coding variants in children with ASD.  Here we establish that transgenic mice expressing the most common of these variants, SERT Ala56, exhibit elevated, p38 MAPK-dependent transporter phosphorylation, enhanced 5-HT clearance rates and hyperserotonemia.  These effects are accompanied by altered basal firing of raphe 5-HT neurons, as well as 5HT1A and 5HT2A receptor hypersensitivity.  Strikingly, SERT Ala56 mice display alterations in social function, communication, and repetitive behavior.  Our efforts provide strong support for the hypothesis that altered 5-HT homeostasis can impact risk for ASD traits and provide a model with construct and face validity that can support further anal. of ASD mechanisms and potentially novel treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqVZ2XOarfFrVg90H21EOLACvtfcHk0lhWPp9iAfixSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslOjsbY%253D&md5=28c4378da3e1dfef11efbe786b5af66e</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1112345109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1112345109%26sid%3Dliteratum%253Aachs%26aulast%3DVeenstra-VanderWeele%26aufirst%3DJ.%26aulast%3DMuller%26aufirst%3DC.%2BL.%26aulast%3DIwamoto%26aufirst%3DH.%26aulast%3DSauer%26aufirst%3DJ.%2BE.%26aulast%3DOwens%26aufirst%3DW.%2BA.%26aulast%3DShah%26aufirst%3DC.%2BR.%26aulast%3DCohen%26aufirst%3DJ.%26aulast%3DMannangatti%26aufirst%3DP.%26aulast%3DJessen%26aufirst%3DT.%26aulast%3DThompson%26aufirst%3DB.%2BJ.%26aulast%3DYe%26aufirst%3DR.%26aulast%3DKerr%26aufirst%3DT.%2BM.%26aulast%3DCarneiro%26aufirst%3DA.%2BM.%26aulast%3DCrawley%26aufirst%3DJ.%2BN.%26aulast%3DSanders-Bush%26aufirst%3DE.%26aulast%3DMcMahon%26aufirst%3DD.%2BG.%26aulast%3DRamamoorthy%26aufirst%3DS.%26aulast%3DDaws%26aufirst%3DL.%2BC.%26aulast%3DSutcliffe%26aufirst%3DJ.%2BS.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26atitle%3DAutism%2520gene%2520variant%2520causes%2520hyperserotonemia%252C%2520serotonin%2520receptor%2520hypersensitivity%252C%2520social%2520impairment%2520and%2520repetitive%2520behavior%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D5469%26epage%3D5474%26doi%3D10.1073%2Fpnas.1112345109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Bortolato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godar, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzghoul, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darling, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellman, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, J. C.</span><span> </span><span class="NLM_article-title">Monoamine oxidase A and A/B knockout mice display autistic-like features</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span><span class="refDoi"> DOI: 10.1017/S1461145712000715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1017%2FS1461145712000715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22850464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvFOisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=869-888&author=M.+Bortolatoauthor=S.+C.+Godarauthor=L.+Alzghoulauthor=J.+Zhangauthor=R.+D.+Darlingauthor=K.+L.+Simpsonauthor=V.+Biniauthor=K.+Chenauthor=C.+L.+Wellmanauthor=R.+C.+Linauthor=J.+C.+Shih&title=Monoamine+oxidase+A+and+A%2FB+knockout+mice+display+autistic-like+features&doi=10.1017%2FS1461145712000715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine oxidase A and A/B knockout mice display autistic-like features</span></div><div class="casAuthors">Bortolato, Marco; Godar, Sean C.; Alzghoul, Loai; Zhang, Junlin; Darling, Ryan D.; Simpson, Kimberly L.; Bini, Valentina; Chen, Kevin; Wellman, Cara L.; Lin, Rick C. S.; Shih, Jean C.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">869-888</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Converging lines of evidence show that a sizable subset of autism-spectrum disorders (ASDs) is characterized by increased blood levels of serotonin (5-hydroxytryptamine, 5-HT), yet the mechanistic link between these two phenomena remains unclear.  The enzymic degrdn. of brain 5-HT is mainly mediated by monoamine oxidase (MAO)A and, in the absence of this enzyme, by its cognate isoenzyme MAOB.  MAOA and A/B knockout (KO) mice display high 5-HT levels, particularly during early developmental stages.  Here we show that both mutant lines exhibit numerous behavioral hallmarks of ASDs, such as social and communication impairments, perseverative and stereotypical responses, behavioral inflexibility, as well as subtle tactile and motor deficits.  Furthermore, both MAOA and A/B KO mice displayed neuropathol. alterations reminiscent of typical ASD features, including reduced thickness of the corpus callosum, increased dendritic arborization of pyramidal neurons in the prefrontal cortex and disrupted microarchitecture of the cerebellum.  The severity of repetitive responses and neuropathol. aberrances was generally greater in MAOA/B KO animals.  These findings suggest that the neurochem. imbalances induced by MAOA deficiency (either by itself or in conjunction with lack of MAOB) may result in an array of abnormalities similar to those obsd. in ASDs.  Thus, MAOA and A/B KO mice may afford valuable models to help elucidate the neurobiol. bases of these disorders and related neurodevelopmental problems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_vfDwK0U56rVg90H21EOLACvtfcHk0lhWPp9iAfixSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvFOisL8%253D&md5=f5cb41b10049afdd6113ac3c4c61c4ce</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1017%2FS1461145712000715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145712000715%26sid%3Dliteratum%253Aachs%26aulast%3DBortolato%26aufirst%3DM.%26aulast%3DGodar%26aufirst%3DS.%2BC.%26aulast%3DAlzghoul%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDarling%26aufirst%3DR.%2BD.%26aulast%3DSimpson%26aufirst%3DK.%2BL.%26aulast%3DBini%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DWellman%26aufirst%3DC.%2BL.%26aulast%3DLin%26aufirst%3DR.%2BC.%26aulast%3DShih%26aufirst%3DJ.%2BC.%26atitle%3DMonoamine%2520oxidase%2520A%2520and%2520A%252FB%2520knockout%2520mice%2520display%2520autistic-like%2520features%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2013%26volume%3D16%26spage%3D869%26epage%3D888%26doi%3D10.1017%2FS1461145712000715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Muller, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anacker, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veenstra-VanderWeele, J.</span><span> </span><span class="NLM_article-title">The serotonin system in autism spectrum disorder: from biomarker to animal models</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2015.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuroscience.2015.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26577932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVChsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2016&pages=24-41&author=C.+L.+Mullerauthor=A.+M.+Anackerauthor=J.+Veenstra-VanderWeele&title=The+serotonin+system+in+autism+spectrum+disorder%3A+from+biomarker+to+animal+models&doi=10.1016%2Fj.neuroscience.2015.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">The serotonin system in autism spectrum disorder: From biomarker to animal models</span></div><div class="casAuthors">Muller, C. L.; Anacker, A. M. J.; Veenstra-VanderWeele, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-41</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Elevated whole blood serotonin, or hyperserotonemia, was the first biomarker identified in autism spectrum disorder (ASD) and is present in more than 25% of affected children.  The serotonin system is a logical candidate for involvement in ASD due to its pleiotropic role across multiple brain systems both dynamically and across development.  Tantalizing clues connect this peripheral biomarker with changes in brain and behavior in ASD, but the contribution of the serotonin system to ASD pathophysiol. remains incompletely understood.  Studies of whole blood serotonin levels in ASD and in a large founder population indicate greater heritability than for the disorder itself and suggest an assocn. with recurrence risk.  Emerging data from both neuroimaging and postmortem samples also indicate changes in the brain serotonin system in ASD.  Genetic linkage and assocn. studies of both whole blood serotonin levels and of ASD risk point to the chromosomal region contg. the serotonin transporter (SERT) gene in males but not in females.  In ASD families with evidence of linkage to this region, multiple rare SERT amino acid variants lead to a convergent increase in serotonin uptake in cell models.  A knock-in mouse model of one of these variants, SERT Gly56Ala, recapitulates the hyperserotonemia biomarker and shows increased brain serotonin clearance, increased serotonin receptor sensitivity, and altered social, communication, and repetitive behaviors.  Data from other rodent models also suggest an important role for the serotonin system in social behavior, in cognitive flexibility, and in sensory development.  Recent work indicates that reciprocal interactions between serotonin and other systems, such as oxytocin, may be particularly important for social behavior.  Collectively, these data point to the serotonin system as a prime candidate for treatment development in a subgroup of children defined by a robust, heritable biomarker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHmqEwuDqonbVg90H21EOLACvtfcHk0lidMHY2ytsi_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVChsbzI&md5=c63627331693d2b166a433571ad88a17</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2015.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2015.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DC.%2BL.%26aulast%3DAnacker%26aufirst%3DA.%2BM.%26aulast%3DVeenstra-VanderWeele%26aufirst%3DJ.%26atitle%3DThe%2520serotonin%2520system%2520in%2520autism%2520spectrum%2520disorder%253A%2520from%2520biomarker%2520to%2520animal%2520models%26jtitle%3DNeuroscience%26date%3D2016%26volume%3D321%26spage%3D24%26epage%3D41%26doi%3D10.1016%2Fj.neuroscience.2015.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Williams, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brignell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silove, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazell, P.</span><span> </span><span class="NLM_article-title">Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD004677</span><span class="refDoi"> DOI: 10.1002/14651858.CD004677.pub3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2F14651858.CD004677.pub3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=CD004677&author=K.+Williamsauthor=A.+Brignellauthor=M.+Randallauthor=N.+Siloveauthor=P.+Hazell&title=Selective+serotonin+reuptake+inhibitors+%28SSRIs%29+for+autism+spectrum+disorders+%28ASD%29&doi=10.1002%2F14651858.CD004677.pub3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1002%2F14651858.CD004677.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F14651858.CD004677.pub3%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DBrignell%26aufirst%3DA.%26aulast%3DRandall%26aufirst%3DM.%26aulast%3DSilove%26aufirst%3DN.%26aulast%3DHazell%26aufirst%3DP.%26atitle%3DSelective%2520serotonin%2520reuptake%2520inhibitors%2520%2528SSRIs%2529%2520for%2520autism%2520spectrum%2520disorders%2520%2528ASD%2529%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2013%26spage%3DCD004677%26doi%3D10.1002%2F14651858.CD004677.pub3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Hollander, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soorya, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anagnostou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferretti, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasserman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settipani, C.</span><span> </span><span class="NLM_article-title">A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span><span class="refDoi"> DOI: 10.1176/appi.ajp.2011.10050764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1176%2Fappi.ajp.2011.10050764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22193531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC383pvFCnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2012&pages=292-299&author=E.+Hollanderauthor=L.+Sooryaauthor=W.+Chaplinauthor=E.+Anagnostouauthor=B.+P.+Taylorauthor=C.+J.+Ferrettiauthor=S.+Wassermanauthor=E.+Swansonauthor=C.+Settipani&title=A+double-blind+placebo-controlled+trial+of+fluoxetine+for+repetitive+behaviors+and+global+severity+in+adult+autism+spectrum+disorders&doi=10.1176%2Fappi.ajp.2011.10050764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders</span></div><div class="casAuthors">Hollander Eric; Soorya Latha; Chaplin William; Anagnostou Evdokia; Taylor Bonnie P; Ferretti Casara J; Wasserman Stacey; Swanson Erika; Settipani Cara</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">292-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  The effects of fluoxetine and placebo on repetitive behaviors and global severity were compared in adults with autism spectrum disorders (ASDs).  METHOD:  Adults with ASDs were enrolled in a 12-week double-blind placebo-controlled fluoxetine trial.  Thirty-seven were randomly assigned to fluoxetine (N=22) or placebo (N=15).  Dosage followed a fixed schedule, starting at 10 mg/day and increasing as tolerated up to 80 mg/day.  Repetitive behaviors were measured with the compulsion subscale of the Yale-Brown Obsessive Compulsive Scale; the Clinical Global Impression (CGI) improvement scale was used to rate improvement in obsessive-compulsive symptoms and overall severity.  RESULTS:  There was a significant treatment-by-time interaction indicating a significantly greater reduction in repetitive behaviors across time for fluoxetine than for placebo.  With overall response defined as a CGI global improvement score of 2 or less, there were significantly more responders at week 12 in the fluoxetine group than in the placebo group.  The risk ratio was 1.5 for CGI global improvement (responders: fluoxetine, 35%; placebo, 0%) and 1.8 for CGI-rated improvement in obsessive-compulsive symptoms (responders: fluoxetine, 50%; placebo, 8%).  Only mild and moderate side effects were observed.  CONCLUSIONS:  Fluoxetine treatment, compared to placebo, resulted in significantly greater improvement in repetitive behaviors, according to both the Yale-Brown compulsion subscale and CGI rating of obsessive-compulsive symptoms, as well as on the CGI overall improvement rating.  Fluoxetine appeared to be well tolerated.  These findings stand in contrast to findings in a trial of citalopram for childhood autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6wMPYGfAiJTAEfvC7EH1LfW6udTcc2eabzQB3RUt-Prntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383pvFCnsA%253D%253D&md5=027bc4110863f52a9b8356c66413c315</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2011.10050764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2011.10050764%26sid%3Dliteratum%253Aachs%26aulast%3DHollander%26aufirst%3DE.%26aulast%3DSoorya%26aufirst%3DL.%26aulast%3DChaplin%26aufirst%3DW.%26aulast%3DAnagnostou%26aufirst%3DE.%26aulast%3DTaylor%26aufirst%3DB.%2BP.%26aulast%3DFerretti%26aufirst%3DC.%2BJ.%26aulast%3DWasserman%26aufirst%3DS.%26aulast%3DSwanson%26aufirst%3DE.%26aulast%3DSettipani%26aufirst%3DC.%26atitle%3DA%2520double-blind%2520placebo-controlled%2520trial%2520of%2520fluoxetine%2520for%2520repetitive%2520behaviors%2520and%2520global%2520severity%2520in%2520adult%2520autism%2520spectrum%2520disorders%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2012%26volume%3D169%26spage%3D292%26epage%3D299%26doi%3D10.1176%2Fappi.ajp.2011.10050764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Chugani, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chugani, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiznitzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parikh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nass, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janisse, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon-Thomas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothermel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzik, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirtz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivaswamy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhilber, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roeder, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katusin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supula, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halverson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guy, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gjolaj, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakraborty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigeluk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosqueda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeBoard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majkowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolinski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naguib, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe-Christensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQueeney, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubinlicht, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zacharski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumer, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toltzis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalic, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosolowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banchy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlake, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabro, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tacket, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adkins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchheit, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepper, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speicher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frohnapfel, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browning, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreischer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blubaugh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garver, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merryman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherrod, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perryman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorduy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angkustsiri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plumer, L.B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siy Leigh, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacalman, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roa, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Govindappa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahajan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bickel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brule, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hare, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarwary, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cargill, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steindorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrykowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Root, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanzel, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwilling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellatly, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oberfield, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedland, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coimbre, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posey, D.</span><span> </span><span class="NLM_article-title">Efficacy of low-dose buspirone for restricted and repetitive behavior in young children with autism spectrum disorder: a randomized trial</span> <span class="citation_source-journal">J. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1016/j.jpeds.2015.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.jpeds.2015.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26746121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28Xis12lsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2016&pages=45-53&author=D.+C.+Chuganiauthor=H.+T.+Chuganiauthor=M.+Wiznitzerauthor=S.+Parikhauthor=P.+A.+Evansauthor=R.+L.+Hansenauthor=R.+Nassauthor=J.+J.+Janisseauthor=P.+Dixon-Thomasauthor=M.+Behenauthor=R.+Rothermelauthor=J.+S.+Parkerauthor=A.+Kumarauthor=O.+Muzikauthor=D.+J.+Edwardsauthor=D.+Hirtzauthor=H.+Jiangauthor=L.+Sivaswamyauthor=G.+Steinhilberauthor=K.+Kennedyauthor=K.+Pawlikauthor=R.+Roederauthor=M.+Malianauthor=H.+Turnerauthor=A.+Hannaauthor=J.+Katusinauthor=D.+Supulaauthor=S.+Halversonauthor=W.+Guyauthor=N.+Gjolajauthor=T.+Mangnerauthor=P.+Chakrabortyauthor=A.+Wigelukauthor=G.+Pattersonauthor=A.+Mosquedaauthor=M.+Burkettauthor=A.+DeBoardauthor=J.+Cornettauthor=M.-L.+Leeauthor=X.+Luauthor=C.+Germainauthor=M.+Majkowskiauthor=B.+Frenchauthor=A.+Stolinskiauthor=S.+Naguibauthor=C.+Wolfe-Christensenauthor=S.+Taylorauthor=J.+Ameliauthor=J.+K.+McQueeneyauthor=M.+Rubinlichtauthor=B.+Gorkaauthor=E.+Zacharskiauthor=J.+L.+Blumerauthor=K.+Maxwellauthor=C.+Tasiauthor=P.+Toltzisauthor=J.+Kalicauthor=D.+Morusauthor=J.+Paulettauthor=B.+Rosolowskiauthor=M.+Banchyauthor=K.+Westlakeauthor=B.+Calabroauthor=C.+Tacketauthor=I.+Adkinsauthor=K.+Buchheitauthor=K.+Hepperauthor=D.+Speicherauthor=S.+Bergantauthor=J.+Hakyauthor=M.+B.+Frohnapfelauthor=C.+Schaeferauthor=A.+Browningauthor=R.+Bauerauthor=R.+Embacherauthor=J.+Knappauthor=S.+Levyauthor=D.+Daviesauthor=D.+Lachauthor=J.+Petrichauthor=S.+Kreischerauthor=P.+Blubaughauthor=M.+A.+Morrisauthor=C.+Garverauthor=M.+Andersenauthor=M.+Greeneauthor=A.+Richardsauthor=M.+Rochaauthor=R.+Merrymanauthor=S.+Gollaauthor=A.+Lorenzenauthor=J.+L.+Sherrodauthor=P.+Perrymanauthor=K.+Lorduyauthor=K.+Angkustsiriauthor=L.B.+Plumerauthor=M.+J.+Siy+Leighauthor=S.+C.+Bacalmanauthor=D.+L.+Roaauthor=K.+Govindappaauthor=G.+Mahajanauthor=E.+Bickelauthor=N.+Bruleauthor=E.+Hareauthor=N.+Sarwaryauthor=D.+Cargillauthor=J.+Leeauthor=S.+Homauthor=D.+Steindorfauthor=M.+Pietrykowskiauthor=K.+Rootauthor=S.+Coffeyauthor=E.+P.+Hanzelauthor=A.+Santanaauthor=C.+Ramirezauthor=S.+Berciauthor=N.+Gabrielauthor=G.+Hirschauthor=E.+Robertsauthor=A.+Zwillingauthor=R.+Gellatlyauthor=D.+Levyauthor=S.+Leeauthor=J.+Rodmanauthor=A.+Hannaauthor=N.+Oberfieldauthor=S.+Friedlandauthor=C.+Lordauthor=R.+Kozloffauthor=C.+Crouseauthor=S.+Millenauthor=A.+J.+Coimbreauthor=K.+L.+McCarterauthor=D.+Posey&title=Efficacy+of+low-dose+buspirone+for+restricted+and+repetitive+behavior+in+young+children+with+autism+spectrum+disorder%3A+a+randomized+trial&doi=10.1016%2Fj.jpeds.2015.11.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of Low-Dose Buspirone for Restricted and Repetitive Behavior in Young Children with Autism Spectrum Disorder: A Randomized Trial</span></div><div class="casAuthors">Chugani, Diane C.; Chugani, Harry T.; Wiznitzer, Max; Parikh, Sumit; Evans, Patricia A.; Hansen, Robin L.; Nass, Ruth; Janisse, James J.; Dixon-Thomas, Pamela; Behen, Michael; Rothermel, Robert; Parker, Jacqueline S.; Kumar, Ajay; Muzik, Otto; Edwards, David J.; Hirtz, Deborah</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pediatrics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">45-53.e4</span>CODEN:
                <span class="NLM_cas:coden">JOPDAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3476</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">To det. safety and efficacy of the 5HT1A serotonin partial agonist buspirone on core autism and assocd. features in children with autism spectrum disorder (ASD).  Children 2-6 years of age with ASD (N = 166) were randomized to receive placebo or 2.5 or 5.0 mg of buspirone twice daily.  The primary objective was to evaluate the effects of 24 wk of buspirone on the Autism Diagnostic Observation Schedule (ADOS) Composite Total Score.  Secondary objectives included evaluating the effects of buspirone on social competence, repetitive behaviors, language, sensory dysfunction, and anxiety and to assess side effects.  Positron emission tomog. measures of tryptophan metab. and blood serotonin concns. were assessed as predictors of buspirone efficacy.  There was no difference in the ADOS Composite Total Score between baseline and 24 wk among the 3 treatment groups (P = .400); however, the ADOS Restricted and Repetitive Behavior score showed a time-by-treatment effect (P = .006); the 2.5-mg buspirone group showed significant improvement (P = .003), whereas placebo and 5.0-mg buspirone groups showed no change.  Children in the 2.5-mg buspirone group were more likely to improve if they had fewer foci of increased brain tryptophan metab. on positron emission tomog. (P = .018) or if they showed normal levels of blood serotonin (P = .044).  Adverse events did not differ significantly among treatment groups.  Treatment with 2.5 mg of buspirone in young children with ASD might be a useful adjunct therapy to target restrictive and repetitive behaviors in conjunction with behavioral interventions.  ClinicalTrials.gov: NCT00873509.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAPUV06l84yrVg90H21EOLACvtfcHk0liUUDnRsYUtzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xis12lsQ%253D%253D&md5=ac77f3940dde32cce96b05719bbf65a9</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.jpeds.2015.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpeds.2015.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DChugani%26aufirst%3DD.%2BC.%26aulast%3DChugani%26aufirst%3DH.%2BT.%26aulast%3DWiznitzer%26aufirst%3DM.%26aulast%3DParikh%26aufirst%3DS.%26aulast%3DEvans%26aufirst%3DP.%2BA.%26aulast%3DHansen%26aufirst%3DR.%2BL.%26aulast%3DNass%26aufirst%3DR.%26aulast%3DJanisse%26aufirst%3DJ.%2BJ.%26aulast%3DDixon-Thomas%26aufirst%3DP.%26aulast%3DBehen%26aufirst%3DM.%26aulast%3DRothermel%26aufirst%3DR.%26aulast%3DParker%26aufirst%3DJ.%2BS.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DMuzik%26aufirst%3DO.%26aulast%3DEdwards%26aufirst%3DD.%2BJ.%26aulast%3DHirtz%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DSivaswamy%26aufirst%3DL.%26aulast%3DSteinhilber%26aufirst%3DG.%26aulast%3DKennedy%26aufirst%3DK.%26aulast%3DPawlik%26aufirst%3DK.%26aulast%3DRoeder%26aufirst%3DR.%26aulast%3DMalian%26aufirst%3DM.%26aulast%3DTurner%26aufirst%3DH.%26aulast%3DHanna%26aufirst%3DA.%26aulast%3DKatusin%26aufirst%3DJ.%26aulast%3DSupula%26aufirst%3DD.%26aulast%3DHalverson%26aufirst%3DS.%26aulast%3DGuy%26aufirst%3DW.%26aulast%3DGjolaj%26aufirst%3DN.%26aulast%3DMangner%26aufirst%3DT.%26aulast%3DChakraborty%26aufirst%3DP.%26aulast%3DWigeluk%26aufirst%3DA.%26aulast%3DPatterson%26aufirst%3DG.%26aulast%3DMosqueda%26aufirst%3DA.%26aulast%3DBurkett%26aufirst%3DM.%26aulast%3DDeBoard%26aufirst%3DA.%26aulast%3DCornett%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.-L.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DGermain%26aufirst%3DC.%26aulast%3DMajkowski%26aufirst%3DM.%26aulast%3DFrench%26aufirst%3DB.%26aulast%3DStolinski%26aufirst%3DA.%26aulast%3DNaguib%26aufirst%3DS.%26aulast%3DWolfe-Christensen%26aufirst%3DC.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DAmeli%26aufirst%3DJ.%26aulast%3DMcQueeney%26aufirst%3DJ.%2BK.%26aulast%3DRubinlicht%26aufirst%3DM.%26aulast%3DGorka%26aufirst%3DB.%26aulast%3DZacharski%26aufirst%3DE.%26aulast%3DBlumer%26aufirst%3DJ.%2BL.%26aulast%3DMaxwell%26aufirst%3DK.%26aulast%3DTasi%26aufirst%3DC.%26aulast%3DToltzis%26aufirst%3DP.%26aulast%3DKalic%26aufirst%3DJ.%26aulast%3DMorus%26aufirst%3DD.%26aulast%3DPaulett%26aufirst%3DJ.%26aulast%3DRosolowski%26aufirst%3DB.%26aulast%3DBanchy%26aufirst%3DM.%26aulast%3DWestlake%26aufirst%3DK.%26aulast%3DCalabro%26aufirst%3DB.%26aulast%3DTacket%26aufirst%3DC.%26aulast%3DAdkins%26aufirst%3DI.%26aulast%3DBuchheit%26aufirst%3DK.%26aulast%3DHepper%26aufirst%3DK.%26aulast%3DSpeicher%26aufirst%3DD.%26aulast%3DBergant%26aufirst%3DS.%26aulast%3DHaky%26aufirst%3DJ.%26aulast%3DFrohnapfel%26aufirst%3DM.%2BB.%26aulast%3DSchaefer%26aufirst%3DC.%26aulast%3DBrowning%26aufirst%3DA.%26aulast%3DBauer%26aufirst%3DR.%26aulast%3DEmbacher%26aufirst%3DR.%26aulast%3DKnapp%26aufirst%3DJ.%26aulast%3DLevy%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DD.%26aulast%3DLach%26aufirst%3DD.%26aulast%3DPetrich%26aufirst%3DJ.%26aulast%3DKreischer%26aufirst%3DS.%26aulast%3DBlubaugh%26aufirst%3DP.%26aulast%3DMorris%26aufirst%3DM.%2BA.%26aulast%3DGarver%26aufirst%3DC.%26aulast%3DAndersen%26aufirst%3DM.%26aulast%3DGreene%26aufirst%3DM.%26aulast%3DRichards%26aufirst%3DA.%26aulast%3DRocha%26aufirst%3DM.%26aulast%3DMerryman%26aufirst%3DR.%26aulast%3DGolla%26aufirst%3DS.%26aulast%3DLorenzen%26aufirst%3DA.%26aulast%3DSherrod%26aufirst%3DJ.%2BL.%26aulast%3DPerryman%26aufirst%3DP.%26aulast%3DLorduy%26aufirst%3DK.%26aulast%3DAngkustsiri%26aufirst%3DK.%26aulast%3DPlumer%26aufirst%3DL.B.%26aulast%3DSiy%2BLeigh%26aufirst%3DM.%2BJ.%26aulast%3DBacalman%26aufirst%3DS.%2BC.%26aulast%3DRoa%26aufirst%3DD.%2BL.%26aulast%3DGovindappa%26aufirst%3DK.%26aulast%3DMahajan%26aufirst%3DG.%26aulast%3DBickel%26aufirst%3DE.%26aulast%3DBrule%26aufirst%3DN.%26aulast%3DHare%26aufirst%3DE.%26aulast%3DSarwary%26aufirst%3DN.%26aulast%3DCargill%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DHom%26aufirst%3DS.%26aulast%3DSteindorf%26aufirst%3DD.%26aulast%3DPietrykowski%26aufirst%3DM.%26aulast%3DRoot%26aufirst%3DK.%26aulast%3DCoffey%26aufirst%3DS.%26aulast%3DHanzel%26aufirst%3DE.%2BP.%26aulast%3DSantana%26aufirst%3DA.%26aulast%3DRamirez%26aufirst%3DC.%26aulast%3DBerci%26aufirst%3DS.%26aulast%3DGabriel%26aufirst%3DN.%26aulast%3DHirsch%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DZwilling%26aufirst%3DA.%26aulast%3DGellatly%26aufirst%3DR.%26aulast%3DLevy%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DRodman%26aufirst%3DJ.%26aulast%3DHanna%26aufirst%3DA.%26aulast%3DOberfield%26aufirst%3DN.%26aulast%3DFriedland%26aufirst%3DS.%26aulast%3DLord%26aufirst%3DC.%26aulast%3DKozloff%26aufirst%3DR.%26aulast%3DCrouse%26aufirst%3DC.%26aulast%3DMillen%26aufirst%3DS.%26aulast%3DCoimbre%26aufirst%3DA.%2BJ.%26aulast%3DMcCarter%26aufirst%3DK.%2BL.%26aulast%3DPosey%26aufirst%3DD.%26atitle%3DEfficacy%2520of%2520low-dose%2520buspirone%2520for%2520restricted%2520and%2520repetitive%2520behavior%2520in%2520young%2520children%2520with%2520autism%2520spectrum%2520disorder%253A%2520a%2520randomized%2520trial%26jtitle%3DJ.%2520Pediatr.%26date%3D2016%26volume%3D170%26spage%3D45%26epage%3D53%26doi%3D10.1016%2Fj.jpeds.2015.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Gould, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hensler, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benno, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onaivi, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daws, L. C.</span><span> </span><span class="NLM_article-title">Density and function of central serotonin (5-HT) transporters, 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span><span class="refDoi"> DOI: 10.1111/j.1471-4159.2010.07104.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1111%2Fj.1471-4159.2010.07104.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21070242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2011&pages=291-303&author=G.+G.+Gouldauthor=J.+G.+Henslerauthor=T.+F.+Burkeauthor=R.+H.+Bennoauthor=E.+S.+Onaiviauthor=L.+C.+Daws&title=Density+and+function+of+central+serotonin+%285-HT%29+transporters%2C+5-HT1A+and+5-HT2A+receptors%2C+and+effects+of+their+targeting+on+BTBR+T%2Btf%2FJ+mouse+social+behavior&doi=10.1111%2Fj.1471-4159.2010.07104.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior</span></div><div class="casAuthors">Gould, Georgianna G.; Hensler, Julie G.; Burke, Teresa F.; Benno, Robert H.; Onaivi, Emmanuel S.; Daws, Lynette C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">291-303</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">BTBR mice are potentially useful tools for autism research because their behavior parallels core social interaction impairments and restricted-repetitive behaviors.  Altered regulation of central serotonin (5-HT) neurotransmission may underlie such behavioral deficits.  To test this, we compared 5-HT transporter (SERT), 5-HT1A and 5-HT2A receptor densities among BTBR and C57 strains.  Autoradiog. [3H] cyanoimipramine (1 nM) binding to SERT was 20-30% lower throughout the adult BTBR brain as compared to C57BL/10J mice.  In hippocampal membrane homogenates, [3H] citalopram maximal binding (Bmax) to SERT was 95 fmol/mg protein in BTBR and 171 fmol/mg protein in C57BL/6J mice, and the BTBR dissocn. const. (KD) was 2.0 nM vs. 1.1 in C57BL/6J mice.  Hippocampal 5-HT1A and 5-HT2A receptor binding was similar among strains.  However, 8-OH-DPAT-stimulated [35S] GTPγS binding in the BTBR hippocampal CA1 region was 28% higher, indicating elevated 5-HT1A capacity to activate G-proteins.  In BTBR mice, the SERT blocker, fluoxetine (10 mg/kg) and the 5-HT1A receptor partial-agonist, buspirone (2 mg/kg) enhanced social interactions.  The D2/5-HT2 receptor antagonist, risperidone (0.1 mg/kg) reduced marble burying, but failed to improve sociability.  Overall, altered SERT and/or 5-HT1A functionality in hippocampus could contribute to the relatively low sociability of BTBR mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7g_18Lb-yXbVg90H21EOLACvtfcHk0ljB-9DY3sUwLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGqtbc%253D&md5=fe417d31e44b476c2789fa4371fbbc47</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2010.07104.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2010.07104.x%26sid%3Dliteratum%253Aachs%26aulast%3DGould%26aufirst%3DG.%2BG.%26aulast%3DHensler%26aufirst%3DJ.%2BG.%26aulast%3DBurke%26aufirst%3DT.%2BF.%26aulast%3DBenno%26aufirst%3DR.%2BH.%26aulast%3DOnaivi%26aufirst%3DE.%2BS.%26aulast%3DDaws%26aufirst%3DL.%2BC.%26atitle%3DDensity%2520and%2520function%2520of%2520central%2520serotonin%2520%25285-HT%2529%2520transporters%252C%25205-HT1A%2520and%25205-HT2A%2520receptors%252C%2520and%2520effects%2520of%2520their%2520targeting%2520on%2520BTBR%2520T%252Btf%252FJ%2520mouse%2520social%2520behavior%26jtitle%3DJ.%2520Neurochem.%26date%3D2011%26volume%3D116%26spage%3D291%26epage%3D303%26doi%3D10.1111%2Fj.1471-4159.2010.07104.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Chadman, K. K.</span><span> </span><span class="NLM_article-title">Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">586</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span><span class="refDoi"> DOI: 10.1016/j.pbb.2010.09.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.pbb.2010.09.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20863848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGgsrjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2011&pages=586-594&author=K.+K.+Chadman&title=Fluoxetine+but+not+risperidone+increases+sociability+in+the+BTBR+mouse+model+of+autism&doi=10.1016%2Fj.pbb.2010.09.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism</span></div><div class="casAuthors">Chadman, Kathryn K.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology, Biochemistry and Behavior</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">586-594</span>CODEN:
                <span class="NLM_cas:coden">PBBHAU</span>;
        ISSN:<span class="NLM_cas:issn">0091-3057</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Autism, a neurodevelopmental disorder, is characterized by abnormal social interactions, impaired social communication and repetitive behaviors and/or restricted interests, along with several assocd. symptoms including irritability and anxiety.  Risperidone is approved for the irritability and self-injurious behaviors found in autism.  Fluoxetine is under evaluation for the repetitive behaviors and anxiety assocd. with autism.  These two drugs were evaluated in the BTBR T + tf/J (BTBR) mouse model of autism and C57BL/6J (B6) mice by using the three-chambered social approach test and elevated plus maze to det. effects on sociability and anxiety.  Fluoxetine increased sociability, defined as time spent with a stranger mouse, in the BTBR mice without affecting anxiety-like behavior in the elevated plus maze.  Fluoxetine did not significantly change either behavior in the B6 mice.  Risperidone did not affect sociability or anxiety-like behaviors and had a sedative-like effect at higher doses.  These findings suggest that fluoxetine may have some therapeutic efficacy for treating the social behaviors in autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9hPVBKhcsR7Vg90H21EOLACvtfcHk0ljB-9DY3sUwLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGgsrjL&md5=444c92fc7db9f205599b7ff10ad6e4c4</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2010.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2010.09.012%26sid%3Dliteratum%253Aachs%26aulast%3DChadman%26aufirst%3DK.%2BK.%26atitle%3DFluoxetine%2520but%2520not%2520risperidone%2520increases%2520sociability%2520in%2520the%2520BTBR%2520mouse%2520model%2520of%2520autism%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2011%26volume%3D97%26spage%3D586%26epage%3D594%26doi%3D10.1016%2Fj.pbb.2010.09.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">File, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, N.</span><span> </span><span class="NLM_article-title">Comparative study of pre- and postsynaptic 5-HT<sub>1A</sub> receptor modulation of anxiety in two ethological animal tests</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4810</span><span class="NLM_x">–</span> <span class="NLM_lpage">4815</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1523%2FJNEUROSCI.16-15-04810.1996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=8764667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADyaK28XksFWisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=4810-4815&author=S.+E.+Fileauthor=L.+E.+Gonzalezauthor=N.+Andrews&title=Comparative+study+of+pre-+and+postsynaptic+5-HT1A+receptor+modulation+of+anxiety+in+two+ethological+animal+tests"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative study of pre- and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests</span></div><div class="casAuthors">File, Sandra E.; Gonzalez, Luis E.; Andrews, Nick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4810-4815</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The purpose of this study was to det. the roles of the presynaptic 5-HT1A receptors in the median raphe nucleus (MRN) and of the postsynaptic 5-HT1A receptors in its projection area of the dorsal hippocampus in the social interaction and elevated plus-maze tests of anxiety.  Direct administration of the 5-HT1A receptor agonist (±)-8-hydroxy-dipropylaminotetralin (8-OH-DPAT, 200 ng) into the MRN had significant anxiolytic effects in all three test situations examd. (social interaction, plus-maze trials 1 and 2).  These anxiolytic effects were antagonized by a silent dose (200 ng) of the 5-HT1A receptor antagonist WAY 100635, confirming that they were mediated by 5-HT1A receptors.  In contrast, after bilateral administration to the dorsal hippocampus, 8-OH-DPAT (100 ng) had significant anxiogenic effects in the social interaction test and in plus-maze trial 2.  These anxiogenic effects were antagonized by silent doses of 5-HT1A receptor antagonists [(+)WAY 100135, 10 mg/kg s.c., and intrahippocampal (±)tertatolol, 3 μg, resp.], confirming mediation by 5-HT1A receptors.  In rats naive to the plus-maze, neither 8-OH-DPAT (50, 100, or 200 ng) nor the 5-HT1A receptor antagonist (±)tertatolol (3 μg) had any significant effect when administered to the dorsal hippocampus.  This demonstrates that previous experience of a rat in the plus-maze has a major effect on the sensitivity of dorsal hippocampal 5-HT1A receptors, as the authors have demonstrated previously for the 5-HT1A receptors in the dorsal raphe nucleus.  Overall, the results provide evidence that stimulation of the presynaptic 5-HT1A receptors in the MRN results in an anxiolytic action, whereas stimulation of the postsynaptic 5-HT1A receptors in its projection area results in an anxiogenic effect.  These results are consistent with an overall redn. in 5-HT neurotransmission in the dorsal hippocampus having an anxiolytic effect, and they explain the relatively weak anxiolytic profile detected when 5-HT1A receptor agonists are given systemically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorxA5nL19fvrVg90H21EOLACvtfcHk0liVD9s0Erwdrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XksFWisrs%253D&md5=a948423eeeec17d71ae0759c1968fc19</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.16-15-04810.1996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.16-15-04810.1996%26sid%3Dliteratum%253Aachs%26aulast%3DFile%26aufirst%3DS.%2BE.%26aulast%3DGonzalez%26aufirst%3DL.%2BE.%26aulast%3DAndrews%26aufirst%3DN.%26atitle%3DComparative%2520study%2520of%2520pre-%2520and%2520postsynaptic%25205-HT1A%2520receptor%2520modulation%2520of%2520anxiety%2520in%2520two%2520ethological%2520animal%2520tests%26jtitle%3DJ.%2520Neurosci.%26date%3D1996%26volume%3D16%26spage%3D4810%26epage%3D4815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Boulougouris, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robbins, T. W.</span><span> </span><span class="NLM_article-title">Enhancement of spatial reversal learning by 5-HT<sub>2C</sub> receptor antagonism is neuroanatomically specific</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">938</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4312-09.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1523%2FJNEUROSCI.4312-09.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20089901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC3c%252Fks1WmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=930-938&author=V.+Boulougourisauthor=T.+W.+Robbins&title=Enhancement+of+spatial+reversal+learning+by+5-HT2C+receptor+antagonism+is+neuroanatomically+specific&doi=10.1523%2FJNEUROSCI.4312-09.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of spatial reversal learning by 5-HT2C receptor antagonism is neuroanatomically specific</span></div><div class="casAuthors">Boulougouris Vasileios; Robbins Trevor W</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of neuroscience : the official journal of the Society for Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">930-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We have recently demonstrated that systemic administration of 5-HT(2C) and 5-HT(2A) receptor antagonists significantly enhanced and impaired spatial reversal learning, respectively.  In this study, the role of 5-HT(2C) and 5-HT(2A) receptor subtypes in the mediation of these opposing effects was further investigated with respect to neuroanatomical specificity.  The roles of 5-HT(2C) and 5-HT(2A) receptors were examined within some of the brain regions implicated in cognitive flexibility, namely the orbitofrontal cortex (OFC), medial prefrontal cortex (mPFC), and nucleus accumbens (NAc), by means of targeted infusions of selective 5-HT(2C) and 5-HT(2A) receptor antagonists (SB 242084 and M100907, respectively).  Intra-OFC 5-HT(2C) receptor antagonism produced dose-dependent effects similar to those of systemic administration, i.e., improved spatial reversal learning by reducing the number of trials (all doses: 0.1, 0.3, and 1.0 microg) and perseverative errors to criterion (0.3 and 1.0 microg) compared with controls.  However, the highest dose (1.0 microg) showed a nonselective effect, as it also affected retention preceding the reversal phase and decreased learning errors.  Intracerebral infusions of SB 242084 into the mPFC or NAc produced no significant effects on any behavioral measures.  Similarly, no significant differences were observed with intra-OFC, -mPFC, or -NAc infusions of M100907.  These data suggest that the improved performance in reversal learning observed after 5-HT(2C) receptor antagonism is mediated within the OFC.  These data also bear on the issue of whether 5-HT(2C) receptor antagonism within the OFC might help elucidate the biological substrate of obsessive-compulsive disorder, offering the potential for therapeutic application.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcROq2wl2Nnf8xJ5E29YNGvQfW6udTcc2eYmyE3f1yINCrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c%252Fks1WmtQ%253D%253D&md5=112e4f66f6fa39dcbdc35a6117c52e5a</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4312-09.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4312-09.2010%26sid%3Dliteratum%253Aachs%26aulast%3DBoulougouris%26aufirst%3DV.%26aulast%3DRobbins%26aufirst%3DT.%2BW.%26atitle%3DEnhancement%2520of%2520spatial%2520reversal%2520learning%2520by%25205-HT2C%2520receptor%2520antagonism%2520is%2520neuroanatomically%2520specific%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D930%26epage%3D938%26doi%3D10.1523%2FJNEUROSCI.4312-09.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Amodeo, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragozzino, M. E.</span><span> </span><span class="NLM_article-title">Risperidone and the 5-HT<sub>2A</sub> receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf/J mice</span> <span class="citation_source-journal">Autism Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span><span class="refDoi"> DOI: 10.1002/aur.1395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2Faur.1395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24894823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2cjovFajtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=555-567&author=D.+A.+Amodeoauthor=J.+H.+Jonesauthor=J.+A.+Sweeneyauthor=M.+E.+Ragozzino&title=Risperidone+and+the+5-HT2A+receptor+antagonist+M100907+improve+probabilistic+reversal+learning+in+BTBR+T+%2B+tf%2FJ+mice&doi=10.1002%2Faur.1395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf/J mice</span></div><div class="casAuthors">Amodeo Dionisio A; Jones Joshua H; Sweeney John A; Ragozzino Michael E</div><div class="citationInfo"><span class="NLM_cas:title">Autism research : official journal of the International Society for Autism Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">555-67</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impaired social interactions with restricted interests and repetitive behaviors (RRBs).  RRBs can severely limit daily living and be particularly stressful to family members.  To date, there are limited options for treating this feature in ASD.  Risperidone, an atypical antipsychotic, is approved to treat irritability in ASD, but less is known about whether it is effective in treating "higher order" RRBs, for example cognitive inflexibility.  Risperidone also has multiple receptor targets in which only a subset may be procognitive and others induce cognitive impairment. 5HT2A receptor blockade represents one promising and more targeted approach, as various preclinical studies have shown that 5HT2A receptor antagonists improve cognition.  The present study investigated whether risperidone and/or M100907, a 5HT2A receptor antagonist, improved probabilistic reversal learning performance in the BTBR T + tf/J (BTBR) mouse model of autism.  The effects of these treatments were also investigated in C57BL/6J (B6) mice as a comparison strain.  Using a spatial reversal learning test with 80/20 probabilistic feedback, similar to one in which ASD individuals exhibit impairments, both risperidone (0.125 mg) and M100907 (0.01 and 0.1 mg) improved reversal learning in BTBR mice.  Risperidone (0.125 mg) impaired reversal learning in B6 mice.  Improvement in probabilistic reversal learning performance resulted from treatments enhancing the maintenance of the newly correct choice pattern.  Because risperidone can lead to unwanted side effects, treatment with a specific 5HT2A receptor antagonist may improve cognitive flexibility in individuals with ASD while also minimizing unwanted side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcD2MeuvJF536HPRus0rAafW6udTcc2eYmyE3f1yINCrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjovFajtQ%253D%253D&md5=07b743b7a123ff77954564d2d7f7e0e2</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1002%2Faur.1395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Faur.1395%26sid%3Dliteratum%253Aachs%26aulast%3DAmodeo%26aufirst%3DD.%2BA.%26aulast%3DJones%26aufirst%3DJ.%2BH.%26aulast%3DSweeney%26aufirst%3DJ.%2BA.%26aulast%3DRagozzino%26aufirst%3DM.%2BE.%26atitle%3DRisperidone%2520and%2520the%25205-HT2A%2520receptor%2520antagonist%2520M100907%2520improve%2520probabilistic%2520reversal%2520learning%2520in%2520BTBR%2520T%2520%252B%2520tf%252FJ%2520mice%26jtitle%3DAutism%2520Res.%26date%3D2014%26volume%3D7%26spage%3D555%26epage%3D567%26doi%3D10.1002%2Faur.1395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Amodeo, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragozzino, M. E.</span><span> </span><span class="NLM_article-title">M100907 attenuates elevated grooming behavior in the BTBR mouse</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1016/j.bbr.2016.06.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bbr.2016.06.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27378338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1aisLjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2016&pages=67-70&author=D.+A.+Amodeoauthor=E.+Riveraauthor=J.+T.+Dunnauthor=M.+E.+Ragozzino&title=M100907+attenuates+elevated+grooming+behavior+in+the+BTBR+mouse&doi=10.1016%2Fj.bbr.2016.06.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">M100907 attenuates elevated grooming behavior in the BTBR mouse</span></div><div class="casAuthors">Amodeo, Dionisio A.; Rivera, Elaine; Dunn, Jeffrey T.; Ragozzino, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">67-70</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Individuals with autism spectrum disorder (ASD) exhibit social-communication deficits along with restricted interests and repetitive behaviors (RRBs).  To date, there is a lack of effective treatments to alleviate RRBs.  A recent study found that treatment with the 5HT2A receptor antagonist M100907 attenuates a reversal learning deficit in the BTBR mouse model of autism.  The BTBR mouse also exhibits elevated grooming behavior which may model stereotyped motor behaviors also obsd. in ASD.  The present study examd. whether 5HT2A receptor blockade with M100907 at either 0.01 or 0.1 mg/kg can reduce repetitive grooming in BTBR mice compared to that of vehicle-treated BTBR and C57BL6/J (B6) mice.  M100907 at 0.1 mg/kg, but not 0.01 mg/kg, significantly attenuated repetitive grooming in BTBR mice compared to that of vehicle-treated BTBR mice.  M100907 at either dose did not affect grooming behavior in B6 mice.  To det. whether 0.1 mg/kg M100907 had a more general effect on activity in BTBR mice, a second expt. detd. whether M100907 at 0.1 mg/kg affected locomotor activity in BTBR mice.  M100907 treatment in BTBR and B6 mice did not alter locomotor activity compared to that of vehicle-treated BTBR and B6 mice.  The present findings taken together with past results suggest that treatment with a 5HT2A receptor antagonist may be effective in ameliorating RRBs in ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1N0hqADZmDbVg90H21EOLACvtfcHk0likt2UwgfTXpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1aisLjP&md5=59027c99b3f84c67e7154a1b5f82c22a</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2016.06.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2016.06.064%26sid%3Dliteratum%253Aachs%26aulast%3DAmodeo%26aufirst%3DD.%2BA.%26aulast%3DRivera%26aufirst%3DE.%26aulast%3DDunn%26aufirst%3DJ.%2BT.%26aulast%3DRagozzino%26aufirst%3DM.%2BE.%26atitle%3DM100907%2520attenuates%2520elevated%2520grooming%2520behavior%2520in%2520the%2520BTBR%2520mouse%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2016%26volume%3D313%26spage%3D67%26epage%3D70%26doi%3D10.1016%2Fj.bbr.2016.06.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Amodeo, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, E. H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragozzino, M. E.</span><span> </span><span class="NLM_article-title">5-HT<sub>2A</sub> receptor blockade in dorsomedial striatum reduces repetitive behaviors in BTBR mice</span> <span class="citation_source-journal">Genes, Brain Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">351</span><span class="refDoi"> DOI: 10.1111/gbb.12343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1111%2Fgbb.12343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27717169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsFCmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=342-351&author=D.+A.+Amodeoauthor=E.+Riveraauthor=E.+H.+Cookauthor=J.+A.+Sweeneyauthor=M.+E.+Ragozzino&title=5-HT2A+receptor+blockade+in+dorsomedial+striatum+reduces+repetitive+behaviors+in+BTBR+mice&doi=10.1111%2Fgbb.12343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">5HT2A receptor blockade in dorsomedial striatum reduces repetitive behaviors in BTBR mice</span></div><div class="casAuthors">Amodeo, D. A.; Rivera, E.; Cook, E. H., Jr.; Sweeney, J. A.; Ragozzino, M. E.</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Brain and Behavior</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">342-351</span>CODEN:
                <span class="NLM_cas:coden">GBBEAO</span>;
        ISSN:<span class="NLM_cas:issn">1601-183X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Restricted and repetitive behaviors are a defining feature of autism, which can be expressed as a cognitive flexibility deficit or stereotyped, motor behaviors.  There is limited knowledge about the underlying neuropathophysiol. contributing to these behaviors.  Previous findings suggest that central 5HT2A receptor activity is altered in autism, while recent work indicates that systemic 5HT2A receptor antagonist treatment reduces repetitive behaviors in an idiopathic model of autism.  5HT2A receptors are expressed in the orbitofrontal cortex and striatum.  These two regions have been shown to be altered in autism.  The present study investigated whether 5HT2A receptor blockade in the dorsomedial striatum or orbitofrontal cortex in the BTBR mouse strain, an idiopathic model of autism, affects the phenotype related to restricted and repetitive behaviors.  Microinfusion of the 5HT2A receptor antagonist, M100907 into the dorsomedial striatum alleviated a reversal learning impairment and attenuated grooming behavior.  M100907 infusion into the orbitofrontal cortex increased perseveration during reversal learning and potentiated grooming.  These findings suggest that increased 5HT2A receptor activity in the dorsomedial striatum may contribute to behavioral inflexibility and stereotyped behaviors in the BTBR mouse.  The 5HT2A receptor signaling in the orbitofrontal cortex may be crit. for inhibiting a previously learned response during reversal learning and expression of stereotyped behavior.  The present results suggest which brain areas exhibit abnormalities underlying repetitive behaviors in an idiopathic mouse model of autism, as well as which brain areas systemic treatment with M100907 may principally act on in BTBR mice to attenuate repetitive behaviors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoLK-d9UGL8rVg90H21EOLACvtfcHk0likt2UwgfTXpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsFCmurw%253D&md5=9042e327b431566410c7ccf9a0934bab</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1111%2Fgbb.12343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fgbb.12343%26sid%3Dliteratum%253Aachs%26aulast%3DAmodeo%26aufirst%3DD.%2BA.%26aulast%3DRivera%26aufirst%3DE.%26aulast%3DCook%26aufirst%3DE.%2BH.%26aulast%3DSweeney%26aufirst%3DJ.%2BA.%26aulast%3DRagozzino%26aufirst%3DM.%2BE.%26atitle%3D5-HT2A%2520receptor%2520blockade%2520in%2520dorsomedial%2520striatum%2520reduces%2520repetitive%2520behaviors%2520in%2520BTBR%2520mice%26jtitle%3DGenes%252C%2520Brain%2520Behav.%26date%3D2017%26volume%3D16%26spage%3D342%26epage%3D351%26doi%3D10.1111%2Fgbb.12343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Kvachnina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dityatev, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumuis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dityateva, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voyno-Yasenetskaya, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponimaskin, E. G.</span><span> </span><span class="NLM_article-title">5-HT<sub>7</sub> receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">7821</span><span class="NLM_x">–</span> <span class="NLM_lpage">7830</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.1790-05.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1523%2FJNEUROSCI.1790-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=16120784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvVKgu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=7821-7830&author=E.+Kvachninaauthor=G.+Liuauthor=A.+Dityatevauthor=U.+Rennerauthor=A.+Dumuisauthor=D.+W.+Richterauthor=G.+Dityatevaauthor=M.+Schachnerauthor=T.+A.+Voyno-Yasenetskayaauthor=E.+G.+Ponimaskin&title=5-HT7+receptor+is+coupled+to+G+alpha+subunits+of+heterotrimeric+G12-protein+to+regulate+gene+transcription+and+neuronal+morphology&doi=10.1523%2FJNEUROSCI.1790-05.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT7 receptor is coupled to Gα subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology</span></div><div class="casAuthors">Kvachnina, Elena; Liu, Guoquan; Dityatev, Alexander; Renner, Ute; Dumuis, Aline; Richter, Diethelm W.; Dityateva, Galina; Schachner, Melitta; Voyno-Yasenetskaya, Tatyana A.; Ponimaskin, Evgeni G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">7821-7830</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The neurotransmitter serotonin (5-HT) plays an important role in the regulation of multiple events in the CNS.  The authors demonstrated recently a coupling between the 5-HT4 receptor and the heterotrimeric G13-protein resulting in RhoA-dependent neurite retraction and cell rounding.  In the present study, the authors identified G12 as an addnl. G-protein that can be activated by another member of serotonin receptors, the 5-HT7 receptor.  Expression of 5-HT7 receptor induced constitutive and agonist-dependent activation of a serum response element-mediated gene transcription through G12-mediated activation of small GTPases.  In NIH3T3 cells, activation of the 5-HT7 receptor induced filopodia formation via a Cdc42-mediated pathway correlating with RhoA-dependent cell rounding.  In mouse hippocampal neurons, activation of the endogenous 5-HT7 receptors significantly increased neurite length, whereas stimulation of 5-HT4 receptors led to a decrease in the length and no. of neurites.  These data demonstrate distinct roles for 5-HT7R/G12 and 5-HT4R/G13 signaling pathways in neurite outgrowth and retraction, suggesting that serotonin plays a prominent role in regulating the neuronal cytoarchitecture in addn. to its classical role as neurotransmitter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYY4-5ryShm7Vg90H21EOLACvtfcHk0li5FXXbwciNJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvVKgu7c%253D&md5=46861cf8fcd57de268bfa8f7450cac69</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1790-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1790-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DKvachnina%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DDityatev%26aufirst%3DA.%26aulast%3DRenner%26aufirst%3DU.%26aulast%3DDumuis%26aufirst%3DA.%26aulast%3DRichter%26aufirst%3DD.%2BW.%26aulast%3DDityateva%26aufirst%3DG.%26aulast%3DSchachner%26aufirst%3DM.%26aulast%3DVoyno-Yasenetskaya%26aufirst%3DT.%2BA.%26aulast%3DPonimaskin%26aufirst%3DE.%2BG.%26atitle%3D5-HT7%2520receptor%2520is%2520coupled%2520to%2520G%2520alpha%2520subunits%2520of%2520heterotrimeric%2520G12-protein%2520to%2520regulate%2520gene%2520transcription%2520and%2520neuronal%2520morphology%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D7821%26epage%3D7830%26doi%3D10.1523%2FJNEUROSCI.1790-05.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Kobe, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guseva, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renner, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medrihan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerholz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzog, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radyushkin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kordi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrenreich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusakov, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponimaskin, E. G.</span><span> </span><span class="NLM_article-title">5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2915</span><span class="NLM_x">–</span> <span class="NLM_lpage">2930</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.2765-11.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1523%2FJNEUROSCI.2765-11.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22378867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XjslKjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=2915-2930&author=F.+Kobeauthor=D.+Gusevaauthor=T.+P.+Jensenauthor=A.+Wirthauthor=U.+Rennerauthor=D.+Hessauthor=M.+M%C3%BCllerauthor=L.+Medrihanauthor=W.+Zhangauthor=M.+Zhangauthor=K.+Braunauthor=S.+Westerholzauthor=A.+Herzogauthor=K.+Radyushkinauthor=A.+El-Kordiauthor=H.+Ehrenreichauthor=D.+W.+Richterauthor=D.+A.+Rusakovauthor=E.+G.+Ponimaskin&title=5-HT7R%2FG12+signaling+regulates+neuronal+morphology+and+function+in+an+age-dependent+manner&doi=10.1523%2FJNEUROSCI.2765-11.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner</span></div><div class="casAuthors">Kobe, Fritz; Guseva, Daria; Jensen, Thomas P.; Wirth, Alexander; Renner, Ute; Hess, Dietmar; Mueller, Michael; Medrihan, Lucian; Zhang, Weiqi; Zhang, Mingyue; Braun, Katharina; Westerholz, Soeren; Herzog, Andreas; Radyushkin, Konstantin; El-Kordi, Ahmed; Ehrenreich, Hannelore; Richter, Diethelm W.; Rusakov, Dmitri A.; Ponimaskin, Evgeni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2915-2930</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The common neurotransmitter serotonin controls different aspects of early neuronal differentiation, although the underlying mechanisms are poorly understood.  Here we report that activation of the serotonin 5-HT7 receptor promotes synaptogenesis and enhances synaptic activity in hippocampal neurons at early postnatal stages.  An anal. of Gα12-deficient mice reveals a crit. role of G12-protein for 5-HT7 receptor-mediated effects in neurons.  In organotypic prepns. from the hippocampus of juvenile mice, stimulation of 5-HT7R/G12 signaling potentiates formation of dendritic spines, increases neuronal excitability, and modulates synaptic plasticity.  In contrast, in older neuronal prepns., morphogenetic and synaptogenic effects of 5-HT7/G12 signaling are abolished.  Moreover, inhibition of 5-HT7 receptor had no effect on synaptic plasticity in hippocampus of adult animals.  Expression anal. reveals that the prodn. of 5-HT7 and Gα12-proteins in the hippocampus undergoes strong regulation with a pronounced transient increase during early postnatal stages.  Thus, regulated expression of 5-HT7 receptor and Gα12-protein may represent a mol. mechanism by which serotonin specifically modulates formation of initial neuronal networks during early postnatal development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcV8lb4lfGdbVg90H21EOLACvtfcHk0li5FXXbwciNJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjslKjt7Y%253D&md5=4cd2f5bc8e09e3d14962a60d37175bdf</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2765-11.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2765-11.2012%26sid%3Dliteratum%253Aachs%26aulast%3DKobe%26aufirst%3DF.%26aulast%3DGuseva%26aufirst%3DD.%26aulast%3DJensen%26aufirst%3DT.%2BP.%26aulast%3DWirth%26aufirst%3DA.%26aulast%3DRenner%26aufirst%3DU.%26aulast%3DHess%26aufirst%3DD.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DMedrihan%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DBraun%26aufirst%3DK.%26aulast%3DWesterholz%26aufirst%3DS.%26aulast%3DHerzog%26aufirst%3DA.%26aulast%3DRadyushkin%26aufirst%3DK.%26aulast%3DEl-Kordi%26aufirst%3DA.%26aulast%3DEhrenreich%26aufirst%3DH.%26aulast%3DRichter%26aufirst%3DD.%2BW.%26aulast%3DRusakov%26aufirst%3DD.%2BA.%26aulast%3DPonimaskin%26aufirst%3DE.%2BG.%26atitle%3D5-HT7R%252FG12%2520signaling%2520regulates%2520neuronal%2520morphology%2520and%2520function%2520in%2520an%2520age-dependent%2520manner%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26spage%3D2915%26epage%3D2930%26doi%3D10.1523%2FJNEUROSCI.2765-11.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Speranza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambery, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Domenico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crispino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Severino, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpicelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellenchi, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Porzio, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone-Capano, C.</span><span> </span><span class="NLM_article-title">The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.10.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuropharm.2012.10.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2013&pages=155-167&author=L.+Speranzaauthor=A.+Chamberyauthor=M.+Di+Domenicoauthor=M.+Crispinoauthor=V.+Severinoauthor=F.+Volpicelliauthor=M.+Leopoldoauthor=G.+C.+Bellenchiauthor=U.+di+Porzioauthor=C.+Perrone-Capano&title=The+serotonin+receptor+7+promotes+neurite+outgrowth+via+ERK+and+Cdk5+signaling+pathways&doi=10.1016%2Fj.neuropharm.2012.10.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DSperanza%26aufirst%3DL.%26aulast%3DChambery%26aufirst%3DA.%26aulast%3DDi%2BDomenico%26aufirst%3DM.%26aulast%3DCrispino%26aufirst%3DM.%26aulast%3DSeverino%26aufirst%3DV.%26aulast%3DVolpicelli%26aufirst%3DF.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DBellenchi%26aufirst%3DG.%2BC.%26aulast%3Ddi%2BPorzio%26aufirst%3DU.%26aulast%3DPerrone-Capano%26aufirst%3DC.%26atitle%3DThe%2520serotonin%2520receptor%25207%2520promotes%2520neurite%2520outgrowth%2520via%2520ERK%2520and%2520Cdk5%2520signaling%2520pathways%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D67%26spage%3D155%26epage%3D167%26doi%3D10.1016%2Fj.neuropharm.2012.10.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Speranza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpicelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Stefano, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambery, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellenchi, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Porzio, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crispino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone-Capano, C.</span><span> </span><span class="NLM_article-title">Activation of 5-HT<sub>7</sub> receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics</span> <span class="citation_source-journal">Front. Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="refDoi"> DOI: 10.3389/fnbeh.2015.00062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3389%2Ffnbeh.2015.00062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25814944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsV2ht7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=62&author=L.+Speranzaauthor=T.+Giulianoauthor=F.+Volpicelliauthor=M.+E.+De+Stefanoauthor=L.+Lombardiauthor=A.+Chamberyauthor=E.+Lacivitaauthor=M.+Leopoldoauthor=G.+C.+Bellenchiauthor=U.+di+Porzioauthor=M.+Crispinoauthor=C.+Perrone-Capano&title=Activation+of+5-HT7+receptor+stimulates+neurite+elongation+through+mTOR%2C+Cdc42+and+actin+filaments+dynamics&doi=10.3389%2Ffnbeh.2015.00062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of 5-HT7 receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics</span></div><div class="casAuthors">Speranza, Luisa; Giuliano, Teresa; Volpicelli, Floriana; De Stefano, M. Egle; Lombardi, Loredana; Chambery, Angela; Lacivita, Enza; Leopoldo, Marcello; Bellenchi, Gian C.; di Porzio, Umberto; Crispino, Marianna; Perrone-Capano, Carla</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">62/1-62/14</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Recent studies have indicated that the serotonin receptor subtype 7 (5-HT7R) plays a crucial role in shaping neuronal morphol. during embryonic and early postnatal life.  Here we show that pharmacol. stimulation of 5-HT7R using a highly selective agonist, LP-211, enhances neurite outgrowth in neuronal primary cultures from the cortex, hippocampus and striatal complex of embryonic mouse brain, through multiple signal transduction pathways.  All these signaling systems, involving mTOR, the Rho GTPase Cdc42, Cdk5, and ERK, are known to converge on the reorganization of cytoskeletal proteins that subserve neurite outgrowth.  Indeed, our data indicate that neurite elongation stimulated by 5-HT7R is modulated by drugs affecting actin polymn.  In addn., we show, by 2D Western blot analyses, that treatment of neuronal cultures with LP-211 alters the expression profile of cofilin, an actin binding protein involved in microfilaments dynamics.  Furthermore, by using microfluidic chambers that phys. sep. axons from the soma and dendrites, we demonstrate that agonist-dependent activation of 5-HT7R stimulates axonal elongation.  Our results identify for the first time several signal transduction pathways, activated by stimulation of 5-HT7R, that converge to promote cytoskeleton reorganization and consequent modulation of axonal elongation.  Therefore, the activation of 5-HT7R might represent one of the key elements regulating CNS connectivity and plasticity during development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbp2mV1sLJ9LVg90H21EOLACvtfcHk0lirygBxA2rMXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2ht7bK&md5=d55b03d0f3f833977f459818e4dafea6</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2015.00062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2015.00062%26sid%3Dliteratum%253Aachs%26aulast%3DSperanza%26aufirst%3DL.%26aulast%3DGiuliano%26aufirst%3DT.%26aulast%3DVolpicelli%26aufirst%3DF.%26aulast%3DDe%2BStefano%26aufirst%3DM.%2BE.%26aulast%3DLombardi%26aufirst%3DL.%26aulast%3DChambery%26aufirst%3DA.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DBellenchi%26aufirst%3DG.%2BC.%26aulast%3Ddi%2BPorzio%26aufirst%3DU.%26aulast%3DCrispino%26aufirst%3DM.%26aulast%3DPerrone-Capano%26aufirst%3DC.%26atitle%3DActivation%2520of%25205-HT7%2520receptor%2520stimulates%2520neurite%2520elongation%2520through%2520mTOR%252C%2520Cdc42%2520and%2520actin%2520filaments%2520dynamics%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2015%26volume%3D9%26spage%3D62%26doi%3D10.3389%2Ffnbeh.2015.00062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Speranza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpicelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guseva, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellenchi, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Porzio, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bijata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone-Capano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponimaskin, E. G.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>7</sub> receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">141</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">661</span><span class="refDoi"> DOI: 10.1111/jnc.13962</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1111%2Fjnc.13962" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=28122114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvVWisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2017&pages=647-661&author=L.+Speranzaauthor=J.+Labusauthor=F.+Volpicelliauthor=D.+Gusevaauthor=E.+Lacivitaauthor=M.+Leopoldoauthor=G.+C.+Bellenchiauthor=U.+di+Porzioauthor=M.+Bijataauthor=C.+Perrone-Capanoauthor=E.+G.+Ponimaskin&title=Serotonin+5-HT7+receptor+increases+the+density+of+dendritic+spines+and+facilitates+synaptogenesis+in+forebrain+neurons&doi=10.1111%2Fjnc.13962"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT7 receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons</span></div><div class="casAuthors">Speranza, Luisa; Labus, Josephine; Volpicelli, Floriana; Guseva, Daria; Lacivita, Enza; Leopoldo, Marcello; Bellenchi, Gian Carlo; di Porzio, Umberto; Bijata, Monika; Perrone-Capano, Carla; Ponimaskin, Evgeni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">647-661</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Precise control of dendritic spine d. and synapse formation is crit. for normal and pathol. brain functions.  Therefore, signaling pathways influencing dendrite outgrowth and remodeling remain a subject of extensive investigations.  Here, we report that prolonged activation of the serotonin 5-HT7 receptor (5-HT7R) with selective agonist LP-211 promotes formation of dendritic spines and facilitates synaptogenesis in postnatal cortical and striatal neurons.  Crit. role of 5-HT7R in neuronal morphogenesis was confirmed by anal. of neurons isolated from 5-HT7R-deficient mice and by pharmacol. inactivation of the receptor.  Acute activation of 5-HT7R results in pronounced neurite elongation in postnatal striatal and cortical neurons, thus extending previous data on the morphogenic role of 5-HT7R in embryonic and hippocampal neurons.  We also obsd. decreased no. of spines in neurons with either genetically (i.e. 5-HT7R-knock-out) or pharmacol. (i.e. antagonist treatment) blocked 5-HT7R, suggesting that constitutive 5-HT7R activity is critically involved in the spinogenesis.  Moreover, cyclin-dependent kinase 5 and small GTPase Cdc42 were identified as important downstream effectors mediating morphogenic effects of 5-HT7R in neurons.  Altogether, our data suggest that the 5-HT7R-mediated structural reorganization during the postnatal development might have a crucial role for the development and plasticity of forebrain areas such as cortex and striatum, and thereby can be implicated in regulation of the higher cognitive functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocjTpuuLOBcrVg90H21EOLACvtfcHk0lhEX7lKipk4-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvVWisL8%253D&md5=f9925d4fa2ebe414faec1234364a1e8f</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13962%26sid%3Dliteratum%253Aachs%26aulast%3DSperanza%26aufirst%3DL.%26aulast%3DLabus%26aufirst%3DJ.%26aulast%3DVolpicelli%26aufirst%3DF.%26aulast%3DGuseva%26aufirst%3DD.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DBellenchi%26aufirst%3DG.%2BC.%26aulast%3Ddi%2BPorzio%26aufirst%3DU.%26aulast%3DBijata%26aufirst%3DM.%26aulast%3DPerrone-Capano%26aufirst%3DC.%26aulast%3DPonimaskin%26aufirst%3DE.%2BG.%26atitle%3DSerotonin%25205-HT7%2520receptor%2520increases%2520the%2520density%2520of%2520dendritic%2520spines%2520and%2520facilitates%2520synaptogenesis%2520in%2520forebrain%2520neurons%26jtitle%3DJ.%2520Neurochem.%26date%3D2017%26volume%3D141%26spage%3D647%26epage%3D661%26doi%3D10.1111%2Fjnc.13962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Vizuete, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venero, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Traiffort, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machado, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano, J.</span><span> </span><span class="NLM_article-title">Expression of 5-HT<sub>7</sub> receptor mRNA in rat brain during postnatal development</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">227</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/S0304-3940(97)00302-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0304-3940%2897%2900302-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=227&publication_year=1997&pages=53-56&author=M.+L.+Vizueteauthor=J.+L.+Veneroauthor=E.+Traiffortauthor=C.+Vargasauthor=A.+Machadoauthor=J.+Cano&title=Expression+of+5-HT7+receptor+mRNA+in+rat+brain+during+postnatal+development&doi=10.1016%2FS0304-3940%2897%2900302-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2897%2900302-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252897%252900302-9%26sid%3Dliteratum%253Aachs%26aulast%3DVizuete%26aufirst%3DM.%2BL.%26aulast%3DVenero%26aufirst%3DJ.%2BL.%26aulast%3DTraiffort%26aufirst%3DE.%26aulast%3DVargas%26aufirst%3DC.%26aulast%3DMachado%26aufirst%3DA.%26aulast%3DCano%26aufirst%3DJ.%26atitle%3DExpression%2520of%25205-HT7%2520receptor%2520mRNA%2520in%2520rat%2520brain%2520during%2520postnatal%2520development%26jtitle%3DNeurosci.%2520Lett.%26date%3D1997%26volume%3D227%26spage%3D53%26epage%3D56%26doi%3D10.1016%2FS0304-3940%2897%2900302-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Leo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adriani, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavaliere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">di Porzio, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone-Capano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laviola, G.</span><span> </span><span class="NLM_article-title">Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology</span> <span class="citation_source-journal">Genes, Brain Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span><span class="refDoi"> DOI: 10.1111/j.1601-183X.2009.00486.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1111%2Fj.1601-183X.2009.00486.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=19243449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtFeis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=356-368&author=D.+Leoauthor=W.+Adrianiauthor=C.+Cavaliereauthor=G.+Cirilloauthor=E.+M.+Marcoauthor=E.+Romanoauthor=U.+di+Porzioauthor=M.+Papaauthor=C.+Perrone-Capanoauthor=G.+Laviola&title=Methylphenidate+to+adolescent+rats+drives+enduring+changes+of+accumbal+Htr7+expression%3A+implications+for+impulsive+behavior+and+neuronal+morphology&doi=10.1111%2Fj.1601-183X.2009.00486.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology</span></div><div class="casAuthors">Leo, D.; Adriani, W.; Cavaliere, C.; Cirillo, G.; Marco, E. M.; Romano, E.; Di Porzio, U.; Papa, M.; Perrone-Capano, C.; Laviola, G.</div><div class="citationInfo"><span class="NLM_cas:title">Genes, Brain and Behavior</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">356-368</span>CODEN:
                <span class="NLM_cas:coden">GBBEAO</span>;
        ISSN:<span class="NLM_cas:issn">1601-1848</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Methylphenidate (MPH) administration to adolescent rodents produces persistent region-specific changes in brain reward circuits and alterations of reward-based behavior.  We show that these modifications include a marked increment of serotonin (5-hydroxy-tryptamine) receptor type 7 (Htr7) expression and synaptic contacts, mainly in the nucleus accumbens, and a redn. of basal behavioral impulsivity.  We show that neural and behavioral consequences are functionally related: administration of a selective Htr7 antagonist fully counteracts the MPH-reduced impulsive behavior and enhances impulsivity when administered alone in naive rats.  Agonist-induced activation of endogenous Htr7 significantly increases neurite length in striatal neuron primary cultures, thus suggesting plastic remodeling of neuronal morphol.  The mixed Htr (1a/7) agonist, 8-OH-DPAT, reduces impulsive behavior in adolescent rats and in naive adults, whose impulsivity is enhanced by the Htr7 antagonist.  In summary, behavioral pharmacol. expts. show that Htr7 mediates self-control behavior, and brain primary cultures expts. indicate that this receptor may be involved in the underlying neural plasticity, through changes in neuronal cytoarchitecture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojF4CMhcNITbVg90H21EOLACvtfcHk0lidBaQyDo-XCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtFeis70%253D&md5=f7238775c5ba3b2f49a76f85b5a369e6</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1111%2Fj.1601-183X.2009.00486.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1601-183X.2009.00486.x%26sid%3Dliteratum%253Aachs%26aulast%3DLeo%26aufirst%3DD.%26aulast%3DAdriani%26aufirst%3DW.%26aulast%3DCavaliere%26aufirst%3DC.%26aulast%3DCirillo%26aufirst%3DG.%26aulast%3DMarco%26aufirst%3DE.%2BM.%26aulast%3DRomano%26aufirst%3DE.%26aulast%3Ddi%2BPorzio%26aufirst%3DU.%26aulast%3DPapa%26aufirst%3DM.%26aulast%3DPerrone-Capano%26aufirst%3DC.%26aulast%3DLaviola%26aufirst%3DG.%26atitle%3DMethylphenidate%2520to%2520adolescent%2520rats%2520drives%2520enduring%2520changes%2520of%2520accumbal%2520Htr7%2520expression%253A%2520implications%2520for%2520impulsive%2520behavior%2520and%2520neuronal%2520morphology%26jtitle%3DGenes%252C%2520Brain%2520Behav.%26date%3D2009%26volume%3D8%26spage%3D356%26epage%3D368%26doi%3D10.1111%2Fj.1601-183X.2009.00486.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">De Filippis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nativio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricceri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adriani, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passarelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laviola, G.</span><span> </span><span class="NLM_article-title">Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2506</span><span class="NLM_x">–</span> <span class="NLM_lpage">2518</span><span class="refDoi"> DOI: 10.1038/npp.2014.105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnpp.2014.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24809912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVGru7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=2506-2518&author=B.+De+Filippisauthor=P.+Nativioauthor=A.+Fabbriauthor=L.+Ricceriauthor=W.+Adrianiauthor=E.+Lacivitaauthor=M.+Leopoldoauthor=F.+Passarelliauthor=A.+Fusoauthor=G.+Laviola&title=Pharmacological+stimulation+of+the+brain+serotonin+receptor+7+as+a+novel+therapeutic+approach+for+Rett+syndrome&doi=10.1038%2Fnpp.2014.105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Stimulation of the Brain Serotonin Receptor 7 as a Novel Therapeutic Approach for Rett Syndrome</span></div><div class="casAuthors">De Filippis, Bianca; Nativio, Paola; Fabbri, Alessia; Ricceri, Laura; Adriani, Walter; Lacivita, Enza; Leopoldo, Marcello; Passarelli, Francesca; Fuso, Andrea; Laviola, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2506-2518</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a rare neurodevelopmental disorder, characterized by severe behavioral and physiol. symptoms.  Mutations in the Me CpG-binding protein 2 gene (MECP2) cause >95% of classic cases, and currently there is no cure for this devastating disorder.  The serotonin receptor 7 (5-HT7R) is linked to neuro-physiol. regulation of circadian rhythm, mood, cognition, and synaptic plasticity.  We presently report that 5-HT7R d. is consistently reduced in cortical and hippocampal brain areas of symptomatic MeCP2-308 male mice, a RTT model.  Systemic repeated treatment with LP-211 (0.25 mg/kg once/day for 7 days), a brain-penetrant selective 5-HT7R agonist, was able to rescue RTT-related defective performance: anxiety-related profiles in a Light/Dark test, motor abilities in a Dowel test, the exploratory behavior in the Marble Burying test, as well as memory in the Novelty Preference task.  In the brain of RTT mice, LP-211 also reversed the abnormal activation of PAK and cofilin (key regulators of actin cytoskeleton dynamics) and of the ribosomal protein (rp) S6, whose reduced activation in MECP2 mutant neurons by mTOR is responsible for the altered protein translational control.  Present findings indicate that pharmacol. targeting of 5-HT7R improves specific behavioral and mol. manifestations of RTT, thus representing a first step toward the validation of an innovative systemic treatment.  Beyond RTT, the latter might be extended to other disorders assocd. with intellectual disability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnrsCidW_X5rVg90H21EOLACvtfcHk0lidBaQyDo-XCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVGru7s%253D&md5=3ca5c55ceaee5c6091033f92eb30a60d</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2014.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2014.105%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFilippis%26aufirst%3DB.%26aulast%3DNativio%26aufirst%3DP.%26aulast%3DFabbri%26aufirst%3DA.%26aulast%3DRicceri%26aufirst%3DL.%26aulast%3DAdriani%26aufirst%3DW.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DPassarelli%26aufirst%3DF.%26aulast%3DFuso%26aufirst%3DA.%26aulast%3DLaviola%26aufirst%3DG.%26atitle%3DPharmacological%2520stimulation%2520of%2520the%2520brain%2520serotonin%2520receptor%25207%2520as%2520a%2520novel%2520therapeutic%2520approach%2520for%2520Rett%2520syndrome%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D2506%26epage%3D2518%26doi%3D10.1038%2Fnpp.2014.105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">De Filippis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiodi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adriani, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domenici, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laviola, G.</span><span> </span><span class="NLM_article-title">Long-lasting beneficial effects of central serotonin receptor 7 stimulation in female mice modeling Rett syndrome</span> <span class="citation_source-journal">Front. Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">86</span><span class="refDoi"> DOI: 10.3389/fnbeh.2015.00086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3389%2Ffnbeh.2015.00086" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25926782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsV2htL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=86&author=B.+De+Filippisauthor=V.+Chiodiauthor=W.+Adrianiauthor=E.+Lacivitaauthor=C.+Mallozziauthor=M.+Leopoldoauthor=M.+R.+Domeniciauthor=A.+Fusoauthor=G.+Laviola&title=Long-lasting+beneficial+effects+of+central+serotonin+receptor+7+stimulation+in+female+mice+modeling+Rett+syndrome&doi=10.3389%2Ffnbeh.2015.00086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Long-lasting beneficial effects of central serotonin receptor 7 stimulation in female mice modeling Rett syndrome</span></div><div class="casAuthors">De Filippis, Bianca; Chiodi, Valentina; Adriani, Walter; Lacivita, Enza; Mallozzi, Cinzia; Leopoldo, Marcello; Domenici, Maria Rosaria; Fuso, Andrea; Laviola, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86/1-86/11</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a rare neurodevelopmental disorder, characterized by severe behavioral and physiol. symptoms.  Mutations in the Me CpG binding protein 2 gene (MECP2) cause more than 95% of classic cases, and currently there is no cure for this devastating disorder.  Recently we have demonstrated that specific behavioral and brain mol. alterations can be rescued in MeCP2-308 male mice, a RTT mouse model, by pharmacol. stimulation of the brain serotonin receptor 7 (5-HT7R).  This member of the serotonin receptor family-crucially involved in the regulation of brain structural plasticity and cognitive processes-can be stimulated by systemic repeated treatment with LP-211, a brain-penetrant selective 5-HT7R agonist.  The present study extends previous findings by demonstrating that the LP-211 treatment (0.25 mg/kg, once per day for 7 days) rescues RTT-related phenotypic alterations, motor coordination (Dowel test), spatial ref. memory (Barnes maze test) and synaptic plasticity (hippocampal long-term-potentiation) in MeCP2-308 heterozygous female mice, the genetic and hormonal milieu that resembles that of RTT patients.  LP-211 also restores the activation of the ribosomal protein (rp) S6, the downstream target of mTOR and S6 kinase, in the hippocampus of RTT female mice.  Notably, the beneficial effects on neurobehavioral and mol. parameters of a seven-day long treatment with LP-211 were evident up to 2 mo after the last injection, thus suggesting long-lasting effects on RTT-related impairments.  Taken together with our previous study, these results provide compelling preclin. evidence of the potential therapeutic value for RTT of a pharmacol. approach targeting the brain 5-HT7R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmp6k2rYlzgrVg90H21EOLACvtfcHk0lgzN4n53N3tXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2htL7N&md5=2ceb672cfb7eaadae64c42e68412f818</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2015.00086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2015.00086%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFilippis%26aufirst%3DB.%26aulast%3DChiodi%26aufirst%3DV.%26aulast%3DAdriani%26aufirst%3DW.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DMallozzi%26aufirst%3DC.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DDomenici%26aufirst%3DM.%2BR.%26aulast%3DFuso%26aufirst%3DA.%26aulast%3DLaviola%26aufirst%3DG.%26atitle%3DLong-lasting%2520beneficial%2520effects%2520of%2520central%2520serotonin%2520receptor%25207%2520stimulation%2520in%2520female%2520mice%2520modeling%2520Rett%2520syndrome%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2015%26volume%3D9%26spage%3D86%26doi%3D10.3389%2Ffnbeh.2015.00086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Valenti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laviola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Filippis, B.</span><span> </span><span class="NLM_article-title">Stimulation of the brain serotonin receptor 7 rescues mitochondrial dysfunction in female mice from two models of Rett syndrome</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.04.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuropharm.2017.04.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=28419872" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntVKqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2017&pages=79-88&author=D.+Valentiauthor=L.+de+Bariauthor=D.+Vigliauthor=E.+Lacivitaauthor=M.+Leopoldoauthor=G.+Laviolaauthor=R.+A.+Vaccaauthor=B.+De+Filippis&title=Stimulation+of+the+brain+serotonin+receptor+7+rescues+mitochondrial+dysfunction+in+female+mice+from+two+models+of+Rett+syndrome&doi=10.1016%2Fj.neuropharm.2017.04.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of the brain serotonin receptor 7 rescues mitochondrial dysfunction in female mice from two models of Rett syndrome</span></div><div class="casAuthors">Valenti, Daniela; de Bari, Lidia; Vigli, Daniele; Lacivita, Enza; Leopoldo, Marcello; Laviola, Giovanni; Vacca, Rosa Anna; De Filippis, Bianca</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Rett syndrome (RTT) is a rare neurodevelopmental disorder, characterized by severe behavioral and physiol. symptoms.  Mutations in the Me CpG binding protein 2 gene (MECP2) cause more than 95% of classic cases, and currently there is no cure for this devastating disorder.  Recently we have demonstrated that neurobehavioral and brain mol. alterations can be rescued in a RTT mouse model, by pharmacol. stimulation of the brain serotonin receptor 7 (5-HT7R).  This member of the serotonin receptor family, crucially involved in the regulation of brain structural plasticity and cognitive processes, can be stimulated by systemic repeated treatment with LP-211, a brain-penetrant selective agonist.  The present study extends previous findings by demonstrating that LP-211 treatment (0.25 mg/kg, once per day for 7 days) rescues mitochondrial respiratory chain impairment, oxidative phosphorylation deficiency and the reduced energy status in the brain of heterozygous female mice from two highly validated mouse models of RTT (MeCP2-308 and MeCP2-Bird mice).  Moreover, LP-211 treatment completely restored the radical species overprodn. by brain mitochondria in the MeCP2-308 model and partially recovered the oxidative imbalance in the more severely affected MeCP2-Bird model.  These results provide the first evidence that RTT brain mitochondrial dysfunction can be rescued targeting the brain 5-HT7R and add compelling preclin. evidence of the potential therapeutic value of LP-211 as a pharmacol. approach for this devastating neurodevelopmental disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcGf0zr-8zC7Vg90H21EOLACvtfcHk0lgzN4n53N3tXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntVKqtbc%253D&md5=e9afc4ce248190af567dc4f38099601e</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.04.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.04.024%26sid%3Dliteratum%253Aachs%26aulast%3DValenti%26aufirst%3DD.%26aulast%3Dde%2BBari%26aufirst%3DL.%26aulast%3DVigli%26aufirst%3DD.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLaviola%26aufirst%3DG.%26aulast%3DVacca%26aufirst%3DR.%2BA.%26aulast%3DDe%2BFilippis%26aufirst%3DB.%26atitle%3DStimulation%2520of%2520the%2520brain%2520serotonin%2520receptor%25207%2520rescues%2520mitochondrial%2520dysfunction%2520in%2520female%2520mice%2520from%2520two%2520models%2520of%2520Rett%2520syndrome%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D121%26spage%3D79%26epage%3D88%26doi%3D10.1016%2Fj.neuropharm.2017.04.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Costa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sardone, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciranna, L.</span><span> </span><span class="NLM_article-title">Novel agonists for serotonin 5-HT<sub>7</sub> receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X syndrome</span> <span class="citation_source-journal">Front. Behav. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="refDoi"> DOI: 10.3389/fnbeh.2015.00065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3389%2Ffnbeh.2015.00065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25814945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsV2htLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=65&author=L.+Costaauthor=L.+M.+Sardoneauthor=E.+Lacivitaauthor=M.+Leopoldoauthor=L.+Ciranna&title=Novel+agonists+for+serotonin+5-HT7+receptors+reverse+metabotropic+glutamate+receptor-mediated+long-term+depression+in+the+hippocampus+of+wild-type+and+Fmr1+KO+mice%2C+a+model+of+Fragile+X+syndrome&doi=10.3389%2Ffnbeh.2015.00065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome</span></div><div class="casAuthors">Costa, Lara; Sardone, Lara M.; Lacivita, Enza; Leopoldo, Marcello; Ciranna, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">65/1-65/11</span>CODEN:
                <span class="NLM_cas:coden">FBNRAA</span>;
        ISSN:<span class="NLM_cas:issn">1662-5153</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Serotonin 5-HT7 receptors are expressed in the hippocampus and modulate the excitability of hippocampal neurons.  We have previously shown that 5-HT7 receptors modulate glutamate-mediated hippocampal synaptic transmission and long-term synaptic plasticity.  In particular, we have shown that activation of 5-HT7 receptors reversed metabotropic glutamate receptor-mediated long-term depression (mGluR-LTD) in wild-type (wt) and in Fmr1 KO mice, a mouse model of Fragile X Syndrome in which mGluR-LTD is abnormally enhanced, suggesting that 5-HT7 receptor agonists might be envisaged as a novel therapeutic strategy for Fragile X Syndrome.  In this perspective, we have characterized the basic in vitro pharmacokinetic properties of novel mols. with high binding affinity and selectivity for 5-HT7 receptors and we have tested their effects on synaptic plasticity using patch clamp on acute hippocampal slices.  Here we show that LP-211, a high affinity selective agonist of 5-HT7 receptors, reverses mGluR-LTD in wt and Fmr1 KO mice, correcting a synaptic malfunction in the mouse model of Fragile X Syndrome.  Among novel putative agonists of 5-HT7 receptors, the compd. BA-10 displayed improved affinity and selectivity for 5-HT7 receptors and improved in vitro pharmacokinetic properties with respect to LP-211.  BA-10 significantly reversed mGluR-LTD in the CA3-CA1 synapse in wt and Fmr1KO mice, indicating that BA-10 behaved as a highly effective agonist of 5-HT7 receptors and reduced exaggerated mGluR-LTD in a mouse model of Fragile X Syndrome.  On the other side, the compds. RA-7 and PM-20, resp. arising from in vivo metab. of LP-211 and BA-10, had no effect on mGluR-LTD thus did not behave as agonists of 5-HT7 receptors in our conditions.  The present results provide information about the structure-activity relationship of novel 5-HT7 receptor agonists and indicate that LP-211 and BA-10 might be used as novel pharmacol. tools for the therapy of Fragile X Syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5rRoHOX7O4LVg90H21EOLACvtfcHk0ljVtR3Wm7c0Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2htLbP&md5=88255a5469d17074e2eea5b7670158f4</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.3389%2Ffnbeh.2015.00065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnbeh.2015.00065%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DL.%26aulast%3DSardone%26aufirst%3DL.%2BM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DCiranna%26aufirst%3DL.%26atitle%3DNovel%2520agonists%2520for%2520serotonin%25205-HT7%2520receptors%2520reverse%2520metabotropic%2520glutamate%2520receptor-mediated%2520long-term%2520depression%2520in%2520the%2520hippocampus%2520of%2520wild-type%2520and%2520Fmr1%2520KO%2520mice%252C%2520a%2520model%2520of%2520Fragile%2520X%2520syndrome%26jtitle%3DFront.%2520Behav.%2520Neurosci.%26date%3D2015%26volume%3D9%26spage%3D65%26doi%3D10.3389%2Ffnbeh.2015.00065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Costa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spatuzza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Antoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaccorso, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trovato, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musumeci, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catania, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciranna, L.</span><span> </span><span class="NLM_article-title">Activation of 5-HT<sub>7</sub> serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X syndrome</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">924</span><span class="NLM_x">–</span> <span class="NLM_lpage">933</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2012.06.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.biopsych.2012.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22817866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVykt7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=924-933&author=L.+Costaauthor=M.+Spatuzzaauthor=S.+D%E2%80%99Antoniauthor=C.+M.+Bonaccorsoauthor=C.+Trovatoauthor=S.+A.+Musumeciauthor=M.+Leopoldoauthor=E.+Lacivitaauthor=M.+V.+Cataniaauthor=L.+Ciranna&title=Activation+of+5-HT7+serotonin+receptors+reverses+metabotropic+glutamate+receptor-mediated+synaptic+plasticity+in+wild-type+and+Fmr1+knockout+mice%2C+a+model+of+Fragile+X+syndrome&doi=10.1016%2Fj.biopsych.2012.06.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of 5-HT7 Serotonin Receptors Reverses Metabotropic Glutamate Receptor-Mediated Synaptic Plasticity in Wild-Type and Fmr1 Knockout Mice, a Model of Fragile X Syndrome</span></div><div class="casAuthors">Costa, Lara; Spatuzza, Michela; D'Antoni, Simona; Bonaccorso, Carmela M.; Trovato, Chiara; Musumeci, Sebastiano A.; Leopoldo, Marcello; Lacivita, Enza; Catania, Maria V.; Ciranna, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">924-933</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Fragile X syndrome (FXS) is a genetic cause of intellectual disability and autism.  Fmr1 knockout (Fmr1 KO) mice, an animal model of FXS, exhibit spatial memory impairment and synapse malfunctioning in the hippocampus, with abnormal enhancement of long-term depression mediated by metabotropic glutamate receptors (mGluR-LTD).  The neurotransmitter serotonin (5-HT) modulates hippocampal-dependent learning through serotonin 1A (5-HT1A) and serotonin 7 (5-HT7) receptors; the underlying mechanisms are unknown.  We used electrophysiol. to test the effects of 5-HT on mGluR-LTD in wild-type and Fmr1 KO mice and immunocytochem. and biotinylation assay to study related changes of 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)propanoic acid (AMPA) glutamate receptor surface expression.  Application of 5-HT or 8-OH-DPAT (a mixed 5-HT1A/5-HT7 agonist) reversed mGluR-LTD in hippocampal slices.  Reversal of mGluR-LTD by 8-OH-DPAT persisted in the presence of the 5-HT1A receptor antagonist WAY-100635, was abolished by SB-269970 (5-HT7 receptor antagonist), and was mimicked by LP-211, a novel selective 5-HT7 receptor agonist.  Consistently, 8-OH-DPAT decreased mGluR-mediated redn. of AMPA glutamate receptor 2 (GluR2) subunit surface expression in hippocampal slices and cultured hippocampal neurons, an effect mimicked by LP-211 and blocked by SB-269970.  In Fmr1 KO mice, mGluR-LTD was abnormally enhanced; similarly to wild-type, 8-OH-DPAT reversed mGluR-LTD and decreased mGluR-induced redn. of surface AMPA receptors, an effect antagonized by SB-269970.  Serotonin 7 receptor activation reverses metabotropic glutamate receptor-induced AMPA receptor internalization and LTD both in wild-type and in Fmr1 KO mice, correcting excessive mGluR-LTD.  Therefore, selective activation of 5-HT7 receptors may represent a novel strategy in the therapy of FXS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8gBMnQibSXbVg90H21EOLACvtfcHk0ljVtR3Wm7c0Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVykt7%252FJ&md5=b4d75fe1118b739b111f7e7f29a32c24</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2012.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2012.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DL.%26aulast%3DSpatuzza%26aufirst%3DM.%26aulast%3DD%25E2%2580%2599Antoni%26aufirst%3DS.%26aulast%3DBonaccorso%26aufirst%3DC.%2BM.%26aulast%3DTrovato%26aufirst%3DC.%26aulast%3DMusumeci%26aufirst%3DS.%2BA.%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DCatania%26aufirst%3DM.%2BV.%26aulast%3DCiranna%26aufirst%3DL.%26atitle%3DActivation%2520of%25205-HT7%2520serotonin%2520receptors%2520reverses%2520metabotropic%2520glutamate%2520receptor-mediated%2520synaptic%2520plasticity%2520in%2520wild-type%2520and%2520Fmr1%2520knockout%2520mice%252C%2520a%2520model%2520of%2520Fragile%2520X%2520syndrome%26jtitle%3DBiol.%2520Psychiatry%26date%3D2012%26volume%3D72%26spage%3D924%26epage%3D933%26doi%3D10.1016%2Fj.biopsych.2012.06.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Canal, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsing, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vemula, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, R. G.</span><span> </span><span class="NLM_article-title">An orally active phenylaminotetralin-chemotype serotonin 5-HT<sub>7</sub> and 5-HT<sub>1A</sub> receptor partial agonist that corrects motor stereotypy in mouse models</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1259</span><span class="NLM_x">–</span> <span class="NLM_lpage">1270</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00099</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00099" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovFKktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1259-1270&author=C.+E.+Canalauthor=D.+E.+Felsingauthor=Y.+Liuauthor=W.+Zhuauthor=J.+T.+Woodauthor=C.+K.+Perryauthor=R.+Vemulaauthor=R.+G.+Booth&title=An+orally+active+phenylaminotetralin-chemotype+serotonin+5-HT7+and+5-HT1A+receptor+partial+agonist+that+corrects+motor+stereotypy+in+mouse+models&doi=10.1021%2Facschemneuro.5b00099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist That Corrects Motor Stereotypy in Mouse Models</span></div><div class="casAuthors">Canal, Clinton E.; Felsing, Daniel E.; Liu, Yue; Zhu, Wanying; Wood, JodiAnne T.; Perry, Charles K.; Vemula, Rajender; Booth, Raymond G.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1259-1270</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Stereotypy (e.g., repetitive hand waving) is a key phenotype of autism spectrum disorder, Fragile X and Rett syndromes, and other neuropsychiatric disorders, and its severity correlates with cognitive and attention deficits.  There are no effective treatments, however, for stereotypy.  Perturbation of serotonin (5-HT) neurotransmission contributes to stereotypy, suggesting that distinct 5-HT receptors may be pharmacotherapeutic targets to treat stereotypy and related neuropsychiatric symptoms.  For example, preclin. studies indicate that 5-HT7 receptor activation corrects deficits in mouse models of Fragile X and Rett syndromes, and clin. trials for autism are underway with buspirone, a 5-HT1A partial agonist with relevant affinity at 5-HT7 receptors.  Herein, we report the synthesis, in vitro mol. pharmacol., behavioral pharmacol., and pharmacokinetic parameters in mice after s.c. and oral administration of (+)-5-(2'-fluorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine ((+)-5-FPT), a new, dual partial agonist targeting both 5-HT7 (Ki = 5.8 nM, EC50 = 34 nM) and 5-HT1A (Ki = 22 nM, EC50 = 40 nM) receptors.  Three unique, heterogeneous mouse models were used to assess the efficacy of (+)-5-FPT to reduce stereotypy: idiopathic jumping in C58/J mice, repetitive body rotations in C57BL/6J mice treated with the NMDA antagonist, MK-801, and repetitive head twitching in C57BL/6J mice treated with the 5-HT2 agonist, DOI.  Systemic (+)-5-FPT potently and efficaciously reduced or eliminated stereotypy in each of the mouse models without altering locomotor behavior on its own, and addnl. tests showed that (+)-5-FPT, at the highest behaviorally active dose tested, enhanced social interaction and did not cause behaviors indicative of serotonin syndrome.  These data suggest that (+)-5-FPT is a promising medication for treating stereotypy in psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzYBDCOy-y8rVg90H21EOLACvtfcHk0lhwDbvjLCee8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovFKktbo%253D&md5=029bb904bf625875d069f2a937a22efa</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00099%26sid%3Dliteratum%253Aachs%26aulast%3DCanal%26aufirst%3DC.%2BE.%26aulast%3DFelsing%26aufirst%3DD.%2BE.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DWood%26aufirst%3DJ.%2BT.%26aulast%3DPerry%26aufirst%3DC.%2BK.%26aulast%3DVemula%26aufirst%3DR.%26aulast%3DBooth%26aufirst%3DR.%2BG.%26atitle%3DAn%2520orally%2520active%2520phenylaminotetralin-chemotype%2520serotonin%25205-HT7%2520and%25205-HT1A%2520receptor%2520partial%2520agonist%2520that%2520corrects%2520motor%2520stereotypy%2520in%2520mouse%2520models%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D1259%26epage%3D1270%26doi%3D10.1021%2Facschemneuro.5b00099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Mohler, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gannon, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shacham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragozzino, M. E.</span><span> </span><span class="NLM_article-title">The effects of PRX-07034, a novel 5-HT<sub>6</sub> antagonist, on cognitive flexibility and working memory in rats</span> <span class="citation_source-journal">Psychopharmacology (Berl)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">220</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">696</span><span class="refDoi"> DOI: 10.1007/s00213-011-2518-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs00213-011-2518-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21989804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC38zmsVWguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=2012&pages=687-696&author=E.+G.+Mohlerauthor=P.+M.+Bakerauthor=K.+S.+Gannonauthor=S.+S.+Jonesauthor=S.+Shachamauthor=J.+A.+Sweeneyauthor=M.+E.+Ragozzino&title=The+effects+of+PRX-07034%2C+a+novel+5-HT6+antagonist%2C+on+cognitive+flexibility+and+working+memory+in+rats&doi=10.1007%2Fs00213-011-2518-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats</span></div><div class="casAuthors">Mohler Eric G; Baker Phillip M; Gannon Kimberly S; Jones Simon S; Shacham Sharon; Sweeney John A; Ragozzino Michael E</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">220</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">687-96</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">RATIONALE:  Accumulating evidence indicates that schizophrenia and autism spectrum disorder patients are marked by cognitive deficits in working memory and strategy switching.  There is accumulating evidence that 5-hydroxytryptamine (5-HT)(6) receptors may serve as a useful target to improve cognitive functioning.  OBJECTIVES:  In the present experiments, the novel 5-HT(6) antagonist, PRX-07034, was examined for its selectivity of the 5-HT(6) receptor, as well as its effect on delayed spontaneous alternation and strategy switching.  METHODS:  The binding affinity of PRX-07034 to the 5-HT(6) receptor, other 5-HT receptors, as well as other G-protein coupled receptors, ion channels, and transporters was evaluated.  Cyclic AMP production was measured from transfected HEK-293 cells.  In separate behavioral experiments, rats received different doses of PRX-07034 (0.1, 1, or 3 mg/kg, i.p.) 30 min prior to delayed spontaneous alternation testing or prior to the acquisition and switch phases in a place-response switch test.  RESULTS:  The results indicated that PRX-07034 is both a potent (Ki = 4-8 nM) and highly selective 5-HT(6) receptor antagonist (≥100-fold selectivity for the 5-HT(6) receptor compared to 68 other GPCRs, ion channels, and transporters, except D(3) (Ki = 71 nM) and 5-HT(1B) (Ki = 260 nM) receptors.  For cyclic AMP quantification, PRX-07034 demonstrated antagonist activity (IC(50) = 19 nM) without an effect on basal levels and did not show any agonist activity up to 10 μM.  PRX-07034 at 1 and 3 mg/kg (but not 0.1 mg/kg) significantly enhanced delayed spontaneous alternation.  The drug at 1 and 3 mg/kg also enhanced switching between a place and response strategy, but did not affect initial learning of either a place or response discrimination.  CONCLUSIONS:  These findings demonstrate that PRX-07034 is a selective 5-HT(6) receptor antagonist that may represent a novel treatment for enhancing working memory and cognitive flexibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkGoJom5qmh8K3uFsUIZtkfW6udTcc2eaNghKB4u99rrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zmsVWguw%253D%253D&md5=8327d396edea80aee527b7e3ffdc4905</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1007%2Fs00213-011-2518-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-011-2518-7%26sid%3Dliteratum%253Aachs%26aulast%3DMohler%26aufirst%3DE.%2BG.%26aulast%3DBaker%26aufirst%3DP.%2BM.%26aulast%3DGannon%26aufirst%3DK.%2BS.%26aulast%3DJones%26aufirst%3DS.%2BS.%26aulast%3DShacham%26aufirst%3DS.%26aulast%3DSweeney%26aufirst%3DJ.%2BA.%26aulast%3DRagozzino%26aufirst%3DM.%2BE.%26atitle%3DThe%2520effects%2520of%2520PRX-07034%252C%2520a%2520novel%25205-HT6%2520antagonist%252C%2520on%2520cognitive%2520flexibility%2520and%2520working%2520memory%2520in%2520rats%26jtitle%3DPsychopharmacology%2520%2528Berl%2529%26date%3D2012%26volume%3D220%26spage%3D687%26epage%3D696%26doi%3D10.1007%2Fs00213-011-2518-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Dayer, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobshagen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaumont-Dubel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marin, P.</span><span> </span><span class="NLM_article-title">5-HT<sub>6</sub> receptor: a new player controlling the development of neural circuits</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span><span class="refDoi"> DOI: 10.1021/cn500326z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn500326z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVOhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=951-960&author=A.+G.+Dayerauthor=M.+Jacobshagenauthor=S.+Chaumont-Dubelauthor=P.+Marin&title=5-HT6+receptor%3A+a+new+player+controlling+the+development+of+neural+circuits&doi=10.1021%2Fcn500326z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT6 Receptor: A New Player Controlling the Development of Neural Circuits</span></div><div class="casAuthors">Dayer, Alexandre G.; Jacobshagen, Moritz; Chaumont-Dubel, Severine; Marin, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">951-960</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  5-HT6 receptor (5-HT6R) is a G protein-coupled receptor that has recently emerged as a new regulator of neural development.  In addn. to the canonical Gs adenylyl cyclase pathway, recent proteomics approaches reveal that 5-HT6R is able to engage key developmental signaling pathways controlling neuronal circuit formation, neuronal connectivity, and psychiatric-relevant behaviors.  For example, at early stages of neuronal development, expression of 5-HT6R constitutively regulates the activity of the cyclin-dependent kinase (Cdk)5 and, through this mechanism, controls cellular processes involved in circuit formation, including neuronal migration and neurite outgrowth.  In addn. to the Cdk5 pathway, 5-HT6R modulates a variety of key developmental targets such as Fyn, Jab1, and mammalian target of rapamycin (mTOR).  Engagement of developmental pathways through 5-HT6R pharmacol. manipulation has led to interesting new therapeutic perspectives in the field of psychiatric-related disorders.  Indeed, 5-HT6R blockade can rescue a pathol. overactivation of the mTOR pathway induced by early life insults in rodents and normalizes the assocd. social and episodic memory deficits.  Here, we review recent evidence supporting the notion that 5-HT6R is at the interface of key developmental signaling pathways and a novel actor in the orchestration of neural circuit formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEHxmpdYBG_7Vg90H21EOLACvtfcHk0lhQan2S96NCRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVOhug%253D%253D&md5=6cf3566bebb39ebd1e4b121f79d1ac5a</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Fcn500326z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500326z%26sid%3Dliteratum%253Aachs%26aulast%3DDayer%26aufirst%3DA.%2BG.%26aulast%3DJacobshagen%26aufirst%3DM.%26aulast%3DChaumont-Dubel%26aufirst%3DS.%26aulast%3DMarin%26aufirst%3DP.%26atitle%3D5-HT6%2520receptor%253A%2520a%2520new%2520player%2520controlling%2520the%2520development%2520of%2520neural%2520circuits%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D951%26epage%3D960%26doi%3D10.1021%2Fcn500326z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Duhr, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Déléris, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Séveno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morisset-Lopez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannoury la Cour, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bockaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaumont-Dubel, S.</span><span> </span><span class="NLM_article-title">Cdk5 induces constitutive activation of 5-HT<sub>6</sub> receptors to promote neurite growth</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">590</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span><span class="refDoi"> DOI: 10.1038/nchembio.1547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnchembio.1547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24880860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFCgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=590-597&author=F.+Duhrauthor=P.+D%C3%A9l%C3%A9risauthor=F.+Raynaudauthor=M.+S%C3%A9venoauthor=S.+Morisset-Lopezauthor=C.+Mannoury+la+Courauthor=M.+J.+Millanauthor=J.+Bockaertauthor=P.+Marinauthor=S.+Chaumont-Dubel&title=Cdk5+induces+constitutive+activation+of+5-HT6+receptors+to+promote+neurite+growth&doi=10.1038%2Fnchembio.1547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growth</span></div><div class="casAuthors">Duhr, Fanny; Deleris, Paul; Raynaud, Fabrice; Seveno, Martial; Morisset-Lopez, Severine; Mannoury la Cour, Clotilde; Millan, Mark J.; Bockaert, Joel; Marin, Philippe; Chaumont-Dubel, Severine</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">590-597</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The serotonin6 receptor (5-HT6R) is a promising target for treating cognitive deficits of schizophrenia often linked to alterations of neuronal development.  This receptor controls neurodevelopmental processes, but the signaling mechanisms involved remain poorly understood.  Using a proteomic strategy, we show that 5-HT6Rs constitutively interact with cyclin-dependent kinase 5 (Cdk5).  Expression of 5-HT6Rs in NG108-15 cells induced neurite growth and expression of voltage-gated Ca2+ channels, two hallmarks of neuronal differentiation.  5-HT6R-elicited neurite growth was agonist independent and prevented by the 5-HT6R antagonist SB258585, which behaved as an inverse agonist.  Moreover, it required receptor phosphorylation at Ser350 by Cdk5 and Cdc42 activity.  Supporting a role of native 5-HT6Rs in neuronal differentiation, neurite growth of primary neurons was reduced by SB258585, by silencing 5-HT6R expression or by mutating Ser350 into alanine.  These results reveal a functional interplay between Cdk5 and a G protein-coupled receptor to control neuronal differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnZu_0TtuhmrVg90H21EOLACvtfcHk0lhQan2S96NCRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFCgt7s%253D&md5=8a4b4db83cffe9361f5c4ba5b27f25ba</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1547%26sid%3Dliteratum%253Aachs%26aulast%3DDuhr%26aufirst%3DF.%26aulast%3DD%25C3%25A9l%25C3%25A9ris%26aufirst%3DP.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DS%25C3%25A9veno%26aufirst%3DM.%26aulast%3DMorisset-Lopez%26aufirst%3DS.%26aulast%3DMannoury%2Bla%2BCour%26aufirst%3DC.%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DBockaert%26aufirst%3DJ.%26aulast%3DMarin%26aufirst%3DP.%26aulast%3DChaumont-Dubel%26aufirst%3DS.%26atitle%3DCdk5%2520induces%2520constitutive%2520activation%2520of%25205-HT6%2520receptors%2520to%2520promote%2520neurite%2520growth%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D590%26epage%3D597%26doi%3D10.1038%2Fnchembio.1547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Caliendo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santagada, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perissutti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorino, F.</span><span> </span><span class="NLM_article-title">Derivatives as 5HT<sub>1A</sub> receptor ligands–past and present</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1721</span><span class="NLM_x">–</span> <span class="NLM_lpage">1753</span><span class="refDoi"> DOI: 10.2174/0929867054367220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.2174%2F0929867054367220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=16029144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD2MXls1Wisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=1721-1753&author=G.+Caliendoauthor=V.+Santagadaauthor=E.+Perissuttiauthor=F.+Fiorino&title=Derivatives+as+5HT1A+receptor+ligands%E2%80%93past+and+present&doi=10.2174%2F0929867054367220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Derivatives as 5HT1A receptor ligands-past and present</span></div><div class="casAuthors">Caliendo, G.; Santagada, V.; Perissutti, E.; Fiorino, F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1721-1753</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Serotonin is a neuromediator, well-know for its implication in mood regulation, anxiety, depression and, insomnia as well as in normal human function such as sleep, sexual activity and appetite.  In this way, serotonin (5-hydroxytryptamine, 5-HT) is one of the most attractive targets for medicinal chemists and pharmaceutical companies.  Among 5-HTRs, the 5-HT1A subtype is the best studied, and it is generally accepted that it is involved in psychiatric disorders such as anxiety and depression.  Several structurally different compds. are known to bind 5-HT1A receptor sites such as aminotetralins, ergolines, arylpiperazines, indolylalkylamines, aporphines and aryloxyalkylamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNq1YopI8Ho7Vg90H21EOLACvtfcHk0lhQan2S96NCRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXls1Wisrg%253D&md5=42c78fb99de63e801880ae4577fe3583</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.2174%2F0929867054367220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867054367220%26sid%3Dliteratum%253Aachs%26aulast%3DCaliendo%26aufirst%3DG.%26aulast%3DSantagada%26aufirst%3DV.%26aulast%3DPerissutti%26aufirst%3DE.%26aulast%3DFiorino%26aufirst%3DF.%26atitle%3DDerivatives%2520as%25205HT1A%2520receptor%2520ligands%25E2%2580%2593past%2520and%2520present%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D1721%26epage%3D1753%26doi%3D10.2174%2F0929867054367220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tricklebank, M. D.</span><span> </span><span class="NLM_article-title">Centrally active 5-HT receptor agonists and antagonists</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1016/S0149-7634(05)80054-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0149-7634%2805%2980054-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1992&pages=75-82&author=D.+N.+Middlemissauthor=M.+D.+Tricklebank&title=Centrally+active+5-HT+receptor+agonists+and+antagonists&doi=10.1016%2FS0149-7634%2805%2980054-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1016%2FS0149-7634%2805%2980054-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0149-7634%252805%252980054-5%26sid%3Dliteratum%253Aachs%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DTricklebank%26aufirst%3DM.%2BD.%26atitle%3DCentrally%2520active%25205-HT%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D1992%26volume%3D16%26spage%3D75%26epage%3D82%26doi%3D10.1016%2FS0149-7634%2805%2980054-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Leysen, J. E.</span><span> </span><span class="NLM_article-title">5-HT<sub>2</sub> receptors</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">11</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.2174/1568007043482598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.2174%2F1568007043482598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=14965241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=11-26&author=J.+E.+Leysen&title=5-HT2+receptors&doi=10.2174%2F1568007043482598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2 receptors</span></div><div class="casAuthors">Leysen, J. E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-26</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  5-HT2 receptors are G-protein coupled receptors that currently comprise 3 subtypes: 5-HT2A, 5-HT2B, and 5-HT2C receptors.  The subtypes are related in their mol. structure, amino acid sequence, and signaling properties.  5-HT2A and 5-HT2C receptors have a widespread distribution and function in the central nervous system.  5-HT2A and 5-HT2C receptor antagonism is a property of certain antipsychotic and antidepressant drugs.  5-HT2B receptors have a restricted expression in the central nervous system.  They have an important role in embryogenesis and in the periphery.  In this article, selected aspects of 5-HT2 receptor research are reviewed for each subtype under 3 main headings: (1) genes, protein structure, and receptor signaling; (2) receptor localization with emphasis on the CNS, and (3) compds.  The general discussion reflects on the reasons for the limited success in the clinic of 5-HT2 receptor subtype selective drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAGTjJwjn8erVg90H21EOLACvtfcHk0lgAirs3Zr-P9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWksrk%253D&md5=9f7316c92e674a8c1cf7b13f48d9711a</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.2174%2F1568007043482598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043482598%26sid%3Dliteratum%253Aachs%26aulast%3DLeysen%26aufirst%3DJ.%2BE.%26atitle%3D5-HT2%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D11%26epage%3D26%26doi%3D10.2174%2F1568007043482598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Benhamú, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martín-Fontecha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vázquez-Villa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Rodríguez, M. L.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>6</sub> receptor antagonists for the treatment of cognitive deficiency in Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">7160</span><span class="NLM_x">–</span> <span class="NLM_lpage">7181</span><span class="refDoi"> DOI: 10.1021/jm5003952</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5003952" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVWjs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=7160-7181&author=B.+Benham%C3%BAauthor=M.+Mart%C3%ADn-Fontechaauthor=H.+V%C3%A1zquez-Villaauthor=L.+Pardoauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&title=Serotonin+5-HT6+receptor+antagonists+for+the+treatment+of+cognitive+deficiency+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm5003952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT6 Receptor Antagonists for the Treatment of Cognitive Deficiency in Alzheimer's Disease</span></div><div class="casAuthors">Benhamu, Bellinda; Martin-Fontecha, Mar; Vazquez-Villa, Henar; Pardo, Leonardo; Lopez-Rodriguez, Maria L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7160-7181</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is one of the most frequent causes of death and disability worldwide and has a significant clin. and socioeconomic impact.  In the search for novel therapeutic strategies, serotonin 5-HT6 receptor (5-HT6R) has been proposed as a promising drug target for cognition enhancement in AD.  This manuscript reviews the compelling evidence for the implication of this receptor in learning and memory processes.  We have summarized the current status of the medicinal chem. of 5-HT6R antagonists and the encouraging preclin. findings that demonstrate their significant procognitive behavioral effects in a no. of learning paradigms, probably acting through modulation of multiple neurotransmitter systems and signaling pathways.  The results of the ongoing clin. trials are eagerly awaited to shed some light on the validation of 5-HT6R antagonists as a new drug class for the treatment of symptomatic cognitive impairment in AD, either as stand-alone therapy or in combination with established agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeTO6_2THvaLVg90H21EOLACvtfcHk0lgAirs3Zr-P9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVWjs7c%253D&md5=bf8d2cba73f72e04a5caf8b295647064</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1021%2Fjm5003952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5003952%26sid%3Dliteratum%253Aachs%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DMart%25C3%25ADn-Fontecha%26aufirst%3DM.%26aulast%3DV%25C3%25A1zquez-Villa%26aufirst%3DH.%26aulast%3DPardo%26aufirst%3DL.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DSerotonin%25205-HT6%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520cognitive%2520deficiency%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D7160%26epage%3D7181%26doi%3D10.1021%2Fjm5003952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group">Leopoldo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacivita, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span> </span><span class="NLM_article-title">Serotonin 5-HT<sub>7</sub> receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2010.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.pharmthera.2010.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20923682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVantQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2011&pages=120-148&author=M.+Leopoldoauthor=E.+Lacivitaauthor=F.+Berardiauthor=R.+Perroneauthor=P.+B.+Hedlund&title=Serotonin+5-HT7+receptor+agents%3A+Structure-activity+relationships+and+potential+therapeutic+applications+in+central+nervous+system+disorders&doi=10.1016%2Fj.pharmthera.2010.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders</span></div><div class="casAuthors">Leopoldo, Marcello; Lacivita, Enza; Berardi, Francesco; Perrone, Roberto; Hedlund, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">120-148</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Since its discovery in the 1940s in serum, the mammalian intestinal mucosa, and in the central nervous system, serotonin (5-HT) has been shown to be involved in virtually all cognitive and behavioral human functions, and alterations in its neurochem. have been implicated in the etiol. of a plethora of neuropsychiatric disorders.  The cloning of 5-HT receptor subtypes has been of importance in enabling them to be classified as specific protein mols. encoded by specific genes.  The 5-HT7 receptor is the most recently classified member of the serotonin receptor family.  Since its identification, it has been the subject of intense research efforts driven by its presence in functionally relevant regions of the brain.  The availability of some selective antagonists and agonists, in combination with genetically modified mice lacking the 5-HT7 receptor, has allowed for a better understanding of the pathophysiol. role of this receptor.  This paper reviews data on localization and pharmacol. properties of the 5-HT7 receptor, and summarizes the results of structure-activity relationship studies aimed at the discovery of selective 5-HT7 receptor ligands.  Addnl., an overview of the potential therapeutic applications of 5-HT7 receptor agonists and antagonists in central nervous system disorders is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWPpaPQfXAkrVg90H21EOLACvtfcHk0lg67EkgO2-SyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVantQ%253D%253D&md5=060ef6a028b4f9a2b6f842a2accdae2c</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2010.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2010.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DLeopoldo%26aufirst%3DM.%26aulast%3DLacivita%26aufirst%3DE.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26atitle%3DSerotonin%25205-HT7%2520receptor%2520agents%253A%2520Structure-activity%2520relationships%2520and%2520potential%2520therapeutic%2520applications%2520in%2520central%2520nervous%2520system%2520disorders%26jtitle%3DPharmacol.%2520Ther.%26date%3D2011%26volume%3D129%26spage%3D120%26epage%3D148%26doi%3D10.1016%2Fj.pharmthera.2010.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group">Karvat, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimchi, T.</span><span> </span><span class="NLM_article-title">Acetylcholine elevation relieves cognitive rigidity and social deficiency in a mouse model of autism</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">840</span><span class="refDoi"> DOI: 10.1038/npp.2013.274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnpp.2013.274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24096295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslajsrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=831-840&author=G.+Karvatauthor=T.+Kimchi&title=Acetylcholine+elevation+relieves+cognitive+rigidity+and+social+deficiency+in+a+mouse+model+of+autism&doi=10.1038%2Fnpp.2013.274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholine Elevation Relieves Cognitive Rigidity and Social Deficiency in a Mouse Model of Autism</span></div><div class="casAuthors">Karvat, Golan; Kimchi, Tali</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">831-840</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Autism spectrum disorders (ASD) are defined by behavioral deficits in social interaction and communication, repetitive stereotyped behaviors, and restricted interests/cognitive rigidity.  Recent studies in humans and animal-models suggest that dysfunction of the cholinergic system may underlie autism-related behavioral symptoms.  Here we tested the hypothesis that augmentation of acetylcholine (ACh) in the synaptic cleft by inhibiting acetylcholinesterase may ameliorate autistic phenotypes.  We first administered the acetylcholinesterase inhibitor (AChEI) Donepezil systemically by i.p. (i.p.) injections.  Second, the drug was injected directly into the rodent homolog of the caudate nucleus, the dorsomedial striatum (DMS), of the inbred mouse strain BTBR T+tf/J (BTBR), a commonly-used model presenting all core autism-related phenotypes and expressing low brain ACh levels.  We found that i.p. injection of AChEI to BTBR mice significantly relieved autism-relevant phenotypes, including decreasing cognitive rigidity, improving social preference, and enhancing social interaction, in a dose-dependent manner.  Microinjection of the drug directly into the DMS, but not into the ventromedial striatum, led to significant amelioration of the cognitive-rigidity and social-deficiency phenotypes.  Taken together, these findings provide evidence of the key role of the cholinergic system and the DMS in the etiol. of ASD, and suggest that elevated cognitive flexibility may result in enhanced social attention.  The potential therapeutic effect of AChEIs in ASD patients is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBinNVK7MHerVg90H21EOLACvtfcHk0lg67EkgO2-SyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslajsrbO&md5=bc0d5545c633d39211738897307d0a9c</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2013.274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2013.274%26sid%3Dliteratum%253Aachs%26aulast%3DKarvat%26aufirst%3DG.%26aulast%3DKimchi%26aufirst%3DT.%26atitle%3DAcetylcholine%2520elevation%2520relieves%2520cognitive%2520rigidity%2520and%2520social%2520deficiency%2520in%2520a%2520mouse%2520model%2520of%2520autism%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D831%26epage%3D840%26doi%3D10.1038%2Fnpp.2013.274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group">Deutsch, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burket, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbano, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, A. D.</span><span> </span><span class="NLM_article-title">The α7 nicotinic acetylcholine receptor: a mediator of pathogenesis and therapeutic target in autism spectrum disorders and Down syndrome</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span><span class="refDoi"> DOI: 10.1016/j.bcp.2015.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bcp.2015.06.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=363-377&author=S.+I.+Deutschauthor=J.+A.+Burketauthor=M.+R.+Urbanoauthor=A.+D.+Benson&title=The+%CE%B17+nicotinic+acetylcholine+receptor%3A+a+mediator+of+pathogenesis+and+therapeutic+target+in+autism+spectrum+disorders+and+Down+syndrome&doi=10.1016%2Fj.bcp.2015.06.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2015.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2015.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DDeutsch%26aufirst%3DS.%2BI.%26aulast%3DBurket%26aufirst%3DJ.%2BA.%26aulast%3DUrbano%26aufirst%3DM.%2BR.%26aulast%3DBenson%26aufirst%3DA.%2BD.%26atitle%3DThe%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%253A%2520a%2520mediator%2520of%2520pathogenesis%2520and%2520therapeutic%2520target%2520in%2520autism%2520spectrum%2520disorders%2520and%2520Down%2520syndrome%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2015%26volume%3D97%26spage%3D363%26epage%3D377%26doi%3D10.1016%2Fj.bcp.2015.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group">Deutsch, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbano, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burket, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herndon, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winebarger, E. E.</span><span> </span><span class="NLM_article-title">Pharmacotherapeutic implications of the association between genomic instability at chromosome 15q13.3 and autism spectrum disorders</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span><span class="refDoi"> DOI: 10.1097/WNF.0b013e31823a1247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1097%2FWNF.0b013e31823a1247" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2011&pages=203-205&author=S.+I.+Deutschauthor=M.+R.+Urbanoauthor=J.+A.+Burketauthor=A.+L.+Herndonauthor=E.+E.+Winebarger&title=Pharmacotherapeutic+implications+of+the+association+between+genomic+instability+at+chromosome+15q13.3+and+autism+spectrum+disorders&doi=10.1097%2FWNF.0b013e31823a1247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1097%2FWNF.0b013e31823a1247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FWNF.0b013e31823a1247%26sid%3Dliteratum%253Aachs%26aulast%3DDeutsch%26aufirst%3DS.%2BI.%26aulast%3DUrbano%26aufirst%3DM.%2BR.%26aulast%3DBurket%26aufirst%3DJ.%2BA.%26aulast%3DHerndon%26aufirst%3DA.%2BL.%26aulast%3DWinebarger%26aufirst%3DE.%2BE.%26atitle%3DPharmacotherapeutic%2520implications%2520of%2520the%2520association%2520between%2520genomic%2520instability%2520at%2520chromosome%252015q13.3%2520and%2520autism%2520spectrum%2520disorders%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2011%26volume%3D34%26spage%3D203%26epage%3D205%26doi%3D10.1097%2FWNF.0b013e31823a1247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudweeks, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakel, J. L.</span><span> </span><span class="NLM_article-title">Nicotinic receptors in the brain: correlating physiology with function</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span><span class="refDoi"> DOI: 10.1016/S0166-2236(99)01471-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0166-2236%2899%2901471-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10542436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADyaK1MXntlegtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1999&pages=555-561&author=S.+Jonesauthor=S.+Sudweeksauthor=J.+L.+Yakel&title=Nicotinic+receptors+in+the+brain%3A+correlating+physiology+with+function&doi=10.1016%2FS0166-2236%2899%2901471-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Nicotinic receptors in the brain: correlating physiology with function</span></div><div class="casAuthors">Jones, S.; Sudweeks, S.; Yakel, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">555-561</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 69 refs.  Nicotinic ACh receptors (nAChRs) have been implicated in a variety of brain functions, including neuronal development, learning and memory formation, and reward.  Although there are substantial data indicating that nAChR subunits are found in many brain regions, the precise cellular roles of these subunits in neuronal functions have remained elusive.  Until recently, nAChRs were thought primarily to serve a modulatory role in the brain by regulating neurotransmitter release from nerve terminals.  However, new evidence has revealed that nAChRs also function in a postsynaptic role by mediating fast ACh-mediated synaptic transmission in the hippocampus and in the sensory cortex, and are found at somatodendritic as well as nerve terminal sites in the reward system.  It is possible that presynaptic and postsynaptic nAChRs mediate changes in the efficacy of synaptic transmission in these brain regions.  These changes could underlie the proposed functions of nAChRs in cognitive functions of the hippocampus and cerebral cortex, in neuronal development in the sensory cortex, and in reward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXA9Bxc8k8kbVg90H21EOLACvtfcHk0lg67EkgO2-SyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntlegtbg%253D&md5=a099fd4c62c8bd6eb3a658ed606680eb</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1016%2FS0166-2236%2899%2901471-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-2236%252899%252901471-X%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DS.%26aulast%3DSudweeks%26aufirst%3DS.%26aulast%3DYakel%26aufirst%3DJ.%2BL.%26atitle%3DNicotinic%2520receptors%2520in%2520the%2520brain%253A%2520correlating%2520physiology%2520with%2520function%26jtitle%3DTrends%2520Neurosci.%26date%3D1999%26volume%3D22%26spage%3D555%26epage%3D561%26doi%3D10.1016%2FS0166-2236%2899%2901471-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group">Beinat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banister, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrera, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassiou, M.</span><span> </span><span class="NLM_article-title">The recent development of α7 nicotinic acetylcholine receptor (nAChR) ligands as therapeutic candidates for the treatment of central nervous system (CNS) diseases</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2134</span><span class="NLM_x">–</span> <span class="NLM_lpage">2151</span><span class="refDoi"> DOI: 10.2174/1381612822666160127114125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.2174%2F1381612822666160127114125" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=2134-2151&author=C.+Beinatauthor=S.+D.+Banisterauthor=M.+Herreraauthor=M.+Kassiou&title=The+recent+development+of+%CE%B17+nicotinic+acetylcholine+receptor+%28nAChR%29+ligands+as+therapeutic+candidates+for+the+treatment+of+central+nervous+system+%28CNS%29+diseases&doi=10.2174%2F1381612822666160127114125"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.2174%2F1381612822666160127114125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612822666160127114125%26sid%3Dliteratum%253Aachs%26aulast%3DBeinat%26aufirst%3DC.%26aulast%3DBanister%26aufirst%3DS.%2BD.%26aulast%3DHerrera%26aufirst%3DM.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DThe%2520recent%2520development%2520of%2520%25CE%25B17%2520nicotinic%2520acetylcholine%2520receptor%2520%2528nAChR%2529%2520ligands%2520as%2520therapeutic%2520candidates%2520for%2520the%2520treatment%2520of%2520central%2520nervous%2520system%2520%2528CNS%2529%2520diseases%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2016%26volume%3D22%26spage%3D2134%26epage%3D2151%26doi%3D10.2174%2F1381612822666160127114125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group">Jones, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span> </span><span class="NLM_article-title">Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1038/npp.2011.199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnpp.2011.199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21956443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ejsrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=16-42&author=C.+K.+Jonesauthor=N.+Byunauthor=M.+Bubser&title=Muscarinic+and+nicotinic+acetylcholine+receptor+agonists+and+allosteric+modulators+for+the+treatment+of+schizophrenia&doi=10.1038%2Fnpp.2011.199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of Schizophrenia</span></div><div class="casAuthors">Jones, Carrie K.; Byun, Nellie; Bubser, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-42</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Muscarinic and nicotinic acetylcholine (ACh) receptors (mAChRs and nAChRs) are emerging as important targets for the development of novel treatments for the symptoms assocd. with schizophrenia.  Preclin. and early proof-of-concept clin. studies have provided strong evidence that activators of specific mAChR (M1 and M4) and nAChR (α7 and α2β4) subtypes are effective in animal models of antipsychotic-like activity and/or cognitive enhancement, and in the treatment of pos. and cognitive symptoms in patients with schizophrenia.  While early attempts to develop selective mAChR and nAChR agonists provided important preliminary findings, these compds. have ultimately failed in clin. development due to a lack of true subtype selectivity and subsequent dose-limiting adverse effects.  In recent years, there have been major advances in the discovery of highly selective activators for the different mAChR and nAChR subtypes with suitable properties for optimization as potential candidates for clin. trials.  One novel strategy has been to identify ligands that activate a specific receptor subtype through actions at sites that are distinct from the highly conserved ACh-binding site, termed allosteric sites.  These allosteric activators, both allosteric agonists and pos. allosteric modulators, of mAChR and nAChR subtypes demonstrate unique mechanisms of action and high selectivity in vivo, and may provide innovative treatment strategies for schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-WrW81ixmbrVg90H21EOLACvtfcHk0ljQMVvYQ0p5Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ejsrfP&md5=75e618b3697dba8e8bd3b3b5e6deecaa</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.199%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DByun%26aufirst%3DN.%26aulast%3DBubser%26aufirst%3DM.%26atitle%3DMuscarinic%2520and%2520nicotinic%2520acetylcholine%2520receptor%2520agonists%2520and%2520allosteric%2520modulators%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D16%26epage%3D42%26doi%3D10.1038%2Fnpp.2011.199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajós, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raggenbass, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higdon, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford-Root, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkenpas, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groppi, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allaman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arneric, S. P.</span><span> </span><span class="NLM_article-title">A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4396</span><span class="NLM_x">–</span> <span class="NLM_lpage">4405</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.5269-04.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1523%2FJNEUROSCI.5269-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=15858066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFKgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=4396-4405&author=R.+S.+Hurstauthor=M.+Haj%C3%B3sauthor=M.+Raggenbassauthor=T.+M.+Wallauthor=N.+R.+Higdonauthor=J.+A.+Lawsonauthor=K.+L.+Rutherford-Rootauthor=M.+B.+Berkenpasauthor=W.+E.+Hoffmannauthor=D.+W.+Piotrowskiauthor=V.+E.+Groppiauthor=G.+Allamanauthor=R.+Ogierauthor=S.+Bertrandauthor=D.+Bertrandauthor=S.+P.+Arneric&title=A+novel+positive+allosteric+modulator+of+the+alpha7+neuronal+nicotinic+acetylcholine+receptor%3A+in+vitro+and+in+vivo+characterization&doi=10.1523%2FJNEUROSCI.5269-04.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">A novel positive allosteric modulator of the α7 neuronal nicotinic acetylcholine receptor: In vitro and in vivo characterization</span></div><div class="casAuthors">Hurst, Raymond S.; Hajos, Mihaly; Raggenbass, Mario; Wall, Theron M.; Higdon, Nicole R.; Lawson, Judy A.; Rutherford-Root, Karen L.; Berkenpas, Mitchell B.; Hoffmann, W. E.; Piotrowski, David W.; Groppi, Vincent E.; Allaman, Geraldine; Ogier, Roch; Bertrand, Sonia; Bertrand, Daniel; Arneric, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4396-4405</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Several lines of evidence suggest a link between the α7 neuronal nicotinic acetylcholine receptor (nAChR) and brain disorders including schizophrenia, Alzheimer's disease, and traumatic brain injury.  The present work describes a novel mol., 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(5-methyl-isoxazol-3-yl)-urea (PNU-120596), which acts as a powerful pos. allosteric modulator of the α7 nAChR.  Discovered in a high-throughput screen, PNU-120596 increased agonist-evoked calcium flux mediated by an engineered variant of the human α7 nAChR.  Electrophysiol. studies confirmed that PNU-120596 increased peak agonist-evoked currents mediated by wild-type receptors and also demonstrated a pronounced prolongation of the evoked response in the continued presence of agonist.  In contrast, PNU-120596 produced no detectable change in currents mediated by α4β2, α3β4, and α9α10 nAChRs.  PNU-120596 increased the channel mean open time of α7 nAChRs but had no effect on ion selectivity and relatively little, if any, effect on unitary conductance.  When applied to acute hippocampal slices, PNU-120596 increased the frequency of ACh-evoked GABAergic postsynaptic currents measured in pyramidal neurons; this effect was suppressed by TTX, suggesting that PNU-120596 modulated the function of α7 nAChRs located on the somatodendritic membrane of hippocampal interneurons.  Accordingly, PNU-120596 greatly enhanced the ACh-evoked inward currents in these interneurons.  Systemic administration of PNU-120596 to rats improved the auditory gating deficit caused by amphetamine, a model proposed to reflect a circuit level disturbance assocd. with schizophrenia.  Together, these results suggest that PNU-120596 represents a new class of mol. that enhances α7 nAChR function and thus has the potential to treat psychiatric and neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq26WDVJ3sdGLVg90H21EOLACvtfcHk0ljQMVvYQ0p5Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFKgtLo%253D&md5=39dd78bcd96ebff54a2beb7d67b68e33</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5269-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5269-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DHaj%25C3%25B3s%26aufirst%3DM.%26aulast%3DRaggenbass%26aufirst%3DM.%26aulast%3DWall%26aufirst%3DT.%2BM.%26aulast%3DHigdon%26aufirst%3DN.%2BR.%26aulast%3DLawson%26aufirst%3DJ.%2BA.%26aulast%3DRutherford-Root%26aufirst%3DK.%2BL.%26aulast%3DBerkenpas%26aufirst%3DM.%2BB.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DAllaman%26aufirst%3DG.%26aulast%3DOgier%26aufirst%3DR.%26aulast%3DBertrand%26aufirst%3DS.%26aulast%3DBertrand%26aufirst%3DD.%26aulast%3DArneric%26aufirst%3DS.%2BP.%26atitle%3DA%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520the%2520alpha7%2520neuronal%2520nicotinic%2520acetylcholine%2520receptor%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520characterization%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D4396%26epage%3D4405%26doi%3D10.1523%2FJNEUROSCI.5269-04.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group">Faghih, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gronlien, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malysz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetterstrand, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ween, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarris, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gfesser, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kouhen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robb, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radek, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnelle, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalakrishnan, M.</span><span> </span><span class="NLM_article-title">Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3377</span><span class="NLM_x">–</span> <span class="NLM_lpage">3384</span><span class="refDoi"> DOI: 10.1021/jm9003818</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9003818" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3377-3384&author=R.+Faghihauthor=S.+M.+Gopalakrishnanauthor=J.+H.+Gronlienauthor=J.+Malyszauthor=C.+A.+Briggsauthor=C.+Wetterstrandauthor=H.+Weenauthor=M.+P.+Curtisauthor=K.+A.+Sarrisauthor=G.+A.+Gfesserauthor=R.+El-Kouhenauthor=H.+M.+Robbauthor=R.+J.+Radekauthor=K.+C.+Marshauthor=W.+H.+Bunnelleauthor=M.+Gopalakrishnan&title=Discovery+of+4-%285-%284-chlorophenyl%29-2-methyl-3-propionyl-1H-pyrrol-1-yl%29benzenesulfonamide+%28A-867744%29+as+a+novel+positive+allosteric+modulator+of+the+alpha7+nicotinic+acetylcholine+receptor&doi=10.1021%2Fjm9003818"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1021%2Fjm9003818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9003818%26sid%3Dliteratum%253Aachs%26aulast%3DFaghih%26aufirst%3DR.%26aulast%3DGopalakrishnan%26aufirst%3DS.%2BM.%26aulast%3DGronlien%26aufirst%3DJ.%2BH.%26aulast%3DMalysz%26aufirst%3DJ.%26aulast%3DBriggs%26aufirst%3DC.%2BA.%26aulast%3DWetterstrand%26aufirst%3DC.%26aulast%3DWeen%26aufirst%3DH.%26aulast%3DCurtis%26aufirst%3DM.%2BP.%26aulast%3DSarris%26aufirst%3DK.%2BA.%26aulast%3DGfesser%26aufirst%3DG.%2BA.%26aulast%3DEl-Kouhen%26aufirst%3DR.%26aulast%3DRobb%26aufirst%3DH.%2BM.%26aulast%3DRadek%26aufirst%3DR.%2BJ.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DBunnelle%26aufirst%3DW.%2BH.%26aulast%3DGopalakrishnan%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25204-%25285-%25284-chlorophenyl%2529-2-methyl-3-propionyl-1H-pyrrol-1-yl%2529benzenesulfonamide%2520%2528A-867744%2529%2520as%2520a%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520the%2520alpha7%2520nicotinic%2520acetylcholine%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3377%26epage%3D3384%26doi%3D10.1021%2Fjm9003818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group">Carter, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witt, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insel, T. R.</span><span> </span><span class="NLM_article-title">Oxytocin and social bonding</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">652</span><span class="NLM_x">, </span> <span class="NLM_fpage">204</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span><span class="refDoi"> DOI: 10.1111/j.1749-6632.1992.tb34356.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1111%2Fj.1749-6632.1992.tb34356.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=652&publication_year=1992&pages=204-211&author=C.+S.+Carterauthor=J.+R.+Williamsauthor=D.+M.+Wittauthor=T.+R.+Insel&title=Oxytocin+and+social+bonding&doi=10.1111%2Fj.1749-6632.1992.tb34356.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.1992.tb34356.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.1992.tb34356.x%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DC.%2BS.%26aulast%3DWilliams%26aufirst%3DJ.%2BR.%26aulast%3DWitt%26aufirst%3DD.%2BM.%26aulast%3DInsel%26aufirst%3DT.%2BR.%26atitle%3DOxytocin%2520and%2520social%2520bonding%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1992%26volume%3D652%26spage%3D204%26epage%3D211%26doi%3D10.1111%2Fj.1749-6632.1992.tb34356.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group">Insel, T. R.</span><span> </span><span class="NLM_article-title">A neurobiological basis of social attachment</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">735</span><span class="refDoi"> DOI: 10.1176/ajp.154.6.726</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1176%2Fajp.154.6.726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=9167498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADyaK2szhtVegsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=1997&pages=726-735&author=T.+R.+Insel&title=A+neurobiological+basis+of+social+attachment&doi=10.1176%2Fajp.154.6.726"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">A neurobiological basis of social attachment</span></div><div class="casAuthors">Insel T R</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">726-35</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Although an inability to form normal social attachments characterizes many forms of psychopathology, there has been little study of the neural basis of social bond formation.  The primary purpose of this article is to describe a novel approach to the neurobiology of attachment.  METHOD:  The author reviews animal research on two closely related neuropeptides, oxytocin and vasopressin, implicated in the central mediation of attachment behaviors.  These neuropeptides appear to be important for the initiation of pair bonds and parental behaviors as well as the infant's response to social separation.  RESULTS:  Both cellular and molecular studies have begun to reveal the mechanisms by which oxytocin and vasopressin neural pathways are regulated, leading to a preliminary understanding of how these hormones act within the brain to influence complex social behaviors.  CONCLUSIONS:  Although their function in the human brain has yet to be demonstrated, the available evidence suggests that oxytocin and vasopressin may prove to be important in the pathophysiology of clinical disorders, such as autism, characterized by an inability to form normal social attachments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRXx1ktA_8fRHO4gDb7JggCfW6udTcc2eYfii9sf2bpkbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2szhtVegsw%253D%253D&md5=2175549d30474a0c51c4757df1b9949c</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1176%2Fajp.154.6.726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fajp.154.6.726%26sid%3Dliteratum%253Aachs%26aulast%3DInsel%26aufirst%3DT.%2BR.%26atitle%3DA%2520neurobiological%2520basis%2520of%2520social%2520attachment%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D1997%26volume%3D154%26spage%3D726%26epage%3D735%26doi%3D10.1176%2Fajp.154.6.726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group">Modahl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterhouse, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, H.</span><span> </span><span class="NLM_article-title">Plasma oxytocin levels in autistic children</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span><span class="refDoi"> DOI: 10.1016/S0006-3223(97)00439-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0006-3223%2897%2900439-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=9513736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADyaK1c7nsV2hsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1998&pages=270-277&author=C.+Modahlauthor=L.+Greenauthor=D.+Feinauthor=M.+Morrisauthor=L.+Waterhouseauthor=C.+Feinsteinauthor=H.+Levin&title=Plasma+oxytocin+levels+in+autistic+children&doi=10.1016%2FS0006-3223%2897%2900439-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma oxytocin levels in autistic children</span></div><div class="casAuthors">Modahl C; Green L; Fein D; Morris M; Waterhouse L; Feinstein C; Levin H</div><div class="citationInfo"><span class="NLM_cas:title">Biological psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">270-7</span>
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    </div><div class="casAbstract">BACKGROUND:  Social impairments are central to the syndrome of autism.  The neuropeptide oxytocin (OT) has been implicated in the regulation of social behavior in animals but has not yet been examined in autistic subjects.  METHODS:  To determine whether autistic children have abnormalities in OT, midday plasma samples from 29 autistic and 30 age-matched normal children, all prepubertal, were analyzed by radioimmunoassay for levels of OT.  RESULTS:  Despite individual variability and overlapping group distributions, the autistic group had significantly lower plasma OT levels than the normal group.  OT increased with age in the normal but not the autistic children.  Elevated OT was associated with higher scores on social and developmental measures for the normal children, but was associated with lower scores for the autistic children.  These relationships were strongest in a subset of autistic children identified as aloof.  CONCLUSIONS:  Although making inferences to central OT functioning from peripheral measurement is difficult, the data suggest that OT abnormalities may exist in autism, and that more direct investigation of central nervous system OT function is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkrIn8D9W2z2LFM_lbR1VmfW6udTcc2ebgcd41rmfc3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c7nsV2hsQ%253D%253D&md5=36ba0a757dc1cfee81be20d30132122b</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2897%2900439-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252897%252900439-3%26sid%3Dliteratum%253Aachs%26aulast%3DModahl%26aufirst%3DC.%26aulast%3DGreen%26aufirst%3DL.%26aulast%3DFein%26aufirst%3DD.%26aulast%3DMorris%26aufirst%3DM.%26aulast%3DWaterhouse%26aufirst%3DL.%26aulast%3DFeinstein%26aufirst%3DC.%26aulast%3DLevin%26aufirst%3DH.%26atitle%3DPlasma%2520oxytocin%2520levels%2520in%2520autistic%2520children%26jtitle%3DBiol.%2520Psychiatry%26date%3D1998%26volume%3D43%26spage%3D270%26epage%3D277%26doi%3D10.1016%2FS0006-3223%2897%2900439-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group">Green, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modahl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterhouse, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M.</span><span> </span><span class="NLM_article-title">Oxytocin and autistic disorder: alterations in peptide forms</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span><span class="refDoi"> DOI: 10.1016/S0006-3223(01)01139-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0006-3223%2801%2901139-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=11690596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvFGqsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=609-613&author=L.+Greenauthor=D.+Feinauthor=C.+Modahlauthor=C.+Feinsteinauthor=L.+Waterhouseauthor=M.+Morris&title=Oxytocin+and+autistic+disorder%3A+alterations+in+peptide+forms&doi=10.1016%2FS0006-3223%2801%2901139-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin and autistic disorder: alterations in peptide forms</span></div><div class="casAuthors">Green, LeeAnne; Fein, Deborah; Modahl, Charlotte; Feinstein, Carl; Waterhouse, Lynn; Morris, Mariana</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">609-613</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Oxytocin (OT) is synthesized as a prohormone that is sequentially processed to peptides.  These peptides are the bioactive amidated form (OT) and the C-terminal extended peptides, OT-Gly, OT-Gly-Lys and OT-Gly-Lys-Arg, which are designated together as OT-X.  As an extension of our previous study finding decreased plasma OT in autism, studies were conducted to det. whether there were changes in OT peptide forms in autistic children.  28 Male subjects (97 ± 20 mo; range, 70-139 mo), diagnosed with DSM-IV autistic disorder through observation and semi-structured interview, were compared with 31 age-matched nonpsychiatric control subjects (106 ± 22 mo; range, 74-140 mo).  Using OT antisera with different specificity for the peptide forms, the authors measured plasma OT and OT-X in each group.  T tests showed that there was a decrease in plasma OT (t = 4.4, p < .0001), an increase in OT-X (t = 2.3, p < .03) and an increase in the ratio of OT-X/OT (t = 4.5, p < .0001) in the autistic sample, compared with control subjects.  The results suggest that children with autistic disorder show alterations in the endocrine OT system.  Deficits in OT peptide processing in children with autism may be important in the development of this syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy-zzsrIaaKbVg90H21EOLACvtfcHk0liRZ9iTxTDNzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvFGqsLc%253D&md5=50b8f68beebf1d162e59b8f4e5f8132e</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2801%2901139-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252801%252901139-8%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DL.%26aulast%3DFein%26aufirst%3DD.%26aulast%3DModahl%26aufirst%3DC.%26aulast%3DFeinstein%26aufirst%3DC.%26aulast%3DWaterhouse%26aufirst%3DL.%26aulast%3DMorris%26aufirst%3DM.%26atitle%3DOxytocin%2520and%2520autistic%2520disorder%253A%2520alterations%2520in%2520peptide%2520forms%26jtitle%3DBiol.%2520Psychiatry%26date%3D2001%26volume%3D50%26spage%3D609%26epage%3D613%26doi%3D10.1016%2FS0006-3223%2801%2901139-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group">LoParo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, I. D.</span><span> </span><span class="NLM_article-title">The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: a meta-analysis</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">640</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span><span class="refDoi"> DOI: 10.1038/mp.2014.77</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fmp.2014.77" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25092245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2cbovVSmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=640-646&author=D.+LoParoauthor=I.+D.+Waldman&title=The+oxytocin+receptor+gene+%28OXTR%29+is+associated+with+autism+spectrum+disorder%3A+a+meta-analysis&doi=10.1038%2Fmp.2014.77"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: a meta-analysis</span></div><div class="casAuthors">LoParo D; Waldman I D</div><div class="citationInfo"><span class="NLM_cas:title">Molecular psychiatry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">640-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The oxytocin receptor gene (OXTR) has been studied as a risk factor for autism spectrum disorder (ASD) owing to converging evidence from multiple levels of analysis that oxytocin (OXT) has an important role in the regulation of affiliative behavior and social bonding in both nonhuman mammals and humans.  Inconsistency in the effect sizes of the OXTR variants included in association studies render it unclear whether OXTR is truly associated with ASD, and, if so, which OXTR single-nucleotide polymorphisms (SNPs) are associated.  Thus, a meta-analytic review of extant studies is needed to determine whether OXTR shows association with ASD, and to elucidate which specific SNPs have a significant effect on ASD.  The current meta-analysis of 16 OXTR SNPs included 3941 individuals with ASD from 11 independent samples, although analyses of each individual SNP included a subset of this total.  We found significant associations between ASD and the SNPs rs7632287, rs237887, rs2268491 and rs2254298.  OXTR was also significantly associated with ASD in a gene-based test.  The current meta-analysis is the largest and most comprehensive investigation of the association of OXTR with ASD and the findings suggest directions for future studies of the etiology of ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXbTryRKs-MBjv2lLSLOxFfW6udTcc2eYvodpVPDHgkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbovVSmsA%253D%253D&md5=c4f507ef2ccd3c7a208b654e2bc69bcb</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1038%2Fmp.2014.77&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2014.77%26sid%3Dliteratum%253Aachs%26aulast%3DLoParo%26aufirst%3DD.%26aulast%3DWaldman%26aufirst%3DI.%2BD.%26atitle%3DThe%2520oxytocin%2520receptor%2520gene%2520%2528OXTR%2529%2520is%2520associated%2520with%2520autism%2520spectrum%2520disorder%253A%2520a%2520meta-analysis%26jtitle%3DMol.%2520Psychiatry%26date%3D2015%26volume%3D20%26spage%3D640%26epage%3D646%26doi%3D10.1038%2Fmp.2014.77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group">Jin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torashima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopatina, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shnayder, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seike, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takasawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munesue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashida, H.</span><span> </span><span class="NLM_article-title">CD38 is critical for social behaviour by regulating oxytocin secretion</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">446</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1038/nature05526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnature05526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=17287729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1arsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2007&pages=41-45&author=D.+Jinauthor=H.+X.+Liuauthor=H.+Hiraiauthor=T.+Torashimaauthor=T.+Nagaiauthor=O.+Lopatinaauthor=N.+A.+Shnayderauthor=K.+Yamadaauthor=M.+Nodaauthor=T.+Seikeauthor=K.+Fujitaauthor=S.+Takasawaauthor=S.+Yokoyamaauthor=K.+Koizumiauthor=Y.+Shiraishiauthor=S.+Tanakaauthor=M.+Hashiiauthor=T.+Yoshiharaauthor=K.+Higashidaauthor=M.+S.+Islamauthor=N.+Yamadaauthor=K.+Hayashiauthor=N.+Noguchiauthor=I.+Katoauthor=H.+Okamotoauthor=A.+Matsushimaauthor=A.+Salminaauthor=T.+Munesueauthor=N.+Shimizuauthor=S.+Mochidaauthor=M.+Asanoauthor=H.+Higashida&title=CD38+is+critical+for+social+behaviour+by+regulating+oxytocin+secretion&doi=10.1038%2Fnature05526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">CD38 is critical for social behavior by regulating oxytocin secretion</span></div><div class="casAuthors">Jin, Duo; Liu, Hong-Xiang; Hirai, Hirokazu; Torashima, Takashi; Nagai, Taku; Lopatina, Olga; Shnayder, Natalia A.; Yamada, Kiyofumi; Noda, Mami; Seike, Toshihiro; Fujita, Kyota; Takasawa, Shin; Yokoyama, Shigeru; Koizumi, Keita; Shiraishi, Yoshitake; Tanaka, Shigenori; Hashii, Minako; Yoshihara, Toru; Higashida, Kazuhiro; Islam, Mohammad Saharul; Yamada, Nobuaki; Hayashi, Kenshi; Noguchi, Naoya; Kato, Ichiro; Okamoto, Hiroshi; Matsushima, Akihiro; Salmina, Alla; Munesue, Toshio; Shimizu, Nobuaki; Mochida, Sumiko; Asano, Masahide; Higashida, Haruhiro</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">446</span>
        (<span class="NLM_cas:issue">7131</span>),
    <span class="NLM_cas:pages">41-45</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">CD38, a transmembrane glycoprotein with ADP-Ribosyl cyclase activity, catalyzes the formation of Ca2+ signaling mols., but its role in the neuroendocrine system is unknown.  Here we show that adult CD38 knockout (CD38-/-) female and male mice show marked defects in maternal nurturing and social behavior, resp., with higher locomotor activity.  Consistently, the plasma level of oxytocin (OT), but not vasopressin, was strongly decreased in CD38-/- mice.  Replacement of OT by s.c. injection or lentiviral-vector-mediated delivery of human CD38 in the hypothalamus rescued social memory and maternal care in CD38-/- mice.  Depolarization-induced OT secretion and Ca2+ elevation in oxytocinergic neurohypophysial axon terminals were disrupted in CD38-/- mice; this was mimicked by CD38 metabolite antagonists in CD38+/+ mice.  These results reveal that CD38 has a key role in neuropeptide release, thereby critically regulating maternal and social behaviors, and may be an element in neuro-developmental disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplMtCpmjbVNrVg90H21EOLACvtfcHk0ljQROZM0EhYUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1arsLw%253D&md5=f9e5a484caaeefd77260e712553d915f</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1038%2Fnature05526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05526%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DH.%2BX.%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DTorashima%26aufirst%3DT.%26aulast%3DNagai%26aufirst%3DT.%26aulast%3DLopatina%26aufirst%3DO.%26aulast%3DShnayder%26aufirst%3DN.%2BA.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DNoda%26aufirst%3DM.%26aulast%3DSeike%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DTakasawa%26aufirst%3DS.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DKoizumi%26aufirst%3DK.%26aulast%3DShiraishi%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DHashii%26aufirst%3DM.%26aulast%3DYoshihara%26aufirst%3DT.%26aulast%3DHigashida%26aufirst%3DK.%26aulast%3DIslam%26aufirst%3DM.%2BS.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DHayashi%26aufirst%3DK.%26aulast%3DNoguchi%26aufirst%3DN.%26aulast%3DKato%26aufirst%3DI.%26aulast%3DOkamoto%26aufirst%3DH.%26aulast%3DMatsushima%26aufirst%3DA.%26aulast%3DSalmina%26aufirst%3DA.%26aulast%3DMunesue%26aufirst%3DT.%26aulast%3DShimizu%26aufirst%3DN.%26aulast%3DMochida%26aufirst%3DS.%26aulast%3DAsano%26aufirst%3DM.%26aulast%3DHigashida%26aufirst%3DH.%26atitle%3DCD38%2520is%2520critical%2520for%2520social%2520behaviour%2520by%2520regulating%2520oxytocin%2520secretion%26jtitle%3DNature%26date%3D2007%26volume%3D446%26spage%3D41%26epage%3D45%26doi%3D10.1038%2Fnature05526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group">Preti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellante, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doneddu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fadda, R.</span><span> </span><span class="NLM_article-title">Oxytocin and autism: a systematic review of randomized controlled trials</span> <span class="citation_source-journal">J. Child Adolesc. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1089/cap.2013.0040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1089%2Fcap.2013.0040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24679173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltlaltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=54-68&author=A.+Pretiauthor=M.+Melisauthor=S.+Siddiauthor=M.+Vellanteauthor=G.+Donedduauthor=R.+Fadda&title=Oxytocin+and+autism%3A+a+systematic+review+of+randomized+controlled+trials&doi=10.1089%2Fcap.2013.0040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Oxytocin and Autism: A Systematic Review of Randomized Controlled Trials</span></div><div class="casAuthors">Preti, Antonio; Melis, Mariangela; Siddi, Sara; Vellante, Marcello; Doneddu, Giuseppe; Fadda, Roberta</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Child and Adolescent Psychopharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">54-68</span>CODEN:
                <span class="NLM_cas:coden">JADPET</span>;
        ISSN:<span class="NLM_cas:issn">1044-5463</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Objective: Little is known about the effectiveness of pharmacol. interventions on autism spectrum disorder (ASD).  This is a systematic review of the randomized controlled trials (RCTs) of oxytocin interventions in autism, made from Jan. 1990 to Sept. 2013.  Method: A search of computerized databases was supplemented by manual search in the bibliogs. of key publications.  The methodol. quality of the studies included in the review was evaluated independently by two researchers, according to a set of formal criteria.  Discrepancies in scoring were resolved through discussion.  Results: The review yielded seven RCTs, including 101 subjects with ASD (males=95) and 8 males with Fragile X syndrome.  The main categories of target symptoms tested in the studies were repetitive behaviors, eye gaze, and emotion recognition.  The studies had a medium to high risk of bias.  Most studies had small samples (median=15).  All the studies but one reported statistically significant between-group differences on at least one outcome variable.  Most findings were characterized by medium effect size.  Only one study had evidence that the improvement in emotion recognition was maintained after 6 wk of treatment with intranasal oxytocin.  Overall, oxytocin was well tolerated and side effects, when present, were generally rated as mild; however, restlessness, increased irritability, and increased energy occurred more often under oxytocin.  Conclusions: RCTs of oxytocin interventions in autism yielded potentially promising findings in measures of emotion recognition and eye gaze, which are impaired early in the course of the ASD condition and might disrupt social skills learning in developing children.  There is a need for larger, more methodol. rigorous RCTs in this area.  Future studies should be better powered to est. outcomes with medium to low effect size, and should try to enroll female participants, who were rarely considered in previous studies.  Risk of bias should be minimized.  Human long-term administration studies are necessary before clin. recommendations can be made.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyfGFQSxkhqLVg90H21EOLACvtfcHk0ljQROZM0EhYUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltlaltbg%253D&md5=4fcb80d475afc80e0bc1b110102bd809</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1089%2Fcap.2013.0040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcap.2013.0040%26sid%3Dliteratum%253Aachs%26aulast%3DPreti%26aufirst%3DA.%26aulast%3DMelis%26aufirst%3DM.%26aulast%3DSiddi%26aufirst%3DS.%26aulast%3DVellante%26aufirst%3DM.%26aulast%3DDoneddu%26aufirst%3DG.%26aulast%3DFadda%26aufirst%3DR.%26atitle%3DOxytocin%2520and%2520autism%253A%2520a%2520systematic%2520review%2520of%2520randomized%2520controlled%2520trials%26jtitle%3DJ.%2520Child%2520Adolesc.%2520Psychopharmacol.%26date%3D2014%26volume%3D24%26spage%3D54%26epage%3D68%26doi%3D10.1089%2Fcap.2013.0040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group">Leng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, M.</span><span> </span><span class="NLM_article-title">Intranasal oxytocin: myths and delusions</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2015.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.biopsych.2015.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26049207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsFegsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=243-250&author=G.+Lengauthor=M.+Ludwig&title=Intranasal+oxytocin%3A+myths+and+delusions&doi=10.1016%2Fj.biopsych.2015.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Intranasal Oxytocin: Myths and Delusions</span></div><div class="casAuthors">Leng, Gareth; Ludwig, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">243-250</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Despite widespread reports that intranasal application of oxytocin has a variety of behavioral effects, very little of the huge amts. applied intranasally appears to reach the cerebrospinal fluid.  However, peripheral concns. are increased to supraphysiol. levels, with likely effects on diverse targets including the gastrointestinal tract, heart, and reproductive tract.  The wish to believe in the effectiveness of intranasal oxytocin appears to be widespread and needs to be guarded against with scepticism and rigor.  Preregistering trials, declaring primary and secondary outcomes in advance, specifying the statistical methods to be applied, and making all data openly available should minimize problems of publication bias and questionable post hoc analyses.  Effects of intranasal oxytocin also need proper dose-response studies, and such studies need to include control subjects for peripheral effects, by administering oxytocin peripherally and by blocking peripheral actions with antagonists.  Reports in the literature of oxytocin measurements include many that have been made with discredited methodol.  Claims that peripheral measurements of oxytocin reflect central release are questionable at best.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoATjOPiHPO2bVg90H21EOLACvtfcHk0lheGA1gxoDRrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsFegsrk%253D&md5=16d266108339c1e0d37e9f2ee2cb4ffb</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2015.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2015.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DLeng%26aufirst%3DG.%26aulast%3DLudwig%26aufirst%3DM.%26atitle%3DIntranasal%2520oxytocin%253A%2520myths%2520and%2520delusions%26jtitle%3DBiol.%2520Psychiatry%26date%3D2016%26volume%3D79%26spage%3D243%26epage%3D250%26doi%3D10.1016%2Fj.biopsych.2015.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group">Wiśniewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alagarsamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galyean, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tariga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiśniewska, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croston, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laporte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivière, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schteingart, C. D.</span><span> </span><span class="NLM_article-title">New, potent, and selective peptidic oxytocin receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5306</span><span class="NLM_x">–</span> <span class="NLM_lpage">5317</span><span class="refDoi"> DOI: 10.1021/jm500365s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500365s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVWhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5306-5317&author=K.+Wi%C5%9Bniewskiauthor=S.+Alagarsamyauthor=R.+Galyeanauthor=H.+Tarigaauthor=D.+Thompsonauthor=B.+Lyauthor=H.+Wi%C5%9Bniewskaauthor=S.+Qiauthor=G.+Crostonauthor=R.+Laporteauthor=P.+J.+Rivi%C3%A8reauthor=C.+D.+Schteingart&title=New%2C+potent%2C+and+selective+peptidic+oxytocin+receptor+agonists&doi=10.1021%2Fjm500365s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">New, Potent, and Selective Peptidic Oxytocin Receptor Agonists</span></div><div class="casAuthors">Wisniewski, Kazimierz; Alagarsamy, Sudarkodi; Galyean, Robert; Tariga, Hiroe; Thompson, Dorain; Ly, Brian; Wisniewska, Halina; Qi, Steve; Croston, Glenn; Laporte, Regent; Riviere, Pierre J.-M.; Schteingart, Claudio D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5306-5317</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mothers of preterm babies frequently have difficulty establishing or maintaining lactation, thought to be due to interference with the milk ejection reflex.  Administration of exogenous oxytocin can produce alveolar contraction and adequate breast emptying resulting in establishment of successful lactation.  The natural hormone oxytocin is not receptor-selective and may cause hyponatremia via V2 receptor mediated antidiuresis.  We have designed a series of potent oxytocin analogs contg. N-alkylglycines in position 7 with excellent selectivity vs. the related V1a, V1b, and V2 vasopressin receptors and short half-life: agonists 31([2-ThiMeGly7]dOT), 47 (carba-6-[Phe2,BuGly7]dOT), 55 (carba-6-[3-MeBzlGly7]dOT), and 57 (carba-1-[4-FBzlGly7]dOT) have EC50 values at hOTR < 0.1 nM, selectivity ratios vs. related human vasopressin receptors of >2000, IC50 at hV1aR > 500 nM, and total clearance in rats in the range of 60-80 mL min-1 kg-1.  Compd. 57 (FE 202767) is currently in clin. development for the treatment of preterm mothers requiring lactation support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_ykZz5KXVXbVg90H21EOLACvtfcHk0lheGA1gxoDRrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVWhs78%253D&md5=8076f2bbeb06371908b462d1c8f25321</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1021%2Fjm500365s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500365s%26sid%3Dliteratum%253Aachs%26aulast%3DWi%25C5%259Bniewski%26aufirst%3DK.%26aulast%3DAlagarsamy%26aufirst%3DS.%26aulast%3DGalyean%26aufirst%3DR.%26aulast%3DTariga%26aufirst%3DH.%26aulast%3DThompson%26aufirst%3DD.%26aulast%3DLy%26aufirst%3DB.%26aulast%3DWi%25C5%259Bniewska%26aufirst%3DH.%26aulast%3DQi%26aufirst%3DS.%26aulast%3DCroston%26aufirst%3DG.%26aulast%3DLaporte%26aufirst%3DR.%26aulast%3DRivi%25C3%25A8re%26aufirst%3DP.%2BJ.%26aulast%3DSchteingart%26aufirst%3DC.%2BD.%26atitle%3DNew%252C%2520potent%252C%2520and%2520selective%2520peptidic%2520oxytocin%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5306%26epage%3D5317%26doi%3D10.1021%2Fjm500365s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group">Ashworth, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batt, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broqua, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigh, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heeney, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laporte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartar, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yea, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, M. B.</span><span> </span><span class="NLM_article-title">Nonpeptide oxytocin agonists</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span><span class="refDoi"> DOI: 10.1358/dof.2006.031.04.980655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1358%2Fdof.2006.031.04.980655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVyltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=345-354&author=D.+M.+Ashworthauthor=A.+R.+Battauthor=A.+J.+Baxterauthor=P.+Broquaauthor=R.+M.+Haighauthor=P.+Hudsonauthor=C.+M.+Heeneyauthor=R.+Laporteauthor=A.+M.+Pensonauthor=G.+R.+Pittauthor=P.+A.+Robsonauthor=D.+P.+Rookerauthor=A.+L.+Tartarauthor=C.+M.+Yeaauthor=M.+B.+Roe&title=Nonpeptide+oxytocin+agonists&doi=10.1358%2Fdof.2006.031.04.980655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpeptide oxytocin agonists</span></div><div class="casAuthors">Ashworth, Doreen M.; Batt, Andrzej R.; Baxter, Andrew J.; Broqua, Pierre; Haigh, Robert M.; Hudson, Peter; Heeney, Celine M. S.; Laporte, Regent; Penson, Andrew; Pitt, Gary R. W.; Robson, Peter A.; Rooker, David P.; Tartar, Andre L.; Yea, Chris M.; Roe, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">345-353</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Oxytocin is a neurohypophyseal hormone that acts at the oxytocin receptor localized both peripherally and centrally and is particularly highly expressed in the pregnant human myometrium.  Synthetic oxytocin has long been used to induce labor and oxytocin antagonists have been introduced for the treatment of preterm labor.  New compds. are described that are potent, selective and efficacious oxytocin receptor agonists with potential utility in promoting labor and for the treatment of conditions such as male and female sexual dysfunction.  These new agents may also be useful as tools for further elucidating the roles of the oxytocin receptor system.  Furthermore, as they are nonpeptidic in nature, they may offer advantages over peptide oxytocin analogs in terms of oral availability and central penetration.  This article describes the various approaches that have been used to discover such compds.  Compds. such as 27, the first nonpeptide oxytocin agonists reported, are currently being investigated as pharmacol. tools in animal models of oxytocin activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxThz83ckUprVg90H21EOLACvtfcHk0lheGA1gxoDRrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVyltr4%253D&md5=398b1bc9e09f4682997567457d6905c8</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.04.980655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.04.980655%26sid%3Dliteratum%253Aachs%26aulast%3DAshworth%26aufirst%3DD.%2BM.%26aulast%3DBatt%26aufirst%3DA.%2BR.%26aulast%3DBaxter%26aufirst%3DA.%2BJ.%26aulast%3DBroqua%26aufirst%3DP.%26aulast%3DHaigh%26aufirst%3DR.%2BM.%26aulast%3DHudson%26aufirst%3DP.%26aulast%3DHeeney%26aufirst%3DC.%2BM.%26aulast%3DLaporte%26aufirst%3DR.%26aulast%3DPenson%26aufirst%3DA.%2BM.%26aulast%3DPitt%26aufirst%3DG.%2BR.%26aulast%3DRobson%26aufirst%3DP.%2BA.%26aulast%3DRooker%26aufirst%3DD.%2BP.%26aulast%3DTartar%26aufirst%3DA.%2BL.%26aulast%3DYea%26aufirst%3DC.%2BM.%26aulast%3DRoe%26aufirst%3DM.%2BB.%26atitle%3DNonpeptide%2520oxytocin%2520agonists%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D345%26epage%3D354%26doi%3D10.1358%2Fdof.2006.031.04.980655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group">Ring, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwyer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platt, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulicicchio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnick, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff Rizzo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logue, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span> </span><span class="NLM_article-title">Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2009.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuropharm.2009.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=19615387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD1Mjjs1GqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2010&pages=69-77&author=R.+H.+Ringauthor=L.+E.+Schechterauthor=S.+K.+Leonardauthor=J.+M.+Dwyerauthor=B.+J.+Plattauthor=R.+Grafauthor=S.+Grauerauthor=C.+Pulicicchioauthor=L.+Resnickauthor=Z.+Rahmanauthor=S.+J.+Sukoff+Rizzoauthor=B.+Luoauthor=C.+E.+Beyerauthor=S.+F.+Logueauthor=K.+L.+Marquisauthor=Z.+A.+Hughesauthor=S.+Rosenzweig-Lipson&title=Receptor+and+behavioral+pharmacology+of+WAY-267464%2C+a+non-peptide+oxytocin+receptor+agonist&doi=10.1016%2Fj.neuropharm.2009.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist</span></div><div class="casAuthors">Ring Robert H; Schechter Lee E; Leonard Sarah K; Dwyer Jason M; Platt Brian J; Graf Radka; Grauer Steven; Pulicicchio Claudine; Resnick Lynn; Rahman Zia; Sukoff Rizzo Stacey J; Luo Bin; Beyer Chad E; Logue Sheree F; Marquis Karen L; Hughes Zoe A; Rosenzweig-Lipson Sharon</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The widely reported effects of oxytocin (OT) on CNS function has generated considerable interest in the therapeutic potential for targeting this system for a variety of human psychiatric diseases, including anxiety disorders, autism, schizophrenia, and depression.  The utility of synthetic OT, as both a research tool and neurotherapeutic, is limited by the physiochemical properties inherent in most neuropeptides, notably its short half-life and poor blood brain barrier penetration.  Subsequently, the discovery and development of non-peptide molecules that act as selective agonists of the oxytocin receptor (OTR) has been an important goal of the field.  In this study, we report the receptor and behavioral pharmacology of WAY-267464, a first generation small-molecule OTR agonist.  WAY-267464 is a high-affinity, potent, and selective (vs.  V1a, V2, V1b) agonist of the OTR.  In assays measuring both behavioral (four-plate test, elevated zero maze) and autonomic (stress-induced hyperthermia) parameters of the anxiety response, WAY-267464 exhibits an anxiolytic-like profile similar to OT.  We have demonstrated that the anxiolytic-like profile of WAY-267464 is mediated through central sites of action.  WAY-267464 also significantly reverses disruption in prepulse inhibition of the acoustic startle reflex induced by either MK-801 or amphetamine, similar to the antipsychotic-like effects previously reported for OT.  Interestingly, in the mouse tail suspension test, WAY-267464 failed to produce changes in immobility that are seen with OT, raising the question of whether the antidepressant-like activity of OT may be working independently of the OTR.  A selective OTR antagonist also failed to block the effects of OT on immobility in the TST.  The significance of these findings for shaping the clinical development of OTR agonists is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8S-KlSxighgMthz5_Rx5rfW6udTcc2eZxdu3DSGmvObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1Mjjs1GqsQ%253D%253D&md5=699434bd2c444cd29345d24db54fbbb5</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2009.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2009.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DRing%26aufirst%3DR.%2BH.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DLeonard%26aufirst%3DS.%2BK.%26aulast%3DDwyer%26aufirst%3DJ.%2BM.%26aulast%3DPlatt%26aufirst%3DB.%2BJ.%26aulast%3DGraf%26aufirst%3DR.%26aulast%3DGrauer%26aufirst%3DS.%26aulast%3DPulicicchio%26aufirst%3DC.%26aulast%3DResnick%26aufirst%3DL.%26aulast%3DRahman%26aufirst%3DZ.%26aulast%3DSukoff%2BRizzo%26aufirst%3DS.%2BJ.%26aulast%3DLuo%26aufirst%3DB.%26aulast%3DBeyer%26aufirst%3DC.%2BE.%26aulast%3DLogue%26aufirst%3DS.%2BF.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DReceptor%2520and%2520behavioral%2520pharmacology%2520of%2520WAY-267464%252C%2520a%2520non-peptide%2520oxytocin%2520receptor%2520agonist%26jtitle%3DNeuropharmacology%26date%3D2010%26volume%3D58%26spage%3D69%26epage%3D77%26doi%3D10.1016%2Fj.neuropharm.2009.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group">Pitt, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batt, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigh, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tartar, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trim, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yea, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, M. B.</span><span> </span><span class="NLM_article-title">Non-peptide oxytocin agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4585</span><span class="NLM_x">–</span> <span class="NLM_lpage">4589</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2004.04.107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bmcl.2004.04.107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4585-4589&author=G.+R.+Pittauthor=A.+R.+Battauthor=R.+M.+Haighauthor=A.+M.+Pensonauthor=P.+A.+Robsonauthor=D.+P.+Rookerauthor=A.+L.+Tartarauthor=J.+E.+Trimauthor=C.+M.+Yeaauthor=M.+B.+Roe&title=Non-peptide+oxytocin+agonists&doi=10.1016%2Fj.bmcl.2004.04.107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.04.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.04.107%26sid%3Dliteratum%253Aachs%26aulast%3DPitt%26aufirst%3DG.%2BR.%26aulast%3DBatt%26aufirst%3DA.%2BR.%26aulast%3DHaigh%26aufirst%3DR.%2BM.%26aulast%3DPenson%26aufirst%3DA.%2BM.%26aulast%3DRobson%26aufirst%3DP.%2BA.%26aulast%3DRooker%26aufirst%3DD.%2BP.%26aulast%3DTartar%26aufirst%3DA.%2BL.%26aulast%3DTrim%26aufirst%3DJ.%2BE.%26aulast%3DYea%26aufirst%3DC.%2BM.%26aulast%3DRoe%26aufirst%3DM.%2BB.%26atitle%3DNon-peptide%2520oxytocin%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4585%26epage%3D4589%26doi%3D10.1016%2Fj.bmcl.2004.04.107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group">Frantz, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boudier, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durroux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouillac, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span> </span><span class="NLM_article-title">Subtlety of the structure-affinity and structure-efficacy relationships around a nonpeptide oxytocin receptor agonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1546</span><span class="NLM_x">–</span> <span class="NLM_lpage">1562</span><span class="refDoi"> DOI: 10.1021/jm901084f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901084f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1546-1562&author=M.+C.+Frantzauthor=J.+Rodrigoauthor=L.+Boudierauthor=T.+Durrouxauthor=B.+Mouillacauthor=M.+Hibert&title=Subtlety+of+the+structure-affinity+and+structure-efficacy+relationships+around+a+nonpeptide+oxytocin+receptor+agonist&doi=10.1021%2Fjm901084f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1021%2Fjm901084f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901084f%26sid%3Dliteratum%253Aachs%26aulast%3DFrantz%26aufirst%3DM.%2BC.%26aulast%3DRodrigo%26aufirst%3DJ.%26aulast%3DBoudier%26aufirst%3DL.%26aulast%3DDurroux%26aufirst%3DT.%26aulast%3DMouillac%26aufirst%3DB.%26aulast%3DHibert%26aufirst%3DM.%26atitle%3DSubtlety%2520of%2520the%2520structure-affinity%2520and%2520structure-efficacy%2520relationships%2520around%2520a%2520nonpeptide%2520oxytocin%2520receptor%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1546%26epage%3D1562%26doi%3D10.1021%2Fjm901084f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group">Bissantz, C.; Grundschober, C.; Nettekoven, M.; Plancher, J. M.; Vifian, W.</span><span> </span><span class="NLM_article-title">Oxytocin Receptor Agonists for the Treatment of CNS Diseases</span>. WIPO Patent WO2014111356,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+Bissantz&author=C.+Grundschober&author=M.+Nettekoven&author=J.+M.+Plancher&author=W.+Vifian&title=Oxytocin+Receptor+Agonists+for+the+Treatment+of+CNS+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26atitle%3DOxytocin%2520Receptor%2520Agonists%2520for%2520the%2520Treatment%2520of%2520CNS%2520Diseases%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group">Izdebska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciosek, J.</span><span> </span><span class="NLM_article-title">Galanin influences on vasopressin and oxytocin release: in vitro studies</span> <span class="citation_source-journal">Neuropeptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span><span class="refDoi"> DOI: 10.1016/j.npep.2010.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.npep.2010.04.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2010&pages=341-348&author=K.+Izdebskaauthor=J.+Ciosek&title=Galanin+influences+on+vasopressin+and+oxytocin+release%3A+in+vitro+studies&doi=10.1016%2Fj.npep.2010.04.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1016%2Fj.npep.2010.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.npep.2010.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DIzdebska%26aufirst%3DK.%26aulast%3DCiosek%26aufirst%3DJ.%26atitle%3DGalanin%2520influences%2520on%2520vasopressin%2520and%2520oxytocin%2520release%253A%2520in%2520vitro%2520studies%26jtitle%3DNeuropeptides%26date%3D2010%26volume%3D44%26spage%3D341%26epage%3D348%26doi%3D10.1016%2Fj.npep.2010.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group">Riebold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankuta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Israel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemanov, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monakhov, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yirmiya, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malavasi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebstein, R. P.</span><span> </span><span class="NLM_article-title">All-trans retinoic acid upregulates reduced CD38 transcription in lymphoblastoid cell lines from autism spectrum disorder</span> <span class="citation_source-journal">Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">806</span><span class="refDoi"> DOI: 10.2119/molmed.2011.00080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.2119%2Fmolmed.2011.00080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21528155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVemurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=799-806&author=M.+Rieboldauthor=D.+Mankutaauthor=E.+Lererauthor=S.+Israelauthor=S.+Zhongauthor=L.+Nemanovauthor=M.+V.+Monakhovauthor=S.+Leviauthor=N.+Yirmiyaauthor=M.+Yaariauthor=F.+Malavasiauthor=R.+P.+Ebstein&title=All-trans+retinoic+acid+upregulates+reduced+CD38+transcription+in+lymphoblastoid+cell+lines+from+autism+spectrum+disorder&doi=10.2119%2Fmolmed.2011.00080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">All-trans retinoic acid upregulates reduced CD38 transcription in lymphoblastoid cell lines from Autism spectrum disorder</span></div><div class="casAuthors">Riebold, Mathias; Mankuta, David; Lerer, Elad; Israel, Salomon; Zhong, Songfa; Nemanov, Luba; Monakhov, Mikhail V.; Levi, Shlomit; Yirmiya, Nurit; Yaari, Maya; Malavasi, Fabio; Ebstein, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">799-806</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1076-1551</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">Deficits in social behavior in mice lacking the CD38 gene were attributed to impaired secretion of oxytocin.  In humans, similar deficits in social behavior are assocd. with autistic spectrum disorder (ASD), for which genetic variants of CD38 were pinpointed as provisional risk factors.  We sought to explore, in an in vitro model, the feasibility of the theory that restoring the level of CD38 in ASD patients could be of potential clin. benefit.  CD38 transcription is highly sensitive to several cytokines and vitamins.  One of these, all-trans retinoic acid (ATRA), a known inducer of CD38, was added during cell culture and tested on a large sample of N = 120 lymphoblastoid cell (LBC) lines from ASD patients and their parents.  Anal. of CD38 mRNA levels shows that ATRA has an upmodulatory potential on LBC derived from ASD patients as well as from their parents.  The next crucial issue addressed in this study was the relationship between levels of CD38 expression and psychol. parameters.  The results obtained indicate a pos. correlation between CD38 expression levels and patient scores on the Vineland Adaptive Behavior Scale.  In addn., anal. of the role of genetic polymorphisms in the dynamics of the mol. revealed that the genotype of a single-nucleotide polymorphism (rs6449182; C>G variation) in the CpG island of intron 1, harboring the retinoic-acid response element, exerts differential roles in CD38 expression in ASD and in parental LBC.  In conclusion,these results provide an empirical basis for the development of a pharmacol. ASD treatment strategy based on retinoids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriy61GX2kvIbVg90H21EOLACvtfcHk0ljLt_61CsGKmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVemurrM&md5=363c795fd0c65ed45b756143003ca8b9</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2011.00080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2011.00080%26sid%3Dliteratum%253Aachs%26aulast%3DRiebold%26aufirst%3DM.%26aulast%3DMankuta%26aufirst%3DD.%26aulast%3DLerer%26aufirst%3DE.%26aulast%3DIsrael%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DS.%26aulast%3DNemanov%26aufirst%3DL.%26aulast%3DMonakhov%26aufirst%3DM.%2BV.%26aulast%3DLevi%26aufirst%3DS.%26aulast%3DYirmiya%26aufirst%3DN.%26aulast%3DYaari%26aufirst%3DM.%26aulast%3DMalavasi%26aufirst%3DF.%26aulast%3DEbstein%26aufirst%3DR.%2BP.%26atitle%3DAll-trans%2520retinoic%2520acid%2520upregulates%2520reduced%2520CD38%2520transcription%2520in%2520lymphoblastoid%2520cell%2520lines%2520from%2520autism%2520spectrum%2520disorder%26jtitle%3DMol.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D799%26epage%3D806%26doi%3D10.2119%2Fmolmed.2011.00080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group">Sabatier, N.</span><span> </span><span class="NLM_article-title">Alpha-melanocyte-stimulating hormone and oxytocin: a peptide signalling cascade in the hypothalamus</span> <span class="citation_source-journal">J. Neuroendocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">703</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span><span class="refDoi"> DOI: 10.1111/j.1365-2826.2006.01464.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1111%2Fj.1365-2826.2006.01464.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=16879169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1Srt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=703-710&author=N.+Sabatier&title=Alpha-melanocyte-stimulating+hormone+and+oxytocin%3A+a+peptide+signalling+cascade+in+the+hypothalamus&doi=10.1111%2Fj.1365-2826.2006.01464.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">α-Melanocyte-stimulating hormone and oxytocin: a peptide signalling cascade in the hypothalamus</span></div><div class="casAuthors">Sabatier, N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroendocrinology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">703-710</span>CODEN:
                <span class="NLM_cas:coden">JOUNE2</span>;
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  α-MSH (α-MSH) and oxytocin share remarkable similarities of effects on behavior in rats; in particular, they both inhibit feeding behavior and stimulate sexual behavior.  Recently, we showed that α-MSH interacts with the magnocellular oxytocin system in the supraoptic nucleus; α-MSH induces the release of oxytocin from the dendrites of magnocellular neurons but it inhibits the secretion of oxytocin from their nerve terminals in the posterior pituitary.  This effect of α-MSH on supraoptic nucleus oxytocin neurons is remarkable for two reasons.  First, it illustrates the capacity of magnocellular neurons to differentially regulate peptide release from dendrites and axons and, second, it emphasizes the putative role of magnocellular neurons as a major source of central oxytocin release, and as a likely substrate of some oxytocin-mediated behaviors.  The ability of peptides to differentially control secretion from different compartments of their targets indicates one way by which peptide signals might have a particularly significant effect on neuronal circuitry.  This suggests a possible explanation for the striking way in which some peptides can influence specific, complex behaviors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD9oIng0TALbVg90H21EOLACvtfcHk0ljLt_61CsGKmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1Srt7Y%253D&md5=c0775a098f5cce02d8725ce8153d416d</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2826.2006.01464.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2826.2006.01464.x%26sid%3Dliteratum%253Aachs%26aulast%3DSabatier%26aufirst%3DN.%26atitle%3DAlpha-melanocyte-stimulating%2520hormone%2520and%2520oxytocin%253A%2520a%2520peptide%2520signalling%2520cascade%2520in%2520the%2520hypothalamus%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D2006%26volume%3D18%26spage%3D703%26epage%3D710%26doi%3D10.1111%2Fj.1365-2826.2006.01464.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group">Peñagarikano, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lázaro, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peles, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maidment, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golshani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwind, D. H.</span><span> </span><span class="NLM_article-title">Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">271ra8</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3010257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1126%2Fscitranslmed.3010257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25609168" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=271ra8&author=O.+Pe%C3%B1agarikanoauthor=M.+T.+L%C3%A1zaroauthor=X.+H.+Luauthor=A.+Gordonauthor=H.+Dongauthor=H.+A.+Lamauthor=E.+Pelesauthor=N.+T.+Maidmentauthor=N.+P.+Murphyauthor=X.+W.+Yangauthor=P.+Golshaniauthor=D.+H.+Geschwind&title=Exogenous+and+evoked+oxytocin+restores+social+behavior+in+the+Cntnap2+mouse+model+of+autism&doi=10.1126%2Fscitranslmed.3010257"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3010257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3010257%26sid%3Dliteratum%253Aachs%26aulast%3DPe%25C3%25B1agarikano%26aufirst%3DO.%26aulast%3DL%25C3%25A1zaro%26aufirst%3DM.%2BT.%26aulast%3DLu%26aufirst%3DX.%2BH.%26aulast%3DGordon%26aufirst%3DA.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DH.%2BA.%26aulast%3DPeles%26aufirst%3DE.%26aulast%3DMaidment%26aufirst%3DN.%2BT.%26aulast%3DMurphy%26aufirst%3DN.%2BP.%26aulast%3DYang%26aufirst%3DX.%2BW.%26aulast%3DGolshani%26aufirst%3DP.%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26atitle%3DExogenous%2520and%2520evoked%2520oxytocin%2520restores%2520social%2520behavior%2520in%2520the%2520Cntnap2%2520mouse%2520model%2520of%2520autism%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2015%26volume%3D7%26spage%3D271ra8%26doi%3D10.1126%2Fscitranslmed.3010257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group">Jørgensen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knigge, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kjaer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warberg, J.</span><span> </span><span class="NLM_article-title">Serotonin receptors involved in vasopressin and oxytocin secretion</span> <span class="citation_source-journal">J. Neuroendocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">242</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1046/j.1365-2826.2003.00978.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1046%2Fj.1365-2826.2003.00978.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=12588512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFyqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=242-249&author=H.+J%C3%B8rgensenauthor=M.+Riisauthor=U.+Kniggeauthor=A.+Kjaerauthor=J.+Warberg&title=Serotonin+receptors+involved+in+vasopressin+and+oxytocin+secretion&doi=10.1046%2Fj.1365-2826.2003.00978.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin receptors involved in vasopressin and oxytocin secretion</span></div><div class="casAuthors">Jorgensen, H.; Riis, M.; Knigge, U.; Kjaer, A.; Warberg, J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroendocrinology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">242-249</span>CODEN:
                <span class="NLM_cas:coden">JOUNE2</span>;
        ISSN:<span class="NLM_cas:issn">0953-8194</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Serotonin (5-HT), 5-HT agonists, the 5-HT precursor 5-hydroxytryptophan, 5-HT-releasers and -reuptake inhibitors stimulate the release of vasopressin and oxytocin.  The authors investigated the involvement of 5-HT receptors in the serotonergic regulation of vasopressin and oxytocin secretion.  Vasopressin and oxytocin secretion was stimulated by 5-HT, the 5-HT1A+1B+5A+7 agonist 5-carboxamidotryptamine (5-CT), the 5-HT2A+2C agonist DOI, the 5-HT2C+2A agonist mCPP, the 5-HT2C agonist MK-212, the 5-HT3 agonist SR 57277 and the 5-HT4 agonist RS 67506.  The 5-HT1A agonist 8-OH-DPAT, which had no effect on vasopressin secretion, stimulated oxytocin secretion.  The 5-HT-induced release of vasopressin and oxytocin was inhibited by central infusion of the 5-HT antagonists WAY 100635 (5-HT1A), LY 53857 (5-HT2A+2C), ICS 205-930 (5-HT3+4) and RS 23597 (5-HT4).  The 5-HT2+6+7 antagonist metergoline in combination with the 5-HT1A+2+7 antagonist methysergide inhibited the stimulatory effect of 5-CT on both hormones, whereas the 5-HT1A+1B antagonist cyanopindolol only inhibited the oxytocin response.  The 5-HT2A antagonist 4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine oxalate had no effect on DOI-induced hormone response.  The 5-HT2C antagonist Y 25130 partly inhibited the stimulating effect of MK-212.  ICS 205-930 and RS 23597 inhibited vasopressin and oxytocin secretion induced by RS 67506.  WAY 100635 inhibited 8-OH-DPAT-induced oxytocin secretion.  The authors conclude that 5-HT-induced vasopressin secretion primarily is mediated via 5-HT2C, 5-HT4 and 5-HT7 receptors, whereas 5-HT2A, 5-HT3 and 5-HT5A receptors seem to be of minor importance.  5-HT-induced oxytocin secretion involves 5-HT1A, 5-HT2C and 5-HT4 receptors; in addn. an involvement of 5-HT1B, 5-HT5A and 5-HT7 receptors seems likely, whereas 5-HT2A and 5-HT3 receptors seem to be less important.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTxnVa0HG29bVg90H21EOLACvtfcHk0lhTAjPSlicg4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFyqs74%253D&md5=dad2cd3529a09c2670927796b8ffeddb</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2826.2003.00978.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2826.2003.00978.x%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DH.%26aulast%3DRiis%26aufirst%3DM.%26aulast%3DKnigge%26aufirst%3DU.%26aulast%3DKjaer%26aufirst%3DA.%26aulast%3DWarberg%26aufirst%3DJ.%26atitle%3DSerotonin%2520receptors%2520involved%2520in%2520vasopressin%2520and%2520oxytocin%2520secretion%26jtitle%3DJ.%2520Neuroendocrinol.%26date%3D2003%26volume%3D15%26spage%3D242%26epage%3D249%26doi%3D10.1046%2Fj.1365-2826.2003.00978.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group">Bagdy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalogeras, K. T.</span><span> </span><span class="NLM_article-title">Stimulation of 5-HT<sub>1A</sub> and 5-HT<sub>2</sub>/5-HT<sub>1C</sub> receptors induce oxytocin release in the male rat</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">611</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span><span class="refDoi"> DOI: 10.1016/0006-8993(93)90521-N</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2F0006-8993%2893%2990521-N" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=8334526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADyaK3sXltV2nsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=611&publication_year=1993&pages=330-332&author=G.+Bagdyauthor=K.+T.+Kalogeras&title=Stimulation+of+5-HT1A+and+5-HT2%2F5-HT1C+receptors+induce+oxytocin+release+in+the+male+rat&doi=10.1016%2F0006-8993%2893%2990521-N"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat</span></div><div class="casAuthors">Bagdy, Gyorgy; Kalogeras, Konstantine T.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">611</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">330-2</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">Plasma oxytocin responses to the 5-HT1A receptor agonists 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), buspirone and ipsapirone, and the 5-HT2/5-HT1C receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) have been studied in conscious, freely moving male rats.  All four compds. caused dose-related increases in plasma oxytocin concns. after i.v. administration.  Oxytocin responses to 8-OH-DPAT were attenuated by pretreatment with the 5-HT1A receptor antagonist NAN-190 while responses to DOI were blocked by pretreatment with 5-HT2/5-HT1C receptor antagonist ritanserin.  Since vasopressin concn. did not change despite the marked elevation in plasma oxytocin, these results suggest that 5-HT1A and 5-HT2/5-HT1C receptors all stimulate oxytocin secretion, and this effect does not reflect a general neurohydrophyseal hormone release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCl_rrMz4e2rVg90H21EOLACvtfcHk0lhTAjPSlicg4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltV2nsLk%253D&md5=419254d6856d5aa32b89f5359818f742</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2893%2990521-N&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252893%252990521-N%26sid%3Dliteratum%253Aachs%26aulast%3DBagdy%26aufirst%3DG.%26aulast%3DKalogeras%26aufirst%3DK.%2BT.%26atitle%3DStimulation%2520of%25205-HT1A%2520and%25205-HT2%252F5-HT1C%2520receptors%2520induce%2520oxytocin%2520release%2520in%2520the%2520male%2520rat%26jtitle%3DBrain%2520Res.%26date%3D1993%26volume%3D611%26spage%3D330%26epage%3D332%26doi%3D10.1016%2F0006-8993%2893%2990521-N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group">Uvnäs-Moberg, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillegaart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alster, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlenius, S.</span><span> </span><span class="NLM_article-title">Effects of 5-HT agonists, selective for different receptor subtypes, on oxytocin, CCK, gastrin and somatostatin plasma levels in the rat</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1635</span><span class="NLM_x">–</span> <span class="NLM_lpage">1640</span><span class="refDoi"> DOI: 10.1016/S0028-3908(96)00078-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0028-3908%2896%2900078-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1996&pages=1635-1640&author=K.+Uvn%C3%A4s-Mobergauthor=V.+Hillegaartauthor=P.+Alsterauthor=S.+Ahlenius&title=Effects+of+5-HT+agonists%2C+selective+for+different+receptor+subtypes%2C+on+oxytocin%2C+CCK%2C+gastrin+and+somatostatin+plasma+levels+in+the+rat&doi=10.1016%2FS0028-3908%2896%2900078-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2896%2900078-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252896%252900078-0%26sid%3Dliteratum%253Aachs%26aulast%3DUvn%25C3%25A4s-Moberg%26aufirst%3DK.%26aulast%3DHillegaart%26aufirst%3DV.%26aulast%3DAlster%26aufirst%3DP.%26aulast%3DAhlenius%26aufirst%3DS.%26atitle%3DEffects%2520of%25205-HT%2520agonists%252C%2520selective%2520for%2520different%2520receptor%2520subtypes%252C%2520on%2520oxytocin%252C%2520CCK%252C%2520gastrin%2520and%2520somatostatin%2520plasma%2520levels%2520in%2520the%2520rat%26jtitle%3DNeuropharmacology%26date%3D1996%26volume%3D35%26spage%3D1635%26epage%3D1640%26doi%3D10.1016%2FS0028-3908%2896%2900078-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group">Lawson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woehrle, N. S.</span><span> </span><span class="NLM_article-title">Effects of oxytocin on serotonin 1B agonist-induced autism-like behavior in mice</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span><span class="refDoi"> DOI: 10.1016/j.bbr.2016.07.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bbr.2016.07.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27439030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWgu7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2016&pages=52-64&author=S.+K.+Lawsonauthor=A.+C.+Grayauthor=N.+S.+Woehrle&title=Effects+of+oxytocin+on+serotonin+1B+agonist-induced+autism-like+behavior+in+mice&doi=10.1016%2Fj.bbr.2016.07.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of oxytocin on serotonin 1B agonist-induced autism-like behavior in mice</span></div><div class="casAuthors">Lawson, Sarah K.; Gray, Andrew C.; Woehrle, Nancy S.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">52-64</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Social impairments in autism remain poorly understood and without approved pharmacotherapies.  Novel animals models are needed to elucidate mechanisms and evaluate novel treatments for the social deficits in autism.  Recently, serotonin 1B receptor (5-HT1B) agonist challenge in mice was shown to induce autism-like behaviors including perseveration, reduced prepulse inhibition, and delayed alternation deficits.  However, the effects of 5-HT1B agonists on autism-related social behaviors in mice remain unknown.  Here, we examine the effects of 5-HT1B agonist challenge on sociability and preference for social novelty in mice.  We also examine the effects of 5-HT1B agonist treatment on av. rearing duration, a putative rodent measure of non-selective attention.  Non-selective attention is an assocd. feature of autism that is also not well understood.  We show that 5-HT1B receptor activation reduces sociability, preference for social novelty, and rearing in mice.  In addn., we examine the ability of oxytocin, an off-label treatment for the social impairments in autism, to reverse 5-HT1B agonist-induced social and attention deficits in mice.  We show that oxytocin restores social novelty preference in mice treated with a 5-HT1B agonist.  We also show that oxytocin attenuates 5-HT1B agonist-induced sociability and rearing deficits in mice.  Our results suggest that 5-HT1B agonist challenge provides a useful pharmacol. mouse model for aspects of autism, and implicate 5-HT1B in autism social and attention deficits.  Moreover, our findings suggest that oxytocin may treat the social deficits in autism through a mechanism involving 5-HT1B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8v6bF2Nb-qLVg90H21EOLACvtfcHk0lh0mYv4sSHuWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWgu7jI&md5=8e635f07885eb30c7b77c1f9437249b1</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2016.07.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2016.07.027%26sid%3Dliteratum%253Aachs%26aulast%3DLawson%26aufirst%3DS.%2BK.%26aulast%3DGray%26aufirst%3DA.%2BC.%26aulast%3DWoehrle%26aufirst%3DN.%2BS.%26atitle%3DEffects%2520of%2520oxytocin%2520on%2520serotonin%25201B%2520agonist-induced%2520autism-like%2520behavior%2520in%2520mice%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2016%26volume%3D314%26spage%3D52%26epage%3D64%26doi%3D10.1016%2Fj.bbr.2016.07.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group">Matsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruoka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujimoto, M.</span><span> </span><span class="NLM_article-title">Expression of placental leucine aminopeptidase/oxytocinase in neuronal cells and its action on neuronal peptides</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">3259</span><span class="NLM_x">–</span> <span class="NLM_lpage">3266</span><span class="refDoi"> DOI: 10.1046/j.1432-1327.2001.02221.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1046%2Fj.1432-1327.2001.02221.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=11389728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlSgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2001&pages=3259-3266&author=H.+Matsumotoauthor=T.+Nagasakaauthor=A.+Hattoriauthor=T.+Rogiauthor=N.+Tsuruokaauthor=S.+Mizutaniauthor=M.+Tsujimoto&title=Expression+of+placental+leucine+aminopeptidase%2Foxytocinase+in+neuronal+cells+and+its+action+on+neuronal+peptides&doi=10.1046%2Fj.1432-1327.2001.02221.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of placental leucine aminopeptidase/oxytocinase in neuronal cells and its action on neuronal peptides</span></div><div class="casAuthors">Matsumoto, Hideko; Nagasaka, Tetsuro; Hattori, Akira; Rogi, Tomohiro; Tsuruoka, Nobuo; Mizutani, Shigehiko; Tsujimoto, Masafumi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3259-3266</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The placental leucine aminopeptidase (P-LAP)/oxytocinase whose serum level increases with gestation is thought to contribute to the maintenance of normal pregnancy.  P-LAP mRNAs are expressed in various tissues other than the placenta.  In this study, the authors identified P-LAP protein in the brain.  In contrast with the placenta where a significant portion of P-LAP is released, the enzyme was localized in the membrane fraction in brain and PC12 cells and no sol. form of the enzyme was detected.  When PC12 cells were differentiated into neuronal cells by nerve growth factor (NGF), a significant increase in the expression level of P-LAP in the cell was obsd.  As in the case of insulin treatment of 3T3-L1 adipocytes, treatment of PC12 cells with forskolin caused the translocation of the enzyme from intracellular vesicle to the cell surface plasma membrane.  In addn., P-LAP was shown to degrade several bioactive neuropeptides such as Met-enkephalin and dynorphin A (1-8).  These results suggest that P-LAP plays an important role in the regulation of neuronal cell function in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQAXE2HPT4wrVg90H21EOLACvtfcHk0lh0mYv4sSHuWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlSgsbo%253D&md5=5ec358847231dc556121be6b18c71c46</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2001.02221.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2001.02221.x%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DH.%26aulast%3DNagasaka%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DA.%26aulast%3DRogi%26aufirst%3DT.%26aulast%3DTsuruoka%26aufirst%3DN.%26aulast%3DMizutani%26aufirst%3DS.%26aulast%3DTsujimoto%26aufirst%3DM.%26atitle%3DExpression%2520of%2520placental%2520leucine%2520aminopeptidase%252Foxytocinase%2520in%2520neuronal%2520cells%2520and%2520its%2520action%2520on%2520neuronal%2520peptides%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2001%26volume%3D268%26spage%3D3259%26epage%3D3266%26doi%3D10.1046%2Fj.1432-1327.2001.02221.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group">Albiston, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diwakarla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernando, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mountford, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeatman, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holien, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, S. Y.</span><span> </span><span class="NLM_article-title">Identification and development of specific inhibitors for insulin-regulated aminopeptidase as a new class of cognitive enhancers</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">164</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01402.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1111%2Fj.1476-5381.2011.01402.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=21470200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOlurfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2011&pages=37-47&author=A.+L.+Albistonauthor=S.+Diwakarlaauthor=R.+N.+Fernandoauthor=S.+J.+Mountfordauthor=H.+R.+Yeatmanauthor=B.+Morganauthor=V.+Phamauthor=J.+K.+Holienauthor=M.+W.+Parkerauthor=P.+E.+Thompsonauthor=S.+Y.+Chai&title=Identification+and+development+of+specific+inhibitors+for+insulin-regulated+aminopeptidase+as+a+new+class+of+cognitive+enhancers&doi=10.1111%2Fj.1476-5381.2011.01402.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and development of specific inhibitors for insulin-regulated aminopeptidase as a new class of cognitive enhancers</span></div><div class="casAuthors">Albiston, Anthony L.; Diwakarla, Shanti; Fernando, Ruani N.; Mountford, Simon J.; Yeatman, Holly R.; Morgan, Broden; Pham, Vi; Holien, Jessica K.; Parker, Michael W.; Thompson, Philip E.; Chai, Siew Yeen</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-47</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Two structurally distinct peptides, angiotensin IV and LVV-haemorphin 7, both competitive high-affinity inhibitors of insulin-regulated aminopeptidase (IRAP), were found to enhance aversion-assocd. and spatial memory in normal rats and to improve performance in a no. of memory tasks in rat deficits models.  These findings provide compelling support for the development of specific, high-affinity inhibitors of the enzyme as new cognitive enhancing agents.  Different classes of IRAP inhibitors were developed including peptidomimetics and small mol. wt. compds. identified through in silico screening with a homol. model of the catalytic domain of IRAP.  The proof of principal that inhibition of IRAP activity results in facilitation of memory was obtained by the demonstration that the small-mol. IRAP inhibitors also exhibit memory-enhancing properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP4XSnUxmUbrVg90H21EOLACvtfcHk0lg2vz0-guNUMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOlurfE&md5=0c9ab209bd0b6cde5bff0c86fe737538</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01402.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01402.x%26sid%3Dliteratum%253Aachs%26aulast%3DAlbiston%26aufirst%3DA.%2BL.%26aulast%3DDiwakarla%26aufirst%3DS.%26aulast%3DFernando%26aufirst%3DR.%2BN.%26aulast%3DMountford%26aufirst%3DS.%2BJ.%26aulast%3DYeatman%26aufirst%3DH.%2BR.%26aulast%3DMorgan%26aufirst%3DB.%26aulast%3DPham%26aufirst%3DV.%26aulast%3DHolien%26aufirst%3DJ.%2BK.%26aulast%3DParker%26aufirst%3DM.%2BW.%26aulast%3DThompson%26aufirst%3DP.%2BE.%26aulast%3DChai%26aufirst%3DS.%2BY.%26atitle%3DIdentification%2520and%2520development%2520of%2520specific%2520inhibitors%2520for%2520insulin-regulated%2520aminopeptidase%2520as%2520a%2520new%2520class%2520of%2520cognitive%2520enhancers%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D164%26spage%3D37%26epage%3D47%26doi%3D10.1111%2Fj.1476-5381.2011.01402.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group">Insel, T. R.</span><span> </span><span class="NLM_article-title">The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">768</span><span class="NLM_x">–</span> <span class="NLM_lpage">779</span><span class="refDoi"> DOI: 10.1016/j.neuron.2010.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuron.2010.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20346754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1KmtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2010&pages=768-779&author=T.+R.+Insel&title=The+challenge+of+translation+in+social+neuroscience%3A+a+review+of+oxytocin%2C+vasopressin%2C+and+affiliative+behavior&doi=10.1016%2Fj.neuron.2010.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior</span></div><div class="casAuthors">Insel, Thomas R.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">768-779</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Social neuroscience is rapidly exploring the complex territory between perception and action where recognition, value, and meaning are instantiated.  This review follows the trail of research on oxytocin and vasopressin as an exemplar of one path for exploring the "dark matter" of social neuroscience.  Studies across vertebrate species suggest that these neuropeptides are important for social cognition, with gender- and steroid-dependent effects.  Comparative research in voles yields a model based on interspecies and intraspecies variation of the geog. of oxytocin receptors and vasopressin V1a receptors in the forebrain.  Highly affiliative species have receptors in brain circuits related to reward or reinforcement.  The neuroanatomical distribution of these receptors may be guided by variations in the regulatory regions of their resp. genes.  This review describes the promises and problems of extrapolating these findings to human social cognition, with specific ref. to the social deficits of autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrre0O9VbZrSLVg90H21EOLACvtfcHk0lg2vz0-guNUMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1KmtLs%253D&md5=92d1b922874d4c759523a5658e740c98</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2010.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2010.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DInsel%26aufirst%3DT.%2BR.%26atitle%3DThe%2520challenge%2520of%2520translation%2520in%2520social%2520neuroscience%253A%2520a%2520review%2520of%2520oxytocin%252C%2520vasopressin%252C%2520and%2520affiliative%2520behavior%26jtitle%3DNeuron%26date%3D2010%26volume%3D65%26spage%3D768%26epage%3D779%26doi%3D10.1016%2Fj.neuron.2010.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group">Ebner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wotjak, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landgraf, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelmann, M.</span><span> </span><span class="NLM_article-title">Forced swimming triggers vasopressin release within the amygdala to modulate stress-coping strategies in rats</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span><span class="refDoi"> DOI: 10.1046/j.0953-816x.2001.01869.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1046%2Fj.0953-816x.2001.01869.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=11849304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BD387ltVymtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=384-388&author=K.+Ebnerauthor=C.+T.+Wotjakauthor=R.+Landgrafauthor=M.+Engelmann&title=Forced+swimming+triggers+vasopressin+release+within+the+amygdala+to+modulate+stress-coping+strategies+in+rats&doi=10.1046%2Fj.0953-816x.2001.01869.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Forced swimming triggers vasopressin release within the amygdala to modulate stress-coping strategies in rats</span></div><div class="casAuthors">Ebner Karl; Wotjak Carsten T; Landgraf Rainer; Engelmann Mario</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">384-8</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Previously, we have demonstrated that forced swimming triggers the release of arginine vasopressin (AVP) within the septum of rats, where AVP modulates stress-coping strategies.  The present study was designed to examine the effects of forced swimming on the release of AVP within the amygdala.  Therefore, adult male Wistar rats were chronically implanted with a microdialysis probe aimed at the amygdala to monitor the local release of AVP under both resting and stress conditions.  A 10-min forced swimming session caused a significant increase in the extracellular AVP concentration (to 366 +/- 90% of baseline; P < 0.05) within this brain area.  In a subsequent experiment we investigated the physiological impact of the stressor-induced release of AVP by administrating the AVP V1 receptor antagonist d(CH2)5Tyr(Me)AVP into the amygdala via inverse microdialysis.  Bilateral antagonist treatment modulated the behavioural response acutely by increasing the time the animals spent struggling and by reducing the time the animals floated.  Our results demonstrate a significant activation of the vasopressinergic system within the amygdala in response to forced swimming.  AVP released within the amygdala seems to be involved in the generation of passive coping strategies in stressful situations.  Taken together with previous findings the results of the present study suggest that AVP is released within septum and amygdala to balance the behavioural response during forced swimming.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQem9MhWlUjNKNc3HjJRoFAfW6udTcc2eZ7fmfp8W7WCbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387ltVymtA%253D%253D&md5=4ec2951b4960f54080f6496d844de1b1</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1046%2Fj.0953-816x.2001.01869.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0953-816x.2001.01869.x%26sid%3Dliteratum%253Aachs%26aulast%3DEbner%26aufirst%3DK.%26aulast%3DWotjak%26aufirst%3DC.%2BT.%26aulast%3DLandgraf%26aufirst%3DR.%26aulast%3DEngelmann%26aufirst%3DM.%26atitle%3DForced%2520swimming%2520triggers%2520vasopressin%2520release%2520within%2520the%2520amygdala%2520to%2520modulate%2520stress-coping%2520strategies%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2002%26volume%3D15%26spage%3D384%26epage%3D388%26doi%3D10.1046%2Fj.0953-816x.2001.01869.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group">Zink, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempf, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakimi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer-Lindenberg, A.</span><span> </span><span class="NLM_article-title">Vasopressin modulates medial prefrontal cortex–amygdala circuitry during emotion processing in humans</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">7017</span><span class="NLM_x">–</span> <span class="NLM_lpage">7022</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4899-09.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1523%2FJNEUROSCI.4899-09.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20484643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVWmsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=7017-7022&author=C.+F.+Zinkauthor=J.+L.+Steinauthor=L.+Kempfauthor=S.+Hakimiauthor=A.+Meyer-Lindenberg&title=Vasopressin+modulates+medial+prefrontal+cortex%E2%80%93amygdala+circuitry+during+emotion+processing+in+humans&doi=10.1523%2FJNEUROSCI.4899-09.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Vasopressin modulates medial prefrontal cortex-amygdala circuitry during emotion processing in humans</span></div><div class="casAuthors">Zink, Caroline F.; Stein, Jason L.; Kempf, Lucas; Hakimi, Shabnam; Meyer-Lindenberg, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7017-7022</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The neuropeptide vasopressin is a modulator of mammalian social behavior and emotion, particularly fear, aggression, and anxiety.  In humans, the neural circuitry underlying behavioral effects of vasopressin is unknown.  Using a double-blind crossover administration of 40 IU of vasopressin or placebo and functional MRI during processing of facial emotions in healthy male volunteers, we show that vasopressin specifically reduces differential activation in the subgenual cingulate cortex.  Structural equation modeling of a previously evaluated circuit between amygdala, subgenual cingulate, and supragenual cingulate revealed altered effective connectivity between subgenual and supragenual cingulate under vasopressin.  Our data demonstrate an impact of vasopressin on activity and connectivity in the cortical component of a medial prefrontal cortex-amygdala circuit implicated in emotional regulation, providing the first data on the neural basis for the effects of vasopressin on social behavior in humans with potential therapeutic significance for mood and anxiety disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRrqFcCp-XArVg90H21EOLACvtfcHk0liTwppVQLplxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVWmsro%253D&md5=d2a72abfa835ba262ebe395301a6dd50</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4899-09.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4899-09.2010%26sid%3Dliteratum%253Aachs%26aulast%3DZink%26aufirst%3DC.%2BF.%26aulast%3DStein%26aufirst%3DJ.%2BL.%26aulast%3DKempf%26aufirst%3DL.%26aulast%3DHakimi%26aufirst%3DS.%26aulast%3DMeyer-Lindenberg%26aufirst%3DA.%26atitle%3DVasopressin%2520modulates%2520medial%2520prefrontal%2520cortex%25E2%2580%2593amygdala%2520circuitry%2520during%2520emotion%2520processing%2520in%2520humans%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D7017%26epage%3D7022%26doi%3D10.1523%2FJNEUROSCI.4899-09.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group">Loup, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tribollet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois-Dauphin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreifuss, J. J.</span><span> </span><span class="NLM_article-title">Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">555</span><span class="NLM_x">, </span> <span class="NLM_fpage">220</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1016/0006-8993(91)90345-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2F0006-8993%2891%2990345-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1657300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADyaK3MXlslGhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=555&publication_year=1991&pages=220-232&author=F.+Loupauthor=E.+Tribolletauthor=M.+Dubois-Dauphinauthor=J.+J.+Dreifuss&title=Localization+of+high-affinity+binding+sites+for+oxytocin+and+vasopressin+in+the+human+brain.+An+autoradiographic+study&doi=10.1016%2F0006-8993%2891%2990345-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain.  An autoradiographic study</span></div><div class="casAuthors">Loup, F.; Tribollet, E.; Dubois-Dauphin, M.; Dreifuss, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">555</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">220-32</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">Sites which bind oxytocin and vasopressin with high affinity were detected in the brain and upper spinal cord of 12 human subjects, using in vitro light microscopic autoradiog.  Tissue sections were incubated with tritiated vasopressin, tritiated oxytocin, or an iodinated oxytocin antagonist.  The ligand specificity of binding was assessed with unlabeled vasopressin or oxytocin in excess, as well as in competition expts. using synthetic structural analogs.  The distribution of vasopressin binding sites differed markedly from that of oxytocin binding sites in the forebrain, while there was overlap in the brain stem.  Vasopressin binding sites were detected in the dorsal part of the lateral septal nucleus, in midline nuclei and adjacent intralaminar nuclei of the thalamus, in the hilus of the dentate gyrus, the dorsolateral part of the basal amygdaloid nucleus and the brain stem.  The distribution of oxytocin binding sites in the brain stem has been recently reported.  Oxytocin binding sites were also obsd. in the basal nucleus of Meynert, the nucleus of the vertical limb of the diagonal band of Broca, the ventral part of the lateral septal nucleus, the preoptic/anterior hypothalamic area, the posterior hypothalamic area, and variably in the globus pallidus and ventral pallidum.  The presence of oxytocin and vasopressin binding sites in limbic and autonomic areas suggests a neurotransmitter or neuromodulator role for these peptides in the human central nervous system.  They may also affect cholinergic transmission in the basal forebrain and consequently play a role in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofbbjy_8Dk0LVg90H21EOLACvtfcHk0lhOFX4TVg0Hsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlslGhu78%253D&md5=617f37734907b365fc7fab5e5f175c75</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2891%2990345-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252891%252990345-V%26sid%3Dliteratum%253Aachs%26aulast%3DLoup%26aufirst%3DF.%26aulast%3DTribollet%26aufirst%3DE.%26aulast%3DDubois-Dauphin%26aufirst%3DM.%26aulast%3DDreifuss%26aufirst%3DJ.%2BJ.%26atitle%3DLocalization%2520of%2520high-affinity%2520binding%2520sites%2520for%2520oxytocin%2520and%2520vasopressin%2520in%2520the%2520human%2520brain.%2520An%2520autoradiographic%2520study%26jtitle%3DBrain%2520Res.%26date%3D1991%26volume%3D555%26spage%3D220%26epage%3D232%26doi%3D10.1016%2F0006-8993%2891%2990345-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref217"><div class="reference"><strong class="refLabel"><a href="#ref217" class="rightTabRefNumLink">217</a></strong><div class="NLM_citation" id="rightTab-cit217"><span><span class="NLM_contrib-group">Ratni, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundschober, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez Sanchez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnider, P.</span><span> </span><span class="NLM_article-title">Discovery of highly selective brain-penetrant vasopressin 1a antagonists for the potential treatment of autism via a chemogenomic and scaffold hopping approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2275</span><span class="NLM_x">–</span> <span class="NLM_lpage">2289</span><span class="refDoi"> DOI: 10.1021/jm501745f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501745f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Sgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2275-2289&author=H.+Ratniauthor=M.+Rogers-Evansauthor=C.+Bissantzauthor=C.+Grundschoberauthor=J.+L.+Moreauauthor=F.+Schulerauthor=H.+Fischerauthor=R.+Alvarez+Sanchezauthor=P.+Schnider&title=Discovery+of+highly+selective+brain-penetrant+vasopressin+1a+antagonists+for+the+potential+treatment+of+autism+via+a+chemogenomic+and+scaffold+hopping+approach&doi=10.1021%2Fjm501745f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Selective Brain-Penetrant Vasopressin 1a Antagonists for the Potential Treatment of Autism via a Chemogenomic and Scaffold Hopping Approach</span></div><div class="casAuthors">Ratni, Hasane; Rogers-Evans, Mark; Bissantz, Caterina; Grundschober, Christophe; Moreau, Jean-Luc; Schuler, Franz; Fischer, Holger; Alvarez Sanchez, Ruben; Schnider, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2275-2289</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">From a micromolar high throughput screening hit 7, the successful complementary application of a chemogenomic approach and of a scaffold hopping exercise rapidly led to a low single digit nanomolar human vasopressin 1a (hV1a) receptor antagonist 38.  Initial optimization of the mouse V1a activities delivered suitable tool compds. which demonstrated a V1a mediated central in vivo effect.  This novel series was further optimized through parallel synthesis with a focus on balancing lipophilicity to achieve robust aq. soly. while avoiding P-gp mediated efflux.  These efforts led to the discovery of the highly potent and selective brain-penetrant hV1a antagonist RO5028442 (8) suitable for human clin. studies in people with autism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpyc3A24J_GLVg90H21EOLACvtfcHk0lhOFX4TVg0Hsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Sgtrc%253D&md5=587fbafaf38372123378586ecd87f10a</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1021%2Fjm501745f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501745f%26sid%3Dliteratum%253Aachs%26aulast%3DRatni%26aufirst%3DH.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DGrundschober%26aufirst%3DC.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DSchuler%26aufirst%3DF.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DAlvarez%2BSanchez%26aufirst%3DR.%26aulast%3DSchnider%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520highly%2520selective%2520brain-penetrant%2520vasopressin%25201a%2520antagonists%2520for%2520the%2520potential%2520treatment%2520of%2520autism%2520via%2520a%2520chemogenomic%2520and%2520scaffold%2520hopping%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2275%26epage%3D2289%26doi%3D10.1021%2Fjm501745f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref218"><div class="reference"><strong class="refLabel"><a href="#ref218" class="rightTabRefNumLink">218</a></strong><div class="NLM_citation" id="rightTab-cit218"><span><span class="NLM_contrib-group">Umbricht, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Valle Rubido, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCracken, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shic, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scahill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noeldeke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boak, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khwaja, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Squassante, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundschober, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kletzl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontoura, P.</span><span> </span><span class="NLM_article-title">A single dose, randomized, controlled proof-of-mechanism study of a novel vasopressin 1a receptor antagonist (RG7713) in high-functioning adults with autism spectrum disorder</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1914</span><span class="NLM_x">–</span> <span class="NLM_lpage">1923</span><span class="refDoi"> DOI: 10.1038/npp.2016.232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnpp.2016.232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27711048" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvV2gtLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=1914-1923&author=D.+Umbrichtauthor=M.+Del+Valle+Rubidoauthor=E.+Hollanderauthor=J.+T.+McCrackenauthor=F.+Shicauthor=L.+Scahillauthor=J.+Noeldekeauthor=L.+Boakauthor=O.+Khwajaauthor=L.+Squassanteauthor=C.+Grundschoberauthor=H.+Kletzlauthor=P.+Fontoura&title=A+single+dose%2C+randomized%2C+controlled+proof-of-mechanism+study+of+a+novel+vasopressin+1a+receptor+antagonist+%28RG7713%29+in+high-functioning+adults+with+autism+spectrum+disorder&doi=10.1038%2Fnpp.2016.232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">A Single Dose, Randomized, Controlled Proof-Of-Mechanism Study of a Novel Vasopressin 1a Receptor Antagonist (RG7713) in High-Functioning Adults with Autism Spectrum Disorder</span></div><div class="casAuthors">Umbricht, Daniel; del Valle Rubido, Marta; Hollander, Eric; McCracken, James T.; Shic, Frederick; Scahill, Lawrence; Noeldeke, Jana; Boak, Lauren; Khwaja, Omar; Squassante, Lisa; Grundschober, Christophe; Kletzl, Heidemarie; Fontoura, Paulo</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1914-1923</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The core symptoms of autism spectrum disorder (ASD) include impaired social communication, repetitive behaviors, and restricted interests.  No effective pharmacotherapy for these core deficits exists.  Within the domain of social communication, the vasopressin system is implicated in social cognition and social signaling deficits of ASD, and represents a potential therapeutic target.  We assessed the effects of a single 20 mg i.v. dose of the arginine vasopressin receptor 1A (V1a) antagonist, RG7713, on exploratory biomarkers (eye tracking), behavioral and clin. measures of social cognition and communication (affective speech recognition (ASR), reading the mind in the eyes, olfactory identification, scripted interaction), and safety and tolerability in a multicenter, randomized, double-blind, placebo-controlled, cross-over study of 19 high-functioning adult male subjects with DSM-IV Autistic Disorder (age 18-45 years; full scale IQ >70; ABC-Irritability subscale ≤13).  Eye-tracking showed an increase in biol. motion orienting preference with RG7713 (ES=0.8, p=0.047) and a non-significant improvement in the composite score (ES=0.2, p=0.29).  RG7713 reduced ability to detect lust (ES=-0.8, p=0.03) and fear (ES=-0.7, p=0.07) in ASR.  However, when all eight individual emotion subscales were combined into an overall ASR performance score, the redn. was non-significant (ES=-0.1, p=0.59).  Thirteen adverse events were reported in 10 subjects; all were of mild (11/13) or moderate (2/13) severity.  Although interpretation should be cautious due to multiple comparisons and small sample size, these results provide preliminary evidence from exptl. and behavioral biomarkers, that blockade of the V1a receptor may improve social communication in adults with high-functioning ASD.  ClinicalTrials.gov identifier: NCT01474278 A Study of RO5028442 in Adult Male High-Functioning Autistic Patients.  Available at: https://clinicaltrials.gov/ct2/show/NCT01474278.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAsg9CGg4pmLVg90H21EOLACvtfcHk0lhOFX4TVg0Hsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvV2gtLvE&md5=c0cfa97b338f184d08a073f21ab0fe7c</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2016.232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2016.232%26sid%3Dliteratum%253Aachs%26aulast%3DUmbricht%26aufirst%3DD.%26aulast%3DDel%2BValle%2BRubido%26aufirst%3DM.%26aulast%3DHollander%26aufirst%3DE.%26aulast%3DMcCracken%26aufirst%3DJ.%2BT.%26aulast%3DShic%26aufirst%3DF.%26aulast%3DScahill%26aufirst%3DL.%26aulast%3DNoeldeke%26aufirst%3DJ.%26aulast%3DBoak%26aufirst%3DL.%26aulast%3DKhwaja%26aufirst%3DO.%26aulast%3DSquassante%26aufirst%3DL.%26aulast%3DGrundschober%26aufirst%3DC.%26aulast%3DKletzl%26aufirst%3DH.%26aulast%3DFontoura%26aufirst%3DP.%26atitle%3DA%2520single%2520dose%252C%2520randomized%252C%2520controlled%2520proof-of-mechanism%2520study%2520of%2520a%2520novel%2520vasopressin%25201a%2520receptor%2520antagonist%2520%2528RG7713%2529%2520in%2520high-functioning%2520adults%2520with%2520autism%2520spectrum%2520disorder%26jtitle%3DNeuropsychopharmacology%26date%3D2017%26volume%3D42%26spage%3D1914%26epage%3D1923%26doi%3D10.1038%2Fnpp.2016.232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref219"><div class="reference"><strong class="refLabel"><a href="#ref219" class="rightTabRefNumLink">219</a></strong><div class="NLM_citation" id="rightTab-cit219"><span><span class="NLM_contrib-group">O’Dushlaine, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">The Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium</span><span> </span><span class="NLM_article-title">Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span><span class="refDoi"> DOI: 10.1038/nn.3922</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1038%2Fnn.3922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25599223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFKjsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2015&pages=199-209&author=C.+O%E2%80%99Dushlaineauthor=The+Network+and+Pathway+Analysis+Subgroup+of+the+Psychiatric+Genomics+Consortium&title=Psychiatric+genome-wide+association+study+analyses+implicate+neuronal%2C+immune+and+histone+pathways&doi=10.1038%2Fnn.3922"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways</span></div><div class="casAuthors">O'Dushlaine, Colm; Rossin, Lizzy; Lee, Phil H.; Duncan, Laramie; Parikshak, Neelroop N.; Newhouse, Stephen; Ripke, Stephan; Neale, Benjamin M.; Purcell, Shaun M.; Posthuma, Danielle; Nurnberger, John I.; Lee, S. Hong; Faraone, Stephen V.; Perlis, Roy H.; Mowry, Bryan J.; Thapar, Anita; Goddard, Michael E.; Witte, John S.; Absher, Devin; Agartz, Ingrid; Akil, Huda; Amin, Farooq; Andreassen, Ole A.; Anjorin, Adebayo; Anney, Richard; Anttila, Verneri; Arking, Dan E.; Asherson, Philip; Azevedo, Maria H.; Backlund, Lena; Badner, Judith A.; Bailey, Anthony J.; Banaschewski, Tobias; Barchas, Jack D.; Barnes, Michael R.; Barrett, Thomas B.; Bass, Nicholas; Battaglia, Agatino; Bauer, Michael; Bayes, Monica; Bellivier, Frank; Bergen, Sarah E.; Berrettini, Wade; Betancur, Catalina; Bettecken, Thomas; Biederman, Joseph; Binder, Elisabeth B.; Black, Donald W.; Blackwood, Douglas H. R.; Bloss, Cinnamon S.; Boehnke, Michael; Boomsma, Dorret I.; Breuer, Rene; Bruggeman, Richard; Cormican, Paul; Buccola, Nancy G.; Buitelaar, Jan K.; Bunney, William E.; Buxbaum, Joseph D.; Byerley, William F.; Byrne, Enda M.; Caesar, Sian; Cahn, Wiepke; Cantor, Rita M.; Casas, Miguel; Chakravarti, Aravinda; Chambert, Kimberly; Choudhury, Khalid; Cichon, Sven; Mattheisen, Manuel; Cloninger, C. Robert; Collier, David A.; Cook, Edwin H.; Coon, Hilary; Cormand, Bru; Corvin, Aiden; Coryell, William H.; Craig, David W.; Craig, Ian W.; Crosbie, Jennifer; Cuccaro, Michael L.; Curtis, David; Czamara, Darina; Datta, Susmita; Dawson, Geraldine; Day, Richard; De Geus, Eco J.; Degenhardt, Franziska; Djurovic, Srdjan; Donohoe, Gary J.; Doyle, Alysa E.; Duan, Jubao; Dudbridge, Frank; Duketis, Eftichia; Ebstein, Richard P.; Edenberg, Howard J.; Elia, Josephine; Ennis, Sean; Etain, Bruno; Fanous, Ayman; Farmer, Anne E.; Ferrier, I. Nicol; Flickinger, Matthew; Fombonne, Eric; Foroud, Tatiana; Frank, Josef; Franke, Barbara; Fraser, Christine; Freedman, Robert; Freimer, Nelson B.; Freitag, Christine M.; Friedl, Marion; Frisen, Louise; Gallagher, Louise; Gejman, Pablo V.; Georgieva, Lyudmila; Gershon, Elliot S.; Giegling, Ina; Gill, Michael; Gordon, Scott D.; Gordon-Smith, Katherine; Green, Elaine K.; Greenwood, Tiffany A.; Grice, Dorothy E.; Gross, Magdalena; Grozeva, Detelina; Guan, Weihua; Gurling, Hugh; De Haan, Lieuwe; Haines, Jonathan L.; Hakonarson, Hakon; Hallmayer, Joachim; Hamilton, Steven P.; Hamshere, Marian L.; Hansen, Thomas F.; Hartmann, Annette M.; Hautzinger, Martin; Heath, Andrew C.; Henders, Anjali K.; Herms, Stefan; Hickie, Ian B.; Hipolito, Maria; Hoefels, Susanne; Holsboer, Florian; Hoogendijk, Witte J.; Hottenga, Jouke-Jan; Hultman, Christina M.; Hus, Vanessa; Ingason, Andres; Ising, Marcus; Jamain, Stephane; Jones, Edward G.; Jones, Ian; Jones, Lisa; Tzeng, Jung-Ying; Kahler, Anna K.; Kahn, Rene S.; Kandaswamy, Radhika; Keller, Matthew C.; Kennedy, James L.; Kenny, Elaine; Kent, Lindsey; Kim, Yunjung; Kirov, George K.; Klauck, Sabine M.; Klei, Lambertus; Knowles, James A.; Kohli, Martin A.; Koller, Daniel L.; Konte, Bettina; Korszun, Ania; Krabbendam, Lydia; Krasucki, Robert; Kuntsi, Jonna; Kwan, Phoenix; Landen, Mikael; Langstrom, Niklas; Lathrop, Mark; Lawrence, Jacob; Lawson, William B.; Leboyer, Marion; Ledbetter, David H.; Lencz, Todd; Lesch, Klaus-Peter; Levinson, Douglas F.; Lewis, Cathryn M.; Li, Jun; Lichtenstein, Paul; Lieberman, Jeffrey A.; Lin, Dan-Yu; Linszen, Don H.; Liu, Chunyu; Lohoff, Falk W.; Loo, Sandra K.; Lord, Catherine; Lowe, Jennifer K.; Lucae, Susanne; MacIntyre, Donald J.; Madden, Pamela A. F.; Maestrini, Elena; Magnusson, Patrik K. E.; Mahon, Pamela B.; Maier, Wolfgang; Malhotra, Anil K.; Mane, Shrikant M.; Martin, Christa L.; Martin, Nicholas G.; Matthews, Keith; Mattingsdal, Morten; McCarroll, Steven A.; McGhee, Kevin A.; McGough, James J.; McGrath, Patrick J.; McGuffin, Peter; McInnis, Melvin G.; McIntosh, Andrew; McKinney, Rebecca; McLean, Alan W.; McMahon, Francis J.; McMahon, William M.; McQuillin, Andrew; Medeiros, Helena; Medland, Sarah E.; Meier, Sandra; Melle, Ingrid; Meng, Fan; Meyer, Jobst; Middeldorp, Christel M.; Middleton, Lefkos; Milanova, Vihra; Miranda, Ana; Monaco, Anthony P.; Montgomery, Grant W.; Moran, Jennifer L.; Moreno-De-Luca, Daniel; Morken, Gunnar; Morris, Derek W.; Morrow, Eric M.; Moskvina, Valentina; Muglia, Pierandrea; Muhleisen, Thomas W.; Muir, Walter J.; Muller-Myhsok, Bertram; Murtha, Michael; Myers, Richard M.; Myin-Germeys, Inez; Neale, Michael C.; Nelson, Stan F.; Nievergelt, Caroline M.; Nikolov, Ivan; Nimgaonkar, Vishwajit; Nolen, Willem A.; Nothen, Markus M.; Nwulia, Evaristus A.; Nyholt, Dale R.; Oades, Robert D.; Olincy, Ann; Oliveira, Guiomar; Olsen, Line; Ophoff, Roel A.; Osby, Urban; Owen, Michael J.; Palotie, Aarno; Parr, Jeremy R.; Paterson, Andrew D.; Pato, Carlos N.; Pato, Michele T.; Penninx, Brenda W.; Pergadia, Michele L.; Pericak-Vance, Margaret A.; Pickard, Benjamin S.; Pimm, Jonathan; Piven, Joseph; Potash, James B.; Poustka, Fritz; Propping, Peter; Puri, Vinay; Quested, Digby J.; Quinn, Emma M.; Ramos-Quiroga, Josep Antoni; Rasmussen, Henrik B.; Raychaudhuri, Soumya; Rehnstrom, Karola; Reif, Andreas; Ribases, Marta; Rice, John P.; Rietschel, Marcella; Roeder, Kathryn; Roeyers, Herbert; Rothenberger, Aribert; Rouleau, Guy; Ruderfer, Douglas; Rujescu, Dan; Sanders, Alan R.; Sanders, Stephan J.; Santangelo, Susan L.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-209</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Genome-wide assocn. studies (GWAS) of psychiatric disorders have identified multiple genetic assocns. with such disorders, but better methods are needed to derive the underlying biol. mechanisms that these signals indicate.  We sought to identify biol. pathways in GWAS data from over 60,000 participants from the Psychiatric Genomics Consortium.  We developed an anal. framework to rank pathways that requires only summary statistics.  We combined this score across disorders to find common pathways across three adult psychiatric disorders: schizophrenia, major depression and bipolar disorder.  Histone methylation processes showed the strongest assocn., and we also found statistically significant evidence for assocns. with multiple immune and neuronal signaling pathways and with the postsynaptic d.  Our study indicates that risk variants for psychiatric disorders aggregate in particular biol. pathways and that these pathways are frequently shared between disorders.  Our results confirm known mechanisms and suggest several novel insights into the etiol. of psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB_fSmQorh1bVg90H21EOLACvtfcHk0lj2l49Ao9H5tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFKjsL4%253D&md5=d1f6b3127f32d006bc01a85486edb6cd</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1038%2Fnn.3922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3922%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Dushlaine%26aufirst%3DC.%26aulast%3D%26atitle%3DPsychiatric%2520genome-wide%2520association%2520study%2520analyses%2520implicate%2520neuronal%252C%2520immune%2520and%2520histone%2520pathways%26jtitle%3DNat.%2520Neurosci.%26date%3D2015%26volume%3D18%26spage%3D199%26epage%3D209%26doi%3D10.1038%2Fnn.3922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref220"><div class="reference"><strong class="refLabel"><a href="#ref220" class="rightTabRefNumLink">220</a></strong><div class="NLM_citation" id="rightTab-cit220"><span><span class="NLM_contrib-group">Merrill, J. E.</span><span> </span><span class="NLM_article-title">Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological</span> <span class="citation_source-journal">Dev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><span class="refDoi"> DOI: 10.1159/000111642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1159%2F000111642" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1-10&author=J.+E.+Merrill&title=Tumor+necrosis+factor+alpha%2C+interleukin+1+and+related+cytokines+in+brain+development%3A+normal+and+pathological&doi=10.1159%2F000111642"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1159%2F000111642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000111642%26sid%3Dliteratum%253Aachs%26aulast%3DMerrill%26aufirst%3DJ.%2BE.%26atitle%3DTumor%2520necrosis%2520factor%2520alpha%252C%2520interleukin%25201%2520and%2520related%2520cytokines%2520in%2520brain%2520development%253A%2520normal%2520and%2520pathological%26jtitle%3DDev.%2520Neurosci.%26date%3D2004%26volume%3D14%26spage%3D1%26epage%3D10%26doi%3D10.1159%2F000111642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref221"><div class="reference"><strong class="refLabel"><a href="#ref221" class="rightTabRefNumLink">221</a></strong><div class="NLM_citation" id="rightTab-cit221"><span><span class="NLM_contrib-group">Miller, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoPreste, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaller, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinarello, C. A.</span><span> </span><span class="NLM_article-title">Neonatal interleukin- 1 beta, interleukin-6, and tumor necrosis factor: cord blood levels and cellular production</span> <span class="citation_source-journal">J. Pediatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">965</span><span class="refDoi"> DOI: 10.1016/S0022-3476(05)80145-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0022-3476%2805%2980145-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=2246700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADyaK3M%252FmtFajtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1990&pages=961-965&author=L.+C.+Millerauthor=S.+Isaauthor=G.+LoPresteauthor=J.+G.+Schallerauthor=C.+A.+Dinarello&title=Neonatal+interleukin-+1+beta%2C+interleukin-6%2C+and+tumor+necrosis+factor%3A+cord+blood+levels+and+cellular+production&doi=10.1016%2FS0022-3476%2805%2980145-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">Neonatal interleukin-1 beta, interleukin-6, and tumor necrosis factor: cord blood levels and cellular production</span></div><div class="casAuthors">Miller L C; Isa S; LoPreste G; Schaller J G; Dinarello C A</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pediatrics</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">961-5</span>
        ISSN:<span class="NLM_cas:issn">0022-3476</span>.
    </div><div class="casAbstract">In a prospective study, levels of interleukin-1 beta (IL-1 beta), interleukin-6) (IL-6), and tumor necrosis factor (TNF) were measured in a blind fashion in cord blood plasma from 92 neonates by specific immunoassays, and were correlated with the clinical courses of the infants, including type of delivery and perinatal complications.  Plasma IL-1 beta concentration was undetectable in infants born by normal vaginal delivery or elective cesarean section but was significantly increased in infants born after induced vaginal deliveries (142 +/- 68 pg/ml) or urgent cesarean section (290 +/- 21 pg/ml; both p less than 0.05 compared with normal deliveries).  The IL-1 beta levels were elevated in infants with severe perinatal complications (282 +/- 116 pg/ml; p less than 0.001), whereas TNF and IL-6 levels were not related to these complications.  Infants with isolated perinatal infectious complications had elevated levels of plasma IL-6 compared with those of sick neonates without infection (p less than 0.001).  In contrast, TNF plasma levels and IL-1 beta production by cord blood leukocytes were decreased in infants with infectious complications alone (both p less than 0.05).  These studies suggest that the levels of IL-1 beta, IL-6, and TNF in the cord plasma relate differentially to clinical complications in the perinatal period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqVm9mR4XMqAyMywPm6HgQfW6udTcc2eaBUJglK6ZDSLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M%252FmtFajtQ%253D%253D&md5=414fc57e3f069ea19b88fa9becc18c80</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1016%2FS0022-3476%2805%2980145-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-3476%252805%252980145-3%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DL.%2BC.%26aulast%3DIsa%26aufirst%3DS.%26aulast%3DLoPreste%26aufirst%3DG.%26aulast%3DSchaller%26aufirst%3DJ.%2BG.%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26atitle%3DNeonatal%2520interleukin-%25201%2520beta%252C%2520interleukin-6%252C%2520and%2520tumor%2520necrosis%2520factor%253A%2520cord%2520blood%2520levels%2520and%2520cellular%2520production%26jtitle%3DJ.%2520Pediatr.%26date%3D1990%26volume%3D117%26spage%3D961%26epage%3D965%26doi%3D10.1016%2FS0022-3476%2805%2980145-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref222"><div class="reference"><strong class="refLabel"><a href="#ref222" class="rightTabRefNumLink">222</a></strong><div class="NLM_citation" id="rightTab-cit222"><span><span class="NLM_contrib-group">Yoon, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Syu, H. C.</span><span> </span><span class="NLM_article-title">Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity</span> <span class="citation_source-journal">Am. J. Obstet. Gynecol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">172</span><span class="NLM_x">, </span> <span class="NLM_fpage">960</span><span class="NLM_x">–</span> <span class="NLM_lpage">970</span><span class="refDoi"> DOI: 10.1016/0002-9378(95)90028-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2F0002-9378%2895%2990028-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=7892891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADyaK2MXltFCjt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=1995&pages=960-970&author=B.+H.+Yoonauthor=R.+Romeroauthor=C.+J.+Kimauthor=J.+K.+Junauthor=R.+Gomezauthor=J.+H.+Choiauthor=H.+C.+Syu&title=Amniotic+fluid+interleukin-6%3A+a+sensitive+test+for+antenatal+diagnosis+of+acute+inflammatory+lesions+of+preterm+placenta+and+prediction+of+perinatal+morbidity&doi=10.1016%2F0002-9378%2895%2990028-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Amniotic fluid interleukin-6: a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity</span></div><div class="casAuthors">Yoon, Bo Hyun; Romero, Roberto; Kim, Chong Jai; Jun, Jong Kwan; Gomez, Ricardo; Choi, Jung-Hwan; Syn, Hee Chul</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Obstetrics and Gynecology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">960-70</span>CODEN:
                <span class="NLM_cas:coden">AJOGAH</span>;
        ISSN:<span class="NLM_cas:issn">0002-9378</span>.
    </div><div class="casAbstract">Our purpose was to det. whether amniotic fluid concns. of interleukin-6 are of value in the antenatal diagnosis of acute inflammatory lesions (histol. chorioamnionitis) of preterm placenta and in the prediction of perinatal morbidity and mortality.  The relation among placental histol. findings, perinatal outcome, and amniotic fluid interleukin-6 concns. was examd. in 50 consecutive patients who delivered preterm neonates within 72 h after amniocentesis.  Interleukin-6 was detd. by enzyme-linked immunosorbent assays.  Receiver-operator characteristic curve was used for anal.  Patients with acute histol. chorioamnionitis had significantly higher median amniotic fluid interleukin-6 concns. than patients without histol. chorioamnionitis (median 70.8 ng/mL, range 0.7 to 499.2 ng/mL vs median 2.9 ng/mL, range 0.8 to 16.0 ng/mL, resp.).  An amniotic fluid interleukin-6 concn. > 17 ng/mL had a sensitivity of 79% (23/29) and a specificity of 100% (21/21) in the diagnosis of acute histol. chorioamnionitis and a sensitivity of 69% (18/26) and a specificity of 79% (19/24) in the prediction of significant neonatal morbidity (defined as neonatal sepsis, respiratory distress syndrome, pneumonia, intraventricular hemorrhage, bronchopulmonary dysplasia, or necrotizing enterocolitis) and mortality.  These sensitivities were significantly higher than those of amniotic fluid culture (79% vs 38%; 69% vs 27%, resp.).  Amniotic fluid interleukin-6 is a sensitive test for the prospective diagnosis of acute histol. chorioamnionitis and the identification of neonates at risk for significant morbidity and mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEDT-icDrJGbVg90H21EOLACvtfcHk0lj2l49Ao9H5tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXltFCjt70%253D&md5=14e6e2ef17014f65847c247ecf6697ba</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1016%2F0002-9378%2895%2990028-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0002-9378%252895%252990028-4%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DB.%2BH.%26aulast%3DRomero%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DC.%2BJ.%26aulast%3DJun%26aufirst%3DJ.%2BK.%26aulast%3DGomez%26aufirst%3DR.%26aulast%3DChoi%26aufirst%3DJ.%2BH.%26aulast%3DSyu%26aufirst%3DH.%2BC.%26atitle%3DAmniotic%2520fluid%2520interleukin-6%253A%2520a%2520sensitive%2520test%2520for%2520antenatal%2520diagnosis%2520of%2520acute%2520inflammatory%2520lesions%2520of%2520preterm%2520placenta%2520and%2520prediction%2520of%2520perinatal%2520morbidity%26jtitle%3DAm.%2520J.%2520Obstet.%2520Gynecol.%26date%3D1995%26volume%3D172%26spage%3D960%26epage%3D970%26doi%3D10.1016%2F0002-9378%2895%2990028-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref223"><div class="reference"><strong class="refLabel"><a href="#ref223" class="rightTabRefNumLink">223</a></strong><div class="NLM_citation" id="rightTab-cit223"><span><span class="NLM_contrib-group">Abbott, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patabendige, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolman, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yusof, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Begley, D. J.</span><span> </span><span class="NLM_article-title">Structure and function of the blood-brain barrier</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span><span class="refDoi"> DOI: 10.1016/j.nbd.2009.07.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.nbd.2009.07.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=19664713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGms73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=13-25&author=N.+J.+Abbottauthor=A.+A.+Patabendigeauthor=D.+E.+Dolmanauthor=S.+R.+Yusofauthor=D.+J.+Begley&title=Structure+and+function+of+the+blood-brain+barrier&doi=10.1016%2Fj.nbd.2009.07.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of the blood-brain barrier</span></div><div class="casAuthors">Abbott, N. Joan; Patabendige, Adjanie A. K.; Dolman, Diana E. M.; Yusof, Siti R.; Begley, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-25</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Neural signalling within the central nervous system (CNS) requires a highly controlled microenvironment.  Cells at three key interfaces form barriers between the blood and the CNS: the blood-brain barrier (BBB), blood-CSF barrier and the arachnoid barrier.  The BBB at the level of brain microvessel endothelium is the major site of blood-CNS exchange.  The structure and function of the BBB is summarized, the phys. barrier formed by the endothelial tight junctions, and the transport barrier resulting from membrane transporters and vesicular mechanisms.  The roles of assocd. cells are outlined, esp. the end feet of astrocytic glial cells, and pericytes and microglia.  The embryonic development of the BBB, and changes in pathol. are described.  The BBB is subject to short and long-term regulation, which may be disturbed in pathol.  Any program for drug discovery or delivery, to target or avoid the CNS, needs to consider the special features of the BBB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLiRwl4gXHmbVg90H21EOLACvtfcHk0lhGCl3kRamZAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGms73P&md5=fa08cd39c1350b4c845121c21a174ad8</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.07.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.07.030%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DN.%2BJ.%26aulast%3DPatabendige%26aufirst%3DA.%2BA.%26aulast%3DDolman%26aufirst%3DD.%2BE.%26aulast%3DYusof%26aufirst%3DS.%2BR.%26aulast%3DBegley%26aufirst%3DD.%2BJ.%26atitle%3DStructure%2520and%2520function%2520of%2520the%2520blood-brain%2520barrier%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2010%26volume%3D37%26spage%3D13%26epage%3D25%26doi%3D10.1016%2Fj.nbd.2009.07.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref224"><div class="reference"><strong class="refLabel"><a href="#ref224" class="rightTabRefNumLink">224</a></strong><div class="NLM_citation" id="rightTab-cit224"><span><span class="NLM_contrib-group">Malik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheikh, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spivack, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span> </span><span class="NLM_article-title">Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects</span> <span class="citation_source-journal">Immunobiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">216</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span><span class="refDoi"> DOI: 10.1016/j.imbio.2010.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.imbio.2010.03.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2011&pages=80-85&author=M.+Malikauthor=A.+M.+Sheikhauthor=G.+Wenauthor=W.+Spivackauthor=W.+T.+Brownauthor=X.+Li&title=Expression+of+inflammatory+cytokines%2C+Bcl2+and+cathepsin+D+are+altered+in+lymphoblasts+of+autistic+subjects&doi=10.1016%2Fj.imbio.2010.03.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1016%2Fj.imbio.2010.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imbio.2010.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DMalik%26aufirst%3DM.%26aulast%3DSheikh%26aufirst%3DA.%2BM.%26aulast%3DWen%26aufirst%3DG.%26aulast%3DSpivack%26aufirst%3DW.%26aulast%3DBrown%26aufirst%3DW.%2BT.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DExpression%2520of%2520inflammatory%2520cytokines%252C%2520Bcl2%2520and%2520cathepsin%2520D%2520are%2520altered%2520in%2520lymphoblasts%2520of%2520autistic%2520subjects%26jtitle%3DImmunobiology%26date%3D2011%26volume%3D216%26spage%3D80%26epage%3D85%26doi%3D10.1016%2Fj.imbio.2010.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref225"><div class="reference"><strong class="refLabel"><a href="#ref225" class="rightTabRefNumLink">225</a></strong><div class="NLM_citation" id="rightTab-cit225"><span><span class="NLM_contrib-group">Depino, A. M.</span><span> </span><span class="NLM_article-title">Peripheral and central inflammation in autism spectrum disorders</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1016/j.mcn.2012.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.mcn.2012.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=23069728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1CjsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=69-76&author=A.+M.+Depino&title=Peripheral+and+central+inflammation+in+autism+spectrum+disorders&doi=10.1016%2Fj.mcn.2012.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral and central inflammation in autism spectrum disorders</span></div><div class="casAuthors">Depino, Amaicha Mara</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">69-76</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Recent reports have given a central role to environmental factors in the etiol. of autism spectrum disorders (ASD).  However, most proposed perinatal factors seem to converge into the activation of the immune system, suggesting that an early inflammatory response could be a unifying factor in the etiol. ASD.  Here the author reviews the evidence of early immune activation in individuals with ASD, and the chronic peripheral and central alterations obsd. in the inflammatory response in ASD.  This evidence shows that ASD is assocd. with altered neuroinflammatory processes and abnormal immune responses in adulthood.  How these immune alterations can affect developmental programming of adult behavior or directly affect behavior later in life is discussed in the context of both clin. and animal models of research.  Recent studies in rodents clearly support a role of elevated cytokines in the behavioral symptoms of ASD, both during development and in adulthood.  This article is part of a Special Issue entitled "Neuroinflammation in neurodegeneration and neurodysfunction".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0RarwsUHoHLVg90H21EOLACvtfcHk0lhGCl3kRamZAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1CjsL%252FL&md5=b30aa1b679c82fbf6942de6d994281f9</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1016%2Fj.mcn.2012.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcn.2012.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DDepino%26aufirst%3DA.%2BM.%26atitle%3DPeripheral%2520and%2520central%2520inflammation%2520in%2520autism%2520spectrum%2520disorders%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2013%26volume%3D53%26spage%3D69%26epage%3D76%26doi%3D10.1016%2Fj.mcn.2012.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref226"><div class="reference"><strong class="refLabel"><a href="#ref226" class="rightTabRefNumLink">226</a></strong><div class="NLM_citation" id="rightTab-cit226"><span><span class="NLM_contrib-group">Auld, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robitaille, R.</span><span> </span><span class="NLM_article-title">Glial cells and neurotransmission: an inclusive view of synaptic function</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span><span class="refDoi"> DOI: 10.1016/S0896-6273(03)00607-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0896-6273%2803%2900607-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2003&pages=389-400&author=D.+S.+Auldauthor=R.+Robitaille&title=Glial+cells+and+neurotransmission%3A+an+inclusive+view+of+synaptic+function&doi=10.1016%2FS0896-6273%2803%2900607-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2803%2900607-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252803%252900607-X%26sid%3Dliteratum%253Aachs%26aulast%3DAuld%26aufirst%3DD.%2BS.%26aulast%3DRobitaille%26aufirst%3DR.%26atitle%3DGlial%2520cells%2520and%2520neurotransmission%253A%2520an%2520inclusive%2520view%2520of%2520synaptic%2520function%26jtitle%3DNeuron%26date%3D2003%26volume%3D40%26spage%3D389%26epage%3D400%26doi%3D10.1016%2FS0896-6273%2803%2900607-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref227"><div class="reference"><strong class="refLabel"><a href="#ref227" class="rightTabRefNumLink">227</a></strong><div class="NLM_citation" id="rightTab-cit227"><span><span class="NLM_contrib-group">Steinmetz, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buard, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claudepierre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nägler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfrieger, F. W.</span><span> </span><span class="NLM_article-title">Regional variations in the glial influence on synapse development in the mouse CNS</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">577</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><span class="refDoi"> DOI: 10.1113/jphysiol.2006.117358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1113%2Fjphysiol.2006.117358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=16959855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yqsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=577&publication_year=2006&pages=249-261&author=C.+C.+Steinmetzauthor=I.+Buardauthor=T.+Claudepierreauthor=K.+N%C3%A4glerauthor=F.+W.+Pfrieger&title=Regional+variations+in+the+glial+influence+on+synapse+development+in+the+mouse+CNS&doi=10.1113%2Fjphysiol.2006.117358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">Regional variations in the glial influence on synapse development in the mouse CNS</span></div><div class="casAuthors">Steinmetz, C. C.; Buard, I.; Claudepierre, T.; Nagler, K.; Pfrieger, F. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">577</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">249-261</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">There is increasing evidence that synapse function depends on interactions with glial cells, namely astrocytes.  Studies on specific neurons of the central nervous system (CNS) indicated that glial signals also control synapse development, but it remained unclear whether this is a general principle that applies to other neuronal cell types.  To address this question, we developed new methods to immunoisolate neurons from different brain regions of postnatal mice and to culture them in a chem. defined medium.  Electrophysiol. recordings and immunocytochem. staining revealed vigorous synaptogenesis in hippocampal and cerebellar neurons, but not in retinal ganglion cells (RGCs) in the absence of glial cells.  Co-culture with glia promoted synapse formation in RGCs as indicated by a strong increase in the incidence and frequency of action potential-independent miniature synaptic currents, but showed no such effects in hippocampal or cerebellar neurons.  On the other hand, glial signals promoted the efficacy of excitatory synapses in all regions as indicated by an increase in the size of spontaneous synaptic events in cerebellar cultures and of miniature synaptic currents in hippocampal neurons and RGCs.  Inhibitory synaptic currents remained largely unaffected by glia.  Our results indicate that in the mammalian CNS, the way that glial signals promote the development of excitatory synapses depends on the type of neuron.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKKHQwseRSz7Vg90H21EOLACvtfcHk0lj04jfepTHUuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yqsLzE&md5=5253934761dd77d0c6138d60b7f04516</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2006.117358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2006.117358%26sid%3Dliteratum%253Aachs%26aulast%3DSteinmetz%26aufirst%3DC.%2BC.%26aulast%3DBuard%26aufirst%3DI.%26aulast%3DClaudepierre%26aufirst%3DT.%26aulast%3DN%25C3%25A4gler%26aufirst%3DK.%26aulast%3DPfrieger%26aufirst%3DF.%2BW.%26atitle%3DRegional%2520variations%2520in%2520the%2520glial%2520influence%2520on%2520synapse%2520development%2520in%2520the%2520mouse%2520CNS%26jtitle%3DJ.%2520Physiol.%26date%3D2006%26volume%3D577%26spage%3D249%26epage%3D261%26doi%3D10.1113%2Fjphysiol.2006.117358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref228"><div class="reference"><strong class="refLabel"><a href="#ref228" class="rightTabRefNumLink">228</a></strong><div class="NLM_citation" id="rightTab-cit228"><span><span class="NLM_contrib-group">Verkhratsky, A.</span><span> </span><span class="NLM_article-title">Physiology of neuronal–glial networking</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">332</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span><span class="refDoi"> DOI: 10.1016/j.neuint.2010.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuint.2010.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20144673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref228/cit228&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFamtLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2010&pages=332-343&author=A.+Verkhratsky&title=Physiology+of+neuronal%E2%80%93glial+networking&doi=10.1016%2Fj.neuint.2010.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit228R"><div class="casContent"><span class="casTitleNuber">228</span><div class="casTitle"><span class="NLM_cas:atitle">Physiology of neuronal-glial networking</span></div><div class="casAuthors">Verkhratsky, Alexei</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">332-343</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Neuronal-glial networks are the substrate for the brain function.  Evolution of the nervous system resulted in the appearance of highly specialized neuronal web optimized for rapid information transfer.  This neuronal web is embedded into glial syncytium, thereby creating sophisticated neuronal-glial circuitry were both types of neural cells are working in concert, ensuring amplification of brain computational power.  In addn. neuroglial cells are fundamental for control of brain homeostasis and they represent the intrinsic brain defense system, being thus intimately involved in pathogenesis of neurol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIh_jgfgnn4rVg90H21EOLACvtfcHk0lj04jfepTHUuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFamtLbI&md5=6ff41045607260073fccc3035e580ba9</span></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2010.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2010.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DVerkhratsky%26aufirst%3DA.%26atitle%3DPhysiology%2520of%2520neuronal%25E2%2580%2593glial%2520networking%26jtitle%3DNeurochem.%2520Int.%26date%3D2010%26volume%3D57%26spage%3D332%26epage%3D343%26doi%3D10.1016%2Fj.neuint.2010.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref229"><div class="reference"><strong class="refLabel"><a href="#ref229" class="rightTabRefNumLink">229</a></strong><div class="NLM_citation" id="rightTab-cit229"><span><span class="NLM_contrib-group">Minghetti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnevale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Simone, R.</span><span> </span><span class="NLM_article-title">Microglia–neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">388</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span><span class="refDoi"> DOI: 10.2174/187152707783399193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.2174%2F187152707783399193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=18220778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitF2kurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=388-397&author=L.+Minghettiauthor=D.+Carnevaleauthor=R.+De+Simone&title=Microglia%E2%80%93neuron+interaction+in+inflammatory+and+degenerative+diseases%3A+role+of+cholinergic+and+noradrenergic+systems&doi=10.2174%2F187152707783399193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems</span></div><div class="casAuthors">Carnevale, D.; De Simone, R.; Minghetti, L.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">388-397</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Reciprocal interactions between glia and neurons are essential for many crit. functions in brain health and disease.  Microglial cells, the brain resident macrophages, and astrocytes, the most prevalent type of cell in brain, are actively involved in the control of neuronal activities both in developing and adult organisms.  At the same time, neurons influence glial functions, through direct cell-to-cell interactions as well as the release of sol. mediators.  Among signals from neurons that may have an active role in controlling glial activation are two major neurotransmitters: acetylcholine and noradrenaline.  Several studies indicate that microglia and astrocytes express adrenergic receptors, whose activation influences the release of pro-inflammatory mediators, controlling the extent of glial reactivity.  Acetylcholine receptors are also expressed by glial cells.  In particular, microglial cells express the nicotinic receptor α7 and its activation attenuates the pro-inflammatory response of microglial cultures, suggesting that acetylcholine may control brain inflammation, in analogy to what demonstrated in peripheral tissues.  Deficiencies of noradrenergic and cholinergic systems are linked to important neurodegenerative diseases such as Parkinson's disease (PD) and Alzheimer's disease (AD) and it has been suggested that in addn. to impairing neuron-to-neuron transmission, noradrenergic and cholinergic hypofunction may contribute to dysregulation of the normal neuron-glia interaction, abnormal glial reaction and, eventually, neurodegeneration.  A deeper knowledge of role of cholinergic and noradrenergic systems in controlling neuron-glia interactions may offer new avenues for disease treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptyib6PWJY37Vg90H21EOLACvtfcHk0lj04jfepTHUuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitF2kurc%253D&md5=ef8d528d8cdf6b749aab73da9e3943ea</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=10.2174%2F187152707783399193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152707783399193%26sid%3Dliteratum%253Aachs%26aulast%3DMinghetti%26aufirst%3DL.%26aulast%3DCarnevale%26aufirst%3DD.%26aulast%3DDe%2BSimone%26aufirst%3DR.%26atitle%3DMicroglia%25E2%2580%2593neuron%2520interaction%2520in%2520inflammatory%2520and%2520degenerative%2520diseases%253A%2520role%2520of%2520cholinergic%2520and%2520noradrenergic%2520systems%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2007%26volume%3D6%26spage%3D388%26epage%3D397%26doi%3D10.2174%2F187152707783399193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref230"><div class="reference"><strong class="refLabel"><a href="#ref230" class="rightTabRefNumLink">230</a></strong><div class="NLM_citation" id="rightTab-cit230"><span><span class="NLM_contrib-group">Byrnes, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoica, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loane, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faden, A. I.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">550</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span><span class="refDoi"> DOI: 10.1002/glia.20783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref230/cit230&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2Fglia.20783" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2009&pages=550-560&author=K.+R.+Byrnesauthor=B.+Stoicaauthor=D.+J.+Loaneauthor=A.+Riccioauthor=M.+I.+Davisauthor=A.+I.+Faden&title=Metabotropic+glutamate+receptor+5+activation+inhibits+microglial+associated+inflammation+and+neurotoxicity&doi=10.1002%2Fglia.20783"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=10.1002%2Fglia.20783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.20783%26sid%3Dliteratum%253Aachs%26aulast%3DByrnes%26aufirst%3DK.%2BR.%26aulast%3DStoica%26aufirst%3DB.%26aulast%3DLoane%26aufirst%3DD.%2BJ.%26aulast%3DRiccio%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DFaden%26aufirst%3DA.%2BI.%26atitle%3DMetabotropic%2520glutamate%2520receptor%25205%2520activation%2520inhibits%2520microglial%2520associated%2520inflammation%2520and%2520neurotoxicity%26jtitle%3DGlia%26date%3D2009%26volume%3D57%26spage%3D550%26epage%3D560%26doi%3D10.1002%2Fglia.20783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref231"><div class="reference"><strong class="refLabel"><a href="#ref231" class="rightTabRefNumLink">231</a></strong><div class="NLM_citation" id="rightTab-cit231"><span><span class="NLM_contrib-group">Loane, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoica, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pajoohesh-Ganji, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrnes, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faden, A. I.</span><span> </span><span class="NLM_article-title">Activation of metabotropic glutamate receptor 5 modulates microglial reactivity and neurotoxicity by inhibiting NADPH oxidase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">15629</span><span class="NLM_x">–</span> <span class="NLM_lpage">15639</span><span class="refDoi"> DOI: 10.1074/jbc.M806139200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1074%2Fjbc.M806139200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=15629-15639&author=D.+J.+Loaneauthor=B.+A.+Stoicaauthor=A.+Pajoohesh-Ganjiauthor=K.+R.+Byrnesauthor=A.+I.+Faden&title=Activation+of+metabotropic+glutamate+receptor+5+modulates+microglial+reactivity+and+neurotoxicity+by+inhibiting+NADPH+oxidase&doi=10.1074%2Fjbc.M806139200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806139200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806139200%26sid%3Dliteratum%253Aachs%26aulast%3DLoane%26aufirst%3DD.%2BJ.%26aulast%3DStoica%26aufirst%3DB.%2BA.%26aulast%3DPajoohesh-Ganji%26aufirst%3DA.%26aulast%3DByrnes%26aufirst%3DK.%2BR.%26aulast%3DFaden%26aufirst%3DA.%2BI.%26atitle%3DActivation%2520of%2520metabotropic%2520glutamate%2520receptor%25205%2520modulates%2520microglial%2520reactivity%2520and%2520neurotoxicity%2520by%2520inhibiting%2520NADPH%2520oxidase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D15629%26epage%3D15639%26doi%3D10.1074%2Fjbc.M806139200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref232"><div class="reference"><strong class="refLabel"><a href="#ref232" class="rightTabRefNumLink">232</a></strong><div class="NLM_citation" id="rightTab-cit232"><span><span class="NLM_contrib-group">Drouin-Ouellet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brownell, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saint-Pierre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fasano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emond, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trudeau, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicchetti, F.</span><span> </span><span class="NLM_article-title">Neuroinflammation is associated with changes in glial mGluR5 expression and the development of neonatal excitotoxic lesions</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span><span class="refDoi"> DOI: 10.1002/glia.21086</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref232/cit232&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2Fglia.21086" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2011&pages=188-199&author=J.+Drouin-Ouelletauthor=A.+L.+Brownellauthor=M.+Saint-Pierreauthor=C.+Fasanoauthor=V.+Emondauthor=L.+E.+Trudeauauthor=D.+Levesqueauthor=F.+Cicchetti&title=Neuroinflammation+is+associated+with+changes+in+glial+mGluR5+expression+and+the+development+of+neonatal+excitotoxic+lesions&doi=10.1002%2Fglia.21086"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=10.1002%2Fglia.21086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.21086%26sid%3Dliteratum%253Aachs%26aulast%3DDrouin-Ouellet%26aufirst%3DJ.%26aulast%3DBrownell%26aufirst%3DA.%2BL.%26aulast%3DSaint-Pierre%26aufirst%3DM.%26aulast%3DFasano%26aufirst%3DC.%26aulast%3DEmond%26aufirst%3DV.%26aulast%3DTrudeau%26aufirst%3DL.%2BE.%26aulast%3DLevesque%26aufirst%3DD.%26aulast%3DCicchetti%26aufirst%3DF.%26atitle%3DNeuroinflammation%2520is%2520associated%2520with%2520changes%2520in%2520glial%2520mGluR5%2520expression%2520and%2520the%2520development%2520of%2520neonatal%2520excitotoxic%2520lesions%26jtitle%3DGlia%26date%3D2011%26volume%3D59%26spage%3D188%26epage%3D199%26doi%3D10.1002%2Fglia.21086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref233"><div class="reference"><strong class="refLabel"><a href="#ref233" class="rightTabRefNumLink">233</a></strong><div class="NLM_citation" id="rightTab-cit233"><span><span class="NLM_contrib-group">Bergeron, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deslauriers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grignon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortier, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepage, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poyart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sébire, G.</span><span> </span><span class="NLM_article-title">White matter injury and autistic-like behavior predominantly affecting male rat offspring exposed to group B streptococcal maternal inflammation</span> <span class="citation_source-journal">Dev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">504</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span><span class="refDoi"> DOI: 10.1159/000355656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1159%2F000355656" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24246964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWltb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2013&pages=504-515&author=J.+D.+Bergeronauthor=J.+Deslauriersauthor=S.+Grignonauthor=L.+C.+Fortierauthor=M.+Lepageauthor=T.+Strohauthor=C.+Poyartauthor=G.+S%C3%A9bire&title=White+matter+injury+and+autistic-like+behavior+predominantly+affecting+male+rat+offspring+exposed+to+group+B+streptococcal+maternal+inflammation&doi=10.1159%2F000355656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">White Matter Injury and Autistic-Like Behavior Predominantly Affecting Male Rat Offspring Exposed to Group B Streptococcal Maternal Inflammation</span></div><div class="casAuthors">Bergeron, J. D. L.; Deslauriers, J.; Grignon, S.; Fortier, L. C.; Lepage, M.; Stroh, T.; Poyart, C.; Sebire, G.</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Neuroscience (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">504-515</span>CODEN:
                <span class="NLM_cas:coden">DENED7</span>;
        ISSN:<span class="NLM_cas:issn">0378-5866</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">The impact of the group B streptococcus (GBS)-induced maternal inflammation on offspring's brain has not yet been investigated despite GBS being one of the most frequent bacteria colonizing or infecting pregnant women.  According to our hypothesis GBS-induced maternal immune activation plays a role in offspring perinatal brain damage and subsequent neurodisabilities such as autism.  Using a new preclin. rat model of maternal inflammation triggered by inactivated GBS, we demonstrated placental, neuropathol. and behavioral impacts on offspring.  GBS-exposed placentas presented cystic lesions and polymorphonuclear infiltration located within the decidual/maternal side of the placenta, contrasting with macrophagic infiltration and necrotic areas located in the labyrinth/fetal compartment of the placenta after lipopolysaccharide-induced maternal inflammation.  Brain damage featured lateral ventricles widening, predominately in the male, redn. of periventricular external capsules thickness, oligodendrocyte loss, and disorganization of frontoparietal subcortical tissue with no glial proliferation.  Autistic hallmarks were found in offspring exposed to GBS, namely deficits in motor behavior, social and communicative impairments, i.e. profound defects in the integration and response to both acoustic and chem. signals that are predominant modes of communication in rats.  Surprisingly, only male offspring were affected by these combined autistic-like traits.  Our results show for the first time that materno-fetal inflammatory response to GBS plays a role in the induction of placental and cerebral insults, remarkably recapitulating cardinal features of human autism such as gender dichotomy and neurobehavioral traits.  Unlike other models of prenatal inflammatory brain damage (induced by viral/toll-like receptor 3 (TLR3) or Gram-neg./TLR4), maternal inflammation resulting from GBS/TLR2 interactions induced a distinctive pattern of chorioamnionitis and cerebral injuries.  These results also provide important evidence that beyond genetic influences, modifiable environmental factors play a role in both the occurrence of autism and its gender imbalance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpre6eNH1YETbVg90H21EOLACvtfcHk0ljnyl92N-G4OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWltb%252FP&md5=de45ce51362af222453044dfb3d47f90</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1159%2F000355656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000355656%26sid%3Dliteratum%253Aachs%26aulast%3DBergeron%26aufirst%3DJ.%2BD.%26aulast%3DDeslauriers%26aufirst%3DJ.%26aulast%3DGrignon%26aufirst%3DS.%26aulast%3DFortier%26aufirst%3DL.%2BC.%26aulast%3DLepage%26aufirst%3DM.%26aulast%3DStroh%26aufirst%3DT.%26aulast%3DPoyart%26aufirst%3DC.%26aulast%3DS%25C3%25A9bire%26aufirst%3DG.%26atitle%3DWhite%2520matter%2520injury%2520and%2520autistic-like%2520behavior%2520predominantly%2520affecting%2520male%2520rat%2520offspring%2520exposed%2520to%2520group%2520B%2520streptococcal%2520maternal%2520inflammation%26jtitle%3DDev.%2520Neurosci.%26date%3D2013%26volume%3D35%26spage%3D504%26epage%3D515%26doi%3D10.1159%2F000355656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref234"><div class="reference"><strong class="refLabel"><a href="#ref234" class="rightTabRefNumLink">234</a></strong><div class="NLM_citation" id="rightTab-cit234"><span><span class="NLM_contrib-group">Le Belle, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghochani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laks, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López-Aranda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornblum, H. I.</span><span> </span><span class="NLM_article-title">Maternal inflammation contributes to brain overgrowth and autism-associated behaviors through altered redox signaling in stem and progenitor cells</span> <span class="citation_source-journal">Stem Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">734</span><span class="refDoi"> DOI: 10.1016/j.stemcr.2014.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.stemcr.2014.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25418720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref234/cit234&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslels7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=725-734&author=J.+E.+Le+Belleauthor=J.+Sperryauthor=A.+Ngoauthor=Y.+Ghochaniauthor=D.+R.+Laksauthor=M.+L%C3%B3pez-Arandaauthor=A.+J.+Silvaauthor=H.+I.+Kornblum&title=Maternal+inflammation+contributes+to+brain+overgrowth+and+autism-associated+behaviors+through+altered+redox+signaling+in+stem+and+progenitor+cells&doi=10.1016%2Fj.stemcr.2014.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit234R"><div class="casContent"><span class="casTitleNuber">234</span><div class="casTitle"><span class="NLM_cas:atitle">Maternal Inflammation Contributes to Brain Overgrowth and Autism-Associated Behaviors through Altered Redox Signaling in Stem and Progenitor Cells</span></div><div class="casAuthors">Le Belle, Janel E.; Sperry, Jantzen; Ngo, Amy; Ghochani, Yasmin; Laks, Dan R.; Lopez-Aranda, Manuel; Silva, Alcino J.; Kornblum, Harley I.</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">725-734</span>CODEN:
                <span class="NLM_cas:coden">SCRTFL</span>;
        ISSN:<span class="NLM_cas:issn">2213-6711</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A period of mild brain overgrowth with an unknown etiol. has been identified as one of the most common phenotypes in autism.  Here, we test the hypothesis that maternal inflammation during crit. periods of embryonic development can cause brain overgrowth and autism-assocd. behaviors as a result of altered neural stem cell function.  Pregnant mice treated with low-dose lipopolysaccharide at embryonic day 9 had offspring with brain overgrowth, with a more pronounced effect in PTEN heterozygotes.  Exposure to maternal inflammation also enhanced NADPH oxidase (NOX)-PI3K pathway signaling, stimulated the hyperproliferation of neural stem and progenitor cells, increased forebrain microglia, and produced abnormal autism-assocd. behaviors in affected pups.  Our evidence supports the idea that a prenatal neuroinflammatory dysregulation in neural stem cell redox signaling can act in concert with underlying genetic susceptibilities to affect cellular responses to environmentally altered cellular levels of reactive oxygen species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzZDIUze4eM7Vg90H21EOLACvtfcHk0liPPJP6onbSxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslels7vJ&md5=a8f7b2de67a5f7c79c0e978030452c8b</span></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=10.1016%2Fj.stemcr.2014.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.stemcr.2014.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BBelle%26aufirst%3DJ.%2BE.%26aulast%3DSperry%26aufirst%3DJ.%26aulast%3DNgo%26aufirst%3DA.%26aulast%3DGhochani%26aufirst%3DY.%26aulast%3DLaks%26aufirst%3DD.%2BR.%26aulast%3DL%25C3%25B3pez-Aranda%26aufirst%3DM.%26aulast%3DSilva%26aufirst%3DA.%2BJ.%26aulast%3DKornblum%26aufirst%3DH.%2BI.%26atitle%3DMaternal%2520inflammation%2520contributes%2520to%2520brain%2520overgrowth%2520and%2520autism-associated%2520behaviors%2520through%2520altered%2520redox%2520signaling%2520in%2520stem%2520and%2520progenitor%2520cells%26jtitle%3DStem%2520Cell%2520Rep.%26date%3D2014%26volume%3D3%26spage%3D725%26epage%3D734%26doi%3D10.1016%2Fj.stemcr.2014.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref235"><div class="reference"><strong class="refLabel"><a href="#ref235" class="rightTabRefNumLink">235</a></strong><div class="NLM_citation" id="rightTab-cit235"><span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persidsky, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, W.</span><span> </span><span class="NLM_article-title">TLR3 activation efficiency by high or low molecular mass poly I:C</span> <span class="citation_source-journal">Innate Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span><span class="refDoi"> DOI: 10.1177/1753425912459975</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1177%2F1753425912459975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=23035017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref235/cit235&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVKrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=184-192&author=Y.+Zhouauthor=M.+Guoauthor=X.+Wangauthor=J.+Liauthor=Y.+Wangauthor=L.+Yeauthor=M.+Daiauthor=L.+Zhouauthor=Y.+Persidskyauthor=W.+Ho&title=TLR3+activation+efficiency+by+high+or+low+molecular+mass+poly+I%3AC&doi=10.1177%2F1753425912459975"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit235R"><div class="casContent"><span class="casTitleNuber">235</span><div class="casTitle"><span class="NLM_cas:atitle">TLR3 activation efficiency by high or low molecular mass poly I:C</span></div><div class="casAuthors">Zhou, Yu; Guo, Ming; Wang, Xu; Li, Jielang; Wang, Yizhong; Ye, Li; Dai, Ming; Zhou, Li; Persidsky, Yuri; Ho, Wenzhe</div><div class="citationInfo"><span class="NLM_cas:title">Innate Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-192, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">IINMCB</span>;
        ISSN:<span class="NLM_cas:issn">1753-4259</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Toll-like receptor 3 (TLR3) plays a crit. role in initiating type I IFN-mediated innate immunity against viral infections.  TLR3 recognizes various forms of double stranded (ds) RNA, including viral dsRNA and a synthetic mimic of dsRNA, poly I:C, which has been used extensively as a TLR3 ligand to induce antiviral immunity.  The activation efficiency of TLR3 by poly I:C is influenced by various factors, including size of the ligands, delivery methods and cell types.  In this study, we examd. the stimulatory effect of two com.-available poly I:Cs [high mol. mass (HMM) and low mol. mass (LMM)] on TLR3 activation in various human cell types by detg. the induction of type I and type III IFNs, as well as the antiviral effect.  We demonstrated that the direct addn. of both HMM- and LMM-poly I:C to the cultures of primary macrophages or a neuroblastoma cell line could activate TLR3.  However, the transfection of poly I:C was necessary to induce TLR3 activation in other cell types studied.  In all the cell lines tested, the efficiency of TLR3 activation by HMM-poly I:C was significantly higher than that by LMM-poly I:C.  These observations indicate the importance and necessity of developing effective TLR3 ligands for antiviral therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQjVOxHGbQlbVg90H21EOLACvtfcHk0liPPJP6onbSxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVKrsrs%253D&md5=59824992b1cad7e8cdc94e74c6418593</span></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=10.1177%2F1753425912459975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1753425912459975%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DDai%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DPersidsky%26aufirst%3DY.%26aulast%3DHo%26aufirst%3DW.%26atitle%3DTLR3%2520activation%2520efficiency%2520by%2520high%2520or%2520low%2520molecular%2520mass%2520poly%2520I%253AC%26jtitle%3DInnate%2520Immun.%26date%3D2013%26volume%3D19%26spage%3D184%26epage%3D192%26doi%3D10.1177%2F1753425912459975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref236"><div class="reference"><strong class="refLabel"><a href="#ref236" class="rightTabRefNumLink">236</a></strong><div class="NLM_citation" id="rightTab-cit236"><span><span class="NLM_contrib-group">Holm, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draeby, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, T.</span><span> </span><span class="NLM_article-title">Microglia are required for astroglial Toll-like receptor 4 response and for optimal TLR2 and TLR3 response</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span><span class="refDoi"> DOI: 10.1002/glia.22296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref236/cit236&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2Fglia.22296" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=630-638&author=T.+H.+Holmauthor=D.+Draebyauthor=T.+Owens&title=Microglia+are+required+for+astroglial+Toll-like+receptor+4+response+and+for+optimal+TLR2+and+TLR3+response&doi=10.1002%2Fglia.22296"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=10.1002%2Fglia.22296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.22296%26sid%3Dliteratum%253Aachs%26aulast%3DHolm%26aufirst%3DT.%2BH.%26aulast%3DDraeby%26aufirst%3DD.%26aulast%3DOwens%26aufirst%3DT.%26atitle%3DMicroglia%2520are%2520required%2520for%2520astroglial%2520Toll-like%2520receptor%25204%2520response%2520and%2520for%2520optimal%2520TLR2%2520and%2520TLR3%2520response%26jtitle%3DGlia%26date%3D2012%26volume%3D60%26spage%3D630%26epage%3D638%26doi%3D10.1002%2Fglia.22296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref237"><div class="reference"><strong class="refLabel"><a href="#ref237" class="rightTabRefNumLink">237</a></strong><div class="NLM_citation" id="rightTab-cit237"><span><span class="NLM_contrib-group">Nadeem, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakheet, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Harbi, N. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Ayadhi, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attia, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoheir, K. M.</span><span> </span><span class="NLM_article-title">Toll-like receptor 4 signaling is associated with upregulated NADPH oxidase expression in peripheral T cells of children with autism</span> <span class="citation_source-journal">Brain, Behav., Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span><span class="refDoi"> DOI: 10.1016/j.bbi.2016.12.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bbi.2016.12.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=146-154&author=A.+Nadeemauthor=S.+F.+Ahmadauthor=S.+A.+Bakheetauthor=N.+O.+Al-Harbiauthor=L.+Y.+Al-Ayadhiauthor=S.+M.+Attiaauthor=K.+M.+Zoheir&title=Toll-like+receptor+4+signaling+is+associated+with+upregulated+NADPH+oxidase+expression+in+peripheral+T+cells+of+children+with+autism&doi=10.1016%2Fj.bbi.2016.12.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1016%2Fj.bbi.2016.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbi.2016.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DNadeem%26aufirst%3DA.%26aulast%3DAhmad%26aufirst%3DS.%2BF.%26aulast%3DBakheet%26aufirst%3DS.%2BA.%26aulast%3DAl-Harbi%26aufirst%3DN.%2BO.%26aulast%3DAl-Ayadhi%26aufirst%3DL.%2BY.%26aulast%3DAttia%26aufirst%3DS.%2BM.%26aulast%3DZoheir%26aufirst%3DK.%2BM.%26atitle%3DToll-like%2520receptor%25204%2520signaling%2520is%2520associated%2520with%2520upregulated%2520NADPH%2520oxidase%2520expression%2520in%2520peripheral%2520T%2520cells%2520of%2520children%2520with%2520autism%26jtitle%3DBrain%252C%2520Behav.%252C%2520Immun.%26date%3D2017%26volume%3D61%26spage%3D146%26epage%3D154%26doi%3D10.1016%2Fj.bbi.2016.12.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref238"><div class="reference"><strong class="refLabel"><a href="#ref238" class="rightTabRefNumLink">238</a></strong><div class="NLM_citation" id="rightTab-cit238"><span><span class="NLM_contrib-group">Naik, U. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbagani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagalla, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manna, S. K.</span><span> </span><span class="NLM_article-title">A study of nuclear transcription factor-kappa B in childhood autism</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e19488</span><span class="refDoi"> DOI: 10.1371/journal.pone.0019488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1371%2Fjournal.pone.0019488" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e19488&author=U.+S.+Naikauthor=C.+Gangadharanauthor=K.+Abbaganiauthor=B.+Nagallaauthor=N.+Dasariauthor=S.+K.+Manna&title=A+study+of+nuclear+transcription+factor-kappa+B+in+childhood+autism&doi=10.1371%2Fjournal.pone.0019488"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0019488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0019488%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DU.%2BS.%26aulast%3DGangadharan%26aufirst%3DC.%26aulast%3DAbbagani%26aufirst%3DK.%26aulast%3DNagalla%26aufirst%3DB.%26aulast%3DDasari%26aufirst%3DN.%26aulast%3DManna%26aufirst%3DS.%2BK.%26atitle%3DA%2520study%2520of%2520nuclear%2520transcription%2520factor-kappa%2520B%2520in%2520childhood%2520autism%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De19488%26doi%3D10.1371%2Fjournal.pone.0019488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref239"><div class="reference"><strong class="refLabel"><a href="#ref239" class="rightTabRefNumLink">239</a></strong><div class="NLM_citation" id="rightTab-cit239"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csakai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span> </span><span class="NLM_article-title">Therapeutic developments targeting Toll-like receptor-4-mediated neuroinflammation</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span><span class="refDoi"> DOI: 10.1002/cmdc.201500188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2Fcmdc.201500188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26136385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWmtL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=154-165&author=J.+Liauthor=A.+Csakaiauthor=J.+Jinauthor=F.+Zhangauthor=H.+Yin&title=Therapeutic+developments+targeting+Toll-like+receptor-4-mediated+neuroinflammation&doi=10.1002%2Fcmdc.201500188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Developments Targeting Toll-like Receptor-4-Mediated Neuroinflammation</span></div><div class="casAuthors">Li, Jing; Csakai, Adam; Jin, Jialin; Zhang, Fengchun; Yin, Hang</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">154-165</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Toll-like receptors (TLRs) have been shown to play an important role in the immune system, which warrants study of their remarkable potential as pharmacol. targets.  Activation of TLRs requires participation from specific pathogen-assocd. mol. patterns (PAMPs) and accessory proteins such as myeloid differentiation protein 2 (MD2), lipopolysaccharide binding protein (LBP), and cluster differentiation antigen 14 (CD14).  Assembly of the TLR4-MD2-LPS complex is essential in TLR4 activation.  Recent studies have revealed that TLR4 activation is a significant trigger of signal transmission pathways in the nervous system, which could result in chronic pain as well as opioid tolerance and dependence.  Researchers of the mol. structure of TLRs and their accessory proteins have opened a door to syntheses of TLRs agonists and antagonists, such as eritoran.  Small-mol. modulators of TLR4, such as MD2-I and tricyclic antidepressants, offer more promising prospects than peptides, given their convenience in oral administration and lower cost.  Herein we mainly discuss the mechanisms and clin. prospects of TLR4 agonists and antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqteb9IWqhr6bVg90H21EOLACvtfcHk0ljBs_CzqQj6Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWmtL7K&md5=53e86dd94e664aeba8734a6de9ab45dc</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500188%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCsakai%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DYin%26aufirst%3DH.%26atitle%3DTherapeutic%2520developments%2520targeting%2520Toll-like%2520receptor-4-mediated%2520neuroinflammation%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D154%26epage%3D165%26doi%3D10.1002%2Fcmdc.201500188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref240"><div class="reference"><strong class="refLabel"><a href="#ref240" class="rightTabRefNumLink">240</a></strong><div class="NLM_citation" id="rightTab-cit240"><span><span class="NLM_contrib-group">Gárate, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Bueno, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madrigal, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caso, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alou, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez-Lus, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leza, J. C.</span><span> </span><span class="NLM_article-title">Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">8</span><span class="refDoi"> DOI: 10.1186/1742-2094-11-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2F1742-2094-11-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=24410883" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12hur3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=8&author=I.+G%C3%A1rateauthor=B.+Garc%C3%ADa-Buenoauthor=J.+L.+Madrigalauthor=J.+R.+Casoauthor=L.+Alouauthor=M.+L.+G%C3%B3mez-Lusauthor=J.+C.+Leza&title=Toll-like+4+receptor+inhibitor+TAK-242+decreases+neuroinflammation+in+rat+brain+frontal+cortex+after+stress&doi=10.1186%2F1742-2094-11-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress</span></div><div class="casAuthors">Garate, Iciar; Garcia-Bueno, Borja; Madrigal, Jose Luis Munoz; Caso, Javier R.; Alou, Luis; Gomez-Lus, Maria Luisa; Leza, Juan Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8/1-8/14, 14</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The innate immune response is the first line of defense against invading microorganisms and it is also activated in different neurol./neurodegenerative pathol. scenarios.  As a result, the family of the innate immune toll-like receptors (TLRs) and, in particular, the genetic/pharmacol. manipulation of the TLR-4 signalling pathway emerges as a potential therapeutic strategy.  Growing evidence relates stress exposure with altered immune responses, but the precise role of TLR-4 remains partly unknown.  Methods: The present study aimed to elucidate whether the elements of the TLR-4 signalling pathway are activated after acute stress exposure in rat brain frontal cortex and its role in the regulation of the stress-induced neuroinflammatory response, by means of its pharmacol. modulation with the i.v. administration of the TLR-4 specific inhibitor TAK-242.  Considering that TLR-4 responds predominantly to lipopolysaccharide from gram-neg. bacteria, we checked whether increased intestinal permeability and a resultant bacterial translocation is a potential regulatory mechanism of stress-induced TLR-4 activation.  Results: Acute restraint stress exposure upregulates TLR-4 expression both at the mRNA and protein level.  Stress-induced TLR-4 upregulation is prevented by the protocol of antibiotic intestinal decontamination made to reduce indigenous gastrointestinal microflora, suggesting a role for bacterial translocation on TLR-4 signalling pathway activation.  TAK-242 pre-stress administration prevents the accumulation of potentially deleterious inflammatory and oxidative/nitrosative mediators in the brain frontal cortex of rats.  Conclusions: The use of TAK-242 or other TLR-4 signalling pathway inhibitory compds. could be considered as a potential therapeutic adjuvant strategy to constrain the inflammatory process taking place after stress exposure and in stress-related neuropsychiatric diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpApSuLWy4znrVg90H21EOLACvtfcHk0ljFsetXIT8bxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12hur3P&md5=35a7e69518b16a61e8cb209ff8022aac</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-11-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-11-8%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25A1rate%26aufirst%3DI.%26aulast%3DGarc%25C3%25ADa-Bueno%26aufirst%3DB.%26aulast%3DMadrigal%26aufirst%3DJ.%2BL.%26aulast%3DCaso%26aufirst%3DJ.%2BR.%26aulast%3DAlou%26aufirst%3DL.%26aulast%3DG%25C3%25B3mez-Lus%26aufirst%3DM.%2BL.%26aulast%3DLeza%26aufirst%3DJ.%2BC.%26atitle%3DToll-like%25204%2520receptor%2520inhibitor%2520TAK-242%2520decreases%2520neuroinflammation%2520in%2520rat%2520brain%2520frontal%2520cortex%2520after%2520stress%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2014%26volume%3D11%26spage%3D8%26doi%3D10.1186%2F1742-2094-11-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref241"><div class="reference"><strong class="refLabel"><a href="#ref241" class="rightTabRefNumLink">241</a></strong><div class="NLM_citation" id="rightTab-cit241"><span><span class="NLM_contrib-group">Hutchinson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loram, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shridhar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezvani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkelhammer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phipps, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landgraf, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falke, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, L. R.</span><span> </span><span class="NLM_article-title">Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">168</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">563</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2010.03.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref241/cit241&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neuroscience.2010.03.067" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2010&pages=551-563&author=M.+R.+Hutchinsonauthor=L.+C.+Loramauthor=Y.+Zhangauthor=M.+Shridharauthor=N.+Rezvaniauthor=D.+Berkelhammerauthor=S.+Phippsauthor=P.+S.+Fosterauthor=K.+Landgrafauthor=J.+J.+Falkeauthor=K.+C.+Riceauthor=S.+F.+Maierauthor=H.+Yinauthor=L.+R.+Watkins&title=Evidence+that+tricyclic+small+molecules+may+possess+toll-like+receptor+and+myeloid+differentiation+protein+2+activity&doi=10.1016%2Fj.neuroscience.2010.03.067"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit241&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2010.03.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2010.03.067%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DM.%2BR.%26aulast%3DLoram%26aufirst%3DL.%2BC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DShridhar%26aufirst%3DM.%26aulast%3DRezvani%26aufirst%3DN.%26aulast%3DBerkelhammer%26aufirst%3DD.%26aulast%3DPhipps%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DP.%2BS.%26aulast%3DLandgraf%26aufirst%3DK.%26aulast%3DFalke%26aufirst%3DJ.%2BJ.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DMaier%26aufirst%3DS.%2BF.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DWatkins%26aufirst%3DL.%2BR.%26atitle%3DEvidence%2520that%2520tricyclic%2520small%2520molecules%2520may%2520possess%2520toll-like%2520receptor%2520and%2520myeloid%2520differentiation%2520protein%25202%2520activity%26jtitle%3DNeuroscience%26date%3D2010%26volume%3D168%26spage%3D551%26epage%3D563%26doi%3D10.1016%2Fj.neuroscience.2010.03.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref242"><div class="reference"><strong class="refLabel"><a href="#ref242" class="rightTabRefNumLink">242</a></strong><div class="NLM_citation" id="rightTab-cit242"><span><span class="NLM_contrib-group">Jaiswal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohanakumar, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajamma, U.</span><span> </span><span class="NLM_article-title">Serotonin mediated immunoregulation and neural functions: complicity in the aetiology of autism spectrum disorders</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span><span class="refDoi"> DOI: 10.1016/j.neubiorev.2015.05.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref242/cit242&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.neubiorev.2015.05.013" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=413-431&author=P.+Jaiswalauthor=K.+P.+Mohanakumarauthor=U.+Rajamma&title=Serotonin+mediated+immunoregulation+and+neural+functions%3A+complicity+in+the+aetiology+of+autism+spectrum+disorders&doi=10.1016%2Fj.neubiorev.2015.05.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit242&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2015.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2015.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DJaiswal%26aufirst%3DP.%26aulast%3DMohanakumar%26aufirst%3DK.%2BP.%26aulast%3DRajamma%26aufirst%3DU.%26atitle%3DSerotonin%2520mediated%2520immunoregulation%2520and%2520neural%2520functions%253A%2520complicity%2520in%2520the%2520aetiology%2520of%2520autism%2520spectrum%2520disorders%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2015%26volume%3D55%26spage%3D413%26epage%3D431%26doi%3D10.1016%2Fj.neubiorev.2015.05.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref243"><div class="reference"><strong class="refLabel"><a href="#ref243" class="rightTabRefNumLink">243</a></strong><div class="NLM_citation" id="rightTab-cit243"><span><span class="NLM_contrib-group">Cloez-Tayarani, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petit-Bertron, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venters, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavaillon, J. M.</span><span> </span><span class="NLM_article-title">Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors</span> <span class="citation_source-journal">Int. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span><span class="refDoi"> DOI: 10.1093/intimm/dxg027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1093%2Fintimm%2Fdxg027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=12578853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref243/cit243&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitFKls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=233-240&author=I.+Cloez-Tayaraniauthor=A.+F.+Petit-Bertronauthor=H.+D.+Ventersauthor=J.+M.+Cavaillon&title=Differential+effect+of+serotonin+on+cytokine+production+in+lipopolysaccharide-stimulated+human+peripheral+blood+mononuclear+cells%3A+involvement+of+5-hydroxytryptamine2A+receptors&doi=10.1093%2Fintimm%2Fdxg027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit243R"><div class="casContent"><span class="casTitleNuber">243</span><div class="casTitle"><span class="NLM_cas:atitle">Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors</span></div><div class="casAuthors">Cloez-Tayarani, Isabelle; Petit-Bertron, Anne-France; Venters, Homer D.; Cavaillon, Jean-Marc</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-240</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">0953-8178</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">In order to provide addnl. insight into the in vivo significance of serotonin [5-hydroxytryptamine (5-HT)] in inflammation, we examd. its effect on the prodn. of tumor necrosis factor (TNF)-α, IL-1α, IL-1β, IL-6, IL-10 and IL-1 receptor antagonist in lipopolysaccharide (LPS)-stimulated human peripheral blood mononuclear cells (PBMC). 5-HT inhibited TNF-α prodn. and increased IL-1β prodn. in PBMC.  The level of IL-1β-converting enzyme/caspase-1 remained unchanged, suggesting that the effect of 5-HT is not directly related to the IL-1β maturation process.  TNF-α mRNA and IL-1β mRNA content did not change in the presence of 5-HT. 5-HT did not have any effect on the prodn. of other cytokines studied.  The inhibitory effect of 5-HT on TNF-α prodn. was antagonized by ketanserin, a selective 5-HT2A antagonist, and mimicked by DOI, a selective 5-HT2A/2C agonist.  These findings suggest that the inhibition of TNF-α prodn. by 5-HT involves the participation of the 5-HT2A receptor subtypes in PBMC.  Accordingly, we detected the presence of 5-HT2A receptors in PBMC by Western blot anal.  Our data support a role of 5-HT in inflammation through its effect on cytokine prodn. in PBMC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraHIWsUpNabrVg90H21EOLACvtfcHk0ljFsetXIT8bxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitFKls7w%253D&md5=5b1d68e182481ed1180e06b39dbb69a4</span></div><a href="/servlet/linkout?suffix=cit243&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2Fdxg027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252Fdxg027%26sid%3Dliteratum%253Aachs%26aulast%3DCloez-Tayarani%26aufirst%3DI.%26aulast%3DPetit-Bertron%26aufirst%3DA.%2BF.%26aulast%3DVenters%26aufirst%3DH.%2BD.%26aulast%3DCavaillon%26aufirst%3DJ.%2BM.%26atitle%3DDifferential%2520effect%2520of%2520serotonin%2520on%2520cytokine%2520production%2520in%2520lipopolysaccharide-stimulated%2520human%2520peripheral%2520blood%2520mononuclear%2520cells%253A%2520involvement%2520of%25205-hydroxytryptamine2A%2520receptors%26jtitle%3DInt.%2520Immunol.%26date%3D2003%26volume%3D15%26spage%3D233%26epage%3D240%26doi%3D10.1093%2Fintimm%2Fdxg027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref244"><div class="reference"><strong class="refLabel"><a href="#ref244" class="rightTabRefNumLink">244</a></strong><div class="NLM_citation" id="rightTab-cit244"><span><span class="NLM_contrib-group">Baganz, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span> </span><span class="NLM_article-title">A dialogue between the immune system and brain, spoken in the language of serotonin</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1021/cn300186b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300186b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref244/cit244&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSjurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=48-63&author=N.+L.+Baganzauthor=R.+D.+Blakely&title=A+dialogue+between+the+immune+system+and+brain%2C+spoken+in+the+language+of+serotonin&doi=10.1021%2Fcn300186b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit244R"><div class="casContent"><span class="casTitleNuber">244</span><div class="casTitle"><span class="NLM_cas:atitle">A Dialogue between the Immune System and Brain, Spoken in the Language of Serotonin</span></div><div class="casAuthors">Baganz, Nicole L.; Blakely, Randy D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-63</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Neuropsychiatric disorders have long been linked to both immune system activation and alterations in serotonin (5-HT) signaling.  In the CNS, the contributions of 5-HT modulate a broad range of targets, most notably, hypothalamic, limbic and cortical circuits linked to the control of mood and mood disorders.  In the periphery, many are aware of the prodn. and actions of 5-HT in the gut but are unaware that the mol. and its receptors are also present in the immune system where evidence suggests they contribute to the both innate and adaptive responses.  In addn., there is clear evidence that the immune system communicates to the brain via both humoral and neuronal mechanisms, and that CNS 5-HT neurons are a direct or indirect target for these actions.  Following a brief primer on the immune system, the authors describe the authors' current understanding of the synthesis, release, and actions of 5-HT in modulating immune function, including the expression of 5-HT biosynthetic enzymes, receptors, and transporters that are typically studied with respect to the roles in the CNS.  The authors then orient the authors' presentation to recent findings that pro-inflammatory cytokines can modulate CNS 5-HT signaling, leading to a conceptualization that among the many roles of 5-HT in the body is an integrated physiol. and behavioral response to inflammatory events and pathogens.  From this perspective, altered 5-HT/immune conversations are likely to contribute to risk for neurobehavioral disorders historically linked to compromised 5-HT function or ameliorated by 5-HT targeted medications, including depression and anxiety disorders, obsessive-compulsive disorder (OCD), and autism.  The authors' review raises the question as to whether genetic variation impacting 5-HT signaling genes may contribute to maladaptive behavior as much through perturbed immune system modulation as through altered brain mechanisms.  Conversely, targeting the immune system for therapeutic development may provide an important opportunity to treat mental illness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBV_HdnFzQaLVg90H21EOLACvtfcHk0lj3Uh3pWzECDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSjurjJ&md5=cf19718241e2bed04cec00624e043a8f</span></div><a href="/servlet/linkout?suffix=cit244&amp;dbid=16384&amp;doi=10.1021%2Fcn300186b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300186b%26sid%3Dliteratum%253Aachs%26aulast%3DBaganz%26aufirst%3DN.%2BL.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26atitle%3DA%2520dialogue%2520between%2520the%2520immune%2520system%2520and%2520brain%252C%2520spoken%2520in%2520the%2520language%2520of%2520serotonin%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D48%26epage%3D63%26doi%3D10.1021%2Fcn300186b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref245"><div class="reference"><strong class="refLabel"><a href="#ref245" class="rightTabRefNumLink">245</a></strong><div class="NLM_citation" id="rightTab-cit245"><span><span class="NLM_contrib-group">Zhu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carneiro, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dostmann, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewlett, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blakely, R. D.</span><span> </span><span class="NLM_article-title">p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">15649</span><span class="NLM_x">–</span> <span class="NLM_lpage">15658</span><span class="refDoi"> DOI: 10.1074/jbc.M410858200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref245/cit245&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1074%2Fjbc.M410858200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=15649-15658&author=C.+B.+Zhuauthor=A.+M.+Carneiroauthor=W.+R.+Dostmannauthor=W.+A.+Hewlettauthor=R.+D.+Blakely&title=p38+MAPK+activation+elevates+serotonin+transport+activity+via+a+trafficking-independent%2C+protein+phosphatase+2A-dependent+process&doi=10.1074%2Fjbc.M410858200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit245&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M410858200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M410858200%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%2BB.%26aulast%3DCarneiro%26aufirst%3DA.%2BM.%26aulast%3DDostmann%26aufirst%3DW.%2BR.%26aulast%3DHewlett%26aufirst%3DW.%2BA.%26aulast%3DBlakely%26aufirst%3DR.%2BD.%26atitle%3Dp38%2520MAPK%2520activation%2520elevates%2520serotonin%2520transport%2520activity%2520via%2520a%2520trafficking-independent%252C%2520protein%2520phosphatase%25202A-dependent%2520process%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D15649%26epage%3D15658%26doi%3D10.1074%2Fjbc.M410858200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref246"><div class="reference"><strong class="refLabel"><a href="#ref246" class="rightTabRefNumLink">246</a></strong><div class="NLM_citation" id="rightTab-cit246"><span><span class="NLM_contrib-group">Angelidou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasiadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alysandratos, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theoharides, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lykouras, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sideri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalogeromitros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theoharides, T. C.</span><span> </span><span class="NLM_article-title">Neurotensin is increased in serum of young children with autistic disorder</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="refDoi"> DOI: 10.1186/1742-2094-7-48</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2F1742-2094-7-48" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=20731814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref246/cit246&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC3cfht1GhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=48&author=A.+Angelidouauthor=K.+Francisauthor=M.+Vasiadiauthor=K.+D.+Alysandratosauthor=B.+Zhangauthor=A.+Theoharidesauthor=L.+Lykourasauthor=K.+Sideriauthor=D.+Kalogeromitrosauthor=T.+C.+Theoharides&title=Neurotensin+is+increased+in+serum+of+young+children+with+autistic+disorder&doi=10.1186%2F1742-2094-7-48"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit246R"><div class="casContent"><span class="casTitleNuber">246</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin is increased in serum of young children with autistic disorder</span></div><div class="casAuthors">Angelidou Asimenia; Francis Konstantinos; Vasiadi Magdalini; Alysandratos Konstantinos-Dionysios; Zhang Bodi; Theoharides Athanasios; Lykouras Lefteris; Sideri Kyriaki; Kalogeromitros Dimitrios; Theoharides Theoharis C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autism spectrum disorders (ASD) are a group of pervasive neurodevelopmental disorders diagnosed in early childhood.  They are associated with a set of "core symptoms" that include disabilities in social interaction skills, verbal and non-verbal communication, as well as repetitive and stereotypic behaviors.  There is no definite pathogenetic mechanism or diagnostic tests.  Many children with ASD also have "allergic-like" symptoms, but test negative implying mast cell activation by non-allergic triggers.  We measured by Milliplex arrays serum levels of 3 neuropeptides that could stimulate mast cells in children with autistic disorder (n = 19; 16 males and 3 females; mean age 3.0 ± 0.4 years) and healthy, unrelated controls (n = 16; 13 males and 3 females; mean age 3 ± 1.2 years).  Only neurotensin (NT) was significantly increased from 60.5 ± 6.0 pg/ml in controls to 105.6 ± 12.4 pg/ml in autistic disorder (p = 0.004).  There was no statistically significant difference in the serum levels of β-endorphin or substance P (SP).  NT could stimulate immune cells, especially mast cells, and/or have direct effects on brain inflammation and ASD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_hk3m1QAJhsK3uFsUIZtkfW6udTcc2ebxZkpZN7mUBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfht1GhsQ%253D%253D&md5=f54cc29bd477e5167713a3536ca63c10</span></div><a href="/servlet/linkout?suffix=cit246&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-7-48&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-7-48%26sid%3Dliteratum%253Aachs%26aulast%3DAngelidou%26aufirst%3DA.%26aulast%3DFrancis%26aufirst%3DK.%26aulast%3DVasiadi%26aufirst%3DM.%26aulast%3DAlysandratos%26aufirst%3DK.%2BD.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DTheoharides%26aufirst%3DA.%26aulast%3DLykouras%26aufirst%3DL.%26aulast%3DSideri%26aufirst%3DK.%26aulast%3DKalogeromitros%26aufirst%3DD.%26aulast%3DTheoharides%26aufirst%3DT.%2BC.%26atitle%3DNeurotensin%2520is%2520increased%2520in%2520serum%2520of%2520young%2520children%2520with%2520autistic%2520disorder%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2010%26volume%3D7%26spage%3D48%26doi%3D10.1186%2F1742-2094-7-48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref247"><div class="reference"><strong class="refLabel"><a href="#ref247" class="rightTabRefNumLink">247</a></strong><div class="NLM_citation" id="rightTab-cit247"><span><span class="NLM_contrib-group">Patel, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsilioni, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeman, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theoharides, T. C.</span><span> </span><span class="NLM_article-title">Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">E7049</span><span class="NLM_x">–</span> <span class="NLM_lpage">E7058</span><span class="refDoi"> DOI: 10.1073/pnas.1604992113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref247/cit247&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1073%2Fpnas.1604992113" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E7049-E7058&author=A.+B.+Patelauthor=I.+Tsilioniauthor=S.+E.+Leemanauthor=T.+C.+Theoharides&title=Neurotensin+stimulates+sortilin+and+mTOR+in+human+microglia+inhibitable+by+methoxyluteolin%2C+a+potential+therapeutic+target+for+autism&doi=10.1073%2Fpnas.1604992113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit247&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1604992113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1604992113%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DA.%2BB.%26aulast%3DTsilioni%26aufirst%3DI.%26aulast%3DLeeman%26aufirst%3DS.%2BE.%26aulast%3DTheoharides%26aufirst%3DT.%2BC.%26atitle%3DNeurotensin%2520stimulates%2520sortilin%2520and%2520mTOR%2520in%2520human%2520microglia%2520inhibitable%2520by%2520methoxyluteolin%252C%2520a%2520potential%2520therapeutic%2520target%2520for%2520autism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3DE7049%26epage%3DE7058%26doi%3D10.1073%2Fpnas.1604992113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref248"><div class="reference"><strong class="refLabel"><a href="#ref248" class="rightTabRefNumLink">248</a></strong><div class="NLM_citation" id="rightTab-cit248"><span><span class="NLM_contrib-group">Nykjaer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willnow, T. E.</span><span> </span><span class="NLM_article-title">Sortilin: a receptor to regulate neuronal viability and function</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span><span class="refDoi"> DOI: 10.1016/j.tins.2012.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.tins.2012.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22341525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref248/cit248&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XivFygs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=261-270&author=A.+Nykjaerauthor=T.+E.+Willnow&title=Sortilin%3A+a+receptor+to+regulate+neuronal+viability+and+function&doi=10.1016%2Fj.tins.2012.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit248R"><div class="casContent"><span class="casTitleNuber">248</span><div class="casTitle"><span class="NLM_cas:atitle">Sortilin: a receptor to regulate neuronal viability and function</span></div><div class="casAuthors">Nykjaer, Anders; Willnow, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Neurosciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">261-270</span>CODEN:
                <span class="NLM_cas:coden">TNSCDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-2236</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sortilin is a type-1 receptor expressed in neurons of the central and peripheral nervous systems.  Initially considered a rather peculiar receptor resembling an intracellular sorting protein in yeast, sortilin has emerged as a key player in the regulation of neuronal viability and function.  It acts as a receptor of neurotrophic factors and neuropeptides, but also as a co-receptor to cytokine receptors, tyrosine receptor kinases, G-protein coupled receptors and ion-channels.  Here, we review recent findings that identified multiple roles for sortilin in the cellular transport and signaling.  Furthermore, we discuss how sortilin contributes not only to the functional integrity of the nervous system during physiol. conditions but also plays an important role during neuronal injury and disease processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtew6HXcTIybVg90H21EOLACvtfcHk0ljMx2Zg_lv3Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivFygs7s%253D&md5=923da52421a21e3d2c1b850811173281</span></div><a href="/servlet/linkout?suffix=cit248&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2012.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2012.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DNykjaer%26aufirst%3DA.%26aulast%3DWillnow%26aufirst%3DT.%2BE.%26atitle%3DSortilin%253A%2520a%2520receptor%2520to%2520regulate%2520neuronal%2520viability%2520and%2520function%26jtitle%3DTrends%2520Neurosci.%26date%3D2012%26volume%3D35%26spage%3D261%26epage%3D270%26doi%3D10.1016%2Fj.tins.2012.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref249"><div class="reference"><strong class="refLabel"><a href="#ref249" class="rightTabRefNumLink">249</a></strong><div class="NLM_citation" id="rightTab-cit249"><span><span class="NLM_contrib-group">Hermans-Borgmeyer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nykjaer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaller, C.</span><span> </span><span class="NLM_article-title">Expression of the 100-kDa neurotensin receptor sortilin during mouse embryonal development</span> <span class="citation_source-journal">Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span><span class="refDoi"> DOI: 10.1016/S0169-328X(99)00022-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2FS0169-328X%2899%2900022-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10064893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref249/cit249&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADyaK1MXhtFeju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1999&pages=216-219&author=I.+Hermans-Borgmeyerauthor=G.+Hermeyauthor=A.+Nykjaerauthor=C.+Schaller&title=Expression+of+the+100-kDa+neurotensin+receptor+sortilin+during+mouse+embryonal+development&doi=10.1016%2FS0169-328X%2899%2900022-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit249R"><div class="casContent"><span class="casTitleNuber">249</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the 100-kDa neurotensin receptor sortilin during mouse embryonal development</span></div><div class="casAuthors">Hermans-Borgmeyer, Irm; Hermey, Guido; Nykjaer, Anders; Schaller, Chica</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">216-219</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Recently, sortilin a non G-protein-coupled receptor has been identified as the 100-kDa neurotensin receptor.  In this paper we describe the expression of its gene during mouse embryonal development.  We show that the nervous system is the main location of sortilin gene expression and that with ongoing development the forebrain exhibits the highest accumulation of transcripts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj2OZQmHqXeLVg90H21EOLACvtfcHk0lgVGxEQ3IUkgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhtFeju7s%253D&md5=8faa197df61c33eec68f5b2b4cd8378c</span></div><a href="/servlet/linkout?suffix=cit249&amp;dbid=16384&amp;doi=10.1016%2FS0169-328X%2899%2900022-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-328X%252899%252900022-4%26sid%3Dliteratum%253Aachs%26aulast%3DHermans-Borgmeyer%26aufirst%3DI.%26aulast%3DHermey%26aufirst%3DG.%26aulast%3DNykjaer%26aufirst%3DA.%26aulast%3DSchaller%26aufirst%3DC.%26atitle%3DExpression%2520of%2520the%2520100-kDa%2520neurotensin%2520receptor%2520sortilin%2520during%2520mouse%2520embryonal%2520development%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D1999%26volume%3D65%26spage%3D216%26epage%3D219%26doi%3D10.1016%2FS0169-328X%2899%2900022-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref250"><div class="reference"><strong class="refLabel"><a href="#ref250" class="rightTabRefNumLink">250</a></strong><div class="NLM_citation" id="rightTab-cit250"><span><span class="NLM_contrib-group">Theoharides, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akin, C.</span><span> </span><span class="NLM_article-title">Mast cells, mastocytosis, and related disorders</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span><span class="refDoi"> DOI: 10.1056/NEJMra1409760</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1056%2FNEJMra1409760" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26154789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref250/cit250&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12qu77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=163-172&author=T.+C.+Theoharidesauthor=P.+Valentauthor=C.+Akin&title=Mast+cells%2C+mastocytosis%2C+and+related+disorders&doi=10.1056%2FNEJMra1409760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit250R"><div class="casContent"><span class="casTitleNuber">250</span><div class="casTitle"><span class="NLM_cas:atitle">Mast cells, mastocytosis, and related disorders</span></div><div class="casAuthors">Theoharides, Theoharis C.; Valent, Peter; Akin, Cem</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">163-172</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Pathol. conditions involving mast cells appear to be more common than once thought.  The diagnosis and treatment of such disorders are challenging, given protean symptoms and the presence of coexisting conditions.  In patients with severe symptoms or those with allergies to hymenoptera venom, the investigation of mast-cell monoclonality may provide the diagnosis.  Identification and avoidance of triggers, including emotional or phys. stress, may be helpful.  Most symptoms can be managed with histamine-receptor antagonists or other drugs that interfere with mast-cell mediators, along with blockers of mast-cell activation.  Patients with aggressive mastocytosis may require addnl. drugs to interfere with the proliferation and survival of mast cells.  Data are lacking to identify reliable biomarkers of mast-cell activation, signaling steps through which many triggers converge, drugs with dual inhibitory activity against mast-cell proliferation and mast-cell activation, and methods for delivering drugs specifically to mast cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC9RqY9NlQgrVg90H21EOLACvtfcHk0lgVGxEQ3IUkgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12qu77I&md5=4be41091da0b611fac401a2fd22aba6e</span></div><a href="/servlet/linkout?suffix=cit250&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1409760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1409760%26sid%3Dliteratum%253Aachs%26aulast%3DTheoharides%26aufirst%3DT.%2BC.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DAkin%26aufirst%3DC.%26atitle%3DMast%2520cells%252C%2520mastocytosis%252C%2520and%2520related%2520disorders%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D163%26epage%3D172%26doi%3D10.1056%2FNEJMra1409760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref251"><div class="reference"><strong class="refLabel"><a href="#ref251" class="rightTabRefNumLink">251</a></strong><div class="NLM_citation" id="rightTab-cit251"><span><span class="NLM_contrib-group">Wilson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naves, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lalloué, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jauberteau, M. O.</span><span> </span><span class="NLM_article-title">The implications of sortilin/vps10p domain receptors in neurological and human diseases</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1354</span><span class="NLM_x">–</span> <span class="NLM_lpage">1365</span><span class="refDoi"> DOI: 10.2174/1871527313666141023151642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.2174%2F1871527313666141023151642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25345507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref251/cit251&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2rtr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=1354-1365&author=C.+M.+Wilsonauthor=T.+Navesauthor=S.+Saadaauthor=S.+Pinetauthor=F.+Vincentauthor=F.+Lallou%C3%A9author=M.+O.+Jauberteau&title=The+implications+of+sortilin%2Fvps10p+domain+receptors+in+neurological+and+human+diseases&doi=10.2174%2F1871527313666141023151642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit251R"><div class="casContent"><span class="casTitleNuber">251</span><div class="casTitle"><span class="NLM_cas:atitle">The Implications of Sortilin/Vps10p Domain Receptors in Neurological and Human Diseases</span></div><div class="casAuthors">Wilson, Cornelia M.; Naves, Thomas; Saada, Sofiane; Pinet, Sandra; Vincent, Francois; Lalloue, Fabrice; Jauberteau, Marie-Odile</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1354-1365</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The neurotensin receptor-3 also known as sortilin is part of the new receptor family of vacuolar protein sorting 10 protein domain.  Growing evidence show that the vacuolar protein sorting 10 protein domain family is implicated as a genetic risk factor for neurodegenerative diseases such as Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease, in addn. to links assocd. with type 2 diabetes mellitus, lysosomal disorders, cardiovascular disease and atherosclerosis.  In fact, sortilin expression is elevated in many human cell lines controlling the trafficking and release of neurotrophins.  Hence, not surprisingly the imbalance of neurotrophin signaling is implicated in several human diseases.  The fine regulation of the growth factor, brain derived nerve factor by sortilin mediates both neuronal and tumor cell survival, whereas in Alzheimer's disease sortilin mediated beta secretase-1 trafficking increases the cleavage of the beta-amyloid precursor protein.  Perturbation of the autocrine/paracrine loop of neurotrophins in combination with the cell surface interaction of sortilin with neurotensin receptor 1 or 2 or tyrosine kinase receptor A or B are dramatically upregulated in both neurodegenerative diseases and cancer.  In cardiovascular diseases, the circulatory low-d. lipoprotein is closely correlated with sortilin expression in hepatocytes.  Herein, this review discusses the multifaceted role played by sortilin and its interacting partners in human disease which could be interesting novel target(s) in drug discovery.  Nevertheless, completely challenging the function of sortilin could prove unfavorable given the important universal role of sortilin plays in the body.  Hence, metab. disorders could be relieved with specific targeted therapeutic challenge of sortilin function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR441ZsnG8gbVg90H21EOLACvtfcHk0ljK2dleaKa8jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2rtr3O&md5=621f31a9b409d2b99b0d461d7afa3312</span></div><a href="/servlet/linkout?suffix=cit251&amp;dbid=16384&amp;doi=10.2174%2F1871527313666141023151642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871527313666141023151642%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DC.%2BM.%26aulast%3DNaves%26aufirst%3DT.%26aulast%3DSaada%26aufirst%3DS.%26aulast%3DPinet%26aufirst%3DS.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DLallou%25C3%25A9%26aufirst%3DF.%26aulast%3DJauberteau%26aufirst%3DM.%2BO.%26atitle%3DThe%2520implications%2520of%2520sortilin%252Fvps10p%2520domain%2520receptors%2520in%2520neurological%2520and%2520human%2520diseases%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2014%26volume%3D13%26spage%3D1354%26epage%3D1365%26doi%3D10.2174%2F1871527313666141023151642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref252"><div class="reference"><strong class="refLabel"><a href="#ref252" class="rightTabRefNumLink">252</a></strong><div class="NLM_citation" id="rightTab-cit252"><span><span class="NLM_contrib-group">Schrøder, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langgård, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltas, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskildsen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagmose, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonsen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biilmann Rønn, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egebjerg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavenhagen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strandbygård, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thirup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uppalanchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervaram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasturi, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eradi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakumudi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span> </span><span class="NLM_article-title">The identification of AF38469: an orally bioavailable inhibitor of the VPS10P family sorting receptor Sortilin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.11.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref252/cit252&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bmcl.2013.11.046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=177-180&author=T.+J.+Schr%C3%B8derauthor=S.+Christensenauthor=S.+Lindbergauthor=M.+Langg%C3%A5rdauthor=L.+Davidauthor=P.+J.+Maltasauthor=J.+Eskildsenauthor=J.+Jacobsenauthor=L.+Tagmoseauthor=K.+B.+Simonsenauthor=L.+C.+Biilmann+R%C3%B8nnauthor=I.+E.+de+Jongauthor=I.+J.+Malikauthor=J.+J.+Karlssonauthor=C.+Bundgaardauthor=J.+Egebjergauthor=J.+B.+Stavenhagenauthor=D.+Strandbyg%C3%A5rdauthor=S.+Thirupauthor=J.+L.+Andersenauthor=S.+Uppalanchiauthor=S.+Pervaramauthor=S.+P.+Kasturiauthor=P.+Eradiauthor=D.+R.+Sakumudiauthor=S.+P.+Watson&title=The+identification+of+AF38469%3A+an+orally+bioavailable+inhibitor+of+the+VPS10P+family+sorting+receptor+Sortilin&doi=10.1016%2Fj.bmcl.2013.11.046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit252&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.11.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.11.046%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B8der%26aufirst%3DT.%2BJ.%26aulast%3DChristensen%26aufirst%3DS.%26aulast%3DLindberg%26aufirst%3DS.%26aulast%3DLangg%25C3%25A5rd%26aufirst%3DM.%26aulast%3DDavid%26aufirst%3DL.%26aulast%3DMaltas%26aufirst%3DP.%2BJ.%26aulast%3DEskildsen%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DJ.%26aulast%3DTagmose%26aufirst%3DL.%26aulast%3DSimonsen%26aufirst%3DK.%2BB.%26aulast%3DBiilmann%2BR%25C3%25B8nn%26aufirst%3DL.%2BC.%26aulast%3Dde%2BJong%26aufirst%3DI.%2BE.%26aulast%3DMalik%26aufirst%3DI.%2BJ.%26aulast%3DKarlsson%26aufirst%3DJ.%2BJ.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DEgebjerg%26aufirst%3DJ.%26aulast%3DStavenhagen%26aufirst%3DJ.%2BB.%26aulast%3DStrandbyg%25C3%25A5rd%26aufirst%3DD.%26aulast%3DThirup%26aufirst%3DS.%26aulast%3DAndersen%26aufirst%3DJ.%2BL.%26aulast%3DUppalanchi%26aufirst%3DS.%26aulast%3DPervaram%26aufirst%3DS.%26aulast%3DKasturi%26aufirst%3DS.%2BP.%26aulast%3DEradi%26aufirst%3DP.%26aulast%3DSakumudi%26aufirst%3DD.%2BR.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26atitle%3DThe%2520identification%2520of%2520AF38469%253A%2520an%2520orally%2520bioavailable%2520inhibitor%2520of%2520the%2520VPS10P%2520family%2520sorting%2520receptor%2520Sortilin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D177%26epage%3D180%26doi%3D10.1016%2Fj.bmcl.2013.11.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref253"><div class="reference"><strong class="refLabel"><a href="#ref253" class="rightTabRefNumLink">253</a></strong><div class="NLM_citation" id="rightTab-cit253"><span><span class="NLM_contrib-group">Andersen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langgård, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltas, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rønn, L. C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strandbygaard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thirup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span> </span><span class="NLM_article-title">The identification of novel acid isostere based inhibitors of the VPS10P family sorting receptor sortilin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2629</span><span class="NLM_x">–</span> <span class="NLM_lpage">2633</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2017.02.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref253/cit253&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.bmcl.2017.02.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2629-2633&author=J.+L.+Andersenauthor=S.+Lindbergauthor=M.+Langg%C3%A5rdauthor=P.+J.+Maltasauthor=L.+C.+B.+R%C3%B8nnauthor=C.+Bundgaardauthor=D.+Strandbygaardauthor=S.+Thirupauthor=S.+P.+Watson&title=The+identification+of+novel+acid+isostere+based+inhibitors+of+the+VPS10P+family+sorting+receptor+sortilin&doi=10.1016%2Fj.bmcl.2017.02.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit253&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.02.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.02.028%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DJ.%2BL.%26aulast%3DLindberg%26aufirst%3DS.%26aulast%3DLangg%25C3%25A5rd%26aufirst%3DM.%26aulast%3DMaltas%26aufirst%3DP.%2BJ.%26aulast%3DR%25C3%25B8nn%26aufirst%3DL.%2BC.%2BB.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DStrandbygaard%26aufirst%3DD.%26aulast%3DThirup%26aufirst%3DS.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26atitle%3DThe%2520identification%2520of%2520novel%2520acid%2520isostere%2520based%2520inhibitors%2520of%2520the%2520VPS10P%2520family%2520sorting%2520receptor%2520sortilin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2629%26epage%3D2633%26doi%3D10.1016%2Fj.bmcl.2017.02.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref254"><div class="reference"><strong class="refLabel"><a href="#ref254" class="rightTabRefNumLink">254</a></strong><div class="NLM_citation" id="rightTab-cit254"><span><span class="NLM_contrib-group">Peng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, H. J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases: a review of their structure and role in systemic sclerosis</span> <span class="citation_source-journal">J. Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1409</span><span class="NLM_x">–</span> <span class="NLM_lpage">1414</span><span class="refDoi"> DOI: 10.1007/s10875-012-9735-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1007%2Fs10875-012-9735-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=22767184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref254/cit254&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFSnsLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=1409-1414&author=W.+Pengauthor=J.+Yanauthor=Y.+Wanauthor=B.+B.+Wangauthor=J.+Taoauthor=G.+Yangauthor=H.+J.+W.+Panauthor=J.+Wang&title=Matrix+metalloproteinases%3A+a+review+of+their+structure+and+role+in+systemic+sclerosis&doi=10.1007%2Fs10875-012-9735-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit254R"><div class="casContent"><span class="casTitleNuber">254</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix Metalloproteinases: A Review of Their Structure and Role in Systemic Sclerosis</span></div><div class="casAuthors">Peng, Wen-jia; Yan, Jun-wei; Wan, Ya-nan; Wang, Bing-xiang; Tao, Jin-hui; Yang, Guo-jun; Pan, Hai-feng; Wang, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1409-1414</span>CODEN:
                <span class="NLM_cas:coden">JCIMDO</span>;
        ISSN:<span class="NLM_cas:issn">0271-9142</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are the main enzymes involved in arterial wall extracellular matrix (ECM) degrdn. and remodeling, whose activity has been involved in various normal and pathol. processes, such as inflammation, fibrosis.  As a result, the MMPs have come to consider as both therapeutic targets and diagnostic tools for the treatment and diagnosis of autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis.  Systemic sclerosis (SSc) is a rare autoimmune disease of unknown etiol. characterized by an excessive over-prodn. of collagen and other ECM, resulting in skin thickening and fibrosis of internal organs.  In recent years, abnormal expression of MMPs has been demonstrated with the pathogenesis of SSc, and the assocn. of different polymorphisms on MMPs genes with SSc has been extensively studied.  This review describes the structure, function and regulation of MMPs and shortly summarizes current understanding on exptl. findings, genetic assocns. of MMPs in SSc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9enZZRy-u7bVg90H21EOLACvtfcHk0lhokZQA1jYJrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFSnsLzE&md5=603fb4bd8b021ad0db40e4ba07d2fb4c</span></div><a href="/servlet/linkout?suffix=cit254&amp;dbid=16384&amp;doi=10.1007%2Fs10875-012-9735-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10875-012-9735-7%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%2BB.%26aulast%3DTao%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DPan%26aufirst%3DH.%2BJ.%2BW.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DMatrix%2520metalloproteinases%253A%2520a%2520review%2520of%2520their%2520structure%2520and%2520role%2520in%2520systemic%2520sclerosis%26jtitle%3DJ.%2520Clin.%2520Immunol.%26date%3D2012%26volume%3D32%26spage%3D1409%26epage%3D1414%26doi%3D10.1007%2Fs10875-012-9735-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref255"><div class="reference"><strong class="refLabel"><a href="#ref255" class="rightTabRefNumLink">255</a></strong><div class="NLM_citation" id="rightTab-cit255"><span><span class="NLM_contrib-group">Abdallah, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, T. M.</span><span> </span><span class="NLM_article-title">Matrix metalloproteinases in autism spectrum disorders</span> <span class="citation_source-journal">J. Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="refDoi"> DOI: 10.1186/2049-9256-1-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2F2049-9256-1-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=25408909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref255/cit255&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC2MzovFaiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2013&pages=16&author=M.+W.+Abdallahauthor=T.+M.+Michel&title=Matrix+metalloproteinases+in+autism+spectrum+disorders&doi=10.1186%2F2049-9256-1-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit255R"><div class="casContent"><span class="casTitleNuber">255</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases in autism spectrum disorders</span></div><div class="casAuthors">Abdallah Morsi W; Michel Tanja M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of molecular psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Autism Spectrum Disorders (ASD) are group of developmental disabilities with a complex neurobiological basis including putative changes in the immune system.  They are characterized by pervasive qualitative abnormalities in social interactions, communication, and stereotyped behaviour.  Matrix metalloproteinases (MMPs) represent a group of proteases which play an important role in neuroinflammation and neurodevelopment.  Therefore, they possibly have a crucial function in the etiopathology of ASD.  In this review, we summarize the plausibility of the hypothesis that MMPs are involved in the neuropathology of ASD.  Possible pathways through which MMPs can contribute to the pathogenesis of ASD are discussed including neuroinflammatory mechanisms inclusive of mediating neuropathological effects of infections, the associations between MMPs and other biomarkers such as cytokines, chemokines and neurotrophic factors.  Despite sufficient evidence for such an involvement of MMPs in the neuropathology of ASD, they have not yet been extensively studied in this context.  Thus, further research in this field is not only urgently needed but also very promising and may also lead to new therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTN5srQYW2OKMzK395ZObgVfW6udTcc2ebEuSC-Q2EwFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzovFaiug%253D%253D&md5=60bdd45e470cffb53308f392d2503338</span></div><a href="/servlet/linkout?suffix=cit255&amp;dbid=16384&amp;doi=10.1186%2F2049-9256-1-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2049-9256-1-16%26sid%3Dliteratum%253Aachs%26aulast%3DAbdallah%26aufirst%3DM.%2BW.%26aulast%3DMichel%26aufirst%3DT.%2BM.%26atitle%3DMatrix%2520metalloproteinases%2520in%2520autism%2520spectrum%2520disorders%26jtitle%3DJ.%2520Mol.%2520Psychiatry%26date%3D2013%26volume%3D1%26spage%3D16%26doi%3D10.1186%2F2049-9256-1-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref256"><div class="reference"><strong class="refLabel"><a href="#ref256" class="rightTabRefNumLink">256</a></strong><div class="NLM_citation" id="rightTab-cit256"><span><span class="NLM_contrib-group">Bilousova, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charles, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethell, I. M.</span><span> </span><span class="NLM_article-title">Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model</span> <span class="citation_source-journal">J. Med. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span><span class="refDoi"> DOI: 10.1136/jmg.2008.061796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1136%2Fjmg.2008.061796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref256/cit256&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=18835858" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2008&pages=94-102&author=T.+V.+Bilousovaauthor=L.+Dansieauthor=M.+Ngoauthor=J.+Ayeauthor=J.+R.+Charlesauthor=D.+W.+Ethellauthor=I.+M.+Ethell&title=Minocycline+promotes+dendritic+spine+maturation+and+improves+behavioural+performance+in+the+fragile+X+mouse+model&doi=10.1136%2Fjmg.2008.061796"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit256&amp;dbid=16384&amp;doi=10.1136%2Fjmg.2008.061796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjmg.2008.061796%26sid%3Dliteratum%253Aachs%26aulast%3DBilousova%26aufirst%3DT.%2BV.%26aulast%3DDansie%26aufirst%3DL.%26aulast%3DNgo%26aufirst%3DM.%26aulast%3DAye%26aufirst%3DJ.%26aulast%3DCharles%26aufirst%3DJ.%2BR.%26aulast%3DEthell%26aufirst%3DD.%2BW.%26aulast%3DEthell%26aufirst%3DI.%2BM.%26atitle%3DMinocycline%2520promotes%2520dendritic%2520spine%2520maturation%2520and%2520improves%2520behavioural%2520performance%2520in%2520the%2520fragile%2520X%2520mouse%2520model%26jtitle%3DJ.%2520Med.%2520Genet.%26date%3D2008%26volume%3D46%26spage%3D94%26epage%3D102%26doi%3D10.1136%2Fjmg.2008.061796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref257"><div class="reference"><strong class="refLabel"><a href="#ref257" class="rightTabRefNumLink">257</a></strong><div class="NLM_citation" id="rightTab-cit257"><span><span class="NLM_contrib-group">Dziembowska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pretto, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janusz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaczmarek, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leigh, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durbin-Johnson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagerman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tassone, F.</span><span> </span><span class="NLM_article-title">High MMP-9 activity levels in fragile X syndrome are lowered by minocycline</span> <span class="citation_source-journal">Am. J. Med. Genet., Part A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">1897</span><span class="NLM_x">–</span> <span class="NLM_lpage">1903</span><span class="refDoi"> DOI: 10.1002/ajmg.a.36023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1002%2Fajmg.a.36023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref257/cit257&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFyht7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2013&pages=1897-1903&author=M.+Dziembowskaauthor=D.+I.+Prettoauthor=A.+Januszauthor=L.+Kaczmarekauthor=M.+J.+Leighauthor=N.+Gabrielauthor=B.+Durbin-Johnsonauthor=R.+J.+Hagermanauthor=F.+Tassone&title=High+MMP-9+activity+levels+in+fragile+X+syndrome+are+lowered+by+minocycline&doi=10.1002%2Fajmg.a.36023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit257R"><div class="casContent"><span class="casTitleNuber">257</span><div class="casTitle"><span class="NLM_cas:atitle">High MMP-9 activity levels in fragile X syndrome are lowered by minocycline</span></div><div class="casAuthors">Dziembowska, Magdalena; Pretto, Dalyir I.; Janusz, Aleksandra; Kaczmarek, Leszek; Leigh, Mary Jacena; Gabriel, Nielsen; Durbin-Johnson, Blythe; Hagerman, Randi J.; Tassone, Flora</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Medical Genetics, Part A</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1897-1903</span>CODEN:
                <span class="NLM_cas:coden">AJMGB8</span>;
        ISSN:<span class="NLM_cas:issn">1552-4825</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Fragile X syndrome (FXS) is a neurodevelopmental disorder characterized by lack of the FMR1 protein, FMRP, a translational repressor.  Its absence leads to up-regulation of locally translated proteins involved in synaptic transmission and plasticity, including the matrix metalloproteinase-9 (MMP-9).  In the Fmr1 knock-out (KO), a mouse model of FXS, an abnormal elevated expression of MMP-9 in the brain was pharmacol. down-regulated after treatment with the tetracycline deriv. minocycline.  Moreover, the rescue of immature dendritic spine morphol. and a significant improvement of abnormal behavior were assocd. with down-regulation of MMP-9.  Here, we report on high plasma activity of MMP-9 in individuals with FXS.  In addn., we investigate MMP-9 changes in patients with FXS who have gone through a minocycline controlled clin. trial and correlate MMP-9 activity to clin. observations.  The results of this study suggest that, in humans, activity levels of MMP-9 are lowered by minocycline and that, in some cases, changes in MMP-9 activity are pos. assocd. with improvement based on clin. measures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe_bjRm7_wxrVg90H21EOLACvtfcHk0lhokZQA1jYJrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFyht7zK&md5=c97c45c77933683aa2869fc612a86d23</span></div><a href="/servlet/linkout?suffix=cit257&amp;dbid=16384&amp;doi=10.1002%2Fajmg.a.36023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fajmg.a.36023%26sid%3Dliteratum%253Aachs%26aulast%3DDziembowska%26aufirst%3DM.%26aulast%3DPretto%26aufirst%3DD.%2BI.%26aulast%3DJanusz%26aufirst%3DA.%26aulast%3DKaczmarek%26aufirst%3DL.%26aulast%3DLeigh%26aufirst%3DM.%2BJ.%26aulast%3DGabriel%26aufirst%3DN.%26aulast%3DDurbin-Johnson%26aufirst%3DB.%26aulast%3DHagerman%26aufirst%3DR.%2BJ.%26aulast%3DTassone%26aufirst%3DF.%26atitle%3DHigh%2520MMP-9%2520activity%2520levels%2520in%2520fragile%2520X%2520syndrome%2520are%2520lowered%2520by%2520minocycline%26jtitle%3DAm.%2520J.%2520Med.%2520Genet.%252C%2520Part%2520A%26date%3D2013%26volume%3D161%26spage%3D1897%26epage%3D1903%26doi%3D10.1002%2Fajmg.a.36023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref258"><div class="reference"><strong class="refLabel"><a href="#ref258" class="rightTabRefNumLink">258</a></strong><div class="NLM_citation" id="rightTab-cit258"><span><span class="NLM_contrib-group">Geschwind, D. H.</span><span> </span><span class="NLM_article-title">Autism: many genes, common pathways?</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">395</span><span class="refDoi"> DOI: 10.1016/j.cell.2008.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref258/cit258&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1016%2Fj.cell.2008.10.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2008&pages=391-395&author=D.+H.+Geschwind&title=Autism%3A+many+genes%2C+common+pathways%3F&doi=10.1016%2Fj.cell.2008.10.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit258&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2008.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2008.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwind%26aufirst%3DD.%2BH.%26atitle%3DAutism%253A%2520many%2520genes%252C%2520common%2520pathways%253F%26jtitle%3DCell%26date%3D2008%26volume%3D135%26spage%3D391%26epage%3D395%26doi%3D10.1016%2Fj.cell.2008.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref259"><div class="reference"><strong class="refLabel"><a href="#ref259" class="rightTabRefNumLink">259</a></strong><div class="NLM_citation" id="rightTab-cit259"><span><span class="NLM_contrib-group">Lim, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaang, B. K.</span><span> </span><span class="NLM_article-title">Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients</span> <span class="citation_source-journal">Mol. Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="refDoi"> DOI: 10.1186/s13041-015-0146-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1186%2Fs13041-015-0146-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=26419846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref259/cit259&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1yqsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=57&author=C.+S.+Limauthor=J.+E.+Yangauthor=Y.+K.+Leeauthor=K.+Leeauthor=J.+A.+Leeauthor=B.+K.+Kaang&title=Understanding+the+molecular+basis+of+autism+in+a+dish+using+hiPSCs-derived+neurons+from+ASD+patients&doi=10.1186%2Fs13041-015-0146-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit259R"><div class="casContent"><span class="casTitleNuber">259</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients</span></div><div class="casAuthors">Lim, Chae-Seok; Yang, Jung-eun; Lee, You-Kyung; Lee, Kyungmin; Lee, Jin-A.; Kaang, Bong-Kiun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57/1-57/17</span>CODEN:
                <span class="NLM_cas:coden">MBORAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-6606</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder characterized by deficits in social cognition, language development, and repetitive/restricted behaviors.  Due to the complexity and heterogeneity of ASD and lack of a proper human cellular model system, the pathophysiol. mechanism of ASD during the developmental process is largely unknown.  However, recent progress in induced pluripotent stem cell (iPSC) technol. as well as in vitro neural differentiation techniques have allowed us to functionally characterize neurons and analyze cortical development during neural differentiation.  These tech. advances will increase our understanding of the pathogenic mechanisms of heterogeneous ASD and help identify mol. biomarkers for patient stratification as well as personalized medicine.  In this review, we summarize our current knowledge of iPSC generation, differentiation of specific neuronal subtypes from iPSCs, and phenotypic characterizations of human ASD patient-derived iPSC models.  Finally, we discuss the current limitations of iPSC technol. and future directions of ASD pathophysiol. studies using iPSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW56H-bUqsA7Vg90H21EOLACvtfcHk0lj9jo2LbrVCKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1yqsr8%253D&md5=f1816ab17d0e23550b41799b8c7e0f5d</span></div><a href="/servlet/linkout?suffix=cit259&amp;dbid=16384&amp;doi=10.1186%2Fs13041-015-0146-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13041-015-0146-6%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DYang%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DY.%2BK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DKaang%26aufirst%3DB.%2BK.%26atitle%3DUnderstanding%2520the%2520molecular%2520basis%2520of%2520autism%2520in%2520a%2520dish%2520using%2520hiPSCs-derived%2520neurons%2520from%2520ASD%2520patients%26jtitle%3DMol.%2520Brain%26date%3D2015%26volume%3D8%26spage%3D57%26doi%3D10.1186%2Fs13041-015-0146-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref260"><div class="reference"><strong class="refLabel"><a href="#ref260" class="rightTabRefNumLink">260</a></strong><div class="NLM_citation" id="rightTab-cit260"><span><span class="NLM_contrib-group">Nargund, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strack, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, T. M.</span><span> </span><span class="NLM_article-title">Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4035</span><span class="NLM_x">–</span> <span class="NLM_lpage">4043</span><span class="refDoi"> DOI: 10.1021/jm058241a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm058241a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4035-4043&author=R.+P.+Nargundauthor=A.+M.+Strackauthor=T.+M.+Fong&title=Melanocortin-4+receptor+%28MC4R%29+agonists+for+the+treatment+of+obesity&doi=10.1021%2Fjm058241a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit260&amp;dbid=16384&amp;doi=10.1021%2Fjm058241a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058241a%26sid%3Dliteratum%253Aachs%26aulast%3DNargund%26aufirst%3DR.%2BP.%26aulast%3DStrack%26aufirst%3DA.%2BM.%26aulast%3DFong%26aufirst%3DT.%2BM.%26atitle%3DMelanocortin-4%2520receptor%2520%2528MC4R%2529%2520agonists%2520for%2520the%2520treatment%2520of%2520obesity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4035%26epage%3D4043%26doi%3D10.1021%2Fjm058241a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref261"><div class="reference"><strong class="refLabel"><a href="#ref261" class="rightTabRefNumLink">261</a></strong><div class="NLM_citation" id="rightTab-cit261"><span><span class="NLM_contrib-group">King, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabbani, N.</span><span> </span><span class="NLM_article-title">Alpha 7 nicotinic receptor coupling to heterotrimeric G proteins modulates RhoA activation, cytoskeletal motility, and structural growth</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">532</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span><span class="refDoi"> DOI: 10.1111/jnc.13660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.1111%2Fjnc.13660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27167578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref261/cit261&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsVyjtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2016&pages=532-545&author=J.+R.+Kingauthor=N.+Kabbani&title=Alpha+7+nicotinic+receptor+coupling+to+heterotrimeric+G+proteins+modulates+RhoA+activation%2C+cytoskeletal+motility%2C+and+structural+growth&doi=10.1111%2Fjnc.13660"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit261R"><div class="casContent"><span class="casTitleNuber">261</span><div class="casTitle"><span class="NLM_cas:atitle">Alpha 7 nicotinic receptor coupling to heterotrimeric G proteins modulates RhoA activation, cytoskeletal motility, and structural growth</span></div><div class="casAuthors">King, Justin R.; Kabbani, Nadine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">532-545</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Nicotinic acetylcholine receptors (nAChRs) modulate the growth and structure of neurons throughout the nervous system.  Ligand stimulation of the α7 nAChR has been shown to regulate the large heterotrimeric GTP-binding protein (G protein) signaling in various types of cells.  Here, we demonstrate a role for α7 nAChR/G protein interaction in the activation of the small (monomeric) RhoA GTPase leading to cytoskeletal changes during neurite growth.  Treatment of PC12 cells with the α7 nAChR agonist choline or PNU-282987 was assocd. with an increase in RhoA activity and an inhibition in neurite growth.  Specifically, choline treatment was found to attenuate the velocity of microtubule growth at the growth cone and decrease the rate of actin polymn. throughout the cell.  The effects of α7 nAChR activation were abolished by expression of a dominant neg. α7 nAChR (α7345-348A) deficient in G protein coupling.  Proteomic anal. of immunopptd. α7 nAChR complexes from differentiating PC12 cells and synaptic fractions of the developing mouse hippocampus revealed the existence of Rho GTPase-regulating guanine nucleotide exchange factors within α7 nAChR interactomes.  These findings underscore the role of α7 nAChR/G protein in cytoskeletal regulation during neurite growth.  This image depicts the hypothesized interaction of the traditionally ionotropic α7 nicotinic acetylcholine receptor (α7 nAChR) and its ability to interact and signal through both large and small G proteins, leading to the regulation of cytoskeletal growth.  Using differentiated PC12 cells, and the specific agonist choline, it was shown that α7 nAChR/G protein interactions mediate both short- and long-term neurite growth dynamics through increased RhoA activation.  Activation of RhoA was shown to decrease actin polymn., and lead to an overall decrease in neurite growth via regulation of the microtubule network.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri7JwZpevyVbVg90H21EOLACvtfcHk0lj9jo2LbrVCKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsVyjtL4%253D&md5=c5ba0e25ca364e425c1f905ec5c27136</span></div><a href="/servlet/linkout?suffix=cit261&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13660%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DJ.%2BR.%26aulast%3DKabbani%26aufirst%3DN.%26atitle%3DAlpha%25207%2520nicotinic%2520receptor%2520coupling%2520to%2520heterotrimeric%2520G%2520proteins%2520modulates%2520RhoA%2520activation%252C%2520cytoskeletal%2520motility%252C%2520and%2520structural%2520growth%26jtitle%3DJ.%2520Neurochem.%26date%3D2016%26volume%3D138%26spage%3D532%26epage%3D545%26doi%3D10.1111%2Fjnc.13660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref262"><div class="reference"><strong class="refLabel"><a href="#ref262" class="rightTabRefNumLink">262</a></strong><div class="NLM_citation" id="rightTab-cit262"><span><span class="NLM_contrib-group">Loth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span> </span><span class="NLM_article-title">Defining precision medicine approaches to autism spectrum disorders: concepts and challenges</span> <span class="citation_source-journal">Front. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="refDoi"> DOI: 10.3389/fpsyt.2016.00188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=10.3389%2Ffpsyt.2016.00188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=27965598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref262/cit262&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;key=1%3ACAS%3A280%3ADC%252BC1c%252FjvVGqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=188&author=E.+Lothauthor=D.+G.+Murphyauthor=W.+Spooren&title=Defining+precision+medicine+approaches+to+autism+spectrum+disorders%3A+concepts+and+challenges&doi=10.3389%2Ffpsyt.2016.00188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit262R"><div class="casContent"><span class="casTitleNuber">262</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Precision Medicine Approaches to Autism Spectrum Disorders: Concepts and Challenges</span></div><div class="casAuthors">Loth Eva; Murphy Declan G; Spooren Will</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">188</span>
        ISSN:<span class="NLM_cas:issn">1664-0640</span>.
    </div><div class="casAbstract">The tremendous clinical and etiological variability between individuals with autism spectrum disorder (ASD) has made precision medicine the most promising treatment approach.  It aims to combine new pathophysiologically based treatments with objective tests (stratification biomarkers) to predict which treatment may be beneficial for a particular person.  Here we discuss significant advances and current challenges for this approach: rare monogenic forms of ASD have provided a major breakthrough for the identification of treatment targets by providing a means to trace causal links from a gene to specific molecular alterations and biological pathways.  To estimate whether treatment targets thus identified may be useful for larger patient groups we need a better understanding of whether different etiologies (i.e., genetic and environmental risk factors acting at different critical time points) lead to convergent or divergent molecular mechanisms, and how they map onto differences in circuit-level brain and cognitive development, and behavioral symptom profiles.  Several recently failed clinical trials with syndromic forms of ASD provide valuable insights into conceptual and methodological issues linked to limitations in the translatability from animal models to humans, placebo effects, and a need for mechanistically plausible, objective outcome measures.  To identify stratification biomarkers that enrich participant selection in clinical trials, large-scale multi-modal longitudinal observational studies are underway.  Addressing these different factors in the next generation of research studies requires a translatable developmental perspective and multidisciplinary, collaborative efforts, with a commitment to sharing protocols and data, to increase transparency and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0sPuNApGhP0EksK8CslK8fW6udTcc2eZJIWKxISO0zLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c%252FjvVGqtg%253D%253D&md5=febaa73b23ecc415d6c121a402c6ed51</span></div><a href="/servlet/linkout?suffix=cit262&amp;dbid=16384&amp;doi=10.3389%2Ffpsyt.2016.00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffpsyt.2016.00188%26sid%3Dliteratum%253Aachs%26aulast%3DLoth%26aufirst%3DE.%26aulast%3DMurphy%26aufirst%3DD.%2BG.%26aulast%3DSpooren%26aufirst%3DW.%26atitle%3DDefining%2520precision%2520medicine%2520approaches%2520to%2520autism%2520spectrum%2520disorders%253A%2520concepts%2520and%2520challenges%26jtitle%3DFront.%2520Psychiatry%26date%3D2016%26volume%3D7%26spage%3D188%26doi%3D10.3389%2Ffpsyt.2016.00188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00965&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-22%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00965" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00965" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67993c7dfc49223c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
